SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Metlife Investors USA Separate Account A, et al. – ‘485BPOS’ on 4/17/15

On:  Friday, 4/17/15, at 4:08pm ET   ·   Effective:  5/1/15   ·   Accession #:  1193125-15-135754   ·   File #s:  811-03365, 333-200240

Previous ‘485BPOS’:  ‘485BPOS’ on 4/17/15   ·   Next:  ‘485BPOS’ on 7/14/15   ·   Latest:  ‘485BPOS’ on 4/12/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 4/17/15  Metlife Investors USA Sep Acct A  485BPOS     5/01/15    3:1.2M                                   RR Donnelley/FABrighthouse Separate Account A Group Flexible Payment Variable Annuity (Flexible Bonus/Retirement Companion/Smart Choice)

Post-Effective Amendment
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 485BPOS     Mli Usa Flexible Bonus Post-Effective Amendment      388   2.08M 
                          No. 1                                                  
 2: EX-99.10    Consent of Independent Registered Public               1      5K 
                          Accounting Firm (Deloitte & Touche LLP)                
 3: EX-99.13    Powers of Attorney                                    15     57K 


485BPOS   —   Mli Usa Flexible Bonus Post-Effective Amendment No. 1
Document Table of Contents

Page (sequential) | (alphabetic) Top
 
11st Page   -   Filing Submission
"Metlife Investors Usa Separate Account A
2The Contracts
4Glossary
6Summary of the Contracts
"Purchase Payments
"Separate Account
7Distribution Expense Charge
"Mortality and Expense Risk Charge
"Transaction Fees
8Free Look Period
"Variable Annuity Payments
9MetLife USA
"Restrictions on Transfers
10Fee Tables and Examples
11Fund Expenses
14Financial and Performance Information
15Description of Metlife Insurance Company Usa, the General Account, the Separate Account, the Funds and Service Providers
"The Insurance Company
"The General Account
17The Funds
18Certain Payments We Receive with Regard to the Funds
20Principal Underwriter
21Servicing Agent
22Contract Charges
"Premium and Other Taxes
"Surrender Charge
24Administrative Fees
26Income Taxes
"Deferred Compensation Plans
27Description of the Contracts
"General
"Assignment
28Transfers
33Cybersecurity
34Modification of the Contracts
35Crediting Accumulation Units in the Separate Account
"Separate Account Accumulation Unit Current Values
"Surrender from the Separate Account
36Payment of Surrender Amount
"Account Statements
37Assumed Investment Return
"Election of Annuity Date and Form of Annuity
38Election of Annuity Date
"Form of Annuity
40Frequency of Payment
"Level Payments Varying Annually
41Annuity Unit Values
"Death Before the Annuity Date
42Death After the Annuity Date
43Abandoned Property Requirements
44Federal Tax Considerations
"Qualified Annuity Contracts
48Death Benefits
53Voting Rights
55Table of Contents of Statement of Additional Information
57Appendix A
79Appendix B
82Appendix C
83Appendix D
86Company
"Surrender Charges
"Net Investment Factor
"Annuity Payments
"Basis of Variable Benefits
"Determination of Amount of Monthly Variable Annuity Payments for First Year
87Determination of Amount of Monthly Variable Annuity Payments for Second and Subsequent Years
"Annuity Unit Value
88Calculation of Performance
89Safekeeping of Securities
"Independent Registered Public Accounting Firm
90Additional Federal Tax Considerations
"Erisa
91Federal Estate Taxes
"Generation-Skipping Transfer Tax
"Annuity Purchase Payments by Nonresident Aliens and Foreign Corporations
"Financial Statements
92Report of Independent Registered Public Accounting Firm
94American Funds
99Lmpvet
107Mist
127Invesco V.I
155FTVIPT Franklin Income VIP Sub-Account
157Invesco V.I. Equity and Income Sub-Account
165MIST ClearBridge Aggressive Growth Sub-Account
167MIST JPMorgan Core Bond Sub-Account
169MIST Met/Templeton International Bond Sub-Account
171MIST Morgan Stanley Mid Cap Growth Sub-Account
175MIST WMC Large Cap Research Sub-Account
177Msf
"MSF Frontier Mid Cap Growth Sub-Account
179MSF MetLife Asset Allocation 40 Sub-Account
181MSF MSCI EAFE Index Sub-Account
185Oppenheimer Va
"Oppenheimer VA Money Sub-Account
187Pimco Vit
189Van Eck Vip
201BlackRock
203LMPVET ClearBridge Variable Large Cap Value Sub-Account
"LMPVIT Western Asset Variable Global High Yield Bond Sub-Account
205MIST American Funds Balanced Allocation Sub-Account
209MSF BlackRock Large Cap Value Sub-Account
211MSF WMC Core Equity Opportunities Sub-Account
"T. Rowe Price International Stock Sub-Account
230Item 8. Financial Statements and Supplementary Data
232Consolidated Balance Sheets
233Consolidated Statements of Operations
234Consolidated Statements of Comprehensive Income (Loss)
235Consolidated Statements of Stockholder's Equity
236Consolidated Statements of Cash Flows
238Notes to the Consolidated Financial Statements
2391. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)
"Separate Accounts
240Insurance
242Deferred Policy Acquisition Costs, Value of Business Acquired and Other Intangibles
243Reinsurance
244Investments
245Mortgage Loans
"Policy Loans
246Short-term investments
247Other Invested Assets
"Derivatives
250Fair Value
"Goodwill
251Income Tax
253Adoption of New Accounting Pronouncements
256Retail
"Corporate Benefit Funding
"Corporate & Other
274Dac
275Dsi
286Evaluation of AFS Securities for OTTI and Evaluating Temporarily Impaired AFS Securities
294Net Unrealized Investment Gains (Losses)
296Securities Lending
298Variable Interest Entities
299CSEs
301Net investment income
304Related Party Investment Transactions
305Interest rate derivatives
307Credit Derivatives
"Equity derivatives
310Net derivative gains (losses)
321Recurring Fair Value Measurements
324Securities, Short-term Investments and Long-term Debt of CSEs -- FVO
327Freestanding Derivatives Valuation Techniques and Key Inputs
"Level 3
330Direct and assumed guaranteed minimum benefits
341Nonrecurring Fair Value Measurements
345PABs
348Balance at December 31, 2012
361Insolvency assessments
364Schedule I
365Schedule III
367Schedule IV
370Item 24. Financial Statements and Exhibits
372Item 25. Directors and Officers of the Depositor
374Item 26. Persons Controlled by or Under Common Control With the Depositor or the Registrant
381Item 27. Number of Contract Owners
"Item 28. Indemnification
384Item 30. Location of Accounts and Records
"Item 31. Management Services
"Item 32. Undertakings
485BPOS1st Page of 388TOCTopPreviousNextBottomJust 1st
 

As filed with the Securities and Exchange Commission on April 17, 2015 REGISTRATION NOS. 333-200240 811-03365 ================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM N-4 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 PRE-EFFECTIVE AMENDMENT NO. [ ] POST-EFFECTIVE AMENDMENT NO. 1 [X] AND REGISTRATION STATEMENT UNDER THE INVESTMENT COMPANY ACT OF 1940 AMENDMENT NO. 591 [X] METLIFE INVESTORS USA SEPARATE ACCOUNT A (EXACT NAME OF REGISTRANT) METLIFE INSURANCE COMPANY USA (NAME OF DEPOSITOR) 11225 NORTH COMMUNITY HOUSE ROAD CHARLOTTE, NC 28277 (212) 578-9500 (ADDRESS OF DEPOSITOR'S PRINCIPAL EXECUTIVE OFFICES) (DEPOSITOR'S TELEPHONE NUMBER, INCLUDING AREA CODE) ERIC T. STEIGERWALT PRESIDENT 11225 NORTH COMMUNITY HOUSE ROAD CHARLOTTE, NC 28277 (NAME AND ADDRESS OF AGENT FOR SERVICE) COPIES TO: W. THOMAS CONNER REED SMITH LLP 1301 K STREET, N.W. WASHINGTON, D.C. 20005-3373 APPROXIMATE DATE OF PROPOSED PUBLIC OFFERING: on May 1, 2015 or as soon thereafter as practicable. It is proposed that this filing will become effective (check appropriate box): [_] immediately upon filing pursuant to paragraph (b) of Rule 485. [X] on May 1, 2015 pursuant to paragraph (b) of Rule 485. [_] 60 days after filing pursuant to paragraph (a) (1) of Rule 485. [_] on (date) pursuant to paragraph (a) (1) of Rule 485. If appropriate, check the following box: [_] this post-effective amendment designates a new effective date for a previously filed post-effective amendment. Title of Securities Registered: Group Flexible Payment Variable Annuity Contracts This registration statement relates to Registration Statement No. 033-37128 ================================================================================
485BPOS2nd Page of 388TOC1stPreviousNextBottomJust 2nd
GROUP FLEXIBLE PAYMENT VARIABLE ANNUITY CONTRACTS (FLEXIBLE BONUS (228), RETIREMENT COMPANION (328), SMART CHOICE) ISSUED BY METLIFE INVESTORS USA SEPARATE ACCOUNT A AND METLIFE INSURANCE COMPANY USA This Prospectus gives you important information about the group flexible payment fixed and variable annuity contracts (the "Contracts") issued by MetLife Investors USA Separate Account A (the "Separate Account") by MetLife Insurance Company USA ("MetLife USA" or "we" or "us" or "our"). Please read it carefully before you invest and keep it for future reference. The Contracts are designed to provide annuity benefits through distributions made from certain retirement plans that qualify for special Federal income tax treatment ("Qualified Plans"). The Contracts are issued to an employer or organization, which is the owner ("Owner") of the Contract. After completing an enrollment form and arranging for your Purchase Payments to begin, you are a participant ("Participant") and, except as provided below, a certificate ("Certificate") will be provided to you that gives you a summary of the Contract provisions. The Certificate also serves as evidence of your participation in the plan (Plan). Certificates are not provided to Participants under deferred compensation or qualified corporate retirement plans. THE CONTRACTS ARE NOT CURRENTLY OFFERED FOR SALE; HOWEVER, CERTIFICATES MAY BE ISSUED TO NEW PARTICIPANTS UNDER EXISTING CONTRACTS. You decide how to allocate your Purchase Payments among the funds offered as investment options under the Contracts (the "Funds"). You may allocate your Purchase Payments to the General Account, which is a fixed account (not described in this Prospectus) that offers an interest rate guaranteed by us, or to the Separate Account. The Separate Account, in turn, invests in the following underlying Funds: AMERICAN FUNDS INSURANCE SERIES(R) -- CLASS 2 American Funds Global Small Capitalization Fund American Funds Growth Fund American Funds Growth-Income Fund DEUTSCHE VARIABLE SERIES I -- CLASS A Deutsche CROCI(R) International VIP FIDELITY(R) VARIABLE INSURANCE PRODUCTS -- INITIAL CLASS Asset Manager Portfolio Contrafund(R) Portfolio Growth Portfolio Money Market Portfolio Overseas Portfolio MET INVESTORS SERIES TRUST -- CLASS A Invesco Small Cap Growth Portfolio Lord Abbett Bond Debenture Portfolio MetLife Small Cap Value Portfolio MFS(R) Research International Portfolio Morgan Stanley Mid Cap Growth Portfolio PIMCO Total Return Portfolio T. Rowe Price Large Cap Value Portfolio METROPOLITAN SERIES FUND -- CLASS A Barclays Aggregate Bond Index Portfolio BlackRock Bond Income Portfolio BlackRock Capital Appreciation Portfolio BlackRock Large Cap Value Portfolio Met/Artisan Mid Cap Value Portfolio MetLife Mid Cap Stock Index Portfolio MetLife Stock Index Portfolio MFS(R) Total Return Portfolio MFS(R) Value Portfolio MSCI EAFE(R) Index Portfolio Neuberger Berman Genesis Portfolio Russell 2000(R) Index Portfolio T. Rowe Price Large Cap Growth Portfolio T. Rowe Price Small Cap Growth Portfolio WMC Core Equity Opportunities Portfolio T. ROWE PRICE GROWTH STOCK FUND, INC. T. Rowe Price Growth Stock Fund, Inc. THE ALGER PORTFOLIOS -- CLASS I-2 Alger Small Cap Growth Portfolio You can choose any combination of the Funds. Your Participant's Account will vary daily to reflect the investment experience of the Funds selected. These Funds are described in detail in the Fund prospectuses. Please read these prospectuses carefully before you invest. The Contracts: .. are not bank deposits .. are not FDIC insured .. are not insured by any federal government agency .. are not guaranteed by any bank or credit union .. may be subject to loss of principal If you would like more information about the Contracts, you can obtain a copy of the Statement of Additional Information ("SAI") dated May 1, 2015. The SAI is legally considered a part of this Prospectus as though it were included in the Prospectus. The Table of Contents of the SAI appears on page 53 of the Prospectus. The Securities and Exchange Commission ("SEC") has a website (http://www.sec.gov) which you may visit to view this Prospectus, the SAI, or additional material that also is legally considered a part of this Prospectus, as well as other information. THE SEC HAS NOT APPROVED OR DISAPPROVED THESE SECURITIES NOR DETERMINED IF THIS PROSPECTUS IS TRUTHFUL OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE. May 1, 2015 1
485BPOS3rd Page of 388TOC1stPreviousNextBottomJust 3rd
[Download Table] TABLE OF CONTENTS PAGE [Download Table] GLOSSARY................................................................... 3 SUMMARY OF THE CONTRACTS................................................... 5 FEE TABLES AND EXAMPLES.................................................... 9 [Download Table] FINANCIAL AND PERFORMANCE INFORMATION...................................... 13 DESCRIPTION OF METLIFE INSURANCE COMPANY USA, THE GENERAL ACCOUNT, THE SEPARATE ACCOUNT, THE FUNDS AND SERVICE PROVIDERS.......................... 14 The Insurance Company................................................... 14 The General Account..................................................... 14 The Separate Account.................................................... 15 The Funds............................................................... 16 Principal Underwriter................................................... 19 Servicing Agent......................................................... 20 CONTRACT CHARGES........................................................... 21 Premium and Other Taxes................................................. 21 Surrender Charge........................................................ 21 Administrative Fees..................................................... 23 Transaction Fees........................................................ 23 Mortality and Expense Risk Charge....................................... 24 Distribution Expense Charge............................................. 24 Income Taxes............................................................ 25 Fund Expenses........................................................... 25 Free Look Period........................................................ 25 Deferred Compensation Plans............................................. 25 DESCRIPTION OF THE CONTRACTS............................................... 26 General................................................................. 26 Assignment.............................................................. 26 Purchase Payments....................................................... 26 Transfers............................................................... 27 Restrictions on Transfers............................................... 29 Loans (403(b) Plans only)............................................... 32 Cybersecurity........................................................... 32 Modification of the Contracts........................................... 33 ACCUMULATION PERIOD........................................................ 34 Crediting Accumulation Units in the Separate Account.................... 34 [Download Table] Separate Account Accumulation Unit Current Values...................... 34 Surrender from the Separate Account.................................... 34 Payment of Surrender Amount............................................ 35 Account Statements..................................................... 35 ANNUITY BENEFITS.......................................................... 36 Variable Annuity Payments.............................................. 36 Assumed Investment Return.............................................. 36 Election of Annuity Date and Form of Annuity........................... 36 Election of Annuity Date............................................... 37 Form of Annuity........................................................ 37 Frequency of Payment................................................... 39 Level Payments Varying Annually........................................ 39 Annuity Unit Values.................................................... 40 DEATH BENEFITS............................................................ 40 Death Before the Annuity Date.......................................... 40 Death After the Annuity Date........................................... 41 Abandoned Property Requirements........................................ 42 FEDERAL TAX CONSIDERATIONS................................................ 43 VOTING RIGHTS............................................................. 52 LEGAL PROCEEDINGS......................................................... 53 ADDITIONAL INFORMATION.................................................... 53 TABLE OF CONTENTS OF STATEMENT OF ADDITIONAL INFORMATION.................. 54 [Download Table] APPENDIX A -- CONDENSED FINANCIAL INFORMATION -- PART 1................... A-1 APPENDIX A -- CONDENSED FINANCIAL INFORMATION -- PART 2................... A-12 APPENDIX B -- PARTICIPATING INVESTMENT PORTFOLIOS......................... B-1 APPENDIX C -- ADDITIONAL INFORMATION REGARDING THE PORTFOLIOS............. C-1 APPENDIX D -- PREMIUM TAX TABLE........................................... D-1 MetLife USA does not intend to offer the Contracts anywhere or to anyone to whom they may not lawfully be offered or sold. MetLife USA has not authorized any information or representations about the Contracts other than the information in this Prospectus, the Fund prospectuses, or supplements to the prospectuses or any supplemental sales material MetLife USA authorizes. 2
485BPOS4th Page of 388TOC1stPreviousNextBottomJust 4th
GLOSSARY These terms have the following meanings when used in this Prospectus: ACCUMULATION UNIT - A measuring unit used to determine the value of your interest in a Series of the Separate Account under a Contract at any time before Annuity payments commence. ANNUITANT - The person on whose life Annuity payments under a Contract are based. ANNUITY - A stream of income payments made to an Annuitant for a defined period of time. ANNUITIZATION OR ANNUITY DATE - The date on which Annuity payments begin. ANNUITY UNIT - A measuring unit used to determine the amount of Variable Annuity payments based on a Series of the Separate Account under a Contract after such payments have commenced. ASSUMED INVESTMENT RETURN - The investment rate selected by the Annuitant for use in determining the Variable Annuity payments. BENEFICIARY - The person who has the right to a Death Benefit upon your death. BUSINESS DAY - Each Monday through Friday except for days the New York Stock Exchange is not open for trading. CERTIFICATE - The form you are given which describes your rights under the Contract. No Certificates are issued for certain deferred compensation or qualified corporate retirement plans. CERTIFICATE DATE - The date you are issued a Certificate. If you are not issued a Certificate, this is the date when your Account is established. CERTIFICATE YEAR - The 12 month period that begins on your Certificate Date and on each anniversary of this date. CONTRACT - The agreement between the Owner and MetLife USA covering your rights. FIXED ANNUITY - An Annuity providing guaranteed level payments. These payments are not based upon the investment experience of the Separate Account. FREE LOOK PERIOD - The 20-day period when you first receive your Certificate. During this time period, you may cancel your interest in the Contract for a full refund of all Purchase Payments (or the greater of Purchase Payments or your Participant's Account in some states). FUND - A diversified, open-end management investment company, or series thereof, registered under the Investment Company Act of 1940 ("1940 Act") which serves as the underlying investment medium for a Series in the Separate Account. GENERAL ACCOUNT - All assets of MetLife USA other than those in the Separate Account or any of its other segregated asset accounts. GOOD ORDER - A request or transaction generally is considered in Good Order if it complies with our administrative procedures and the required information is complete and accurate. A request or transaction may be rejected or delayed if not in Good Order. Good Order generally means the actual receipt by us of the instructions relating to the requested transaction in writing (or, when permitted, by telephone or Internet) along with all forms, information and supporting legal documentation necessary to effect the transaction. This information and documentation generally includes to the extent applicable to the transaction: your completed application; your contract number; the transaction amount (in dollars or percentage terms); the names and allocations to and/or from the Investment Portfolios affected by the requested transaction; the signatures of all contract Owners (exactly as indicated on the contract), if necessary; Social Security Number or Tax I.D.; and any other information or supporting documentation that we may require, including any spousal or Joint Owner's consents. With respect to Purchase Payments, Good Order also generally includes receipt by us of sufficient funds to effect the purchase. We may, in our sole discretion, determine whether any particular transaction request is in Good Order, and we reserve the right to change or waive any Good Order requirement at any time. If you have any questions, you should contact us or your registered representative before submitting the form or request. NORMAL ANNUITY DATE - The date on which Annuity payments begin if you do not select another date. OWNER - The person who has title to the Contract. PARTICIPANT - You, the person who makes Purchase Payments, or the person for whom Purchase Payments are made. PARTICIPANT'S ACCOUNT - The sum of your interest in each Series of the Separate Account and your interest in the General Account. Your interest in the Series of the Separate Account is the sum of the values of the Accumulation Units. Your interest in the General Account is the 3
485BPOS5th Page of 388TOC1stPreviousNextBottomJust 5th
accumulated value of the amounts allocated to the General Account plus credited interest as guaranteed in the Contract, less any prior withdrawals and/or amounts applied to Annuity options. PLAN - The 403(b) plan, deferred compensation plan, qualified retirement plan, or individual retirement annuity to which the Contract is issued. PURCHASE PAYMENT - The amounts paid by or for you to MetLife USA in order to provide benefits under the Contract. SEPARATE ACCOUNT - The segregated asset account entitled "MetLife Investors USA Separate Account A" which has been established by us under Delaware law to receive and invest amounts allocated by you and other Participants under the Contracts and to provide Variable Annuity benefits under the Contracts. The Separate Account is registered as a unit investment trust under the 1940 Act. SERIES - Series are subdivisions of the Separate Account. Accumulation Unit values and Annuity Unit values are maintained separately for each Series corresponding to a designated Fund. SURRENDER CHARGE - A percentage charge which is deducted when you fully or partially surrender. The amount varies depending on how long Purchase Payments have been with MetLife USA. VALUATION DATE - Any Business Day used by the Separate Account to determine the value of part or all of its assets for purposes of determining Accumulation and Annuity Unit values for the Contract. Accumulation Unit values will be determined each Business Day as of the close of trading on the New York Stock Exchange (currently 4 p.m. Eastern time.) There will be one Valuation Date in each calendar week for Annuity Unit values. MetLife USA will establish the Valuation Date at its discretion, but until notice to the contrary is given, that date will be the last Business Day in a week. VALUATION PERIOD - The period of time from one Valuation Date through the next Valuation Date. VARIABLE ANNUITY - An Annuity providing payments that will vary annually in accordance with the net investment experience of the applicable Series of the Separate Account. 4
485BPOS6th Page of 388TOC1stPreviousNextBottomJust 6th
SUMMARY OF THE CONTRACTS THE CONTRACTS The Contracts may be offered to: .. Qualified Plans such as: * Section 403(b) tax-sheltered annuities; * Section 457 deferred compensation plans; * Section 401 pension and profit sharing plans; and * individual retirement annuities under Section 408 of the Internal Revenue Code. [SIDE BAR: Please see the section "Federal Tax Considerations" for more information.] Note: The dollars in a Qualified Plan are tax deferred. Contracts purchased for use with a Qualified Plan provide no additional tax deferral, and there should be reasons other than tax deferral for purchasing the Contract. This Prospectus describes all the material features of the Contracts. THIS PROSPECTUS APPLIES ONLY TO THE VARIABLE PORTION OF THE CONTRACT PURCHASE PAYMENTS Purchase Payments under the Contracts are made to the General Account, the Separate Account, or allocated between them. The minimum Purchase Payment is as little as $20, but there is an annual minimum of $240 (for IRAs, the minimum is $2,000 for an initial Purchase Payment and $50 for each additional payment). There is no initial sales charge; however, the charges and deductions described under "Contract Charges" will be deducted from the Participant's Account. [SIDE BAR: Please see "Transfers" for more information.] Amounts allocated to the General Account may be transferred to the Separate Account subject to certain limitations as to time and amount. Unless you have exercised a special option, the minimum transfer is the lesser of $500 or the balance of your Participant's Account allocated to the General Account or to the Separate Account. You can transfer amounts allocated to the Separate Account: .. between any of the Series, at any time and as many times as you choose .. to the General Account at any time before the amount has been applied to a Variable Annuity option See, however, restrictions on transfers in "Description of the Contracts - Restrictions on Transfers." [SIDE BAR: Please see "The Separate Account" and "The Funds" for more information.] SEPARATE ACCOUNT Purchase Payments allocated to the Separate Account are invested at net asset value in Accumulation Units in one or more Series of the Separate Account, each of which invests in one of the underlying Funds. 5
485BPOS7th Page of 388TOC1stPreviousNextBottomJust 7th
[SIDE BAR: Please see "Contract Charges" for more information.] CHARGES AND DEDUCTIONS The following fees and expenses apply under the Contracts: DISTRIBUTION EXPENSE CHARGE MetLife USA assumes the risk that surrender charges will be insufficient to cover the actual costs of distribution. As compensation for assuming this risk, MetLife USA will make a deduction of .000274% on a daily basis (0.10% per year) from the value of the Separate Account assets funding the Contract. The distribution expense charge (sales load), together with any contingent deferred sales charge will never exceed 9% of Purchase Payments. MORTALITY AND EXPENSE RISK CHARGE MetLife USA charges a fee for bearing certain mortality and expense risks under the Contract. You pay the mortality and expense risk charge during the accumulation phase and the income phase. As compensation for assuming these risks, MetLife USA will make a daily deduction from the value of the Separate Account's assets equal to 1.25% per year. ADMINISTRATIVE FEE There is an administrative Fee of $21.50 plus $2.50 for each Series in which you invest. MetLife USA currently waives these administrative fees for any Certificate Year during which you contribute $2,000 or more to your Participant's Account or your Participant's Account has a value at the end of the Certificate Year of $10,000 or more. This reduction is permanent for Certificates issued before the termination or reduction of the waiver. (No such termination or reduction of the waiver is contemplated at this time). TRANSACTION FEES A charge of $10 may be deducted for: .. A transfer from any Series; .. A full or partial surrender (the charge is the lesser of $10 or 2% of the amount of the surrender); or .. Annuitization of all or a part of your Participant's Account. We currently waive the transaction charge for transfers from any Series, but reserve the right to impose the charge in the future. See, however, restrictions on transfers in "Description of the Contracts - Restrictions on Transfers." SURRENDER CHARGE (CONTINGENT DEFERRED SALES CHARGE) A surrender charge is deducted if you request a full or partial surrender of Purchase Payments from the Separate Account within 60 months after the Purchase Payment is made. The charge is 7% of the Purchase Payment and amounts credited to it. 6
485BPOS8th Page of 388TOC1stPreviousNextBottomJust 8th
However, for 403(b) plans, we will not deduct any surrender charge once nine (9) full years have elapsed since your Certificate Date; and for the first surrender in each year, you may surrender up to 10% of the value of your interest in the Separate Account without a surrender charge. WITHDRAWALS FROM 403(b) PLANS MAY BE RESTRICTED BY THE INTERNAL REVENUE CODE. The following expenses may be waived for certain deferred compensation plans: .. administrative fees .. transaction charges .. distribution fees .. surrender charges on certain surrenders PREMIUM TAXES State premium taxes (ranging from 0% to 3.5%, which are applicable only in certain jurisdictions), are payable to a state or government agency with respect to the Contract. They may be deducted on or after the date the tax is incurred. Currently, MetLife USA deducts these taxes upon annuitization. [SIDE BAR: Please see "Free Look Period" for more information.] FREE LOOK PERIOD You may cancel your interest in the Contract within 20 days after you receive your Certificate (or longer depending on state law) for a full refund of all Purchase Payments (or the greater of Purchase Payments or the Participant's Account in some states). Purchase Payments allocated to the Separate Account will be initially allocated to the Money Market Series during the Free Look Period. VARIABLE ANNUITY PAYMENTS You select the Annuity Date, an Annuity payment option and an assumed investment return. You may change any of your selections before your Annuity Date. Your monthly Annuity payments will start on the Annuity Date and will vary from year to year based on a comparison of the assumed investment returns you selected with the actual investment experience of the Series in which the Participant's Account is invested. If your monthly payments from a particular Series are less than $50, MetLife USA may change the frequency of your payments so that each payment will be at least $50 from that Series. [SIDE BAR: Please see "Surrender Charge" and "Federal Tax Considerations" for more information.] SURRENDER You may surrender all or part of your Participant's Account before the Annuity Date. You may not make a partial surrender if: .. it would cause your interest in any Series or the General Account to fall below $200 (unless you are surrendering your entire interest in a Series) 7
485BPOS9th Page of 388TOC1stPreviousNextBottomJust 9th
However, if you are surrendering the entire amount allocated to a Series; these restrictions do not apply. You may be assessed a surrender charge. In addition, any amounts surrendered will be taxed as ordinary income and may be subject to a penalty tax under the Internal Revenue Code. Certain restrictions apply for qualified contracts. LOANS - 403(B) PLANS ONLY You may be able to obtain a loan from the portion of your Participant's Account allocated to the General Account. Fees may be charged for loan set-up and administration. Currently, the loan set-up fee is $50. This amount is deducted from the loan proceeds. At this time, there is no fee for administration. Loan proceeds may be considered taxable distributions under the Internal Revenue Code in the event of a default in repayments. MetLife USA: .. may terminate loans .. change the terms under which loans are made Any action taken by MetLife USA would not affect outstanding loans. [SIDE BAR: Please see "Death Benefits" for more information.] DEATH BENEFIT You name your Beneficiary(ies). If you die before attaining age 65 and prior to the Annuity Date, the amount of any lump sum settlement will be the greater of: .. the total of all Purchase Payments less any partial surrenders; or .. the value of the Participant's Account at settlement. If the death occurs on or after age 65, the death benefit will be equal to the Participant's Account. STATE VARIATIONS Contracts issued in your state may provide different features and benefits from, and impose different costs than, those described in this Prospectus because of state law variations. These differences include, among other things, free look rights, age issuance limitations, transfer rights and limitations, the right to assess transfer fees, requirements for unisex annuity rates and the availability of certain features of riders. However, please note that the maximum fees and charges for all features and benefits are set forth in the fee table in this Prospectus. This Prospectus describes all the material features of the Contract. If you would like to review a copy of the Contract and any endorsements, contact our administrative office. RESTRICTIONS ON TRANSFERS MetLife USA has adopted policies and procedures that attempt to detect transfer activity that may adversely affect Participants or the Funds. Upon detection of this activity, restrictions may be imposed on transfers. 8
485BPOS10th Page of 388TOC1stPreviousNextBottomJust 10th
FEE TABLES AND EXAMPLES THE FOLLOWING TABLES DESCRIBE THE FEES AND EXPENSES THAT YOU WILL PAY WHEN BUYING, OWNING, AND SURRENDERING THE CERTIFICATE. THE FIRST TABLE DESCRIBES THE FEES AND EXPENSES THAT YOU WILL PAY AT THE TIME THAT YOU BUY THE CERTIFICATE, SURRENDER THE CERTIFICATE, OR TRANSFER CASH VALUE BETWEEN INVESTMENT OPTIONS. STATE PREMIUM TAXES (RANGING FROM 0% TO 3.5%, WHICH ARE APPLICABLE ONLY IN CERTAIN JURISDICTIONS -- SEE APPENDIX D) MAY ALSO BE DEDUCTED. -------------------------------------------------------------------------------- [Enlarge/Download Table] PARTICIPANT TRANSACTION EXPENSES TABLE SURRENDER CHARGE/1/ 7% (as a percentage of amounts accumulated with respect to a Purchase Payment) TRANSACTION FEE/2,3/ (each surrender, annuitization and transfer) $10.00 LOAN SET-UP FEE/4/ $50.00 -------------------------------------------------------------------------------- THE NEXT TABLES DESCRIBE THE FEES AND EXPENSES THAT YOU WILL PAY PERIODICALLY DURING THE TIME THAT YOU OWN THE CERTIFICATE, NOT INCLUDING FUND FEES AND EXPENSES. -------------------------------------------------------------------------------- [Enlarge/Download Table] PERIODIC FEES AND EXPENSES TABLE ADMINISTRATIVE FEE/5/ $21.50 plus (deducted annually) $ 2.50 for each Series SEPARATE ACCOUNT ANNUAL EXPENSES (referred to as Separate Account Product Charges) (as a percentage of average Participant's Account value in the Separate Account) Mortality and Expense Risk Charge 1.25% Distribution Expense Charge 0.10% ----- Total Separate Account Annual Expenses/6/ 1.35% -------------------------------------------------------------------------------- THE NEXT TABLE SHOWS THE MINIMUM AND MAXIMUM TOTAL OPERATING EXPENSES CHARGED BY THE FUNDS THAT YOU MAY PAY PERIODICALLY DURING THE TIME THAT YOU OWN THE CERTIFICATE. CERTAIN FUNDS MAY IMPOSE A REDEMPTION FEE IN THE FUTURE. MORE DETAIL CONCERNING EACH FUND'S FEES AND EXPENSES IS CONTAINED IN THE PROSPECTUSES FOR THE FUNDS AND IN THE FOLLOWING TABLES. PLEASE READ THE PROSPECTUSES CAREFULLY BEFORE MAKING YOUR ALLOCATIONS TO THE INVESTMENT OPTIONS. -------------------------------------------------------------------------------- [Enlarge/Download Table] Minimum Maximum ------- ------- Total Annual Fund Operating Expenses 0.25% 1.04% (expenses that are deducted from Fund assets, including management fees, 12b-1/Service fees, and other expenses) as of December 31, 2014 -------------------------------------------------------------------------------- Notes 1. Surrender charges decline based on date of Purchase Payment. (See "Contract Charges - Surrender Charge") [Download Table] Number of Complete Months from Receipt of Purchase Payment % Charge ------------------------------ -------- 60 months or less 7 More than 60 months 0 Amounts surrendered are attributed to Purchase Payments made (and any accumulation) on a first-in, first-out basis. 2. In the event of a surrender, the fee is the lesser of $10 or 2% of the amount surrendered. 3. In the event of a transfer, the fee applies to each transfer from a Series. We currently waive this fee. 4. For 403(b) Plans only, loans will be charged an initial set-up fee of $50.00. 5. The Administrative Charge is currently waived if you make purchase payments of $2,000 or more in a Certificate Year or if your Participant's Account value is $10,000 or more at the end of the Certificate Year. 6. Total Separate Account Expenses are 1.25% under the Retirement Companion version of the Contract. 9
485BPOS11th Page of 388TOC1stPreviousNextBottomJust 11th
FUND EXPENSES (as a percentage of the average daily net assets of a Fund) The following table is a summary. For more complete information on Fund fees and expenses, please refer to the prospectus for each Fund. [Enlarge/Download Table] DISTRIBUTION NET AND/OR ACQUIRED TOTAL FEE WAIVER TOTAL SERVICE FUND ANNUAL AND/OR ANNUAL MANAGEMENT (12B-1) OTHER FEES AND OPERATING EXPENSE OPERATING FUND FEE FEES EXPENSES EXPENSES EXPENSES REIMBURSEMENT EXPENSES ----------------------------------------------------------------------------------------------------------------- AMERICAN FUNDS INSURANCE SERIES(R)--CLASS 2 ----------------------------------------------------------------------------------------------------------------- American Funds Global Small Capitalization Fund 0.70% 0.25% 0.04% -- 0.99% -- 0.99% ----------------------------------------------------------------------------------------------------------------- American Funds Growth Fund 0.33% 0.25% 0.02% -- 0.60% -- 0.60% ----------------------------------------------------------------------------------------------------------------- American Funds Growth-Income Fund 0.27% 0.25% 0.02% -- 0.54% -- 0.54% ----------------------------------------------------------------------------------------------------------------- DEUTSCHE VARIABLE SERIES I-- CLASS A ----------------------------------------------------------------------------------------------------------------- Deutsche CROCI(R) International VIP 0.79% -- 0.25% -- 1.04% 0.05% 0.99% ----------------------------------------------------------------------------------------------------------------- FIDELITY(R) VARIABLE INSURANCE PRODUCTS--INITIAL CLASS ----------------------------------------------------------------------------------------------------------------- Asset Manager Portfolio 0.50% -- 0.12% -- 0.62% -- 0.62% ----------------------------------------------------------------------------------------------------------------- Contrafund(R) Portfolio 0.55% -- 0.08% -- 0.63% -- 0.63% ----------------------------------------------------------------------------------------------------------------- Growth Portfolio 0.55% -- 0.10% -- 0.65% -- 0.65% ----------------------------------------------------------------------------------------------------------------- Money Market Portfolio 0.17% -- 0.08% -- 0.25% -- 0.25% ----------------------------------------------------------------------------------------------------------------- Overseas Portfolio 0.67% -- 0.13% -- 0.80% -- 0.80% ----------------------------------------------------------------------------------------------------------------- MET INVESTORS SERIES TRUST-- CLASS A ----------------------------------------------------------------------------------------------------------------- Invesco Small Cap Growth Portfolio 0.84% -- 0.03% -- 0.87% 0.01% 0.86% ----------------------------------------------------------------------------------------------------------------- Lord Abbett Bond Debenture Portfolio 0.51% -- 0.04% -- 0.55% 0.01% 0.54% ----------------------------------------------------------------------------------------------------------------- MetLife Small Cap Value Portfolio 0.74% -- 0.03% -- 0.77% 0.01% 0.76% ----------------------------------------------------------------------------------------------------------------- MFS(R) Research International Portfolio 0.69% -- 0.07% -- 0.76% 0.06% 0.70% ----------------------------------------------------------------------------------------------------------------- Morgan Stanley Mid Cap Growth Portfolio 0.64% -- 0.05% -- 0.69% 0.01% 0.68% ----------------------------------------------------------------------------------------------------------------- PIMCO Total Return Portfolio 0.48% -- 0.03% -- 0.51% 0.04% 0.47% ----------------------------------------------------------------------------------------------------------------- T. Rowe Price Large Cap Value Portfolio 0.57% -- 0.02% -- 0.59% -- 0.59% ----------------------------------------------------------------------------------------------------------------- 10
485BPOS12th Page of 388TOC1stPreviousNextBottomJust 12th
[Enlarge/Download Table] DISTRIBUTION NET AND/OR ACQUIRED TOTAL FEE WAIVER TOTAL SERVICE FUND ANNUAL AND/OR ANNUAL MANAGEMENT (12B-1) OTHER FEES AND OPERATING EXPENSE OPERATING FUND FEE FEES EXPENSES EXPENSES EXPENSES REIMBURSEMENT EXPENSES ----------------------------------------------------------------------------------------------------------------- METROPOLITAN SERIES FUND-- CLASS A ----------------------------------------------------------------------------------------------------------------- Barclays Aggregate Bond Index Portfolio 0.25% -- 0.03% -- 0.28% 0.00% 0.28% ----------------------------------------------------------------------------------------------------------------- BlackRock Bond Income Portfolio 0.32% -- 0.03% -- 0.35% 0.00% 0.35% ----------------------------------------------------------------------------------------------------------------- BlackRock Capital Appreciation Portfolio 0.69% -- 0.02% -- 0.71% 0.06% 0.65% ----------------------------------------------------------------------------------------------------------------- BlackRock Large Cap Value Portfolio 0.63% -- 0.02% -- 0.65% 0.03% 0.62% ----------------------------------------------------------------------------------------------------------------- Met/Artisan Mid Cap Value Portfolio 0.81% -- 0.03% -- 0.84% -- 0.84% ----------------------------------------------------------------------------------------------------------------- MetLife Mid Cap Stock Index Portfolio 0.25% -- 0.05% 0.01% 0.31% 0.00% 0.31% ----------------------------------------------------------------------------------------------------------------- MetLife Stock Index Portfolio 0.25% -- 0.02% -- 0.27% 0.01% 0.26% ----------------------------------------------------------------------------------------------------------------- MFS(R) Total Return Portfolio 0.55% -- 0.05% -- 0.60% -- 0.60% ----------------------------------------------------------------------------------------------------------------- MFS(R) Value Portfolio 0.70% -- 0.02% -- 0.72% 0.14% 0.58% ----------------------------------------------------------------------------------------------------------------- MSCI EAFE(R) Index Portfolio 0.30% -- 0.10% 0.01% 0.41% 0.00% 0.41% ----------------------------------------------------------------------------------------------------------------- Neuberger Berman Genesis Portfolio 0.80% -- 0.03% -- 0.83% 0.00% 0.83% ----------------------------------------------------------------------------------------------------------------- Russell 2000(R) Index Portfolio 0.25% -- 0.07% 0.05% 0.37% 0.01% 0.36% ----------------------------------------------------------------------------------------------------------------- T. Rowe Price Large Cap Growth Portfolio 0.60% -- 0.03% -- 0.63% 0.02% 0.61% ----------------------------------------------------------------------------------------------------------------- T. Rowe Price Small Cap Growth Portfolio 0.47% -- 0.04% -- 0.51% -- 0.51% ----------------------------------------------------------------------------------------------------------------- WMC Core Equity Opportunities Portfolio 0.70% -- 0.03% -- 0.73% 0.11% 0.62% ----------------------------------------------------------------------------------------------------------------- T. ROWE PRICE GROWTH STOCK FUND, INC. ----------------------------------------------------------------------------------------------------------------- T. Rowe Price Growth Stock Fund, Inc. 0.52% -- 0.16% -- 0.68% -- 0.68% ----------------------------------------------------------------------------------------------------------------- THE ALGER PORTFOLIOS--CLASS I-2 ----------------------------------------------------------------------------------------------------------------- Alger Small Cap Growth Portfolio 0.81% -- 0.15% -- 0.96% -- 0.96% ----------------------------------------------------------------------------------------------------------------- The information shown in the table above was provided by the Funds and we have not independently verified that information. Net Total Annual Operating Expenses shown in the table reflect any current fee waiver or expense reimbursement arrangement that will remain in effect for a period of at least one year from the date of the Fund's 2015 prospectus. "0.00%" in the Fee Waiver and/or Expense Reimbursement column indicates that there is such an arrangement in effect for the Fund, but that the expenses of the Fund are below the level that would trigger the waiver or reimbursement. Fee waiver and expense reimbursement arrangements with a duration of less than one year, or arrangements that may be terminated without the consent of the Fund's board of directors or trustees, are not shown. 11
485BPOS13th Page of 388TOC1stPreviousNextBottomJust 13th
EXAMPLES THESE EXAMPLES ARE INTENDED TO HELP YOU COMPARE THE COST OF INVESTING IN THE CERTIFICATE WITH THE COST OF INVESTING IN OTHER VARIABLE ANNUITY CONTRACTS. THESE COSTS INCLUDE CONTRACT OWNER TRANSACTION EXPENSES, CONTRACT FEES, SEPARATE ACCOUNT ANNUAL EXPENSES, AND FUND FEES AND EXPENSES. THE EXAMPLES ASSUME THAT YOU INVEST $10,000 IN THE CERTIFICATE FOR THE TIME PERIODS INDICATED. THE EXAMPLES ALSO ASSUME THAT YOUR INVESTMENT HAS A 5% RETURN EACH YEAR AND ASSUME THE: A) MAXIMUM AND (B) MINIMUM FEES AND EXPENSES OF ANY OF THE FUNDS (BEFORE REIMBURSEMENT AND/OR WAIVER). ALTHOUGH YOUR ACTUAL COSTS MAY BE HIGHER OR LOWER, BASED ON THESE ASSUMPTIONS, YOUR COSTS WOULD BE: (1) IF YOU SURRENDER YOUR CERTIFICATE AT THE END OF THE APPLICABLE TIME PERIOD: [Enlarge/Download Table] Time Periods 1 Year 3 Years 5 Years 10 Years --------------------------------------------------------------------------------------------------------------- (a) $972 (a) $1,444 (a) $2,010 (a) $2,907 (b) $894 (b) $1,206 (b) $1,610 (b) $2,095 (2) IF YOU ANNUITIZE AT THE END OF THE APPLICABLE TIME PERIOD: [Enlarge/Download Table] Time Periods 1 Year 3 Years 5 Years 10 Years --------------------------------------------------------------------------------------------------------------- (a) $272 (a) $814 (a) $1,380 (a) $2,907 (b) $194 (b) $576 (b) $ 980 (b) $2,095 (3) IF YOU DO NOT SURRENDER YOUR CERTIFICATE: Time Periods 1 Year 3 Years 5 Years 10 Years ---------------------------------------- (a) $262 (a) $804 (a) $1,370 (a) $2,897 (b) $184 (b) $566 (b) $ 970 (a) $2,085 The Examples should not be considered a representation of past or future expenses or annual rates of return of any Fund. Actual expenses and annual rates of return may be more or less than those assumed for the purpose of the examples. 12
485BPOS14th Page of 388TOC1stPreviousNextBottomJust 14th
FINANCIAL AND PERFORMANCE INFORMATION [SIDE BAR: All performance numbers are based upon historical earnings. These numbers are not intended to indicate future results. Yields and average annual total returns are determined in accordance with the computation methods required by the Securities and Exchange Commission (the "SEC") in the Form N-4 Registration Statement. These methods are described in detail in the Statement of Additional Information.] PERFORMANCE INFORMATION We periodically advertise Series performance relating to the various Funds. We will calculate performance by determining the percentage change in the value of an accumulation unit by dividing the increase (decrease) for that unit by the value of the accumulation unit at the beginning of the period. This performance number reflects the deduction of the Separate Account product charges and the Fund expenses. It does not reflect the deduction of any applicable Transaction Fee or surrender charge. The deduction of these charges would reduce the percentage increase or make greater any percentage decrease. Any advertisement will also include total return figures which reflect the deduction of the Separate Account product charges, account fees, surrender charges and the Transaction Fees. For periods starting prior to the date the Contract was first offered, the performance will be based on the historical performance of the corresponding Funds for the periods commencing from the date on which the particular Fund was made available through the Separate Account. In addition, certain Fund performance may be shown for the period commencing from the inception date of the Fund. These figures should not be interpreted to reflect actual historical performance of the Separate Account. We may, from time to time, include in our advertising and sales materials, performance information for Funds or Series related to the Funds and/or their investment advisers or subadvisers. Such related performance information also may reflect the deduction of certain Contract charges. We may also include in our advertising and sales materials, tax deferred compounding charts and other hypothetical illustrations, which may include comparisons of currently taxable and tax deferred investment programs, based on selected tax brackets. You should know that for any performance we illustrate, future performance will vary and results shown are not necessarily representative of future results. FINANCIAL INFORMATION Financial Statements of the Separate Account and MetLife USA are contained in the Statement of Additional Information. Please see the section "Additional Information" of this Prospectus for information on how to obtain a copy of the Statement of Additional Information. 13
485BPOS15th Page of 388TOC1stPreviousNextBottomJust 15th
DESCRIPTION OF METLIFE INSURANCE COMPANY USA, THE GENERAL ACCOUNT, THE SEPARATE ACCOUNT, THE FUNDS AND SERVICE PROVIDERS THE INSURANCE COMPANY MetLife Insurance Company USA ("MetLife USA") is a stock life insurance company originally chartered in Connecticut in 1863 and currently subject to the laws of the State of Delaware. MetLife USA was previously known as MetLife Insurance Company of Connecticut but changed its name to MetLife Insurance Company USA when it changed its state of domicile from Connecticut to Delaware on November 14, 2014. MetLife USA is licensed to conduct business in all states of the United States except New York, and in the District of Columbia, Puerto Rico, Guam, the U.S. and British Virgin Islands and the Bahamas. The company is a wholly-owned subsidiary of MetLife, Inc., a publicly-traded company. MetLife, Inc., through its subsidiaries and affiliates, is a leading provider of insurance and financial services to individuals and institutional customers. The company's executive offices are located at 11225 North Community House Road, Charlotte, NC 28277. Prior to November 17, 2014, the Contracts were issued by MetLife Investors USA Insurance Company ("MetLife Investors USA"). On November 14, 2014, following the close of business, MetLife Investors USA merged into MetLife USA and MetLife USA replaced MetLife Investors USA as the issuer of the Contracts. THE GENERAL ACCOUNT All of the assets of MetLife USA, except for those in the Separate Account and other segregated asset accounts, make up the assets of the General Account. You may allocate to the General Account. Amounts allocated to the General Account are credited with interest at an interest rate that is guaranteed by MetLife USA. The minimum interest rate depends on the date your Contract is issued but will not be less than 3%. Your registered representative can tell you the current and minimum rates that apply. Because of exemptive and exclusionary provisions, interests in the General Account have not been registered under the Securities Act of 1933 and the General Account has not been registered as an investment company under the Investment Company Act of 1940. Instead of you bearing the risk of fluctuations in the value of the assets as is the case for amounts invested in the Separate Account, MetLife USA bears the full investment risk for amounts in the General Account. MetLife USA has sole discretion to invest the assets of the General Account, subject to applicable law. All guarantees as to Purchase Payments or Account value allocated to the General Account, interest credited to the General Account, and Fixed Annuity payments are subject to MetLife USA's financial strength and claim-paying ability. Please see the terms of your Certificate for more information. 14
485BPOS16th Page of 388TOC1stPreviousNextBottomJust 16th
THE SEPARATE ACCOUNT The Board of Directors of MetLife Investors USA adopted a resolution to establish the Separate Account in accordance with the Delaware Insurance Code on May 29, 1980. On November 14, 2014, following the close of business, MetLife Investors USA merged into MetLife USA and the Separate Account became a separate account of MetLife USA. The purpose of the Separate Account is to hold the variable assets that underlie the Contracts and some other variable annuity contracts that MetLife USA offers. The Separate Account is registered with the SEC as a unit investment trust under the 1940 Act. The assets of the Separate Account are held in MetLife USA's name on behalf of the Separate Account and legally belong to MetLife USA. Although the Separate Account, and each of the Series that make up the Separate Account, are considered as part of MetLife USA's general business, the Separate Account's assets are solely for the benefit of those who invest in the Separate Account and no one else, including MetLife USA's creditors. All the income, gains and losses (realized and unrealized) resulting from these assets are credited to or charged against the Contracts issued from this Separate Account without regard to MetLife USA's other business. Under state law and the terms of the Contract, the assets of the Separate Account will not be responsible for liabilities arising out of MetLife USA's other business. Furthermore, MetLife USA is obligated to pay all money it owes under the Contracts even if that amount exceeds the assets in the Separate Account. However, the amount of these payments is guaranteed only to the extent of the level amount calculated at the beginning of each Annuity year. Any obligations that exceed the assets in the Separate Account are payable by the General Account. The amount of the death benefit that exceeds the Contract Value is paid from the General Account. Benefit amounts paid from the General Account are subject to the claims-paying ability of MetLife USA and MetLife USA's long-term ability to make such payments and are not guaranteed by any other party. For other annuity contracts and life insurance policies that MetLife USA issues, all amounts owed under the contracts and policies are paid from the General Account. MetLife USA is regulated as an insurance company under state law, which generally imposes restrictions on the amount and type of investments in the General Account. However, there is no guarantee that MetLife USA will be able to meet all claims-paying obligations. There are risks to purchasing any insurance product. The Separate Account is divided into a number of investment Series of Accumulation and Annuity Units. Over twenty-five of these Series are available under the Contracts as investment choices. Each Series invests in the shares of only one of the Funds. The investment adviser to certain of the Funds offered with the Contracts or with other Variable Annuity contracts issued through the Separate Account may be regulated as Commodity Pool Operators. While it does not concede that the Separate Account is a commodity pool, MetLife USA has claimed an exclusion from the definition of the term "commodity pool operator" under the Commodities Exchange Act ("CEA"), and is not subject to registration or regulation as a pool operator under the CEA. 15
485BPOS17th Page of 388TOC1stPreviousNextBottomJust 17th
THE FUNDS The following Funds are available as investment options under the Contract. YOU SHOULD READ THE PROSPECTUSES FOR THESE FUNDS CAREFULLY. YOU CAN OBTAIN COPIES OF THE FUND PROSPECTUSES BY CALLING OR WRITING TO US AT: METLIFE INSURANCE COMPANY USA, 11225 NORTH COMMUNITY HOUSE ROAD, CHARLOTTE, NC 28277, (800) 343-8496. Certain Funds described in the prospectuses may not be available with your Contract. Appendix B contains a summary of investment objectives and the names of the subadviser, if any, for each Fund. THE ALGER PORTFOLIOS (CLASS I-2) The Alger Portfolios is a mutual fund with multiple portfolios, one of which is offered under the Contract. Fred Alger Management, Inc. is the investment adviser to each of the portfolios. The following Class I-2 portfolio is available under the Contract: Alger Small Cap Growth Portfolio AMERICAN FUNDS INSURANCE SERIES(R) (CLASS 2) American Funds Insurance Series(R) is a mutual fund with multiple funds, three of which are offered under the Contract. Capital Research and Management Company is the investment adviser to each Series. The following Class 2 funds are available under the Contract: American Funds Global Small Capitalization Fund American Funds Growth Fund American Funds Growth-Income Fund DEUTSCHE VARIABLE SERIES I (CLASS A) Deutsche Variable Series I is a mutual fund with multiple series, one of which is offered under the Contract. Deutsche Investment Management Americas Inc. is the investment adviser to each series. The following Class A series is available under the Contract: Deutsche CROCI(R) International VIP FIDELITY(R) VARIABLE INSURANCE PRODUCTS (INITIAL CLASS) Fidelity Variable Insurance Products is a mutual fund with multiple portfolios, five of which are offered under the Contract. Fidelity Management & Research Company (FMR) is the investment adviser to each of the portfolios. The following Initial Class portfolios are available under the Contract: Asset Manager Portfolio Contrafund(R) Portfolio Growth Portfolio Money Market Portfolio Overseas Portfolio (2) MET INVESTORS SERIES TRUST (CLASS A) Met Investors Series Trust is a mutual fund with multiple portfolios. MetLife Advisers, LLC, an affiliate of MetLife USA, is the investment manager of Met Investors Series Trust. MetLife Advisers, LLC has engaged subadvisers to provide investment advice for the individual portfolios. The following Class A portfolios are available under the Contract: Invesco Small Cap Growth Portfolio Lord Abbett Bond Debenture Portfolio MFS(R) Research International Portfolio Morgan Stanley Mid Cap Growth Portfolio PIMCO Total Return Portfolio T. Rowe Price Large Cap Value Portfolio MetLife Small Cap Value Portfolio METROPOLITAN SERIES FUND (CLASS A) Metropolitan Series Fund is a mutual fund with multiple portfolios. MetLife Advisers, LLC is the investment adviser for all of the portfolios. MetLife Advisers, LLC has engaged subadvisers to provide investment advice for the individual portfolios. The following Class A portfolios are available under the Contract: Barclays Aggregate Bond Index Portfolio BlackRock Bond Income Portfolio BlackRock Capital Appreciation Portfolio BlackRock Large Cap Value Portfolio Met/Artisan Mid Cap Value Portfolio MetLife Mid Cap Stock Index Portfolio MetLife Stock Index Portfolio MFS(R) Total Return Portfolio MFS(R) Value Portfolio MSCI EAFE(R) Index Portfolio Neuberger Berman Genesis Portfolio Russell 2000(R) Index Portfolio T. Rowe Price Large Cap Growth Portfolio T. Rowe Price Small Cap Growth Portfolio WMC Core Equity Opportunities Portfolio T. ROWE PRICE GROWTH STOCK FUND, INC.(2) The T. Rowe Price Growth Stock Fund, Inc. is a mutual fund. T. Rowe Price Associates, Inc. is the investment adviser for the fund. (1) Not available under the Retirement Companion version of the Contract. (2) Not available for 403(b) plans. 16
485BPOS18th Page of 388TOC1stPreviousNextBottomJust 18th
[SIDE BAR: While the Series and their comparably named Funds may have names, investment objectives and management which are identical or similar to publicly available mutual funds, these are not those retail mutual funds. The Funds most likely will not have the same performance experience as any retail mutual fund. Moreover, a Series that invests in a retail fund will have lower investment performance than the retail fund due to Contract charges and expenses.] Shares of each Fund are purchased for the corresponding Series. These Funds invest in stocks, bonds and other investments. All dividends declared by the Funds are earned by the Separate Account and reinvested. Therefore, no dividends are distributed to you under the Contract. Instead, dividends generally increase the Accumulation or Annuity Unit Value. You pay no transaction expenses (i.e., front-end or back-end load sales charges) as a result of the Separate Account's purchase or sale of these Fund shares. The Funds listed above other than the T. Rowe Price Growth Stock Fund, Inc. are available only by purchasing annuities and life insurance policies offered by MetLife USA or by other insurance companies and are never sold directly to the public. The shares of each Fund are purchased, without sales charge, for the corresponding Series at the next net asset value per share determined by a Fund after your payment is received by MetLife USA. Fund shares will be redeemed by the Series to the extent necessary for MetLife USA to make annuity or other payments under the Contracts. Each of the Funds is a portfolio or series of an open-end management investment company registered with the SEC under the 1940 Act. Registration does not involve supervision by the SEC of the investment or investment policies of the Funds. There can be no guarantee that a Fund will meet its investment objectives. A Fund's performance may be affected by risks specific to certain types of investments, such as foreign securities, derivative instruments, non-investment grade securities, initial public offerings (IPOs) or companies with relatively small market capitalizations. IPOs and other investment techniques may have a magnified performance impact on a Fund with a small asset base. A Fund may not experience similar performance as its assets grow. [SIDE BAR: The Funds are more fully described in the Fund prospectuses and their Statements of Additional Information.] The Funds are available to other registered separate accounts offering variable annuity and variable life products in addition to MetLife USA's Separate Account. In the future, a conflict may develop between one or more separate accounts invested in the same Fund. The conflict could develop due to change in the law affecting variable annuity products or from differences in voting instructions of owners of the different separate accounts. MetLife USA monitors the Series for this type of conflict and will remedy the situation if such a conflict develops. This may include the withdrawal of amounts invested in the Funds by you and other Participants and Owners. CERTAIN PAYMENTS WE RECEIVE WITH REGARD TO THE FUNDS. An investment adviser (other than our affiliate MetLife Advisers, LLC) or subadviser of a Fund or its affiliates may make payments to us and/or certain of our affiliates. These payments may be used for a variety of purposes, including payment of expenses for certain administrative, marketing, and support services with respect to the Contracts and, in MetLife USA's role as intermediary, with respect to the Funds. MetLife USA and its affiliates may profit from these payments. These payments may be derived, in whole or in part, from the advisory fee deducted from 17
485BPOS19th Page of 388TOC1stPreviousNextBottomJust 19th
Fund assets. Contract Owners, through their indirect investment in the Funds, bear the costs of these advisory fees (see the Funds' prospectuses for more information). The amount of the payments we receive is based on a percentage of assets of the Funds attributable to the Contracts and certain other variable insurance products that we and our affiliates issue. These percentages differ and some advisers or subadvisers (or other affiliates) may pay us more than others. These percentages currently range up to 0.50%. Additionally, an investment adviser (other than our affiliate, MetLife Advisers, LLC) or subadviser of a Fund or its affiliates may provide us with wholesaling services that assist in the distribution of the Contracts and may pay us and/or certain affiliates amounts to participate in sales meetings. These amounts may be significant and may provide the adviser or subadviser (or its affiliate) with increased access to persons involved in the distribution of the Contracts. We and/or certain of our affiliated insurance companies have joint ownership interests in our affiliated investment adviser, MetLife Advisers, LLC, which is formed as a "limited liability company." Our ownership interests in MetLife Advisers, LLC entitle us to profit distributions if the adviser makes a profit with respect to the advisory fees it receives from the Funds. We will benefit accordingly from assets allocated to the Funds to the extent they result in profits to the adviser. (See "Fee Tables and Examples - Fund Expenses" for information on the management fees paid by the Funds and the Statement of Additional Information for the Funds for information on the management fees paid by the adviser to the subadvisers.) Certain Funds have adopted a Distribution Plan under Rule 12b-1 of the 1940 Act. A Fund's 12b-1 Plan, if any, is described in more detail in the Fund's prospectus. (See "Fee Tables and Examples - Fund Expenses" and "Principal Underwriter.") Any payments we receive pursuant to those 12b-1 Plans are paid to us or to our Distributor. Payments under a Fund's 12b-1 Plan decrease the Fund's investment return. HOW WE SELECT THE FUNDS. We select the Funds offered through the Contract based on a number of criteria, including asset class coverage, the strength of the adviser's or sub-adviser's reputation and tenure, brand recognition, performance, and the capability and qualification of each investment firm. Another factor we consider during the selection process is whether the Fund's adviser or sub-adviser is one of our affiliates or whether the Fund, its adviser, its sub-adviser(s), or an affiliate will make payment to us or our affiliates. For additional information on these arrangements, see "Certain Payments We Receive with Regard to the Funds" above. In this regard, the profit distributions we receive from our affiliated investment advisers are a component of the total revenue that we consider in configuring the features and investment choices available in the variable insurance products that we and our affiliated insurance companies issue. Since we and our affiliated insurance companies may benefit more from the allocation of assets to Funds advised by our affiliates than those that are not, we may be more inclined to offer Funds 18
485BPOS20th Page of 388TOC1stPreviousNextBottomJust 20th
advised by our affiliates in the variable insurance products we issue. In some cases, we have included Funds based on recommendations made by selling firms. These selling firms may receive payments from the Funds they recommend and may benefit accordingly from the allocation of Account value to such Funds. We review the Funds periodically and may remove a Fund or limit its availability to new Purchase Payments and/or transfers of Participant's Account value if we determine that the Fund no longer meets one or more of the selection criteria, and/or if the Fund has not attracted significant allocations from Participants. We make certain payments to American Funds Distributors, Inc., principal underwriter for the American Funds Insurance Series. (See "Principal Underwriter.") WE DO NOT PROVIDE INVESTMENT ADVICE AND DO NOT RECOMMEND OR ENDORSE ANY PARTICULAR FUND. YOU BEAR THE RISK OF ANY DECLINE IN THE ACCOUNT VALUE OF YOUR CONTRACT RESULTING FROM THE PERFORMANCE OF THE FUNDS YOU HAVE CHOSEN. SUBSTITUTION OF FUND SHARES. MetLife USA may substitute shares of another fund for Fund shares if the shares of a Fund are no longer available or further investment in such shares is determined to be inappropriate by MetLife USA's management in view of the purposes of the Contracts. The substituted fund may have different fees and expenses. However, no substitution is allowed unless a majority of the Owners entitled to vote (those who have invested in the Series) and the SEC approves the substitution under the 1940 Act. Furthermore, we may close investment portfolios to allocation of purchase payments or Contract value, or both, at any time in our sole discretion. PRINCIPAL UNDERWRITER MetLife Investors Distribution Company ("Distributor"), 1095 Avenue of the Americas, New York, NY 10036, a broker-dealer registered under the Securities Exchange Act of 1934 and a member of the Financial Industry Regulatory Authority ("FINRA"), an affiliate and principal underwriter for the Contracts. FINRA provides background information about broker-dealers and their registered representatives through FINRA BrokerCheck. You may contact the FINRA BrokerCheck Hotline at 1-800-289-9999, or log on to www.finra.org. An investor brochure that includes information describing FINRA BrokerCheck is available through the Hotline or on-line. The Distributor is a Missouri corporation. MetLife USA has entered into a distribution agreement with MetLife Investors Distribution Company, for the distribution of the Certificates. We pay compensation to Distributor for sales of the Contracts and Certificates by the selling firm. We pay amounts to Distributor that may be used for its operating and other expenses, including the following sales expenses: compensation and bonuses for the Distributor's management team, advertising expenses, and other expenses of distributing the contracts. Distributor's management team also may be eligible for non-cash compensation items that we may provide jointly with Distributor. Non-cash items include conferences, 19
485BPOS21st Page of 388TOC1stPreviousNextBottomJust 21st
seminars and trips (including travel, lodging and meals in connection therewith), entertainment, merchandise and other similar items. We and Distributor have entered into selling agreements with other affiliated and unaffiliated selling firms for the sale of the Contracts. All selling firms receive commissions and they may receive some form of non-cash compensation. These commissions and other incentives or payments are not charged directly to Participants or the Separate Account. We intend to recoup commissions and other sales expenses through fees and charges deducted under the Contract or from our general account. A portion of the payments made to selling firms may be passed on to their sales representatives in accordance with their internal compensation programs. Those programs may also include other types of cash and non-cash compensation and other benefits. We and Distributor pay compensation to all selling firms in the form of commissions and may provide certain types of non-cash compensation. The maximum commission payable for contract sales and additional purchase payments by selling firms is 8.5% of purchase payments. We also pay commissions when a Participant elects to begin receiving Annuity payments. (See "Annuity Benefits - Variable Annuity Payments.") SERVICING AGENT MetLife Group, Inc. and Metropolitan Life Insurance Company provide MetLife USA with personnel and administrative services, including: officers, office space, supplies, utilities, office equipment, travel expenses and periodic reports. 20
485BPOS22nd Page of 388TOC1stPreviousNextBottomJust 22nd
CONTRACT CHARGES MetLife USA deducts the charges described below, and we may also deduct a charge for taxes, if applicable. Unless otherwise specified, charges are deducted proportionately from all Series, and the General Account in which you are invested. These charges may not be changed under the Contract, and MetLife USA may profit from these charges in the aggregate. PREMIUM AND OTHER TAXES MetLife USA reserves the right to deduct from Purchase Payments, surrenders, death benefits or Annuity payments any taxes relating to the Contracts (including, but not limited to, premium taxes) paid by us to any government entity. Examples of these taxes include, but are not limited to, premium tax, generation-skipping transfer tax or a similar excise tax under federal or state law which is imposed on payments we make to certain persons and income tax withholdings on surrenders and Annuity payments to the extent required by law. Premium taxes generally range from 0 to 3.5%, depending on the state. We will, at out sole discretion, determine when taxes relate to the Contracts. We may, at our sole discretion, pay taxes when due and deduct that amount from the Participant's Account value at a later date. Payment at any earlier date does not waive any right we may have to deduct amounts at a later date. It is our current practice not to charge premium taxes until Annuity payments begin. See Appendix D for more information. SURRENDER CHARGE [SIDE BAR: The surrender charge covers marketing expenses for the sale of Contracts, such as commissions to sales personnel and other promotion and acquisition expenses.] No sales charge is deducted from any Purchase Payment. However, a surrender charge (contingent deferred sales charge) may be imposed on a partial or full surrender of the Participant's Account. During the accumulation phase, you can withdraw part or all of the Participant's Account. For 403(b) Plans only, in the first surrender of each calendar year, you may surrender up to 10% of the value of your interest in the Separate Account without surrender charges, provided that the proceeds are paid solely to the Participant or the Beneficiary. If you withdraw money in excess of 10%, you might have to pay a surrender charge on the excess amount. Withdrawals from 403(b) Plans may be restricted by the Internal Revenue Code. If the amount you withdraw is determined to include the withdrawal of any of your prior Purchase Payments, a surrender charge is assessed against each Purchase Payment withdrawn. To determine what portion (if any) of a withdrawal is subject to a surrender charge, amounts are withdrawn from your Contract in the following order: 1. Earnings in your Contract (earnings are equal to the Participant's Account, less Purchase Payments not previously withdrawn); then 2. For 403(b) Plans only, the free withdrawal amount described above (deducted from Purchase Payments not previously withdrawn, in the 21
485BPOS23rd Page of 388TOC1stPreviousNextBottomJust 23rd
order such Purchase Payments were made, with the oldest Purchase Payment first, as described below); then 3. Purchase Payment not previously withdrawn, in the order such Purchase Payments were made: the oldest Purchase Payment first, the next Purchase Payment second, etc. until all Purchase Payments have been withdrawn. The following schedule shows the surrender charges that apply during the 60 months following each Purchase Payment: [Download Table] Number of Months Since Purchase Payment Date Surrender Charge --------------------------------------------- 60 months or less 7% More than 60 months 0% The Surrender Charge amount is the gross surrender amount multiplied by the Surrender Charge. gross surrender amount x Surrender Charge = Surrender Charge amount [SIDE BAR: The surrender charge covers marketing expenses for the sale of Contracts, such as commissions to sales personnel and other promotion and acquisition expenses.] If you make a partial surrender, you will receive a check in the amount requested. The surrender charge, if any, will be deducted from the Series from which the partial surrender was taken. If the amount in a particular Series is completely surrendered, the charge will be taken from the remaining Series in which you have an interest. A surrender charge, if any, will not be applied to the amounts deducted to cover the surrender charge. MetLife USA will not deduct any surrender charge once 9 years have elapsed since your Certificate Date. DIVORCE. A withdrawal pursuant to a divorce or separation instrument is subject to the same surrender charge provisions described in this section, if permissible under tax law. In addition, the withdrawal will reduce the Participant's Account and the death benefit. The withdrawal could have a significant negative impact on the death benefit. EXCEPTIONS TO SURRENDER CHARGE In some cases, MetLife USA will not charge you the surrender charge when you make a surrender. You do not pay the surrender charge: .. on transfers made within the Contract; .. on withdrawals of Purchase Payments you made over 60 months ago; .. If you die during the pay-in phase. Your Beneficiary(ies) will receive the full death benefit without deduction; .. If you are a 403(b) Plan Participant and you withdraw no more than 10% of your interest in any calendar year (subject to Internal Revenue Code restrictions); .. If you are confined to a hospital for at least 30 consecutive days or a skilled nursing home for at least 90 consecutive days. The withdrawal must be in a lump sum and must be requested within 60 days after termination of confinement. This Contract feature is not available in Massachusetts and South Dakota; 22
485BPOS24th Page of 388TOC1stPreviousNextBottomJust 24th
[SIDE BAR:Please note that deductions are made and expenses paid out of the underlying Funds' assets, as well. A description of these fees and expenses are described in each Fund's prospectus.] .. When you are an officer, director or full time employee of MetLife USA or its affiliates. In this case, the purchase of the Contract is for personal investment purposes only; .. on required minimum distributions from, or excess contributions to, a qualified contract (but only with respect to amounts required to be distributed from this contract); and .. If permitted in your state, if you are the Plan Participant and you make a direct transfer of your Participant's Account to another funding option or annuity contract issued by MetLife USA or one of its affiliates and MetLife USA or its affiliate agrees. ADMINISTRATIVE FEES An administrative fee of $21.50 plus $2.50 for each Series in which you have Accumulation Units is deducted from your Participant's Account on a yearly basis. The fee is prorated between Series in your Account based on their values on the date of the deduction. Contract administration expenses we incur include: .. the cost of Contract issuance; .. rent; .. stationery and postage; .. telephone and travel expenses; .. salaries; .. legal, administrative, actuarial and accounting fees; .. periodic reports; and .. office equipment, and custodial expenses. The administrative fee will be waived for any Certificate Year during which you contribute Purchase Payments of $2,000 or more or your Participant's Account is $10,000 or more at the end of the Certificate Year. TRANSACTION CHARGES A $10 transaction charge will be deducted from your Account for each transfer from a Series (see "Transfers") and upon annuitizaton of all or a portion of your Participant's Account (see "Annuity Benefits"). When you make a full or partial surrender, a transaction charge will be deducted from your Participant's Account in an amount equal to the lesser of: .. $10 or .. 2% of the amount surrendered. These charges are at cost. MetLife USA does not anticipate profiting from them. Transaction charges for transfers from one Series of the Separate Account to another Series of the Separate Account are currently waived. (See, however, "Description of the Contracts - Restrictions on Transfers.") 23
485BPOS25th Page of 388TOC1stPreviousNextBottomJust 25th
MORTALITY AND EXPENSE RISK CHARGE MetLife USA charges a fee for bearing certain mortality and expense risks under the Contract. You pay the mortality and expense risk charge during the accumulation phase and the income phase. Examples of these risks include a guarantee of annuity rates, the death benefits, and assuming the risk that the expense charges and fees are less than actual administrative and operating expenses. As compensation for assuming these risks, MetLife USA will make a daily deduction from the value of the Separate Account's assets equal to 1.25% per year. If MetLife USA has gains from the receipt of the mortality and expense risk charges over its cost of assuming these risks, it may use the gains as it sees fit. This may include the reduction of expenses incurred in distributing the Contracts. MetLife USA may voluntarily waive a portion of the mortality and administrative expense risk charges. Any waiver of these expenses may be terminated at any time. DISTRIBUTION EXPENSE CHARGE MetLife USA also assumes the risk that surrender charges described above will be insufficient to cover the actual costs of distribution. These costs include: .. commissions, .. fees, .. registration costs, .. direct and indirect selling expenses (including advertising, sales materials, illustrations, marketing personnel, printing, and related overhead) As compensation for assuming this risk, MetLife USA will make a deduction of ..000274% on a daily basis (0.10% per year) from the value of the Separate Account assets funding the Contract (the staff of the Securities and Exchange Commission deems this charge a deferred sales charge). The distribution expense charge (sales load), together with any contingent deferred sales charge imposed as described under "Surrender Charge" above, will never exceed 9% of purchase payments. LOAN SET-UP FEE - 403(B) PLANS ONLY You may be able to obtain a loan from the portion of your Participant's Account allocated to the General Account. Fees may be charged for loan set-up and administration. Currently, the loan set-up fee is $50. This amount is deducted from the loan proceeds. At this time, there is no fee for administration. Loan proceeds may be considered taxable distributions under the Internal Revenue Code in the event of a default in repayments. MetLife USA: .. may terminate loans .. change the terms under which loans are made Any action taken by MetLife USA would not affect outstanding loans. 24
485BPOS26th Page of 388TOC1stPreviousNextBottomJust 26th
INCOME TAXES We reserve the right to deduct from the Contract for any income taxes which we incur because of the Contract. In general, we believe under current federal income tax law, we are entitled to hold reserves with respect to the Contract that offset Separate Account income. If this should change, it is possible we could incur income tax with respect to the Contract, and in that event we may deduct such tax from the Contract. At the present time, however, we are not incurring any such income tax or making any such deductions. FUND EXPENSES There are deductions from and expenses paid out of the assets of the various Funds, which are described in the fee table in this prospectus and in the Fund prospectuses. These deductions and expenses are not charges under the terms of the Contract but are represented in the share values of the investment options. FREE LOOK PERIOD You may cancel your interest in the Contract within a certain time period. This is known as a "free look." Your Free Look Period is the 20-day period (or longer in certain states) starting when you receive your Certificate. If you decide to cancel your interest in the Contract, MetLife USA must receive your request to cancel in writing at its administrative office within the 20-day period. If the Certificate is mailed to MetLife USA, it will be considered to be received on the postmark date. If the Certificate is sent by certified or registered mail, the date of certification or registration will be considered the date of its return to MetLife USA. The returned Certificate will be treated as if MetLife USA never issued it, and MetLife USA will refund your Purchase Payments or, if permitted by state law, the greater of the Purchase Payments or the Participant's Account. Purchase Payments that you make to the Separate Account will be allocated to the Money Market Portfolio for the number of days of the Free Look Period required by the state in which you live. At the end of the Free Look Period, the account value in the Money Market Portfolio will be reallocated to the Series of the Separate Account that you selected in your Contract application. DEFERRED COMPENSATION PLANS For qualified Section 457 deferred compensation Plans, MetLife USA may agree to reduce or waive the administrative fees, transaction charges, and the distribution expense fee. Also, deductions for sales charges may be reduced or waived if a surrender is the result of your: .. death, .. disability, .. retirement, .. termination of employment, .. unforseeable emergency, or .. transfer to another investment provider. 25
485BPOS27th Page of 388TOC1stPreviousNextBottomJust 27th
DESCRIPTION OF THE CONTRACTS GENERAL The Contracts (known as Form 226R1) may be offered to Qualified Plans such as: .. Section 403(b) tax-sheltered annuities; .. Section 457 deferred compensation plans; .. Section 401 pension and profit sharing plans; and .. individual retirement annuities under Section 408 of the Internal Revenue Code. The Contracts are designed to fulfill long-term financial needs. They should not be considered as short-term or temporary investments. A group Contract is issued to an employer or organization which is the Owner. This Contract covers all present and future Participants. After completing an enrollment form and arranging for Purchase Payments to begin, except as provided below, you and all other Participants will receive a Certificate that gives you a summary of the Contract provisions. This Certificate also serves as evidence of your participation in the Plan. NO CERTIFICATES ARE ISSUED TO PARTICIPANTS UNDER DEFERRED COMPENSATION OR QUALIFIED CORPORATE RETIREMENT PLANS. The group Contracts may be restricted by the Plan as to your exercise of certain rights provided under the Contracts. You should refer to the Plan for information concerning these restrictions. Due to IRS regulations affecting 403(b) plans, we will only issue new Certificates where your employer currently permits salary reduction contributions to be made to the Certificate. ASSIGNMENT If permitted by the Plan, you may assign your interest in the Contract by providing MetLife USA with written notice. Where a Contract is issued in connection with a non-governmental deferred compensation plan, all rights and powers under the Contract are vested in the Owner, not you. MetLife USA will not be bound by the assignment until written notice of the assignment is recorded by us. We will not be liable for any payment or other action we take in accordance with the Contract before we record the assignment. AN ASSIGNMENT MAY BE A TAXABLE EVENT. PURCHASE PAYMENTS You may make Purchase Payments yearly, semi-yearly, quarterly, monthly, or in periods agreed to by MetLife USA. You may change when you make Purchase Payments if permitted by the Plan. The minimum Purchase Payment is $20, with a yearly minimum of $240 (for IRAs, the minimum is $2,000 for an initial Purchase Payment and $50 for each additional 26
485BPOS28th Page of 388TOC1stPreviousNextBottomJust 28th
payment), or such lesser amount as is required by federal tax law. Purchase Payments may be allocated to the Separate Account, the General Account, or between them according to your decision. You will periodically receive a confirmation of Purchase Payments which have been received. We accept Purchase Payments made by check or cashier's check. We do not accept cash, money orders or traveler's checks. We reserve the right to refuse Purchase Payments made via a personal check in excess of $100,000. Purchase payments over $100,000 may be accepted in other forms, including but not limited to, EFT/wire transfers, certified checks, corporate checks, and checks written on financial institutions. The form in which we receive a Purchase Payment may determine how soon subsequent disbursement requests may be fulfilled. (See "Payment of Surrender Amount.") If you send a Purchase Payment or transaction request to an address other than the one we have designated for receipt of such Purchase Payments or requests, we may return the Purchase Payment to you, or there may be a delay in applying the Purchase Payment or transaction to your Participant's Account. TRANSFERS ACCUMULATION UNITS Except as otherwise limited under "Restrictions on Transfers" below, you may transfer Accumulation Units from one Series to another or from a Series to the General Account at any time. You may not make a transfer from the General Account to Accumulation Units of a Series of more than 20% of your interest in the General Account in any one year. It is important to note that it will take over 10 years (assuming no additional purchase payments or transfers into the General Account and discounting any accrued interest) to make a complete transfer of your interest from the General Account to Accumulation Units of a Series because of the transfer allowance restriction indicated above. This is because the 20% transfer allowance is based on a declining interest in the General Account rather than transfers based upon a fixed number of years. For example (based upon the assumptions above), if your initial interest in the General Account is $100, the 20% transfer allowance only allows you to transfer up to $20 the first year. If you transfer the maximum transfer allowance that year, you may only transfer up to $16 the following year based on the 20% transfer allowance of the $80 interest remaining in the General Account for the year. It is important to consider when deciding to invest in the General Account whether this 20% transfer allowance restriction fits your risk tolerance and time horizon. Your transfer instructions must be in writing or, if permitted by MetLife USA, by telephone, Internet or other means approved by MetLife USA. 27
485BPOS29th Page of 388TOC1stPreviousNextBottomJust 29th
Requests for service may be made: .. By telephone at (1-800-560-5001), between the hours of 7:30AM and 5:30PM Central Time Monday through Thursday and 7:30AM and 5:00PM Central Time on Friday; or .. In writing to us at the Annuity Service Center at 4700 Westown Parkway, Ste. 200, West Des Moines, Iowa 50266. Your transfer requst must be in Good Order. If MetLife USA permits transfers by telephone, you will be required to complete an authorization on the Certificate enrollment or on another form that MetLife USA may require. We will use reasonable procedures such as requiring certain identifying information, tape recording the telephone instructions, and providing written confirmation of the transaction, in order to confirm that instructions communicated by telephone, fax, Internet or other means are genuine. Any telephone, fax or Internet instructions reasonably believed by us to be genuine will be your responsibility, including losses arising from any errors in the communication of instructions. As a result of this policy, you will bear the risk of loss. If we do not employ reasonable procedures to confirm that instructions communicated by telephone, fax or Internet are genuine, we may be liable for any losses due to unauthorized or fraudulent transactions. All other requests and elections under your contract must be in writing signed by the proper party, must include any necessary documentation and must be received at our Annuity Service Center to be effective. If acceptable to us, requests or elections relating to Beneficiaries and Ownership. will take effect as of the date signed unless we have already acted in reliance on the prior status. We are not responsible for the validity of any written request or action. Because telephone or Internet transactions will be available to anyone who provides certain information about you or your Contract, you should protect that information. We may not be able to verify that you are the person providing telephone or Internet instructions, or that you have authorized any such person to act for you. Telephone or computer systems may not always be available. Any telephone or computer system can experience outages or slowdowns for a variety of reasons. These outages or slowdowns may delay or prevent our processing of your request. Although we have taken precautions to help our systems handle heavy use, we cannot promise complete reliability under all circumstances. If you are experiencing problems, you should make your request in writing to MetLife Insurance Company USA, 11225 North Community House Road, Charlotte, NC 28277. Transfers will be effected on the first Valuation Date after receipt of written, telephone or Internet instructions. Accumulation Unit values are determined as of the close of trading on the New York Stock Exchange. The New York Stock Exchange usually closes at 4:00 p.m. Eastern time but may close earlier or later. If your transfer instructions are received up to that time your transfer will be effected at the value calculated on that Valuation Date. If your instructions are received after the close of trading on a valuation day, your transfer instructions will be carried out at the value next calculated. 28
485BPOS30th Page of 388TOC1stPreviousNextBottomJust 30th
ANNUITY UNITS You may convert Annuity Units from one Series to another at any time. You may not convert Annuity Units from a Series to the General Account. However, any amounts that you have in the General Account that have not been applied to a fixed annuity income option may be transferred to Annuity Units in one or more Series for Variable Annuity payments. Conversions of Annuity Units may only be requested in writing and will be effective on the first valuation following receipt of the instructions. MINIMUM TRANSFER A minimum of $500 must be transferred from any Series or from the General Account. The value of the Accumulation and Annuity Units transferred will be calculated as of the close of business on the day that the transfer occurs. RESTRICTIONS ON TRANSFERS RESTRICTIONS ON FREQUENT TRANSFERS. Frequent requests from Participants to make transfers may dilute the value of a Fund's shares if the frequent trading involves an attempt to take advantage of pricing inefficiencies created by a lag between a change in the value of the securities held by the Fund and the reflection of that change in the Fund's share price ("arbitrage trading"). Frequent transfers involving arbitrage trading may adversely affect the long-term performance of the Funds, which may in turn adversely affect Participants and other persons who may have an interest in the Contracts (e.g., annuitants and beneficiaries). We have policies and procedures that attempt to detect and deter frequent transfers in situations where we determine there is a potential for arbitrage trading. Currently, we believe that such situations may be presented in the international, small-cap, and high-yield Funds (i.e., Alger Small Cap Growth Portfolio, American Funds Global Small Capitalization Fund, American Funds Growth Fund, American Funds Growth-Income Fund, DWS International VIP, Fidelity VIP Overseas Portfolio, Lord Abbett Bond Debenture Portfolio, Invesco Small Cap Growth Portfolio, MFS(R) Research International Portfolio, MetLife Small Cap Value Portfolio, MSCI EAFE(R) Index Portfolio, Neuberger Berman Genesis Portfolio, Russell 2000(R) Index Portfolio and T. Rowe Price Small Cap Growth Portfolio - (the "Monitored Portfolios") and we monitor transfer activity in those Monitored Portfolios. In addition, as described below, we treat all American Funds Insurance Series portfolios ("American Funds portfolios") as Monitored Portfolios. We employ various means to monitor transfer activity, such as examining the frequency and size of transfers into and out of the Monitored Portfolios within given periods of time. For example, we currently monitor transfer activity to determine if, for each category of international, small-cap, and high-yield Portfolios, in a 12-month period there were, (1) six or more transfers involving the given category; (2) cumulative gross transfers involving the given category that exceed the current Participant's Account value; and (3) two or more "round-trips" 29
485BPOS31st Page of 388TOC1stPreviousNextBottomJust 31st
involving any Fund in the given category. A round-trip generally is defined as a transfer in followed by a transfer out within the next seven calendar days or a transfer out followed by a transfer in within the next seven calendar days, in either case subject to certain other criteria. WE DO NOT BELIEVE THAT OTHER FUNDS PRESENT A SIGNIFICANT OPPORTUNITY TO ENGAGE IN ARBITRAGE TRADING AND THEREFORE DO NOT MONITOR TRANSFER ACTIVITY IN THOSE FUNDS. We may change the Monitored Portfolios at any time without notice in our sole discretion. As a condition to making their Funds available in our products, American Funds requires us to treat all American Funds portfolios as Monitored Portfolios under our current frequent transfer policies and procedures. Further, American Funds requires us to impose additional specified monitoring criteria for all American Funds portfolios available under the Contract, regardless of the potential for arbitrage trading. We are required to monitor transfer activity in American Funds portfolios to determine if there were two or more transfers in followed by transfers out, in each case of a certain dollar amount or greater, in any 30-day period. A first violation of the American Funds monitoring policy will result in a written notice of violation; each additional violation will result in the imposition of a six-month restriction, during which period we will require all transfer requests to or from an American Funds portfolio to be submitted with an original signature. Further, as Monitored Portfolios, all American Funds portfolios also will be subject to our current frequent transfer policies, procedures and restrictions (described below), and transfer restrictions may be imposed upon a violation of either monitoring policy. Our policies and procedures may result in transfer restrictions being applied to deter frequent transfers. Currently, when we detect transfer activity in the Monitored Portfolios that exceeds our current transfer limits, we require future transfer requests to or from any Monitored Portfolios under that Contract to be submitted in writing with an original signature. A first occurrence will result in the imposition of this restriction for a six-month period; a second occurrence will result in the permanent imposition of the restriction. The detection and deterrence of harmful transfer activity involves judgments that are inherently subjective, such as the decision to monitor only those Funds that we believe are susceptible to arbitrage trading or the determination of the transfer limits. Our ability to detect and/or restrict such transfer activity may be limited by operational and technological systems, as well as our ability to predict strategies employed by Contract Owners to avoid such detection. Our ability to restrict such transfer activity also may be limited by provisions of the Contract. Accordingly, there is no assurance that we will prevent all transfer activity that may adversely affect Contract Owners and other persons with interests in the Contracts. We do not accommodate frequent transfers in any Fund and there are no arrangements in place to permit any Contract Owner to engage in frequent transfers; we apply our policies and procedures without exception, waiver, or special arrangement. 30
485BPOS32nd Page of 388TOC1stPreviousNextBottomJust 32nd
The Funds may have adopted their own policies and procedures with respect to frequent transfers in their respective shares, and we reserve the right to enforce these policies and procedures. For example, Funds may assess a redemption fee (which we reserve the right to collect) on shares held for a relatively short period. The prospectuses for the Funds describe any such policies and procedures, which may be more or less restrictive than the policies and procedures we have adopted. Although we may not have the contractual authority or the operational capacity to apply the frequent transfer policies and procedures of the Funds, we have entered into a written agreement, as required by SEC regulation, with each Fund or its principal underwriter that obligates us to provide to the Fund promptly upon request certain information about the trading activity of individual Contract Owners, and to execute instructions from the Fund to restrict or prohibit further purchases or transfers by specific Contract Owners who violate the frequent transfer policies established by the Fund. In addition, Contract Owners and other persons with interests in the Contracts should be aware that the purchase and redemption orders received by the Funds generally are "omnibus" orders from intermediaries such as retirement plans or separate accounts funding variable insurance products. The omnibus orders reflect the aggregation and netting of multiple orders from individual owners of variable insurance products and/or individual retirement plan participants. The omnibus nature of these orders may limit the Funds in their ability to apply their frequent transfer policies and procedures. In addition, the other insurance companies and/or retirement plans may have different policies and procedures or may not have any such policies and procedures because of contractual limitations. For these reasons, we cannot guarantee that the Funds (and thus Participants) will not be harmed by transfer activity relating to other insurance companies and/or retirement plans that may invest in the Funds. If a Fund believes that an omnibus order reflects one or more transfer requests from Participants engaged in frequent trading, the Fund may reject the entire omnibus order. In accordance with applicable law, we reserve the right to modify or terminate the transfer privilege at any time. We also reserve the right to defer or restrict the transfer privilege at any time that we are unable to purchase or redeem shares of any of the Funds, including any refusal or restriction on purchases or redemptions of their shares as a result of their own policies and procedures on frequent transfers (even if an entire omnibus order is rejected due to the frequent transfers of a single Participant). You should read the Portfolio prospectuses for more details. RESTRICTIONS ON LARGE TRANSFERS/REALLOCATIONS. Large transfers/reallocations may increase brokerage and administrative costs of the underlying Portfolios and may disrupt portfolio management strategy, requiring a Portfolio to maintain a high cash position and possibly resulting in lost investment opportunities and forced liquidations. We do not monitor for large transfers/reallocations to or from Portfolios except where the portfolio manager of a particular underlying Portfolio has 31
485BPOS33rd Page of 388TOC1stPreviousNextBottomJust 33rd
brought large transfer/reallocation activity to our attention for investigation on a case-by-case basis. For example, some portfolio managers have asked us to monitor for "block transfers" where transfer/reallocation requests have been submitted on behalf of multiple Contract Owners by a third party such as an investment adviser. When we detect such large trades, we may impose restrictions similar to those described above where future transfer/reallocation requests from that third party must be submitted in writing with an original signature. A first occurrence will result in the imposition of this restriction for a six-month period; a second occurrence will result in the permanent imposition of the restriction. LOANS -- 403(B) PLANS ONLY If you are in a 403(b) Plan, you may obtain a loan under the Contract from the value of your Participant's Account allocated to the General Account. Accumulation Units in the Separate Account are taken into account in determining the maximum amount of the loan. You would then be permitted to transfer Accumulation Units from the Separate Account to the General Account before the loan is made. Your Participant's Account serves as the only security for the loan. MetLife USA may terminate a loan at its discretion in the event of a request for surrender. The Internal Revenue Code imposes limits on the amounts, duration, and repayment schedule for all 403(b) plan loans. If the Plan is subject to the requirements of Title 1 of the Employee Retirement Income Security Act of 1974, eligibility for, and the terms and conditions of the loan may be further limited by the terms of the Plan and will be determined by the plan administrator or other designated Plan official. Loan proceeds may cause you to incur tax liability (see "Federal Tax Considerations"). MetLife USA may modify or terminate the granting of loans at any time, provided that any modification or termination will not affect outstanding loans. Fees may be charged for loan set-up and administration. Currently, the loan set-up fee is $50. This amount is deducted from the loan proceeds. At this time, there is no fee for administration. CYBERSECURITY Our variable annuity contract business is largely conducted through digital communications and data storage networks and systems operated by us and our service providers or other business partners (e.g., the Funds and the firms involved in the distribution and sale of our variable annuity contracts). For example, many routine operations, such as processing Owners' requests and elections and day-to-day record keeping, are all executed through computer networks and systems. We have established administrative and technical controls and a business continuity plan to protect our operations against cybersecurity breaches. 32
485BPOS34th Page of 388TOC1stPreviousNextBottomJust 34th
Despite these protocols, a cybersecurity breach could have a material, negative impact on MetLife USA and the Separate Account, as well as Contract Owners and their Contracts. Our operations also could be negatively affected by a cybersecurity breach at a third party, such as a governmental or regulatory authority or another participant in the financial markets. Cybersecurity breaches can be intentional or unintentional events, and can occur through unauthorized access to computer systems, networks or devices; infection from computer viruses or other malicious software code; or attacks that shut down, disable, slow or otherwise disrupt operations, business processes or website access or functionality. Cybersecurity breaches can interfere with our processing of contract transactions, including the processing of transfer orders from our website or with the Funds; impact our ability to calculate Accumulation Unit values; cause the release and possible destruction of confidential Contract Owner or business information; or impede order processing or cause other operational issues. Although we continually make efforts to identify and reduce our exposure to cybersecurity risk, there is no guarantee that we will be able to successfully manage this risk at all times. MODIFICATION OF THE CONTRACTS MetLife USA must make Annuity payments involving life contingencies at no less than the minimum guaranteed Annuity rates incorporated into the Contracts, even if actual mortality experience is different. MetLife USA is legally bound under the Contract to maintain these Annuity purchase rates. MetLife USA must also abide by the Contract's provisions concerning: .. death benefits .. deductions from Purchase Payments .. deductions from Participant's Accounts for transaction charges .. deductions from the Separate Account for actuarial risk and administrative expense risk fees .. guaranteed rates with respect to fixed benefits MetLife USA and the Owner may change the Contract by mutual agreement at any time. No such change may affect any Participant's Account where the Participant's interest is nonforfeitable, without the written consent of that Participant. Changes must be made in writing. Any changes must comply with state laws where the Contract is delivered. MetLife USA may change such provisions without your consent to the extent permitted by the Contract, but only: .. with respect to any Purchase Payments received as a tax free transfer under the Internal Revenue Code after the effective date of the change; .. with respect to benefits and values provided by Purchase Payments made after the effective date of the change to the extent that such 33
485BPOS35th Page of 388TOC1stPreviousNextBottomJust 35th
Purchase Payments in any Certificate Year exceed the first year's Purchase Payments; or .. to the extent necessary to conform the Contract to any Federal or state law, regulation or ruling. We will notify you of any Contract changes. If you have any questions about any of the provisions of your Contract, you may write or call: MetLife Insurance Company USA 11225 North Community House Road, Charlotte, NC 28277 Phone: (800) 283-4536 [SIDE BAR: ACCUMULATION PERIOD] CREDITING ACCUMULATION UNITS IN THE SEPARATE ACCOUNT MetLife USA will credit Accumulation Units to a Series upon receipt of your Purchase Payment or transfer. MetLife USA determines the number of Accumulation Units to be credited to a Series by dividing the net amount allocated to a Series out of your Purchase Payment by the value of an Accumulation Unit in the Series next computed following receipt of the Purchase Payment or transfer. SEPARATE ACCOUNT ACCUMULATION UNIT CURRENT VALUES [SIDE BAR: The Net Investment Factor is an index of the percentage change (adjusted for distributions by the Fund and the deduction of the mortality and expense risk and distribution expense charges) in the net asset value of the Fund in which a Series is invested, since the preceding Valuation Date. The net investment factor may be greater or less than 1 depending upon the Fund's investment performance.] The current value of Accumulation Units of a particular Series depends upon the investment experience of the Fund in which the Series invests its assets and the deduction of the separate account charge as described below. Purchase Payments and transfer requests are credited to a Participant's Account on the basis of the Accumulation Unit value next determined after receipt of a Purchase Payment or transfer request. The value of Accumulation Units is determined each Business Day as of the close of trading on the New York Stock Exchange (currently 4:00 p.m. Eastern time). The value is calculated by multiplying the value of an Accumulation Unit in the Series on the immediately preceding Valuation Date by the net investment factor for the period since that day. The net investment factor is determined for any Business Day by dividing (i) the net asset value of a share of the Fund which is represented by such Series at the close of business on such day, plus the per share amount of any distributions made by such Fund on such day by (ii) the net asset value of a share of such Fund determined as of the close of business on the preceding Business Day and then subtracting from the result the daily factors for mortality and expense risks (.003699%) for each calendar day between the preceding Business Day and the end of the current Business Day. You bear the risk that the aggregate current value invested in the Series may at any time be less than, equal to or more than the amount that you originally allocated to the Series. SURRENDER FROM THE SEPARATE ACCOUNT You may surrender all or a portion of the cash value of your Participant's Account at any time prior to the Annuity Date. A surrender may result in adverse Federal income tax consequences to you including current 34
485BPOS36th Page of 388TOC1stPreviousNextBottomJust 36th
taxation on the distribution and a penalty tax on the early withdrawal and may be restricted by the plan or Federal tax law. These consequences are discussed in more detail under "Federal Tax Considerations." You should consult your tax adviser before making a withdrawal. The surrender value of your Participant's Account in the Separate Account prior to the Annuity Date is determined by multiplying the number of Accumulation Units for each Series credited to your Contract by the current value of an Accumulation Unit in the Series and subtracting any applicable surrender charges. MetLife USA will determine the value of the number of Accumulation Units withdrawn at the next computed Accumulation Unit value. If you request a partial surrender from more than one Series you must specify the allocation of the partial surrender among the Series. You may not make a partial surrender if the surrender would cause your interest in any Series or the General Account to have an after surrender value of less than $200. However, if you are withdrawing the entire amount allocated to a Series these restrictions do not apply. PAYMENT OF SURRENDER AMOUNT Payment of any amount surrendered from a Series will be made to you within seven days of the date that MetLife USA receives your written request. MetLife USA may suspend surrenders when: .. The SEC restricts trading on the New York Stock Exchange or the Exchange is closed for other than weekends or holidays. .. The SEC permits the suspension of withdrawals. .. The SEC determines that an emergency exists that makes disposal of portfolio securities or valuation of assets of the Funds not reasonably practicable. We may withhold payment of surrender, withdrawal or loan proceeds if any portion of those proceeds would be derived from a Contract Owner's check that has not yet cleared (i.e., that could still be dishonored by your banking institution). We may use telephone, fax, Internet or other means of communications to verify that payment from the Contract Owner's check has been or will be collected. We will not delay payment longer than necessary for us to verify that payment has been or will be collected. Contract Owners may avoid the possibility of delay in the disbursement of proceeds coming from a check that has not yet cleared by providing us with a certified check. ACCOUNT STATEMENTS You will receive a written account statement each calendar quarter in which a transaction occurs before the Annuity Date. Even if you do not engage in any transactions you will receive at least one written account statement per year. The statement shows: .. all transactions for the period being reported 35
485BPOS37th Page of 388TOC1stPreviousNextBottomJust 37th
.. the number of Accumulation Units that are credited to your Participant's Account in each Series .. the current Accumulation Unit value for each Series .. your Participant's Account as of the end of the reporting period MetLife USA is careful to ensure the accuracy of calculations and transfers to and within the Separate Account. However, errors may still occur. You should review your statements and confirmations of transactions carefully and promptly advise MetLife USA of any discrepancy. Allocations and transfers reflected in a statement will be considered final at the end of 60 days from the date of the statement. [SIDE BAR: ANNUITY BENEFITS] VARIABLE ANNUITY PAYMENTS The value of your Participant's Account in each Series may be applied to provide you with Variable Annuity payments. The dollar amount of the Variable Annuity payments that you receive will reflect the investment experience of the Series, but will not be affected by adverse mortality experience which may exceed the mortality risk charge established under the Contract. ASSUMED INVESTMENT RETURN Unless you elect otherwise, the Assumed Investment Return is 4.25% per year. If the laws and regulations of your State allow, you may elect an Assumed Investment Return of 3.50%, 5% or 6%. The Assumed Investment Return does not bear any relationship to the actual net investment experience of the Series. Your choice of Assumed Investment Return affects the pattern of your Annuity payments. Your Annuity payments will vary from the Assumed Investment Return depending on whether the investment experience of the Series in which you have an interest is better or worse than the Assumed Investment Return. The higher your Assumed Investment Return, the higher your first Annuity payment will be. Your next payments will only increase in proportion to the amount by which the investment experience of your chosen Series exceeds the Assumed Investment Return and Separate Account charges. Likewise, your payments will decrease if the investment experience of your chosen Series is less than the Assumed Investment Return and Separate Account charges. A lower Assumed Investment Return will result in a lower initial Annuity payment, but subsequent Annuity payments will increase more rapidly or decline more slowly as changes occur in the investment experience of the Series. Conversely, a higher Assumed Investment Return would result in a higher initial payment than a lower Assumed Investment Return, but later payments will rise more slowly or fall more rapidly. [SIDE BAR: There are two people who are involved in payments under your Annuity: - you - the Beneficiary] ELECTION OF ANNUITY DATE AND FORM OF ANNUITY You choose the Annuity Date and the form of Annuity payment. 36
485BPOS38th Page of 388TOC1stPreviousNextBottomJust 38th
ELECTION OF ANNUITY DATE If you do not choose an Annuity Date at least thirty-one days before Annuitization, your Normal Annuity Date automatically will be the later of: .. the month in which you attain age 75, or .. the date you are required to take a distribution under the terms of the Plan to which the Contract was issued. You may select an optional Annuity Date that is earlier than the Normal Annuity Date described above. This Annuity Date may be the first day of any month before the Normal Annuity Date. Please note that Qualified Contracts may require a different Normal Annuity Date and may prohibit the selection of certain optional Annuity Dates. FORM OF ANNUITY Currently, MetLife USA provides you with five forms of Annuity payments. Each Annuity payment option, except Option 5, is available on both a Fixed Annuity payment and Variable Annuity payment basis. Option 5 is available on a Fixed Annuity payment basis only. OPTION 1 -- LIFE ANNUITY You receive Annuity payments monthly during your lifetime. These payments stop with the last payment due before your death. Because MetLife USA does not guarantee a minimum number of payments under this arrangement, this option offers the maximum level of monthly payments, involving a life contingency. OPTION 2 -- LIFE ANNUITY WITH 120, 180, OR 240 MONTHLY PAYMENTS CERTAIN You receive a guaranteed minimum number of monthly Annuity payments during your lifetime. In addition, MetLife USA guarantees that your Beneficiary will receive monthly payments for the remainder of the period certain, if you die during that period. OPTION 3 -- INSTALLMENT REFUND LIFE ANNUITY An Annuity payable monthly during the lifetime of an individual. You receive a guaranteed minimum number of monthly payments which are equal to the amount of your Participant's Account allocated to this option divided by the first monthly payment. If you die before receiving the minimum number of payments, the remaining payments will be made to your Beneficiary. OPTION 4 -- JOINT AND LAST SURVIVOR LIFE ANNUITY You receive Annuity payments monthly during the lifetime of you and another payee (the joint payee) and payments are made during the lifetime of the survivor of the two of you. MetLife USA stops making payments with the last payment before the death of the last surviving payee. MetLife USA does not guarantee a minimum number of payments under this 37
485BPOS39th Page of 388TOC1stPreviousNextBottomJust 39th
arrangement. For example, you or the other payee might receive only one Annuity payment if both of you die before the second Annuity payment. The election of this option is ineffective if either of you dies before Annuitization. In that case, the survivor becomes the sole payee, and MetLife USA does not pay death proceeds because of the death of the other payee. OPTION 5 -- PAYMENTS FOR A DESIGNATED PERIOD (FIXED ANNUITY ONLY) MetLife USA makes Annuity payments monthly to you or to the Beneficiary at your death, for a selected number of years ranging from five to thirty. The amount of each payment will be based on an interest rate determined by MetLife USA that will not be less than an assumed rate of return of 3.50% per year. You may not commute Fixed Annuity payments to a lump sum under this option. If your Contract is a Qualified Contract, this option may not always satisfy minimum required distribution rules. Consult a tax advisor before electing this option. Due to underwriting, administrative or Internal Revenue Code considerations, there may be limitations on payments to the survivor under Option 4 and/or the duration of the guarantee period under Options 2 and 5. If you do not choose a form of Annuity payment, Option 2, a life annuity with a guaranteed minimum of 120 monthly payments, will automatically be applied under the Contract. You may make changes in the optional form of Annuity payment at any time until 31 days before the Annuity date. The first year's Annuity payment described in Options 1 - 4 is calculated on the basis of: .. the mortality table specified in the Contract .. the age, and where permitted, the sex of the Annuitant .. the type of Annuity payment option selected, and .. the assumed investment return selected. Your Annuity payments will depend on your choices. For lifetime options, the age of the Annuitant will also be considered. For example, if you select an Annuity Option that guarantees payments for your lifetime and your spouse's lifetime, your payments will be lower than if you selected an Annuity Option with payments over only your lifetime. Annuity Options that guarantee that payments will be made for a certain number of years regardless of whether you are alive (such as a Life Annuity with 120, 180, or 240 Monthly Payments Certain and Installment Life Refund Annuity) result in payments smaller than with Annuity Options without such guarantee (such as Life Annuity and Joint and Last Survivor Life Annuity). In addition, to the extent the Annuity Option has a guarantee period, choosing a shorter guarantee period will result in each payment being larger. 38
485BPOS40th Page of 388TOC1stPreviousNextBottomJust 40th
If you were issued a certificate before state law mandated unisex annuity rates (if applicable in your state) and that certificate had annuity rates that took the annuitant's sex into account, the annuity rates we use for that certificate will not be less than the guaranteed rates in the certificate when it was issued. The Fixed Annuity payments described in Option 5 are calculated on the basis of: .. the number of years in the payment period, and .. the interest rate guaranteed with respect to the option. Fixed Annuities are funded through the General Account of MetLife USA. FREQUENCY OF PAYMENT Your payments under all options will be made on a monthly basis unless you and MetLife USA have agreed to a different arrangement (choosing less frequent payments will result in each payment being larger). Payments from each Series must be at least $50. If a payment from a Series will be less than $50, MetLife USA has the right to decrease the frequency of payments so that each payment from a Series will be at least $50. LEVEL PAYMENTS VARYING ANNUALLY Your Variable Annuity payments are determined yearly rather than monthly. As a result, you will receive a uniform monthly Annuity payment for each Annuity year. The level of payments for each year is based on the investment performance of the Series up to the Valuation Date as of which the payments are determined for the year. As a result, the amounts of the Annuity payments will vary with the investment performance of the Series from year to year rather than from month to month. Your monthly Variable Annuity payments for the first year will be calculated on the last Valuation Date of the second calendar week before the Annuity date. The amount of your monthly Variable Annuity payments will be calculated using a formula described in the Contract. On each anniversary of the Annuity date, MetLife USA will determine the total monthly payments for the year then beginning. These payments will be determined by multiplying the number of Annuity units in each Series from which payments are to be made by the annuity unit value of that Series for the valuation period in which the first payment for that period is due. After calculating the amount due to you, MetLife USA transfers the amount of the year's Variable Annuity payments to a General Account at the beginning of the year. Although the amount in the Separate Account is credited to you and transferred to the General Account, you do not have any property rights in this amount. You do have a contractual right to receive your Annuity payments. The monthly Annuity payments for the year are made from the General Account with interest using the standard assumed investment return of 4.25% or the Assumed Investment Return that you selected. As a result, 39
485BPOS41st Page of 388TOC1stPreviousNextBottomJust 41st
MetLife USA will experience profits or losses on the amounts placed in the General Account in providing level monthly payments to you during the year that meet the Assumed Investment Return that you selected. For example, if the net investment income and gains in the General Account are lower than the Assumed Investment Return selected, MetLife USA will experience a loss. You will not benefit from any increases or be disadvantaged from any decreases in any Annuity Unit Values during the year because the Annuity payments for that year are set at the beginning of the year. These increases and decreases will be reflected in the calculation of Annuity payments for the following year. ANNUITY UNIT VALUES This is how MetLife USA calculates the Annuity Unit Value for each Series: .. First, MetLife USA determines the change in investment experience (including any investment-related charge) for the underlying Fund from the previous trading day to the current trading day. .. Next, it subtracts the daily equivalent of your insurance-related charge (general administrative expense and mortality and expense risk charges) for each day since the last day the Annuity Unit Value was calculated. .. Then, it divides the result by the quantity of one plus the weekly equivalent of your Assumed Investment Return. .. Finally, the previous Annuity Unit Value is multiplied by this result. [SIDE BAR: DEATH BENEFITS] DEATH BEFORE THE ANNUITY DATE If you die before the Annuity Date, your Beneficiary(ies) will receive a death benefit that is equal to the Participant's Account. If you are younger than age 65 at the time of your death, your Beneficiary(ies) will be entitled to receive a lump sum settlement equal to the greater of: .. your Purchase Payments less partial withdrawals or amounts already applied to Annuity payments (including any applicable surrender charge); or .. your Participant's Account. Your Beneficiary(ies) receive the death benefit as either: 1) A lump sum that must be made within five (5) years of your death; or 2) Annuity income under Annuity Income Options One, Two or Five described in Article 7 of the Contract. If your Beneficiary(ies) chooses one of the Annuity income options: .. Payments must begin within one year of your death (However, if your spouse is the sole designated beneficiary under a Qualified Contract, 40
485BPOS42nd Page of 388TOC1stPreviousNextBottomJust 42nd
your spouse may delay commencement of payments to the date that you would have reached 70 1/2.) .. The guaranteed period under Option Two or the designated period under Option Five may not be longer than the Beneficiary's life expectancy under applicable tables specified by the Internal Revenue Service. .. The Participant's Account on the date of the first Annuity payment will be used to determine the amount of the death benefit. The death benefit will be determined when MetLife USA receives both due proof of death and an election for the payment method. Note that if MetLife USA is notified of your death before any requested transaction is completed (including transactions under a dollar cost averaging or reallocation program), we will cancel the request. If your spouse is your sole Beneficiary under an IRA, he or she may choose to succeed to your rights as Participant rather than to take the death benefit. Any Internal Revenue Code reference to "spouse" includes those persons who are married spouses under state law, regardless of sex. All Contract provisions will be interpreted and administered in accordance with the requirements of the Internal Revenue Code. If you have more than one Beneficiary living at the time of your death, each will share the proceeds of the death benefit equally unless you elect otherwise. If you outlive all of your Beneficiaries, the death benefit will be paid to your estate in a lump sum. No Beneficiary shall have the right to assign or transfer any future payments under the Options, except as provided in the election or by law. You will also be considered to have outlived your Beneficiary(ies) in the following situations: .. Your Beneficiary(ies) and you die at the same time. .. Your Beneficiary(ies) dies within 15 days of your death and proof of your death is received by MetLife USA before the date due. Proof of death includes a certified death certificate, or attending physician's statement, a decree of a court of competent jurisdiction as to the finding of death, or other documents that MetLife USA agrees to accept as proof of death. DEATH AFTER THE ANNUITY DATE If the Annuitant dies on or after the Annuity Date, the amounts payable to the Beneficiary(ies) or other properly designated payees will consist of any continuing payments under the Annuity Payment option in effect. In this case, the Beneficiary will: .. have all the remaining rights and powers under a Contract, and .. be subject to all the terms and conditions of the Contract. 41
485BPOS43rd Page of 388TOC1stPreviousNextBottomJust 43rd
If none of your Beneficiaries survive the Annuitant, the value of any remaining payments certain on the death of Annuitant, calculated on the basis of the assumed investment return that you previously chose, will be paid in a lump sum to the Annuitant's estate unless other provisions have been made and approved by MetLife USA. This value is calculated on the next day of payment following receipt of due proof of death. Unless otherwise restricted, a Beneficiary receiving variable payments under Option Two or Three may elect at any time to receive the present value of the remaining number of Annuity payments certain in a lump sum payment after the death of an Annuitant. The present value of the remaining Annuity payments will be calculated on the basis of the assumed investment return previously selected. This lump sum payment election is not available to a Beneficiary receiving Fixed Annuity payments. ABANDONED PROPERTY REQUIREMENTS Every state has unclaimed property laws which generally declare non-ERISA (Employee Retirement Income Security Act of 1974) annuity contracts to be abandoned after a period of inactivity of three to five years from the contract's maturity date (the last day on which annuity payments may begin under the Contract) or the date the death benefit is due and payable. For example, if the payment of a death benefit has been triggered, but, after a thorough search, we are still unable to locate the Beneficiary of the death benefit, or the Beneficiary does not come forward to claim the death benefit in a timely manner, the death benefit will be paid to the abandoned property division or unclaimed property office of the state in which the Beneficiary or you last resided, as shown on our books and records, or to our state of domicile. ("Escheatment" is the formal, legal name for this process.) However, the state is obligated to pay the death benefit (without interest) if your Beneficiary steps forward to claim it with the proper documentation. To prevent your Contract's proceeds from being paid to the state abandoned or unclaimed property office, it is important that you update your Beneficiary designations, including addresses, if and as they change. Please contact us to make such changes. 42
485BPOS44th Page of 388TOC1stPreviousNextBottomJust 44th
FEDERAL TAX CONSIDERATIONS INTRODUCTION The following information on taxes is a general discussion of the subject. It is not intended as tax advice. The Internal Revenue Code (the "Code") and the provisions of the Code that govern the Contract are complex and subject to change. The applicability of Federal income tax rules may vary with your particular circumstances. This discussion does not include all the Federal income tax rules that may affect You and your Contract. Nor does this discussion address other Federal tax consequences (such as estate and gift taxes, sales to foreign individuals or entities), or state or local tax consequences, which may affect your investment in the Contract. As a result, You should always consult a tax adviser for complete information and advice applicable to your individual situation. You are responsible for determining whether your purchase of a Contract, withdrawals, income payments and any other transactions under your Contract satisfy applicable tax law. We are not responsible for determining if your employer's plan or arrangement satisfies the requirements of the Code and/or the Employee Retirement Income Security Act of 1974 ("ERISA"). We do not expect to incur Federal, state or local income taxes on the earnings or realized capital gains attributable to the Separate Account. However, if we do incur such taxes in the future, we reserve the right to charge amounts allocated to the Separate Account for these taxes. To the extent permitted under Federal tax law, we may claim the benefit of the corporate dividends received deduction and of certain foreign tax credits attributable to taxes paid by certain of the portfolios to foreign jurisdictions. Any Code reference to "spouse" includes those persons who are married spouses under state law, regardless of sex. QUALIFIED ANNUITY CONTRACTS INTRODUCTION The Contract may be purchased through certain types of retirement plans that receive favorable treatment under the Code ("tax qualified plans"). Tax-qualified plans include arrangements described in Code Sections 401(a), 401(k), 403(a), 403(b) or tax sheltered annuities ("TSA"), 408 or "IRAs" (including SEP and SIMPLE IRAs), 408A or "Roth IRAs" or 457 (b) or 457(b) governmental plans. Extensive special tax rules apply to qualified plans and to the annuity Contracts used in connection with these plans. Therefore, the following discussion provides only general information about the use of the Contract with the various types of qualified plans. Adverse tax consequences may result if You do not ensure that contributions, distributions and other transactions with respect to the Contract comply with the law. 43
485BPOS45th Page of 388TOC1stPreviousNextBottomJust 45th
The rights to any benefit under the plan will be subject to the terms and conditions of the plan itself as well as the terms and conditions of the Contract. We exercise no control over whether a particular retirement plan or a particular contribution to the plan satisfies the applicable requirements of the Code, or whether a particular individual is entitled to participate or benefit under a plan. All qualified plans and arrangements receive tax deferral under the Code. Since there are no additional tax benefits in funding such retirement arrangements with an annuity, there should be reasons other than tax deferral for acquiring the annuity within the plan. Such non-tax benefits may include additional insurance benefits, such as the availability of a guaranteed income for life. A Contract may also be available in connection with an employer's non-qualified deferred compensation plan and qualified governmental excess benefit arrangement to provide benefits to certain employees in the plan. The tax rules regarding these plans are complex. We do not provide tax advice. Please consult your tax adviser about your particular situation. ACCUMULATION The tax rules applicable to qualified plans vary according to the type of plan and the terms and conditions of the plan itself. Both the amount of the contribution that may be made and the tax deduction or exclusion that You may claim for that contribution are limited under qualified plans. See the SAI for a description of qualified plan types and annual current contribution limitations which are subject to change from year-to-year. Purchase payments or contributions to IRAs or tax qualified retirement plans of an employer may be taken from current income on a before tax basis or after tax basis. Purchase payments made on a "before tax" basis entitle You to a tax deduction or are not subject to current income tax. Purchase payments made on an "after tax" basis do not reduce your taxable income or give You a tax deduction. Contributions may also consist of transfers or rollovers as described below which are not subject to the annual limitations on contributions. The Contract will accept as a single purchase payment a transfer or rollover from another IRA or rollover from an eligible retirement plan of an employer (i.e., 401(a), 401(k), 403(a), 403(b) or governmental 457(b) plan.) It will also accept a rollover or transfer from a SIMPLE IRA after the taxpayer has participated in such arrangement for at least two years. As part of the single purchase payment, the IRA Contract will also accept an IRA contribution subject to the Code limits for the year of purchase. For income annuities established as "pay-outs" of SIMPLE IRAs, the Contract will only accept a single purchase payment consisting of a transfer or rollover from another SIMPLE IRA. For income annuities established in accordance with a distribution option under a retirement plan of an employer (e.g., 401(a), 401(k), 403(a), 403(b) or 457(b) plan), 44
485BPOS46th Page of 388TOC1stPreviousNextBottomJust 46th
the Contract will only accept as its single purchase payment a transfer from such employer retirement plan. TAXATION OF ANNUITY DISTRIBUTIONS If contributions are made on a "before tax" basis, You generally pay income taxes on the full amount of money You withdraw as well as income earned under the Contract. Withdrawals attributable to any after-tax contributions are your basis in the Contract and not subject to income tax (except for the portion of the withdrawal allocable to earnings). Under current Federal income tax rules, the taxable portion of distributions under annuity contracts and qualified plans (including IRAs) is not eligible for the reduced tax rate applicable to long-term capital gains and qualifying dividends. With respect to IRA Contracts, we will withhold a portion of the taxable amount of your withdrawal for income taxes, unless You elect otherwise. The amount we withhold is determined by the Code. WITHDRAWALS PRIOR TO AGE 59 1/2 A taxable withdrawal or distribution from a qualified plan which is subject to income tax may also be subject to a 10% Federal income tax penalty for "early" distribution if taken prior to age 59 1/2, unless an exception described below applies. The penalty rate is 25% for SIMPLE plan Contracts if the distribution occurs within the first 2 years of your participation in the plan. These exceptions include distributions made: (a) on account of your death or disability, or (b) as part of a series of substantially equal periodic payments payable for your life or joint lives of You and your designated beneficiary and You are separated from employment. If You receive systematic payments that You intend to qualify for the "substantially equal periodic payments" exception noted above, any modifications (except due to death or disability) to your payment before age 59 1/2 or within five years after beginning these payments, whichever is later, will result in the retroactive imposition of the 10% Federal income tax penalty with interest. Such modifications may include additional purchase payments or withdrawals (including tax-free transfers or rollovers of income payments) from the Contract. In addition, a withdrawal or distribution from a qualified annuity Contract other than an IRA (including SEPs and SIMPLEs) will avoid the penalty if: (1) the distribution is on separation from employment after age 55; (2) the distribution is made pursuant to a qualified domestic relations order ("QDRO"); (3) the distribution is to pay deductible medical expenses; or (4) if the distribution is to pay IRS levies (and made after December 31, 1999). 45
485BPOS47th Page of 388TOC1stPreviousNextBottomJust 47th
The 10% Federal income tax penalty on early distribution does not apply to governmental 457(b) plan Contracts. However, it does apply to distributions from 457(b) plans of employers which are state or local governments to the extent that the distribution is attributable to rollovers accepted from other types of eligible retirement plans. In addition to death, disability and as part of a series of substantially equal periodic payments as indicated above, a withdrawal or distribution from an IRA (including SEPs and SIMPLEs) will avoid the penalty (1) if the distribution is to pay deductible medical expenses; (2) if the distribution is to pay IRS levies (and made after December 31, 1999); (3) if the distribution is used to pay for medical insurance (if You are unemployed), qualified higher education expenses, or for a qualified first time home purchase up to $10,000. Other exceptions may be applicable under certain circumstances and special rules may be applicable in connection with the exceptions enumerated above. ROLLOVERS Your Contract is non-forfeitable (i.e., not subject to the claims of your creditors) and non-transferable (i.e., You may not transfer it to someone else). Nevertheless, Contracts held in certain employer plans subject to ERISA may be transferred in part pursuant to a QDRO. Under certain circumstances, You may be able to transfer amounts distributed from your Contract to another eligible retirement plan or IRA. For 457(b) plans maintained by non-governmental employers, if certain conditions are met, amounts may be transferred into another 457(b) plan maintained by a non-governmental employer. You may make rollovers and direct transfers into your SIMPLE IRA annuity Contract from another SIMPLE IRA annuity contract or account. No other rollovers or transfers can be made to your SIMPLE IRA. Rollovers and direct transfers from a SIMPLE IRA can only be made to another SIMPLE IRA or account during the first two years that You participate in the SIMPLE IRA plan. After this two year period, rollovers and transfers may be made from your SIMPLE IRA into a Traditional IRA or account, as well as into another SIMPLE IRA. Generally, a distribution may be eligible for rollover. Certain types of distributions cannot be rolled over, such as distributions received on account of: (a) minimum distribution requirements, or (b) financial hardship. 20% WITHHOLDING ON ELIGIBLE ROLLOVER DISTRIBUTIONS For certain qualified employer plans, we are required to withhold 20% of the taxable portion of your withdrawal that constitutes an "eligible rollover distribution" for Federal income taxes. The amount we withhold is determined by the Code. You may avoid withholding if You assign or transfer a withdrawal from this Contract directly into another qualified 46
485BPOS48th Page of 388TOC1stPreviousNextBottomJust 48th
plan or IRA. Similarly, You may be able to avoid withholding on a transfer into this Contract from an existing qualified plan You may have with another provider by arranging to have the transfer made directly to us. For taxable withdrawals that are not "eligible rollover distributions," the Code requires different withholding rules which determine the withholding amounts. DEATH BENEFITS The death benefit is taxable to the recipient in the same manner as if paid to the Contract owner or plan participant (under the rules for withdrawals or income payments, whichever is applicable). Distributions required from a qualified annuity Contract following your death depend on whether You die before You had converted your Contract to an annuity form and started taking annuity payments (your Annuity Starting Date). If You die on or after your Annuity Starting Date, the remaining portion of the interest in the Contract must be distributed at least as rapidly as under the method of distribution being used as of the date of death. If You die before your Annuity Starting Date, the entire interest in the Contract must be distributed within five (5) years after the date of death, or as periodic payments over a period not extending beyond the life or life expectancy of the designated beneficiary (provided such payments begin within one year of your death). Your designated beneficiary is the person to whom benefit rights under the Contract pass by reason of death; the beneficiary must be a natural person in order to elect a periodic payment option based on life expectancy or a period exceeding five years. Additionally, if the annuity is payable to (or for the benefit of) your surviving spouse, that portion of the Contract may be continued with your spouse as the owner. If your spouse is your beneficiary, and your Contract permits, your spouse may delay the start of these payments until December 31 of the year in which You would have reached age 70 1/2. If your spouse is your beneficiary, your spouse may be able to rollover the death proceeds into another eligible retirement plan in which he or she participates, if permitted under the receiving plan. Alternatively, if your spouse is your sole beneficiary, he or she may elect to rollover the death proceeds into his or her own IRA. If your beneficiary is not your spouse and your plan and Contract permit, your beneficiary may be able to rollover the death proceeds via a direct trustee-to-trustee transfer into an inherited IRA. However, a non-spouse beneficiary may not treat the inherited IRA as his or her own IRA. Additionally, for Contracts issued in connection with qualified plans subject to ERISA, the spouse or ex-spouse of the owner may have rights in the Contract. In such a case, the owner may need the consent of the spouse or ex-spouse to change annuity options or make a withdrawal from the Contract. 47
485BPOS49th Page of 388TOC1stPreviousNextBottomJust 49th
REQUIRED MINIMUM DISTRIBUTIONS Generally, You must begin receiving retirement plan withdrawals by April 1 following the latter of: (a) the calendar year in which You reach age 70 1/2, or (b) the calendar year You retire, provided You do not own more than 5% of your employer. For IRAs (including SEPs and SIMPLEs), You must begin receiving withdrawals by April 1 of the year after You reach age 70 1/2 even if You have not retired. A tax penalty of 50% applies to the amount by which the required minimum distribution exceeds the actual distribution. You may not satisfy minimum distributions for one employer's qualified plan (i.e., 401(a), 403(a), 457(b)) with distributions from another qualified plan of the same or a different employer. However, an aggregation rule does apply in the case of IRAs (including SEPs and SIMPLEs) or 403(b) plans. The minimum required distribution is calculated with respect to each IRA, but the aggregate distribution may be taken from any one or more of your IRAs/SEPs. Similarly, the amount of required minimum distribution is calculated separately with respect to each 403(b) arrangement, but the aggregate amount of the required distribution may be taken from any one or more of the your 403(b) plan contracts. For SIMPLE IRAs, the aggregate amount of the required distribution may be taken from any one or more of your SIMPLE IRAs. Complex rules apply to the calculation of these withdrawals. In general, income tax regulations permit income payments to increase based not only with respect to the investment experience of the portfolios but also with respect to actuarial gains. The regulations also require that the value of benefits under a deferred annuity including certain death benefits in excess of Contract value must be added to the amount credited to your account in computing the amount required to be distributed over the applicable period. We will provide You with additional information regarding the amount that is subject to minimum distribution under this rule. You should consult your own tax adviser as to how these rules affect your own distribution under this rule. If You intend to receive your minimum distributions which are payable over the joint lives of You and a beneficiary who is not your spouse (or over a period not exceeding the joint life expectancy of You and your non-spousal beneficiary), be advised that Federal tax rules may require that payments be made over a shorter period or may require that payments to the beneficiary be reduced after your death to meet the minimum distribution incidental benefit rules and avoid the 50% excise tax. You should consult your own tax adviser as to how these rules affect your own Contract. 48
485BPOS50th Page of 388TOC1stPreviousNextBottomJust 50th
ADDITIONAL INFORMATION REGARDING TSA (ERISA AND NON-ERISA) 403(B) SPECIAL RULES REGARDING EXCHANGES In order to satisfy tax regulations, contract exchanges within a 403(b) plan after September 24, 2007, must, at a minimum, meet the following requirements: (1) the plan must allow the exchange; (2) the exchange must not result in a reduction in a participant's or a beneficiary's accumulated benefit: (3) the receiving contract includes distribution restrictions that are no less stringent than those imposed on the contract being exchanged; and (4) if the issuer receiving the exchanges is not part of the plan, the employer enters into an agreement with the issuer to provide information to enable the contract provider to comply with Code requirements. Such information would include details concerning severance from employment, hardship withdrawals, loans and tax basis. You should consult your tax or legal counsel for any advice relating to Contract exchanges or any other matter relating to these regulations. WITHDRAWALS If You are under age 59 1/2, You generally cannot withdraw money from your TSA Contract unless the withdrawal: 1. Related to purchase payments made prior to 1989 and pre-1989 earnings on those purchase payments; 2. Is exchanged to another permissible investment under your 403(b) plan; 3. Relates to contributions to an annuity contract that are not salary reduction elective deferrals , if your plan allows it; 4. Occurs after You die, leave your job or become disabled (as defined by the Code); 5. Is for financial hardship (but only to the extent of elective deferrals), if your plan allows it; 6. Relates to distributions attributable to certain TSA plan terminations, if the conditions of the Code are met; 7. Relates to rollover or after-tax contributions; or 8. Is for the purchase of permissive service credit under a governmental defined benefit plan. In addition, a Section 403(b) Contract is permitted to distribute retirement benefits attributable to pre-tax contributions other than elective deferrals to the participant no earlier than upon the earlier of the participant's severance from employment or upon the prior occurrence of some event, such as after a fixed number of years, the attainment of a stated age or disability. ADDITIONAL INFORMATION REGARDING IRAS PURCHASE PAYMENTS Traditional IRA purchase payments (except for permissible rollovers and direct transfers) are generally not permitted after you attain age 70 1/2. 49
485BPOS51st Page of 388TOC1stPreviousNextBottomJust 51st
Except for permissible rollovers and direct transfers, purchase payments for individuals are limited in the aggregate to the lesser of 100% of compensation or the deductible amount established each year under the Code. A purchase payment up to the deductible amount can also be made for a non-working spouse provided the couple's compensation is at least equal to their aggregate contributions. Individuals age 50 and older are permitted to make additional "catch-up" contributions if they have sufficient compensation. If you or your spouse are an active participant in a retirement plan of an employer, your deductible contributions may be limited. If you exceed purchase payment limits You may be subject to a tax penalty. WITHDRAWALS If and to the extent that Traditional IRA purchase payments are made on an "after tax" basis, withdrawals would be included in income except for the portion that represents a return of non-deductible purchase payments. This portion is generally determined based upon the ratio of all non-deductible purchase payments to the total value of all your Traditional IRAs (including SEP IRAs and SIMPLE IRAs). We withhold a portion of the amount of your withdrawal for income taxes, unless You elect otherwise. The amount we withhold is determined by the Code. DISTINCTION FOR PUERTO RICO CODE An annuity Contract may be purchased by an employer for an employee under a qualified pension, profit sharing, stock bonus, annuity, or a "cash or deferred" arrangement plan established pursuant to Section 1081.01 of the 2011 PR Code. To be tax qualified under the 2011 PR Code, a plan must comply with the requirements of Section 1081.01(a) of the 2011 PR Code which includes certain participation requirements, among other requirements. A trust created to hold assets for a qualified plan is exempt from tax on its investment income. CONTRIBUTIONS The employer is entitled to a current income tax deduction for contributions made to a qualified plan, subject to statutory limitations on the amount that may be contributed each year. The plan contributions by the employer are not required to be included in the current income of the employee. DISTRIBUTIONS Any amount received or made available to the employee under the qualified plan is includible in the gross income of the employee in the taxable year in which received or made available. In such case, the amount paid or contributed by the employer shall not constitute consideration paid by the employee for the Contract for purposes of determining the amount of annuity payments required to be included in the employee's gross income. Thus, amounts actually distributed or made available to any employee under the qualified plan will be included in their entirety in the employee's gross income. The value of accrued benefits in a qualified retirement plan with respect to which the special 8% tax under Puerto Rico Act No. 77-2014 was 50
485BPOS52nd Page of 388TOC1stPreviousNextBottomJust 52nd
prepaid will be considered as part of the participant's tax basis in his retirement plan account. Thus, any distributions attributable to the benefits for which such taxes were prepaid will not be subject to income taxes when the same are subsequently received by the participant. However, the investment income and the appreciation in value, if any, accrued on the benefits with respect to which the special tax was prepaid, will be taxed as provided by the tax rules in effect at the time of distribution. Lump-sum proceeds from a Puerto Rico qualified retirement plan due to separation from service will generally be taxed at a 20% capital gain tax rate to be withheld at the source. A special rate of 10% may apply instead, if the plan satisfies the following requirements: (1) the plan's trust is organized under the laws of Puerto Rico, or has a Puerto Rico resident trustee and uses such trustee as paying agent; and (2) 10% of all plan's trust assets (calculated based on the average balance of the investments of the trust) attributable to participants who are Puerto Rico residents must be invested in "property located in Puerto Rico" for a three-year period. If these two requirements are not satisfied, the distribution will generally be subject to the 20% tax rate. The three-year period includes the year of the distribution and the two immediately preceding years. In the case of a defined contribution plan that maintains separate accounts for each participant, the described 10% investment requirement may be satisfied in the accounts of a participant that chooses to invest in such fashion rather than at the trust level. Property located in Puerto Rico includes shares of stock of a Puerto Rico Registered Investment Company (RIC), fixed or variable annuities issued by a domestic insurance company or by a foreign insurance company that derives more than 80% of its gross income from sources within Puerto Rico and bank deposits. The PR 2011 Code does not impose a penalty tax in cases of early (premature) distributions from a qualified plan. ROLLOVER Deferral of the recognition of income continues upon the receipt of a distribution by a participant from a qualified plan, if the distribution is contributed to another qualified retirement plan or traditional individual retirement account for the employee's benefit no later than sixty (60) days after the distribution. ERISA CONSIDERATIONS In the context of a Puerto Rico qualified retirement plan trust, the IRS has recently held that the transfer of assets and liabilities from a qualified retirement plan trust under the Code to that type of plan would generally be treated as a distribution includible in gross income for U.S. income tax purposes even if the Puerto Rico retirement plan is a plan described in ERISA Section 1022(i)(1). By contrast, a transfer from a qualified retirement plan trust under the Code to a Puerto Rico qualified retirement plan trust that has made an election under ERISA Section 1022(i)(2) is not 51
485BPOS53rd Page of 388TOC1stPreviousNextBottomJust 53rd
treated as a distribution from the transferor plan for U.S. income tax purposes because a Puerto Rico retirement plan that has made an election under ERISA Section 1022(i)(2) is treated as a qualified retirement plan for purposes Code Section 401(a). The IRS has determined that the above described rules prescribing the inclusion in income of transfers of assets and liabilities to a Puerto Rico retirement plan trust described in ERISA Section 1022(i)(1) would be applicable to transfers taking effect after December 31, 2012. Similar to the IRS Revenue Ruling 2013-17, the U.S. Department of Labor issued DOL Technical Release No. 2013-04 on September 18, 2013 providing that, where the Secretary of Labor has authority to regulate with respect to the provisions of ERISA dealing with the use of the term "spouse", spouse will be read to refer to any individuals who are lawfully married under any state law, including same-sex spouses, and without regard to whether their state of domicile recognizes same-sex marriage. Thus, for ERISA purposes as well as Federal tax purposes, an employee benefit plan participant who marries a person of the same sex in a jurisdiction that recognizes same-sex marriage will continue to be treated as married even if the couple moves to a jurisdiction, like Puerto Rico, that does not recognize same-sex marriage. VOTING RIGHTS As the owner of the Separate Account, MetLife USA is the legal owner of the shares of the Funds. Based upon MetLife USA's current view of applicable law, we will vote shares of the Funds (which are deemed attributable to the Contracts) based on instructions received from those having voting interests under the Contract concerning Fund shares and who are entitled to vote on Fund proposals at all regular and special shareholders meetings. The persons who have voting interests under a particular plan may include the plan administrator or the Participant if voting is passed through to such individuals. Your plan administrator can provide you with information in this regard. MetLife USA will vote all shares of the underlying Funds as directed. MetLife USA will send to those with voting interests, at a last known address, all periodic reports, proxy materials and written requests for instructions on how to vote those shares. When MetLife USA receives these instructions, it will vote all of the shares in proportion to the instructions. If MetLife USA does not receive voting instructions, from a recipient, it will vote their interest in the same proportion as represented by the votes it has received. The effect of this proportional voting is that a small number of those with voting interests may control the outcome of a vote. If MetLife USA determines that it is permitted to vote the shares in its own right due to changes in the law or in the interpretation of the law it may do so. MetLife USA is under no duty to inquire into voting instructions or into the authority of the person issuing such instructions. All instructions will be valid unless MetLife USA has actual knowledge that they are not. 52
485BPOS54th Page of 388TOC1stPreviousNextBottomJust 54th
When Annuity payments begin, the Annuitant will have all voting rights in regard to Fund shares. There are certain circumstances under which MetLife USA may disregard voting instructions. However, in this event, a summary of our action and the reasons for such action will appear in the next semiannual report. The number of votes that each person having the right to vote receives is determined on a record date that is set no more than 90 days before the meeting. Voting instructions will be requested at least 10 days before the meeting. Only Owners or Annuitants on the record date may vote. The number of shares to which you are entitled to vote is calculated by dividing the portion of your Participant's Account allocated to that Fund on the record date by the net asset value of a Fund share on the same date. LEGAL PROCEEDINGS MetLife USA, like other life insurance companies, is involved on occasion in lawsuits, including class action lawsuits. In some class action and other lawsuits involving insurers, substantial damages have been sought and/or material settlement payments have been made. MetLife USA does not believe any such litigation or proceedings will have a material adverse effect upon the Separate Account or upon the ability of MetLife Investors Distribution Company to perform its contract with the Separate Account or of MetLife USA to meet its obligations under the contracts. ADDITIONAL INFORMATION You may contact MetLife USA at the address and phone number listed on page 28 for further information. A copy of the Statement of Additional Information, dated November 17, 2014, which provides more detailed information about the Contracts, may be obtained by completing and mailing the form on the following page. The table of contents for the Statement of Additional Information is provided below. A Registration Statement has been filed with the SEC under the Securities Act of 1933 for the Contracts offered by this Prospectus. This Prospectus does not contain all of the information in the Registration Statement. Please refer to this Registration Statement for further information about the Separate Account, MetLife USA and the Contracts. Any statements in this Prospectus about the contents of the Contracts and other legal instruments are only summaries. Please see the filed versions of these documents for a complete statement of any terms. 53
485BPOS55th Page of 388TOC1stPreviousNextBottomJust 55th
TABLE OF CONTENTS OF STATEMENT OF ADDITIONAL INFORMATION The Insurance Company Surrender Charges Net Investment Factor Annuity Payments Basis of Variable Benefits Determination of Amount of Monthly Variable Annuity Payments for First Year Determination of Amount of Monthly Variable Annuity Payments for Second and Subsequent Years Annuity Unit Value Underwriters, Distribution of the Contracts Calculation of Performance Voting Rights Safekeeping of Securities Servicing Agent Independent Registered Public Accounting Firm Additional Federal Tax Considerations Qualified Annuity Contracts Types of Qualified Contracts ERISA Federal Estate Taxes Generation-Skipping Transfer Tax Annuity Purchase Payments by Nonresident Aliens and Foreign Corporations Financial Statements 54
485BPOS56th Page of 388TOC1stPreviousNextBottomJust 56th
If you would like the Statement of Additional Information dated May 1, 2015, for the annuity contract issued by MetLife Insurance Company USA, at no charge, please print and fill in all information and mail to: MetLife Insurance Company USA Attn: Variable Products 11225 North Community House Road Charlotte, NC 28277 [Download Table] --------------------------------------------- Name --------------------------------------------- Address --------------------------------------------- City State Zip Code BOOK-702 (11/14) SAI-USAFLEXBONUS 14 ---------- --------------------------------------------------------------------
485BPOS57th Page of 388TOC1stPreviousNextBottomJust 57th
APPENDIX A CONDENSED FINANCIAL INFORMATION PART 1 The following table sets forth condensed financial information on Accumulation Units with respect to Contracts issued under this prospectus that are subject to a daily Separate Account deduction of 1.35%. [Enlarge/Download Table] AUV AT AUV AT ACCUM UNITS BEGINNING END END OF PERIOD OF PERIOD OF PERIOD ------------------------------------------------------------------------------------------ ALGER SMALL CAP GROWTH PORTFOLIO - CLASS I-2 01/01/2004 to 12/31/2004 6.10 7.01 7,517,869 01/01/2005 to 12/31/2005 7.01 8.09 7,055,726 01/01/2006 to 12/31/2006 8.09 9.57 6,743,520 01/01/2007 to 12/31/2007 9.57 11.07 5,891,694 01/01/2008 to 12/31/2008 11.07 5.83 5,755,192 01/01/2009 to 12/31/2009 5.83 8.37 5,514,037 01/01/2010 to 12/31/2010 8.37 10.35 5,077,642 01/01/2011 to 12/31/2011 10.35 9.89 4,710,473 01/01/2012 to 12/31/2012 9.89 10.98 4,352,356 01/01/2013 to 12/31/2013 10.98 14.54 3,990,480 01/01/2014 to 12/31/2014 14.54 14.41 3,625,507 ------------------------------------------------------------------------------------------ AMERICAN FUNDS GLOBAL SMALL CAPITALIZATION FUND - CLASS 2 01/01/2004 to 12/31/2004 16.42 19.58 276,227 01/01/2005 to 12/31/2005 19.58 24.22 455,056 01/01/2006 to 12/31/2006 24.22 29.64 648,230 01/01/2007 to 12/31/2007 29.64 35.51 664,762 01/01/2008 to 12/31/2008 35.51 16.28 757,735 01/01/2009 to 12/31/2009 16.28 25.91 793,690 01/01/2010 to 12/31/2010 25.91 31.29 692,613 01/01/2011 to 12/31/2011 31.29 24.96 608,210 01/01/2012 to 12/31/2012 24.96 29.10 549,030 01/01/2013 to 12/31/2013 29.10 36.83 497,651 01/01/2014 to 12/31/2014 36.83 37.11 444,456 ------------------------------------------------------------------------------------------ AMERICAN FUNDS GROWTH FUND - CLASS 2 01/01/2004 to 12/31/2004 116.56 129.36 130,416 01/01/2005 to 12/31/2005 129.36 148.30 194,602 01/01/2006 to 12/31/2006 148.30 161.27 231,002 01/01/2007 to 12/31/2007 161.27 178.74 199,191 01/01/2008 to 12/31/2008 178.74 98.80 230,814 01/01/2009 to 12/31/2009 98.80 135.89 225,889 01/01/2010 to 12/31/2010 135.89 159.11 197,917 01/01/2011 to 12/31/2011 159.11 150.27 169,705 01/01/2012 to 12/31/2012 150.27 174.76 151,416 01/01/2013 to 12/31/2013 174.76 224.32 137,400 01/01/2014 to 12/31/2014 224.32 240.15 121,838 ------------------------------------------------------------------------------------------ AMERICAN FUNDS GROWTH-INCOME FUND - CLASS 2 01/01/2004 to 12/31/2004 90.71 98.77 135,701 01/01/2005 to 12/31/2005 98.77 103.14 190,268 01/01/2006 to 12/31/2006 103.14 117.23 222,514 ------------------------------------------------------------------------------------------ A-1
485BPOS58th Page of 388TOC1stPreviousNextBottomJust 58th
APPENDIX A CONDENSED FINANCIAL INFORMATION (CONTINUED) [Enlarge/Download Table] AUV AT AUV AT ACCUM UNITS BEGINNING END END OF PERIOD OF PERIOD OF PERIOD ---------------------------------------------------------------------------------------- AMERICAN FUNDS GROWTH-INCOME FUND - CLASS 2 (CONTINUED) 01/01/2007 to 12/31/2007 117.23 121.48 212,107 01/01/2008 to 12/31/2008 121.48 74.48 247,002 01/01/2009 to 12/31/2009 74.48 96.44 255,289 01/01/2010 to 12/31/2010 96.44 106.02 241,144 01/01/2011 to 12/31/2011 106.02 102.69 226,239 01/01/2012 to 12/31/2012 102.69 119.02 216,725 01/01/2013 to 12/31/2013 119.02 156.76 208,850 01/01/2014 to 12/31/2014 156.76 171.10 196,811 ---------------------------------------------------------------------------------------- DWS INTERNATIONAL VIP - CLASS A 01/01/2004 to 12/31/2004 6.79 7.81 3,014,614 01/01/2005 to 12/31/2005 7.81 8.95 3,052,862 01/01/2006 to 12/31/2006 8.95 11.12 3,136,467 01/01/2007 to 12/31/2007 11.12 12.57 3,082,699 01/01/2008 to 12/31/2008 12.57 6.42 2,789,082 01/01/2009 to 12/31/2009 6.42 8.46 2,672,474 01/01/2010 to 12/31/2010 8.46 8.48 2,447,082 01/01/2011 to 12/31/2011 8.48 6.97 2,222,356 01/01/2012 to 12/31/2012 6.97 8.30 2,020,827 01/01/2013 to 12/31/2013 8.30 9.85 1,870,650 01/01/2014 to 12/31/2014 9.85 8.57 1,716,481 ---------------------------------------------------------------------------------------- FIDELITY VIP ASSET MANAGER/SM/ - INITIAL CLASS 01/01/2004 to 12/31/2004 9.50 9.88 10,211,365 01/01/2005 to 12/31/2005 9.88 10.03 3,448,974 01/01/2006 to 12/31/2006 10.03 10.74 8,387,396 01/01/2007 to 12/31/2007 10.74 12.24 7,434,895 01/01/2008 to 12/31/2008 12.24 8.60 6,755,499 01/01/2009 to 12/31/2009 8.60 10.96 6,155,071 01/01/2010 to 12/31/2010 10.96 12.36 5,419,609 01/01/2011 to 12/31/2011 12.36 11.88 4,844,552 01/01/2012 to 12/31/2012 11.88 13.18 4,319,513 01/01/2013 to 12/31/2013 13.18 15.05 3,896,807 01/01/2014 to 12/31/2014 15.05 15.71 3,599,721 ---------------------------------------------------------------------------------------- FIDELITY VIP CONTRAFUND(R) - INITIAL CLASS 01/01/2004 to 12/31/2004 13.14 14.97 16,395,321 01/01/2005 to 12/31/2005 14.97 17.27 16,339,678 01/01/2006 to 12/31/2006 17.27 19.03 15,855,985 01/01/2007 to 12/31/2007 19.03 22.08 13,255,971 01/01/2008 to 12/31/2008 22.08 12.52 13,549,154 01/01/2009 to 12/31/2009 12.52 16.76 12,583,716 01/01/2010 to 12/31/2010 16.76 19.39 11,454,929 ---------------------------------------------------------------------------------------- A-2
485BPOS59th Page of 388TOC1stPreviousNextBottomJust 59th
APPENDIX A CONDENSED FINANCIAL INFORMATION (CONTINUED) [Enlarge/Download Table] AUV AT AUV AT ACCUM UNITS BEGINNING END END OF PERIOD OF PERIOD OF PERIOD --------------------------------------------------------------------------------------- FIDELITY VIP CONTRAFUND(R) - INITIAL CLASS (CONTINUED) 01/01/2011 to 12/31/2011 19.39 18.64 10,240,819 01/01/2012 to 12/31/2012 18.64 21.41 9,341,071 01/01/2013 to 12/31/2013 21.41 27.74 8,490,723 01/01/2014 to 12/31/2014 27.74 30.63 7,690,600 --------------------------------------------------------------------------------------- FIDELITY VIP GROWTH - INITIAL CLASS 01/01/2004 to 12/31/2004 11.85 12.09 13,813,796 01/01/2005 to 12/31/2005 12.09 12.62 12,332,033 01/01/2006 to 12/31/2006 12.62 13.30 11,074,999 01/01/2007 to 12/31/2007 13.30 16.66 9,779,300 01/01/2008 to 12/31/2008 16.66 8.68 9,064,321 01/01/2009 to 12/31/2009 8.68 10.99 8,488,348 01/01/2010 to 12/31/2010 10.99 13.47 7,853,052 01/01/2011 to 12/31/2011 13.47 13.31 7,170,100 01/01/2012 to 12/31/2012 13.31 15.06 6,645,597 01/01/2013 to 12/31/2013 15.06 20.26 6,024,227 01/01/2014 to 12/31/2014 20.26 22.25 5,562,134 --------------------------------------------------------------------------------------- FIDELITY VIP INDEX 500 - INITIAL CLASS 01/01/2004 to 12/31/2004 12.70 13.86 11,071,681 01/01/2005 to 12/31/2005 13.86 14.34 9,187,813 01/01/2006 to 12/31/2006 14.34 16.37 7,822,188 01/01/2007 to 12/31/2007 16.37 17.03 6,793,561 01/01/2008 to 12/31/2008 17.03 10.58 5,925,742 01/01/2009 to 12/31/2009 10.58 13.22 5,187,366 01/01/2010 to 12/31/2010 13.22 15.00 4,473,766 01/01/2011 to 12/31/2011 15.00 15.10 3,900,585 01/01/2012 to 12/31/2012 15.10 17.27 3,463,716 01/01/2013 to 12/31/2013 17.27 22.53 3,034,899 01/01/2014 to 12/31/2014 22.53 25.25 2,728,777 --------------------------------------------------------------------------------------- FIDELITY VIP MONEY MARKET - INITIAL CLASS 01/01/2004 to 12/31/2004 6.80 6.79 3,326,994 01/01/2005 to 12/31/2005 6.79 6.91 3,562,276 01/01/2006 to 12/31/2006 6.91 7.15 3,961,132 01/01/2007 to 12/31/2007 7.15 7.41 4,202,396 01/01/2008 to 12/31/2008 7.41 7.54 4,726,587 01/01/2009 to 12/31/2009 7.54 7.49 4,304,049 01/01/2010 to 12/31/2010 7.49 7.41 3,880,302 01/01/2011 to 12/31/2011 7.41 7.31 3,604,218 01/01/2012 to 12/31/2012 7.31 7.23 3,266,490 --------------------------------------------------------------------------------------- A-3
485BPOS60th Page of 388TOC1stPreviousNextBottomJust 60th
APPENDIX A CONDENSED FINANCIAL INFORMATION (CONTINUED) [Enlarge/Download Table] AUV AT AUV AT ACCUM UNITS BEGINNING END END OF PERIOD OF PERIOD OF PERIOD ---------------------------------------------------------------------------------------------------- FIDELITY VIP MONEY MARKET - INITIAL CLASS (CONTINUED) 01/01/2013 to 12/31/2013 7.23 7.13 3,074,432 01/01/2014 to 12/31/2014 7.13 7.04 2,775,755 ---------------------------------------------------------------------------------------------------- MIST - INVESCO SMALL CAP GROWTH - CLASS A 01/01/2004 to 12/31/2004 11.67 12.29 33,497 01/01/2005 to 12/31/2005 12.29 13.17 50,996 01/01/2006 to 12/31/2006 13.17 14.80 34,662 01/01/2007 to 12/31/2007 14.80 16.27 33,616 01/01/2008 to 12/31/2008 16.27 9.85 35,689 01/01/2009 to 12/31/2009 9.85 13.05 38,931 01/01/2010 to 12/31/2010 13.05 16.28 38,951 01/01/2011 to 12/31/2011 16.28 15.92 49,265 01/01/2012 to 12/31/2012 15.92 18.62 37,289 01/01/2013 to 12/31/2013 18.62 25.81 43,008 01/01/2014 to 12/31/2014 25.81 27.55 41,911 ---------------------------------------------------------------------------------------------------- MIST - J.P. MORGAN QUALITY BOND - CLASS A 01/01/2004 to 11/19/2004 12.00 12.35 1,429,559 ---------------------------------------------------------------------------------------------------- MIST - LORD ABBETT BOND DEBENTURE - CLASS A 01/01/2004 to 12/31/2004 16.27 17.41 88,340 01/01/2005 to 12/31/2005 17.41 17.48 152,640 01/01/2006 to 12/31/2006 17.48 18.86 219,609 01/01/2007 to 12/31/2007 18.86 19.88 253,278 01/01/2008 to 12/31/2008 19.88 16.01 310,940 01/01/2009 to 12/31/2009 16.01 21.66 302,830 01/01/2010 to 12/31/2010 21.66 24.18 280,087 01/01/2011 to 12/31/2011 24.18 25.01 249,802 01/01/2012 to 12/31/2012 25.01 27.93 244,193 01/01/2013 to 12/31/2013 27.93 29.80 222,634 01/01/2014 to 12/31/2014 29.80 30.91 213,961 ---------------------------------------------------------------------------------------------------- MIST - METLIFE SMALL CAP VALUE PORTFOLIO - CLASS A (FORMERLY MIST - THIRD AVENUE SMALL CAP VALUE - CLASS A) 01/01/2004 to 12/31/2004 11.52 14.41 188,702 01/01/2005 to 12/31/2005 14.41 16.46 365,598 01/01/2006 to 12/31/2006 16.46 18.42 501,550 01/01/2007 to 12/31/2007 18.42 17.66 416,807 01/01/2008 to 12/31/2008 17.66 12.25 517,443 01/01/2009 to 12/31/2009 12.25 15.33 480,776 01/01/2010 to 12/31/2010 15.33 18.17 410,887 01/01/2011 to 12/31/2011 18.17 16.37 357,960 01/01/2012 to 12/31/2012 16.37 19.10 315,401 ---------------------------------------------------------------------------------------------------- A-4
485BPOS61st Page of 388TOC1stPreviousNextBottomJust 61st
APPENDIX A CONDENSED FINANCIAL INFORMATION (CONTINUED) [Enlarge/Download Table] AUV AT AUV AT ACCUM UNITS BEGINNING END END OF PERIOD OF PERIOD OF PERIOD ---------------------------------------------------------------------------------------------------- MIST - METLIFE SMALL CAP VALUE PORTFOLIO - CLASS A (FORMERLY MIST - THIRD AVENUE SMALL CAP VALUE - CLASS A) (CONTINUED) 01/01/2013 to 12/31/2013 19.10 25.02 281,699 01/01/2014 to 12/31/2014 25.02 25.17 232,259 ---------------------------------------------------------------------------------------------------- MIST - MFS(R) RESEARCH INTERNATIONAL - CLASS A 05/01/2004 to 12/31/2004 9.81 11.29 45,121 01/01/2005 to 12/31/2005 11.29 13.01 142,641 01/01/2006 to 12/31/2006 13.01 16.29 395,245 01/01/2007 to 12/31/2007 16.29 18.25 464,094 01/01/2008 to 12/31/2008 18.25 10.40 645,979 01/01/2009 to 12/31/2009 10.40 13.53 725,312 01/01/2010 to 12/31/2010 13.53 14.91 704,722 01/01/2011 to 12/31/2011 14.91 13.17 711,230 01/01/2012 to 12/31/2012 13.17 15.20 681,940 01/01/2013 to 12/31/2013 15.20 17.93 657,489 01/01/2014 to 12/31/2014 17.93 16.50 623,682 ---------------------------------------------------------------------------------------------------- MIST - MORGAN STANLEY MID CAP GROWTH - CLASS A 05/03/2010 to 12/31/2010 13.51 15.71 255,187 01/01/2011 to 12/31/2011 15.71 14.47 233,241 01/01/2012 to 12/31/2012 14.47 15.64 215,418 01/01/2013 to 12/31/2013 15.64 21.49 193,355 01/01/2014 to 12/31/2014 21.49 21.47 173,270 ---------------------------------------------------------------------------------------------------- MIST - PIMCO TOTAL RETURN - CLASS A 01/01/2004 to 12/31/2004 7.93 8.23 3,171,069 01/01/2005 to 12/31/2005 8.23 8.32 3,554,555 01/01/2006 to 12/31/2006 8.32 8.60 3,609,330 01/01/2007 to 12/31/2007 8.60 9.15 3,107,389 01/01/2008 to 12/31/2008 9.15 13.51 4,213,750 01/01/2009 to 12/31/2009 13.51 10.61 4,201,202 01/01/2010 to 12/31/2010 10.61 11.35 4,279,742 01/01/2011 to 12/31/2011 11.35 11.58 3,918,425 01/01/2012 to 12/31/2012 11.58 12.52 3,749,817 01/01/2013 to 12/31/2013 12.52 12.14 3,285,635 01/01/2014 to 12/31/2014 12.14 12.52 2,919,823 ---------------------------------------------------------------------------------------------------- MIST - T.ROWE PRICE LARGE CAP VALUE - CLASS A (FORMERLY LORD ABBETT GROWTH AND INCOME - CLASS A) 01/01/2004 to 12/31/2004 22.62 25.20 7,300,584 01/01/2005 to 12/31/2005 25.20 27.13 1,881,625 01/01/2006 to 12/31/2006 27.13 31.59 1,682,218 01/01/2007 to 12/31/2007 31.59 30.80 5,816,218 ---------------------------------------------------------------------------------------------------- A-5
485BPOS62nd Page of 388TOC1stPreviousNextBottomJust 62nd
APPENDIX A CONDENSED FINANCIAL INFORMATION (CONTINUED) [Enlarge/Download Table] AUV AT AUV AT ACCUM UNITS BEGINNING END END OF PERIOD OF PERIOD OF PERIOD ---------------------------------------------------------------------------------------------------- MIST - T.ROWE PRICE LARGE CAP VALUE - CLASS A (FORMERLY LORD ABBETT GROWTH AND INCOME - CLASS A) (CONTINUED) 01/01/2008 to 12/31/2008 30.80 19.39 5,393,174 01/01/2009 to 12/31/2009 19.39 22.70 4,899,632 01/01/2010 to 12/31/2010 22.70 26.28 4,432,352 01/01/2011 to 12/31/2011 26.28 24.95 3,985,555 01/01/2012 to 12/31/2012 24.95 29.11 3,644,435 01/01/2013 to 12/31/2013 29.11 38.51 3,321,629 01/01/2014 to 12/31/2014 38.51 43.15 3,025,516 ---------------------------------------------------------------------------------------------------- MSF - BARCLAY'S AGGREGATE BOND INDEX - CLASS A (FORMERLY MSF - BARCLAYS CAPITAL AGGREGATE BOND INDEX - CLASS A) 01/01/2004 to 12/31/2004 12.76 13.10 174,272 01/01/2005 to 12/31/2005 13.10 13.19 283,812 01/01/2006 to 12/31/2006 13.19 13.55 334,785 01/01/2007 to 12/31/2007 13.55 14.29 366,229 01/01/2008 to 12/31/2008 14.29 14.94 503,693 01/01/2009 to 12/31/2009 14.94 15.50 528,637 01/01/2010 to 12/31/2010 15.50 16.22 515,107 01/01/2011 to 12/31/2011 16.22 17.20 482,591 01/01/2012 to 12/31/2012 17.20 17.63 480,941 01/01/2013 to 12/31/2013 17.63 16.99 420,029 01/01/2014 to 12/31/2014 16.99 17.74 419,324 ---------------------------------------------------------------------------------------------------- MSF - BLACKROCK BOND INCOME - CLASS A 01/01/2004 to 12/31/2004 46.37 47.77 40,781 01/01/2005 to 12/31/2005 47.77 48.27 66,938 01/01/2006 to 12/31/2006 48.27 49.72 94,525 01/01/2007 to 12/31/2007 49.72 52.14 90,214 01/01/2008 to 12/31/2008 52.14 49.68 113,490 01/01/2009 to 12/31/2009 49.68 53.65 108,244 01/01/2010 to 12/31/2010 53.65 57.35 97,632 01/01/2011 to 12/31/2011 57.35 60.29 84,849 01/01/2012 to 12/31/2012 60.29 63.97 84,176 01/01/2013 to 12/31/2013 63.97 62.63 69,840 01/01/2014 to 12/31/2014 62.63 66.16 76,732 ---------------------------------------------------------------------------------------------------- MSF - BLACKROCK CAPITAL APPRECIATION - CLASS A (FORMERLY MSF - BLACKROCK LEGACY LARGE CAP GROWTH - CLASS A) 01/01/2004 to 12/31/2004 24.33 26.12 11,340 01/01/2005 to 12/31/2005 26.12 27.57 15,645 01/01/2006 to 12/31/2006 27.57 28.33 18,436 01/01/2007 to 12/31/2007 28.33 33.18 25,875 ---------------------------------------------------------------------------------------------------- A-6
485BPOS63rd Page of 388TOC1stPreviousNextBottomJust 63rd
APPENDIX A CONDENSED FINANCIAL INFORMATION (CONTINUED) [Enlarge/Download Table] AUV AT AUV AT ACCUM UNITS BEGINNING END END OF PERIOD OF PERIOD OF PERIOD ----------------------------------------------------------------------------------------------- MSF - BLACKROCK CAPITAL APPRECIATION - CLASS A (FORMERLY MSF - BLACKROCK LEGACY LARGE CAP GROWTH - CLASS A) (CONTINUED) 01/01/2008 to 12/31/2008 33.18 20.78 47,717 01/01/2009 to 12/31/2009 20.78 28.05 48,908 01/01/2010 to 12/31/2010 28.05 33.15 38,917 01/01/2011 to 12/31/2011 33.15 29.78 34,481 01/01/2012 to 12/31/2012 29.78 33.60 32,933 01/01/2013 to 12/31/2013 33.60 44.50 33,708 01/01/2014 to 12/31/2014 44.50 47.81 33,666 ----------------------------------------------------------------------------------------------- MSF - BLACKROCK LARGE CAP VALUE - CLASS A 01/01/2004 to 12/31/2004 10.62 11.88 50,655 01/01/2005 to 12/31/2005 11.88 12.42 73,946 01/01/2006 to 12/31/2006 12.42 14.62 148,113 01/01/2007 to 12/31/2007 14.62 14.92 203,478 01/01/2008 to 12/31/2008 14.92 9.58 250,147 01/01/2009 to 12/31/2009 9.58 10.51 253,918 01/01/2010 to 12/31/2010 10.51 11.33 239,093 01/01/2011 to 12/31/2011 11.33 11.44 233,330 01/01/2012 to 12/31/2012 11.44 12.89 203,789 01/01/2013 to 12/31/2013 12.89 16.80 196,278 01/01/2014 to 12/31/2014 16.80 18.22 198,465 ----------------------------------------------------------------------------------------------- MSF - FI MID CAP OPPORTUNITIES - CLASS A 01/01/2004 to 04/30/2004 11.41 14.98 78,915 ----------------------------------------------------------------------------------------------- MSF - FI MID CAP OPPORTUNITIES - CLASS A 05/01/2004 to 12/31/2004 14.98 17.03 128,005 01/01/2005 to 12/31/2005 17.03 17.96 170,442 01/01/2006 to 12/31/2006 17.96 19.82 213,880 01/01/2007 to 12/31/2007 19.82 21.18 227,669 01/01/2008 to 12/31/2008 21.18 9.34 261,434 01/01/2009 to 12/31/2009 9.34 12.34 260,602 01/01/2010 to 12/31/2010 12.34 13.36 0 ----------------------------------------------------------------------------------------------- MSF - MET/ARTISAN MID CAP VALUE - CLASS A 01/01/2004 to 12/31/2004 31.46 34.12 356,061 01/01/2005 to 12/31/2005 34.12 37.02 572,755 01/01/2006 to 12/31/2006 37.02 41.08 646,340 01/01/2007 to 12/31/2007 41.08 37.75 516,563 01/01/2008 to 12/31/2008 37.75 20.11 499,127 01/01/2009 to 12/31/2009 20.11 28.09 478,574 01/01/2010 to 12/31/2010 28.09 31.88 434,802 01/01/2011 to 12/31/2011 31.88 33.58 393,641 ----------------------------------------------------------------------------------------------- A-7
485BPOS64th Page of 388TOC1stPreviousNextBottomJust 64th
APPENDIX A CONDENSED FINANCIAL INFORMATION (CONTINUED) [Enlarge/Download Table] AUV AT AUV AT ACCUM UNITS BEGINNING END END OF PERIOD OF PERIOD OF PERIOD -------------------------------------------------------------------------------------- MSF - MET/ARTISAN MID CAP VALUE - CLASS A (CONTINUED) 01/01/2012 to 12/31/2012 33.58 37.05 346,562 01/01/2013 to 12/31/2013 37.05 50.03 338,125 01/01/2014 to 12/31/2014 50.03 50.31 298,768 -------------------------------------------------------------------------------------- MSF - METLIFE MID CAP STOCK INDEX - CLASS A 01/01/2004 to 12/31/2004 11.57 13.24 339,222 01/01/2005 to 12/31/2005 13.24 14.67 498,849 01/01/2006 to 12/31/2006 14.67 15.93 699,124 01/01/2007 to 12/31/2007 15.93 16.94 761,353 01/01/2008 to 12/31/2008 16.94 10.67 933,376 01/01/2009 to 12/31/2009 10.67 14.42 1,097,615 01/01/2010 to 12/31/2010 14.42 17.97 1,152,810 01/01/2011 to 12/31/2011 17.97 17.39 1,153,633 01/01/2012 to 12/31/2012 17.39 20.17 1,178,450 01/01/2013 to 12/31/2013 20.17 26.50 1,192,706 01/01/2014 to 12/31/2014 26.50 28.63 1,156,150 -------------------------------------------------------------------------------------- MSF - METLIFE STOCK INDEX - CLASS A 01/01/2004 to 12/31/2004 35.70 38.95 1,140,897 01/01/2005 to 12/31/2005 38.95 40.22 1,265,214 01/01/2006 to 12/31/2006 40.22 45.82 1,259,590 01/01/2007 to 12/31/2007 45.82 47.57 675,856 01/01/2008 to 12/31/2008 47.57 29.52 1,196,677 01/01/2009 to 12/31/2009 29.52 36.76 1,181,819 01/01/2010 to 12/31/2010 36.76 41.64 1,134,947 01/01/2011 to 12/31/2011 41.64 41.84 1,058,394 01/01/2012 to 12/31/2012 41.84 47.78 1,015,815 01/01/2013 to 12/31/2013 47.78 62.24 977,832 01/01/2014 to 12/31/2014 62.24 69.61 914,216 -------------------------------------------------------------------------------------- MSF - MFS(R) TOTAL RETURN - CLASS A 01/01/2004 to 12/31/2004 38.75 42.53 92,767 01/01/2005 to 12/31/2005 42.53 43.27 174,181 01/01/2006 to 12/31/2006 43.27 47.90 202,242 01/01/2007 to 12/31/2007 47.90 49.32 203,395 01/01/2008 to 12/31/2008 49.32 37.88 242,106 01/01/2009 to 12/31/2009 37.88 44.32 236,951 01/01/2010 to 12/31/2010 44.32 48.14 202,835 01/01/2011 to 12/31/2011 48.14 48.64 182,215 01/01/2012 to 12/31/2012 48.64 53.54 167,290 01/01/2013 to 12/31/2013 53.54 62.86 159,287 01/01/2014 to 12/31/2014 62.86 67.37 146,167 -------------------------------------------------------------------------------------- A-8
485BPOS65th Page of 388TOC1stPreviousNextBottomJust 65th
APPENDIX A CONDENSED FINANCIAL INFORMATION (CONTINUED) [Download Table] AUV AT AUV AT ACCUM UNITS BEGINNING END END OF PERIOD OF PERIOD OF PERIOD ------------------------------------------------------------------------- MSF - MFS(R) VALUE - CLASS A 01/01/2004 to 12/31/2004 12.12 13.32 329,589 01/01/2005 to 12/31/2005 13.32 12.96 414,847 01/01/2006 to 12/31/2006 12.96 15.10 413,600 01/01/2007 to 12/31/2007 15.10 14.33 387,453 01/01/2008 to 12/31/2008 14.33 9.41 432,253 01/01/2009 to 12/31/2009 9.41 11.21 477,350 01/01/2010 to 12/31/2010 11.21 12.33 469,533 01/01/2011 to 12/31/2011 12.33 12.27 475,614 01/01/2012 to 12/31/2012 12.27 14.12 468,500 01/01/2013 to 12/31/2013 14.12 18.90 462,130 01/01/2014 to 12/31/2014 18.90 20.67 442,820 ------------------------------------------------------------------------- MSF - MSCI EAFE(R) INDEX - CLASS A 01/01/2004 to 12/31/2004 9.67 11.42 344,405 01/01/2005 to 12/31/2005 11.42 12.76 619,087 01/01/2006 to 12/31/2006 12.76 15.83 877,870 01/01/2007 to 12/31/2007 15.83 17.30 890,137 01/01/2008 to 12/31/2008 17.30 9.89 1,082,509 01/01/2009 to 12/31/2009 9.89 12.55 1,190,238 01/01/2010 to 12/31/2010 12.55 13.40 1,201,156 01/01/2011 to 12/31/2011 13.40 11.57 1,181,644 01/01/2012 to 12/31/2012 11.57 13.50 1,200,375 01/01/2013 to 12/31/2013 13.50 16.23 1,156,352 01/01/2014 to 12/31/2014 16.23 15.05 1,134,965 ------------------------------------------------------------------------- MSF - NEUBERGER BERMAN GENESIS - CLASS A 01/01/2004 to 12/31/2004 16.11 18.33 494,108 01/01/2005 to 12/31/2005 18.33 18.84 591,411 01/01/2006 to 12/31/2006 18.84 21.69 604,495 01/01/2007 to 12/31/2007 21.69 20.66 547,498 01/01/2008 to 12/31/2008 20.66 12.56 578,098 01/01/2009 to 12/31/2009 12.56 14.02 595,779 01/01/2010 to 12/31/2010 14.02 16.81 568,716 01/01/2011 to 12/31/2011 16.81 17.55 552,249 01/01/2012 to 12/31/2012 17.55 19.05 520,656 01/01/2013 to 12/31/2013 19.05 26.03 497,783 01/01/2014 to 12/31/2014 26.03 25.69 459,734 ------------------------------------------------------------------------- MSF - RUSSELL 2000(R) INDEX - CLASS A 01/01/2004 to 12/31/2004 13.61 15.82 320,592 01/01/2005 to 12/31/2005 15.82 16.31 384,939 01/01/2006 to 12/31/2006 16.31 18.98 385,268 ------------------------------------------------------------------------- A-9
485BPOS66th Page of 388TOC1stPreviousNextBottomJust 66th
APPENDIX A CONDENSED FINANCIAL INFORMATION (CONTINUED) [Enlarge/Download Table] AUV AT AUV AT ACCUM UNITS BEGINNING END END OF PERIOD OF PERIOD OF PERIOD ---------------------------------------------------------------------------------------------------- MSF - RUSSELL 2000(R) INDEX - CLASS A (CONTINUED) 01/01/2007 to 12/31/2007 18.98 18.44 355,849 01/01/2008 to 12/31/2008 18.44 12.10 397,753 01/01/2009 to 12/31/2009 12.10 15.04 434,045 01/01/2010 to 12/31/2010 15.04 18.83 466,860 01/01/2011 to 12/31/2011 18.83 17.82 474,458 01/01/2012 to 12/31/2012 17.82 20.46 479,291 01/01/2013 to 12/31/2013 20.46 27.96 490,621 01/01/2014 to 12/31/2014 27.96 28.98 473,023 ---------------------------------------------------------------------------------------------------- MSF - T. ROWE PRICE LARGE CAP GROWTH - CLASS A (FORMERLY MIST - RCM TECHNOLOGY - CLASS A) 01/01/2004 to 12/31/2004 4.65 4.39 160,263 01/01/2005 to 12/31/2005 4.39 4.82 156,903 01/01/2006 to 12/31/2006 4.82 5.02 186,271 01/01/2007 to 12/31/2007 5.02 6.52 214,957 01/01/2008 to 12/31/2008 6.52 3.58 253,169 01/01/2009 to 12/31/2009 3.58 5.63 395,082 01/01/2010 to 12/31/2010 5.63 7.12 480,648 01/01/2011 to 12/31/2011 7.12 6.34 324,023 01/01/2012 to 12/31/2012 6.34 7.03 291,511 01/01/2013 to 12/31/2013 7.03 9.36 280,940 01/01/2014 to 12/31/2014 9.36 10.07 304,446 ---------------------------------------------------------------------------------------------------- MSF - T. ROWE PRICE SMALL CAP GROWTH - CLASS A 05/01/2004 to 12/31/2004 10.00 13.43 17,487 01/01/2005 to 12/31/2005 13.43 14.71 42,583 01/01/2006 to 12/31/2006 14.71 15.08 43,758 01/01/2007 to 12/31/2007 15.08 16.34 45,674 01/01/2008 to 12/31/2008 16.34 10.28 60,781 01/01/2009 to 12/31/2009 10.28 14.10 96,481 01/01/2010 to 12/31/2010 14.10 18.77 115,650 01/01/2011 to 12/31/2011 18.77 18.84 134,679 01/01/2012 to 12/31/2012 18.84 21.60 124,345 01/01/2013 to 12/31/2013 21.60 30.80 146,538 01/01/2014 to 12/31/2014 30.80 32.49 132,846 ---------------------------------------------------------------------------------------------------- MSF - WMC CORE EQUITY OPPORTUNITIES - CLASS A (FORMERLY MSF - DAVIS VENTURE VALUE - CLASS A) 01/01/2004 to 12/31/2004 28.56 31.66 80,404 01/01/2005 to 12/31/2005 31.66 34.46 172,753 01/01/2006 to 12/31/2006 34.46 38.95 272,790 01/01/2007 to 12/31/2007 38.95 40.19 263,401 ---------------------------------------------------------------------------------------------------- A-10
485BPOS67th Page of 388TOC1stPreviousNextBottomJust 67th
APPENDIX A CONDENSED FINANCIAL INFORMATION (CONTINUED) [Enlarge/Download Table] AUV AT AUV AT ACCUM UNITS BEGINNING END END OF PERIOD OF PERIOD OF PERIOD ---------------------------------------------------------------------------------------------------- MSF - WMC CORE EQUITY OPPORTUNITIES - CLASS A (FORMERLY MSF - DAVIS VENTURE VALUE - CLASS A) (CONTINUED) 01/01/2008 to 12/31/2008 40.19 24.05 337,871 01/01/2009 to 12/31/2009 24.05 31.31 336,634 01/01/2010 to 12/31/2010 31.31 34.60 305,513 01/01/2011 to 12/31/2011 34.60 32.76 269,378 01/01/2012 to 12/31/2012 32.76 36.47 240,840 01/01/2013 to 12/31/2013 36.47 48.11 219,114 01/01/2014 to 12/31/2014 48.11 52.51 195,595 ---------------------------------------------------------------------------------------------------- A-11
485BPOS68th Page of 388TOC1stPreviousNextBottomJust 68th
APPENDIX A CONDENSED FINANCIAL INFORMATION PART 2 The following table sets forth condensed financial information on Accumulation Units with respect to Contracts issued under this prospectus that are subject to a daily Separate Account deduction of 1.25%. [Enlarge/Download Table] AUV AT AUV AT ACCUM UNITS BEGINNING END END OF PERIOD OF PERIOD OF PERIOD ------------------------------------------------------------------------------------------ ALGER SMALL CAP GROWTH PORTFOLIO - CLASS I-2 01/01/2004 to 12/31/2004 6.10 7.03 259,192 01/01/2005 to 12/31/2005 7.03 8.11 251,411 01/01/2006 to 12/31/2006 8.11 9.61 245,090 01/01/2007 to 12/31/2007 9.61 11.13 242,115 01/01/2008 to 12/31/2008 11.13 5.87 219,694 01/01/2009 to 12/31/2009 5.87 8.43 206,871 01/01/2010 to 12/31/2010 8.43 10.44 184,281 01/01/2011 to 12/31/2011 10.44 9.98 175,667 01/01/2012 to 12/31/2012 9.98 11.09 164,846 01/01/2013 to 12/31/2013 11.09 14.70 145,728 01/01/2014 to 12/31/2014 14.70 14.58 125,176 ------------------------------------------------------------------------------------------ AMERICAN FUNDS GLOBAL SMALL CAPITALIZATION FUND - CLASS 2 01/01/2004 to 12/31/2004 16.51 19.71 2,386 01/01/2005 to 12/31/2005 19.71 24.41 9,692 01/01/2006 to 12/31/2006 24.41 29.90 9,118 01/01/2007 to 12/31/2007 29.90 35.85 17,949 01/01/2008 to 12/31/2008 35.85 16.46 13,488 01/01/2009 to 12/31/2009 16.46 26.21 15,756 01/01/2010 to 12/31/2010 26.21 31.69 16,767 01/01/2011 to 12/31/2011 31.69 25.31 17,323 01/01/2012 to 12/31/2012 25.13 29.53 15,451 01/01/2013 to 12/31/2013 29.53 37.41 14,973 01/01/2014 to 12/31/2014 37.41 37.73 15,396 ------------------------------------------------------------------------------------------ AMERICAN FUNDS GROWTH FUND - CLASS 2 01/01/2004 to 12/31/2004 118.90 132.10 1,006 01/01/2005 to 12/31/2005 132.10 151.58 1,410 01/01/2006 to 12/31/2006 151.58 165.00 1,695 01/01/2007 to 12/31/2007 165.00 183.06 2,562 01/01/2008 to 12/31/2008 183.06 101.29 4,021 01/01/2009 to 12/31/2009 101.29 139.45 4,630 01/01/2010 to 12/31/2010 139.45 163.45 6,826 01/01/2011 to 12/31/2011 163.45 154.52 6,901 01/01/2012 to 12/31/2012 154.52 179.89 7,847 01/01/2013 to 12/31/2013 179.89 231.13 7,928 01/01/2014 to 12/31/2014 231.13 247.69 8,083 ------------------------------------------------------------------------------------------ A-12
485BPOS69th Page of 388TOC1stPreviousNextBottomJust 69th
APPENDIX A CONDENSED FINANCIAL INFORMATION (CONTINUED) [Download Table] AUV AT AUV AT ACCUM UNITS BEGINNING END END OF PERIOD OF PERIOD OF PERIOD ------------------------------------------------------------------------------- AMERICAN FUNDS GROWTH-INCOME FUND - CLASS 2 01/01/2004 to 12/31/2004 92.53 100.86 1,023 01/01/2005 to 12/31/2005 100.86 105.42 1,732 01/01/2006 to 12/31/2006 105.42 119.94 1,812 01/01/2007 to 12/31/2007 119.94 124.42 2,214 01/01/2008 to 12/31/2008 124.42 76.36 2,280 01/01/2009 to 12/31/2009 76.36 98.97 2,527 01/01/2010 to 12/31/2010 98.97 108.91 4,982 01/01/2011 to 12/31/2011 108.91 105.60 5,438 01/01/2012 to 12/31/2012 105.60 122.51 6,351 01/01/2013 to 12/31/2013 122.51 161.52 6,828 01/01/2014 to 12/31/2014 161.52 176.47 6,836 ------------------------------------------------------------------------------- FIDELITY VIP ASSET MANAGER/SM/ - INITIAL CLASS 01/01/2004 to 12/31/2004 9.51 9.90 158,905 01/01/2005 to 12/31/2005 9.90 10.17 146,460 01/01/2006 to 12/31/2006 10.17 10.78 133,906 01/01/2007 to 12/31/2007 10.78 12.30 124,552 01/01/2008 to 12/31/2008 12.30 8.66 106,448 01/01/2009 to 12/31/2009 8.66 11.04 96,266 01/01/2010 to 12/31/2010 11.04 12.46 81,009 01/01/2011 to 12/31/2011 12.46 11.99 63,391 01/01/2012 to 12/31/2012 11.99 13.32 62,354 01/01/2013 to 12/31/2013 13.32 15.22 58,402 01/01/2014 to 12/31/2014 15.22 15.90 53,221 ------------------------------------------------------------------------------- FIDELITY VIP CONTRAFUND(R) - INITIAL CLASS 01/01/2004 to 12/31/2004 13.15 15.00 255,642 01/01/2005 to 12/31/2005 15.00 17.32 268,680 01/01/2006 to 12/31/2006 17.32 19.11 269,007 01/01/2007 to 12/31/2007 19.11 22.19 267,064 01/01/2008 to 12/31/2008 22.19 12.60 252,530 01/01/2009 to 12/31/2009 12.60 16.88 249,519 01/01/2010 to 12/31/2010 16.88 19.55 243,566 01/01/2011 to 12/31/2011 19.55 18.82 227,820 01/01/2012 to 12/31/2012 18.82 21.63 220,796 01/01/2013 to 12/31/2013 21.63 28.05 204,045 01/01/2014 to 12/31/2014 28.05 31.01 198,328 ------------------------------------------------------------------------------- FIDELITY VIP GROWTH - INITIAL CLASS 01/01/2004 to 12/31/2004 11.87 12.12 247,756 01/01/2005 to 12/31/2005 12.12 12.66 237,352 01/01/2006 to 12/31/2006 12.66 13.36 233,148 ------------------------------------------------------------------------------- A-13
485BPOS70th Page of 388TOC1stPreviousNextBottomJust 70th
APPENDIX A CONDENSED FINANCIAL INFORMATION (CONTINUED) [Download Table] AUV AT AUV AT ACCUM UNITS BEGINNING END END OF PERIOD OF PERIOD OF PERIOD -------------------------------------------------------------------------------- FIDELITY VIP GROWTH - INITIAL CLASS (CONTINUED) 01/01/2007 to 12/31/2007 13.36 16.75 227,521 01/01/2008 to 12/31/2008 16.75 8.74 207,815 01/01/2009 to 12/31/2009 8.74 11.07 189,135 01/01/2010 to 12/31/2010 11.07 13.58 179,245 01/01/2011 to 12/31/2011 13.58 13.44 166,443 01/01/2012 to 12/31/2012 13.44 15.22 160,847 01/01/2013 to 12/31/2013 15.22 20.49 146,083 01/01/2014 to 12/31/2014 20.49 22.52 136,627 -------------------------------------------------------------------------------- FIDELITY VIP INDEX 500 - INITIAL CLASS 01/01/2004 to 12/31/2004 12.72 13.89 236,274 01/01/2005 to 12/31/2005 13.89 14.38 201,167 01/01/2006 to 12/31/2006 14.38 16.44 172,591 01/01/2007 to 12/31/2007 16.44 17.12 157,031 01/01/2008 to 12/31/2008 17.12 10.65 129,789 01/01/2009 to 12/31/2009 10.65 13.31 108,906 01/01/2010 to 12/31/2010 13.31 15.12 87,733 01/01/2011 to 12/31/2011 15.12 15.24 72,290 01/01/2012 to 12/31/2012 15.24 17.45 65,057 01/01/2013 to 12/31/2013 17.45 22.79 55,057 01/01/2014 to 12/31/2014 22.79 25.56 48,213 -------------------------------------------------------------------------------- FIDELITY VIP MONEY MARKET - INITIAL CLASS 01/01/2004 to 12/31/2004 6.81 6.81 113,288 01/01/2005 to 12/31/2005 6.81 6.93 132,557 01/01/2006 to 12/31/2006 6.93 7.18 150,587 01/01/2007 to 12/31/2007 7.18 7.45 154,082 01/01/2008 to 12/31/2008 7.45 7.58 173,542 01/01/2009 to 12/31/2009 7.58 7.54 136,663 01/01/2010 to 12/31/2010 7.54 7.47 118,421 01/01/2011 to 12/31/2011 7.47 7.38 139,733 01/01/2012 to 12/31/2012 7.38 7.30 156,790 01/01/2013 to 12/31/2013 7.30 7.21 126,865 01/01/2014 to 12/31/2014 7.21 7.12 109,213 -------------------------------------------------------------------------------- FIDELITY VIP OVERSEAS - INITIAL CLASS 01/01/2004 to 12/31/2004 8.18 9.18 135,991 01/01/2005 to 12/31/2005 9.18 10.79 143,552 01/01/2006 to 12/31/2006 10.79 12.59 146,283 01/01/2007 to 12/31/2007 12.59 14.58 142,084 01/01/2008 to 12/31/2008 14.58 8.09 129,929 01/01/2009 to 12/31/2009 8.09 10.11 127,780 -------------------------------------------------------------------------------- A-14
485BPOS71st Page of 388TOC1stPreviousNextBottomJust 71st
APPENDIX A CONDENSED FINANCIAL INFORMATION (CONTINUED) [Enlarge/Download Table] AUV AT AUV AT ACCUM UNITS BEGINNING END END OF PERIOD OF PERIOD OF PERIOD ---------------------------------------------------------------------------------------------------- FIDELITY VIP OVERSEAS - INITIAL CLASS (CONTINUED) 01/01/2010 to 12/31/2010 10.11 11.30 121,653 01/01/2011 to 12/31/2011 11.30 9.24 119,049 01/01/2012 to 12/31/2012 9.24 11.02 116,094 01/01/2013 to 12/31/2013 11.02 14.19 102,607 01/01/2014 to 12/31/2014 14.19 12.89 93,963 ---------------------------------------------------------------------------------------------------- MIST - INVESCO SMALL CAP GROWTH - CLASS A 01/01/2004 to 12/31/2004 11.70 12.33 1,047 01/01/2005 to 12/31/2005 12.33 13.23 1,547 01/01/2006 to 12/31/2006 13.23 14.88 1,663 01/01/2007 to 12/31/2007 14.88 16.37 1,420 01/01/2008 to 12/31/2008 16.37 9.92 1,040 01/01/2009 to 12/31/2009 9.92 13.15 1,628 01/01/2010 to 12/31/2010 13.15 16.43 9,151 01/01/2011 to 12/31/2011 16.43 16.09 1,930 01/01/2012 to 12/31/2012 16.09 18.83 1,576 01/01/2013 to 12/31/2013 18.83 26.13 1,469 01/01/2014 to 12/31/2014 26.13 27.92 5,592 ---------------------------------------------------------------------------------------------------- MIST - J.P. MORGAN QUALITY BOND - CLASS A 01/01/2004 to 11/19/2004 12.02 12.38 28,764 ---------------------------------------------------------------------------------------------------- MIST - LORD ABBETT BOND DEBENTURE - CLASS A 01/01/2004 to 12/31/2004 16.40 17.56 763 01/01/2005 to 12/31/2005 17.56 17.65 3,592 01/01/2006 to 12/31/2006 17.65 19.07 8,493 01/01/2007 to 12/31/2007 19.07 20.12 13,384 01/01/2008 to 12/31/2008 20.12 16.21 21,351 01/01/2009 to 12/31/2009 16.21 21.95 18,927 01/01/2010 to 12/31/2010 21.95 24.54 20,182 01/01/2011 to 12/31/2011 24.54 25.40 19,862 01/01/2012 to 12/31/2012 25.40 28.40 17,282 01/01/2013 to 12/31/2013 28.40 30.33 16,171 01/01/2014 to 12/31/2014 30.33 31.49 18,860 ---------------------------------------------------------------------------------------------------- MIST - METLIFE SMALL CAP VALUE PORTFOLIO - CLASS A (FORMERLY MIST - THIRD AVENUE SMALL CAP VALUE - CLASS A) 01/01/2004 to 12/31/2004 11.54 14.45 5,614 01/01/2005 to 12/31/2005 14.45 16.52 5,643 01/01/2006 to 12/31/2006 16.52 18.50 6,559 01/01/2007 to 12/31/2007 18.50 17.76 7,584 01/01/2008 to 12/31/2008 17.76 12.33 9,323 ---------------------------------------------------------------------------------------------------- A-15
485BPOS72nd Page of 388TOC1stPreviousNextBottomJust 72nd
APPENDIX A CONDENSED FINANCIAL INFORMATION (CONTINUED) [Enlarge/Download Table] AUV AT AUV AT ACCUM UNITS BEGINNING END END OF PERIOD OF PERIOD OF PERIOD ----------------------------------------------------------------------------------------------------- MIST - METLIFE SMALL CAP VALUE PORTFOLIO - CLASS A (FORMERLY MIST - THIRD AVENUE SMALL CAP VALUE - CLASS A) (CONTINUED) 01/01/2009 to 12/31/2009 12.33 15.44 11,362 01/01/2010 to 12/31/2010 15.44 18.33 11,533 01/01/2011 to 12/31/2011 18.33 16.52 12,268 01/01/2012 to 12/31/2012 16.52 19.30 11,321 01/01/2013 to 12/31/2013 19.30 25.32 11,470 01/01/2014 to 12/31/2014 25.32 25.49 10,828 ----------------------------------------------------------------------------------------------------- MIST - MORGAN STANLEY MID CAP GROWTH - CLASS A 05/03/2010 to 12/31/2010 13.69 15.93 3,624 01/01/2011 to 12/31/2011 15.93 14.68 2,979 01/01/2012 to 12/31/2012 14.68 15.89 2,750 01/01/2013 to 12/31/2013 15.89 21.85 2,974 01/01/2014 to 12/31/2014 21.85 21.86 2,743 ----------------------------------------------------------------------------------------------------- MIST - PIMCO TOTAL RETURN - CLASS A 01/01/2004 to 12/31/2004 11.82 12.29 31,340 01/01/2005 to 12/31/2005 12.29 12.43 45,160 01/01/2006 to 12/31/2006 12.43 12.87 56,187 01/01/2007 to 12/31/2007 12.87 13.70 68,395 01/01/2008 to 12/31/2008 13.70 13.62 90,312 01/01/2009 to 12/31/2009 13.62 15.93 85,660 01/01/2010 to 12/31/2010 15.93 17.05 77,391 01/01/2011 to 12/31/2011 17.05 17.42 77,314 01/01/2012 to 12/31/2012 17.42 18.84 77,709 01/01/2013 to 12/31/2013 18.84 18.29 80,636 01/01/2014 to 12/31/2014 18.29 18.87 75,627 ----------------------------------------------------------------------------------------------------- MIST - T. ROWE PRICE LARGE CAP VALUE - CLASS A (FORMERLY LORD ABBETT GROWTH AND INCOME - CLASS A) 01/01/2004 to 12/31/2004 22.65 25.26 194,533 01/01/2005 to 12/31/2005 25.26 25.86 191,536 01/01/2006 to 12/31/2006 25.86 30.14 192,777 01/01/2007 to 12/31/2007 30.14 30.96 186,701 01/01/2008 to 12/31/2008 30.96 19.51 168,557 01/01/2009 to 12/31/2009 19.51 22.87 161,255 01/01/2010 to 12/31/2010 22.87 26.49 146,046 01/01/2011 to 12/31/2011 26.49 25.18 136,440 01/01/2012 to 12/31/2012 25.18 29.41 129,457 01/01/2013 to 12/31/2013 29.41 38.95 118,445 01/01/2014 to 12/31/2014 38.95 43.68 117,815 ----------------------------------------------------------------------------------------------------- A-16
485BPOS73rd Page of 388TOC1stPreviousNextBottomJust 73rd
APPENDIX A CONDENSED FINANCIAL INFORMATION (CONTINUED) [Enlarge/Download Table] AUV AT AUV AT ACCUM UNITS BEGINNING END END OF PERIOD OF PERIOD OF PERIOD ---------------------------------------------------------------------------------------------- MSF - BARCLAYS AGGREGATE BOND INDEX - CLASS A (FORMERLY MSF - BARCLAY'S CAPITAL AGGREGATE BOND INDEX - CLASS A) 01/01/2004 to 12/31/2004 12.82 13.18 774 01/01/2005 to 12/31/2005 13.18 13.29 2,973 01/01/2006 to 12/31/2006 13.29 13.66 4,638 01/01/2007 to 12/31/2007 13.66 14.42 9,466 01/01/2008 to 12/31/2008 14.42 15.09 11,875 01/01/2009 to 12/31/2009 15.09 15.68 12,769 01/01/2010 to 12/31/2010 15.68 16.42 9,887 01/01/2011 to 12/31/2011 16.42 17.43 10,040 01/01/2012 to 12/31/2012 17.43 17.88 9,719 01/01/2013 to 12/31/2013 17.88 17.25 8,931 01/01/2014 to 12/31/2014 17.25 18.03 9,444 ---------------------------------------------------------------------------------------------- MSF - BLACKROCK BOND INCOME - CLASS A 01/01/2004 to 12/31/2004 47.32 48.80 392 01/01/2005 to 12/31/2005 48.80 49.36 1,470 01/01/2006 to 12/31/2006 49.36 50.90 1,851 01/01/2007 to 12/31/2007 50.90 53.43 3,336 01/01/2008 to 12/31/2008 53.43 50.95 4.893 01/01/2009 to 12/31/2009 50.95 55.09 4,876 01/01/2010 to 12/31/2010 55.09 58.94 5,412 01/01/2011 to 12/31/2011 58.94 62.03 5,672 01/01/2012 to 12/31/2012 62.03 65.87 5,648 01/01/2013 to 12/31/2013 65.87 64.56 4,302 01/01/2014 to 12/31/2014 64.56 68.27 3,997 ---------------------------------------------------------------------------------------------- MSF - BLACKROCK CAPITAL APPRECIATION - CLASS A 01/01/2004 to 12/31/2004 24.55 26.38 242 01/01/2005 to 12/31/2005 26.38 27.88 381 01/01/2006 to 12/31/2006 27.88 28.67 472 01/01/2007 to 12/31/2007 28.67 33.62 636 01/01/2008 to 12/31/2008 33.62 21.08 517 01/01/2009 to 12/31/2009 21.08 28.47 1,222 01/01/2010 to 12/31/2010 28.47 33.69 1,396 01/01/2011 to 12/31/2011 33.69 30.30 1,519 01/01/2012 to 12/31/2012 30.30 34.22 6,180 01/01/2013 to 12/31/2013 34.22 45.36 5,993 01/01/2014 to 12/31/2014 45.36 48.78 1,819 ---------------------------------------------------------------------------------------------- MSF - BLACKROCK LARGE CAP VALUE - CLASS A 01/01/2004 to 12/31/2004 10.64 11.91 469 01/01/2005 to 12/31/2005 11.91 12.47 3,266 ---------------------------------------------------------------------------------------------- A-17
485BPOS74th Page of 388TOC1stPreviousNextBottomJust 74th
APPENDIX A CONDENSED FINANCIAL INFORMATION (CONTINUED) [Enlarge/Download Table] AUV AT AUV AT ACCUM UNITS BEGINNING END END OF PERIOD OF PERIOD OF PERIOD -------------------------------------------------------------------------------------- MSF - BLACKROCK LARGE CAP VALUE - CLASS A (CONTINUED) 01/01/2006 to 12/31/2006 12.47 14.69 6,207 01/01/2007 to 12/31/2007 14.69 15.00 6,142 01/01/2008 to 12/31/2008 15.00 9.64 6,255 01/01/2009 to 12/31/2009 9.64 10.59 9,688 01/01/2010 to 12/31/2010 10.59 11.42 12,674 01/01/2011 to 12/31/2011 11.42 11.55 16,966 01/01/2012 to 12/31/2012 11.55 13.03 21,517 01/01/2013 to 12/31/2013 13.03 17.00 22,893 01/01/2014 to 12/31/2014 17.00 18.45 25,128 -------------------------------------------------------------------------------------- MSF - FI MID CAP OPPORTUNITIES - CLASS A 01/01/2004 to 04/30/2004 11.43 11.22 2,961 05/01/2004 to 12/31/2004 11.22 11.33 1,739 01/01/2005 to 12/31/2005 11.33 18.12 2,741 01/01/2006 to 12/31/2006 18.12 20.02 2,921 01/01/2007 to 12/31/2007 20.02 21.41 2,394 01/01/2008 to 12/31/2008 21.41 9.46 2,761 01/01/2009 to 12/31/2009 9.46 12.49 3,242 01/01/2010 to 12/31/2010 12.49 13.54 0 -------------------------------------------------------------------------------------- MSF - MET/ARTISAN MID CAP VALUE - CLASS A 01/01/2004 to 12/31/2004 31.80 34.52 2,645 01/01/2005 to 12/31/2005 34.52 37.50 3,962 01/01/2006 to 12/31/2006 37.50 41.64 4,780 01/01/2007 to 12/31/2007 41.64 38.31 5,146 01/01/2008 to 12/31/2008 38.31 20.43 5,391 01/01/2009 to 12/31/2009 20.43 28.56 6,512 01/01/2010 to 12/31/2010 28.56 32.45 5,974 01/01/2011 to 12/31/2011 32.45 34.21 5,922 01/01/2012 to 12/31/2012 34.21 37.79 5,862 01/01/2013 to 12/31/2013 37.79 51.08 4,798 01/01/2014 to 12/31/2014 51.08 51.41 4,900 -------------------------------------------------------------------------------------- MSF - METLIFE MID CAP STOCK INDEX - CLASS A 01/01/2004 to 12/31/2004 11.61 13.30 24,560 01/01/2005 to 12/31/2005 13.30 14.75 32,407 01/01/2006 to 12/31/2006 14.75 16.04 38,302 01/01/2007 to 12/31/2007 16.04 17.07 38,884 01/01/2008 to 12/31/2008 17.07 10.76 43,316 01/01/2009 to 12/31/2009 10.76 14.56 50,545 01/01/2010 to 12/31/2010 14.56 18.15 53,129 01/01/2011 to 12/31/2011 18.15 17.59 47,683 -------------------------------------------------------------------------------------- A-18
485BPOS75th Page of 388TOC1stPreviousNextBottomJust 75th
APPENDIX A CONDENSED FINANCIAL INFORMATION (CONTINUED) [Enlarge/Download Table] AUV AT AUV AT ACCUM UNITS BEGINNING END END OF PERIOD OF PERIOD OF PERIOD ---------------------------------------------------------------------------------------- MSF - METLIFE MID CAP STOCK INDEX - CLASS A (CONTINUED) 01/01/2012 to 12/31/2012 17.59 20.43 53,824 01/01/2013 to 12/31/2013 20.43 26.86 56,449 01/01/2014 to 12/31/2014 26.86 29.04 59,072 ---------------------------------------------------------------------------------------- MSF - METLIFE STOCK INDEX - CLASS A 01/01/2004 to 12/31/2004 36.18 39.49 8,298 01/01/2005 to 12/31/2005 39.49 40.81 12,176 01/01/2006 to 12/31/2006 40.81 46.54 17,301 01/01/2007 to 12/31/2007 46.54 48.37 22,249 01/01/2008 to 12/31/2008 48.37 30.04 20,414 01/01/2009 to 12/31/2009 30.04 37.45 22,938 01/01/2010 to 12/31/2010 37.45 42.47 25,261 01/01/2011 to 12/31/2011 42.47 42.72 18,793 01/01/2012 to 12/31/2012 42.72 48.83 19,490 01/01/2013 to 12/31/2013 48.83 63.66 17,605 01/01/2014 to 12/31/2014 63.66 71.28 16,659 ---------------------------------------------------------------------------------------- MSF - MFS(R) TOTAL RETURN - CLASS A 01/01/2004 to 12/31/2004 39.40 43.29 565 01/01/2005 to 12/31/2005 43.29 44.08 1,230 01/01/2006 to 12/31/2006 44.08 48.85 2,191 01/01/2007 to 12/31/2007 48.85 50.35 2,059 01/01/2008 to 12/31/2008 50.35 38.71 2,414 01/01/2009 to 12/31/2009 38.71 45.34 3,975 01/01/2010 to 12/31/2010 45.34 49.29 4,177 01/01/2011 to 12/31/2011 49.29 49.85 4,202 01/01/2012 to 12/31/2012 49.85 54.94 4,003 01/01/2013 to 12/31/2013 54.94 64.56 4,284 01/01/2014 to 12/31/2014 64.56 69.26 4,226 ---------------------------------------------------------------------------------------- MSF - MFS(R) VALUE - CLASS A 01/01/2004 to 12/31/2004 12.18 13.40 3,479 01/01/2005 to 12/31/2005 13.40 13.05 4,665 01/01/2006 to 12/31/2006 13.05 15.23 6,328 01/01/2007 to 12/31/2007 15.23 14.47 6,093 01/01/2008 to 12/31/2008 14.47 9.50 5,068 01/01/2009 to 12/31/2009 9.50 11.34 6,102 01/01/2010 to 12/31/2010 11.34 12.48 9,119 01/01/2011 to 12/31/2011 12.48 12.43 10,806 01/01/2012 to 12/31/2012 12.43 14.32 12,523 01/01/2013 to 12/31/2013 14.32 19.19 14,129 01/01/2014 to 12/31/2014 19.19 21.00 15,100 ---------------------------------------------------------------------------------------- A-19
485BPOS76th Page of 388TOC1stPreviousNextBottomJust 76th
APPENDIX A CONDENSED FINANCIAL INFORMATION (CONTINUED) [Enlarge/Download Table] AUV AT AUV AT ACCUM UNITS BEGINNING END END OF PERIOD OF PERIOD OF PERIOD ---------------------------------------------------------------------------------------------------- MSF - MSCI EAFE(R) INDEX - CLASS A 01/01/2004 to 12/31/2004 9.72 11.49 2,285 01/01/2005 to 12/31/2005 11.49 12.85 12,106 01/01/2006 to 12/31/2006 12.85 15.96 20,485 01/01/2007 to 12/31/2007 15.96 17.46 22,743 01/01/2008 to 12/31/2008 17.46 9.99 29,217 01/01/2009 to 12/31/2009 9.99 12.69 37,041 01/01/2010 to 12/31/2010 12.69 13.56 55,099 01/01/2011 to 12/31/2011 13.56 11.72 63,230 01/01/2012 to 12/31/2012 11.72 13.69 63,476 01/01/2013 to 12/31/2013 13.69 16.48 65,950 01/01/2014 to 12/31/2014 16.48 15.30 70,496 ---------------------------------------------------------------------------------------------------- MSF - NEUBERGER BERMAN GENESIS - CLASS A 01/01/2004 to 12/31/2004 16.16 18.41 2,727 01/01/2005 to 12/31/2005 18.41 18.94 5,286 01/01/2006 to 12/31/2006 18.94 21.83 6,817 01/01/2007 to 12/31/2007 21.83 20.82 8,606 01/01/2008 to 12/31/2008 20.82 12.66 7,441 01/01/2009 to 12/31/2009 12.66 14.15 8,115 01/01/2010 to 12/31/2010 14.15 16.99 7,925 01/01/2011 to 12/31/2011 16.99 17.75 9,973 01/01/2012 to 12/31/2012 17.75 19.29 8,857 01/01/2013 to 12/31/2013 19.29 26.39 7,627 01/01/2014 to 12/31/2014 26.39 26.06 7,296 ---------------------------------------------------------------------------------------------------- MSF - RUSSELL 2000(R) INDEX - CLASS A 01/01/2004 to 12/31/2004 13.68 15.91 8,102 01/01/2005 to 12/31/2005 15.91 16.43 6,070 01/01/2006 to 12/31/2006 16.43 19.14 9,284 01/01/2007 to 12/31/2007 19.14 18.61 10,116 01/01/2008 to 12/31/2008 18.61 12.22 11,755 01/01/2009 to 12/31/2009 12.22 15.21 13,195 01/01/2010 to 12/31/2010 15.21 19.06 15,140 01/01/2011 to 12/31/2011 19.06 18.06 15,113 01/01/2012 to 12/31/2012 18.06 20.75 17,427 01/01/2013 to 12/31/2013 20.75 28.39 18,780 01/01/2014 to 12/31/2014 28.39 29.45 18,870 ---------------------------------------------------------------------------------------------------- MSF - T. ROWE PRICE LARGE CAP GROWTH - CLASS A (FORMERLY MIST - RCM TECHNOLOGY - CLASS A) 01/01/2004 to 12/31/2004 4.66 4.40 801 01/01/2005 to 12/31/2005 4.40 4.84 1,495 ---------------------------------------------------------------------------------------------------- A-20
485BPOS77th Page of 388TOC1stPreviousNextBottomJust 77th
APPENDIX A CONDENSED FINANCIAL INFORMATION (CONTINUED) [Enlarge/Download Table] AUV AT AUV AT ACCUM UNITS BEGINNING END END OF PERIOD OF PERIOD OF PERIOD ---------------------------------------------------------------------------------------------------- MSF - T. ROWE PRICE LARGE CAP GROWTH - CLASS A (FORMERLY MIST - RCM TECHNOLOGY - CLASS A) (CONTINUED) 01/01/2006 to 12/31/2006 4.84 5.05 1,906 01/01/2007 to 12/31/2007 5.05 6.56 3,662 01/01/2008 to 12/31/2008 6.56 3.61 4,044 01/01/2009 to 12/31/2009 3.61 5.68 7,372 01/01/2010 to 12/31/2010 5.68 7.19 10,981 01/01/2011 to 12/31/2011 7.19 6.41 12,061 01/01/2012 to 12/31/2012 6.41 7.11 13,211 01/01/2013 to 12/31/2013 7.11 23.27 -- 01/01/2014 to 12/31/2014 23.27 25.07 -- ---------------------------------------------------------------------------------------------------- MSF - T. ROWE PRICE SMALL CAP GROWTH - CLASS A 05/01/2004 to 12/31/2004 12.82 13.53 0 01/01/2005 to 12/31/2005 13.53 14.84 0 01/01/2006 to 12/31/2006 14.84 15.22 0 01/01/2007 to 12/31/2007 15.22 18.44 5,760 01/01/2008 to 12/31/2008 18.44 10.41 7,538 01/01/2009 to 12/31/2009 10.41 16.06 8,272 01/01/2010 to 12/31/2010 16.06 21.48 15,126 01/01/2011 to 12/31/2011 21.48 21.67 18,409 01/01/2012 to 12/31/2012 21.67 24.95 17,593 01/01/2013 to 12/31/2013 24.95 35.74 17,787 01/01/2014 to 12/31/2014 35.74 37.87 17,646 ---------------------------------------------------------------------------------------------------- MSF - WMC CORE EQUITY OPPORTUNITIES - CLASS A (FORMERLY MSF - DAVIS VENTURE VALUE - CLASS A) 01/01/2004 to 12/31/2004 28.82 31.99 603 01/01/2005 to 12/31/2005 31.99 34.84 2,334 01/01/2006 to 12/31/2006 34.84 39.43 4,098 01/01/2007 to 12/31/2007 39.43 40.72 4,597 01/01/2008 to 12/31/2008 40.72 24.39 5,728 01/01/2009 to 12/31/2009 24.39 31.79 5,649 01/01/2010 to 12/31/2010 31.79 35.16 11,679 01/01/2011 to 12/31/2011 35.16 33.33 12,367 01/01/2012 to 12/31/2012 33.33 37.14 12,728 01/01/2013 to 12/31/2013 37.14 49.04 12,898 01/01/2014 to 12/31/2014 49.04 53.58 13,306 ---------------------------------------------------------------------------------------------------- T. ROWE PRICE GROWTH STOCK FUND 01/01/2004 to 12/31/2004 62.15 67.90 30,524 01/01/2005 to 12/31/2005 67.90 71.72 29,722 01/01/2006 to 12/31/2006 71.72 81.07 28,898 ---------------------------------------------------------------------------------------------------- A-21
485BPOS78th Page of 388TOC1stPreviousNextBottomJust 78th
APPENDIX A CONDENSED FINANCIAL INFORMATION (CONTINUED) [Download Table] AUV AT AUV AT ACCUM UNITS BEGINNING END END OF PERIOD OF PERIOD OF PERIOD ---------------------------------------------------------------------------- T. ROWE PRICE GROWTH STOCK FUND (CONTINUED) 01/01/2007 to 12/31/2007 81.07 88.67 28,721 01/01/2008 to 12/31/2008 88.67 50.75 24,876 01/01/2009 to 12/31/2009 50.75 72.05 24,043 01/01/2010 to 12/31/2010 72.05 83.50 85,875 01/01/2011 to 12/31/2011 83.50 81.96 73,401 01/01/2012 to 12/31/2012 81.96 96.60 66,302 01/01/2013 to 12/31/2013 96.60 133.27 62,571 01/01/2014 to 12/31/2014 133.27 143.75 52,254 ---------------------------------------------------------------------------- A-22
485BPOS79th Page of 388TOC1stPreviousNextBottomJust 79th
APPENDIX B PARTICIPATING INVESTMENT PORTFOLIOS Below are the investment objectives of each Fund available under the Contract. The Fund prospectuses contain more complete information, including a description of the investment objectives, policies, restrictions and risks. THERE CAN BE NO ASSURANCE THAT THE INVESTMENT OBJECTIVES WILL BE ACHIEVED. THE ALGER PORTFOLIOS (CLASS I-2) The Alger Portfolios is a mutual fund with multiple portfolios, one of which is offered under the Contract. Fred Alger Management, Inc. is the investment adviser to each of the portfolios. The following Class I-2 portfolio is available under the Contract: Alger Small Cap Growth Portfolio Investment Objective: Seeks long-term capital appreciation. AMERICAN FUNDS INSURANCE SERIES(R) (CLASS 2) American Funds Insurance Series(R) is a mutual fund with multiple funds, three of which are offered under the contract. Capital Research and Management Company is the investment adviser to each fund. The following Class 2 funds are available under the Contract: American Funds Global Small Capitalization Fund Investment Objective: Seeks long-term growth of capital. American Funds Growth Fund Investment Objective: Seeks growth of capital. American Funds Growth-Income Fund Investment Objective: Seeks long-term growth of capital and income. DEUTSCHE VARIABLE SERIES I (CLASS A) Deutsche Variable Series I is a mutual fund with multiple series, one of which is offered under the Contract. Deutsche Investment Management Americas Inc. is the investment adviser to each series. The following Class A series is available under the Contract: Deutsche CROCI(R) International VIP Investment Objective: Seeks long-term growth of capital. FIDELITY(R) VARIABLE INSURANCE PRODUCTS (INITIAL CLASS) Fidelity Variable Insurance Products is a mutual fund with multiple portfolios, five of which are offered under the contract. Fidelity Management & Research Company is the investment adviser to each of the portfolios. The following Initial Class portfolios are available under the Contract: Asset Manager Portfolio Subadvisers: FMR Co., Inc.; Fidelity Investments Money Management, Inc. Investment Objective: Seeks to obtain high total return with reduced risk over the long-term by allocating its assets among stocks, bonds, and short-term instruments. Contrafund(R) Portfolio Subadviser: FMR Co., Inc. Investment Objective: Seeks long-term capital appreciation. Growth Portfolio Subadviser: FMR Co., Inc. Investment Objective: Seeks to achieve capital appreciation. Money Market Portfolio Subadviser: Fidelity Investments Money Management, Inc. Investment Objective: Seeks as high a level of current income as is consistent with preservation of capital and liquidity. B-1
485BPOS80th Page of 388TOC1stPreviousNextBottomJust 80th
Overseas Portfolio Subadviser: FMR Co., Inc. Investment Objective: Seeks long-term growth of capital. MET INVESTORS SERIES TRUST (CLASS A) Met Investors Series Trust is a mutual fund with multiple portfolios. MetLife Advisers, LLC, an affiliate of MetLife Investors USA, is the investment manager of Met Investors Series Trust. MetLife Advisers, LLC has engaged subadvisers to provide investment advice for the individual portfolios. The following Class A portfolios are available under the Contract: Invesco Small Cap Growth Portfolio Subadviser: Invesco Advisers, Inc. Investment Objective: Seeks long-term growth of capital. Lord Abbett Bond Debenture Portfolio Subadviser: Lord, Abbett & Co. LLC Investment Objective: Seeks high current income and the opportunity for capital appreciation to produce a high total return. MetLife Small Cap Value Portfolio Subadvisers: Delaware Investments Fund Advisers; Wells Capital Management Incorporated Investment Objective: Seeks long-term capital appreciation. MFS(R) Research International Portfolio Subadviser: Massachusetts Financial Services Company Investment Objective: Seeks capital appreciation. Morgan Stanley Mid Cap Growth Portfolio Subadviser: Morgan Stanley Investment Management Inc. Investment Objective: Seeks capital appreciation. PIMCO Total Return Portfolio Subadviser: Pacific Investment Management Company LLC Investment Objective: Seeks maximum total return, consistent with the preservation of capital and prudent investment management. T. Rowe Price Large Cap Value Portfolio Subadviser: T. Rowe Price Associates, Inc. Investment Objective: Seeks long-term capital appreciation by investing in common stocks believed to be undervalued. Income is a secondary objective. METROPOLITAN SERIES FUND (CLASS A) Metropolitan Series Fund is a mutual fund with multiple portfolios. MetLife Advisers, LLC is the investment adviser for all of the portfolios. MetLife Advisers, LLC has engaged subadvisers to provide investment advice for the individual portfolios. The following Class A portfolios are available under the Contract: Barclays Aggregate Bond Index Portfolio Subadviser: MetLife Investment Management, LLC Investment Objective: Seeks to track the performance of the Barclays U.S. Aggregate Bond Index. BlackRock Bond Income Portfolio Subadviser: BlackRock Advisors, LLC Investment Objective: Seeks a competitive total return primarily from investing in fixed-income securities. BlackRock Capital Appreciation Portfolio Subadviser: BlackRock Advisors, LLC Investment Objective: Seeks long-term growth of capital. BlackRock Large Cap Value Portfolio Subadviser: BlackRock Advisors, LLC Investment Objective: Seeks long-term growth of capital. B-2
485BPOS81st Page of 388TOC1stPreviousNextBottomJust 81st
Met/Artisan Mid Cap Value Portfolio Subadviser: Artisan Partners Limited Partnership Investment Objective: Seeks long-term capital growth. MetLife Mid Cap Stock Index Portfolio Subadviser: MetLife Investment Management, LLC/ / Investment Objective: Seeks to track the performance of the Standard & Poor's MidCap 400(R) Composite Stock Price Index. MetLife Stock Index Portfolio Subadviser: MetLife Investment Management, LLC/ / Investment Objective: Seeks to track the performance of the Standard & Poor's 500(R) Composite Stock Price Index. MFS(R) Total Return Portfolio Subadviser: Massachusetts Financial Services Company Investment Objective: Seeks a favorable total return through investment in a diversified portfolio. MFS(R) Value Portfolio Subadviser: Massachusetts Financial Services Company Investment Objective: Seeks capital appreciation. MSCI EAFE(R) Index Portfolio Subadviser: MetLife Investment Management, LLC/ / Investment Objective: Seeks to track the performance of the MSCI EAFE(R) Index. Neuberger Berman Genesis Portfolio Subadviser: Neuberger Berman Management LLC Investment Objective: Seeks high total return, consisting principally of capital appreciation. Russell 2000(R) Index Portfolio Subadviser: MetLife Investment Management, LLC/ / Investment Objective: Seeks to track the performance of the Russell 2000(R) Index. T. Rowe Price Large Cap Growth Portfolio Subadviser: T. Rowe Price Associates, Inc. Investment Objective: Seeks long-term growth of capital. T. Rowe Price Small Cap Growth Portfolio Subadviser: T. Rowe Price Associates, Inc. Investment Objective: Seeks long-term capital growth. WMC Core Equity Opportunities Portfolio Subadviser: Wellington Management Company LLP Investment Objective: Seeks to provide a growing stream of income over time and, secondarily, long-term capital appreciation and current income. T. ROWE PRICE GROWTH STOCK FUND, INC. The T. Rowe Price Growth Stock Fund, Inc. is a mutual fund. T. Rowe Price Associates, Inc. is the investment adviser for the fund. Investment Objective: Seeks long-term capital growth through investments in stock. B-3
485BPOS82nd Page of 388TOC1stPreviousNextBottomJust 82nd
APPENDIX C ADDITIONAL INFORMATION REGARDING THE PORTFOLIOS The Fund below was subject to a name change. The chart identifies the former name and new name of the Fund. FUND NAME CHANGE FORMER FUND NEW FUND -------------------------------------- ------------------------------------- MET INVESTORS SERIES TRUST MET INVESTORS SERIES TRUST Third Avenue Small Cap Value Portfolio MetLife Small Cap Value Portfolio DWS VARIABLE SERIES I DEUTSCHE VARIABLE SERIES I DWS International VIP Deutsche CROCI (R) International VIP C-1
485BPOS83rd Page of 388TOC1stPreviousNextBottomJust 83rd
APPENDIX D PREMIUM TAX TABLE If You are a resident of one of the following jurisdictions, the percentage amount listed by that jurisdiction is the premium tax rate applicable to your Contract. [Download Table] QUALIFIED NON-QUALIFIED CONTRACTS CONTRACTS - --------- ------------- California/(1)/... 0.50% 2.35% Florida/(2)/...... 1.00% 1.00% Maine/(3)/........ 0.00% 2.00% Nevada/(4)/....... 0.00% 3.50% Puerto Rico/(5)/.. 1.00% 1.00% South Dakota/(6)/. 0.00% 1.25% West Virginia..... 1.00% 1.00% Wyoming/(4)/...... 0.00% 1.00% -------- /(1)/ California applies the qualified tax rate to plans that qualify under the following Code sections: 401(a), 403(b), 404, 408(b) and 501(a). /(2)/ Annuity premiums are exempt from taxation provided the tax savings are passed back to the contract holders. Otherwise, they are taxable at 1%. /(3)/ Maine applies the qualified tax rate to plans that qualify under the following Code sections: 401, 403, 403(b), 404, 408, 457 and 501. /(4)/ Nevada and Wyoming apply the qualified tax rate to plans that qualify under the following Code sections: 401, 403, 404, 408 and 501. /(5)/ We will not deduct premium taxes paid by Us to Puerto Rico from purchase payments, account balances, withdrawals, death benefits or income payments. /(6)/ Special rate applies for large case annuity policies. Rate is 8/100 of 1% for that portion of the annuity considerations received on a contract exceeding $500,000 annually. Special rate on large case policies is not subject to retaliation. South Dakota applies the qualified tax rate to plans that qualify under the following Code sections: 401, 403(b), 404, 408, 457 and 501(a). D-1
485BPOS84th Page of 388TOC1stPreviousNextBottomJust 84th
STATEMENT OF ADDITIONAL INFORMATION METLIFE INVESTORS USA SEPARATE ACCOUNT A GROUP FLEXIBLE PAYMENT FIXED AND VARIABLE ANNUITY CONTRACTS METLIFE INSURANCE COMPANY USA MAY 1, 2015 THIS STATEMENT OF ADDITIONAL INFORMATION IS NOT A PROSPECTUS AND SHOULD BE READ IN CONJUNCTION WITH THE PROSPECTUS. A COPY OF THE PROSPECTUS, DATED MAY 1, 2015, MAY BE OBTAINED WITHOUT CHARGE BY WRITING TO METLIFE INSURANCE COMPANY USA, 11225 NORTH COMMUNITY HOUSE ROAD, CHARLOTTE, NC 28277 OR BY TELEPHONING (800) 283-4536. NOTE: CERTAIN TERMS USED IN THIS STATEMENT OF ADDITIONAL INFORMATION HAVE SPECIAL MEANINGS. IF A TERM IS NOT DEFINED HEREIN, IT HAS THE MEANING GIVEN TO IT IN THE PROSPECTUS. SAI-USAFLEXBONUS 11/14
485BPOS85th Page of 388TOC1stPreviousNextBottomJust 85th
[Download Table] TABLE OF CONTENTS PAGE THE INSURANCE COMPANY........................................... 3 SURRENDER CHARGES............................................... 3 NET INVESTMENT FACTOR........................................... 3 ANNUITY PAYMENTS................................................ 3 Basis of Variable Benefits.................................... 3 Determination of Amount of Monthly Variable Annuity Payments for First Year....................................... 3 Determination of Amount of Monthly Variable Annuity Payments for Second and Subsequent Years.............................................. 4 Annuity Unit Value............................................ 4 UNDERWRITERS, DISTRIBUTION OF THE CONTRACT...................... 4 CALCULATION OF PERFORMANCE...................................... 5 VOTING RIGHTS................................................... 5 SAFEKEEPING OF SECURITIES....................................... 6 SERVICING AGENT................................................. 6 INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM................................................. 6 ADDITIONAL FEDERAL TAX CONSIDERATIONS........................... 7 Qualified Annuity Contracts................................... 7 Types of Qualified Contracts.................................. 7 ERISA......................................................... 7 Federal Estate Taxes.......................................... 8 Generation-Skipping Transfer Tax.............................. 8 Annuity Purchase Payments by Nonresident Aliens and Foreign Corporations.................................................. 8 FINANCIAL STATEMENTS............................................ 8 2
485BPOS86th Page of 388TOC1stPreviousNextBottomJust 86th
COMPANY MetLife USA is a stock life insurance company originally chartered in Connecticut in 1863 and currently subject to the laws of the State of Delaware. MetLife USA is licensed to conduct business in all states of the United States, except New York, and in the District of Columbia, Puerto Rico, Guam, the U.S. and British Virgin Islands and the Bahamas. MetLife USA is a wholly-owned subsidiary of MetLife, Inc., a publicly-traded company. MetLife, Inc., through its subsidiaries and affiliates, is a leading provider of insurance and financial services to individuals and institutional customers. MetLife USA's principal executive offices are located at 11225 North Community House Road, Charlotte, NC 28277. SURRENDER CHARGES Subject to the individual's retirement plan requirements, all or a portion of the Participant's account may be surrendered at any time prior to the annuity date. Unless a certificate has been in effect for more than nine full calendar years after the Certificate Date, a surrender charge (contingent deferred sales charge) will be deducted in the event the Participant requests a full or partial surrender from the Separate Account. The charge is based on a percentage of the amount surrendered. For 403(b) Plans only, no surrender charge will be applied for that part of the first surrender from the Separate Account in a calendar year that does not exceed 10% of the value of the Participant's Account. The surrender charge amounts to 7% for surrenders attributable to purchase payments received within 60 months prior to the date of the surrender. In no event will the sum of these surrender charges and the distribution expense charge exceed 9% of the purchase payments. NET INVESTMENT FACTOR The Separate Account net investment factor is an index of the percentage change (adjusted for distributions by the Fund and the deduction of the actuarial risk fee) in the net asset value of each Fund in which the Series in invested, since the preceding Business Day. The Separate Account net investment factor for each Series of Accumulation Units is determined for any Business Day by dividing (i) the net asset value of a share of the Fund which is represented by such Series at the close of business on such day, plus the per share amount of any distributions made by such Fund on such day by (ii) the net asset value of a share of such Fund determined as of the close of business on the preceding Business Day and then subtracting from the result the daily factors for mortality and expense risks (.003699%) for each calendar day between the preceding Business Day and the end of the current Business Day. ANNUITY PAYMENTS BASIS OF VARIABLE BENEFITS The Variable Annuity benefits rates used in determining Annuity Payments under the Contracts are based on actuarial assumptions, reflected in tables in the Contracts, as to the expected mortality and adjusted age and the form of Annuity selected. The mortality basis for these tables is Annuity 2000 Mortality Table, projected to the year 2020 on Projection Scale G, with interest at 4.25% for all functions involving life contingencies and the portion of any period certain beyond 10 years, and 3.25% for the first 10 years of any certain period. Adjusted age in those tables means actual age to the nearest birthday at the time the first payment is due, adjusted according to the following table: [Download Table] YEAR OF BIRTH AGE ADJUSTMENT BEFORE 1945 ACTUAL AGE 1946 - 1965 Age Minus 1 Year 1966 - 1985 Age Minus 2 Years 1986 - 2005 Age Minus 3 Years DETERMINATION OF AMOUNT OF MONTHLY VARIABLE ANNUITY PAYMENTS FOR FIRST YEAR The Separate Account value used to establish the monthly variable annuity payment for the first year consists of the value of accumulation units of each Series of the Separate Account credited to a Participant on the last valuation date of the second calendar week before the annuity date. The Contract contains tables showing monthly payment factors and annuity premium rates per $1,000 of Separate Account value to be applied under Options 1 through 4. At the beginning of the first payment year, an amount is transferred from the Separate Account to MetLife USA's General Account and level monthly annuity payments for the year are made out of the General Account. The amount to be transferred is determined by multiplying the annuity premium rate per $1,000 set forth in the Contract tables by the number of thousands of dollars of Separate Account value credited to a Participant. The level monthly payment for the first payment year is then determined by multiplying the amount transferred (the "Annuity 3
485BPOS87th Page of 388TOC1stPreviousNextBottomJust 87th
Premium") by the monthly payment factor in the same table. In the event the Contract involved has Separate Account accumulation units in more than one Series, the total monthly annuity payment for the first year is the sum of the monthly annuity payments, determined in the same manner as above, for each Series. At the time the first year's monthly payments are determined, a number of annuity units for each Separate Account Series is also established for the annuitant by dividing the first year monthly payment from that series by the Separate Account annuity unit values for the series on the last valuation date of the second calendar week before the first annuity payment is due. The number of annuity units remains fixed during the annuity period unless annuity units are converted to or from another series. DETERMINATION OF AMOUNT OF MONTHLY VARIABLE ANNUITY PAYMENTS FOR SECOND AND SUBSEQUENT YEARS As of each anniversary of the annuity date, MetLife USA will determine the amount of the monthly variable annuity payments for the year then beginning. Separate determinations will be made for each Separate Account Series in which the annuitant has annuity units, with the total annuity payment being the sum of the payments derived from the Series. The amount of monthly payments for any Separate Account Series for any year after the first will be determined by multiplying the number of annuity units for that Series by the annuity unit value for that Series for the valuation period in which the first payment for the year is due. It will be MetLife USA's practice to mail variable annuity payments no later than seven days after the last day of the valuation period upon which they are based or the monthly anniversary thereof. The objective of a variable annuity contract is to provide level payments during periods when the economy is relatively stable and to reflect as increased payments only the excess of investment results flowing from inflation or an increase in productivity. The achievement of this objective will depend, in part, upon the validity of the assumption that the net investment return of the Separate Account equals the assumed investment return during periods of stable prices. Subsequent years' payments will be smaller than, equal to or greater than the first year's payments depending on whether the actual net investment return for the Separate Account is smaller than equal to or greater than the Assumed Investment Return. ANNUITY UNIT VALUE The initial value of an Annuity Unit is $5 for each Series for the first Valuation Period as of which the first Variable Annuity Payment from such Series is made. The value of an Annuity Unit for each Series on any later date is determined by multiplying the value of an Annuity Unit at the end of the preceding Valuation Period by the "Annuity change factor" for the second preceding Valuation Period. The Annuity change factor is an adjusted measurement of the investment performance of the Fund since the end of the preceding Valuation Period. The Annuity change factor is determined by dividing the value of an Accumulation Unit at the end of the Valuation Period by the value of an Accumulation Unit at the end of the preceding Valuation Period and multiplying the result by a neutralization factor. Variable Annuity Payments for each year after the first reflect variations in the investment performance of the Separate Account above and below an Assumed Investment Return. This assumed investment rate is included for purposes of actuarial computations and does not relate to the actual investment performance of the underlying Fund. Therefore, the Assumed Investment Return must be "neutralized" in computing the Annuity change factor. For weekly Valuation Periods and a 4.25% Assumed Investment Return, the neutralization factor is 0.9991999. UNDERWRITERS, DISTRIBUTION OF THE CONTRACTS Information about the distribution of the Contracts is contained in the prospectus. (See "Principal Underwriter.") Additional information is provided below. The Contracts are not currently offered for sale. However, new Participants may be added under existing Contracts and, where applicable, we will continue to issue Certificates to new Participants. MetLife Investors Distribution Company ("Distributor") serves as principal underwriter for the Contracts. Distributor is a Missouri corporation and its home office is located at 1095 Avenue of the Americas, New York, NY 10036. Distributor is an indirect, wholly-owned subsidiary of MetLife, Inc. Distributor is registered as a broker-dealer with the Securities and Exchange Commission under the Securities Exchange Act of 1934 and is a member of FINRA. Distributor is not a member of the Securities Investor Protection Corporation. Distributor has entered into selling agreements with other broker-dealers ("selling firms") and compensates them for their services. 4
485BPOS88th Page of 388TOC1stPreviousNextBottomJust 88th
Distributor (including its predecessor) received sales compensation with respect to the Contracts and all other contracts issued from the Separate Account in the following amounts during the periods indicated: [Download Table] Aggregate Amount of Commissions Aggregate Retained by Amount of Distributor Commissions After Payments Paid to to Selling Fiscal Year Distributor Firms ---------------------------------------- 2012 $689,121,186 $0 2013 $456,083,088 $0 2014 $463,545,565 $0 Distributor passes through commissions to selling firms for their sales. In addition we pay compensation to Distributor to offset its expenses, including compensation costs, marketing and distribution expenses, advertising, wholesaling, printing and other expenses of distributing the Contracts. CALCULATION OF PERFORMANCE Average annual total return was computed by finding the average annual compounded rates of return over the 1, 5 and 10 year periods that would equate the initial amount invested to the ending redeemable value, according to the following formula: P(1+T)/(n)/ = ERV Where: P = a hypothetical initial payment of $1,000 T = average annual total return n = number of years ERV = ending redeemable value of a hypothetical $1,000 payment made at the beginning of the 1, 5, or 10 year periods (or fractional portion thereof). The computation of average annual total returns does take into consideration recurring charges and any non-recurring charges applicable to a Contract which is surrendered in full at the end of the stated holding period. In addition, certain Fund performance may be shown for the period commencing from the inception date of the Fund. These figures should not be interpreted to reflect actual historical performance of the Separate Account. We may, from time to time, include in our advertising and sales materials, performance information for Funds or Series related to the Funds and/or their investment advisers or subadvisers. Such related performance information also may reflect the deduction of certain Contract charges. We may also include in our advertising and sales materials, tax deferred compounding charts and other hypothetical illustrations, which may include comparisons of currently taxable and tax deferred investment programs, based on selected tax brackets. You should know that for any performance we illustrate, future performance will vary and results shown are not necessarily representative of future results. VOTING RIGHTS As the owner of the Separate Account, MetLife USA is the legal owner of the shares of the Funds. Based upon MetLife USA's current view of applicable law, we will vote shares of the Funds (which are deemed attributable to the Contracts) based on instructions received from those having voting interests under the Contract concerning Fund shares and who are entitled to vote on Fund proposals at all regular and special shareholders meetings. The persons who have voting interests under a particular plan may include the plan administrator or the Participant if voting is passed through to such individuals. Your plan administrator can provide you with information in this regard. MetLife USA will vote all shares of the underlying Funds as directed. MetLife USA will send to those with voting interests, at a last known address, all periodic reports, proxy materials and written requests for instructions on how to vote those shares. When MetLife USA receives these instructions, it will vote of the shares in proportion to the instructions. If MetLife USA does not receive voting instructions, from a recipient, it will vote their interest in the same proportion as represented by the votes it has received. The effect of this proportional voting is that a small number of those with voting interests may control the outcome of the vote. If MetLife USA determines that it is permitted to vote the shares in its own right due to changes in the law or in the interpretation of the law it may do so. MetLife USA is under no duty to inquire into voting instructions or into the authority of the person issuing such instructions. All instructions will be valid unless MetLife USA has actual knowledge that they are not. 5
485BPOS89th Page of 388TOC1stPreviousNextBottomJust 89th
When Annuity payments begin, the Annuitant will have all voting rights in regard to Fund shares. There are certain circumstances under which MetLife USA may disregard voting instructions. However, in this event, a summary of our action and the reasons for such action will appear in the next semiannual report. The number of votes that each person having the right to vote receives is determined on a record date that is set no more than 90 days before the meeting. Voting instructions will be requested at least 30 days before the meeting. Only Owners or Annuitants on the record date may vote. The number of shares to which a Participant is entitled to vote is calculated by dividing the portion of his or her Participant's Account allocated to that Fund on the record date by the net asset value of a Fund share on the same date. SAFEKEEPING OF SECURITIES Custody of all assets of the Separate Account are held by MetLife USA. The assets of each Separate Account Series will be kept physically segregated by MetLife USA and held separate from the assets of any other firm, person, or corporation. Additional protection for the assets of the Separate Account is afforded by fidelity bonds covering all of MetLife USA's officers and employees. SERVICING AGENT Administrative services agreements have been entered into between MetLife USA and each of MetLife Group, Inc. and Metropolitan Life Insurance Company under which the latter have agreed to perform certain of the personnel and administrative services relating to the Contracts and for the Separate Account. MetLife USA has paid fees to MetLife Group and Metropolitan Life Insurance Company for these services. INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM The financial statements and financial highlights comprising each of the Sub-Accounts of MetLife Investors USA Separate Account A included in this Statement of Additional Information, have been audited by Deloitte & Touche LLP, an independent registered public accounting firm, as stated in their report appearing herein. Such financial statements and financial highlights are included in reliance upon the report of such firm given upon their authority as experts in accounting and auditing. The consolidated financial statements and related financial statement schedules of MetLife Insurance Company USA and subsidiaries (the "Company") included in this Statement of Additional Information, have been audited by Deloitte & Touche LLP, an independent registered public accounting firm, as stated in their report appearing herein (which report expresses an unqualified opinion and includes an explanatory paragraph regarding the renaming of the Company, its mergers with entities under common control, and the retrospective adjustment of the consolidated financial statements for all periods presented to reflect the mergers in a manner similar to a pooling-of-interests as described in Note 3). Such financial statements and financial statement schedules are included in reliance upon the report of such firm given upon their authority as experts in accounting and auditing. The principal business address of Deloitte & Touche LLP is 30 Rockefeller Plaza, New York, New York 10112-0015. 6
485BPOS90th Page of 388TOC1stPreviousNextBottomJust 90th
ADDITIONAL FEDERAL TAX CONSIDERATIONS QUALIFIED ANNUITY CONTRACTS Annuity contracts purchased through tax qualified plans are subject to limitations imposed by the Code and regulations as a condition of tax qualification. There are various types of tax qualified plans which have certain beneficial tax consequences for Contract owners and plan participants. TYPES OF QUALIFIED PLANS The following list includes individual account-type plans which may hold an annuity Contract as described in the Prospectus. Except for Traditional IRAs, they are established by an employer for participation of its employees. IRA Established by an individual, or employer as part of an employer plan. SIMPLE Established by a for-profit employer with fewer than 100 employees, based on IRA accounts for each participant. SEP Established by a for-profit employer, based on IRA accounts for each participant. Employer only contributions. 401(K), 401(A) Established by for-profit employers, Section 501(c)(3) tax exempt and non-tax exempt entities, Indian Tribes. 403(B) TAX SHELTERED ANNUITY ("TSA") Established by Section 501(c)(3) tax exempt entities, public schools (K-12), public colleges, universities, churches, synagogues and mosques. 457(B) GOVERNMENTAL SPONSOR Established by state and local governments, public schools (K-12), public colleges and universities. 457(B) NON-GOVERNMENTAL SPONSOR Established by a tax-exempt entity. Under a non-governmental plan, which must be a tax-exempt entity under Section 501(c) of the Code, all such investments of the plan are owned by and are subject to the claims of the general creditors of the sponsoring employer. In general, all amounts received under a non-governmental Section 457(b) plan are taxable and are subject to Federal income tax withholding as wages. Additional information regarding 457(b) plans A 457(b) plan may provide a one-time election to make special one-time "catch-up" contributions in one or more of the participant's last three taxable years ending before the participant's normal retirement age under the plan. Participants in governmental 457(b) plans may not use both the age 50 or older catch-up and the special one-time catch-up contribution in the same taxable year. In general, contribution limits with respect to elective deferral and to age 50 plus catch-up contributions are not aggregated with contributions under the other types of qualified plans for the purposes of determining the limitations applicable to participants. 403(A) If your benefit under the 403(b) plan is worth more than $5,000, the Code requires that your annuity protect your spouse if You die before You receive any payments under the annuity or if You die while payments are being made. You may waive these requirements with the written consent of your spouse. In general, designating a beneficiary other than your spouse is considered a waiver and requires your spouse's written consent. Waiving these requirements may cause your monthly benefit to increase during your lifetime. Special rules apply to the withdrawal of excess contributions. ERISA If your plan is subject to ERISA and You are married, the income payments, withdrawal provisions, and methods of payment of the death benefit under your Contract may be subject to your spouse's rights as described below. Generally, the spouse must give qualified consent whenever You elect to: (a) Choose income payments other than on a qualified joint and survivor annuity basis ("QJSA") (one under which we make payments to You during your lifetime and then make payments reduced by no more than 50% to your spouse for his or her remaining life, if any): or choose to waive the qualified pre-retirement survivor annuity benefit ("QPSA") (the benefit payable to the surviving spouse of a participant who dies with a vested interest in an accrued retirement benefit under the plan before payment of the benefit has begun); (b) Make certain withdrawals under plans for which a qualified consent is required; (c) Name someone other than the spouse as your beneficiary; or 7
485BPOS91st Page of 388TOC1stPreviousNextBottomJust 91st
(d) Use your accrued benefit as security for a loan exceeding $5,000. Generally, there is no limit to the number of your elections as long as a qualified consent is given each time. The consent to waive the QJSA must meet certain requirements, including that it be in writing, that it acknowledges the identity of the designated beneficiary and the form of benefit selected, dated, signed by your spouse, witnessed by a notary public or plan representative, and that it be in a form satisfactory to us. The waiver of the QJSA generally must be executed during the 180 day period (90 days for certain loans) ending on the date on which income payments are to commence, or the withdrawal or the loan is to be made, as the case may be. If You die before benefits commence, your surviving spouse will be your beneficiary unless he or she has given a qualified consent otherwise. The qualified consent to waive the QPSA benefit and the beneficiary designation must be made in writing that acknowledges the designated beneficiary, dated, signed by your spouse, witnessed by a notary public or plan representative and in a form satisfactory to us. Generally, there is no limit to the number of beneficiary designations as long as a qualified consent accompanies each designation. The waiver of and the qualified consent for the QPSA benefit generally may not be given until the plan year in which You attain age 35. The waiver period for the QPSA ends on the date of your death. If the present value of your benefit is worth $5,000 or less, your plan generally may provide for distribution of your entire interest in a lump sum without spousal consent. Comparison of Plan Limits for Individual Contributions: [Download Table] -------------------------------------------------------- PLAN TYPE ELECTIVE CONTRIBUTION CATCH-UP CONTRIBUTION -------------------------------------------------------- IRA $5,500 $1,000 -------------------------------------------------------- SIMPLE $12,500 $3,000 -------------------------------------------------------- 401(k) $18,000 $6,000 -------------------------------------------------------- 401(a) (Employer contributions only) -------------------------------------------------------- 403(b)(TSA) $18,000 $6,000 -------------------------------------------------------- 457(b) $18,000 $6,000 -------------------------------------------------------- Dollar limits are for 2015 and subject to cost-of-living adjustments in future years. Employer-sponsored individual account plans (other than 457(b) plans) may provide for additional employer contributions such that total annual plan contributions do not to exceed the greater of $53,000 or 25% of an employee's compensation for 2015. FEDERAL ESTATE TAXES While no attempt is being made to discuss the Federal estate tax implications of the Contract, You should bear in mind that the value of an annuity contract owned by a decedent and payable to a beneficiary by virtue of surviving the decedent is included in the decedent's gross estate. Depending on the terms of the annuity contract, the value of the annuity included in the gross estate may be the value of the lump sum payment payable to the designated beneficiary or the actuarial value of the payments to be received by the beneficiary. Consult an estate planning adviser for more information. GENERATION-SKIPPING TRANSFER TAX Under certain circumstances, the Code may impose a "generation-skipping transfer tax" when all or part of an annuity contract is transferred to, or a death benefit is paid to, an individual two or more generations younger than the contract owner. Regulations issued under the Code may require us to deduct the tax from your contract, or from any applicable payment, and pay it directly to the IRS. ANNUITY PURCHASE PAYMENTS BY NONRESIDENT ALIENS AND FOREIGN CORPORATIONS The discussion above provides general information regarding U.S. Federal income tax consequences to annuity purchasers that are U.S. citizens or residents. Purchasers that are not U.S. citizens or residents will generally be subject to U.S. Federal withholding tax on taxable distributions from annuity contracts at a 30% rate, unless a lower treaty rate applies. In addition, purchasers may be subject to state and/or municipal taxes and taxes that may be imposed by the purchaser's country of citizenship or residence. Prospective purchasers are advised to consult with a qualified tax adviser regarding U.S., state and foreign taxation with respect to an annuity contract purchase. FINANCIAL STATEMENTS The financial statements and financial highlights of MetLife Investors USA Separate Account A and the consolidated financial statements are included herein. The financial statements of the Company included herein should be considered only as bearing upon the ability of the Company to meet its obligations under the Contract. 8
485BPOS92nd Page of 388TOC1stPreviousNextBottomJust 92nd
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Contract Owners of MetLife Investors USA Separate Account A and Board of Directors of MetLife Insurance Company USA We have audited the accompanying statements of assets and liabilities of MetLife Investors USA Separate Account A (the "Separate Account") of MetLife Insurance Company USA (the "Company") comprising each of the individual Sub-Accounts listed in Note 2.A as of December 31, 2014, the related statements of operations for the respective stated period in the year then ended, the statements of changes in net assets for the respective stated periods in the two years then ended, and the financial highlights in Note 8 for the respective stated periods in the five years then ended. These financial statements and financial highlights are the responsibility of the Separate Account's management. Our responsibility is to express an opinion on these financial statements and financial highlights based on our audits. We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements and financial highlights are free of material misstatement. The Separate Account is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Separate Account's internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. Our procedures included confirmation of investments owned as of December 31, 2014, by correspondence with the custodian or mutual fund companies. We believe that our audits provide a reasonable basis for our opinion. In our opinion, the financial statements and financial highlights referred to above present fairly, in all material respects, the financial position of each of the Sub-Accounts constituting the Separate Account of the Company as of December 31, 2014, the results of their operations for the respective stated period in the year then ended, the changes in their net assets for the respective stated periods in the two years then ended, and the financial highlights for the respective stated periods in the five years then ended, in conformity with accounting principles generally accepted in the United States of America. /s/ DELOITTE & TOUCHE LLP Certified Public Accountants Tampa, Florida March 27, 2015
485BPOS93rd Page of 388TOC1stPreviousNextBottomJust 93rd
This page is intentionally left blank.
485BPOS94th Page of 388TOC1stPreviousNextBottomJust 94th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF ASSETS AND LIABILITIES DECEMBER 31, 2014 [Enlarge/Download Table] AMERICAN FUNDS ALGER AMERICAN FUNDS AMERICAN FUNDS GLOBAL SMALL SMALL CAP GROWTH BOND GLOBAL GROWTH CAPITALIZATION SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- ------------------- ------------------- ASSETS: Investments at fair value.............. $ 57,195,868 $ 151,245,977 $ 312,209,262 $ 122,112,150 Due from MetLife Insurance Company USA.......................... -- -- -- -- ------------------- -------------------- ------------------- ------------------- Total Assets...................... 57,195,868 151,245,977 312,209,262 122,112,150 ------------------- -------------------- ------------------- ------------------- LIABILITIES: Accrued fees........................... -- 31 74 79 Due to MetLife Insurance Company USA.......................... -- -- 1 1 ------------------- -------------------- ------------------- ------------------- Total Liabilities................. -- 31 75 80 ------------------- -------------------- ------------------- ------------------- NET ASSETS................................ $ 57,195,868 $ 151,245,946 $ 312,209,187 $ 122,112,070 =================== ==================== =================== =================== CONTRACT OWNERS' EQUITY Net assets from accumulation units..... $ 57,195,868 $ 151,229,105 $ 312,200,050 $ 122,103,236 Net assets from contracts in payout.... -- 16,841 9,137 8,834 ------------------- -------------------- ------------------- ------------------- Total Net Assets.................. $ 57,195,868 $ 151,245,946 $ 312,209,187 $ 122,112,070 =================== ==================== =================== =================== The accompanying notes are an integral part of these financial statements. 1
485BPOS95th Page of 388TOC1stPreviousNextBottomJust 95th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF ASSETS AND LIABILITIES -- (CONTINUED) DECEMBER 31, 2014 [Enlarge/Download Table] AMERICAN FUNDS AMERICAN FUNDS BLACKROCK GLOBAL DEUTSCHE I GROWTH GROWTH-INCOME ALLOCATION V.I. INTERNATIONAL SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- -------------------- -------------------- -------------------- ASSETS: Investments at fair value............ $ 821,201,224 $ 390,905,794 $ 8,564 $ 14,851,303 Due from MetLife Insurance Company USA........................ -- -- -- -- -------------------- -------------------- -------------------- -------------------- Total Assets.................... 821,201,224 390,905,794 8,564 14,851,303 -------------------- -------------------- -------------------- -------------------- LIABILITIES: Accrued fees......................... 92 78 7 -- Due to MetLife Insurance Company USA........................ -- -- -- -- -------------------- -------------------- -------------------- -------------------- Total Liabilities............... 92 78 7 -- -------------------- -------------------- -------------------- -------------------- NET ASSETS.............................. $ 821,201,132 $ 390,905,716 $ 8,557 $ 14,851,303 ==================== ==================== ==================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 821,169,291 $ 390,850,420 $ 8,557 $ 14,851,303 Net assets from contracts in payout.. 31,841 55,296 -- -- -------------------- -------------------- -------------------- -------------------- Total Net Assets................ $ 821,201,132 $ 390,905,716 $ 8,557 $ 14,851,303 ==================== ==================== ==================== ==================== FEDERATED HIGH FEDERATED FIDELITY VIP FIDELITY VIP INCOME BOND KAUFMAN ASSET MANAGER CONTRAFUND SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- -------------------- -------------------- ASSETS: Investments at fair value............ $ 26,378 $ 47,257 $ 84,977,764 $ 631,948,788 Due from MetLife Insurance Company USA........................ -- -- 1 -- ------------------- -------------------- -------------------- -------------------- Total Assets.................... 26,378 47,257 84,977,765 631,948,788 ------------------- -------------------- -------------------- -------------------- LIABILITIES: Accrued fees......................... 2 4 2 55 Due to MetLife Insurance Company USA........................ -- -- -- -- ------------------- -------------------- -------------------- -------------------- Total Liabilities............... 2 4 2 55 ------------------- -------------------- -------------------- -------------------- NET ASSETS.............................. $ 26,376 $ 47,253 $ 84,977,763 $ 631,948,733 =================== ==================== ==================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 26,376 $ 47,253 $ 84,977,763 $ 631,948,080 Net assets from contracts in payout.. -- -- -- 653 ------------------- -------------------- -------------------- -------------------- Total Net Assets................ $ 26,376 $ 47,253 $ 84,977,763 $ 631,948,733 =================== ==================== ==================== ==================== FIDELITY VIP FIDELITY VIP EQUITY-INCOME FUNDSMANAGER 50% SUB-ACCOUNT SUB-ACCOUNT -------------------- -------------------- ASSETS: Investments at fair value............ $ 5,676,328 $ 3,538,458,593 Due from MetLife Insurance Company USA........................ -- -- -------------------- -------------------- Total Assets.................... 5,676,328 3,538,458,593 -------------------- -------------------- LIABILITIES: Accrued fees......................... -- -- Due to MetLife Insurance Company USA........................ -- -- -------------------- -------------------- Total Liabilities............... -- -- -------------------- -------------------- NET ASSETS.............................. $ 5,676,328 $ 3,538,458,593 ==================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 5,676,328 $ 3,538,458,593 Net assets from contracts in payout.. -- -- -------------------- -------------------- Total Net Assets................ $ 5,676,328 $ 3,538,458,593 ==================== ==================== The accompanying notes are an integral part of these financial statements. 2
485BPOS96th Page of 388TOC1stPreviousNextBottomJust 96th
The accompanying notes are an integral part of these financial statements. 3
485BPOS97th Page of 388TOC1stPreviousNextBottomJust 97th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF ASSETS AND LIABILITIES -- (CONTINUED) DECEMBER 31, 2014 [Enlarge/Download Table] FIDELITY VIP FIDELITY VIP FIDELITY VIP FIDELITY VIP FUNDSMANAGER 60% GROWTH INDEX 500 MID CAP SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- -------------------- ------------------- ------------------- ASSETS: Investments at fair value............ $ 3,994,437,491 $ 167,673,936 $ 70,165,996 $ 446,277,707 Due from MetLife Insurance Company USA........................ -- -- -- 1 -------------------- -------------------- ------------------- ------------------- Total Assets.................... 3,994,437,491 167,673,936 70,165,996 446,277,708 -------------------- -------------------- ------------------- ------------------- LIABILITIES: Accrued fees......................... -- 5 14 15 Due to MetLife Insurance Company USA........................ -- 1 -- -- -------------------- -------------------- ------------------- ------------------- Total Liabilities............... -- 6 14 15 -------------------- -------------------- ------------------- ------------------- NET ASSETS.............................. $ 3,994,437,491 $ 167,673,930 $ 70,165,982 $ 446,277,693 ==================== ==================== =================== =================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 3,994,437,491 $ 167,673,930 $ 70,165,982 $ 446,262,210 Net assets from contracts in payout.. -- -- -- 15,483 -------------------- -------------------- ------------------- ------------------- Total Net Assets................ $ 3,994,437,491 $ 167,673,930 $ 70,165,982 $ 446,277,693 ==================== ==================== =================== =================== FIDELITY VIP FIDELITY VIP FTVIPT FRANKLIN FTVIPT FRANKLIN MONEY MARKET OVERSEAS INCOME VIP MUTUAL SHARES VIP SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- ------------------- ------------------- -------------------- ASSETS: Investments at fair value............ $ 50,947,658 $ 4,942,746 $ 294,909,970 $ 153,109,236 Due from MetLife Insurance Company USA........................ -- -- 1 1 -------------------- ------------------- ------------------- -------------------- Total Assets.................... 50,947,658 4,942,746 294,909,971 153,109,237 -------------------- ------------------- ------------------- -------------------- LIABILITIES: Accrued fees......................... 10 -- 43 14 Due to MetLife Insurance Company USA........................ -- -- -- -- -------------------- ------------------- ------------------- -------------------- Total Liabilities............... 10 -- 43 14 -------------------- ------------------- ------------------- -------------------- NET ASSETS.............................. $ 50,947,648 $ 4,942,746 $ 294,909,928 $ 153,109,223 ==================== =================== =================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 50,947,648 $ 4,942,746 $ 294,876,463 $ 153,099,739 Net assets from contracts in payout.. -- -- 33,465 9,484 -------------------- ------------------- ------------------- -------------------- Total Net Assets................ $ 50,947,648 $ 4,942,746 $ 294,909,928 $ 153,109,223 ==================== =================== =================== ==================== FTVIPT FRANKLIN FTVIPT TEMPLETON SMALL CAP VALUE VIP FOREIGN VIP SUB-ACCOUNT SUB-ACCOUNT -------------------- -------------------- ASSETS: Investments at fair value............ $ 126,502,560 $ 73,607,849 Due from MetLife Insurance Company USA........................ -- 1 -------------------- -------------------- Total Assets.................... 126,502,560 73,607,850 -------------------- -------------------- LIABILITIES: Accrued fees......................... 3 70 Due to MetLife Insurance Company USA........................ 1 -- -------------------- -------------------- Total Liabilities............... 4 70 -------------------- -------------------- NET ASSETS.............................. $ 126,502,556 $ 73,607,780 ==================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 126,502,080 $ 73,607,780 Net assets from contracts in payout.. 476 -- -------------------- -------------------- Total Net Assets................ $ 126,502,556 $ 73,607,780 ==================== ==================== The accompanying notes are an integral part of these financial statements. 4
485BPOS98th Page of 388TOC1stPreviousNextBottomJust 98th
The accompanying notes are an integral part of these financial statements. 5
485BPOS99th Page of 388TOC1stPreviousNextBottomJust 99th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF ASSETS AND LIABILITIES -- (CONTINUED) DECEMBER 31, 2014 [Enlarge/Download Table] FTVIPT TEMPLETON INVESCO V.I. INVESCO V.I. INVESCO V.I. GLOBAL BOND VIP AMERICAN FRANCHISE CORE EQUITY EQUITY AND INCOME SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- -------------------- -------------------- -------------------- ASSETS: Investments at fair value............ $ 250,150,024 $ 15,119 $ 231,978 $ 681,211,335 Due from MetLife Insurance Company USA........................ -- -- -- -- -------------------- -------------------- -------------------- -------------------- Total Assets.................... 250,150,024 15,119 231,978 681,211,335 -------------------- -------------------- -------------------- -------------------- LIABILITIES: Accrued fees......................... 12 5 -- 33 Due to MetLife Insurance Company USA........................ -- 7 -- 1 -------------------- -------------------- -------------------- -------------------- Total Liabilities............... 12 12 -- 34 -------------------- -------------------- -------------------- -------------------- NET ASSETS.............................. $ 250,150,012 $ 15,107 $ 231,978 $ 681,211,301 ==================== ==================== ==================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 250,142,442 $ 15,107 $ 231,978 $ 681,188,907 Net assets from contracts in payout.. 7,570 -- -- 22,394 -------------------- -------------------- -------------------- -------------------- Total Net Assets................ $ 250,150,012 $ 15,107 $ 231,978 $ 681,211,301 ==================== ==================== ==================== ==================== LMPVET INVESCO V.I. INVESCO V.I. IVY FUNDS VIP CLEARBRIDGE VARIABLE GROWTH AND INCOME INTERNATIONAL GROWTH ASSET STRATEGY AGGRESSIVE GROWTH SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- -------------------- -------------------- -------------------- ASSETS: Investments at fair value............ $ 6,935 $ 275,881,000 $ 45,030 $ 316,449,078 Due from MetLife Insurance Company USA........................ 2 -- -- 1 -------------------- -------------------- -------------------- -------------------- Total Assets.................... 6,937 275,881,000 45,030 316,449,079 -------------------- -------------------- -------------------- -------------------- LIABILITIES: Accrued fees......................... 10 27 6 146 Due to MetLife Insurance Company USA........................ -- 1 1 -- -------------------- -------------------- -------------------- -------------------- Total Liabilities............... 10 28 7 146 -------------------- -------------------- -------------------- -------------------- NET ASSETS.............................. $ 6,927 $ 275,880,972 $ 45,023 $ 316,448,933 ==================== ==================== ==================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 6,927 $ 275,871,788 $ 45,023 $ 316,437,331 Net assets from contracts in payout.. -- 9,184 -- 11,602 -------------------- -------------------- -------------------- -------------------- Total Net Assets................ $ 6,927 $ 275,880,972 $ 45,023 $ 316,448,933 ==================== ==================== ==================== ==================== LMPVET LMPVET CLEARBRIDGE VARIABLE CLEARBRIDGE VARIABLE APPRECIATION EQUITY INCOME SUB-ACCOUNT SUB-ACCOUNT -------------------- -------------------- ASSETS: Investments at fair value............ $ 426,519,499 $ 205,573,539 Due from MetLife Insurance Company USA........................ -- 1 -------------------- -------------------- Total Assets.................... 426,519,499 205,573,540 -------------------- -------------------- LIABILITIES: Accrued fees......................... 58 58 Due to MetLife Insurance Company USA........................ -- -- -------------------- -------------------- Total Liabilities............... 58 58 -------------------- -------------------- NET ASSETS.............................. $ 426,519,441 $ 205,573,482 ==================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 426,518,386 $ 205,566,151 Net assets from contracts in payout.. 1,055 7,331 -------------------- -------------------- Total Net Assets................ $ 426,519,441 $ 205,573,482 ==================== ==================== The accompanying notes are an integral part of these financial statements. 6
485BPOS100th Page of 388TOC1stPreviousNextBottomJust 100th
The accompanying notes are an integral part of these financial statements. 7
485BPOS101st Page of 388TOC1stPreviousNextBottomJust 101st
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF ASSETS AND LIABILITIES -- (CONTINUED) DECEMBER 31, 2014 [Enlarge/Download Table] LMPVET LMPVET LMPVET LMPVET CLEARBRIDGE VARIABLE CLEARBRIDGE VARIABLE CLEARBRIDGE VARIABLE PERMAL ALTERNATIVE LARGE CAP GROWTH LARGE CAP VALUE SMALL CAP GROWTH SELECT VIT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- -------------------- -------------------- ------------------- ASSETS: Investments at fair value............ $ 4,631,649 $ 8,744,244 $ 115,942,858 $ 641,061 Due from MetLife Insurance Company USA........................ 1 -- -- -- -------------------- -------------------- -------------------- ------------------- Total Assets.................... 4,631,650 8,744,244 115,942,858 641,061 -------------------- -------------------- -------------------- ------------------- LIABILITIES: Accrued fees......................... 49 67 57 27 Due to MetLife Insurance Company USA........................ -- -- -- -- -------------------- -------------------- -------------------- ------------------- Total Liabilities............... 49 67 57 27 -------------------- -------------------- -------------------- ------------------- NET ASSETS.............................. $ 4,631,601 $ 8,744,177 $ 115,942,801 $ 641,034 ==================== ==================== ==================== =================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 4,631,601 $ 8,744,177 $ 115,942,801 $ 641,034 Net assets from contracts in payout.. -- -- -- -- -------------------- -------------------- -------------------- ------------------- Total Net Assets................ $ 4,631,601 $ 8,744,177 $ 115,942,801 $ 641,034 ==================== ==================== ==================== =================== LMPVET LMPVET LMPVET LMPVIT WESTERN VARIABLE LIFESTYLE VARIABLE LIFESTYLE VARIABLE LIFESTYLE ASSET VARIABLE GLOBAL ALLOCATION 50% ALLOCATION 70% ALLOCATION 85% HIGH YIELD BOND SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- ------------------- --------------------- ASSETS: Investments at fair value............ $ 42,335,509 $ 1,923,863 $ 92,760,229 $ 100,641,746 Due from MetLife Insurance Company USA........................ -- -- -- -- ------------------- -------------------- ------------------- --------------------- Total Assets.................... 42,335,509 1,923,863 92,760,229 100,641,746 ------------------- -------------------- ------------------- --------------------- LIABILITIES: Accrued fees......................... 36 25 9 57 Due to MetLife Insurance Company USA........................ 1 -- -- 1 ------------------- -------------------- ------------------- --------------------- Total Liabilities............... 37 25 9 58 ------------------- -------------------- ------------------- --------------------- NET ASSETS.............................. $ 42,335,472 $ 1,923,838 $ 92,760,220 $ 100,641,688 =================== ==================== =================== ===================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 42,335,472 $ 1,923,838 $ 92,760,220 $ 100,638,902 Net assets from contracts in payout.. -- -- -- 2,786 ------------------- -------------------- ------------------- --------------------- Total Net Assets................ $ 42,335,472 $ 1,923,838 $ 92,760,220 $ 100,641,688 =================== ==================== =================== ===================== MFS VIT MFS VIT INVESTORS TRUST NEW DISCOVERY SUB-ACCOUNT SUB-ACCOUNT -------------------- ------------------- ASSETS: Investments at fair value............ $ 9,621 $ 40,609 Due from MetLife Insurance Company USA........................ -- -- -------------------- ------------------- Total Assets.................... 9,621 40,609 -------------------- ------------------- LIABILITIES: Accrued fees......................... 2 2 Due to MetLife Insurance Company USA........................ -- -- -------------------- ------------------- Total Liabilities............... 2 2 -------------------- ------------------- NET ASSETS.............................. $ 9,619 $ 40,607 ==================== =================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 9,619 $ 40,607 Net assets from contracts in payout.. -- -- -------------------- ------------------- Total Net Assets................ $ 9,619 $ 40,607 ==================== =================== The accompanying notes are an integral part of these financial statements. 8
485BPOS102nd Page of 388TOC1stPreviousNextBottomJust 102nd
The accompanying notes are an integral part of these financial statements. 9
485BPOS103rd Page of 388TOC1stPreviousNextBottomJust 103rd
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF ASSETS AND LIABILITIES -- (CONTINUED) DECEMBER 31, 2014 [Enlarge/Download Table] MIST MIST ALLIANCEBERNSTEIN ALLIANZ GLOBAL MIST AMERICAN GLOBAL DYNAMIC INVESTORS DYNAMIC FUNDS BALANCED MFS VIT RESEARCH ALLOCATION MULTI-ASSET PLUS ALLOCATION SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- -------------------- -------------------- ASSETS: Investments at fair value............ $ 26,580 $ 3,373,491,434 $ 18,986,524 $ 3,417,834,616 Due from MetLife Insurance Company USA........................ -- -- -- -- ------------------- ------------------- -------------------- -------------------- Total Assets.................... 26,580 3,373,491,434 18,986,524 3,417,834,616 ------------------- ------------------- -------------------- -------------------- LIABILITIES: Accrued fees......................... 9 96 68 41 Due to MetLife Insurance Company USA........................ -- -- -- 1 ------------------- ------------------- -------------------- -------------------- Total Liabilities............... 9 96 68 42 ------------------- ------------------- -------------------- -------------------- NET ASSETS.............................. $ 26,571 $ 3,373,491,338 $ 18,986,456 $ 3,417,834,574 =================== =================== ==================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 26,571 $ 3,373,431,824 $ 18,986,456 $ 3,417,726,068 Net assets from contracts in payout.. -- 59,514 -- 108,506 ------------------- ------------------- -------------------- -------------------- Total Net Assets................ $ 26,571 $ 3,373,491,338 $ 18,986,456 $ 3,417,834,574 =================== =================== ==================== ==================== MIST AMERICAN MIST AMERICAN MIST AQR FUNDS GROWTH MIST AMERICAN FUNDS MODERATE GLOBAL RISK ALLOCATION FUNDS GROWTH ALLOCATION BALANCED SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- -------------------- ------------------- -------------------- ASSETS: Investments at fair value............ $ 1,852,260,713 $ 648,671,561 $ 1,744,157,182 $ 3,001,302,263 Due from MetLife Insurance Company USA........................ -- -- -- -- -------------------- -------------------- ------------------- -------------------- Total Assets.................... 1,852,260,713 648,671,561 1,744,157,182 3,001,302,263 -------------------- -------------------- ------------------- -------------------- LIABILITIES: Accrued fees......................... 46 75 59 67 Due to MetLife Insurance Company USA........................ -- 2 -- 1 -------------------- -------------------- ------------------- -------------------- Total Liabilities............... 46 77 59 68 -------------------- -------------------- ------------------- -------------------- NET ASSETS.............................. $ 1,852,260,667 $ 648,671,484 $ 1,744,157,123 $ 3,001,302,195 ==================== ==================== =================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 1,851,771,574 $ 648,605,633 $ 1,743,554,487 $ 3,000,889,741 Net assets from contracts in payout.. 489,093 65,851 602,636 412,454 -------------------- -------------------- ------------------- -------------------- Total Net Assets................ $ 1,852,260,667 $ 648,671,484 $ 1,744,157,123 $ 3,001,302,195 ==================== ==================== =================== ==================== MIST BLACKROCK GLOBAL TACTICAL MIST BLACKROCK STRATEGIES HIGH YIELD SUB-ACCOUNT SUB-ACCOUNT -------------------- ------------------- ASSETS: Investments at fair value............ $ 5,423,637,112 $ 238,216,029 Due from MetLife Insurance Company USA........................ -- -- -------------------- ------------------- Total Assets.................... 5,423,637,112 238,216,029 -------------------- ------------------- LIABILITIES: Accrued fees......................... 79 141 Due to MetLife Insurance Company USA........................ 1 1 -------------------- ------------------- Total Liabilities............... 80 142 -------------------- ------------------- NET ASSETS.............................. $ 5,423,637,032 $ 238,215,887 ==================== =================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 5,423,550,927 $ 238,212,515 Net assets from contracts in payout.. 86,105 3,372 -------------------- ------------------- Total Net Assets................ $ 5,423,637,032 $ 238,215,887 ==================== =================== The accompanying notes are an integral part of these financial statements. 10
485BPOS104th Page of 388TOC1stPreviousNextBottomJust 104th
The accompanying notes are an integral part of these financial statements. 11
485BPOS105th Page of 388TOC1stPreviousNextBottomJust 105th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF ASSETS AND LIABILITIES -- (CONTINUED) DECEMBER 31, 2014 [Enlarge/Download Table] MIST MIST MIST CLARION MIST CLEARBRIDGE GOLDMAN SACHS HARRIS OAKMARK GLOBAL REAL ESTATE AGGRESSIVE GROWTH MID CAP VALUE INTERNATIONAL SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- ------------------- -------------------- ------------------- ASSETS: Investments at fair value............ $ 330,178,733 $ 586,572,644 $ 178,512,732 $ 663,509,362 Due from MetLife Insurance Company USA........................ -- 2 -- -- -------------------- ------------------- -------------------- ------------------- Total Assets..................... 330,178,733 586,572,646 178,512,732 663,509,362 -------------------- ------------------- -------------------- ------------------- LIABILITIES: Accrued fees......................... 89 141 62 110 Due to MetLife Insurance Company USA........................ 1 -- 1 -- -------------------- ------------------- -------------------- ------------------- Total Liabilities................ 90 141 63 110 -------------------- ------------------- -------------------- ------------------- NET ASSETS.............................. $ 330,178,643 $ 586,572,505 $ 178,512,669 $ 663,509,252 ==================== =================== ==================== =================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 330,153,127 $ 586,499,132 $ 178,469,747 $ 663,340,501 Net assets from contracts in payout.. 25,516 73,373 42,922 168,751 -------------------- ------------------- -------------------- ------------------- Total Net Assets................. $ 330,178,643 $ 586,572,505 $ 178,512,669 $ 663,509,252 ==================== =================== ==================== =================== MIST INVESCO BALANCED-RISK MIST INVESCO MIST INVESCO MIST INVESCO ALLOCATION COMSTOCK MID CAP VALUE SMALL CAP GROWTH SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- ------------------- -------------------- ASSETS: Investments at fair value............ $ 832,374,525 $ 813,000,163 $ 258,407,718 $ 308,642,373 Due from MetLife Insurance Company USA........................ -- -- -- -- ------------------- ------------------- ------------------- -------------------- Total Assets..................... 832,374,525 813,000,163 258,407,718 308,642,373 ------------------- ------------------- ------------------- -------------------- LIABILITIES: Accrued fees......................... 78 86 109 100 Due to MetLife Insurance Company USA........................ 2 1 -- -- ------------------- ------------------- ------------------- -------------------- Total Liabilities................ 80 87 109 100 ------------------- ------------------- ------------------- -------------------- NET ASSETS.............................. $ 832,374,445 $ 813,000,076 $ 258,407,609 $ 308,642,273 =================== =================== =================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 832,374,445 $ 812,950,677 $ 258,398,671 $ 308,576,753 Net assets from contracts in payout.. -- 49,399 8,938 65,520 ------------------- ------------------- ------------------- -------------------- Total Net Assets................. $ 832,374,445 $ 813,000,076 $ 258,407,609 $ 308,642,273 =================== =================== =================== ==================== MIST JPMORGAN MIST JPMORGAN GLOBAL ACTIVE CORE BOND ALLOCATION SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- ASSETS: Investments at fair value............ $ 355,237,997 $ 905,975,523 Due from MetLife Insurance Company USA........................ -- -- ------------------- -------------------- Total Assets..................... 355,237,997 905,975,523 ------------------- -------------------- LIABILITIES: Accrued fees......................... 36 64 Due to MetLife Insurance Company USA........................ 1 1 ------------------- -------------------- Total Liabilities................ 37 65 ------------------- -------------------- NET ASSETS.............................. $ 355,237,960 $ 905,975,458 =================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 355,232,400 $ 905,975,458 Net assets from contracts in payout.. 5,560 -- ------------------- -------------------- Total Net Assets................. $ 355,237,960 $ 905,975,458 =================== ==================== The accompanying notes are an integral part of these financial statements. 12
485BPOS106th Page of 388TOC1stPreviousNextBottomJust 106th
The accompanying notes are an integral part of these financial statements. 13
485BPOS107th Page of 388TOC1stPreviousNextBottomJust 107th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF ASSETS AND LIABILITIES -- (CONTINUED) DECEMBER 31, 2014 [Enlarge/Download Table] MIST MIST JPMORGAN MIST LOOMIS SAYLES MIST LORD ABBETT MET/EATON VANCE SMALL CAP VALUE GLOBAL MARKETS BOND DEBENTURE FLOATING RATE SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- -------------------- ------------------- ASSETS: Investments at fair value............ $ 27,932,671 $ 177,351,113 $ 234,576,705 $ 73,909,283 Due from MetLife Insurance Company USA........................ -- -- -- -- ------------------- -------------------- -------------------- ------------------- Total Assets.................... 27,932,671 177,351,113 234,576,705 73,909,283 ------------------- -------------------- -------------------- ------------------- LIABILITIES: Accrued fees......................... 170 82 146 71 Due to MetLife Insurance Company USA........................ 1 1 1 2 ------------------- -------------------- -------------------- ------------------- Total Liabilities............... 171 83 147 73 ------------------- -------------------- -------------------- ------------------- NET ASSETS.............................. $ 27,932,500 $ 177,351,030 $ 234,576,558 $ 73,909,210 =================== ==================== ==================== =================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 27,932,500 $ 177,351,030 $ 234,361,305 $ 73,909,210 Net assets from contracts in payout.. -- -- 215,253 -- ------------------- -------------------- -------------------- ------------------- Total Net Assets................ $ 27,932,500 $ 177,351,030 $ 234,576,558 $ 73,909,210 =================== ==================== ==================== =================== MIST MET/FRANKLIN LOW DURATION MIST MET/TEMPLETON MIST METLIFE MIST METLIFE TOTAL RETURN INTERNATIONAL BOND ASSET ALLOCATION 100 BALANCED PLUS SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- -------------------- -------------------- -------------------- ASSETS: Investments at fair value............ $ 173,125,015 $ 47,183,949 $ 641,574,848 $ 7,268,454,205 Due from MetLife Insurance Company USA........................ -- -- -- -- -------------------- -------------------- -------------------- -------------------- Total Assets.................... 173,125,015 47,183,949 641,574,848 7,268,454,205 -------------------- -------------------- -------------------- -------------------- LIABILITIES: Accrued fees......................... 97 73 54 72 Due to MetLife Insurance Company USA........................ 1 1 -- 1 -------------------- -------------------- -------------------- -------------------- Total Liabilities............... 98 74 54 73 -------------------- -------------------- -------------------- -------------------- NET ASSETS.............................. $ 173,124,917 $ 47,183,875 $ 641,574,794 $ 7,268,454,132 ==================== ==================== ==================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 173,124,917 $ 47,183,875 $ 641,512,488 $ 7,268,307,577 Net assets from contracts in payout.. -- -- 62,306 146,555 -------------------- -------------------- -------------------- -------------------- Total Net Assets................ $ 173,124,917 $ 47,183,875 $ 641,574,794 $ 7,268,454,132 ==================== ==================== ==================== ==================== MIST METLIFE MULTI-INDEX MIST METLIFE TARGETED RISK SMALL CAP VALUE SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- ASSETS: Investments at fair value............ $ 421,514,023 $ 291,013,971 Due from MetLife Insurance Company USA........................ -- -- ------------------- -------------------- Total Assets.................... 421,514,023 291,013,971 ------------------- -------------------- LIABILITIES: Accrued fees......................... 67 70 Due to MetLife Insurance Company USA........................ 1 1 ------------------- -------------------- Total Liabilities............... 68 71 ------------------- -------------------- NET ASSETS.............................. $ 421,513,955 $ 291,013,900 =================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 421,513,955 $ 290,844,236 Net assets from contracts in payout.. -- 169,664 ------------------- -------------------- Total Net Assets................ $ 421,513,955 $ 291,013,900 =================== ==================== The accompanying notes are an integral part of these financial statements. 14
485BPOS108th Page of 388TOC1stPreviousNextBottomJust 108th
The accompanying notes are an integral part of these financial statements. 15
485BPOS109th Page of 388TOC1stPreviousNextBottomJust 109th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF ASSETS AND LIABILITIES -- (CONTINUED) DECEMBER 31, 2014 [Enlarge/Download Table] MIST MIST MIST MFS EMERGING MFS RESEARCH MORGAN STANLEY MIST OPPENHEIMER MARKETS EQUITY INTERNATIONAL MID CAP GROWTH GLOBAL EQUITY SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- ------------------- ------------------- ASSETS: Investments at fair value............ $ 425,619,474 $ 287,913,119 $ 240,528,764 $ 72,351,117 Due from MetLife Insurance Company USA........................ -- 1 1 4 ------------------- ------------------- ------------------- ------------------- Total Assets..................... 425,619,474 287,913,120 240,528,765 72,351,121 ------------------- ------------------- ------------------- ------------------- LIABILITIES: Accrued fees......................... 88 111 77 122 Due to MetLife Insurance Company USA........................ -- -- -- -- ------------------- ------------------- ------------------- ------------------- Total Liabilities................ 88 111 77 122 ------------------- ------------------- ------------------- ------------------- NET ASSETS.............................. $ 425,619,386 $ 287,913,009 $ 240,528,688 $ 72,350,999 =================== =================== =================== =================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 425,583,019 $ 287,825,920 $ 240,528,118 $ 72,350,999 Net assets from contracts in payout.. 36,367 87,089 570 -- ------------------- ------------------- ------------------- ------------------- Total Net Assets................. $ 425,619,386 $ 287,913,009 $ 240,528,688 $ 72,350,999 =================== =================== =================== =================== MIST MIST PANAGORA GLOBAL PIMCO INFLATION MIST MIST DIVERSIFIED RISK PROTECTED BOND PIMCO TOTAL RETURN PIONEER FUND SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- -------------------- -------------------- ASSETS: Investments at fair value............ $ 10,161,728 $ 732,596,547 $ 1,787,038,159 $ 305,917,633 Due from MetLife Insurance Company USA........................ -- -- -- 1 ------------------- ------------------- -------------------- -------------------- Total Assets..................... 10,161,728 732,596,547 1,787,038,159 305,917,634 ------------------- ------------------- -------------------- -------------------- LIABILITIES: Accrued fees......................... 83 142 131 170 Due to MetLife Insurance Company USA........................ 1 1 2 -- ------------------- ------------------- -------------------- -------------------- Total Liabilities................ 84 143 133 170 ------------------- ------------------- -------------------- -------------------- NET ASSETS.............................. $ 10,161,644 $ 732,596,404 $ 1,787,038,026 $ 305,917,464 =================== =================== ==================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 10,161,644 $ 732,474,140 $ 1,786,748,928 $ 305,909,200 Net assets from contracts in payout.. -- 122,264 289,098 8,264 ------------------- ------------------- -------------------- -------------------- Total Net Assets................. $ 10,161,644 $ 732,596,404 $ 1,787,038,026 $ 305,917,464 =================== =================== ==================== ==================== MIST PIONEER MIST PYRAMIS STRATEGIC INCOME GOVERNMENT INCOME SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- ASSETS: Investments at fair value............ $ 943,852,965 $ 680,446,382 Due from MetLife Insurance Company USA........................ -- -- ------------------- ------------------- Total Assets..................... 943,852,965 680,446,382 ------------------- ------------------- LIABILITIES: Accrued fees......................... 130 102 Due to MetLife Insurance Company USA........................ 3 2 ------------------- ------------------- Total Liabilities................ 133 104 ------------------- ------------------- NET ASSETS.............................. $ 943,852,832 $ 680,446,278 =================== =================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 943,838,894 $ 680,240,700 Net assets from contracts in payout.. 13,938 205,578 ------------------- ------------------- Total Net Assets................. $ 943,852,832 $ 680,446,278 =================== =================== The accompanying notes are an integral part of these financial statements. 16
485BPOS110th Page of 388TOC1stPreviousNextBottomJust 110th
The accompanying notes are an integral part of these financial statements. 17
485BPOS111th Page of 388TOC1stPreviousNextBottomJust 111th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF ASSETS AND LIABILITIES -- (CONTINUED) DECEMBER 31, 2014 [Enlarge/Download Table] MIST PYRAMIS MIST SCHRODERS MIST SSGA GROWTH MIST SSGA MANAGED RISK GLOBAL MULTI-ASSET AND INCOME ETF GROWTH ETF SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- ------------------- ------------------- ASSETS: Investments at fair value............ $ 163,513,477 $ 493,381,059 $ 1,513,705,698 $ 501,804,786 Due from MetLife Insurance Company USA........................ -- -- 1 -- ------------------- ------------------- ------------------- ------------------- Total Assets..................... 163,513,477 493,381,059 1,513,705,699 501,804,786 ------------------- ------------------- ------------------- ------------------- LIABILITIES: Accrued fees......................... 87 79 67 81 Due to MetLife Insurance Company USA........................ 1 1 -- -- ------------------- ------------------- ------------------- ------------------- Total Liabilities................ 88 80 67 81 ------------------- ------------------- ------------------- ------------------- NET ASSETS.............................. $ 163,513,389 $ 493,380,979 $ 1,513,705,632 $ 501,804,705 =================== =================== =================== =================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 163,513,389 $ 493,380,979 $ 1,513,519,313 $ 501,804,705 Net assets from contracts in payout.. -- -- 186,319 -- ------------------- ------------------- ------------------- ------------------- Total Net Assets................. $ 163,513,389 $ 493,380,979 $ 1,513,705,632 $ 501,804,705 =================== =================== =================== =================== MIST T. ROWE PRICE MIST T. ROWE PRICE MIST WMC MSF BAILLIE GIFFORD LARGE CAP VALUE MID CAP GROWTH LARGE CAP RESEARCH INTERNATIONAL STOCK SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- ------------------- -------------------- ASSETS: Investments at fair value............ $ 838,816,511 $ 537,586,266 $ 17,260,533 $ 269,502,492 Due from MetLife Insurance Company USA........................ 37 -- -- -- ------------------- ------------------- ------------------- -------------------- Total Assets..................... 838,816,548 537,586,266 17,260,533 269,502,492 ------------------- ------------------- ------------------- -------------------- LIABILITIES: Accrued fees......................... 126 57 138 58 Due to MetLife Insurance Company USA........................ -- 1 -- 3 ------------------- ------------------- ------------------- -------------------- Total Liabilities................ 126 58 138 61 ------------------- ------------------- ------------------- -------------------- NET ASSETS.............................. $ 838,816,422 $ 537,586,208 $ 17,260,395 $ 269,502,431 =================== =================== =================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 838,476,822 $ 537,465,126 $ 17,260,395 $ 269,496,853 Net assets from contracts in payout.. 339,600 121,082 -- 5,578 ------------------- ------------------- ------------------- -------------------- Total Net Assets................. $ 838,816,422 $ 537,586,208 $ 17,260,395 $ 269,502,431 =================== =================== =================== ==================== MSF BARCLAYS MSF BLACKROCK AGGREGATE BOND INDEX BOND INCOME SUB-ACCOUNT SUB-ACCOUNT -------------------- ------------------- ASSETS: Investments at fair value............ $ 213,476,121 $ 63,615,159 Due from MetLife Insurance Company USA........................ -- -- -------------------- ------------------- Total Assets..................... 213,476,121 63,615,159 -------------------- ------------------- LIABILITIES: Accrued fees......................... 121 113 Due to MetLife Insurance Company USA........................ 1 1 -------------------- ------------------- Total Liabilities................ 122 114 -------------------- ------------------- NET ASSETS.............................. $ 213,475,999 $ 63,615,045 ==================== =================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 213,470,419 $ 63,607,681 Net assets from contracts in payout.. 5,580 7,364 -------------------- ------------------- Total Net Assets................. $ 213,475,999 $ 63,615,045 ==================== =================== The accompanying notes are an integral part of these financial statements. 18
485BPOS112th Page of 388TOC1stPreviousNextBottomJust 112th
The accompanying notes are an integral part of these financial statements. 19
485BPOS113th Page of 388TOC1stPreviousNextBottomJust 113th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF ASSETS AND LIABILITIES -- (CONTINUED) DECEMBER 31, 2014 [Enlarge/Download Table] MSF BLACKROCK MSF BLACKROCK MSF BLACKROCK MSF FRONTIER CAPITAL APPRECIATION LARGE CAP VALUE MONEY MARKET MID CAP GROWTH SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- ------------------- ------------------- -------------------- ASSETS: Investments at fair value............ $ 14,686,667 $ 4,201,574 $ 395,886,560 $ 81,297,599 Due from MetLife Insurance Company USA........................ 2 -- 57 -- -------------------- ------------------- ------------------- -------------------- Total Assets..................... 14,686,669 4,201,574 395,886,617 81,297,599 -------------------- ------------------- ------------------- -------------------- LIABILITIES: Accrued fees......................... 241 9 250 61 Due to MetLife Insurance Company USA........................ -- 1 -- -- -------------------- ------------------- ------------------- -------------------- Total Liabilities................ 241 10 250 61 -------------------- ------------------- ------------------- -------------------- NET ASSETS.............................. $ 14,686,428 $ 4,201,564 $ 395,886,367 $ 81,297,538 ==================== =================== =================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 14,686,428 $ 4,201,564 $ 395,836,852 $ 81,268,735 Net assets from contracts in payout.. -- -- 49,515 28,803 -------------------- ------------------- ------------------- -------------------- Total Net Assets................. $ 14,686,428 $ 4,201,564 $ 395,886,367 $ 81,297,538 ==================== =================== =================== ==================== MSF MSF LOOMIS SAYLES MSF LOOMIS SAYLES MSF MET/ARTISAN JENNISON GROWTH SMALL CAP CORE SMALL CAP GROWTH MID CAP VALUE SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- ------------------- ------------------- ------------------- ASSETS: Investments at fair value............ $ 529,020,407 $ 13,706,569 $ 293,479 $ 244,385,573 Due from MetLife Insurance Company USA........................ -- -- 1 -- -------------------- ------------------- ------------------- ------------------- Total Assets..................... 529,020,407 13,706,569 293,480 244,385,573 -------------------- ------------------- ------------------- ------------------- LIABILITIES: Accrued fees......................... 83 98 47 48 Due to MetLife Insurance Company USA........................ 1 -- -- 2 -------------------- ------------------- ------------------- ------------------- Total Liabilities................ 84 98 47 50 -------------------- ------------------- ------------------- ------------------- NET ASSETS.............................. $ 529,020,323 $ 13,706,471 $ 293,433 $ 244,385,523 ==================== =================== =================== =================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 528,638,813 $ 13,706,471 $ 293,433 $ 244,204,544 Net assets from contracts in payout.. 381,510 -- -- 180,979 -------------------- ------------------- ------------------- ------------------- Total Net Assets................. $ 529,020,323 $ 13,706,471 $ 293,433 $ 244,385,523 ==================== =================== =================== =================== MSF MET/DIMENSIONAL INTERNATIONAL SMALL MSF METLIFE COMPANY ASSET ALLOCATION 20 SUB-ACCOUNT SUB-ACCOUNT -------------------- -------------------- ASSETS: Investments at fair value............ $ 58,174,167 $ 41,687,651 Due from MetLife Insurance Company USA........................ -- -- -------------------- -------------------- Total Assets..................... 58,174,167 41,687,651 -------------------- -------------------- LIABILITIES: Accrued fees......................... 78 107 Due to MetLife Insurance Company USA........................ 1 1 -------------------- -------------------- Total Liabilities................ 79 108 -------------------- -------------------- NET ASSETS.............................. $ 58,174,088 $ 41,687,543 ==================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 58,174,088 $ 41,687,543 Net assets from contracts in payout.. -- -- -------------------- -------------------- Total Net Assets................. $ 58,174,088 $ 41,687,543 ==================== ==================== The accompanying notes are an integral part of these financial statements. 20
485BPOS114th Page of 388TOC1stPreviousNextBottomJust 114th
The accompanying notes are an integral part of these financial statements. 21
485BPOS115th Page of 388TOC1stPreviousNextBottomJust 115th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF ASSETS AND LIABILITIES -- (CONTINUED) DECEMBER 31, 2014 [Enlarge/Download Table] MSF METLIFE MSF METLIFE MSF METLIFE MSF METLIFE ASSET ALLOCATION 40 ASSET ALLOCATION 60 ASSET ALLOCATION 80 MID CAP STOCK INDEX SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- -------------------- -------------------- ------------------- ASSETS: Investments at fair value............ $ 4,991,456,871 $ 7,527,991,215 $ 6,507,894,396 $ 127,735,941 Due from MetLife Insurance Company USA........................ -- -- 9 -- -------------------- -------------------- -------------------- ------------------- Total Assets..................... 4,991,456,871 7,527,991,215 6,507,894,405 127,735,941 -------------------- -------------------- -------------------- ------------------- LIABILITIES: Accrued fees......................... 61 58 58 69 Due to MetLife Insurance Company USA........................ 2 1 -- -- -------------------- -------------------- -------------------- ------------------- Total Liabilities................ 63 59 58 69 -------------------- -------------------- -------------------- ------------------- NET ASSETS.............................. $ 4,991,456,808 $ 7,527,991,156 $ 6,507,894,347 $ 127,735,872 ==================== ==================== ==================== =================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 4,990,904,086 $ 7,526,229,859 $ 6,507,167,274 $ 127,735,872 Net assets from contracts in payout.. 552,722 1,761,297 727,073 -- -------------------- -------------------- -------------------- ------------------- Total Net Assets................. $ 4,991,456,808 $ 7,527,991,156 $ 6,507,894,347 $ 127,735,872 ==================== ==================== ==================== =================== MSF METLIFE MSF MSF MSCI STOCK INDEX MFS TOTAL RETURN MSF MFS VALUE EAFE INDEX SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- ------------------- -------------------- ASSETS: Investments at fair value............ $ 610,830,320 $ 45,817,625 $ 255,402,150 $ 101,223,384 Due from MetLife Insurance Company USA........................ -- -- -- 1 ------------------- -------------------- ------------------- -------------------- Total Assets..................... 610,830,320 45,817,625 255,402,150 101,223,385 ------------------- -------------------- ------------------- -------------------- LIABILITIES: Accrued fees......................... 87 170 179 97 Due to MetLife Insurance Company USA........................ -- -- 5 -- ------------------- -------------------- ------------------- -------------------- Total Liabilities................ 87 170 184 97 ------------------- -------------------- ------------------- -------------------- NET ASSETS.............................. $ 610,830,233 $ 45,817,455 $ 255,401,966 $ 101,223,288 =================== ==================== =================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 610,688,854 $ 45,817,455 $ 255,392,733 $ 101,223,288 Net assets from contracts in payout.. 141,379 -- 9,233 -- ------------------- -------------------- ------------------- -------------------- Total Net Assets................. $ 610,830,233 $ 45,817,455 $ 255,401,966 $ 101,223,288 =================== ==================== =================== ==================== MSF NEUBERGER MSF BERMAN GENESIS RUSSELL 2000 INDEX SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- ASSETS: Investments at fair value............ $ 150,104,356 $ 144,858,222 Due from MetLife Insurance Company USA........................ 1 -- ------------------- -------------------- Total Assets..................... 150,104,357 144,858,222 ------------------- -------------------- LIABILITIES: Accrued fees......................... 132 75 Due to MetLife Insurance Company USA........................ -- 1 ------------------- -------------------- Total Liabilities................ 132 76 ------------------- -------------------- NET ASSETS.............................. $ 150,104,225 $ 144,858,146 =================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 150,074,776 $ 144,858,146 Net assets from contracts in payout.. 29,449 -- ------------------- -------------------- Total Net Assets................. $ 150,104,225 $ 144,858,146 =================== ==================== The accompanying notes are an integral part of these financial statements. 22
485BPOS116th Page of 388TOC1stPreviousNextBottomJust 116th
The accompanying notes are an integral part of these financial statements. 23
485BPOS117th Page of 388TOC1stPreviousNextBottomJust 117th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF ASSETS AND LIABILITIES -- (CONTINUED) DECEMBER 31, 2014 [Enlarge/Download Table] MSF VAN ECK MSF WESTERN ASSET MSF T. ROWE PRICE MSF T. ROWE PRICE GLOBAL NATURAL MANAGEMENT STRATEGIC LARGE CAP GROWTH SMALL CAP GROWTH RESOURCES BOND OPPORTUNITIES SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- ------------------- -------------------- ASSETS: Investments at fair value............ $ 166,959,423 $ 9,976,456 $ 89,288,183 $ 12,748 Due from MetLife Insurance Company USA........................ -- 1 -- -- ------------------- ------------------- ------------------- -------------------- Total Assets..................... 166,959,423 9,976,457 89,288,183 12,748 ------------------- ------------------- ------------------- -------------------- LIABILITIES: Accrued fees......................... 86 37 54 5 Due to MetLife Insurance Company USA........................ -- -- 1 -- ------------------- ------------------- ------------------- -------------------- Total Liabilities................ 86 37 55 5 ------------------- ------------------- ------------------- -------------------- NET ASSETS.............................. $ 166,959,337 $ 9,976,420 $ 89,288,128 $ 12,743 =================== =================== =================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 166,918,677 $ 9,976,420 $ 89,288,128 $ 12,743 Net assets from contracts in payout.. 40,660 -- -- -- ------------------- ------------------- ------------------- -------------------- Total Net Assets................. $ 166,959,337 $ 9,976,420 $ 89,288,128 $ 12,743 =================== =================== =================== ==================== MSF WESTERN ASSET MSF WMC MANAGEMENT CORE EQUITY NEUBERGER OPPENHEIMER VA U.S. GOVERNMENT OPPORTUNITIES BERMAN GENESIS CORE BOND SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- ------------------- -------------------- ASSETS: Investments at fair value............ $ 276,085,791 $ 609,015,260 $ 9,019 $ 8,346 Due from MetLife Insurance Company USA........................ -- -- -- 1 ------------------- -------------------- ------------------- -------------------- Total Assets..................... 276,085,791 609,015,260 9,019 8,347 ------------------- -------------------- ------------------- -------------------- LIABILITIES: Accrued fees......................... 128 147 6 1 Due to MetLife Insurance Company USA........................ 1 -- -- -- ------------------- -------------------- ------------------- -------------------- Total Liabilities................ 129 147 6 1 ------------------- -------------------- ------------------- -------------------- NET ASSETS.............................. $ 276,085,662 $ 609,015,113 $ 9,013 $ 8,346 =================== ==================== =================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 276,070,488 $ 608,686,202 $ 9,013 $ 8,346 Net assets from contracts in payout.. 15,174 328,911 -- -- ------------------- -------------------- ------------------- -------------------- Total Net Assets................. $ 276,085,662 $ 609,015,113 $ 9,013 $ 8,346 =================== ==================== =================== ==================== OPPENHEIMER VA OPPENHEIMER VA GLOBAL STRATEGIC MAIN STREET INCOME SMALL CAP SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- ASSETS: Investments at fair value............ $ 4,558 $ 126,466,517 Due from MetLife Insurance Company USA........................ 1 -- ------------------- -------------------- Total Assets..................... 4,559 126,466,517 ------------------- -------------------- LIABILITIES: Accrued fees......................... 3 2 Due to MetLife Insurance Company USA........................ -- 1 ------------------- -------------------- Total Liabilities................ 3 3 ------------------- -------------------- NET ASSETS.............................. $ 4,556 $ 126,466,514 =================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 4,556 $ 126,466,514 Net assets from contracts in payout.. -- -- ------------------- -------------------- Total Net Assets................. $ 4,556 $ 126,466,514 =================== ==================== The accompanying notes are an integral part of these financial statements. 24
485BPOS118th Page of 388TOC1stPreviousNextBottomJust 118th
The accompanying notes are an integral part of these financial statements. 25
485BPOS119th Page of 388TOC1stPreviousNextBottomJust 119th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF ASSETS AND LIABILITIES -- (CONTINUED) DECEMBER 31, 2014 [Enlarge/Download Table] PIMCO VIT PIMCO VIT OPPENHEIMER VA OPPENHEIMER VA COMMODITYREALRETURN EMERGING MAIN STREET MONEY STRATEGY MARKET BOND SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- ------------------- -------------------- ------------------- ASSETS: Investments at fair value............ $ 106,093 $ 3,803 $ 13,183 $ 15,210 Due from MetLife Insurance Company USA........................ -- -- -- -- -------------------- ------------------- -------------------- ------------------- Total Assets..................... 106,093 3,803 13,183 15,210 -------------------- ------------------- -------------------- ------------------- LIABILITIES: Accrued fees......................... 8 10 13 7 Due to MetLife Insurance Company USA........................ -- -- -- 1 -------------------- ------------------- -------------------- ------------------- Total Liabilities................ 8 10 13 8 -------------------- ------------------- -------------------- ------------------- NET ASSETS.............................. $ 106,085 $ 3,793 $ 13,170 $ 15,202 ==================== =================== ==================== =================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 106,085 $ 3,793 $ 13,170 $ 15,202 Net assets from contracts in payout.. -- -- -- -- -------------------- ------------------- -------------------- ------------------- Total Net Assets................. $ 106,085 $ 3,793 $ 13,170 $ 15,202 ==================== =================== ==================== =================== PIMCO VIT PIONEER VCT PIONEER VCT T. ROWE PRICE UNCONSTRAINED BOND MID CAP VALUE REAL ESTATE SHARES GROWTH STOCK SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- ------------------- -------------------- ASSETS: Investments at fair value............ $ 4,760 $ 74,903,043 $ 249,972 $ 7,511,743 Due from MetLife Insurance Company USA........................ -- 1 -- -- ------------------- -------------------- ------------------- -------------------- Total Assets..................... 4,760 74,903,044 249,972 7,511,743 ------------------- -------------------- ------------------- -------------------- LIABILITIES: Accrued fees......................... 1 48 93 -- Due to MetLife Insurance Company USA........................ -- -- -- 1 ------------------- -------------------- ------------------- -------------------- Total Liabilities................ 1 48 93 1 ------------------- -------------------- ------------------- -------------------- NET ASSETS.............................. $ 4,759 $ 74,902,996 $ 249,879 $ 7,511,742 =================== ==================== =================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 4,759 $ 74,902,996 $ 249,879 $ 7,511,742 Net assets from contracts in payout.. -- -- -- -- ------------------- -------------------- ------------------- -------------------- Total Net Assets................. $ 4,759 $ 74,902,996 $ 249,879 $ 7,511,742 =================== ==================== =================== ==================== T. ROWE PRICE T. ROWE PRICE INTERNATIONAL STOCK PRIME RESERVE SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- ASSETS: Investments at fair value............ $ 623,024 $ 514,215 Due from MetLife Insurance Company USA........................ -- -- ------------------- ------------------- Total Assets..................... 623,024 514,215 ------------------- ------------------- LIABILITIES: Accrued fees......................... -- -- Due to MetLife Insurance Company USA........................ -- -- ------------------- ------------------- Total Liabilities................ -- -- ------------------- ------------------- NET ASSETS.............................. $ 623,024 $ 514,215 =================== =================== CONTRACT OWNERS' EQUITY Net assets from accumulation units... $ 623,024 $ 514,215 Net assets from contracts in payout.. -- -- ------------------- ------------------- Total Net Assets................. $ 623,024 $ 514,215 =================== =================== The accompanying notes are an integral part of these financial statements. 26
485BPOS120th Page of 388TOC1stPreviousNextBottomJust 120th
The accompanying notes are an integral part of these financial statements. 27
485BPOS121st Page of 388TOC1stPreviousNextBottomJust 121st
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF ASSETS AND LIABILITIES -- (CONCLUDED) DECEMBER 31, 2014 [Enlarge/Download Table] TAP 1919 VARIABLE VAN ECK VIP SOCIALLY RESPONSIVE UIF GLOBAL LONG/SHORT BALANCED INFRASTRUCTURE EQUITY INDEX SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- -------------------- -------------------- ASSETS: Investments at fair value................................... $ 253,880 $ 8,469 $ 16,779 Due from MetLife Insurance Company USA............................................... 1 -- -- -------------------- -------------------- -------------------- Total Assets........................................... 253,881 8,469 16,779 -------------------- -------------------- -------------------- LIABILITIES: Accrued fees................................................ 41 4 9 Due to MetLife Insurance Company USA............................................... -- -- 1 -------------------- -------------------- -------------------- Total Liabilities...................................... 41 4 10 -------------------- -------------------- -------------------- NET ASSETS..................................................... $ 253,840 $ 8,465 $ 16,769 ==================== ==================== ==================== CONTRACT OWNERS' EQUITY Net assets from accumulation units.......................... $ 253,840 $ 8,465 $ 16,769 Net assets from contracts in payout......................... -- -- -- -------------------- -------------------- -------------------- Total Net Assets....................................... $ 253,840 $ 8,465 $ 16,769 ==================== ==================== ==================== The accompanying notes are an integral part of these financial statements. 28
485BPOS122nd Page of 388TOC1stPreviousNextBottomJust 122nd
This page is intentionally left blank.
485BPOS123rd Page of 388TOC1stPreviousNextBottomJust 123rd
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF OPERATIONS FOR THE YEAR ENDED DECEMBER 31, 2014 [Enlarge/Download Table] AMERICAN FUNDS ALGER AMERICAN FUNDS AMERICAN FUNDS GLOBAL SMALL SMALL CAP GROWTH BOND GLOBAL GROWTH CAPITALIZATION SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- ------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ -- $ 2,943,284 $ 3,596,844 $ 152,541 ------------------- ------------------- ------------------- ------------------- EXPENSES: Mortality and expense risk and other charges...................... 798,826 1,659,056 3,693,821 1,418,413 Administrative charges............... -- 378,400 772,469 263,914 ------------------- ------------------- ------------------- ------------------- Total expenses..................... 798,826 2,037,456 4,466,290 1,682,327 ------------------- ------------------- ------------------- ------------------- Net investment income (loss)..... (798,826) 905,828 (869,446) (1,529,786) ------------------- ------------------- ------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 5,263,274 55,659 30,333,970 555,180 Realized gains (losses) on sale of investments........................ 531,702 250,756 4,507,434 2,222,446 ------------------- ------------------- ------------------- ------------------- Net realized gains (losses)...... 5,794,976 306,415 34,841,404 2,777,626 ------------------- ------------------- ------------------- ------------------- Change in unrealized gains (losses) on investments..................... (5,736,249) 4,487,780 (31,374,425) (217,375) ------------------- ------------------- ------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... 58,727 4,794,195 3,466,979 2,560,251 ------------------- ------------------- ------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ (740,099) $ 5,700,023 $ 2,597,533 $ 1,030,465 =================== =================== =================== =================== AMERICAN FUNDS AMERICAN FUNDS BLACKROCK GLOBAL DEUTSCHE I GROWTH GROWTH-INCOME ALLOCATION V.I. INTERNATIONAL SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT (a) SUB-ACCOUNT ------------------- ------------------- ------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ 6,425,095 $ 4,950,647 $ 183 $ 303,234 ------------------- ------------------- ------------------- ------------------- EXPENSES: Mortality and expense risk and other charges...................... 9,986,171 4,847,033 6 233,075 Administrative charges............... 1,993,293 885,227 1 -- ------------------- ------------------- ------------------- ------------------- Total expenses..................... 11,979,464 5,732,260 7 233,075 ------------------- ------------------- ------------------- ------------------- Net investment income (loss)..... (5,554,369) (781,613) 176 70,159 ------------------- ------------------- ------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 40,539,557 18,739,094 655 -- Realized gains (losses) on sale of investments........................ 33,606,757 12,219,050 -- (332,105) ------------------- ------------------- ------------------- ------------------- Net realized gains (losses)...... 74,146,314 30,958,144 655 (332,105) ------------------- ------------------- ------------------- ------------------- Change in unrealized gains (losses) on investments..................... (13,021,445) 3,352,629 (974) (2,003,646) ------------------- ------------------- ------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... 61,124,869 34,310,773 (319) (2,335,751) ------------------- ------------------- ------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 55,570,500 $ 33,529,160 $ (143) $ (2,265,592) =================== =================== =================== =================== FEDERATED HIGH FEDERATED INCOME BOND KAUFMAN SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ 1,573 $ -- ------------------- ------------------- EXPENSES: Mortality and expense risk and other charges...................... 374 636 Administrative charges............... -- -- ------------------- ------------------- Total expenses..................... 374 636 ------------------- ------------------- Net investment income (loss)..... 1,199 (636) ------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... -- 4,778 Realized gains (losses) on sale of investments........................ 1 482 ------------------- ------------------- Net realized gains (losses)...... 1 5,260 ------------------- ------------------- Change in unrealized gains (losses) on investments..................... (866) (1,010) ------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... (865) 4,250 ------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 334 $ 3,614 =================== =================== (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. The accompanying notes are an integral part of these financial statements. 30
485BPOS124th Page of 388TOC1stPreviousNextBottomJust 124th
The accompanying notes are an integral part of these financial statements. 31
485BPOS125th Page of 388TOC1stPreviousNextBottomJust 125th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF OPERATIONS -- (CONTINUED) FOR THE YEAR ENDED DECEMBER 31, 2014 [Enlarge/Download Table] FIDELITY VIP FIDELITY VIP FIDELITY VIP FIDELITY VIP ASSET MANAGER CONTRAFUND EQUITY-INCOME FUNDSMANAGER 50% SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- ------------------- -------------------- INVESTMENT INCOME: Dividends............................ $ 1,289,608 $ 5,468,276 $ 159,700 $ 39,994,738 ------------------- -------------------- ------------------- -------------------- EXPENSES: Mortality and expense risk and other charges...................... 1,189,338 7,421,280 81,418 54,593,742 Administrative charges............... -- 915,061 -- -- ------------------- -------------------- ------------------- -------------------- Total expenses..................... 1,189,338 8,336,341 81,418 54,593,742 ------------------- -------------------- ------------------- -------------------- Net investment income (loss).... 100,270 (2,868,065) 78,282 (14,599,004) ------------------- -------------------- ------------------- -------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 4,083,560 12,377,051 79,224 27,091,468 Realized gains (losses) on sale of investments........................ 1,009,810 26,454,957 53,544 2,515 ------------------- -------------------- ------------------- -------------------- Net realized gains (losses)..... 5,093,370 38,832,008 132,768 27,093,983 ------------------- -------------------- ------------------- -------------------- Change in unrealized gains (losses) on investments..................... (1,349,291) 25,038,910 191,058 69,079,003 ------------------- -------------------- ------------------- -------------------- Net realized and change in unrealized gains (losses) on investments..................... 3,744,079 63,870,918 323,826 96,172,986 ------------------- -------------------- ------------------- -------------------- Net increase (decrease) in net assets resulting from operations.......... $ 3,844,349 $ 61,002,853 $ 402,108 $ 81,573,982 =================== ==================== =================== ==================== FIDELITY VIP FIDELITY VIP FIDELITY VIP FIDELITY VIP FUNDSMANAGER 60% GROWTH INDEX 500 MID CAP SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- ------------------- -------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ 49,645,312 $ 308,790 $ 1,101,320 $ 84,231 -------------------- ------------------- -------------------- ------------------- EXPENSES: Mortality and expense risk and other charges...................... 79,383,909 2,269,180 934,355 4,909,789 Administrative charges............... -- -- -- 1,100,532 -------------------- ------------------- -------------------- ------------------- Total expenses..................... 79,383,909 2,269,180 934,355 6,010,321 -------------------- ------------------- -------------------- ------------------- Net investment income (loss).... (29,738,597) (1,960,390) 166,965 (5,926,090) -------------------- ------------------- -------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 106,313,573 -- 61,135 10,457,143 Realized gains (losses) on sale of investments........................ 44,775,147 6,685,051 2,907,020 5,343,375 -------------------- ------------------- -------------------- ------------------- Net realized gains (losses)..... 151,088,720 6,685,051 2,968,155 15,800,518 -------------------- ------------------- -------------------- ------------------- Change in unrealized gains (losses) on investments..................... 10,595,817 11,054,078 4,754,472 10,107,932 -------------------- ------------------- -------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... 161,684,537 17,739,129 7,722,627 25,908,450 -------------------- ------------------- -------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 131,945,940 $ 15,778,739 $ 7,889,592 $ 19,982,360 ==================== =================== ==================== =================== FIDELITY VIP FIDELITY VIP MONEY MARKET OVERSEAS SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- INVESTMENT INCOME: Dividends............................ $ 8,944 $ 71,100 ------------------- -------------------- EXPENSES: Mortality and expense risk and other charges...................... 1,625,244 68,683 Administrative charges............... -- -- ------------------- -------------------- Total expenses..................... 1,625,244 68,683 ------------------- -------------------- Net investment income (loss).... (1,616,300) 2,417 ------------------- -------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... -- 1,431 Realized gains (losses) on sale of investments........................ -- 58,714 ------------------- -------------------- Net realized gains (losses)..... -- 60,145 ------------------- -------------------- Change in unrealized gains (losses) on investments..................... -- (589,122) ------------------- -------------------- Net realized and change in unrealized gains (losses) on investments..................... -- (528,977) ------------------- -------------------- Net increase (decrease) in net assets resulting from operations.......... $ (1,616,300) $ (526,560) =================== ==================== (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. The accompanying notes are an integral part of these financial statements. 32
485BPOS126th Page of 388TOC1stPreviousNextBottomJust 126th
The accompanying notes are an integral part of these financial statements. 33
485BPOS127th Page of 388TOC1stPreviousNextBottomJust 127th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF OPERATIONS -- (CONTINUED) FOR THE YEAR ENDED DECEMBER 31, 2014 [Enlarge/Download Table] FTVIPT FRANKLIN FTVIPT FRANKLIN FTVIPT FRANKLIN FTVIPT TEMPLETON INCOME VIP MUTUAL SHARES VIP SMALL CAP VALUE VIP FOREIGN VIP SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- -------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ 15,199,458 $ 3,135,687 $ 766,132 $ 1,533,782 ------------------- -------------------- -------------------- ------------------- EXPENSES: Mortality and expense risk and other charges...................... 3,401,258 1,778,227 1,360,274 1,279,065 Administrative charges............... 763,744 391,037 313,235 206,418 ------------------- -------------------- -------------------- ------------------- Total expenses..................... 4,165,002 2,169,264 1,673,509 1,485,483 ------------------- -------------------- -------------------- ------------------- Net investment income (loss).... 11,034,456 966,423 (907,377) 48,299 ------------------- -------------------- -------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... -- 815,306 9,238,289 -- Realized gains (losses) on sale of investments........................ 2,072,298 3,503,129 2,014,411 1,031,529 ------------------- -------------------- -------------------- ------------------- Net realized gains (losses)..... 2,072,298 4,318,435 11,252,700 1,031,529 ------------------- -------------------- -------------------- ------------------- Change in unrealized gains (losses) on investments..................... (3,371,554) 3,347,372 (11,208,452) (11,682,571) ------------------- -------------------- -------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... (1,299,256) 7,665,807 44,248 (10,651,042) ------------------- -------------------- -------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 9,735,200 $ 8,632,230 $ (863,129) $ (10,602,743) =================== ==================== ==================== =================== FTVIPT TEMPLETON INVESCO V.I. INVESCO V.I. INVESCO V.I. GLOBAL BOND VIP AMERICAN FRANCHISE CORE EQUITY EQUITY AND INCOME SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- -------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ 13,120,254 $ -- $ 2,179 $ 10,470,109 ------------------- -------------------- -------------------- ------------------- EXPENSES: Mortality and expense risk and other charges...................... 2,781,549 724 3,500 7,442,427 Administrative charges............... 642,197 -- -- 1,660,128 ------------------- -------------------- -------------------- ------------------- Total expenses..................... 3,423,746 724 3,500 9,102,555 ------------------- -------------------- -------------------- ------------------- Net investment income (loss).... 9,696,508 (724) (1,321) 1,367,554 ------------------- -------------------- -------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... -- -- 1,217 32,290,517 Realized gains (losses) on sale of investments........................ (97,489) 46,339 12,927 10,802,571 ------------------- -------------------- -------------------- ------------------- Net realized gains (losses)..... (97,489) 46,339 14,144 43,093,088 ------------------- -------------------- -------------------- ------------------- Change in unrealized gains (losses) on investments..................... (8,236,911) (52,381) 2,433 2,305,377 ------------------- -------------------- -------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... (8,334,400) (6,042) 16,577 45,398,465 ------------------- -------------------- -------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 1,362,108 $ (6,766) $ 15,256 $ 46,766,019 =================== ==================== ==================== =================== INVESCO V.I. INVESCO V.I. GROWTH AND INCOME INTERNATIONAL GROWTH SUB-ACCOUNT SUB-ACCOUNT -------------------- -------------------- INVESTMENT INCOME: Dividends............................ $ 126 $ 3,897,094 -------------------- -------------------- EXPENSES: Mortality and expense risk and other charges...................... 1,274,926 3,099,816 Administrative charges............... 285,712 703,728 -------------------- -------------------- Total expenses..................... 1,560,638 3,803,544 -------------------- -------------------- Net investment income (loss).... (1,560,512) 93,550 -------------------- -------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 817 -- Realized gains (losses) on sale of investments........................ 119,592,828 3,452,220 -------------------- -------------------- Net realized gains (losses)..... 119,593,645 3,452,220 -------------------- -------------------- Change in unrealized gains (losses) on investments..................... (115,750,581) (6,631,350) -------------------- -------------------- Net realized and change in unrealized gains (losses) on investments..................... 3,843,064 (3,179,130) -------------------- -------------------- Net increase (decrease) in net assets resulting from operations.......... $ 2,282,552 $ (3,085,580) ==================== ==================== (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. The accompanying notes are an integral part of these financial statements. 34
485BPOS128th Page of 388TOC1stPreviousNextBottomJust 128th
The accompanying notes are an integral part of these financial statements. 35
485BPOS129th Page of 388TOC1stPreviousNextBottomJust 129th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF OPERATIONS -- (CONTINUED) FOR THE YEAR ENDED DECEMBER 31, 2014 [Enlarge/Download Table] LMPVET LMPVET LMPVET IVY FUNDS VIP CLEARBRIDGE VARIABLE CLEARBRIDGE VARIABLE CLEARBRIDGE VARIABLE ASSET STRATEGY AGGRESSIVE GROWTH APPRECIATION EQUITY INCOME SUB-ACCOUNT (a) SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- -------------------- -------------------- INVESTMENT INCOME: Dividends............................ $ -- $ 520,648 $ 4,838,410 $ 4,076,515 ------------------- -------------------- -------------------- -------------------- EXPENSES: Mortality and expense risk and other charges...................... 5 3,545,931 4,691,757 2,270,124 Administrative charges............... 1 755,366 1,029,463 498,162 ------------------- -------------------- -------------------- -------------------- Total expenses..................... 6 4,301,297 5,721,220 2,768,286 ------------------- -------------------- -------------------- -------------------- Net investment income (loss)..... (6) (3,780,649) (882,810) 1,308,229 ------------------- -------------------- -------------------- -------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... -- 19,619,365 16,068,149 -- Realized gains (losses) on sale of investments........................ -- 13,107,269 7,597,048 4,299,834 ------------------- -------------------- -------------------- -------------------- Net realized gains (losses)...... -- 32,726,634 23,665,197 4,299,834 ------------------- -------------------- -------------------- -------------------- Change in unrealized gains (losses) on investments..................... (526) 22,284,631 14,760,295 16,931,806 ------------------- -------------------- -------------------- -------------------- Net realized and change in unrealized gains (losses) on investments..................... (526) 55,011,265 38,425,492 21,231,640 ------------------- -------------------- -------------------- -------------------- Net increase (decrease) in net assets resulting from operations.......... $ (532) $ 51,230,616 $ 37,542,682 $ 22,539,869 =================== ==================== ==================== ==================== LMPVET LMPVET LMPVET LMPVET CLEARBRIDGE VARIABLE CLEARBRIDGE VARIABLE CLEARBRIDGE VARIABLE PERMAL ALTERNATIVE LARGE CAP GROWTH LARGE CAP VALUE SMALL CAP GROWTH SELECT VIT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT (a) -------------------- -------------------- -------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ 23,233 $ 152,233 $ -- $ 1,231 -------------------- -------------------- -------------------- ------------------- EXPENSES: Mortality and expense risk and other charges...................... 73,244 116,402 1,270,738 210 Administrative charges............... 12,057 19,407 272,921 49 -------------------- -------------------- -------------------- ------------------- Total expenses..................... 85,301 135,809 1,543,659 259 -------------------- -------------------- -------------------- ------------------- Net investment income (loss)..... (62,068) 16,424 (1,543,659) 972 -------------------- -------------------- -------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 604,827 624,894 12,271,711 -- Realized gains (losses) on sale of investments........................ 314,912 201,624 2,590,249 -- -------------------- -------------------- -------------------- ------------------- Net realized gains (losses)...... 919,739 826,518 14,861,960 -- -------------------- -------------------- -------------------- ------------------- Change in unrealized gains (losses) on investments..................... (332,781) (94,646) (10,235,288) 314 -------------------- -------------------- -------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... 586,958 731,872 4,626,672 314 -------------------- -------------------- -------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 524,890 $ 748,296 $ 3,083,013 $ 1,286 ==================== ==================== ==================== =================== LMPVET LMPVET VARIABLE LIFESTYLE VARIABLE LIFESTYLE ALLOCATION 50% ALLOCATION 70% SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ 1,082,804 $ 38,179 ------------------- ------------------- EXPENSES: Mortality and expense risk and other charges...................... 486,828 30,279 Administrative charges............... 109,932 5,490 ------------------- ------------------- Total expenses..................... 596,760 35,769 ------------------- ------------------- Net investment income (loss)..... 486,044 2,410 ------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... -- -- Realized gains (losses) on sale of investments........................ 1,019,129 134,694 ------------------- ------------------- Net realized gains (losses)...... 1,019,129 134,694 ------------------- ------------------- Change in unrealized gains (losses) on investments..................... (36,134) (62,721) ------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... 982,995 71,973 ------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 1,469,039 $ 74,383 =================== =================== (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. The accompanying notes are an integral part of these financial statements. 36
485BPOS130th Page of 388TOC1stPreviousNextBottomJust 130th
The accompanying notes are an integral part of these financial statements. 37
485BPOS131st Page of 388TOC1stPreviousNextBottomJust 131st
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF OPERATIONS -- (CONTINUED) FOR THE YEAR ENDED DECEMBER 31, 2014 [Enlarge/Download Table] LMPVET LMPVIT WESTERN VARIABLE LIFESTYLE ASSET VARIABLE GLOBAL MFS VIT MFS VIT ALLOCATION 85% HIGH YIELD BOND INVESTORS TRUST NEW DISCOVERY SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- --------------------- ------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ 1,656,044 $ 7,537,431 $ 88 $ -- ------------------- --------------------- ------------------- ------------------- EXPENSES: Mortality and expense risk and other charges...................... 1,048,102 1,239,948 201 579 Administrative charges............... 234,319 265,108 -- -- ------------------- --------------------- ------------------- ------------------- Total expenses..................... 1,282,421 1,505,056 201 579 ------------------- --------------------- ------------------- ------------------- Net investment income (loss)..... 373,623 6,032,375 (113) (579) ------------------- --------------------- ------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 2,933,617 -- 720 8,458 Realized gains (losses) on sale of investments........................ 2,501,026 113,974 6,712 508 ------------------- --------------------- ------------------- ------------------- Net realized gains (losses)...... 5,434,643 113,974 7,432 8,966 ------------------- --------------------- ------------------- ------------------- Change in unrealized gains (losses) on investments..................... (2,807,313) (8,718,909) (6,574) (12,305) ------------------- --------------------- ------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... 2,627,330 (8,604,935) 858 (3,339) ------------------- --------------------- ------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 3,000,953 $ (2,572,560) $ 745 $ (3,918) =================== ===================== =================== =================== MIST MIST ALLIANCEBERNSTEIN ALLIANZ GLOBAL MIST AMERICAN GLOBAL DYNAMIC INVESTORS DYNAMIC FUNDS BALANCED MFS VIT RESEARCH ALLOCATION MULTI-ASSET PLUS ALLOCATION SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT (b) SUB-ACCOUNT ------------------- ------------------- -------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ 387 $ 65,209,125 $ 80,594 $ 43,573,207 ------------------- ------------------- -------------------- ------------------- EXPENSES: Mortality and expense risk and other charges...................... 682 39,348,602 60,973 44,254,065 Administrative charges............... -- 8,397,787 14,797 8,594,116 ------------------- ------------------- -------------------- ------------------- Total expenses..................... 682 47,746,389 75,770 52,848,181 ------------------- ------------------- -------------------- ------------------- Net investment income (loss)..... (295) 17,462,736 4,824 (9,274,974) ------------------- ------------------- -------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 3,513 64,924,369 169,949 332,687,325 Realized gains (losses) on sale of investments........................ 15,644 26,348,829 1,372 45,787,128 ------------------- ------------------- -------------------- ------------------- Net realized gains (losses)...... 19,157 91,273,198 171,321 378,474,453 ------------------- ------------------- -------------------- ------------------- Change in unrealized gains (losses) on investments..................... (16,582) 81,273,478 67,003 (221,142,935) ------------------- ------------------- -------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... 2,575 172,546,676 238,324 157,331,518 ------------------- ------------------- -------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 2,280 $ 190,009,412 $ 243,148 $ 148,056,544 =================== =================== ==================== =================== MIST AMERICAN FUNDS GROWTH MIST AMERICAN ALLOCATION FUNDS GROWTH SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ 19,016,568 $ 3,496,860 ------------------- ------------------- EXPENSES: Mortality and expense risk and other charges...................... 24,317,518 8,083,381 Administrative charges............... 4,628,783 1,577,377 ------------------- ------------------- Total expenses..................... 28,946,301 9,660,758 ------------------- ------------------- Net investment income (loss)..... (9,929,733) (6,163,898) ------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 282,001,792 37,016,758 Realized gains (losses) on sale of investments........................ 29,425,874 21,121,263 ------------------- ------------------- Net realized gains (losses)...... 311,427,666 58,138,021 ------------------- ------------------- Change in unrealized gains (losses) on investments..................... (216,740,668) (11,947,440) ------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... 94,686,998 46,190,581 ------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 84,757,265 $ 40,026,683 =================== =================== (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. The accompanying notes are an integral part of these financial statements. 38
485BPOS132nd Page of 388TOC1stPreviousNextBottomJust 132nd
The accompanying notes are an integral part of these financial statements. 39
485BPOS133rd Page of 388TOC1stPreviousNextBottomJust 133rd
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF OPERATIONS -- (CONTINUED) FOR THE YEAR ENDED DECEMBER 31, 2014 [Enlarge/Download Table] MIST AMERICAN MIST AQR MIST BLACKROCK FUNDS MODERATE GLOBAL RISK GLOBAL TACTICAL MIST BLACKROCK ALLOCATION BALANCED STRATEGIES HIGH YIELD SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- ------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ 25,942,038 $ -- $ 61,497,671 $ 16,189,549 ------------------- ------------------- ------------------- ------------------- EXPENSES: Mortality and expense risk and other charges...................... 22,791,824 37,431,539 64,217,014 3,498,630 Administrative charges............... 4,438,090 8,010,789 13,701,030 665,106 ------------------- ------------------- ------------------- ------------------- Total expenses..................... 27,229,914 45,442,328 77,918,044 4,163,736 ------------------- ------------------- ------------------- ------------------- Net investment income (loss)..... (1,287,876) (45,442,328) (16,420,373) 12,025,813 ------------------- ------------------- ------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 154,394,431 14,732,500 290,055,944 12,328,315 Realized gains (losses) on sale of investments........................ 22,369,485 8,917,836 36,092,852 388,485 ------------------- ------------------- ------------------- ------------------- Net realized gains (losses)...... 176,763,916 23,650,336 326,148,796 12,716,800 ------------------- ------------------- ------------------- ------------------- Change in unrealized gains (losses) on investments..................... (97,636,993) 108,694,006 (72,592,431) (19,968,507) ------------------- ------------------- ------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... 79,126,923 132,344,342 253,556,365 (7,251,707) ------------------- ------------------- ------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 77,839,047 $ 86,902,014 $ 237,135,992 $ 4,774,106 =================== =================== =================== =================== MIST MIST MIST CLARION MIST CLEARBRIDGE GOLDMAN SACHS HARRIS OAKMARK GLOBAL REAL ESTATE AGGRESSIVE GROWTH MID CAP VALUE INTERNATIONAL SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- ------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ 2,939,912 $ 602,873 $ 921,727 $ 16,629,378 ------------------- ------------------- ------------------- ------------------- EXPENSES: Mortality and expense risk and other charges...................... 3,712,146 7,298,827 2,322,451 9,229,813 Administrative charges............... 713,293 1,360,440 429,183 1,727,882 ------------------- ------------------- ------------------- ------------------- Total expenses..................... 4,425,439 8,659,267 2,751,634 10,957,695 ------------------- ------------------- ------------------- ------------------- Net investment income (loss)..... (1,485,527) (8,056,394) (1,829,907) 5,671,683 ------------------- ------------------- ------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... -- -- 29,842,041 66,592,068 Realized gains (losses) on sale of investments........................ 1,432,009 36,635,069 5,064,218 8,223,909 ------------------- ------------------- ------------------- ------------------- Net realized gains (losses)...... 1,432,009 36,635,069 34,906,259 74,815,977 ------------------- ------------------- ------------------- ------------------- Change in unrealized gains (losses) on investments..................... 29,887,079 56,948,433 (14,180,162) (131,491,626) ------------------- ------------------- ------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... 31,319,088 93,583,502 20,726,097 (56,675,649) ------------------- ------------------- ------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 29,833,561 $ 85,527,108 $ 18,896,190 $ (51,003,966) =================== =================== =================== =================== MIST INVESCO BALANCED-RISK MIST INVESCO ALLOCATION COMSTOCK SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ -- $ 4,170,318 ------------------- ------------------- EXPENSES: Mortality and expense risk and other charges...................... 9,454,240 8,375,886 Administrative charges............... 2,079,801 1,742,449 ------------------- ------------------- Total expenses..................... 11,534,041 10,118,335 ------------------- ------------------- Net investment income (loss)..... (11,534,041) (5,948,017) ------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 38,797,809 -- Realized gains (losses) on sale of investments........................ 1,704,073 19,778,596 ------------------- ------------------- Net realized gains (losses)...... 40,501,882 19,778,596 ------------------- ------------------- Change in unrealized gains (losses) on investments..................... 4,357,344 42,690,949 ------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... 44,859,226 62,469,545 ------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 33,325,185 $ 56,521,528 =================== =================== (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. The accompanying notes are an integral part of these financial statements. 40
485BPOS134th Page of 388TOC1stPreviousNextBottomJust 134th
The accompanying notes are an integral part of these financial statements. 41
485BPOS135th Page of 388TOC1stPreviousNextBottomJust 135th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF OPERATIONS -- (CONTINUED) FOR THE YEAR ENDED DECEMBER 31, 2014 [Enlarge/Download Table] MIST JPMORGAN MIST INVESCO MIST INVESCO MIST JPMORGAN GLOBAL ACTIVE MID CAP VALUE SMALL CAP GROWTH CORE BOND ALLOCATION SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- ------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ 737,527 $ -- $ 4,627,654 $ 9,641,772 ------------------- ------------------- ------------------- ------------------- EXPENSES: Mortality and expense risk and other charges...................... 2,870,504 4,044,756 4,232,507 9,836,384 Administrative charges............... 559,463 768,448 813,815 2,139,255 ------------------- ------------------- ------------------- ------------------- Total expenses..................... 3,429,967 4,813,204 5,046,322 11,975,639 ------------------- ------------------- ------------------- ------------------- Net investment income (loss)..... (2,692,440) (4,813,204) (418,668) (2,333,867) ------------------- ------------------- ------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 27,568,499 36,435,193 1,754,274 26,321,334 Realized gains (losses) on sale of investments........................ 4,714,795 11,314,956 (459,411) 1,218,964 ------------------- ------------------- ------------------- ------------------- Net realized gains (losses)...... 32,283,294 47,750,149 1,294,863 27,540,298 ------------------- ------------------- ------------------- ------------------- Change in unrealized gains (losses) on investments..................... (9,866,841) (24,251,382) 10,102,500 19,805,708 ------------------- ------------------- ------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... 22,416,453 23,498,767 11,397,363 47,346,006 ------------------- ------------------- ------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 19,724,013 $ 18,685,563 $ 10,978,695 $ 45,012,139 =================== =================== =================== =================== MIST MIST JPMORGAN MIST LOOMIS SAYLES MIST LORD ABBETT MET/EATON VANCE SMALL CAP VALUE GLOBAL MARKETS BOND DEBENTURE FLOATING RATE SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- ------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ 291,033 $ 3,650,465 $ 14,555,989 $ 2,980,447 ------------------- ------------------- ------------------- ------------------- EXPENSES: Mortality and expense risk and other charges...................... 407,340 2,307,636 3,549,683 1,116,813 Administrative charges............... 67,776 438,865 621,433 204,411 ------------------- ------------------- ------------------- ------------------- Total expenses..................... 475,116 2,746,501 4,171,116 1,321,224 ------------------- ------------------- ------------------- ------------------- Net investment income (loss)..... (184,083) 903,964 10,384,873 1,659,223 ------------------- ------------------- ------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 3,224,542 -- 7,077,870 370,498 Realized gains (losses) on sale of investments........................ 840,940 5,851,208 3,798,700 (159,240) ------------------- ------------------- ------------------- ------------------- Net realized gains (losses)...... 4,065,482 5,851,208 10,876,570 211,258 ------------------- ------------------- ------------------- ------------------- Change in unrealized gains (losses) on investments..................... (3,083,282) (3,452,819) (13,286,737) (2,518,686) ------------------- ------------------- ------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... 982,200 2,398,389 (2,410,167) (2,307,428) ------------------- ------------------- ------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 798,117 $ 3,302,353 $ 7,974,706 $ (648,205) =================== =================== =================== =================== MIST MET/FRANKLIN LOW DURATION MIST MET/TEMPLETON TOTAL RETURN INTERNATIONAL BOND SUB-ACCOUNT SUB-ACCOUNT ------------------ ------------------- INVESTMENT INCOME: Dividends............................ $ 3,758,068 $ 2,342,050 ------------------ ------------------- EXPENSES: Mortality and expense risk and other charges...................... 2,290,724 641,367 Administrative charges............... 436,996 126,381 ------------------ ------------------- Total expenses..................... 2,727,720 767,748 ------------------ ------------------- Net investment income (loss)..... 1,030,348 1,574,302 ------------------ ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... -- -- Realized gains (losses) on sale of investments........................ (132,806) (178,047) ------------------ ------------------- Net realized gains (losses)...... (132,806) (178,047) ------------------ ------------------- Change in unrealized gains (losses) on investments..................... (1,819,015) (1,505,639) ------------------ ------------------- Net realized and change in unrealized gains (losses) on investments..................... (1,951,821) (1,683,686) ------------------ ------------------- Net increase (decrease) in net assets resulting from operations.......... $ (921,473) $ (109,384) ================== =================== (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. The accompanying notes are an integral part of these financial statements. 42
485BPOS136th Page of 388TOC1stPreviousNextBottomJust 136th
The accompanying notes are an integral part of these financial statements. 43
485BPOS137th Page of 388TOC1stPreviousNextBottomJust 137th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF OPERATIONS -- (CONTINUED) FOR THE YEAR ENDED DECEMBER 31, 2014 [Enlarge/Download Table] MIST METLIFE MIST METLIFE MIST METLIFE MULTI-INDEX MIST METLIFE ASSET ALLOCATION 100 BALANCED PLUS TARGETED RISK SMALL CAP VALUE SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- ------------------- ------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ 4,637,241 $ 121,337,282 $ -- $ 138,649 -------------------- ------------------- ------------------- ------------------- EXPENSES: Mortality and expense risk and other charges...................... 8,859,623 80,443,367 3,876,561 4,203,910 Administrative charges............... 1,628,395 17,305,788 847,479 754,614 -------------------- ------------------- ------------------- ------------------- Total expenses..................... 10,488,018 97,749,155 4,724,040 4,958,524 -------------------- ------------------- ------------------- ------------------- Net investment income (loss)..... (5,850,777) 23,588,127 (4,724,040) (4,819,875) -------------------- ------------------- ------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... -- 537,909,978 1,029,216 12,962,190 Realized gains (losses) on sale of investments........................ 16,294,442 14,161,916 411,784 15,771,165 -------------------- ------------------- ------------------- ------------------- Net realized gains (losses)...... 16,294,442 552,071,894 1,441,000 28,733,355 -------------------- ------------------- ------------------- ------------------- Change in unrealized gains (losses) on investments..................... 11,631,228 (36,064,867) 28,321,809 (23,969,258) -------------------- ------------------- ------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... 27,925,670 516,007,027 29,762,809 4,764,097 -------------------- ------------------- ------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 22,074,893 $ 539,595,154 $ 25,038,769 $ (55,778) ==================== =================== =================== =================== MIST MIST MIST MFS EMERGING MFS RESEARCH MORGAN STANLEY MIST OPPENHEIMER MARKETS EQUITY INTERNATIONAL MID CAP GROWTH GLOBAL EQUITY SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------ ------------------- ------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ 3,828,445 $ 7,109,698 $ 2,610 $ 623,583 ------------------ ------------------- ------------------- ------------------- EXPENSES: Mortality and expense risk and other charges...................... 5,849,647 4,255,944 2,821,599 823,705 Administrative charges............... 1,138,624 763,563 590,481 189,172 ------------------ ------------------- ------------------- ------------------- Total expenses..................... 6,988,271 5,019,507 3,412,080 1,012,877 ------------------ ------------------- ------------------- ------------------- Net investment income (loss)..... (3,159,826) 2,090,191 (3,409,470) (389,294) ------------------ ------------------- ------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... -- -- -- 2,284,012 Realized gains (losses) on sale of investments........................ 2,820,880 1,753,034 5,684,794 1,211,781 ------------------ ------------------- ------------------- ------------------- Net realized gains (losses)...... 2,820,880 1,753,034 5,684,794 3,495,793 ------------------ ------------------- ------------------- ------------------- Change in unrealized gains (losses) on investments..................... (35,285,750) (30,446,779) (2,736,107) (2,567,600) ------------------ ------------------- ------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... (32,464,870) (28,693,745) 2,948,687 928,193 ------------------ ------------------- ------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ (35,624,696) $ (26,603,554) $ (460,783) $ 538,899 ================== =================== =================== =================== MIST MIST PANAGORA GLOBAL PIMCO INFLATION DIVERSIFIED RISK PROTECTED BOND SUB-ACCOUNT (b) SUB-ACCOUNT ------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ 26,867 $ 12,126,214 ------------------- ------------------- EXPENSES: Mortality and expense risk and other charges...................... 40,488 10,476,635 Administrative charges............... 9,901 1,964,476 ------------------- ------------------- Total expenses..................... 50,389 12,441,111 ------------------- ------------------- Net investment income (loss)..... (23,522) (314,897) ------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 194,785 -- Realized gains (losses) on sale of investments........................ 12,836 (10,840,115) ------------------- ------------------- Net realized gains (losses)...... 207,621 (10,840,115) ------------------- ------------------- Change in unrealized gains (losses) on investments..................... (153,203) 22,930,848 ------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... 54,418 12,090,733 ------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 30,896 $ 11,775,836 =================== =================== (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. The accompanying notes are an integral part of these financial statements. 44
485BPOS138th Page of 388TOC1stPreviousNextBottomJust 138th
The accompanying notes are an integral part of these financial statements. 45
485BPOS139th Page of 388TOC1stPreviousNextBottomJust 139th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF OPERATIONS -- (CONTINUED) FOR THE YEAR ENDED DECEMBER 31, 2014 [Enlarge/Download Table] MIST MIST MIST PIONEER MIST PYRAMIS PIMCO TOTAL RETURN PIONEER FUND STRATEGIC INCOME GOVERNMENT INCOME SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------ ------------------- ------------------ ------------------- INVESTMENT INCOME: Dividends............................ $ 44,715,531 $ 4,964,495 $ 47,381,038 $ 17,867,325 ------------------ ------------------- ------------------ ------------------- EXPENSES: Mortality and expense risk and other charges...................... 25,204,204 3,397,763 10,744,260 7,894,371 Administrative charges............... 4,655,125 749,286 2,378,040 1,719,147 ------------------ ------------------- ------------------ ------------------- Total expenses..................... 29,859,329 4,147,049 13,122,300 9,613,518 ------------------ ------------------- ------------------ ------------------- Net investment income (loss)..... 14,856,202 817,446 34,258,738 8,253,807 ------------------ ------------------- ------------------ ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... -- 83,758,457 9,512,058 -- Realized gains (losses) on sale of investments........................ (1,792,640) 4,153,016 2,746,355 (2,556,572) ------------------ ------------------- ------------------ ------------------- Net realized gains (losses)...... (1,792,640) 87,911,473 12,258,413 (2,556,572) ------------------ ------------------- ------------------ ------------------- Change in unrealized gains (losses) on investments..................... 36,415,773 (61,223,094) (17,661,136) 34,979,601 ------------------ ------------------- ------------------ ------------------- Net realized and change in unrealized gains (losses) on investments..................... 34,623,133 26,688,379 (5,402,723) 32,423,029 ------------------ ------------------- ------------------ ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 49,479,335 $ 27,505,825 $ 28,856,015 $ 40,676,836 ================== =================== ================== =================== MIST PYRAMIS MIST SCHRODERS MIST SSGA GROWTH MIST SSGA MANAGED RISK GLOBAL MULTI-ASSET AND INCOME ETF GROWTH ETF SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------ ------------------- ------------------ INVESTMENT INCOME: Dividends............................ $ -- $ 6,219,544 $ 34,660,381 $ 9,464,132 ------------------- ------------------ ------------------- ------------------ EXPENSES: Mortality and expense risk and other charges...................... 1,430,326 5,467,098 19,537,196 6,511,544 Administrative charges............... 301,410 1,180,854 3,869,634 1,260,972 ------------------- ------------------ ------------------- ------------------ Total expenses..................... 1,731,736 6,647,952 23,406,830 7,772,516 ------------------- ------------------ ------------------- ------------------ Net investment income (loss)..... (1,731,736) (428,408) 11,253,551 1,691,616 ------------------- ------------------ ------------------- ------------------ NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 387,657 17,005,335 91,560,188 31,239,331 Realized gains (losses) on sale of investments........................ 127,585 1,512,218 21,817,267 9,921,674 ------------------- ------------------ ------------------- ------------------ Net realized gains (losses)...... 515,242 18,517,553 113,377,455 41,161,005 ------------------- ------------------ ------------------- ------------------ Change in unrealized gains (losses) on investments..................... 9,325,602 10,370,401 (60,416,484) (24,023,767) ------------------- ------------------ ------------------- ------------------ Net realized and change in unrealized gains (losses) on investments..................... 9,840,844 28,887,954 52,960,971 17,137,238 ------------------- ------------------ ------------------- ------------------ Net increase (decrease) in net assets resulting from operations.......... $ 8,109,108 $ 28,459,546 $ 64,214,522 $ 18,828,854 =================== ================== =================== ================== MIST T. ROWE PRICE MIST T. ROWE PRICE LARGE CAP VALUE MID CAP GROWTH SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------ INVESTMENT INCOME: Dividends............................ $ 9,043,710 $ -- ------------------- ------------------ EXPENSES: Mortality and expense risk and other charges...................... 10,194,998 7,315,478 Administrative charges............... 1,441,290 1,368,814 ------------------- ------------------ Total expenses..................... 11,636,288 8,684,292 ------------------- ------------------ Net investment income (loss)..... (2,592,578) (8,684,292) ------------------- ------------------ NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... -- 55,165,010 Realized gains (losses) on sale of investments........................ 22,160,919 28,182,665 ------------------- ------------------ Net realized gains (losses)...... 22,160,919 83,347,675 ------------------- ------------------ Change in unrealized gains (losses) on investments..................... 67,563,377 (17,691,662) ------------------- ------------------ Net realized and change in unrealized gains (losses) on investments..................... 89,724,296 65,656,013 ------------------- ------------------ Net increase (decrease) in net assets resulting from operations.......... $ 87,131,718 $ 56,971,721 =================== ================== (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. The accompanying notes are an integral part of these financial statements. 46
485BPOS140th Page of 388TOC1stPreviousNextBottomJust 140th
The accompanying notes are an integral part of these financial statements. 47
485BPOS141st Page of 388TOC1stPreviousNextBottomJust 141st
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF OPERATIONS -- (CONTINUED) FOR THE YEAR ENDED DECEMBER 31, 2014 [Enlarge/Download Table] MIST WMC MSF BAILLIE GIFFORD MSF BARCLAYS MSF BLACKROCK LARGE CAP RESEARCH INTERNATIONAL STOCK AGGREGATE BOND INDEX BOND INCOME SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- -------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ 132,983 $ 3,615,555 $ 4,927,769 $ 1,940,729 ------------------- ------------------- -------------------- ------------------- EXPENSES: Mortality and expense risk and other charges...................... 243,807 3,720,735 2,348,125 850,832 Administrative charges............... 41,487 718,128 450,463 137,316 ------------------- ------------------- -------------------- ------------------- Total expenses..................... 285,294 4,438,863 2,798,588 988,148 ------------------- ------------------- -------------------- ------------------- Net investment income (loss)..... (152,311) (823,308) 2,129,181 952,581 ------------------- ------------------- -------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... -- -- -- -- Realized gains (losses) on sale of investments........................ 962,687 2,816,068 (108,055) 40,190 ------------------- ------------------- -------------------- ------------------- Net realized gains (losses)...... 962,687 2,816,068 (108,055) 40,190 ------------------- ------------------- -------------------- ------------------- Change in unrealized gains (losses) on investments..................... 1,050,584 (15,452,332) 4,954,438 2,001,494 ------------------- ------------------- -------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... 2,013,271 (12,636,264) 4,846,383 2,041,684 ------------------- ------------------- -------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 1,860,960 $ (13,459,572) $ 6,975,564 $ 2,994,265 =================== =================== ==================== =================== MSF BLACKROCK MSF BLACKROCK MSF BLACKROCK MSF FRONTIER CAPITAL APPRECIATION LARGE CAP VALUE MONEY MARKET MID CAP GROWTH SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- ------------------- ------------------- ------------------ INVESTMENT INCOME: Dividends............................ $ 8,821 $ 52,453 $ -- $ -- -------------------- ------------------- ------------------- ------------------ EXPENSES: Mortality and expense risk and other charges...................... 199,329 55,088 5,700,637 1,117,620 Administrative charges............... 31,137 1 1,066,269 205,249 -------------------- ------------------- ------------------- ------------------ Total expenses..................... 230,466 55,089 6,766,906 1,322,869 -------------------- ------------------- ------------------- ------------------ Net investment income (loss)..... (221,645) (2,636) (6,766,906) (1,322,869) -------------------- ------------------- ------------------- ------------------ NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... -- 955,775 -- 7,739,497 Realized gains (losses) on sale of investments........................ 1,124,532 (34,510) -- 1,990,712 -------------------- ------------------- ------------------- ------------------ Net realized gains (losses)...... 1,124,532 921,265 -- 9,730,209 -------------------- ------------------- ------------------- ------------------ Change in unrealized gains (losses) on investments..................... 32,868 (583,420) -- (1,239,505) -------------------- ------------------- ------------------- ------------------ Net realized and change in unrealized gains (losses) on investments..................... 1,157,400 337,845 -- 8,490,704 -------------------- ------------------- ------------------- ------------------ Net increase (decrease) in net assets resulting from operations.......... $ 935,755 $ 335,209 $ (6,766,906) $ 7,167,835 ==================== =================== =================== ================== MSF MSF LOOMIS SAYLES JENNISON GROWTH SMALL CAP CORE SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ 197,268 $ -- ------------------- ------------------- EXPENSES: Mortality and expense risk and other charges...................... 7,445,742 206,598 Administrative charges............... 1,355,668 34,490 ------------------- ------------------- Total expenses..................... 8,801,410 241,088 ------------------- ------------------- Net investment income (loss)..... (8,604,142) (241,088) ------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 30,187,427 1,865,120 Realized gains (losses) on sale of investments........................ 26,920,084 455,815 ------------------- ------------------- Net realized gains (losses)...... 57,107,511 2,320,935 ------------------- ------------------- Change in unrealized gains (losses) on investments..................... (11,083,979) (1,853,055) ------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... 46,023,532 467,880 ------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 37,419,390 $ 226,792 =================== =================== (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. The accompanying notes are an integral part of these financial statements. 48
485BPOS142nd Page of 388TOC1stPreviousNextBottomJust 142nd
The accompanying notes are an integral part of these financial statements. 49
485BPOS143rd Page of 388TOC1stPreviousNextBottomJust 143rd
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF OPERATIONS -- (CONTINUED) FOR THE YEAR ENDED DECEMBER 31, 2014 [Enlarge/Download Table] MSF MET/DIMENSIONAL MSF LOOMIS SAYLES MSF MET/ARTISAN INTERNATIONAL SMALL MSF METLIFE SMALL CAP GROWTH MID CAP VALUE COMPANY ASSET ALLOCATION 20 SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- ------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ -- $ 1,472,681 $ 1,248,428 $ 264,075 ------------------- -------------------- ------------------- ------------------- EXPENSES: Mortality and expense risk and other charges...................... 2,311 3,618,266 828,219 301,504 Administrative charges............... 583 624,727 154,213 55,991 ------------------- -------------------- ------------------- ------------------- Total expenses..................... 2,894 4,242,993 982,432 357,495 ------------------- -------------------- ------------------- ------------------- Net investment income (loss)..... (2,894) (2,770,312) 265,996 (93,420) ------------------- -------------------- ------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 30,933 -- 2,173,734 286,319 Realized gains (losses) on sale of investments........................ 2,102 9,182,228 1,940,889 303,511 ------------------- -------------------- ------------------- ------------------- Net realized gains (losses)...... 33,035 9,182,228 4,114,623 589,830 ------------------- -------------------- ------------------- ------------------- Change in unrealized gains (losses) on investments..................... (27,964) (6,138,938) (9,176,434) (85,239) ------------------- -------------------- ------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... 5,071 3,043,290 (5,061,811) 504,591 ------------------- -------------------- ------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 2,177 $ 272,978 $ (4,795,815) $ 411,171 =================== ==================== =================== =================== MSF METLIFE MSF METLIFE MSF METLIFE MSF METLIFE ASSET ALLOCATION 40 ASSET ALLOCATION 60 ASSET ALLOCATION 80 MID CAP STOCK INDEX SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- -------------------- -------------------- -------------------- INVESTMENT INCOME: Dividends............................ $ 219,754 $ 900,272 $ 922,358 $ 1,068,975 ------------------- -------------------- -------------------- -------------------- EXPENSES: Mortality and expense risk and other charges...................... 47,673,890 70,192,993 62,393,559 1,657,801 Administrative charges............... 8,982,816 13,215,503 11,448,724 230,847 ------------------- -------------------- -------------------- -------------------- Total expenses..................... 56,656,706 83,408,496 73,842,283 1,888,648 ------------------- -------------------- -------------------- -------------------- Net investment income (loss)..... (56,436,952) (82,508,224) (72,919,925) (819,673) ------------------- -------------------- -------------------- -------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 282,372 1,689,985 -- 5,986,438 Realized gains (losses) on sale of investments........................ 14,697,072 18,025,699 18,208,146 5,573,256 ------------------- -------------------- -------------------- -------------------- Net realized gains (losses)...... 14,979,444 19,715,684 18,208,146 11,559,694 ------------------- -------------------- -------------------- -------------------- Change in unrealized gains (losses) on investments..................... 181,094,658 325,337,909 313,139,176 (1,212,992) ------------------- -------------------- -------------------- -------------------- Net realized and change in unrealized gains (losses) on investments..................... 196,074,102 345,053,593 331,347,322 10,346,702 ------------------- -------------------- -------------------- -------------------- Net increase (decrease) in net assets resulting from operations.......... $ 139,637,150 $ 262,545,369 $ 258,427,397 $ 9,527,029 =================== ==================== ==================== ==================== MSF METLIFE MSF STOCK INDEX MFS TOTAL RETURN SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ 8,650,510 $ 1,037,227 ------------------- ------------------- EXPENSES: Mortality and expense risk and other charges...................... 8,169,934 634,571 Administrative charges............... 1,246,417 88,086 ------------------- ------------------- Total expenses..................... 9,416,351 722,657 ------------------- ------------------- Net investment income (loss)..... (765,841) 314,570 ------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 14,298,345 -- Realized gains (losses) on sale of investments........................ 24,689,374 1,124,465 ------------------- ------------------- Net realized gains (losses)...... 38,987,719 1,124,465 ------------------- ------------------- Change in unrealized gains (losses) on investments..................... 23,647,160 1,597,039 ------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... 62,634,879 2,721,504 ------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 61,869,038 $ 3,036,074 =================== =================== (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. The accompanying notes are an integral part of these financial statements. 50
485BPOS144th Page of 388TOC1stPreviousNextBottomJust 144th
The accompanying notes are an integral part of these financial statements. 51
485BPOS145th Page of 388TOC1stPreviousNextBottomJust 145th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF OPERATIONS -- (CONTINUED) FOR THE YEAR ENDED DECEMBER 31, 2014 [Enlarge/Download Table] MSF MSCI MSF NEUBERGER MSF MSF MFS VALUE EAFE INDEX BERMAN GENESIS RUSSELL 2000 INDEX SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------- ------------------- ------------------ ------------------- INVESTMENT INCOME: Dividends............................ $ 3,988,712 $ 2,560,143 $ 349,614 $ 1,316,027 ------------------- ------------------- ------------------ ------------------- EXPENSES: Mortality and expense risk and other charges...................... 3,433,548 1,355,678 2,163,993 1,808,055 Administrative charges............... 612,780 213,247 362,078 306,834 ------------------- ------------------- ------------------ ------------------- Total expenses..................... 4,046,328 1,568,925 2,526,071 2,114,889 ------------------- ------------------- ------------------ ------------------- Net investment income (loss)..... (57,616) 991,218 (2,176,457) (798,862) ------------------- ------------------- ------------------ ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 12,112,589 -- -- 3,120,572 Realized gains (losses) on sale of investments........................ 6,560,127 2,887,187 4,329,229 5,246,886 ------------------- ------------------- ------------------ ------------------- Net realized gains (losses)...... 18,672,716 2,887,187 4,329,229 8,367,458 ------------------- ------------------- ------------------ ------------------- Change in unrealized gains (losses) on investments..................... 2,950,546 (11,944,228) (5,677,025) (3,199,788) ------------------- ------------------- ------------------ ------------------- Net realized and change in unrealized gains (losses) on investments..................... 21,623,262 (9,057,041) (1,347,796) 5,167,670 ------------------- ------------------- ------------------ ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 21,565,646 $ (8,065,823) $ (3,524,253) $ 4,368,808 =================== =================== ================== =================== MSF VAN ECK MSF WESTERN ASSET MSF T. ROWE PRICE MSF T. ROWE PRICE GLOBAL NATURAL MANAGEMENT STRATEGIC LARGE CAP GROWTH SMALL CAP GROWTH RESOURCES BOND OPPORTUNITIES SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT (a) ------------------ ------------------- ------------------- -------------------- INVESTMENT INCOME: Dividends............................ $ 1,687 $ 945 $ 270,768 $ -- ------------------ ------------------- ------------------- -------------------- EXPENSES: Mortality and expense risk and other charges...................... 2,102,334 142,476 1,310,718 4 Administrative charges............... 381,511 11,716 254,406 1 ------------------ ------------------- ------------------- -------------------- Total expenses..................... 2,483,845 154,192 1,565,124 5 ------------------ ------------------- ------------------- -------------------- Net investment income (loss)..... (2,482,158) (153,247) (1,294,356) (5) ------------------ ------------------- ------------------- -------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 10,983,579 789,869 1,705,108 -- Realized gains (losses) on sale of investments........................ 3,410,255 674,821 82,770 -- ------------------ ------------------- ------------------- -------------------- Net realized gains (losses)...... 14,393,834 1,464,690 1,787,878 -- ------------------ ------------------- ------------------- -------------------- Change in unrealized gains (losses) on investments..................... (1,397,928) (830,342) (19,515,189) 48 ------------------ ------------------- ------------------- -------------------- Net realized and change in unrealized gains (losses) on investments..................... 12,995,906 634,348 (17,727,311) 48 ------------------ ------------------- ------------------- -------------------- Net increase (decrease) in net assets resulting from operations.......... $ 10,513,748 $ 481,101 $ (19,021,667) $ 43 ================== =================== =================== ==================== MSF WESTERN ASSET MSF WMC MANAGEMENT CORE EQUITY U.S. GOVERNMENT OPPORTUNITIES SUB-ACCOUNT SUB-ACCOUNT ------------------ ------------------- INVESTMENT INCOME: Dividends............................ $ 4,803,092 $ 3,680,864 ------------------ ------------------- EXPENSES: Mortality and expense risk and other charges...................... 3,391,531 8,504,333 Administrative charges............... 713,947 1,543,651 ------------------ ------------------- Total expenses..................... 4,105,478 10,047,984 ------------------ ------------------- Net investment income (loss)..... 697,614 (6,367,120) ------------------ ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... -- 54,385,564 Realized gains (losses) on sale of investments........................ (3,865) 36,633,301 ------------------ ------------------- Net realized gains (losses)...... (3,865) 91,018,865 ------------------ ------------------- Change in unrealized gains (losses) on investments..................... 2,454,211 (33,491,386) ------------------ ------------------- Net realized and change in unrealized gains (losses) on investments..................... 2,450,346 57,527,479 ------------------ ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 3,147,960 $ 51,160,359 ================== =================== (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. The accompanying notes are an integral part of these financial statements. 52
485BPOS146th Page of 388TOC1stPreviousNextBottomJust 146th
The accompanying notes are an integral part of these financial statements. 53
485BPOS147th Page of 388TOC1stPreviousNextBottomJust 147th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF OPERATIONS -- (CONTINUED) FOR THE YEAR ENDED DECEMBER 31, 2014 [Enlarge/Download Table] OPPENHEIMER VA OPPENHEIMER VA NEUBERGER OPPENHEIMER VA GLOBAL STRATEGIC MAIN STREET BERMAN GENESIS CORE BOND INCOME SMALL CAP SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------ ------------------- ------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ 5 $ 470 $ 195 $ 770,584 ------------------ ------------------- ------------------- ------------------- EXPENSES: Mortality and expense risk and other charges...................... 93 123 62 1,342,693 Administrative charges............... -- -- -- 303,187 ------------------ ------------------- ------------------- ------------------- Total expenses..................... 93 123 62 1,645,880 ------------------ ------------------- ------------------- ------------------- Net investment income (loss)..... (88) 347 133 (875,296) ------------------ ------------------- ------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 688 -- -- 17,095,411 Realized gains (losses) on sale of investments........................ 783 (267) 5 4,873,313 ------------------ ------------------- ------------------- ------------------- Net realized gains (losses)...... 1,471 (267) 5 21,968,724 ------------------ ------------------- ------------------- ------------------- Change in unrealized gains (losses) on investments..................... (1,551) 416 (73) (9,177,366) ------------------ ------------------- ------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... (80) 149 (68) 12,791,358 ------------------ ------------------- ------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ (168) $ 496 $ 65 $ 11,916,062 ================== =================== =================== =================== PIMCO VIT PIMCO VIT OPPENHEIMER VA OPPENHEIMER VA COMMODITYREALRETURN EMERGING MAIN STREET MONEY STRATEGY MARKET BOND SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT (a) SUB-ACCOUNT (a) ------------------ ------------------- ------------------- ------------------- INVESTMENT INCOME: Dividends............................ $ 878 $ -- $ 24 $ 36 ------------------ ------------------- ------------------- ------------------- EXPENSES: Mortality and expense risk and other charges...................... 1,467 53 10 6 Administrative charges............... -- -- 3 1 ------------------ ------------------- ------------------- ------------------- Total expenses..................... 1,467 53 13 7 ------------------ ------------------- ------------------- ------------------- Net investment income (loss)..... (589) (53) 11 29 ------------------ ------------------- ------------------- ------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... 2,122 -- -- -- Realized gains (losses) on sale of investments........................ 3,163 -- -- -- ------------------ ------------------- ------------------- ------------------- Net realized gains (losses)...... 5,285 -- -- -- ------------------ ------------------- ------------------- ------------------- Change in unrealized gains (losses) on investments..................... 4,566 -- (1,741) 76 ------------------ ------------------- ------------------- ------------------- Net realized and change in unrealized gains (losses) on investments..................... 9,851 -- (1,741) 76 ------------------ ------------------- ------------------- ------------------- Net increase (decrease) in net assets resulting from operations.......... $ 9,262 $ (53) $ (1,730) $ 105 ================== =================== =================== =================== PIMCO VIT PIONEER VCT UNCONSTRAINED BOND MID CAP VALUE SUB-ACCOUNT (a) SUB-ACCOUNT ------------------- ------------------ INVESTMENT INCOME: Dividends............................ $ 1 $ 475,379 ------------------- ------------------ EXPENSES: Mortality and expense risk and other charges...................... 1 829,292 Administrative charges............... -- 182,078 ------------------- ------------------ Total expenses..................... 1 1,011,370 ------------------- ------------------ Net investment income (loss)..... -- (535,991) ------------------- ------------------ NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions.......... -- 9,760,052 Realized gains (losses) on sale of investments........................ -- 1,926,035 ------------------- ------------------ Net realized gains (losses)...... -- 11,686,087 ------------------- ------------------ Change in unrealized gains (losses) on investments..................... (4) (2,093,671) ------------------- ------------------ Net realized and change in unrealized gains (losses) on investments..................... (4) 9,592,416 ------------------- ------------------ Net increase (decrease) in net assets resulting from operations.......... $ (4) $ 9,056,425 =================== ================== (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. The accompanying notes are an integral part of these financial statements. 54
485BPOS148th Page of 388TOC1stPreviousNextBottomJust 148th
The accompanying notes are an integral part of these financial statements. 55
485BPOS149th Page of 388TOC1stPreviousNextBottomJust 149th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF OPERATIONS -- (CONCLUDED) FOR THE YEAR ENDED DECEMBER 31, 2014 [Enlarge/Download Table] PIONEER VCT T. ROWE PRICE T. ROWE PRICE T. ROWE PRICE REAL ESTATE SHARES GROWTH STOCK INTERNATIONAL STOCK PRIME RESERVE SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------- -------------------- -------------------- -------------------- INVESTMENT INCOME: Dividends............................. $ 5,970 $ -- $ 7,337 $ 65 -------------------- -------------------- -------------------- -------------------- EXPENSES: Mortality and expense risk and other charges....................... 3,556 68,593 5,777 5,422 Administrative charges................ 646 -- -- -- -------------------- -------------------- -------------------- -------------------- Total expenses...................... 4,202 68,593 5,777 5,422 -------------------- -------------------- -------------------- -------------------- Net investment income (loss)..... 1,768 (68,593) 1,560 (5,357) -------------------- -------------------- -------------------- -------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions........... 25,808 680,368 13,516 -- Realized gains (losses) on sale of investments......................... 22,068 901,812 9,975 -- -------------------- -------------------- -------------------- -------------------- Net realized gains (losses)...... 47,876 1,582,180 23,491 -- -------------------- -------------------- -------------------- -------------------- Change in unrealized gains (losses) on investments...................... 16,387 (938,069) (35,473) -- -------------------- -------------------- -------------------- -------------------- Net realized and change in unrealized gains (losses) on investments...................... 64,263 644,111 (11,982) -- -------------------- -------------------- -------------------- -------------------- Net increase (decrease) in net assets resulting from operations........... $ 66,031 $ 575,518 $ (10,422) $ (5,357) ==================== ==================== ==================== ==================== TAP 1919 VARIABLE VAN ECK VIP SOCIALLY RESPONSIVE UIF GLOBAL LONG/SHORT BALANCED INFRASTRUCTURE EQUITY INDEX SUB-ACCOUNT SUB-ACCOUNT (a) SUB-ACCOUNT (a) -------------------- -------------------- -------------------- INVESTMENT INCOME: Dividends............................. $ 2,144 $ -- $ -- -------------------- -------------------- -------------------- EXPENSES: Mortality and expense risk and other charges....................... 3,304 3 8 Administrative charges................ 614 1 2 -------------------- -------------------- -------------------- Total expenses...................... 3,918 4 10 -------------------- -------------------- -------------------- Net investment income (loss)..... (1,774) (4) (10) -------------------- -------------------- -------------------- NET REALIZED AND CHANGE IN UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Realized gain distributions........... 28,819 -- -- Realized gains (losses) on sale of investments......................... 15,713 -- -- -------------------- -------------------- -------------------- Net realized gains (losses)...... 44,532 -- -- -------------------- -------------------- -------------------- Change in unrealized gains (losses) on investments...................... (24,999) 44 80 -------------------- -------------------- -------------------- Net realized and change in unrealized gains (losses) on investments...................... 19,533 44 80 -------------------- -------------------- -------------------- Net increase (decrease) in net assets resulting from operations........... $ 17,759 $ 40 $ 70 ==================== ==================== ==================== (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. The accompanying notes are an integral part of these financial statements. 56
485BPOS150th Page of 388TOC1stPreviousNextBottomJust 150th
The accompanying notes are an integral part of these financial statements. 57
485BPOS151st Page of 388TOC1stPreviousNextBottomJust 151st
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF CHANGES IN NET ASSETS FOR THE YEARS ENDED DECEMBER 31, 2014 AND 2013 [Enlarge/Download Table] ALGER SMALL CAP GROWTH AMERICAN FUNDS BOND SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ---------------------------------- 2014 2013 2014 2013 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (798,826) $ (795,350) $ 905,828 $ 718,730 Net realized gains (losses).... 5,794,976 8,468,060 306,415 1,750,573 Change in unrealized gains (losses) on investments...... (5,736,249) 8,688,799 4,487,780 (7,601,790) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations........... (740,099) 16,361,509 5,700,023 (5,132,487) ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 1,408,289 1,617,076 4,263,222 11,875,043 Net transfers (including fixed account)..................... (2,077,029) (2,035,008) 7,408,301 11,294,017 Contract charges............... (7,514) (8,421) (1,458,856) (1,263,411) Transfers for contract benefits and terminations............. (5,159,978) (4,789,042) (10,825,095) (9,827,827) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions..... (5,836,232) (5,215,395) (612,428) 12,077,822 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets............. (6,576,331) 11,146,114 5,087,595 6,945,335 NET ASSETS: Beginning of year.............. 63,772,199 52,626,085 146,158,351 139,213,016 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 57,195,868 $ 63,772,199 $ 151,245,946 $ 146,158,351 ================ ================ ================ ================ AMERICAN FUNDS AMERICAN FUNDS GLOBAL GROWTH GLOBAL SMALL CAPITALIZATION SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ----------------------------------- 2014 2013 2014 2013 ----------------- ---------------- ---------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (869,446) $ (526,928) $ (1,529,786) $ (549,405) Net realized gains (losses).... 34,841,404 3,982,592 2,777,626 1,957,425 Change in unrealized gains (losses) on investments...... (31,374,425) 65,109,148 (217,375) 25,083,432 ----------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from operations........... 2,597,533 68,564,812 1,030,465 26,491,452 ----------------- ---------------- ---------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 11,042,741 23,766,765 4,879,074 10,382,354 Net transfers (including fixed account)..................... 7,854,131 (8,540,368) 719,962 (3,851,967) Contract charges............... (2,816,132) (2,337,645) (1,028,221) (874,487) Transfers for contract benefits and terminations............. (21,295,289) (17,922,689) (7,673,213) (6,349,695) ----------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions..... (5,214,549) (5,033,937) (3,102,398) (693,795) ----------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets............. (2,617,016) 63,530,875 (2,071,933) 25,797,657 NET ASSETS: Beginning of year.............. 314,826,203 251,295,328 124,184,003 98,386,346 ----------------- ---------------- ---------------- ----------------- End of year.................... $ 312,209,187 $ 314,826,203 $ 122,112,070 $ 124,184,003 ================= ================ ================ ================= BLACKROCK GLOBAL AMERICAN FUNDS GROWTH AMERICAN FUNDS GROWTH-INCOME ALLOCATION V.I. SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ----------------------------------- ----------------- 2014 2013 2014 2013 2014 (a) ---------------- ---------------- ----------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (5,554,369) $ (4,016,566) $ (781,613) $ (469,223) $ 176 Net realized gains (losses).... 74,146,314 16,990,100 30,958,144 6,900,940 655 Change in unrealized gains (losses) on investments...... (13,021,445) 182,361,798 3,352,629 89,831,743 (974) ---------------- ---------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations........... 55,570,500 195,335,332 33,529,160 96,263,460 (143) ---------------- ---------------- ----------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 4,101,900 48,884,879 14,177,344 21,737,754 8,700 Net transfers (including fixed account)..................... (29,722,388) (28,227,693) (13,563,643) (13,953,890) -- Contract charges............... (7,787,497) (6,793,715) (3,334,870) (2,765,946) -- Transfers for contract benefits and terminations............. (57,521,587) (49,304,587) (28,222,265) (25,784,839) -- ---------------- ---------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions..... (90,929,572) (35,441,116) (30,943,434) (20,766,921) 8,700 ---------------- ---------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets............. (35,359,072) 159,894,216 2,585,726 75,496,539 8,557 NET ASSETS: Beginning of year.............. 856,560,204 696,665,988 388,319,990 312,823,451 -- ---------------- ---------------- ----------------- ---------------- ---------------- End of year.................... $ 821,201,132 $ 856,560,204 $ 390,905,716 $ 388,319,990 $ 8,557 ================ ================ ================= ================ ================ (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. (c) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 58
485BPOS152nd Page of 388TOC1stPreviousNextBottomJust 152nd
The accompanying notes are an integral part of these financial statements. 59
485BPOS153rd Page of 388TOC1stPreviousNextBottomJust 153rd
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2014 AND 2013 [Enlarge/Download Table] DEUTSCHE I INTERNATIONAL FEDERATED HIGH INCOME BOND SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ---------------------------------- 2014 2013 2014 2013 ---------------- ----------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ 70,159 $ 689,035 $ 1,199 $ 1,375 Net realized gains (losses)..... (332,105) (490,812) 1 -- Change in unrealized gains (losses) on investments....... (2,003,646) 2,799,643 (866) (4) ---------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ (2,265,592) 2,997,866 334 1,371 ---------------- ----------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... 659,698 653,441 -- -- Net transfers (including fixed account)...................... (584,266) (612,834) -- -- Contract charges................ (1,681) (1,860) -- -- Transfers for contract benefits and terminations.............. (1,549,650) (1,377,035) (124) (113) ---------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (1,475,899) (1,338,288) (124) (113) ---------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets.............. (3,741,491) 1,659,578 210 1,258 NET ASSETS: Beginning of year............... 18,592,794 16,933,216 26,166 24,908 ---------------- ----------------- ---------------- ---------------- End of year..................... $ 14,851,303 $ 18,592,794 $ 26,376 $ 26,166 ================ ================= ================ ================ FEDERATED KAUFMAN FIDELITY VIP ASSET MANAGER SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ------------------------------------ 2014 2013 2014 2013 ----------------- ---------------- ---------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ (636) $ (544) $ 100,270 $ 166,950 Net realized gains (losses)..... 5,260 3,616 5,093,370 806,245 Change in unrealized gains (losses) on investments....... (1,010) 9,524 (1,349,291) 10,480,801 ----------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from operations............ 3,614 12,596 3,844,349 11,453,996 ----------------- ---------------- ---------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... -- -- 1,446,073 1,646,197 Net transfers (including fixed account)...................... -- -- (804,686) (2,338,518) Contract charges................ -- -- (11,406) (12,381) Transfers for contract benefits and terminations.............. (1,268) (1,113) (7,771,050) (8,115,163) ----------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions...... (1,268) (1,113) (7,141,069) (8,819,865) ----------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets.............. 2,346 11,483 (3,296,720) 2,634,131 NET ASSETS: Beginning of year............... 44,907 33,424 88,274,483 85,640,352 ----------------- ---------------- ---------------- ----------------- End of year..................... $ 47,253 $ 44,907 $ 84,977,763 $ 88,274,483 ================= ================ ================ ================= FIDELITY VIP CONTRAFUND FIDELITY VIP EQUITY-INCOME SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ------------------------------------ 2014 2013 2014 2013 ---------------- ---------------- ----------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ (2,868,065) $ (1,697,392) $ 78,282 $ 58,439 Net realized gains (losses)..... 38,832,008 11,601,258 132,768 367,626 Change in unrealized gains (losses) on investments....... 25,038,910 130,225,189 191,058 916,971 ---------------- ---------------- ----------------- ----------------- Net increase (decrease) in net assets resulting from operations............ 61,002,853 140,129,055 402,108 1,343,036 ---------------- ---------------- ----------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... 21,736,852 46,614,319 49,080 24,011 Net transfers (including fixed account)...................... (14,481,072) (6,126,568) (33,795) (72,869) Contract charges................ (3,870,205) (2,923,183) -- -- Transfers for contract benefits and terminations.............. (44,412,621) (36,834,423) (695,665) (862,819) ---------------- ---------------- ----------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions...... (41,027,046) 730,145 (680,380) (911,677) ---------------- ---------------- ----------------- ----------------- Net increase (decrease) in net assets.............. 19,975,807 140,859,200 (278,272) 431,359 NET ASSETS: Beginning of year............... 611,972,926 471,113,726 5,954,600 5,523,241 ---------------- ---------------- ----------------- ----------------- End of year..................... $ 631,948,733 $ 611,972,926 $ 5,676,328 $ 5,954,600 ================ ================ ================= ================= FIDELITY VIP FUNDSMANAGER 50% SUB-ACCOUNT ----------------------------------- 2014 2013 ---------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ (14,599,004) $ (5,248,600) Net realized gains (losses)..... 27,093,983 10,771,735 Change in unrealized gains (losses) on investments....... 69,079,003 141,257,707 ---------------- ----------------- Net increase (decrease) in net assets resulting from operations............ 81,573,982 146,780,842 ---------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... -- -- Net transfers (including fixed account)...................... 1,509,904,970 1,474,414,428 Contract charges................ -- -- Transfers for contract benefits and terminations.............. (86,814,147) (31,224,567) ---------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions...... 1,423,090,823 1,443,189,861 ---------------- ----------------- Net increase (decrease) in net assets.............. 1,504,664,805 1,589,970,703 NET ASSETS: Beginning of year............... 2,033,793,788 443,823,085 ---------------- ----------------- End of year..................... $ 3,538,458,593 $ 2,033,793,788 ================ ================= (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. (c) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 60
485BPOS154th Page of 388TOC1stPreviousNextBottomJust 154th
The accompanying notes are an integral part of these financial statements. 61
485BPOS155th Page of 388TOC1stPreviousNextBottomJust 155th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2014 AND 2013 [Enlarge/Download Table] FIDELITY VIP FUNDSMANAGER 60% FIDELITY VIP GROWTH SUB-ACCOUNT SUB-ACCOUNT ------------------------------------ ----------------------------------- 2014 2013 2014 2013 ----------------- ----------------- ---------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ (29,738,597) $ (31,238,110) $ (1,960,390) $ (1,579,739) Net realized gains (losses)..... 151,088,720 171,159,819 6,685,051 4,112,179 Change in unrealized gains (losses) on investments....... 10,595,817 435,136,185 11,054,078 41,938,391 ----------------- ----------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from operations............ 131,945,940 575,057,894 15,778,739 44,470,831 ----------------- ----------------- ---------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... 2,544,619 5,496,546 3,540,118 3,349,924 Net transfers (including fixed account)...................... 18 -- (2,748,482) (5,049,310) Contract charges................ -- -- (20,848) (22,025) Transfers for contract benefits and terminations.............. (171,576,910) (145,663,704) (14,844,036) (13,580,293) ----------------- ----------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions...... (169,032,273) (140,167,158) (14,073,248) (15,301,704) ----------------- ----------------- ---------------- ----------------- Net increase (decrease) in net assets.............. (37,086,333) 434,890,736 1,705,491 29,169,127 NET ASSETS: Beginning of year............... 4,031,523,824 3,596,633,088 165,968,439 136,799,312 ----------------- ----------------- ---------------- ----------------- End of year..................... $ 3,994,437,491 $ 4,031,523,824 $ 167,673,930 $ 165,968,439 ================= ================= ================ ================= FIDELITY VIP INDEX 500 FIDELITY VIP MID CAP SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ------------------------------------ 2014 2013 2014 2013 ----------------- ---------------- ----------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ 166,965 $ 325,124 $ (5,926,090) $ (4,216,245) Net realized gains (losses)..... 2,968,155 2,857,955 15,800,518 56,577,725 Change in unrealized gains (losses) on investments....... 4,754,472 14,178,938 10,107,932 61,592,202 ----------------- ---------------- ----------------- ----------------- Net increase (decrease) in net assets resulting from operations............ 7,889,592 17,362,017 19,982,360 113,953,682 ----------------- ---------------- ----------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... -- -- 17,813,812 45,946,288 Net transfers (including fixed account)...................... (1,329,473) (2,603,865) (7,392,472) (13,593,184) Contract charges................ (22,548) (23,942) (4,591,308) (3,645,078) Transfers for contract benefits and terminations.............. (6,048,836) (6,041,583) (26,116,641) (20,912,658) ----------------- ---------------- ----------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions...... (7,400,857) (8,669,390) (20,286,609) 7,795,368 ----------------- ---------------- ----------------- ----------------- Net increase (decrease) in net assets.............. 488,735 8,692,627 (304,249) 121,749,050 NET ASSETS: Beginning of year............... 69,677,247 60,984,620 446,581,942 324,832,892 ----------------- ---------------- ----------------- ----------------- End of year..................... $ 70,165,982 $ 69,677,247 $ 446,277,693 $ 446,581,942 ================= ================ ================= ================= FIDELITY VIP MONEY MARKET FIDELITY VIP OVERSEAS SUB-ACCOUNT SUB-ACCOUNT ------------------------------------ ---------------------------------- 2014 2013 2014 2013 ---------------- ----------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ (1,616,300) $ (1,597,325) $ 2,417 $ 5,035 Net realized gains (losses)..... -- -- 60,145 11,595 Change in unrealized gains (losses) on investments....... -- -- (589,122) 1,380,290 ---------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ (1,616,300) (1,597,325) (526,560) 1,396,920 ---------------- ----------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... 1,490,641,290 1,482,045,626 91,282 83,529 Net transfers (including fixed account)...................... (1,511,055,592) (1,474,484,969) (55,632) (260,389) Contract charges................ (2,577) (3,153) (50) (46) Transfers for contract benefits and terminations.............. (3,174,519) (3,464,232) (491,815) (535,530) ---------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (23,591,398) 4,093,272 (456,215) (712,436) ---------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets.............. (25,207,698) 2,495,947 (982,775) 684,484 NET ASSETS: Beginning of year............... 76,155,346 73,659,399 5,925,521 5,241,037 ---------------- ----------------- ---------------- ---------------- End of year..................... $ 50,947,648 $ 76,155,346 $ 4,942,746 $ 5,925,521 ================ ================= ================ ================ FTVIPT FRANKLIN INCOME VIP SUB-ACCOUNT ----------------------------------- 2014 2013 ----------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ 11,034,456 $ 13,802,960 Net realized gains (losses)..... 2,072,298 335,927 Change in unrealized gains (losses) on investments....... (3,371,554) 18,152,582 ----------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 9,735,200 32,291,469 ----------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... 9,617,562 24,164,029 Net transfers (including fixed account)...................... 3,414,903 10,135,357 Contract charges................ (2,715,246) (2,217,562) Transfers for contract benefits and terminations.............. (22,963,961) (19,716,164) ----------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (12,646,742) 12,365,660 ----------------- ---------------- Net increase (decrease) in net assets.............. (2,911,542) 44,657,129 NET ASSETS: Beginning of year............... 297,821,470 253,164,341 ----------------- ---------------- End of year..................... $ 294,909,928 $ 297,821,470 ================= ================ (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. (c) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 62
485BPOS156th Page of 388TOC1stPreviousNextBottomJust 156th
The accompanying notes are an integral part of these financial statements. 63
485BPOS157th Page of 388TOC1stPreviousNextBottomJust 157th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2014 AND 2013 [Enlarge/Download Table] FTVIPT FRANKLIN FTVIPT FRANKLIN MUTUAL SHARES VIP SMALL CAP VALUE VIP SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ---------------------------------- 2014 2013 2014 2013 ---------------- ----------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ 966,423 $ 1,028,572 $ (907,377) $ (24,107) Net realized gains (losses)..... 4,318,435 1,531,390 11,252,700 3,335,986 Change in unrealized gains (losses) on investments....... 3,347,372 31,136,595 (11,208,452) 28,858,586 ---------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 8,632,230 33,696,557 (863,129) 32,170,465 ---------------- ----------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... 3,237,944 7,934,359 6,121,715 18,861,799 Net transfers (including fixed account)...................... (423,430) (3,863,825) 741,344 (3,726,532) Contract charges................ (1,293,554) (1,093,363) (1,402,055) (1,067,656) Transfers for contract benefits and terminations.............. (13,122,538) (10,375,719) (6,144,302) (4,485,166) ---------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (11,601,578) (7,398,548) (683,298) 9,582,445 ---------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets.............. (2,969,348) 26,298,009 (1,546,427) 41,752,910 NET ASSETS: Beginning of year............... 156,078,571 129,780,562 128,048,983 86,296,073 ---------------- ----------------- ---------------- ---------------- End of year..................... $ 153,109,223 $ 156,078,571 $ 126,502,556 $ 128,048,983 ================ ================= ================ ================ FTVIPT FTVIPT TEMPLETON FOREIGN VIP TEMPLETON GLOBAL BOND VIP SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ------------------------------------ 2014 2013 2014 2013 ----------------- ---------------- ---------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ 48,299 $ 479,595 $ 9,696,508 $ 8,251,988 Net realized gains (losses)..... 1,031,529 527,295 (97,489) 2,892,611 Change in unrealized gains (losses) on investments....... (11,682,571) 14,782,128 (8,236,911) (10,624,497) ----------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from operations............ (10,602,743) 15,789,018 1,362,108 520,102 ----------------- ---------------- ---------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... 661,634 1,244,169 8,661,712 31,796,531 Net transfers (including fixed account)...................... 3,823,200 (3,114,726) 3,812,491 20,195,269 Contract charges................ (893,355) (910,114) (2,805,331) (2,382,478) Transfers for contract benefits and terminations.............. (7,102,249) (6,075,431) (15,564,382) (12,509,439) ----------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions...... (3,510,770) (8,856,102) (5,895,510) 37,099,883 ----------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets.............. (14,113,513) 6,932,916 (4,533,402) 37,619,985 NET ASSETS: Beginning of year............... 87,721,293 80,788,377 254,683,414 217,063,429 ----------------- ---------------- ---------------- ----------------- End of year..................... $ 73,607,780 $ 87,721,293 $ 250,150,012 $ 254,683,414 ================= ================ ================ ================= INVESCO V.I. AMERICAN FRANCHISE INVESCO V.I. CORE EQUITY SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ------------------------------------ 2014 2013 2014 2013 ---------------- ---------------- ----------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ (724) $ (1,401) $ (1,321) $ (90) Net realized gains (losses)..... 46,339 4,184 14,144 11,977 Change in unrealized gains (losses) on investments....... (52,381) 44,589 2,433 45,509 ---------------- ---------------- ----------------- ----------------- Net increase (decrease) in net assets resulting from operations............ (6,766) 47,372 15,256 57,396 ---------------- ---------------- ----------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... -- -- -- -- Net transfers (including fixed account)...................... (131,317) (8,489) (16,139) (15,058) Contract charges................ -- -- -- -- Transfers for contract benefits and terminations.............. (10,523) (25,032) (16,835) (33,651) ---------------- ---------------- ----------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions...... (141,840) (33,521) (32,974) (48,709) ---------------- ---------------- ----------------- ----------------- Net increase (decrease) in net assets.............. (148,606) 13,851 (17,718) 8,687 NET ASSETS: Beginning of year............... 163,713 149,862 249,696 241,009 ---------------- ---------------- ----------------- ----------------- End of year..................... $ 15,107 $ 163,713 $ 231,978 $ 249,696 ================ ================ ================= ================= INVESCO V.I. EQUITY AND INCOME SUB-ACCOUNT ----------------------------------- 2014 2013 ---------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ 1,367,554 $ 960,409 Net realized gains (losses)..... 43,093,088 2,646,648 Change in unrealized gains (losses) on investments....... 2,305,377 115,194,853 ---------------- ----------------- Net increase (decrease) in net assets resulting from operations............ 46,766,019 118,801,910 ---------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... 31,728,304 67,597,697 Net transfers (including fixed account)...................... 11,169,077 8,022,603 Contract charges................ (6,221,284) (4,836,300) Transfers for contract benefits and terminations.............. (51,553,513) (37,208,806) ---------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions...... (14,877,416) 33,575,194 ---------------- ----------------- Net increase (decrease) in net assets.............. 31,888,603 152,377,104 NET ASSETS: Beginning of year............... 649,322,698 496,945,594 ---------------- ----------------- End of year..................... $ 681,211,301 $ 649,322,698 ================ ================= (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. (c) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 64
485BPOS158th Page of 388TOC1stPreviousNextBottomJust 158th
The accompanying notes are an integral part of these financial statements. 65
485BPOS159th Page of 388TOC1stPreviousNextBottomJust 159th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2014 AND 2013 [Enlarge/Download Table] IVY FUNDS VIP INVESCO V.I. GROWTH AND INCOME INVESCO V.I. INTERNATIONAL GROWTH ASSET STRATEGY SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ----------------------------------- ---------------- 2014 2013 2014 2013 2014 (a) ---------------- ----------------- ---------------- ----------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (1,560,512) $ (188,424) $ 93,550 $ (636,105) $ (6) Net realized gains (losses).... 119,593,645 5,964,860 3,452,220 1,305,822 -- Change in unrealized gains (losses) on investments...... (115,750,581) 81,951,879 (6,631,350) 40,017,340 (526) ---------------- ----------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from operations........... 2,282,552 87,728,315 (3,085,580) 40,687,057 (532) ---------------- ----------------- ---------------- ----------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 5,543,775 41,201,557 8,698,690 29,193,980 45,555 Net transfers (including fixed account)..................... (365,872,848) (9,892,159) 6,394,539 6,799,837 -- Contract charges............... (1,114,771) (3,013,438) (3,065,550) (2,450,016) -- Transfers for contract benefits and terminations............. (6,802,394) (18,283,675) (15,060,333) (12,015,352) -- ---------------- ----------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions..... (368,246,238) 10,012,285 (3,032,654) 21,528,449 45,555 ---------------- ----------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets............. (365,963,686) 97,740,600 (6,118,234) 62,215,506 45,023 NET ASSETS: Beginning of year.............. 365,970,613 268,230,013 281,999,206 219,783,700 -- ---------------- ----------------- ---------------- ----------------- ---------------- End of year.................... $ 6,927 $ 365,970,613 $ 275,880,972 $ 281,999,206 $ 45,023 ================ ================= ================ ================= ================ LMPVET CLEARBRIDGE LMPVET CLEARBRIDGE VARIABLE AGGRESSIVE GROWTH VARIABLE APPRECIATION SUB-ACCOUNT SUB-ACCOUNT ------------------------------------ ----------------------------------- 2014 2013 2014 2013 ----------------- ----------------- ---------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (3,780,649) $ (2,728,091) $ (882,810) $ (340,789) Net realized gains (losses).... 32,726,634 17,861,500 23,665,197 13,852,622 Change in unrealized gains (losses) on investments...... 22,284,631 71,695,365 14,760,295 72,638,328 ----------------- ----------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from operations........... 51,230,616 86,828,774 37,542,682 86,150,161 ----------------- ----------------- ---------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 21,151,291 26,964,170 20,094,287 47,967,753 Net transfers (including fixed account)..................... (10,983,120) (1,165,621) (5,501,606) 4,628,653 Contract charges............... (2,546,686) (1,696,014) (4,105,122) (3,067,660) Transfers for contract benefits and terminations............. (23,148,368) (17,174,971) (26,797,021) (20,584,065) ----------------- ----------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions..... (15,526,883) 6,927,564 (16,309,462) 28,944,681 ----------------- ----------------- ---------------- ----------------- Net increase (decrease) in net assets............. 35,703,733 93,756,338 21,233,220 115,094,842 NET ASSETS: Beginning of year.............. 280,745,200 186,988,862 405,286,221 290,191,379 ----------------- ----------------- ---------------- ----------------- End of year.................... $ 316,448,933 $ 280,745,200 $ 426,519,441 $ 405,286,221 ================= ================= ================ ================= LMPVET CLEARBRIDGE LMPVET CLEARBRIDGE VARIABLE EQUITY INCOME VARIABLE LARGE CAP GROWTH SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ----------------------------------- 2014 2013 2014 2013 ---------------- ----------------- ---------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 1,308,229 $ 427,485 $ (62,068) $ (58,170) Net realized gains (losses).... 4,299,834 646,901 919,739 745,423 Change in unrealized gains (losses) on investments...... 16,931,806 33,452,314 (332,781) 710,461 ---------------- ----------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from operations........... 22,539,869 34,526,700 524,890 1,397,714 ---------------- ----------------- ---------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 10,710,030 27,050,110 6,741 648 Net transfers (including fixed account)..................... (2,238,829) 8,008,781 (142,316) (33,103) Contract charges............... (1,903,736) (1,307,320) (16,298) (17,152) Transfers for contract benefits and terminations............. (14,703,505) (12,039,748) (753,806) (647,971) ---------------- ----------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions..... (8,136,040) 21,711,823 (905,679) (697,578) ---------------- ----------------- ---------------- ----------------- Net increase (decrease) in net assets............. 14,403,829 56,238,523 (380,789) 700,136 NET ASSETS: Beginning of year.............. 191,169,653 134,931,130 5,012,390 4,312,254 ---------------- ----------------- ---------------- ----------------- End of year.................... $ 205,573,482 $ 191,169,653 $ 4,631,601 $ 5,012,390 ================ ================= ================ ================= (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. (c) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 66
485BPOS160th Page of 388TOC1stPreviousNextBottomJust 160th
The accompanying notes are an integral part of these financial statements. 67
485BPOS161st Page of 388TOC1stPreviousNextBottomJust 161st
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2014 AND 2013 [Enlarge/Download Table] LMPVET PERMAL LMPVET CLEARBRIDGE LMPVET CLEARBRIDGE ALTERNATIVE SELECT VARIABLE LARGE CAP VALUE VARIABLE SMALL CAP GROWTH VIT PORTFOLIO SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ----------------------------------- ------------------ 2014 2013 2014 2013 2014 (a) ---------------- ----------------- ---------------- ----------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 16,424 $ 1,148 $ (1,543,659) $ (1,235,439) $ 972 Net realized gains (losses).... 826,518 466,613 14,861,960 8,864,593 -- Change in unrealized gains (losses) on investments...... (94,646) 1,056,824 (10,235,288) 24,881,277 314 ---------------- ----------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from operations........... 748,296 1,524,585 3,083,013 32,510,431 1,286 ---------------- ----------------- ---------------- ----------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 238,085 282,593 5,976,685 16,380,155 546,752 Net transfers (including fixed account)..................... 1,446,278 813,486 1,425,057 3,443,300 93,489 Contract charges............... (72,588) (46,356) (1,145,114) (824,479) -- Transfers for contract benefits and terminations............. (508,848) (424,843) (5,895,860) (3,891,881) (493) ---------------- ----------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions..... 1,102,927 624,880 360,768 15,107,095 639,748 ---------------- ----------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets............. 1,851,223 2,149,465 3,443,781 47,617,526 641,034 NET ASSETS: Beginning of year.............. 6,892,954 4,743,489 112,499,020 64,881,494 -- ---------------- ----------------- ---------------- ----------------- ---------------- End of year.................... $ 8,744,177 $ 6,892,954 $ 115,942,801 $ 112,499,020 $ 641,034 ================ ================= ================ ================= ================ LMPVET LMPVET VARIABLE LIFESTYLE ALLOCATION 50% VARIABLE LIFESTYLE ALLOCATION 70% SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ---------------------------------- 2014 2013 2014 2013 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 486,044 $ 335,965 $ 2,410 $ (5,215) Net realized gains (losses).... 1,019,129 294,643 134,694 164,204 Change in unrealized gains (losses) on investments...... (36,134) 4,402,903 (62,721) 307,412 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations........... 1,469,039 5,033,511 74,383 466,401 ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 2,274,676 6,821,630 120 120 Net transfers (including fixed account)..................... (1,127,378) 3,040,842 (34,510) 208,852 Contract charges............... (425,453) (323,071) (636) (702) Transfers for contract benefits and terminations............. (3,956,813) (3,091,539) (420,518) (943,181) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions..... (3,234,968) 6,447,862 (455,544) (734,911) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets............. (1,765,929) 11,481,373 (381,161) (268,510) NET ASSETS: Beginning of year.............. 44,101,401 32,620,028 2,304,999 2,573,509 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 42,335,472 $ 44,101,401 $ 1,923,838 $ 2,304,999 ================ ================ ================ ================ LMPVET LMPVIT WESTERN ASSET VARIABLE LIFESTYLE ALLOCATION 85% VARIABLE GLOBAL HIGH YIELD BOND SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ---------------------------------- 2014 2013 2014 2013 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 373,623 $ 265,832 $ 6,032,375 $ 4,754,059 Net realized gains (losses).... 5,434,643 1,739,917 113,974 97,460 Change in unrealized gains (losses) on investments...... (2,807,313) 17,385,552 (8,718,909) (303,455) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations........... 3,000,953 19,391,301 (2,572,560) 4,548,064 ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 2,747,741 3,896,642 3,068,117 12,043,147 Net transfers (including fixed account)..................... (1,896,512) (70,391) 6,130,634 6,173,096 Contract charges............... (856,409) (739,142) (923,174) (741,652) Transfers for contract benefits and terminations............. (5,309,837) (7,221,465) (9,801,780) (9,054,116) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions..... (5,315,017) (4,134,356) (1,526,203) 8,420,475 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets............. (2,314,064) 15,256,945 (4,098,763) 12,968,539 NET ASSETS: Beginning of year.............. 95,074,284 79,817,339 104,740,451 91,771,912 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 92,760,220 $ 95,074,284 $ 100,641,688 $ 104,740,451 ================ ================ ================ ================ (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. (c) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 68
485BPOS162nd Page of 388TOC1stPreviousNextBottomJust 162nd
The accompanying notes are an integral part of these financial statements. 69
485BPOS163rd Page of 388TOC1stPreviousNextBottomJust 163rd
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2014 AND 2013 [Enlarge/Download Table] MFS VIT INVESTORS TRUST MFS VIT NEW DISCOVERY SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ----------------------------------- 2014 2013 2014 2013 ----------------- ---------------- ----------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ (113) $ (69) $ (579) $ (581) Net realized gains (losses)..... 7,432 292 8,966 2,006 Change in unrealized gains (losses) on investments....... (6,574) 5,877 (12,305) 12,769 ----------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 745 6,100 (3,918) 14,194 ----------------- ---------------- ----------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... -- -- -- -- Net transfers (including fixed account)...................... -- -- -- -- Contract charges................ -- -- -- -- Transfers for contract benefits and terminations.............. (17,077) (637) (1,495) (9,835) ----------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (17,077) (637) (1,495) (9,835) ----------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets.............. (16,332) 5,463 (5,413) 4,359 NET ASSETS: Beginning of year............... 25,951 20,488 46,020 41,661 ----------------- ---------------- ----------------- ---------------- End of year..................... $ 9,619 $ 25,951 $ 40,607 $ 46,020 ================= ================ ================= ================ MIST ALLIANZ GLOBAL MIST ALLIANCEBERNSTEIN INVESTORS DYNAMIC MFS VIT RESEARCH GLOBAL DYNAMIC ALLOCATION MULTI-ASSET PLUS SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ----------------------------------- ----------------- 2014 2013 2014 2013 2014 (b) ---------------- ---------------- ---------------- ----------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ (295) $ (610) $ 17,462,736 $ (4,610,871) $ 4,824 Net realized gains (losses)..... 19,157 1,133 91,273,198 73,047,817 171,321 Change in unrealized gains (losses) on investments....... (16,582) 14,560 81,273,478 213,779,983 67,003 ---------------- ---------------- ---------------- ----------------- ----------------- Net increase (decrease) in net assets resulting from operations............ 2,280 15,083 190,009,412 282,216,929 243,148 ---------------- ---------------- ---------------- ----------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... -- -- 55,989,983 248,776,609 10,740,886 Net transfers (including fixed account)...................... (19,607) -- (21,381,907) 93,377,580 8,194,795 Contract charges................ -- -- (48,104,869) (43,781,572) (41,475) Transfers for contract benefits and terminations.............. (19,937) (1,403) (116,695,473) (90,758,771) (150,898) ---------------- ---------------- ---------------- ----------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions...... (39,544) (1,403) (130,192,266) 207,613,846 18,743,308 ---------------- ---------------- ---------------- ----------------- ----------------- Net increase (decrease) in net assets.............. (37,264) 13,680 59,817,146 489,830,775 18,986,456 NET ASSETS: Beginning of year............... 63,835 50,155 3,313,674,192 2,823,843,417 -- ---------------- ---------------- ---------------- ----------------- ----------------- End of year..................... $ 26,571 $ 63,835 $ 3,373,491,338 $ 3,313,674,192 $ 18,986,456 ================ ================ ================ ================= ================= MIST AMERICAN FUNDS MIST AMERICAN FUNDS BALANCED ALLOCATION GROWTH ALLOCATION SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ----------------------------------- 2014 2013 2014 2013 ---------------- ----------------- ----------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss).... $ (9,274,974) $ (5,388,861) $ (9,929,733) $ (9,394,519) Net realized gains (losses)..... 378,474,453 250,625,904 311,427,666 121,285,044 Change in unrealized gains (losses) on investments....... (221,142,935) 260,897,780 (216,740,668) 233,109,626 ---------------- ----------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 148,056,544 506,134,823 84,757,265 345,000,151 ---------------- ----------------- ----------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners.......... 25,164,897 29,549,572 16,363,073 19,707,302 Net transfers (including fixed account)...................... 81,773,177 (8,307,267) 52,035,269 66,168,229 Contract charges................ (39,628,718) (37,993,157) (19,090,909) (16,411,723) Transfers for contract benefits and terminations.............. (227,918,364) (165,057,262) (110,126,406) (82,807,176) ---------------- ----------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (160,609,008) (181,808,114) (60,818,973) (13,343,368) ---------------- ----------------- ----------------- ---------------- Net increase (decrease) in net assets.............. (12,552,464) 324,326,709 23,938,292 331,656,783 NET ASSETS: Beginning of year............... 3,430,387,038 3,106,060,329 1,828,322,375 1,496,665,592 ---------------- ----------------- ----------------- ---------------- End of year..................... $ 3,417,834,574 $ 3,430,387,038 $ 1,852,260,667 $ 1,828,322,375 ================ ================= ================= ================ (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. (c) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 70
485BPOS164th Page of 388TOC1stPreviousNextBottomJust 164th
The accompanying notes are an integral part of these financial statements. 71
485BPOS165th Page of 388TOC1stPreviousNextBottomJust 165th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2014 AND 2013 [Enlarge/Download Table] MIST AMERICAN FUNDS MIST AMERICAN FUNDS GROWTH MODERATE ALLOCATION SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ---------------------------------- 2014 2013 2014 2013 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (6,163,898) $ (6,517,995) $ (1,287,876) $ 2,016,609 Net realized gains (losses).... 58,138,021 55,767,296 176,763,916 119,968,172 Change in unrealized gains (losses) on investments...... (11,947,440) 96,031,643 (97,636,993) 74,888,275 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations........... 40,026,683 145,280,944 77,839,047 196,873,056 ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 23,913,774 14,629,823 12,830,009 17,989,884 Net transfers (including fixed account)..................... 213,217 (37,937,636) 1,602,305 (30,931,042) Contract charges............... (6,974,136) (6,691,159) (21,095,644) (21,278,076) Transfers for contract benefits and terminations............. (40,894,690) (28,561,135) (123,385,571) (100,612,790) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions..... (23,741,835) (58,560,107) (130,048,901) (134,832,024) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets............. 16,284,848 86,720,837 (52,209,854) 62,041,032 NET ASSETS: Beginning of year.............. 632,386,636 545,665,799 1,796,366,977 1,734,325,945 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 648,671,484 $ 632,386,636 $ 1,744,157,123 $ 1,796,366,977 ================ ================ ================ ================ MIST BLACKROCK MIST AQR GLOBAL RISK BALANCED GLOBAL TACTICAL STRATEGIES SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ---------------------------------- 2014 2013 2014 2013 ---------------- ----------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (45,442,328) $ 24,454,360 $ (16,420,373) $ (3,617,558) Net realized gains (losses).... 23,650,336 131,410,280 326,148,796 133,255,577 Change in unrealized gains (losses) on investments...... 108,694,006 (347,099,092) (72,592,431) 311,060,284 ---------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations........... 86,902,014 (191,234,452) 237,135,992 440,698,303 ---------------- ----------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 29,606,314 299,929,057 84,068,820 411,567,881 Net transfers (including fixed account)..................... (204,080,674) (449,932,361) (84,585,142) (28,640,096) Contract charges............... (46,773,091) (50,307,360) (78,223,830) (73,176,143) Transfers for contract benefits and terminations............. (112,828,345) (113,288,370) (192,637,569) (149,396,119) ---------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions..... (334,075,796) (313,599,034) (271,377,721) 160,355,523 ---------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets............. (247,173,782) (504,833,486) (34,241,729) 601,053,826 NET ASSETS: Beginning of year.............. 3,248,475,977 3,753,309,463 5,457,878,761 4,856,824,935 ---------------- ----------------- ---------------- ---------------- End of year.................... $ 3,001,302,195 $ 3,248,475,977 $ 5,423,637,032 $ 5,457,878,761 ================ ================= ================ ================ MIST BLACKROCK HIGH YIELD MIST CLARION GLOBAL REAL ESTATE SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ---------------------------------- 2014 2013 2014 2013 ----------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 12,025,813 $ 14,596,196 $ (1,485,527) $ 9,853,299 Net realized gains (losses).... 12,716,800 9,642,339 1,432,009 (92,999) Change in unrealized gains (losses) on investments...... (19,968,507) (4,631,091) 29,887,079 (6,455,197) ----------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations........... 4,774,106 19,607,444 29,833,561 3,305,103 ----------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 6,303,734 13,943,237 4,948,277 1,804,117 Net transfers (including fixed account)..................... (14,899,754) (26,718,376) 137,827,843 14,576,022 Contract charges............... (2,737,425) (2,612,849) (2,672,557) (1,769,594) Transfers for contract benefits and terminations............. (20,374,580) (16,046,952) (22,432,403) (12,559,683) ----------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions..... (31,708,025) (31,434,940) 117,671,160 2,050,862 ----------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets............. (26,933,919) (11,827,496) 147,504,721 5,355,965 NET ASSETS: Beginning of year.............. 265,149,806 276,977,302 182,673,922 177,317,957 ----------------- ---------------- ---------------- ---------------- End of year.................... $ 238,215,887 $ 265,149,806 $ 330,178,643 $ 182,673,922 ================= ================ ================ ================ MIST CLEARBRIDGE AGGRESSIVE GROWTH SUB-ACCOUNT ---------------------------------- 2014 2013 ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (8,056,394) $ (5,039,430) Net realized gains (losses).... 36,635,069 11,473,473 Change in unrealized gains (losses) on investments...... 56,948,433 123,052,679 ---------------- ---------------- Net increase (decrease) in net assets resulting from operations........... 85,527,108 129,486,722 ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 5,690,997 5,418,106 Net transfers (including fixed account)..................... 90,599,582 52,077,391 Contract charges............... (4,874,183) (3,110,264) Transfers for contract benefits and terminations............. (42,081,564) (25,033,154) ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions..... 49,334,832 29,352,079 ---------------- ---------------- Net increase (decrease) in net assets............. 134,861,940 158,838,801 NET ASSETS: Beginning of year.............. 451,710,565 292,871,764 ---------------- ---------------- End of year.................... $ 586,572,505 $ 451,710,565 ================ ================ (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. (c) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 72
485BPOS166th Page of 388TOC1stPreviousNextBottomJust 166th
The accompanying notes are an integral part of these financial statements. 73
485BPOS167th Page of 388TOC1stPreviousNextBottomJust 167th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2014 AND 2013 [Enlarge/Download Table] MIST MIST GOLDMAN SACHS MID CAP VALUE HARRIS OAKMARK INTERNATIONAL SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ---------------------------------- 2014 2013 2014 2013 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (1,829,907) $ (1,173,155) $ 5,671,683 $ 5,201,015 Net realized gains (losses).... 34,906,259 12,013,375 74,815,977 11,702,177 Change in unrealized gains (losses) on investments...... (14,180,162) 31,704,368 (131,491,626) 134,182,838 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 18,896,190 42,544,588 (51,003,966) 151,086,030 ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 1,617,745 1,260,840 13,222,191 17,704,175 Net transfers (including fixed account)..................... 6,895,267 158,750 67,256,961 27,865,479 Contract charges............... (1,396,608) (1,323,450) (6,242,202) (5,353,619) Transfers for contract benefits and terminations............. (17,538,311) (11,814,121) (53,706,976) (36,258,075) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (10,421,907) (11,717,981) 20,529,974 3,957,960 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. 8,474,283 30,826,607 (30,473,992) 155,043,990 NET ASSETS: Beginning of year.............. 170,038,386 139,211,779 693,983,244 538,939,254 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 178,512,669 $ 170,038,386 $ 663,509,252 $ 693,983,244 ================ ================ ================ ================ MIST INVESCO BALANCED-RISK ALLOCATION MIST INVESCO COMSTOCK SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ---------------------------------- 2014 2013 2014 2013 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (11,534,041) $ (12,158,692) $ (5,948,017) $ (1,674,772) Net realized gains (losses).... 40,501,882 10,077,015 19,778,596 9,703,108 Change in unrealized gains (losses) on investments...... 4,357,344 4,078,692 42,690,949 101,696,056 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 33,325,185 1,997,015 56,521,528 109,724,392 ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 46,938,907 168,173,765 18,779,139 20,478,377 Net transfers (including fixed account)..................... (45,599,752) 45,607,989 351,468,472 11,030,539 Contract charges............... (11,948,746) (10,692,799) (6,851,970) (3,417,107) Transfers for contract benefits and terminations............. (33,501,846) (23,347,690) (50,479,016) (23,713,080) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (44,111,437) 179,741,265 312,916,625 4,378,729 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. (10,786,252) 181,738,280 369,438,153 114,103,121 NET ASSETS: Beginning of year.............. 843,160,697 661,422,417 443,561,923 329,458,802 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 832,374,445 $ 843,160,697 $ 813,000,076 $ 443,561,923 ================ ================ ================ ================ MIST INVESCO MID CAP VALUE MIST INVESCO SMALL CAP GROWTH SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ---------------------------------- 2014 2013 2014 2013 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (2,692,440) $ (1,314,553) $ (4,813,204) $ (3,674,573) Net realized gains (losses).... 32,283,294 7,722,920 47,750,149 24,585,422 Change in unrealized gains (losses) on investments...... (9,866,841) 30,620,411 (24,251,382) 67,501,884 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 19,724,013 37,028,778 18,685,563 88,412,733 ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 5,541,819 2,155,363 6,584,864 10,016,335 Net transfers (including fixed account)..................... 91,176,014 (10,011,007) (5,472,948) 1,587,973 Contract charges............... (2,498,611) (1,678,656) (2,652,796) (2,269,655) Transfers for contract benefits and terminations............. (13,576,001) (7,603,595) (27,691,755) (19,026,821) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... 80,643,221 (17,137,895) (29,232,635) (9,692,168) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. 100,367,234 19,890,883 (10,547,072) 78,720,565 NET ASSETS: Beginning of year.............. 158,040,375 138,149,492 319,189,345 240,468,780 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 258,407,609 $ 158,040,375 $ 308,642,273 $ 319,189,345 ================ ================ ================ ================ MIST JPMORGAN CORE BOND SUB-ACCOUNT ---------------------------------- 2014 2013 ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (418,668) $ (4,238,910) Net realized gains (losses).... 1,294,863 24,886,829 Change in unrealized gains (losses) on investments...... 10,102,500 (36,171,178) ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 10,978,695 (15,523,259) ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 2,044,373 2,386,585 Net transfers (including fixed account)..................... 58,496,687 1,463,200 Contract charges............... (3,817,976) (3,775,856) Transfers for contract benefits and terminations............. (24,333,751) (19,173,185) ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... 32,389,333 (19,099,256) ---------------- ---------------- Net increase (decrease) in net assets.............. 43,368,028 (34,622,515) NET ASSETS: Beginning of year.............. 311,869,932 346,492,447 ---------------- ---------------- End of year.................... $ 355,237,960 $ 311,869,932 ================ ================ (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. (c) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 74
485BPOS168th Page of 388TOC1stPreviousNextBottomJust 168th
The accompanying notes are an integral part of these financial statements. 75
485BPOS169th Page of 388TOC1stPreviousNextBottomJust 169th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2014 AND 2013 [Enlarge/Download Table] MIST JPMORGAN GLOBAL ACTIVE ALLOCATION MIST JPMORGAN SMALL CAP VALUE SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ----------------------------------- 2014 2013 2014 2013 ---------------- ---------------- ----------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (2,333,867) $ (6,934,561) $ (184,083) $ (280,527) Net realized gains (losses).... 27,540,298 2,430,024 4,065,482 1,241,336 Change in unrealized gains (losses) on investments...... 19,805,708 53,369,009 (3,083,282) 6,048,540 ---------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from operations........... 45,012,139 48,864,472 798,117 7,009,349 ---------------- ---------------- ----------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 61,831,643 122,948,435 375,799 370,757 Net transfers (including fixed account)..................... 91,593,515 313,227,408 1,061,177 (1,450,951) Contract charges............... (12,087,064) (6,988,131) (294,244) (290,764) Transfers for contract benefits and terminations............. (27,224,492) (13,774,602) (1,874,915) (1,786,801) ---------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions..... 114,113,602 415,413,110 (732,183) (3,157,759) ---------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets............. 159,125,741 464,277,582 65,934 3,851,590 NET ASSETS: Beginning of year.............. 746,849,717 282,572,135 27,866,566 24,014,976 ---------------- ---------------- ----------------- ---------------- End of year.................... $ 905,975,458 $ 746,849,717 $ 27,932,500 $ 27,866,566 ================ ================ ================= ================ MIST LOOMIS SAYLES GLOBAL MARKETS MIST LORD ABBETT BOND DEBENTURE SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ---------------------------------- 2014 2013 2014 2013 ---------------- ----------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 903,964 $ 1,519,876 $ 10,384,873 $ 12,964,602 Net realized gains (losses).... 5,851,208 5,872,725 10,876,570 4,166,635 Change in unrealized gains (losses) on investments...... (3,452,819) 18,236,473 (13,286,737) (1,363,498) ---------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations........... 3,302,353 25,629,074 7,974,706 15,767,739 ---------------- ----------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 1,804,342 2,604,900 2,605,721 2,945,951 Net transfers (including fixed account)..................... 6,834,599 (13,383,801) (8,200,868) 3,690,479 Contract charges............... (1,718,440) (1,759,667) (1,568,374) (1,551,965) Transfers for contract benefits and terminations............. (13,467,605) (10,275,135) (25,529,114) (27,568,008) ---------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions..... (6,547,104) (22,813,703) (32,692,635) (22,483,543) ---------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets............. (3,244,751) 2,815,371 (24,717,929) (6,715,804) NET ASSETS: Beginning of year.............. 180,595,781 177,780,410 259,294,487 266,010,291 ---------------- ----------------- ---------------- ---------------- End of year.................... $ 177,351,030 $ 180,595,781 $ 234,576,558 $ 259,294,487 ================ ================= ================ ================ MIST MET/FRANKLIN MIST MET/EATON VANCE FLOATING RATE LOW DURATION TOTAL RETURN SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ----------------------------------- 2014 2013 2014 2013 ----------------- ---------------- ---------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 1,659,223 $ 1,167,863 $ 1,030,348 $ (409,213) Net realized gains (losses).... 211,258 371,454 (132,806) 31,429 Change in unrealized gains (losses) on investments...... (2,518,686) (202,111) (1,819,015) 351,282 ----------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from operations........... (648,205) 1,337,206 (921,473) (26,502) ----------------- ---------------- ---------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 1,192,071 1,243,464 2,090,130 2,247,876 Net transfers (including fixed account)..................... (1,922,295) 31,075,652 46,451,435 100,397,861 Contract charges............... (776,640) (606,811) (2,104,842) (860,351) Transfers for contract benefits and terminations............. (7,051,558) (4,130,678) (12,697,479) (5,061,682) ----------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions..... (8,558,422) 27,581,627 33,739,244 96,723,704 ----------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets............. (9,206,627) 28,918,833 32,817,771 96,697,202 NET ASSETS: Beginning of year.............. 83,115,837 54,197,004 140,307,146 43,609,944 ----------------- ---------------- ---------------- ----------------- End of year.................... $ 73,909,210 $ 83,115,837 $ 173,124,917 $ 140,307,146 ================= ================ ================ ================= MIST MET/TEMPLETON INTERNATIONAL BOND SUB-ACCOUNT ---------------------------------- 2014 2013 ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 1,574,302 $ 276,907 Net realized gains (losses).... (178,047) 98,819 Change in unrealized gains (losses) on investments...... (1,505,639) (752,953) ---------------- ---------------- Net increase (decrease) in net assets resulting from operations........... (109,384) (377,227) ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 226,823 293,635 Net transfers (including fixed account)..................... (1,575,024) (1,527,452) Contract charges............... (654,339) (704,031) Transfers for contract benefits and terminations............. (2,990,340) (2,400,039) ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions..... (4,992,880) (4,337,887) ---------------- ---------------- Net increase (decrease) in net assets............. (5,102,264) (4,715,114) NET ASSETS: Beginning of year.............. 52,286,139 57,001,253 ---------------- ---------------- End of year.................... $ 47,183,875 $ 52,286,139 ================ ================ (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. (c) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 76
485BPOS170th Page of 388TOC1stPreviousNextBottomJust 170th
The accompanying notes are an integral part of these financial statements. 77
485BPOS171st Page of 388TOC1stPreviousNextBottomJust 171st
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2014 AND 2013 [Enlarge/Download Table] MIST METLIFE ASSET ALLOCATION 100 MIST METLIFE BALANCED PLUS SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ----------------------------------- 2014 2013 2014 2013 ---------------- ---------------- ---------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (5,850,777) $ (5,162,875) $ 23,588,127 $ (12,169,666) Net realized gains (losses).... 16,294,442 8,803,988 552,071,894 109,386,034 Change in unrealized gains (losses) on investments...... 11,631,228 141,558,132 (36,064,867) 560,925,735 ---------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from operations............ 22,074,893 145,199,245 539,595,154 658,142,103 ---------------- ---------------- ---------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 6,121,321 6,117,615 180,291,226 512,612,376 Net transfers (including fixed account)..................... 4,111,278 344,230 440,513,036 934,128,079 Contract charges............... (4,988,560) (4,668,056) (95,398,763) (75,280,741) Transfers for contract benefits and terminations............. (45,715,642) (32,065,600) (251,273,497) (168,084,256) ---------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions...... (40,471,603) (30,271,811) 274,132,002 1,203,375,458 ---------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets.............. (18,396,710) 114,927,434 813,727,156 1,861,517,561 NET ASSETS: Beginning of year.............. 659,971,504 545,044,070 6,454,726,976 4,593,209,415 ---------------- ---------------- ---------------- ----------------- End of year.................... $ 641,574,794 $ 659,971,504 $ 7,268,454,132 $ 6,454,726,976 ================ ================ ================ ================= MIST METLIFE MULTI-INDEX TARGETED RISK MIST METLIFE SMALL CAP VALUE SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ----------------------------------- 2014 2013 2014 2013 ---------------- ---------------- ---------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (4,724,040) $ (699,118) $ (4,819,875) $ (1,972,508) Net realized gains (losses).... 1,441,000 3,617,087 28,733,355 14,422,998 Change in unrealized gains (losses) on investments...... 28,321,809 7,257,662 (23,969,258) 71,078,415 ---------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from operations............ 25,038,769 10,175,631 (55,778) 83,528,905 ---------------- ---------------- ---------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 39,107,524 48,451,797 2,163,105 2,497,715 Net transfers (including fixed account)..................... 164,988,787 142,884,678 (7,179,469) (16,141,981) Contract charges............... (4,851,352) (796,188) (2,208,499) (2,257,569) Transfers for contract benefits and terminations............. (12,726,825) (2,006,845) (32,407,421) (24,465,425) ---------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions...... 186,518,134 188,533,442 (39,632,284) (40,367,260) ---------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets.............. 211,556,903 198,709,073 (39,688,062) 43,161,645 NET ASSETS: Beginning of year.............. 209,957,052 11,247,979 330,701,962 287,540,317 ---------------- ---------------- ---------------- ----------------- End of year.................... $ 421,513,955 $ 209,957,052 $ 291,013,900 $ 330,701,962 ================ ================ ================ ================= MIST MFS EMERGING MARKETS EQUITY MIST MFS RESEARCH INTERNATIONAL SUB-ACCOUNT SUB-ACCOUNT ------------------------------------ ---------------------------------- 2014 2013 2014 2013 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (3,159,826) $ (2,103,697) $ 2,090,191 $ 3,181,971 Net realized gains (losses).... 2,820,880 1,835,792 1,753,034 522,322 Change in unrealized gains (losses) on investments...... (35,285,750) (28,154,915) (30,446,779) 47,772,611 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ (35,624,696) (28,422,820) (26,603,554) 51,476,904 ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 7,559,248 18,621,868 4,632,660 5,992,222 Net transfers (including fixed account)..................... 29,309,475 44,696,703 6,352,582 (11,184,676) Contract charges............... (4,822,730) (4,647,330) (2,468,848) (2,476,702) Transfers for contract benefits and terminations............. (26,878,803) (22,864,787) (25,488,292) (23,934,709) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... 5,167,190 35,806,454 (16,971,898) (31,603,865) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. (30,457,506) 7,383,634 (43,575,452) 19,873,039 NET ASSETS: Beginning of year.............. 456,076,892 448,693,258 331,488,461 311,615,422 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 425,619,386 $ 456,076,892 $ 287,913,009 $ 331,488,461 ================ ================ ================ ================ MIST MORGAN STANLEY MID CAP GROWTH SUB-ACCOUNT ---------------------------------- 2014 2013 ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (3,409,470) $ (1,696,520) Net realized gains (losses).... 5,684,794 2,455,142 Change in unrealized gains (losses) on investments...... (2,736,107) 64,718,433 ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ (460,783) 65,477,055 ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 11,815,143 30,911,631 Net transfers (including fixed account)..................... 261,603 (5,530,092) Contract charges............... (2,627,209) (2,046,240) Transfers for contract benefits and terminations............. (13,039,300) (10,333,215) ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (3,589,763) 13,002,084 ---------------- ---------------- Net increase (decrease) in net assets.............. (4,050,546) 78,479,139 NET ASSETS: Beginning of year.............. 244,579,234 166,100,095 ---------------- ---------------- End of year.................... $ 240,528,688 $ 244,579,234 ================ ================ (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. (c) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 78
485BPOS172nd Page of 388TOC1stPreviousNextBottomJust 172nd
The accompanying notes are an integral part of these financial statements. 79
485BPOS173rd Page of 388TOC1stPreviousNextBottomJust 173rd
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2014 AND 2013 [Enlarge/Download Table] MIST PANAGORA GLOBAL MIST PIMCO MIST OPPENHEIMER GLOBAL EQUITY DIVERSIFIED RISK INFLATION PROTECTED BOND SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ---------------- ---------------------------------- 2014 2013 2014 (b) 2014 2013 ---------------- ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (389,294) $ (523,132) $ (23,522) $ (314,897) $ 5,656,555 Net realized gains (losses).... 3,495,793 471,553 207,621 (10,840,115) 44,720,235 Change in unrealized gains (losses) on investments...... (2,567,600) 11,622,690 (153,203) 22,930,848 (156,230,192) ---------------- ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 538,899 11,571,111 30,896 11,775,836 (105,853,402) ---------------- ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 399,861 974,476 2,980,950 5,645,359 7,816,286 Net transfers (including fixed account)..................... 480,602 59,782,304 7,342,567 (42,539,161) (33,502,041) Contract charges............... (525,821) (334,651) (46,489) (8,436,136) (9,760,980) Transfers for contract benefits and terminations............. (6,941,115) (3,578,136) (146,280) (55,305,583) (58,283,070) ---------------- ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (6,586,473) 56,843,993 10,130,748 (100,635,521) (93,729,805) ---------------- ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. (6,047,574) 68,415,104 10,161,644 (88,859,685) (199,583,207) NET ASSETS: Beginning of year.............. 78,398,573 9,983,469 -- 821,456,089 1,021,039,296 ---------------- ---------------- ---------------- ---------------- ---------------- End of year.................... $ 72,350,999 $ 78,398,573 $ 10,161,644 $ 732,596,404 $ 821,456,089 ================ ================ ================ ================ ================ MIST PIMCO TOTAL RETURN MIST PIONEER FUND SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ---------------------------------- 2014 2013 2014 2013 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 14,856,202 $ 57,226,440 $ 817,446 $ 4,682,697 Net realized gains (losses).... (1,792,640) 42,284,668 87,911,473 4,614,621 Change in unrealized gains (losses) on investments...... 36,415,773 (175,186,613) (61,223,094) 61,555,660 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 49,479,335 (75,675,505) 27,505,825 70,852,978 ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 14,074,315 23,558,528 9,637,842 28,240,878 Net transfers (including fixed account)..................... (98,518,340) (36,143,738) (8,227,980) (4,702,128) Contract charges............... (20,347,053) (21,824,762) (3,315,269) (2,681,923) Transfers for contract benefits and terminations............. (151,437,179) (130,498,036) (17,438,624) (13,997,790) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (256,228,257) (164,908,008) (19,344,031) 6,859,037 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. (206,748,922) (240,583,513) 8,161,794 77,712,015 NET ASSETS: Beginning of year.............. 1,993,786,948 2,234,370,461 297,755,670 220,043,655 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 1,787,038,026 $ 1,993,786,948 $ 305,917,464 $ 297,755,670 ================ ================ ================ ================ MIST PIONEER STRATEGIC INCOME MIST PYRAMIS GOVERNMENT INCOME SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ---------------------------------- 2014 2013 2014 2013 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 34,258,738 $ 30,105,308 $ 8,253,807 $ 1,187,173 Net realized gains (losses).... 12,258,413 3,348,132 (2,556,572) 2,758,477 Change in unrealized gains (losses) on investments...... (17,661,136) (32,752,219) 34,979,601 (56,847,411) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 28,856,015 701,221 40,676,836 (52,901,761) ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 28,345,716 95,062,807 3,770,560 63,436,489 Net transfers (including fixed account)..................... 42,682,881 81,921,721 (28,818,734) (213,162,045) Contract charges............... (9,619,195) (7,949,861) (10,709,776) (12,240,571) Transfers for contract benefits and terminations............. (65,741,442) (55,184,071) (40,212,165) (38,279,793) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (4,332,040) 113,850,596 (75,970,115) (200,245,920) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. 24,523,975 114,551,817 (35,293,279) (253,147,681) NET ASSETS: Beginning of year.............. 919,328,857 804,777,040 715,739,557 968,887,238 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 943,852,832 $ 919,328,857 $ 680,446,278 $ 715,739,557 ================ ================ ================ ================ (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. (c) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 80
485BPOS174th Page of 388TOC1stPreviousNextBottomJust 174th
The accompanying notes are an integral part of these financial statements. 81
485BPOS175th Page of 388TOC1stPreviousNextBottomJust 175th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2014 AND 2013 [Enlarge/Download Table] MIST PYRAMIS MANAGED RISK MIST SCHRODERS GLOBAL MULTI-ASSET SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ----------------------------------- 2014 2013 (c) 2014 2013 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (1,731,736) $ 251,733 $ (428,408) $ (4,795,245) Net realized gains (losses).... 515,242 1,330,956 18,517,553 2,079,740 Change in unrealized gains (losses) on investments...... 9,325,602 1,889,489 10,370,401 31,029,531 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 8,109,108 3,472,178 28,459,546 28,314,026 ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 21,094,105 11,152,445 19,796,572 68,362,808 Net transfers (including fixed account)..................... 61,855,680 64,918,197 32,175,596 161,034,274 Contract charges............... (1,600,359) (309,972) (6,709,852) (4,470,986) Transfers for contract benefits and terminations............. (4,362,374) (815,619) (15,546,572) (9,919,594) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... 76,987,052 74,945,051 29,715,744 215,006,502 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. 85,096,160 78,417,229 58,175,290 243,320,528 NET ASSETS: Beginning of year.............. 78,417,229 -- 435,205,689 191,885,161 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 163,513,389 $ 78,417,229 $ 493,380,979 $ 435,205,689 ================ ================ ================ ================ MIST SSGA GROWTH AND INCOME ETF MIST SSGA GROWTH ETF SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ---------------------------------- 2014 2013 2014 2013 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 11,253,551 $ 15,406,854 $ 1,691,616 $ 2,717,724 Net realized gains (losses).... 113,377,455 56,799,502 41,161,005 25,386,819 Change in unrealized gains (losses) on investments...... (60,416,484) 92,923,301 (24,023,767) 44,458,197 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 64,214,522 165,129,657 18,828,854 72,562,740 ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 10,439,074 11,860,244 6,532,143 5,978,512 Net transfers (including fixed account)..................... (25,023,322) (37,705,533) (3,398,510) 6,512,325 Contract charges............... (18,124,397) (18,210,457) (5,200,778) (4,933,205) Transfers for contract benefits and terminations............. (95,978,922) (64,397,713) (24,564,862) (18,680,473) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (128,687,567) (108,453,459) (26,632,007) (11,122,841) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. (64,473,045) 56,676,198 (7,803,153) 61,439,899 NET ASSETS: Beginning of year.............. 1,578,178,677 1,521,502,479 509,607,858 448,167,959 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 1,513,705,632 $ 1,578,178,677 $ 501,804,705 $ 509,607,858 ================ ================ ================ ================ MIST MIST T. ROWE PRICE LARGE CAP VALUE T. ROWE PRICE MID CAP GROWTH SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ---------------------------------- 2014 2013 2014 2013 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (2,592,578) $ 274,524 $ (8,684,292) $ (7,216,909) Net realized gains (losses).... 22,160,919 12,380,070 83,347,675 44,126,921 Change in unrealized gains (losses) on investments...... 67,563,377 154,938,541 (17,691,662) 116,792,789 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 87,131,718 167,593,135 56,971,721 153,702,801 ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 12,253,858 7,988,896 3,338,843 4,862,681 Net transfers (including fixed account)..................... 159,566,655 4,058,593 (37,998,561) (21,028,467) Contract charges............... (4,113,653) (3,122,742) (4,959,686) (4,805,296) Transfers for contract benefits and terminations............. (73,966,475) (55,363,943) (48,648,856) (31,385,247) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... 93,740,385 (46,439,196) (88,268,260) (52,356,329) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. 180,872,103 121,153,939 (31,296,539) 101,346,472 NET ASSETS: Beginning of year.............. 657,944,319 536,790,380 568,882,747 467,536,275 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 838,816,422 $ 657,944,319 $ 537,586,208 $ 568,882,747 ================ ================ ================ ================ MIST WMC LARGE CAP RESEARCH SUB-ACCOUNT ---------------------------------- 2014 2013 ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (152,311) $ (69,719) Net realized gains (losses).... 962,687 843,040 Change in unrealized gains (losses) on investments...... 1,050,584 3,552,916 ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 1,860,960 4,326,237 ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 307,777 654,278 Net transfers (including fixed account)..................... (607,575) (847,332) Contract charges............... (197,017) (180,167) Transfers for contract benefits and terminations............. (973,400) (1,522,513) ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (1,470,215) (1,895,734) ---------------- ---------------- Net increase (decrease) in net assets.............. 390,745 2,430,503 NET ASSETS: Beginning of year.............. 16,869,650 14,439,147 ---------------- ---------------- End of year.................... $ 17,260,395 $ 16,869,650 ================ ================ (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. (c) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 82
485BPOS176th Page of 388TOC1stPreviousNextBottomJust 176th
The accompanying notes are an integral part of these financial statements. 83
485BPOS177th Page of 388TOC1stPreviousNextBottomJust 177th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2014 AND 2013 [Enlarge/Download Table] MSF BAILLIE GIFFORD INTERNATIONAL STOCK MSF BARCLAYS AGGREGATE BOND INDEX SUB-ACCOUNT SUB-ACCOUNT ------------------------------------ ----------------------------------- 2014 2013 2014 2013 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (823,308) $ (3,165,848) $ 2,129,181 $ 2,684,004 Net realized gains (losses).... 2,816,068 1,385,436 (108,055) (145,067) Change in unrealized gains (losses) on investments...... (15,452,332) 31,198,214 4,954,438 (8,883,122) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ (13,459,572) 29,417,802 6,975,564 (6,344,185) ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 1,436,654 1,422,162 9,707,112 11,149,289 Net transfers (including fixed account)..................... 324,776 282,688,482 51,418,453 15,951,296 Contract charges............... (3,197,760) (2,205,156) (2,153,905) (1,698,851) Transfers for contract benefits and terminations............. (19,054,714) (10,455,850) (15,043,074) (8,039,466) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (20,491,044) 271,449,638 43,928,586 17,362,268 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. (33,950,616) 300,867,440 50,904,150 11,018,083 NET ASSETS: Beginning of year.............. 303,453,047 2,585,607 162,571,849 151,553,766 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 269,502,431 $ 303,453,047 $ 213,475,999 $ 162,571,849 ================ ================ ================ ================ MSF MSF BLACKROCK BOND INCOME BLACKROCK CAPITAL APPRECIATION SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ---------------------------------- 2014 2013 2014 2013 ----------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 952,581 $ 1,256,228 $ (221,645) $ (112,438) Net realized gains (losses).... 40,190 1,515,855 1,124,532 691,188 Change in unrealized gains (losses) on investments...... 2,001,494 (4,322,733) 32,868 3,229,055 ----------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 2,994,265 (1,550,650) 935,755 3,807,805 ----------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 2,147,683 5,100,261 465,737 1,032,741 Net transfers (including fixed account)..................... 6,751,669 1,673,798 (848,033) (69,939) Contract charges............... (621,824) (567,749) (110,785) (108,766) Transfers for contract benefits and terminations............. (4,908,655) (5,292,686) (1,028,588) (1,221,109) ----------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... 3,368,873 913,624 (1,521,669) (367,073) ----------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. 6,363,138 (637,026) (585,914) 3,440,732 NET ASSETS: Beginning of year.............. 57,251,907 57,888,933 15,272,342 11,831,610 ----------------- ---------------- ---------------- ---------------- End of year.................... $ 63,615,045 $ 57,251,907 $ 14,686,428 $ 15,272,342 ================= ================ ================ ================ MSF BLACKROCK LARGE CAP VALUE MSF BLACKROCK MONEY MARKET SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ---------------------------------- 2014 2013 2014 2013 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (2,636) $ 1,769 $ (6,766,906) $ (8,012,597) Net realized gains (losses).... 921,265 196,427 -- -- Change in unrealized gains (losses) on investments...... (583,420) 706,190 -- -- ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 335,209 904,386 (6,766,906) (8,012,597) ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 187,882 170,505 16,019,042 35,808,232 Net transfers (including fixed account)..................... 257,815 180,009 38,236,997 (7,315,471) Contract charges............... (155) (147) (4,868,193) (5,349,795) Transfers for contract benefits and terminations............. (372,113) (439,359) (108,077,463) (122,897,380) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... 73,429 (88,992) (58,689,617) (99,754,414) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. 408,638 815,394 (65,456,523) (107,767,011) NET ASSETS: Beginning of year.............. 3,792,926 2,977,532 461,342,890 569,109,901 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 4,201,564 $ 3,792,926 $ 395,886,367 $ 461,342,890 ================ ================ ================ ================ MSF FRONTIER MID CAP GROWTH SUB-ACCOUNT ----------------------------------- 2014 2013 (c) ---------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (1,322,869) $ (897,791) Net realized gains (losses).... 9,730,209 1,222,819 Change in unrealized gains (losses) on investments...... (1,239,505) 14,503,587 ---------------- ----------------- Net increase (decrease) in net assets resulting from operations............ 7,167,835 14,828,615 ---------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 593,698 339,204 Net transfers (including fixed account)..................... (3,064,927) 73,026,037 Contract charges............... (703,442) (461,156) Transfers for contract benefits and terminations............. (6,346,789) (4,081,537) ---------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions...... (9,521,460) 68,822,548 ---------------- ----------------- Net increase (decrease) in net assets.............. (2,353,625) 83,651,163 NET ASSETS: Beginning of year.............. 83,651,163 -- ---------------- ----------------- End of year.................... $ 81,297,538 $ 83,651,163 ================ ================= (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. (c) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 84
485BPOS178th Page of 388TOC1stPreviousNextBottomJust 178th
The accompanying notes are an integral part of these financial statements. 85
485BPOS179th Page of 388TOC1stPreviousNextBottomJust 179th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2014 AND 2013 [Enlarge/Download Table] MSF JENNISON GROWTH MSF LOOMIS SAYLES SMALL CAP CORE SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ---------------------------------- 2014 2013 2014 2013 ---------------- ----------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (8,604,142) $ (7,335,002) $ (241,088) $ (200,052) Net realized gains (losses).... 57,107,511 20,299,862 2,320,935 1,982,997 Change in unrealized gains (losses) on investments...... (11,083,979) 145,943,839 (1,853,055) 2,464,698 ---------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations........... 37,419,390 158,908,699 226,792 4,247,643 ---------------- ----------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 2,880,660 3,447,603 156,508 344,417 Net transfers (including fixed account)..................... (44,484,377) (2,923,592) (366,480) (1,074,960) Contract charges............... (4,133,996) (3,962,178) (175,842) (173,285) Transfers for contract benefits and terminations............. (48,285,573) (38,611,159) (745,280) (1,065,267) ---------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions..... (94,023,286) (42,049,326) (1,131,094) (1,969,095) ---------------- ----------------- ---------------- ---------------- Net increase (decrease) in net assets............. (56,603,896) 116,859,373 (904,302) 2,278,548 NET ASSETS: Beginning of year.............. 585,624,219 468,764,846 14,610,773 12,332,225 ---------------- ----------------- ---------------- ---------------- End of year.................... $ 529,020,323 $ 585,624,219 $ 13,706,471 $ 14,610,773 ================ ================= ================ ================ MSF LOOMIS SAYLES SMALL CAP GROWTH MSF MET/ARTISAN MID CAP VALUE SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ----------------------------------- 2014 2013 2014 2013 ---------------- ---------------- ----------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (2,894) $ (1,411) $ (2,770,312) $ (2,081,656) Net realized gains (losses).... 33,035 10,812 9,182,228 2,704,503 Change in unrealized gains (losses) on investments...... (27,964) 37,804 (6,138,938) 71,939,639 ---------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from operations........... 2,177 47,205 272,978 72,562,486 ---------------- ---------------- ----------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 34,767 71,019 2,279,317 2,406,731 Net transfers (including fixed account)..................... 33,954 72,654 (15,880,836) 15,760,862 Contract charges............... (817) (292) (1,707,607) (1,572,787) Transfers for contract benefits and terminations............. (3,450) (4,711) (26,349,339) (20,643,858) ---------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions..... 64,454 138,670 (41,658,465) (4,049,052) ---------------- ---------------- ----------------- ---------------- Net increase (decrease) in net assets............. 66,631 185,875 (41,385,487) 68,513,434 NET ASSETS: Beginning of year.............. 226,802 40,927 285,771,010 217,257,576 ---------------- ---------------- ----------------- ---------------- End of year.................... $ 293,433 $ 226,802 $ 244,385,523 $ 285,771,010 ================ ================ ================= ================ MSF MET/DIMENSIONAL INTERNATIONAL SMALL COMPANY MSF METLIFE ASSET ALLOCATION 20 SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ----------------------------------- 2014 2013 2014 2013 ---------------- ---------------- ---------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 265,996 $ 75,530 $ (93,420) $ 123,598 Net realized gains (losses).... 4,114,623 2,053,871 589,830 324,295 Change in unrealized gains (losses) on investments...... (9,176,434) 11,472,763 (85,239) (227,599) ---------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from operations........... (4,795,815) 13,602,164 411,171 220,294 ---------------- ---------------- ---------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 815,496 946,915 365,589 -- Net transfers (including fixed account)..................... 191,200 2,187,268 35,836,944 (726,171) Contract charges............... (593,152) (559,879) (223,118) (83,224) Transfers for contract benefits and terminations............. (3,606,060) (2,632,342) (2,200,451) (1,568,517) ---------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions..... (3,192,516) (58,038) 33,778,964 (2,377,912) ---------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets............. (7,988,331) 13,544,126 34,190,135 (2,157,618) NET ASSETS: Beginning of year.............. 66,162,419 52,618,293 7,497,408 9,655,026 ---------------- ---------------- ---------------- ----------------- End of year.................... $ 58,174,088 $ 66,162,419 $ 41,687,543 $ 7,497,408 ================ ================ ================ ================= MSF METLIFE ASSET ALLOCATION 40 SUB-ACCOUNT ---------------------------------- 2014 2013 ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (56,436,952) $ 60,178 Net realized gains (losses).... 14,979,444 205,663 Change in unrealized gains (losses) on investments...... 181,094,658 395,866 ---------------- ---------------- Net increase (decrease) in net assets resulting from operations........... 139,637,150 661,707 ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 12,615,751 -- Net transfers (including fixed account)..................... 5,139,621,026 151,035 Contract charges............... (34,412,284) (63,032) Transfers for contract benefits and terminations............. (273,737,211) (594,121) ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions..... 4,844,087,282 (506,118) ---------------- ---------------- Net increase (decrease) in net assets............. 4,983,724,432 155,589 NET ASSETS: Beginning of year.............. 7,732,376 7,576,787 ---------------- ---------------- End of year.................... $ 4,991,456,808 $ 7,732,376 ================ ================ (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. (c) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 86
485BPOS180th Page of 388TOC1stPreviousNextBottomJust 180th
The accompanying notes are an integral part of these financial statements. 87
485BPOS181st Page of 388TOC1stPreviousNextBottomJust 181st
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2014 AND 2013 [Enlarge/Download Table] MSF METLIFE ASSET ALLOCATION 60 MSF METLIFE ASSET ALLOCATION 80 SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ---------------------------------- 2014 2013 2014 2013 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (82,508,224) $ 111,426 $ (72,919,925) $ (147,761) Net realized gains (losses).... 19,715,684 1,018,931 18,208,146 927,158 Change in unrealized gains (losses) on investments...... 325,337,909 5,244,250 313,139,176 10,180,246 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 262,545,369 6,374,607 258,427,397 10,959,643 ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 24,283,519 333,489 24,181,255 209,284 Net transfers (including fixed account)..................... 7,634,512,209 189,896 6,518,639,731 (1,014,032) Contract charges............... (48,104,618) (368,244) (40,179,976) (511,319) Transfers for contract benefits and terminations............. (389,900,744) (3,563,775) (310,434,847) (4,103,646) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... 7,220,790,366 (3,408,634) 6,192,206,163 (5,419,713) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. 7,483,335,735 2,965,973 6,450,633,560 5,539,930 NET ASSETS: Beginning of year.............. 44,655,421 41,689,448 57,260,787 51,720,857 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 7,527,991,156 $ 44,655,421 $ 6,507,894,347 $ 57,260,787 ================ ================ ================ ================ MSF METLIFE MID CAP STOCK INDEX MSF METLIFE STOCK INDEX SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ---------------------------------- 2014 2013 2014 2013 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (819,673) $ (566,013) $ (765,841) $ 126,616 Net realized gains (losses).... 11,559,694 6,964,753 38,987,719 23,490,755 Change in unrealized gains (losses) on investments...... (1,212,992) 23,599,476 23,647,160 106,939,595 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 9,527,029 29,998,216 61,869,038 130,556,966 ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 3,512,620 3,805,517 7,247,240 9,905,483 Net transfers (including fixed account)..................... (1,166,141) 9,018,341 32,842,922 10,729,964 Contract charges............... (1,039,460) (966,588) (3,860,753) (3,364,435) Transfers for contract benefits and terminations............. (8,982,254) (4,961,109) (48,542,701) (33,312,519) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (7,675,235) 6,896,161 (12,313,292) (16,041,507) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. 1,851,794 36,894,377 49,555,746 114,515,459 NET ASSETS: Beginning of year.............. 125,884,078 88,989,701 561,274,487 446,759,028 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 127,735,872 $ 125,884,078 $ 610,830,233 $ 561,274,487 ================ ================ ================ ================ MSF MFS TOTAL RETURN MSF MFS VALUE SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ---------------------------------- 2014 2013 2014 2013 ----------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 314,570 $ 297,490 $ (57,616) $ (1,920,146) Net realized gains (losses).... 1,124,465 439,651 18,672,716 5,190,690 Change in unrealized gains (losses) on investments...... 1,597,039 5,520,960 2,950,546 43,048,658 ----------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 3,036,074 6,258,101 21,565,646 46,319,202 ----------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 2,026,445 2,347,250 3,231,894 3,226,292 Net transfers (including fixed account)..................... 695,451 5,946,371 (9,606,231) 176,696,995 Contract charges............... (252,458) (195,752) (2,466,657) (1,727,489) Transfers for contract benefits and terminations............. (5,732,469) (3,656,176) (17,796,650) (12,316,297) ----------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (3,263,031) 4,441,693 (26,637,644) 165,879,501 ----------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. (226,957) 10,699,794 (5,071,998) 212,198,703 NET ASSETS: Beginning of year.............. 46,044,412 35,344,618 260,473,964 48,275,261 ----------------- ---------------- ---------------- ---------------- End of year.................... $ 45,817,455 $ 46,044,412 $ 255,401,966 $ 260,473,964 ================= ================ ================ ================ MSF MSCI EAFE INDEX SUB-ACCOUNT ---------------------------------- 2014 2013 ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 991,218 $ 1,388,628 Net realized gains (losses).... 2,887,187 1,008,944 Change in unrealized gains (losses) on investments...... (11,944,228) 15,456,919 ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ (8,065,823) 17,854,491 ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 2,309,427 3,337,616 Net transfers (including fixed account)..................... 4,727,833 14,653,612 Contract charges............... (974,058) (946,782) Transfers for contract benefits and terminations............. (8,971,260) (4,106,316) ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (2,908,058) 12,938,130 ---------------- ---------------- Net increase (decrease) in net assets.............. (10,973,881) 30,792,621 NET ASSETS: Beginning of year.............. 112,197,169 81,404,548 ---------------- ---------------- End of year.................... $ 101,223,288 $ 112,197,169 ================ ================ (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. (c) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 88
485BPOS182nd Page of 388TOC1stPreviousNextBottomJust 182nd
The accompanying notes are an integral part of these financial statements. 89
485BPOS183rd Page of 388TOC1stPreviousNextBottomJust 183rd
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2014 AND 2013 [Enlarge/Download Table] MSF NEUBERGER BERMAN GENESIS MSF RUSSELL 2000 INDEX SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ----------------------------------- 2014 2013 2014 2013 ---------------- ---------------- ---------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (2,176,457) $ (1,702,008) $ (798,862) $ (279,727) Net realized gains (losses).... 4,329,229 2,307,614 8,367,458 2,980,519 Change in unrealized gains (losses) on investments...... (5,677,025) 36,584,374 (3,199,788) 32,072,788 ---------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from operations............ (3,524,253) 37,189,980 4,368,808 34,773,580 ---------------- ---------------- ---------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 1,992,969 1,534,745 2,652,120 3,036,517 Net transfers (including fixed account)..................... (5,425,832) 130,824,603 5,859,193 17,108,088 Contract charges............... (1,280,963) (883,958) (1,176,186) (979,907) Transfers for contract benefits and terminations............. (13,905,156) (8,216,818) (7,916,247) (4,618,795) ---------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions...... (18,618,982) 123,258,572 (581,120) 14,545,903 ---------------- ---------------- ---------------- ----------------- Net increase (decrease) in net assets.............. (22,143,235) 160,448,552 3,787,688 49,319,483 NET ASSETS: Beginning of year.............. 172,247,460 11,798,908 141,070,458 91,750,975 ---------------- ---------------- ---------------- ----------------- End of year.................... $ 150,104,225 $ 172,247,460 $ 144,858,146 $ 141,070,458 ================ ================ ================ ================= MSF MSF T. ROWE PRICE LARGE CAP GROWTH T. ROWE PRICE SMALL CAP GROWTH SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ---------------------------------- 2014 2013 2014 2013 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (2,482,158) $ (1,361,307) $ (153,247) $ (118,410) Net realized gains (losses).... 14,393,834 1,274,164 1,464,690 1,190,765 Change in unrealized gains (losses) on investments...... (1,397,928) 29,734,972 (830,342) 2,047,671 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 10,513,748 29,647,829 481,101 3,120,026 ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 2,948,471 1,216,598 281,198 217,643 Net transfers (including fixed account)..................... 17,437,802 125,845,085 (504,932) 76,680 Contract charges............... (1,330,553) (670,738) (62,439) (65,804) Transfers for contract benefits and terminations............. (14,540,202) (5,610,315) (741,321) (634,727) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... 4,515,518 120,780,630 (1,027,494) (406,208) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. 15,029,266 150,428,459 (546,393) 2,713,818 NET ASSETS: Beginning of year.............. 151,930,071 1,501,612 10,522,813 7,808,995 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 166,959,337 $ 151,930,071 $ 9,976,420 $ 10,522,813 ================ ================ ================ ================ MSF WESTERN ASSET MANAGEMENT MSF STRATEGIC BOND MSF WESTERN ASSET VAN ECK GLOBAL NATURAL RESOURCES OPPORTUNITIES MANAGEMENT U.S. GOVERNMENT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ----------------------------------- ----------------- ----------------------------------- 2014 2013 2014 (a) 2014 2013 ---------------- ----------------- ----------------- ---------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (1,294,356) $ (992,724) $ (5) $ 697,614 $ 1,546,993 Net realized gains (losses).... 1,787,878 (2,668,683) -- (3,865) 12,769 Change in unrealized gains (losses) on investments...... (19,515,189) 13,797,608 48 2,454,211 (8,825,000) ---------------- ----------------- ----------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from operations............ (19,021,667) 10,136,201 43 3,147,960 (7,265,238) ---------------- ----------------- ----------------- ---------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 402,973 944,635 12,700 5,112,381 17,581,036 Net transfers (including fixed account)..................... 8,185,185 (11,189,728) -- 2,857,487 (7,036,962) Contract charges............... (1,298,545) (1,460,573) -- (3,072,371) (3,057,823) Transfers for contract benefits and terminations............. (5,429,317) (3,878,019) -- (23,830,183) (21,660,910) ---------------- ----------------- ----------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions...... 1,860,296 (15,583,685) 12,700 (18,932,686) (14,174,659) ---------------- ----------------- ----------------- ---------------- ----------------- Net increase (decrease) in net assets.............. (17,161,371) (5,447,484) 12,743 (15,784,726) (21,439,897) NET ASSETS: Beginning of year.............. 106,449,499 111,896,983 -- 291,870,388 313,310,285 ---------------- ----------------- ----------------- ---------------- ----------------- End of year.................... $ 89,288,128 $ 106,449,499 $ 12,743 $ 276,085,662 $ 291,870,388 ================ ================= ================= ================ ================= (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. (c) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 90
485BPOS184th Page of 388TOC1stPreviousNextBottomJust 184th
The accompanying notes are an integral part of these financial statements. 91
485BPOS185th Page of 388TOC1stPreviousNextBottomJust 185th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2014 AND 2013 [Enlarge/Download Table] MSF WMC CORE EQUITY OPPORTUNITIES NEUBERGER BERMAN GENESIS SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ---------------------------------- 2014 2013 2014 2013 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (6,367,120) $ (2,024,413) $ (88) $ (53) Net realized gains (losses).... 91,018,865 40,523,317 1,471 749 Change in unrealized gains (losses) on investments...... (33,491,386) 130,538,788 (1,551) 2,197 ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 51,160,359 169,037,692 (168) 2,893 ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 3,408,051 5,918,436 -- -- Net transfers (including fixed account)..................... (44,285,835) (37,323,562) -- -- Contract charges............... (4,874,727) (4,862,149) -- -- Transfers for contract benefits and terminations............. (54,954,173) (46,536,304) (1,810) (3) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (100,706,684) (82,803,579) (1,810) (3) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. (49,546,325) 86,234,113 (1,978) 2,890 NET ASSETS: Beginning of year.............. 658,561,438 572,327,325 10,991 8,101 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 609,015,113 $ 658,561,438 $ 9,013 $ 10,991 ================ ================ ================ ================ OPPENHEIMER VA OPPENHEIMER VA CORE BOND GLOBAL STRATEGIC INCOME SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ---------------------------------- 2014 2013 2014 2013 ---------------- ---------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 347 $ 335 $ 133 $ 164 Net realized gains (losses).... (267) (126) 5 8 Change in unrealized gains (losses) on investments...... 416 (342) (73) (240) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 496 (133) 65 (68) ---------------- ---------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... -- -- -- -- Net transfers (including fixed account)..................... -- -- -- -- Contract charges............... -- -- -- -- Transfers for contract benefits and terminations............. (796) (279) (1) (2) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (796) (279) (1) (2) ---------------- ---------------- ---------------- ---------------- Net increase (decrease) in net assets.............. (300) (412) 64 (70) NET ASSETS: Beginning of year.............. 8,646 9,058 4,492 4,562 ---------------- ---------------- ---------------- ---------------- End of year.................... $ 8,346 $ 8,646 $ 4,556 $ 4,492 ================ ================ ================ ================ OPPENHEIMER VA MAIN STREET SMALL CAP OPPENHEIMER VA MAIN STREET SUB-ACCOUNT SUB-ACCOUNT --------------------------------- ---------------------------------- 2014 2013 2014 2013 ---------------- --------------- ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (875,296) $ (725,297) $ (589) $ (280) Net realized gains (losses).... 21,968,724 6,330,488 5,285 1,403 Change in unrealized gains (losses) on investments...... (9,177,366) 30,298,071 4,566 23,373 ---------------- --------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ 11,916,062 35,903,262 9,262 24,496 ---------------- --------------- ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 3,589,850 7,423,119 -- -- Net transfers (including fixed account)..................... (3,769,755) (9,338,929) -- -- Contract charges............... (1,193,884) (1,036,361) -- -- Transfers for contract benefits and terminations............. (7,121,166) (5,997,839) (7,216) (4,120) ---------------- --------------- ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (8,494,955) (8,950,010) (7,216) (4,120) ---------------- --------------- ---------------- ---------------- Net increase (decrease) in net assets.............. 3,421,107 26,953,252 2,046 20,376 NET ASSETS: Beginning of year.............. 123,045,407 96,092,155 104,039 83,663 ---------------- --------------- ---------------- ---------------- End of year.................... $ 126,466,514 $ 123,045,407 $ 106,085 $ 104,039 ================ =============== ================ ================ OPPENHEIMER VA MONEY SUB-ACCOUNT ---------------------------------- 2014 2013 ---------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ (53) $ (102) Net realized gains (losses).... -- -- Change in unrealized gains (losses) on investments...... -- -- ---------------- ---------------- Net increase (decrease) in net assets resulting from operations............ (53) (102) ---------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... -- -- Net transfers (including fixed account)..................... -- -- Contract charges............... -- -- Transfers for contract benefits and terminations............. (154) (108,863) ---------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions...... (154) (108,863) ---------------- ---------------- Net increase (decrease) in net assets.............. (207) (108,965) NET ASSETS: Beginning of year.............. 4,000 112,965 ---------------- ---------------- End of year.................... $ 3,793 $ 4,000 ================ ================ (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. (c) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 92
485BPOS186th Page of 388TOC1stPreviousNextBottomJust 186th
The accompanying notes are an integral part of these financial statements. 93
485BPOS187th Page of 388TOC1stPreviousNextBottomJust 187th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF CHANGES IN NET ASSETS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2014 AND 2013 [Enlarge/Download Table] PIMCO VIT COMMODITY- PIMCO VIT PIMCO VIT REALRETURN EMERGING UNCONSTRAINED STRATEGY MARKET BOND BOND PIONEER VCT MID CAP SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT VALUE SUB-ACCOUNT ----------------- ---------------- ----------------- ----------------------------------- 2014 (a) 2014 (a) 2014 (a) 2014 2013 ----------------- ---------------- ----------------- ----------------- ---------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 11 $ 29 $ -- $ (535,991) $ (422,216) Net realized gains (losses).... -- -- -- 11,686,087 856,609 Change in unrealized gains (losses) on investments...... (1,741) 76 (4) (2,093,671) 16,961,029 ----------------- ---------------- ----------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from operations........... (1,730) 105 (4) 9,056,425 17,395,422 ----------------- ---------------- ----------------- ----------------- ---------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 14,900 15,098 4,763 2,291,113 5,065,892 Net transfers (including fixed account)..................... -- -- -- (1,539,510) (2,540,776) Contract charges............... -- -- -- (602,056) (481,800) Transfers for contract benefits and terminations............. -- (1) -- (6,203,018) (3,983,623) ----------------- ---------------- ----------------- ----------------- ---------------- Net increase (decrease) in net assets resulting from contract transactions..... 14,900 15,097 4,763 (6,053,471) (1,940,307) ----------------- ---------------- ----------------- ----------------- ---------------- Net increase (decrease) in net assets............. 13,170 15,202 4,759 3,002,954 15,455,115 NET ASSETS: Beginning of year.............. -- -- -- 71,900,042 56,444,927 ----------------- ---------------- ----------------- ----------------- ---------------- End of year.................... $ 13,170 $ 15,202 $ 4,759 $ 74,902,996 $ 71,900,042 ================= ================ ================= ================= ================ PIONEER VCT REAL ESTATE SHARES T. ROWE PRICE GROWTH STOCK SUB-ACCOUNT SUB-ACCOUNT ------------------------------------ ----------------------------------- 2014 2013 2014 2013 ----------------- ----------------- ---------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 1,768 $ 1,359 $ (68,593) $ (60,820) Net realized gains (losses).... 47,876 18,057 1,582,180 357,589 Change in unrealized gains (losses) on investments...... 16,387 (19,131) (938,069) 2,047,793 ----------------- ----------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from operations........... 66,031 285 575,518 2,344,562 ----------------- ----------------- ---------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 305 895 239,809 219,130 Net transfers (including fixed account)..................... (41,306) 17,963 (718,459) (113,852) Contract charges............... (3,087) (2,841) (1,508) (1,536) Transfers for contract benefits and terminations............. (24,717) (1,163) (922,810) (513,697) ----------------- ----------------- ---------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions..... (68,805) 14,854 (1,402,968) (409,955) ----------------- ----------------- ---------------- ----------------- Net increase (decrease) in net assets............. (2,774) 15,139 (827,450) 1,934,607 NET ASSETS: Beginning of year.............. 252,653 237,514 8,339,192 6,404,585 ----------------- ----------------- ---------------- ----------------- End of year.................... $ 249,879 $ 252,653 $ 7,511,742 $ 8,339,192 ================= ================= ================ ================= T. ROWE PRICE INTERNATIONAL STOCK T. ROWE PRICE PRIME RESERVE SUB-ACCOUNT SUB-ACCOUNT ---------------------------------- ------------------------------------ 2014 2013 2014 2013 ---------------- ---------------- ----------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)... $ 1,560 $ 503 $ (5,357) $ (6,339) Net realized gains (losses).... 23,491 10,324 -- -- Change in unrealized gains (losses) on investments...... (35,473) 71,247 -- -- ---------------- ---------------- ----------------- ----------------- Net increase (decrease) in net assets resulting from operations........... (10,422) 82,074 (5,357) (6,339) ---------------- ---------------- ----------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners......... 33,720 21,103 -- 208 Net transfers (including fixed account)..................... (46,190) (7,638) 24,583 (93,657) Contract charges............... (139) (151) (128) (155) Transfers for contract benefits and terminations............. (9,346) (79,868) (63,332) (64,754) ---------------- ---------------- ----------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions..... (21,955) (66,554) (38,877) (158,358) ---------------- ---------------- ----------------- ----------------- Net increase (decrease) in net assets............. (32,377) 15,520 (44,234) (164,697) NET ASSETS: Beginning of year.............. 655,401 639,881 558,449 723,146 ---------------- ---------------- ----------------- ----------------- End of year.................... $ 623,024 $ 655,401 $ 514,215 $ 558,449 ================ ================ ================= ================= (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. (c) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 94
485BPOS188th Page of 388TOC1stPreviousNextBottomJust 188th
The accompanying notes are an integral part of these financial statements. 95
485BPOS189th Page of 388TOC1stPreviousNextBottomJust 189th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA STATEMENTS OF CHANGES IN NET ASSETS -- (CONCLUDED) FOR THE YEARS ENDED DECEMBER 31, 2014 AND 2013 [Enlarge/Download Table] VAN ECK VIP TAP 1919 VARIABLE SOCIALLY UIF GLOBAL LONG/SHORT RESPONSIVE BALANCED INFRASTRUCTURE EQUITY INDEX SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------------------------ ----------------- ----------------- 2014 2013 2014 (a) 2014 (a) ----------------- ----------------- ----------------- ----------------- INCREASE (DECREASE) IN NET ASSETS: FROM OPERATIONS: Net investment income (loss)......................... $ (1,774) $ (2,213) $ (4) $ (10) Net realized gains (losses).......................... 44,532 8,209 -- -- Change in unrealized gains (losses) on investments............................ (24,999) 39,556 44 80 ----------------- ----------------- ----------------- ----------------- Net increase (decrease) in net assets resulting from operations................................. 17,759 45,552 40 70 ----------------- ----------------- ----------------- ----------------- CONTRACT TRANSACTIONS: Purchase payments received from contract owners............................... 1,080 -- 8,425 16,699 Net transfers (including fixed account)........................................... (33,535) 9,338 -- -- Contract charges..................................... (128) (130) -- -- Transfers for contract benefits and terminations................................... (23,622) (51,803) -- -- ----------------- ----------------- ----------------- ----------------- Net increase (decrease) in net assets resulting from contract transactions........................... (56,205) (42,595) 8,425 16,699 ----------------- ----------------- ----------------- ----------------- Net increase (decrease) in net assets................................... (38,446) 2,957 8,465 16,769 NET ASSETS: Beginning of year.................................... 292,286 289,329 -- -- ----------------- ----------------- ----------------- ----------------- End of year.......................................... $ 253,840 $ 292,286 $ 8,465 $ 16,769 ================= ================= ================= ================= (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. (c) For the period April 29, 2013 to December 31, 2013. The accompanying notes are an integral part of these financial statements. 96
485BPOS190th Page of 388TOC1stPreviousNextBottomJust 190th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA NOTES TO THE FINANCIAL STATEMENTS 1. ORGANIZATION MetLife Investors USA Separate Account A (the "Separate Account"), a separate account of MetLife Insurance Company USA (the "Company"), was established by the Board of Directors of MetLife Investors USA Insurance Company ("MLI-USA") on May 29, 1980 to support operations of MLI-USA with respect to certain variable annuity contracts (the "Contracts"). On November 14, 2014, MLI-USA merged into MetLife Insurance Company of Connecticut, which subsequently changed its name to MetLife Insurance Company USA and its state of domicile to Delaware, and the Separate Account became a separate account of the Company. The Company is a direct wholly-owned subsidiary of MetLife, Inc., a Delaware corporation. The Separate Account is registered as a unit investment trust under the Investment Company Act of 1940, as amended, and exists in accordance with the regulations of the Delaware Department of Insurance. The Separate Account is divided into Sub-Accounts, each of which is treated as an individual accounting entity for financial reporting purposes. Each Sub-Account invests in shares of the corresponding portfolio, series or fund (with the same name) of registered investment management companies (the "Trusts"), which are presented below: [Enlarge/Download Table] AIM Variable Insurance Funds (Invesco Variable Met Investors Series Trust ("MIST")* Insurance Funds) ("Invesco V.I.") Metropolitan Series Fund ("MSF")* American Funds Insurance Series ("American Funds") MFS Variable Insurance Trust ("MFS VIT") BlackRock Variable Series Funds, Inc. ("BlackRock") Neuberger Berman Equity Funds ("Neuberger Berman") Deutsche Variable Series I ("Deutsche I") Oppenheimer Variable Account Funds Federated Insurance Series ("Federated") ("Oppenheimer VA") Fidelity Variable Insurance Products ("Fidelity VIP") PIMCO Variable Insurance Trust ("PIMCO VIT") Franklin Templeton Variable Insurance Products Trust Pioneer Variable Contracts Trust ("Pioneer VCT") ("FTVIPT") T. Rowe Price Growth Stock Fund, Inc. Ivy Funds Variable Insurance Portfolios ("Ivy T. Rowe Price International Funds, Inc Funds VIP") T. Rowe Price Prime Reserve Fund, Inc. Janus Aspen Series ("Janus Aspen") The Alger Portfolios ("Alger") Legg Mason Partners Variable Equity Trust Trust For Advised Portfolios ("TAP") ("LMPVET") The Universal Institutional Funds, Inc. ("UIF") Legg Mason Partners Variable Income Trust Van Eck VIP Trust ("Van Eck VIP") ("LMPVIT") * See Note 5 for a discussion of additional information on related party transactions. The assets of each of the Sub-Accounts of the Separate Account are registered in the name of the Company. Under applicable insurance law, the assets and liabilities of the Separate Account are clearly identified and distinguished from the Company's other assets and liabilities. The portion of the Separate Account's assets applicable to the Contracts is not chargeable with liabilities arising out of any other business the Company may conduct. 2. LIST OF SUB-ACCOUNTS A. Purchase payments, less any applicable charges, applied to the Separate Account are invested in one or more Sub-Accounts in accordance with the selection made by the contract owner. The following Sub-Accounts had net assets as of December 31, 2014: [Enlarge/Download Table] Alger Small Cap Growth Sub-Account BlackRock Global Allocation V.I. Sub-Account (b) American Funds Bond Sub-Account Deutsche I International Sub-Account American Funds Global Growth Sub-Account Federated High Income Bond Sub-Account American Funds Global Small Capitalization Federated Kaufman Sub-Account Sub-Account (a) Fidelity VIP Asset Manager Sub-Account American Funds Growth Sub-Account Fidelity VIP Contrafund Sub-Account (a) American Funds Growth-Income Sub-Account Fidelity VIP Equity-Income Sub-Account 97
485BPOS191st Page of 388TOC1stPreviousNextBottomJust 191st
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 2. LIST OF SUB-ACCOUNTS -- (CONTINUED) [Enlarge/Download Table] Fidelity VIP FundsManager 50% Sub-Account MIST American Funds Growth Allocation Fidelity VIP FundsManager 60% Sub-Account Sub-Account Fidelity VIP Growth Sub-Account MIST American Funds Growth Sub-Account Fidelity VIP Index 500 Sub-Account MIST American Funds Moderate Allocation Fidelity VIP Mid Cap Sub-Account Sub-Account Fidelity VIP Money Market Sub-Account (a) MIST AQR Global Risk Balanced Sub-Account Fidelity VIP Overseas Sub-Account MIST BlackRock Global Tactical Strategies FTVIPT Franklin Income VIP Sub-Account Sub-Account FTVIPT Franklin Mutual Shares VIP Sub-Account MIST BlackRock High Yield Sub-Account (a) FTVIPT Franklin Small Cap Value VIP Sub-Account MIST Clarion Global Real Estate Sub-Account FTVIPT Templeton Foreign VIP Sub-Account MIST ClearBridge Aggressive Growth Sub-Account (a) FTVIPT Templeton Global Bond VIP Sub-Account MIST Goldman Sachs Mid Cap Value Sub-Account Invesco V.I. American Franchise Sub-Account MIST Harris Oakmark International Sub-Account (a) Invesco V.I. Core Equity Sub-Account MIST Invesco Balanced-Risk Allocation Sub-Account Invesco V.I. Equity and Income Sub-Account (a) MIST Invesco Comstock Sub-Account Invesco V.I. Growth and Income Sub-Account MIST Invesco Mid Cap Value Sub-Account Invesco V.I. International Growth Sub-Account (a) MIST Invesco Small Cap Growth Sub-Account (a) Ivy Funds VIP Asset Strategy Sub-Account (b) MIST JPMorgan Core Bond Sub-Account LMPVET ClearBridge Variable Aggressive Growth MIST JPMorgan Global Active Allocation Sub-Account (a) Sub-Account LMPVET ClearBridge Variable Appreciation MIST JPMorgan Small Cap Value Sub-Account (a) Sub-Account MIST Loomis Sayles Global Markets Sub-Account LMPVET ClearBridge Variable Equity Income MIST Lord Abbett Bond Debenture Sub-Account (a) Sub-Account (a) MIST Met/Eaton Vance Floating Rate Sub-Account LMPVET ClearBridge Variable Large Cap Growth MIST Met/Franklin Low Duration Total Return Sub-Account Sub-Account LMPVET ClearBridge Variable Large Cap Value MIST Met/Templeton International Bond Sub-Account Sub-Account MIST MetLife Asset Allocation 100 Sub-Account LMPVET ClearBridge Variable Small Cap Growth MIST MetLife Balanced Plus Sub-Account Sub-Account MIST MetLife Multi-Index Targeted Risk LMPVET Permal Alternative Select VIT Sub-Account Sub-Account (b) MIST MetLife Small Cap Value Sub-Account (a) LMPVET Variable Lifestyle Allocation 50% MIST MFS Emerging Markets Equity Sub-Account Sub-Account MIST MFS Research International Sub-Account (a) LMPVET Variable Lifestyle Allocation 70% MIST Morgan Stanley Mid Cap Growth Sub-Account (a) Sub-Account MIST Oppenheimer Global Equity Sub-Account LMPVET Variable Lifestyle Allocation 85% MIST PanAgora Global Diversified Risk Sub-Account Sub-Account (b) LMPVIT Western Asset Variable Global High Yield MIST PIMCO Inflation Protected Bond Sub-Account Bond Sub-Account MIST PIMCO Total Return Sub-Account (a) MFS VIT Investors Trust Sub-Account MIST Pioneer Fund Sub-Account (a) MFS VIT New Discovery Sub-Account MIST Pioneer Strategic Income Sub-Account (a) MFS VIT Research Sub-Account MIST Pyramis Government Income Sub-Account MIST AllianceBernstein Global Dynamic Allocation MIST Pyramis Managed Risk Sub-Account Sub-Account MIST Schroders Global Multi-Asset Sub-Account MIST Allianz Global Investors Dynamic Multi-Asset MIST SSgA Growth and Income ETF Sub-Account Plus Sub-Account (b) MIST SSgA Growth ETF Sub-Account MIST American Funds Balanced Allocation MIST T. Rowe Price Large Cap Value Sub-Account (a) Sub-Account MIST T. Rowe Price Mid Cap Growth Sub-Account 98
485BPOS192nd Page of 388TOC1stPreviousNextBottomJust 192nd
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 2. LIST OF SUB-ACCOUNTS -- (CONCLUDED) [Enlarge/Download Table] MIST WMC Large Cap Research Sub-Account (a) MSF Van Eck Global Natural Resources Sub-Account MSF Baillie Gifford International Stock Sub-Account (a) MSF Western Asset Management Strategic Bond MSF Barclays Aggregate Bond Index Sub-Account (a) Opportunities Sub-Account (b) MSF BlackRock Bond Income Sub-Account (a) MSF Western Asset Management U.S. Government MSF BlackRock Capital Appreciation Sub-Account (a) Sub-Account (a) MSF BlackRock Large Cap Value Sub-Account (a) MSF WMC Core Equity Opportunities Sub-Account (a) MSF BlackRock Money Market Sub-Account (a) Neuberger Berman Genesis Sub-Account MSF Frontier Mid Cap Growth Sub-Account Oppenheimer VA Core Bond Sub-Account MSF Jennison Growth Sub-Account (a) Oppenheimer VA Global Strategic Income MSF Loomis Sayles Small Cap Core Sub-Account Sub-Account MSF Loomis Sayles Small Cap Growth Sub-Account Oppenheimer VA Main Street Small Cap MSF Met/Artisan Mid Cap Value Sub-Account (a) Sub-Account (a) MSF Met/Dimensional International Small Company Oppenheimer VA Main Street Sub-Account Sub-Account Oppenheimer VA Money Sub-Account MSF MetLife Asset Allocation 20 Sub-Account PIMCO VIT CommodityRealReturn Strategy MSF MetLife Asset Allocation 40 Sub-Account Sub-Account (b) MSF MetLife Asset Allocation 60 Sub-Account PIMCO VIT Emerging Market Bond Sub-Account (b) MSF MetLife Asset Allocation 80 Sub-Account PIMCO VIT Unconstrained Bond Sub-Account (b) MSF MetLife Mid Cap Stock Index Sub-Account (a) Pioneer VCT Mid Cap Value Sub-Account MSF MetLife Stock Index Sub-Account (a) Pioneer VCT Real Estate Shares Sub-Account MSF MFS Total Return Sub-Account (a) T. Rowe Price Growth Stock Sub-Account MSF MFS Value Sub-Account (a) T. Rowe Price International Stock Sub-Account MSF MSCI EAFE Index Sub-Account (a) T. Rowe Price Prime Reserve Sub-Account MSF Neuberger Berman Genesis Sub-Account (a) TAP 1919 Variable Socially Responsive Balanced MSF Russell 2000 Index Sub-Account (a) Sub-Account MSF T. Rowe Price Large Cap Growth Sub-Account (a) UIF Global Infrastructure Sub-Account (b) MSF T. Rowe Price Small Cap Growth Sub-Account (a) Van Eck VIP Long/Short Equity Index (b) (a) This Sub-Account invests in two or more share classes within the underlying portfolio, series or fund of the Trusts. (b) This Sub-Account began operations during the year ended December 31, 2014. B. The following Sub-Accounts had no net assets as of December 31, 2014: Janus Aspen Global Research Sub-Account MIST Met/Artisan International Sub-Account* * This Investment Division commenced on November 19, 2014. 3. PORTFOLIO CHANGES The following Sub-Accounts ceased operations during the year ended December 31, 2014: [Enlarge/Download Table] LMPVET ClearBridge Variable All Cap Value MIST MetLife Moderate Strategy Sub-Account Sub-Account Pioneer VCT Disciplined Value Sub-Account Invesco V.I. American Value Sub-Account Pioneer VCT Emerging Markets Sub-Account Invesco V.I. Global Real Estate Sub-Account Pioneer VCT Equity Income Sub-Account MIST ClearBridge Aggressive Growth II Sub-Account Pioneer VCT Ibbotson Growth Allocation Sub-Account MIST MetLife Balanced Strategy Sub-Account Pioneer VCT Ibbotson Moderate Allocation MIST MetLife Defensive Strategy Sub-Account Sub-Account MIST MetLife Growth Strategy Sub-Account UIF U.S. Real Estate Sub-Account 99
485BPOS193rd Page of 388TOC1stPreviousNextBottomJust 193rd
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 3. PORTFOLIO CHANGES -- (CONTINUED) The operations of the Sub-Accounts were affected by the following changes that occurred during the year ended December 31, 2014: NAME CHANGES: [Enlarge/Download Table] Former Name New Name Franklin Income Securities Fund Franklin Income VIP Fund Franklin Small Cap Value Securities Fund Franklin Small Cap Value VIP Fund Mutual Shares Securities Fund Franklin Mutual Shares VIP Fund Templeton Foreign Securities Fund Templeton Foreign VIP Fund Templeton Global Bond Securities Fund Templeton Global Bond VIP Fund (MIST) BlackRock Large Cap Core Portfolio (MIST) WMC Large Cap Research Portfolio (MIST) MetLife Aggressive Strategy Portfolio (MIST) MetLife Asset Allocation 100 Portfolio (MIST) Third Avenue Small Cap Value Portfolio (MIST) MetLife Small Cap Value Portfolio (MSF) Davis Venture Value Portfolio (MSF) WMC Core Equity Opportunities Portfolio (MSF) MetLife Conservative Allocation Portfolio (MSF) MetLife Asset Allocation 20 Portfolio (MSF) MetLife Conservative to Moderate Allocation (MSF) MetLife Asset Allocation 40 Portfolio Portfolio (MSF) MetLife Moderate Allocation Portfolio (MSF) MetLife Asset Allocation 60 Portfolio (MSF) MetLife Moderate to Aggressive Allocation (MSF) MetLife Asset Allocation 80 Portfolio Portfolio MERGERS: [Enlarge/Download Table] Former Portfolio New Portfolio (MIST) ClearBridge Aggressive Growth Portfolio II (MIST) ClearBridge Aggressive Growth Portfolio (MIST) MetLife Balanced Strategy Portfolio (MSF) MetLife Asset Allocation 60 Portfolio (MIST) MetLife Defensive Strategy Portfolio (MSF) MetLife Asset Allocation 40 Portfolio (MIST) MetLife Growth Strategy Portfolio (MSF) MetLife Asset Allocation 80 Portfolio (MIST) MetLife Moderate Strategy Portfolio (MSF) MetLife Asset Allocation 40 Portfolio REORGANIZATION: [Enlarge/Download Table] Former Portfolio New Portfolio (LMPVET) Legg Mason Investment Counsel Variable (TAP) 1919 Variable Socially Responsive Balanced Fund Social Awareness Portfolio SUBSTITUTIONS: [Enlarge/Download Table] Former Portfolio New Portfolio ClearBridge Variable All Cap Value Portfolio (MIST) T. Rowe Price Large Cap Value Portfolio Invesco V.I. American Value Fund (MIST) Invesco Mid Cap Value Portfolio Invesco V.I. Global Real Estate Fund (MIST) Clarion Global Real Estate Portfolio Pioneer Disciplined Value VCT Portfolio (MSF) MFS Value Portfolio Pioneer Emerging Markets VCT Portfolio (MIST) MFS Emerging Markets Equity Portfolio Pioneer Equity Income VCT Portfolio (MIST) Invesco Comstock Portfolio Pioneer Ibbotson Growth Allocation VCT Portfolio (MSF) MetLife Asset Allocation 80 Portfolio Pioneer Ibbotson Moderate Allocation VCT Portfolio (MSF) MetLife Asset Allocation 60 Portfolio (UIF) U.S. Real Estate Portfolio (MIST) Clarion Global Real Estate Portfolio 100
485BPOS194th Page of 388TOC1stPreviousNextBottomJust 194th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 3. PORTFOLIO CHANGES -- (CONCLUDED) TRUST NAME CHANGE: [Download Table] Former Name New Name DWS Variable Series I Deutsche Variable Series I 4. SIGNIFICANT ACCOUNTING POLICIES BASIS OF ACCOUNTING The financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") applicable for variable annuity separate accounts registered as unit investment trusts, which follow the accounting and reporting guidance in Financial Accounting Standards Board ACCOUNTING STANDARDS CODIFICATION TOPIC 946. SECURITY TRANSACTIONS Security transactions are recorded on a trade date basis. Realized gains and losses on the sales of investments are computed on the basis of the average cost of the investment sold. Income from dividends and realized gain distributions are recorded on the ex-distribution date. SECURITY VALUATION A Sub-Account's investment in shares of a portfolio, series or fund of the Trusts is valued at fair value based on the closing net asset value ("NAV") or price per share as determined by the Trusts as of the end of the year. All changes in fair value are recorded as changes in unrealized gains (losses) on investments in the statements of operations of the applicable Sub-Accounts. The Separate Account defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The Separate Account prioritizes the inputs to fair valuation techniques and allows for the use of unobservable inputs to the extent that observable inputs are not available. The Separate Account has categorized its assets based on the priority of the inputs to the respective valuation technique. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets (Level 1) and the lowest priority to unobservable inputs (Level 3). An asset's classification within the fair value hierarchy is based on the lowest level of significant input to its valuation. The input levels are as follows: Level 1 Unadjusted quoted prices in active markets for identical assets that the Separate Account has the ability to access. Level 2 Observable inputs other than quoted prices in Level 1 that are observable either directly or indirectly. These inputs may include quoted prices for the identical instrument on an inactive market or prices for similar instruments. Level 3 Unobservable inputs that are supported by little or no market activity and are significant to the fair value of the assets, representing the Separate Account's own assumptions about the assumptions a market participant would use in valuing the asset, and based on the best information available. Each Sub-Account invests in shares of open-end mutual funds which calculate a daily NAV based on the fair value of the underlying securities in their portfolios. As a result, and as required by law, shares of open-end mutual funds are purchased and redeemed at their quoted daily NAV as reported by the Trusts at the close of each business day. On that basis, the inputs used to value all shares held by the Separate Account, which are measured at fair value on a recurring basis, are classified as Level 2. There were no transfers between Level 1 and Level 2, and no activity in Level 3 during the year. 101
485BPOS195th Page of 388TOC1stPreviousNextBottomJust 195th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 4. SIGNIFICANT ACCOUNTING POLICIES -- (CONCLUDED) FEDERAL INCOME TAXES The operations of the Separate Account form a part of the total operations of the Company and are not taxed separately. The Company is taxed as a life insurance company under the provisions of the Internal Revenue Code ("IRC"). Under the current provisions of the IRC, the Company does not expect to incur federal income taxes on the earnings of the Separate Account to the extent the earnings are credited under the Contracts. Accordingly, no charge is currently being made to the Separate Account for federal income taxes. The Company will periodically review the status of this policy in the event of changes in the tax law. A charge may be made in future years for any federal income taxes that would be attributable to the Contracts. ANNUITY PAYOUTS Net assets allocated to Contracts in the payout period are computed according to industry standard mortality tables. The assumed investment return is between 3.0 and 6.0 percent. The mortality risk is fully borne by the Company and may result in additional amounts being transferred into the Separate Account by the Company to cover greater longevity of annuitants than expected. Conversely, if amounts allocated exceed amounts required, transfers may be made to the Company. PURCHASE PAYMENTS Purchase payments received from contract owners by the Company are credited as accumulation units as of the end of the valuation period in which received, as provided in the prospectus of the Contracts, and are reported as contract transactions on the statements of changes in net assets of the applicable Sub-Accounts. NET TRANSFERS Funds transferred by the contract owner into or out of Sub-Accounts within the Separate Account or into or out of the fixed account, which is part of the Company's general account, are recorded on a net basis as net transfers in the statements of changes in net assets of the applicable Sub-Accounts. USE OF ESTIMATES The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported herein. Actual results could differ from these estimates. 5. EXPENSES AND RELATED PARTY TRANSACTIONS The following annual Separate Account charges paid to the Company are asset-based charges assessed through a daily reduction in unit values, which are recorded as expenses in the accompanying statements of operations of the applicable Sub-Accounts: Mortality and Expense Risk -- The mortality risk assumed by the Company is the risk that those insured may die sooner than anticipated and therefore, the Company will pay an aggregate amount of death benefits greater than anticipated. The expense risk assumed is the risk that expenses incurred in issuing and administering the Contracts will exceed the amounts realized from the administrative charges assessed against the Contracts. In addition, the charge compensates the Company for the risk that the investor may live longer than estimated and the Company would be obligated to pay more in income payments than anticipated. Administrative -- The Company has responsibility for the administration of the Contracts and the Separate Account. Generally, the administrative charge is related to the maintenance, including distribution, of each contract and the Separate Account. Optional Death Benefit Rider -- For an additional charge, the total death benefit payable may be increased based on increases in account value of the Contracts. Distribution Expense -- The risk that surrender charges will be insufficient to cover the actual costs of distribution which includes commissions, fees, registration costs, direct and indirect selling expenses. 102
485BPOS196th Page of 388TOC1stPreviousNextBottomJust 196th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 5. EXPENSES AND RELATED PARTY TRANSACTIONS -- (CONTINUED) Guaranteed Minimum Accumulation Benefit -- For an additional charge, the Company will guarantee that the contract value will not be less than a guaranteed minimum amount at the end of a specified number of years. Guaranteed Withdrawal Benefit for Life -- For an additional charge that includes the Mortality and Expense Risk charge and a Guaranteed Withdrawal Benefit, the Company will guarantee the periodic return on the investment for life of a single annuitant or joint annuitants. Earnings Preservation Benefit -- For an additional charge, the Company will provide this additional death benefit. The table below represents the range of effective annual rates for each respective charge for the year ended December 31, 2014: [Enlarge/Download Table] ---------------------------------------------------------------------------------------------------------------------------- Mortality and Expense Risk 0.70% - 2.05% ---------------------------------------------------------------------------------------------------------------------------- Administrative 0.10% - 0.25% ---------------------------------------------------------------------------------------------------------------------------- Optional Death Benefit Rider 0.15% - 0.35% ---------------------------------------------------------------------------------------------------------------------------- Distribution Expense 0.10% ---------------------------------------------------------------------------------------------------------------------------- Guaranteed Minimum Accumulation Benefit 1.50% ---------------------------------------------------------------------------------------------------------------------------- Guaranteed Withdrawal Benefit for Life 1.90% - 2.05% ---------------------------------------------------------------------------------------------------------------------------- Earnings Preservation Benefit 0.25% ---------------------------------------------------------------------------------------------------------------------------- The above referenced charges may not necessarily correspond to the costs associated with providing the services or benefits indicated by the designation of the charge or associated with a particular contract. The range of effective rates disclosed above excludes any waivers granted to certain Sub-Accounts. The following optional rider charges paid to the Company are charged at each contract anniversary date through the redemption of units and are recorded as contract charges in the accompanying statements of changes in net assets of the applicable Sub-Accounts: Guaranteed Minimum Accumulation Benefit -- For an additional charge, the Company will guarantee that the contract value will not be less than a guaranteed minimum amount at the end of a specified number of years. Lifetime Withdrawal Guarantee -- For an additional charge, the Company will guarantee minimum withdrawals for life regardless of market conditions. Guaranteed Withdrawal Benefit -- For an additional charge, the Company will guarantee minimum withdrawals regardless of market conditions. Guaranteed Minimum Income Benefit -- For an additional charge, the Company will guarantee a minimum payment regardless of market conditions. Enhanced Death Benefit -- For an additional charge, the Company will guarantee a death benefit equal to the greater of the account value or the higher of two death benefit bases. Enhanced Guaranteed Withdrawal Benefit -- For an additional charge, the Company will guarantee that at least the entire amount of purchase payments will be returned through a series of withdrawals without annuitizing. The table below represents the range of effective annual rates for each respective charge for the year ended December 31, 2014: [Enlarge/Download Table] ------------------------------------------------------------------------------------------------------------------------- Guaranteed Minimum Accumulation Benefit 0.75% ------------------------------------------------------------------------------------------------------------------------- Lifetime Withdrawal Guarantee 0.50% - 1.80% ------------------------------------------------------------------------------------------------------------------------- Guaranteed Withdrawal Benefit 0.25% - 1.80% ------------------------------------------------------------------------------------------------------------------------- Guaranteed Minimum Income Benefit 0.50% - 1.50% ------------------------------------------------------------------------------------------------------------------------- Enhanced Death Benefit 0.60% - 1.50% ------------------------------------------------------------------------------------------------------------------------- Enhanced Guaranteed Withdrawal Benefit 0.55% - 1.00% ------------------------------------------------------------------------------------------------------------------------- 103
485BPOS197th Page of 388TOC1stPreviousNextBottomJust 197th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 5. EXPENSES AND RELATED PARTY TRANSACTIONS -- (CONCLUDED) The above referenced charges may not necessarily correspond to the costs associated with providing the services or benefits indicated by the designation of the charge or associated with a particular contract. A contract maintenance fee ranging from $30 to $40 is assessed on an annual basis for Contracts with a value of less than $50,000. A transfer fee ranging from $0 to $25 may be deducted after twelve transfers are made in a contract year or, for certain contracts, 2% of the amount transferred from the contract value, if less. For certain Contracts, an administrative charge is also assessed which ranges from $12 to $29.50 for each Sub-Account in which the contract owner invests (waived if purchase payments equal or exceed $2,000 in the year, or if the account value is $10,000 or more at year end). For other Contracts, the administrative charge is $21.50 plus $2.50 for each Sub-Account selected, subject to the same waiver terms. In addition, the Contracts impose a surrender charge which ranges from 0% to 9% if the contract is partially or fully surrendered within the specified surrender charge period. For certain Contracts, a transaction charge of the lesser of $10 or 2% of the surrender is imposed on surrenders and a $10 charge is assessed for annuitizations. For those contract owners who choose optional living benefit riders or certain optional death benefit riders, these charges range from 0.25% to 1.80% of the benefit base and are charged at each contract anniversary date. These charges are paid to the Company and recorded as contract charges in the accompanying statements of changes in net assets of the applicable Sub-Accounts. MetLife Advisers, LLC, which acts in the capacity of investment adviser to the portfolios of the MIST and MSF Trusts, is an affiliate of the Company. 104
485BPOS198th Page of 388TOC1stPreviousNextBottomJust 198th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 6. STATEMENTS OF INVESTMENTS [Enlarge/Download Table] FOR THE YEAR ENDED AS OF DECEMBER 31, 2014 DECEMBER 31, 2014 ------------------------------- ------------------------------- COST OF PROCEEDS SHARES COST ($) PURCHASES ($) FROM SALES ($) ------------- -------------- -------------- -------------- Alger Small Cap Growth Sub-Account......................... 1,921,904 56,410,072 5,701,946 7,073,730 American Funds Bond Sub-Account............................ 13,812,418 147,739,730 10,486,743 10,137,686 American Funds Global Growth Sub-Account................... 11,436,237 252,267,241 44,095,190 19,845,237 American Funds Global Small Capitalization Sub-Account..... 4,762,551 93,187,327 5,221,405 9,298,382 American Funds Growth Sub-Account.......................... 10,285,586 551,851,214 47,817,936 103,762,294 American Funds Growth-Income Sub-Account................... 7,458,611 274,040,357 28,221,125 41,207,102 BlackRock Global Allocation V.I. Fund Sub-Account (a)...... 604 9,538 9,538 -- Deutsche I International Sub-Account....................... 1,889,479 19,018,355 618,802 2,024,549 Federated High Income Bond Sub-Account..................... 3,817 26,798 1,573 500 Federated Kaufman Sub-Account.............................. 2,498 34,361 4,778 1,902 Fidelity VIP Asset Manager Sub-Account..................... 4,954,972 76,274,293 5,698,674 8,655,913 Fidelity VIP Contrafund Sub-Account........................ 16,968,941 418,638,148 45,355,592 76,873,656 Fidelity VIP Equity-Income Sub-Account..................... 233,882 5,304,022 304,308 827,182 Fidelity VIP FundsManager 50% Sub-Account.................. 285,820,565 3,329,107,504 1,435,620,203 36,916 Fidelity VIP FundsManager 60% Sub-Account.................. 333,704,051 3,288,428,521 156,845,075 249,302,372 Fidelity VIP Growth Sub-Account............................ 2,641,366 100,196,604 1,523,225 17,556,858 Fidelity VIP Index 500 Sub-Account......................... 337,142 43,801,197 1,215,605 8,388,363 Fidelity VIP Mid Cap Sub-Account........................... 12,113,944 357,069,993 13,965,900 29,721,451 Fidelity VIP Money Market Sub-Account...................... 50,947,658 50,947,658 309,339,300 334,547,008 Fidelity VIP Overseas Sub-Account.......................... 264,318 4,825,817 252,574 704,940 FTVIPT Franklin Income VIP Sub-Account..................... 18,431,873 278,040,576 22,674,326 24,286,646 FTVIPT Franklin Mutual Shares VIP Sub-Account.............. 6,774,745 117,971,223 5,489,620 15,309,497 FTVIPT Franklin Small Cap Value VIP Sub-Account............ 5,667,677 93,183,451 14,010,853 6,363,239 FTVIPT Templeton Foreign VIP Sub-Account................... 4,890,887 73,303,878 4,819,621 8,282,088 FTVIPT Templeton Global Bond VIP Sub-Account............... 13,904,949 257,436,845 19,709,348 15,908,355 Invesco V.I. American Franchise Sub-Account................ 275 15,220 15,331 157,895 Invesco V.I. Core Equity Sub-Account....................... 5,657 144,542 3,447 36,534 Invesco V.I. Equity and Income Sub-Account................. 36,119,351 514,710,087 60,568,209 41,787,557 Invesco V.I. Growth and Income Sub-Account................. 276 4,960 957,202 370,763,165 Invesco V.I. International Growth Sub-Account.............. 8,015,089 217,329,704 10,913,396 13,852,487 Ivy Funds VIP Asset Strategy Sub-Account (a)............... 4,143 45,556 45,556 -- LMPVET ClearBridge Variable Aggressive Growth Sub-Account.............................................. 10,520,313 187,099,946 30,909,176 30,597,361 LMPVET ClearBridge Variable Appreciation Sub-Account....... 12,034,975 303,745,114 25,192,463 26,316,576 LMPVET ClearBridge Variable Equity Income Sub-Account...... 12,835,854 146,261,173 11,411,659 18,239,523 LMPVET ClearBridge Variable Large Cap Growth Sub-Account.............................................. 211,491 3,709,556 828,727 1,191,668 LMPVET ClearBridge Variable Large Cap Value Sub-Account.... 449,114 7,468,384 2,769,690 1,025,471 LMPVET ClearBridge Variable Small Cap Growth Sub-Account.............................................. 5,176,020 90,210,538 20,444,282 9,355,470 LMPVET Permal Alternative Select VIT Sub-Account (a)....... 63,978 640,747 640,747 -- LMPVET Variable Lifestyle Allocation 50% Sub-Account....... 2,911,658 36,024,608 3,620,479 6,369,390 LMPVET Variable Lifestyle Allocation 70% Sub-Account....... 133,047 1,492,107 119,188 572,323 LMPVET Variable Lifestyle Allocation 85% Sub-Account....... 5,638,920 67,472,969 6,263,215 8,271,003 LMPVIT Western Asset Variable Global High Yield Bond Sub-Account.............................................. 13,563,578 110,885,714 11,851,027 7,344,876 MFS VIT Investors Trust Sub-Account........................ 316 6,074 808 17,284 MFS VIT New Discovery Sub-Account.......................... 2,488 38,286 8,458 2,074 MFS VIT Research Sub-Account............................... 913 15,925 3,900 40,221 MIST AllianceBernstein Global Dynamic Allocation Sub-Account.............................................. 284,923,263 2,853,449,838 144,211,615 192,016,750 MIST Allianz Global Investors Dynamic Multi-Asset Plus Sub-Account (b).......................................... 1,806,520 18,919,521 19,059,019 140,871 (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. 105
485BPOS199th Page of 388TOC1stPreviousNextBottomJust 199th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 6. STATEMENTS OF INVESTMENTS -- (CONTINUED) [Enlarge/Download Table] FOR THE YEAR ENDED AS OF DECEMBER 31, 2014 DECEMBER 31, 2014 ------------------------------ ------------------------------- COST OF PROCEEDS SHARES COST ($) PURCHASES ($) FROM SALES ($) ------------- ------------- ------------- -------------- MIST American Funds Balanced Allocation Sub-Account........ 317,642,622 2,862,627,588 428,527,756 265,724,402 MIST American Funds Growth Allocation Sub-Account.......... 179,135,466 1,502,067,867 348,997,889 137,744,824 MIST American Funds Growth Sub-Account..................... 51,563,717 437,148,040 72,693,944 65,582,917 MIST American Funds Moderate Allocation Sub-Account........ 165,322,956 1,526,751,985 188,426,230 165,368,571 MIST AQR Global Risk Balanced Sub-Account.................. 275,854,987 2,961,390,036 22,309,985 387,095,609 MIST BlackRock Global Tactical Strategies Sub-Account...... 495,762,076 4,872,361,034 358,579,278 356,321,429 MIST BlackRock High Yield Sub-Account...................... 29,269,034 241,821,094 73,293,116 80,646,995 MIST Clarion Global Real Estate Sub-Account................ 26,713,490 303,659,729 151,367,497 35,181,869 MIST ClearBridge Aggressive Growth Sub-Account............. 37,584,237 363,627,480 141,753,028 100,474,548 MIST Goldman Sachs Mid Cap Value Sub-Account............... 10,958,424 148,140,639 45,984,522 28,394,324 MIST Harris Oakmark International Sub-Account.............. 42,321,442 604,092,616 145,273,246 52,479,482 MIST Invesco Balanced-Risk Allocation Sub-Account.......... 78,230,688 813,069,969 65,787,197 82,634,844 MIST Invesco Comstock Sub-Account.......................... 51,717,568 596,742,598 379,220,526 72,251,945 MIST Invesco Mid Cap Value Sub-Account..................... 12,907,478 210,471,123 127,362,685 21,843,428 MIST Invesco Small Cap Growth Sub-Account.................. 16,288,613 226,054,520 45,284,214 42,894,922 MIST JPMorgan Core Bond Sub-Account........................ 33,994,067 356,001,562 59,103,743 25,378,801 MIST JPMorgan Global Active Allocation Sub-Account......... 76,453,631 825,292,219 153,830,015 15,728,971 MIST JPMorgan Small Cap Value Sub-Account.................. 1,544,917 21,221,731 5,399,018 3,090,765 MIST Loomis Sayles Global Markets Sub-Account.............. 11,831,295 138,811,364 20,384,702 26,027,858 MIST Lord Abbett Bond Debenture Sub-Account................ 18,177,106 223,623,014 52,921,520 68,151,387 MIST Met/Eaton Vance Floating Rate Sub-Account............. 7,217,703 75,038,729 12,627,495 19,156,208 MIST Met/Franklin Low Duration Total Return Sub-Account.... 17,452,118 174,038,518 62,962,803 28,193,206 MIST Met/Templeton International Bond Sub-Account.......... 4,197,860 49,071,172 4,154,159 7,572,730 MIST MetLife Asset Allocation 100 Sub-Account.............. 45,892,335 475,205,970 19,734,972 66,057,349 MIST MetLife Balanced Plus Sub-Account..................... 621,235,402 6,333,490,785 962,734,371 127,104,250 MIST MetLife Multi-Index Targeted Risk Sub-Account......... 34,437,420 385,845,359 190,242,454 7,419,128 MIST MetLife Small Cap Value Sub-Account................... 14,291,208 204,549,781 21,767,957 53,257,969 MIST MFS Emerging Markets Equity Sub-Account............... 44,661,015 434,427,179 50,349,264 48,341,898 MIST MFS Research International Sub-Account................ 26,576,070 288,125,691 12,008,398 26,890,087 MIST Morgan Stanley Mid Cap Growth Sub-Account............. 15,089,872 161,252,193 9,999,539 16,998,756 MIST Oppenheimer Global Equity Sub-Account................. 3,576,427 62,306,045 3,588,549 8,280,296 MIST PanAgora Global Diversified Risk Sub-Account (b)...... 985,619 10,314,930 11,332,144 1,030,049 MIST PIMCO Inflation Protected Bond Sub-Account............ 73,186,468 806,061,401 21,411,716 122,362,115 MIST PIMCO Total Return Sub-Account........................ 150,232,412 1,780,157,239 139,220,533 380,592,554 MIST Pioneer Fund Sub-Account.............................. 21,156,620 280,146,125 102,239,647 37,007,775 MIST Pioneer Strategic Income Sub-Account.................. 86,380,369 918,333,787 119,499,319 80,060,627 MIST Pyramis Government Income Sub-Account................. 63,004,295 677,141,712 53,529,572 121,245,887 MIST Pyramis Managed Risk Sub-Account...................... 14,268,192 152,298,385 78,015,380 2,372,387 MIST Schroders Global Multi-Asset Sub-Account.............. 41,670,698 448,865,996 66,373,985 20,081,337 MIST SSgA Growth and Income ETF Sub-Account................ 120,806,520 1,314,026,600 133,925,529 159,799,370 MIST SSgA Growth ETF Sub-Account........................... 40,240,961 416,051,011 60,786,330 54,487,396 MIST T. Rowe Price Large Cap Value Sub-Account............. 23,443,759 617,164,183 183,366,611 92,218,809 MIST T. Rowe Price Mid Cap Growth Sub-Account.............. 44,948,684 379,805,857 61,860,124 103,647,664 MIST WMC Large Cap Research Sub-Account.................... 1,200,640 11,362,206 1,492,923 3,115,416 MSF Baillie Gifford International Stock Sub-Account........ 27,194,816 254,615,427 8,847,931 30,162,284 MSF Barclays Aggregate Bond Index Sub-Account.............. 19,444,175 212,520,304 60,915,462 14,857,673 MSF BlackRock Bond Income Sub-Account...................... 578,980 62,010,679 12,182,525 7,861,114 MSF BlackRock Capital Appreciation Sub-Account............. 356,710 9,405,836 1,763,471 3,506,733 MSF BlackRock Large Cap Value Sub-Account.................. 424,837 4,396,139 1,685,861 659,285 MSF BlackRock Money Market Sub-Account..................... 3,958,866 395,886,560 141,398,632 206,855,258 MSF Frontier Mid Cap Growth Sub-Account.................... 2,332,786 68,033,516 10,387,155 13,491,977 MSF Jennison Growth Sub-Account............................ 32,954,752 384,110,698 32,787,334 105,227,319 MSF Loomis Sayles Small Cap Core Sub-Account............... 48,938 11,117,176 2,654,335 2,161,399 (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. 106
485BPOS200th Page of 388TOC1stPreviousNextBottomJust 200th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 6. STATEMENTS OF INVESTMENTS -- (CONCLUDED) [Enlarge/Download Table] FOR THE YEAR ENDED AS OF DECEMBER 31, 2014 DECEMBER 31, 2014 ------------------------------ ------------------------------- COST OF PROCEEDS SHARES COST ($) PURCHASES ($) FROM SALES ($) ------------- ------------- ------------- -------------- MSF Loomis Sayles Small Cap Growth Sub-Account............. 20,799 282,616 116,781 24,274 MSF Met/Artisan Mid Cap Value Sub-Account.................. 922,396 196,739,162 3,708,653 48,137,456 MSF Met/Dimensional International Small Company Sub-Account.............................................. 3,938,671 57,102,993 13,319,702 14,072,519 MSF MetLife Asset Allocation 20 Sub-Account................ 3,621,864 41,029,687 50,262,356 16,290,440 MSF MetLife Asset Allocation 40 Sub-Account................ 394,893,740 4,808,965,070 5,402,394,516 614,461,783 MSF MetLife Asset Allocation 60 Sub-Account................ 556,804,084 7,194,105,012 7,692,735,157 552,762,987 MSF MetLife Asset Allocation 80 Sub-Account................ 437,947,133 6,182,364,748 6,605,783,735 486,497,477 MSF MetLife Mid Cap Stock Index Sub-Account................ 6,800,171 95,881,249 21,987,305 24,495,794 MSF MetLife Stock Index Sub-Account........................ 13,575,398 415,511,357 80,457,500 79,238,240 MSF MFS Total Return Sub-Account........................... 267,160 38,061,728 4,582,770 7,531,296 MSF MFS Value Sub-Account.................................. 13,986,421 204,346,509 25,944,977 40,527,640 MSF MSCI EAFE Index Sub-Account............................ 8,153,122 95,811,245 17,855,093 19,771,908 MSF Neuberger Berman Genesis Sub-Account................... 8,440,200 120,024,328 2,939,870 23,735,312 MSF Russell 2000 Index Sub-Account......................... 7,354,493 104,413,455 21,358,909 19,618,337 MSF T. Rowe Price Large Cap Growth Sub-Account............. 6,810,459 138,371,173 38,727,784 25,710,827 MSF T. Rowe Price Small Cap Growth Sub-Account............. 436,375 6,731,390 2,103,464 2,494,342 MSF Van Eck Global Natural Resources Sub-Account........... 7,936,727 113,761,568 18,816,498 16,545,440 MSF Western Asset Management Strategic Bond Opportunities Sub-Account (a).......................................... 954 12,700 12,700 -- MSF Western Asset Management U.S. Government Sub-Account.............................................. 22,906,799 275,434,548 20,239,634 38,474,699 MSF WMC Core Equity Opportunities Sub-Account.............. 14,199,539 404,866,838 65,934,004 118,622,278 Neuberger Berman Genesis Sub-Account....................... 152 5,888 693 1,903 Oppenheimer VA Core Bond Sub-Account....................... 1,049 10,685 470 921 Oppenheimer VA Global Strategic Income Sub-Account......... 860 4,249 195 62 Oppenheimer VA Main Street Small Cap Sub-Account........... 4,815,871 79,577,709 20,039,216 12,314,071 Oppenheimer VA Main Street Sub-Account..................... 3,157 65,832 2,999 8,677 Oppenheimer VA Money Sub-Account........................... 3,803 3,803 -- 205 PIMCO VIT CommodityRealReturn Strategy Sub-Account (a)..... 2,712 14,924 14,924 -- PIMCO VIT Emerging Market Bond Sub-Account (a)............. 1,199 15,134 15,134 -- PIMCO VIT Unconstrained Bond Sub-Account (a)............... 456 4,764 4,764 -- Pioneer VCT Mid Cap Value Sub-Account...................... 3,315,761 59,362,049 11,877,109 8,706,537 Pioneer VCT Real Estate Shares Sub-Account................. 11,573 175,291 36,347 77,549 T. Rowe Price Growth Stock Sub-Account..................... 144,596 4,793,545 1,302,510 2,093,703 T. Rowe Price International Stock Sub-Account.............. 39,912 558,383 51,928 58,806 T. Rowe Price Prime Reserve Sub-Account.................... 514,215 514,215 495,379 539,614 TAP 1919 Variable Socially Responsive Balanced Sub-Account. 8,531 218,941 45,433 74,591 UIF Global Infrastructure Sub-Account (a).................. 914 8,425 8,425 -- Van Eck VIP Long/Short Equity Index Sub-Account (a)........ 659 16,699 16,699 -- (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. 107
485BPOS201st Page of 388TOC1stPreviousNextBottomJust 201st
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 7. SCHEDULES OF UNITS FOR THE YEARS ENDED DECEMBER 31, 2014 AND 2013: [Enlarge/Download Table] ALGER SMALL CAP GROWTH AMERICAN FUNDS BOND AMERICAN FUNDS GLOBAL GROWTH SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------------------- ------------------------------- ------------------------------- 2014 2013 2014 2013 2014 2013 -------------- --------------- --------------- -------------- --------------- -------------- Units beginning of year.......... 4,387,118 4,795,545 8,361,945 7,687,811 8,333,553 8,485,913 Units issued and transferred from other funding options.... 162,051 231,164 1,138,757 2,005,667 958,883 1,261,036 Units redeemed and transferred to other funding options......... (578,312) (639,591) (1,166,873) (1,331,533) (1,098,505) (1,413,396) -------------- --------------- --------------- -------------- --------------- -------------- Units end of year................ 3,970,857 4,387,118 8,333,829 8,361,945 8,193,931 8,333,553 ============== =============== =============== ============== =============== ============== AMERICAN FUNDS GLOBAL SMALL CAPITALIZATION AMERICAN FUNDS GROWTH SUB-ACCOUNT SUB-ACCOUNT ------------------------------- -------------------------------- 2014 2013 2014 2013 --------------- -------------- --------------- --------------- Units beginning of year.......... 3,375,743 3,385,796 3,937,244 4,113,319 Units issued and transferred from other funding options.... 375,100 652,214 132,323 453,387 Units redeemed and transferred to other funding options......... (453,829) (662,267) (541,863) (629,462) --------------- -------------- --------------- --------------- Units end of year................ 3,297,014 3,375,743 3,527,704 3,937,244 =============== ============== =============== =============== AMERICAN FUNDS GROWTH-INCOME SUB-ACCOUNT ------------------------------- 2014 2013 -------------- --------------- Units beginning of year.......... 2,581,885 2,745,842 Units issued and transferred from other funding options.... 209,589 297,744 Units redeemed and transferred to other funding options......... (412,906) (461,701) -------------- --------------- Units end of year................ 2,378,568 2,581,885 ============== =============== [Enlarge/Download Table] BLACKROCK GLOBAL ALLOCATION V.I. FUND DEUTSCHE I INTERNATIONAL FEDERATED HIGH INCOME BOND SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ---------------- -------------------------------- --------------------------------- 2014 (A) 2014 2013 2014 2013 ---------------- --------------- --------------- --------------- ---------------- Units beginning of year.......... -- 1,888,612 2,040,232 2,545 2,556 Units issued and transferred from other funding options.... 402 102,848 147,844 -- -- Units redeemed and transferred to other funding options......... -- (258,501) (299,464) (11) (11) ---------------- --------------- --------------- --------------- ---------------- Units end of year................ 402 1,732,959 1,888,612 2,534 2,545 ================ =============== =============== =============== ================ FEDERATED KAUFMAN FIDELITY VIP ASSET MANAGER SUB-ACCOUNT SUB-ACCOUNT -------------------------------- -------------------------------- 2014 2013 2014 2013 --------------- --------------- --------------- --------------- Units beginning of year.......... 5,836 6,002 5,885,530 6,517,939 Units issued and transferred from other funding options.... -- -- 170,327 203,227 Units redeemed and transferred to other funding options......... (160) (166) (629,497) (835,636) --------------- --------------- --------------- --------------- Units end of year................ 5,676 5,836 5,426,360 5,885,530 =============== =============== =============== =============== FIDELITY VIP CONTRAFUND SUB-ACCOUNT --------------------------------- 2014 2013 ---------------- --------------- Units beginning of year.......... 17,717,451 15,604,750 Units issued and transferred from other funding options.... 5,468,074 4,408,947 Units redeemed and transferred to other funding options......... (2,802,892) (2,296,246) ---------------- --------------- Units end of year................ 20,382,633 17,717,451 ================ =============== [Enlarge/Download Table] FIDELITY VIP EQUITY-INCOME FIDELITY VIP FUNDSMANAGER 50% SUB-ACCOUNT SUB-ACCOUNT -------------------------------- -------------------------------- 2014 2013 2014 2013 --------------- --------------- --------------- --------------- Units beginning of year.......... 341,560 400,352 158,954,030 39,080,828 Units issued and transferred from other funding options.... 3,835 5,137 117,006,306 123,377,437 Units redeemed and transferred to other funding options......... (41,684) (63,929) (7,533,924) (3,504,235) --------------- --------------- --------------- --------------- Units end of year................ 303,711 341,560 268,426,412 158,954,030 =============== =============== =============== =============== FIDELITY VIP FUNDSMANAGER 60% FIDELITY VIP GROWTH SUB-ACCOUNT SUB-ACCOUNT -------------------------------- -------------------------------- 2014 2013 2014 2013 --------------- --------------- --------------- --------------- Units beginning of year.......... 333,151,686 345,636,001 8,194,380 9,085,626 Units issued and transferred from other funding options.... 415,030 492,775 316,464 341,709 Units redeemed and transferred to other funding options......... (14,141,697) (12,977,090) (971,968) (1,232,955) --------------- --------------- --------------- --------------- Units end of year................ 319,425,019 333,151,686 7,538,876 8,194,380 =============== =============== =============== =============== FIDELITY VIP INDEX 500 FIDELITY VIP MID CAP SUB-ACCOUNT SUB-ACCOUNT -------------------------------- -------------------------------- 2014 2013 2014 2013 --------------- --------------- --------------- --------------- Units beginning of year.......... 3,091,556 3,530,426 7,792,671 7,598,912 Units issued and transferred from other funding options.... 17,659 21,793 669,936 1,446,862 Units redeemed and transferred to other funding options......... (330,761) (460,663) (1,016,983) (1,253,103) --------------- --------------- --------------- --------------- Units end of year................ 2,778,454 3,091,556 7,445,624 7,792,671 =============== =============== =============== =============== [Enlarge/Download Table] FIDELITY VIP MONEY MARKET FIDELITY VIP OVERSEAS SUB-ACCOUNT SUB-ACCOUNT -------------------------------- ------------------------------- 2014 2013 2014 2013 --------------- --------------- --------------- -------------- Units beginning of year.......... 8,307,410 8,041,430 447,143 509,517 Units issued and transferred from other funding options.... 142,794,372 139,410,710 21,166 12,503 Units redeemed and transferred to other funding options......... (145,207,494) (139,144,730) (57,034) (74,877) --------------- --------------- --------------- -------------- Units end of year................ 5,894,288 8,307,410 411,275 447,143 =============== =============== =============== ============== FTVIPT FRANKLIN FTVIPT FRANKLIN INCOME VIP MUTUAL SHARES VIP SUB-ACCOUNT SUB-ACCOUNT ------------------------------- -------------------------------- 2014 2013 2014 2013 -------------- --------------- --------------- --------------- Units beginning of year.......... 4,919,666 4,708,870 5,477,366 5,768,385 Units issued and transferred from other funding options.... 486,023 860,767 353,975 550,522 Units redeemed and transferred to other funding options......... (688,503) (649,971) (750,654) (841,541) -------------- --------------- --------------- --------------- Units end of year................ 4,717,186 4,919,666 5,080,687 5,477,366 ============== =============== =============== =============== FTVIPT FRANKLIN SMALL CAP VALUE VIP FTVIPT TEMPLETON FOREIGN VIP SUB-ACCOUNT SUB-ACCOUNT ------------------------------- -------------------------------- 2014 2013 2014 2013 -------------- --------------- --------------- --------------- Units beginning of year.......... 9,184,423 8,321,925 2,457,017 2,730,167 Units issued and transferred from other funding options.... 1,139,686 2,576,537 274,424 184,075 Units redeemed and transferred to other funding options......... (1,179,055) (1,714,039) (376,658) (457,225) -------------- --------------- --------------- --------------- Units end of year................ 9,145,054 9,184,423 2,354,783 2,457,017 ============== =============== =============== =============== (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. (c) For the period April 29, 2013 to December 31, 2013. 108
485BPOS202nd Page of 388TOC1stPreviousNextBottomJust 202nd
109
485BPOS203rd Page of 388TOC1stPreviousNextBottomJust 203rd
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 7. SCHEDULES OF UNITS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2014 AND 2013: [Enlarge/Download Table] FTVIPT TEMPLETON GLOBAL BOND VIP INVESCO V.I. AMERICAN FRANCHISE SUB-ACCOUNT SUB-ACCOUNT --------------------------------- --------------------------------- 2014 2013 2014 2013 ---------------- --------------- ---------------- --------------- Units beginning of year.......... 12,950,902 11,067,808 22,147 28,015 Units issued and transferred from other funding options.... 1,551,847 3,547,855 2,240 5 Units redeemed and transferred to other funding options......... (1,835,132) (1,664,761) (22,476) (5,873) ---------------- --------------- ---------------- --------------- Units end of year................ 12,667,617 12,950,902 1,911 22,147 ================ =============== ================ =============== INVESCO V.I. CORE EQUITY INVESCO V.I. EQUITY AND INCOME SUB-ACCOUNT SUB-ACCOUNT --------------------------------- --------------------------------- 2014 2013 2014 2013 --------------- ---------------- --------------- ---------------- Units beginning of year.......... 39,835 49,005 31,328,255 29,563,858 Units issued and transferred from other funding options.... 17 1 3,381,596 5,739,587 Units redeemed and transferred to other funding options......... (5,149) (9,171) (4,086,964) (3,975,190) --------------- ---------------- --------------- ---------------- Units end of year................ 34,703 39,835 30,622,887 31,328,255 =============== ================ =============== ================ INVESCO V.I. GROWTH AND INCOME INVESCO V.I. INTERNATIONAL GROWTH SUB-ACCOUNT SUB-ACCOUNT --------------------------------- ---------------------------------- 2014 2013 2014 2013 --------------- ---------------- --------------- ---------------- Units beginning of year.......... 13,799,854 13,407,203 8,901,354 8,127,475 Units issued and transferred from other funding options.... 379,286 2,432,918 898,858 1,760,912 Units redeemed and transferred to other funding options......... (14,178,475) (2,040,267) (979,701) (987,033) --------------- ---------------- --------------- ---------------- Units end of year................ 665 13,799,854 8,820,511 8,901,354 =============== ================ =============== ================ [Enlarge/Download Table] IVY FUNDS VIP LMPVET CLEARBRIDGE LMPVET CLEARBRIDGE ASSET STRATEGY VARIABLE AGGRESSIVE GROWTH VARIABLE APPRECIATION SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT --------------- ------------------------------- ------------------------------- 2014 (A) 2014 2013 2014 2013 --------------- -------------- --------------- --------------- -------------- Units beginning of year.......... -- 11,979,001 11,687,754 8,604,407 7,908,912 Units issued and transferred from other funding options.... 2,575 1,920,641 2,702,461 851,450 1,753,644 Units redeemed and transferred to other funding options......... -- (2,565,916) (2,411,214) (1,187,136) (1,058,149) --------------- -------------- --------------- --------------- -------------- Units end of year................ 2,575 11,333,726 11,979,001 8,268,721 8,604,407 =============== ============== =============== =============== ============== LMPVET CLEARBRIDGE LMPVET CLEARBRIDGE VARIABLE VARIABLE EQUITY INCOME LARGE CAP GROWTH SUB-ACCOUNT SUB-ACCOUNT -------------------------------- ------------------------------- 2014 2013 2014 2013 --------------- --------------- -------------- --------------- Units beginning of year.......... 10,244,154 9,055,914 242,954 283,429 Units issued and transferred from other funding options.... 1,214,502 2,599,732 14,647 16,933 Units redeemed and transferred to other funding options......... (1,662,434) (1,411,492) (57,222) (57,408) --------------- --------------- -------------- --------------- Units end of year................ 9,796,222 10,244,154 200,379 242,954 =============== =============== ============== =============== LMPVET CLEARBRIDGE VARIABLE LARGE CAP VALUE SUB-ACCOUNT ------------------------------- 2014 2013 -------------- --------------- Units beginning of year.......... 319,601 286,427 Units issued and transferred from other funding options.... 102,351 91,925 Units redeemed and transferred to other funding options......... (52,727) (58,751) -------------- --------------- Units end of year................ 369,225 319,601 ============== =============== [Enlarge/Download Table] LMPVET PERMAL LMPVET CLEARBRIDGE VARIABLE ALTERNATIVE LMPVET VARIABLE SMALL CAP GROWTH SELECT VIT LIFESTYLE ALLOCATION 50% SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------------------- --------------- -------------------------------- 2014 2013 2014 (A) 2014 2013 -------------- --------------- --------------- --------------- --------------- Units beginning of year.......... 4,102,827 3,457,289 -- 2,011,433 1,699,443 Units issued and transferred from other funding options.... 797,486 1,487,008 64,025 227,347 532,901 Units redeemed and transferred to other funding options......... (794,707) (841,470) -- (372,481) (220,911) -------------- --------------- --------------- --------------- --------------- Units end of year................ 4,105,606 4,102,827 64,025 1,866,299 2,011,433 ============== =============== =============== =============== =============== LMPVET VARIABLE LMPVET VARIABLE LIFESTYLE LIFESTYLE ALLOCATION 70% ALLOCATION 85% SUB-ACCOUNT SUB-ACCOUNT ------------------------------- -------------------------------- 2014 2013 2014 2013 --------------- -------------- --------------- --------------- Units beginning of year.......... 121,395 162,342 4,790,185 5,015,187 Units issued and transferred from other funding options.... 5,821 12,965 247,187 343,106 Units redeemed and transferred to other funding options......... (28,799) (53,912) (508,043) (568,108) --------------- -------------- --------------- --------------- Units end of year................ 98,417 121,395 4,529,329 4,790,185 =============== ============== =============== =============== LMPVIT WESTERN ASSET VARIABLE GLOBAL HIGH YIELD BOND SUB-ACCOUNT -------------------------------- 2014 2013 --------------- --------------- Units beginning of year.......... 4,386,878 4,039,328 Units issued and transferred from other funding options.... 599,910 1,173,324 Units redeemed and transferred to other funding options......... (666,641) (825,774) --------------- --------------- Units end of year................ 4,320,147 4,386,878 =============== =============== (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. (c) For the period April 29, 2013 to December 31, 2013. 110
485BPOS204th Page of 388TOC1stPreviousNextBottomJust 204th
111
485BPOS205th Page of 388TOC1stPreviousNextBottomJust 205th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 7. SCHEDULES OF UNITS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2014 AND 2013: [Enlarge/Download Table] MFS VIT INVESTORS TRUST MFS VIT NEW DISCOVERY SUB-ACCOUNT SUB-ACCOUNT -------------------------------- -------------------------------- 2014 2013 2014 2013 --------------- --------------- --------------- --------------- Units beginning of year.......... 3,517 3,616 3,294 4,161 Units issued and transferred from other funding options.... -- -- -- -- Units redeemed and transferred to other funding options......... (2,326) (99) (116) (867) --------------- --------------- --------------- --------------- Units end of year................ 1,191 3,517 3,178 3,294 =============== =============== =============== =============== MIST ALLIANZ GLOBAL INVESTORS MIST ALLIANCEBERNSTEIN GLOBAL DYNAMIC MFS VIT RESEARCH DYNAMIC ALLOCATION MULTI-ASSET PLUS SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------------------- -------------------------------- ---------------- 2014 2013 2014 2013 2014 (B) --------------- --------------- --------------- --------------- --------------- Units beginning of year.......... 8,132 8,335 286,256,086 267,334,005 -- Units issued and transferred from other funding options.... -- 92 14,726,914 49,782,034 19,099,470 Units redeemed and transferred to other funding options......... (5,017) (295) (25,638,063) (30,859,953) (879,946) --------------- --------------- --------------- --------------- --------------- Units end of year................ 3,115 8,132 275,344,937 286,256,086 18,219,524 =============== =============== =============== =============== =============== MIST AMERICAN FUNDS BALANCED ALLOCATION SUB-ACCOUNT -------------------------------- 2014 2013 --------------- --------------- Units beginning of year.......... 276,830,535 292,605,761 Units issued and transferred from other funding options.... 16,871,646 18,431,005 Units redeemed and transferred to other funding options......... (29,558,236) (34,206,231) --------------- --------------- Units end of year................ 264,143,945 276,830,535 =============== =============== [Enlarge/Download Table] MIST AMERICAN FUNDS GROWTH ALLOCATION MIST AMERICAN FUNDS GROWTH SUB-ACCOUNT SUB-ACCOUNT ------------------------------- -------------------------------- 2014 2013 2014 2013 --------------- -------------- --------------- --------------- Units beginning of year.......... 147,794,512 149,020,463 59,593,818 54,812,434 Units issued and transferred from other funding options.... 15,093,995 20,136,813 25,206,532 19,877,224 Units redeemed and transferred to other funding options......... (19,947,947) (21,362,764) (12,939,646) (15,095,840) --------------- -------------- --------------- --------------- Units end of year................ 142,940,560 147,794,512 71,860,704 59,593,818 =============== ============== =============== =============== MIST AMERICAN FUNDS MIST AQR GLOBAL RISK MODERATE ALLOCATION BALANCED SUB-ACCOUNT SUB-ACCOUNT ------------------------------- ------------------------------- 2014 2013 2014 2013 -------------- --------------- --------------- -------------- Units beginning of year.......... 147,773,215 159,499,085 295,108,196 324,843,850 Units issued and transferred from other funding options.... 5,811,912 6,661,377 14,864,956 59,582,950 Units redeemed and transferred to other funding options......... (16,274,521) (18,387,247) (44,065,069) (89,318,604) -------------- --------------- --------------- -------------- Units end of year................ 137,310,606 147,773,215 265,908,083 295,108,196 ============== =============== =============== ============== MIST BLACKROCK GLOBAL TACTICAL STRATEGIES MIST BLACKROCK HIGH YIELD SUB-ACCOUNT SUB-ACCOUNT -------------------------------- ------------------------------- 2014 2013 2014 2013 --------------- --------------- -------------- --------------- Units beginning of year.......... 487,574,727 471,913,542 10,783,682 11,949,833 Units issued and transferred from other funding options.... 21,197,067 76,646,145 3,291,085 4,448,298 Units redeemed and transferred to other funding options......... (44,809,238) (60,984,960) (4,477,857) (5,614,449) --------------- --------------- -------------- --------------- Units end of year................ 463,962,556 487,574,727 9,596,910 10,783,682 =============== =============== ============== =============== [Enlarge/Download Table] MIST CLEARBRIDGE MIST CLARION GLOBAL REAL ESTATE AGGRESSIVE GROWTH SUB-ACCOUNT SUB-ACCOUNT --------------------------------- ------------------------------- 2014 2013 2014 2013 --------------- --------------- --------------- -------------- Units beginning of year.......... 11,099,591 10,967,900 36,299,683 33,802,849 Units issued and transferred from other funding options.... 9,572,619 3,149,547 15,149,360 12,353,599 Units redeemed and transferred to other funding options......... (3,426,313) (3,017,856) (12,976,785) (9,856,765) --------------- --------------- --------------- -------------- Units end of year................ 17,245,897 11,099,591 38,472,258 36,299,683 =============== =============== =============== ============== MIST GOLDMAN SACHS MIST HARRIS OAKMARK MID CAP VALUE INTERNATIONAL SUB-ACCOUNT SUB-ACCOUNT -------------------------------- ------------------------------- 2014 2013 2014 2013 --------------- --------------- --------------- -------------- Units beginning of year.......... 7,939,384 8,486,283 25,769,452 25,722,293 Units issued and transferred from other funding options.... 1,518,268 2,123,717 5,859,747 6,769,558 Units redeemed and transferred to other funding options......... (1,980,053) (2,670,616) (5,078,007) (6,722,399) --------------- --------------- --------------- -------------- Units end of year................ 7,477,599 7,939,384 26,551,192 25,769,452 =============== =============== =============== ============== MIST INVESCO BALANCED-RISK ALLOCATION MIST INVESCO COMSTOCK SUB-ACCOUNT SUB-ACCOUNT -------------------------------- ------------------------------- 2014 2013 2014 2013 --------------- --------------- --------------- -------------- Units beginning of year.......... 800,860,953 631,214,101 26,889,264 26,662,653 Units issued and transferred from other funding options.... 107,191,182 443,294,590 23,440,874 6,360,415 Units redeemed and transferred to other funding options......... (149,157,421) (273,647,738) (7,154,465) (6,133,804) --------------- --------------- --------------- -------------- Units end of year................ 758,894,714 800,860,953 43,175,673 26,889,264 =============== =============== =============== ============== [Enlarge/Download Table] MIST INVESCO MID CAP VALUE MIST INVESCO SMALL CAP GROWTH MIST JPMORGAN CORE BOND SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------------------- ------------------------------- ------------------------------ 2014 2013 2014 2013 2014 2013 -------------- --------------- -------------- --------------- -------------- -------------- Units beginning of year.......... 4,619,902 5,175,603 13,003,134 13,528,657 29,439,490 31,242,391 Units issued and transferred from other funding options.... 3,350,673 726,776 1,937,345 3,270,520 8,988,746 69,538,044 Units redeemed and transferred to other funding options......... (1,042,705) (1,282,477) (3,116,204) (3,796,043) (6,023,904) (71,340,945) -------------- --------------- -------------- --------------- -------------- -------------- Units end of year................ 6,927,870 4,619,902 11,824,275 13,003,134 32,404,332 29,439,490 ============== =============== ============== =============== ============== ============== MIST JPMORGAN GLOBAL MIST LOOMIS SAYLES ACTIVE ALLOCATION MIST JPMORGAN SMALL CAP VALUE GLOBAL MARKETS SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------------------ ------------------------------- ------------------------------- 2014 2013 2014 2013 2014 2013 -------------- -------------- --------------- -------------- --------------- -------------- Units beginning of year.......... 649,853,969 269,034,003 1,455,583 1,643,159 10,842,823 12,318,466 Units issued and transferred from other funding options.... 170,099,962 441,036,411 187,504 124,281 1,881,971 1,930,340 Units redeemed and transferred to other funding options......... (72,687,747) (60,216,445) (225,143) (311,857) (2,280,062) (3,405,983) -------------- -------------- --------------- -------------- --------------- -------------- Units end of year................ 747,266,184 649,853,969 1,417,944 1,455,583 10,444,732 10,842,823 ============== ============== =============== ============== =============== ============== (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. (c) For the period April 29, 2013 to December 31, 2013. 112
485BPOS206th Page of 388TOC1stPreviousNextBottomJust 206th
113
485BPOS207th Page of 388TOC1stPreviousNextBottomJust 207th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 7. SCHEDULES OF UNITS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2014 AND 2013: [Enlarge/Download Table] MIST LORD ABBETT MIST MET/EATON VANCE BOND DEBENTURE FLOATING RATE SUB-ACCOUNT SUB-ACCOUNT ------------------------------- -------------------------------- 2014 2013 2014 2013 -------------- --------------- --------------- --------------- Units beginning of year.......... 9,341,018 10,178,078 7,519,969 5,007,151 Units issued and transferred from other funding options.... 1,778,947 2,088,131 1,914,132 4,910,363 Units redeemed and transferred to other funding options......... (2,929,850) (2,925,191) (2,690,662) (2,397,545) -------------- --------------- --------------- --------------- Units end of year................ 8,190,115 9,341,018 6,743,439 7,519,969 ============== =============== =============== =============== MIST MET/FRANKLIN MIST MET/TEMPLETON LOW DURATION TOTAL RETURN INTERNATIONAL BOND SUB-ACCOUNT SUB-ACCOUNT -------------------------------- ------------------------------- 2014 2013 2014 2013 --------------- --------------- -------------- --------------- Units beginning of year.......... 14,050,793 4,349,231 3,905,329 4,238,395 Units issued and transferred from other funding options.... 9,769,054 13,737,199 444,582 985,885 Units redeemed and transferred to other funding options......... (6,398,165) (4,035,637) (812,414) (1,318,951) --------------- --------------- -------------- --------------- Units end of year................ 17,421,682 14,050,793 3,537,497 3,905,329 =============== =============== ============== =============== MIST METLIFE MIST METLIFE ASSET ALLOCATION 100 BALANCED PLUS SUB-ACCOUNT SUB-ACCOUNT -------------------------------- -------------------------------- 2014 2013 2014 2013 --------------- --------------- --------------- --------------- Units beginning of year.......... 42,451,280 44,655,767 547,096,627 438,994,467 Units issued and transferred from other funding options.... 3,131,273 4,811,432 67,969,703 154,477,158 Units redeemed and transferred to other funding options......... (5,666,683) (7,015,919) (45,207,144) (46,374,998) --------------- --------------- --------------- --------------- Units end of year................ 39,915,870 42,451,280 569,859,186 547,096,627 =============== =============== =============== =============== [Enlarge/Download Table] MIST METLIFE MULTI-INDEX MIST MFS TARGETED RISK MIST METLIFE SMALL CAP VALUE EMERGING MARKETS EQUITY SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------------------- ------------------------------- ------------------------------- 2014 2013 2014 2013 2014 2013 -------------- --------------- -------------- --------------- -------------- --------------- Units beginning of year.......... 153,950,143 11,094,386 13,992,716 15,859,523 41,623,177 38,352,212 Units issued and transferred from other funding options.... 155,759,625 150,360,164 1,447,253 1,894,187 10,380,546 12,177,917 Units redeemed and transferred to other funding options......... (28,192,850) (7,504,407) (3,140,882) (3,760,994) (9,821,392) (8,906,952) -------------- --------------- -------------- --------------- -------------- --------------- Units end of year................ 281,516,918 153,950,143 12,299,087 13,992,716 42,182,331 41,623,177 ============== =============== ============== =============== ============== =============== MIST MFS MIST MORGAN STANLEY MIST OPPENHEIMER RESEARCH INTERNATIONAL MID CAP GROWTH GLOBAL EQUITY SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------------------- ------------------------------- ------------------------------- 2014 2013 2014 2013 2014 2013 -------------- --------------- -------------- --------------- -------------- --------------- Units beginning of year.......... 19,616,483 21,667,563 13,099,903 12,225,316 3,127,720 500,711 Units issued and transferred from other funding options.... 1,973,110 2,142,621 1,969,239 3,100,228 158,724 3,443,548 Units redeemed and transferred to other funding options......... (3,003,931) (4,193,701) (2,140,592) (2,225,641) (420,366) (816,539) -------------- --------------- -------------- --------------- -------------- --------------- Units end of year................ 18,585,662 19,616,483 12,928,550 13,099,903 2,866,078 3,127,720 ============== =============== ============== =============== ============== =============== [Enlarge/Download Table] MIST PANAGORA GLOBAL MIST PIMCO MIST PIMCO DIVERSIFIED RISK INFLATION PROTECTED BOND TOTAL RETURN SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ---------------- ------------------------------- ------------------------------- 2014 (B) 2014 2013 2014 2013 ---------------- --------------- -------------- --------------- -------------- Units beginning of year.......... -- 57,648,505 64,013,091 118,419,838 128,302,689 Units issued and transferred from other funding options.... 11,245,493 6,093,264 14,947,068 16,795,318 24,830,457 Units redeemed and transferred to other funding options......... (1,457,385) (12,990,560) (21,311,654) (31,710,569) (34,713,308) ---------------- --------------- -------------- --------------- -------------- Units end of year................ 9,788,108 50,751,209 57,648,505 103,504,587 118,419,838 ================ =============== ============== =============== ============== MIST PIONEER MIST PYRAMIS MIST PIONEER FUND STRATEGIC INCOME GOVERNMENT INCOME SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------------------- ------------------------------- ------------------------------- 2014 2013 2014 2013 2014 2013 --------------- -------------- --------------- -------------- --------------- -------------- Units beginning of year.......... 12,432,551 11,331,680 41,450,021 29,638,373 69,488,361 88,599,553 Units issued and transferred from other funding options.... 2,058,176 3,073,514 21,542,858 17,942,693 9,869,116 20,394,869 Units redeemed and transferred to other funding options......... (1,941,350) (1,972,643) (8,521,536) (6,131,045) (17,070,524) (39,506,061) --------------- -------------- --------------- -------------- --------------- -------------- Units end of year................ 12,549,377 12,432,551 54,471,343 41,450,021 62,286,953 69,488,361 =============== ============== =============== ============== =============== ============== [Enlarge/Download Table] MIST SCHRODERS MIST SSGA MIST PYRAMIS MANAGED RISK GLOBAL MULTI-ASSET GROWTH AND INCOME ETF SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------------------- ------------------------------- ------------------------------ 2014 2013 (C) 2014 2013 2014 2013 -------------- --------------- -------------- --------------- -------------- -------------- Units beginning of year.......... 7,294,047 -- 375,261,358 179,641,654 110,435,377 118,446,237 Units issued and transferred from other funding options.... 8,511,959 7,910,133 78,123,472 254,720,312 4,643,095 8,842,539 Units redeemed and transferred to other funding options......... (1,601,740) (616,086) (52,924,615) (59,100,608) (13,462,353) (16,853,399) -------------- --------------- -------------- --------------- -------------- -------------- Units end of year................ 14,204,266 7,294,047 400,460,215 375,261,358 101,616,119 110,435,377 ============== =============== ============== =============== ============== ============== MIST T. ROWE PRICE MIST T. ROWE PRICE MIST SSGA GROWTH ETF LARGE CAP VALUE MID CAP GROWTH SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------------------ ------------------------------- ------------------------------- 2014 2013 2014 2013 2014 2013 -------------- -------------- --------------- -------------- --------------- -------------- Units beginning of year.......... 35,919,224 36,733,044 11,320,980 12,231,249 37,965,912 41,941,697 Units issued and transferred from other funding options.... 3,767,077 5,769,705 4,566,334 1,603,300 3,650,675 6,286,743 Units redeemed and transferred to other funding options......... (5,593,912) (6,583,525) (2,365,967) (2,513,569) (9,306,316) (10,262,528) -------------- -------------- --------------- -------------- --------------- -------------- Units end of year................ 34,092,389 35,919,224 13,521,347 11,320,980 32,310,271 37,965,912 ============== ============== =============== ============== =============== ============== (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. (c) For the period April 29, 2013 to December 31, 2013. 114
485BPOS208th Page of 388TOC1stPreviousNextBottomJust 208th
115
485BPOS209th Page of 388TOC1stPreviousNextBottomJust 209th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 7. SCHEDULES OF UNITS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2014 AND 2013: [Enlarge/Download Table] MIST WMC MSF BAILLIE GIFFORD LARGE CAP RESEARCH INTERNATIONAL STOCK SUB-ACCOUNT SUB-ACCOUNT ------------------------------- -------------------------------- 2014 2013 2014 2013 --------------- -------------- --------------- --------------- Units beginning of year.......... 1,260,254 1,423,242 29,549,817 219,106 Units issued and transferred from other funding options.... 135,560 248,426 2,706,528 35,014,663 Units redeemed and transferred to other funding options......... (244,143) (411,414) (4,683,228) (5,683,952) --------------- -------------- --------------- --------------- Units end of year................ 1,151,671 1,260,254 27,573,117 29,549,817 =============== ============== =============== =============== MSF BARCLAYS MSF BLACKROCK MSF BLACKROCK AGGREGATE BOND INDEX BOND INCOME CAPITAL APPRECIATION SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------------------- ------------------------------- ------------------------------- 2014 2013 2014 2013 2014 2013 -------------- --------------- -------------- --------------- --------------- -------------- Units beginning of year.......... 13,536,937 10,756,748 1,054,348 1,045,629 721,215 745,728 Units issued and transferred from other funding options.... 6,144,916 6,105,533 243,287 259,586 99,371 149,273 Units redeemed and transferred to other funding options......... (3,582,152) (3,325,344) (191,883) (250,867) (180,678) (173,786) -------------- --------------- -------------- --------------- --------------- -------------- Units end of year................ 16,099,701 13,536,937 1,105,752 1,054,348 639,908 721,215 ============== =============== ============== =============== =============== ============== MSF BLACKROCK LARGE CAP VALUE SUB-ACCOUNT -------------------------------- 2014 2013 --------------- --------------- Units beginning of year.......... 225,190 230,438 Units issued and transferred from other funding options.... 49,481 39,765 Units redeemed and transferred to other funding options......... (44,704) (45,013) --------------- --------------- Units end of year................ 229,967 225,190 =============== =============== [Enlarge/Download Table] MSF BLACKROCK MONEY MARKET MSF FRONTIER MID CAP GROWTH MSF JENNISON GROWTH SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------------------- ------------------------------- ------------------------------ 2014 2013 2014 2013 (C) 2014 2013 -------------- --------------- -------------- --------------- -------------- -------------- Units beginning of year.......... 44,329,198 53,484,009 4,767,721 -- 32,574,197 35,125,323 Units issued and transferred from other funding options.... 34,263,648 42,460,926 469,614 5,813,772 2,242,773 6,890,303 Units redeemed and transferred to other funding options......... (39,524,364) (51,615,737) (988,963) (1,046,051) (7,288,583) (9,441,429) -------------- --------------- -------------- --------------- -------------- -------------- Units end of year................ 39,068,482 44,329,198 4,248,372 4,767,721 27,528,387 32,574,197 ============== =============== ============== =============== ============== ============== MSF LOOMIS SAYLES MSF LOOMIS SAYLES MSF MET/ARTISAN SMALL CAP CORE SMALL CAP GROWTH MID CAP VALUE SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------------------ ------------------------------- ------------------------------- 2014 2013 2014 2013 2014 2013 -------------- -------------- --------------- -------------- --------------- -------------- Units beginning of year.......... 283,327 330,015 12,506 3,306 13,125,790 13,419,571 Units issued and transferred from other funding options.... 28,393 60,857 5,011 13,578 999,169 2,613,526 Units redeemed and transferred to other funding options......... (50,660) (107,545) (1,215) (4,378) (2,919,692) (2,907,307) -------------- -------------- --------------- -------------- --------------- -------------- Units end of year................ 261,060 283,327 16,302 12,506 11,205,267 13,125,790 ============== ============== =============== ============== =============== ============== [Enlarge/Download Table] MSF MET/DIMENSIONAL MSF METLIFE INTERNATIONAL SMALL COMPANY ASSET ALLOCATION 20 SUB-ACCOUNT SUB-ACCOUNT -------------------------------- -------------------------------- 2014 2013 2014 2013 --------------- --------------- --------------- --------------- Units beginning of year.......... 3,208,551 3,203,412 557,035 735,694 Units issued and transferred from other funding options.... 923,235 832,391 4,014,103 51,604 Units redeemed and transferred to other funding options......... (1,061,462) (827,252) (1,597,561) (230,263) --------------- --------------- --------------- --------------- Units end of year................ 3,070,324 3,208,551 2,973,577 557,035 =============== =============== =============== =============== MSF METLIFE MSF METLIFE ASSET ALLOCATION 40 ASSET ALLOCATION 60 SUB-ACCOUNT SUB-ACCOUNT -------------------------------- -------------------------------- 2014 2013 2014 2013 --------------- --------------- --------------- --------------- Units beginning of year.......... 550,896 588,986 3,073,122 3,326,548 Units issued and transferred from other funding options.... 384,962,898 17,083 533,719,873 91,734 Units redeemed and transferred to other funding options......... (44,496,679) (55,173) (46,954,770) (345,160) --------------- --------------- --------------- --------------- Units end of year................ 341,017,115 550,896 489,838,225 3,073,122 =============== =============== =============== =============== MSF METLIFE MSF METLIFE ASSET ALLOCATION 80 MID CAP STOCK INDEX SUB-ACCOUNT SUB-ACCOUNT -------------------------------- -------------------------------- 2014 2013 2014 2013 --------------- --------------- --------------- --------------- Units beginning of year.......... 3,927,901 4,335,356 5,501,359 4,914,049 Units issued and transferred from other funding options.... 453,377,945 54,564 1,229,805 2,339,087 Units redeemed and transferred to other funding options......... (36,732,921) (462,019) (1,552,703) (1,751,777) --------------- --------------- --------------- --------------- Units end of year................ 420,572,925 3,927,901 5,178,461 5,501,359 =============== =============== =============== =============== [Enlarge/Download Table] MSF METLIFE STOCK INDEX MSF MFS TOTAL RETURN MSF MFS VALUE SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------------------ ------------------------------ ------------------------------ 2014 2013 2014 2013 2014 2013 -------------- -------------- -------------- -------------- -------------- -------------- Units beginning of year............ 28,624,388 29,109,224 814,124 730,405 12,139,878 3,025,966 Units issued and transferred from other funding options...... 6,253,090 6,636,730 82,183 213,323 1,347,935 11,667,337 Units redeemed and transferred to other funding options........... (6,612,604) (7,121,566) (140,240) (129,604) (2,570,905) (2,553,425) -------------- -------------- -------------- -------------- -------------- -------------- Units end of year.................. 28,264,874 28,624,388 756,067 814,124 10,916,908 12,139,878 ============== ============== ============== ============== ============== ============== MSF MSCI EAFE INDEX MSF NEUBERGER BERMAN GENESIS MSF RUSSELL 2000 INDEX SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------------------- ------------------------------ ------------------------------ 2014 2013 2014 2013 2014 2013 --------------- -------------- -------------- -------------- -------------- -------------- Units beginning of year............ 8,809,646 7,172,234 8,020,175 626,194 5,835,501 5,078,788 Units issued and transferred from other funding options...... 1,960,333 3,468,301 707,452 8,992,058 1,445,125 2,243,147 Units redeemed and transferred to other funding options........... (2,072,447) (1,830,889) (1,617,845) (1,598,077) (1,473,612) (1,486,434) --------------- -------------- -------------- -------------- -------------- -------------- Units end of year.................. 8,697,532 8,809,646 7,109,782 8,020,175 5,807,014 5,835,501 =============== ============== ============== ============== ============== ============== (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. (c) For the period April 29, 2013 to December 31, 2013. 116
485BPOS210th Page of 388TOC1stPreviousNextBottomJust 210th
117
485BPOS211th Page of 388TOC1stPreviousNextBottomJust 211th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 7. SCHEDULES OF UNITS -- (CONTINUED) FOR THE YEARS ENDED DECEMBER 31, 2014 AND 2013: [Enlarge/Download Table] MSF T. ROWE PRICE MSF T. ROWE PRICE LARGE CAP GROWTH SMALL CAP GROWTH SUB-ACCOUNT SUB-ACCOUNT ------------------------------- -------------------------------- 2014 2013 2014 2013 --------------- -------------- --------------- --------------- Units beginning of year.......... 14,688,080 39,346 356,919 380,162 Units issued and transferred from other funding options.... 5,921,810 18,370,073 53,389 74,979 Units redeemed and transferred to other funding options......... (5,594,516) (3,721,339) (89,235) (98,222) --------------- -------------- --------------- --------------- Units end of year................ 15,015,374 14,688,080 321,073 356,919 =============== ============== =============== =============== MSF WESTERN ASSET MANAGEMENT MSF VAN ECK STRATEGIC BOND MSF WESTERN ASSET MANAGEMENT GLOBAL NATURAL RESOURCES OPPORTUNITIES U.S. GOVERNMENT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------------------- -------------- -------------------------------- 2014 2013 2014 (A) 2014 2013 -------------- --------------- -------------- --------------- --------------- Units beginning of year.......... 6,278,667 7,200,491 -- 16,417,493 17,244,875 Units issued and transferred from other funding options.... 1,787,920 1,538,360 398 2,668,864 4,180,259 Units redeemed and transferred to other funding options......... (1,479,922) (2,460,184) -- (3,739,821) (5,007,641) -------------- --------------- -------------- --------------- --------------- Units end of year................ 6,586,665 6,278,667 398 15,346,536 16,417,493 ============== =============== ============== =============== =============== MSF WMC CORE EQUITY OPPORTUNITIES SUB-ACCOUNT ------------------------------- 2014 2013 -------------- --------------- Units beginning of year.......... 36,209,587 41,401,029 Units issued and transferred from other funding options.... 2,050,455 3,841,529 Units redeemed and transferred to other funding options......... (7,542,024) (9,032,971) -------------- --------------- Units end of year................ 30,718,018 36,209,587 ============== =============== [Enlarge/Download Table] OPPENHEIMER VA NEUBERGER BERMAN GENESIS OPPENHEIMER VA CORE BOND GLOBAL STRATEGIC INCOME SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------------------- ------------------------------- ------------------------------- 2014 2013 2014 2013 2014 2013 -------------- --------------- -------------- --------------- -------------- --------------- Units beginning of year.......... 474 474 1,493 1,541 443 443 Units issued and transferred from other funding options.... -- -- -- -- -- -- Units redeemed and transferred to other funding options......... (81) -- (131) (48) -- -- -------------- --------------- -------------- --------------- -------------- --------------- Units end of year................ 393 474 1,362 1,493 443 443 ============== =============== ============== =============== ============== =============== OPPENHEIMER VA MAIN STREET SMALL CAP OPPENHEIMER VA MAIN STREET OPPENHEIMER VA MONEY SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT ------------------------------- ------------------------------- ------------------------------- 2014 2013 2014 2013 2014 2013 -------------- --------------- -------------- --------------- --------------- -------------- Units beginning of year.......... 4,655,290 5,041,901 14,316 14,959 723 20,150 Units issued and transferred from other funding options.... 411,658 643,815 -- -- -- -- Units redeemed and transferred to other funding options......... (720,446) (1,030,426) (944) (643) (27) (19,427) -------------- --------------- -------------- --------------- --------------- -------------- Units end of year................ 4,346,502 4,655,290 13,372 14,316 696 723 ============== =============== ============== =============== =============== ============== [Enlarge/Download Table] PIMCO VIT COMMODITY- PIMCO VIT PIMCO VIT REALRETURN EMERGING UNCONSTRAINED STRATEGY MARKET BOND BOND PIONEER VCT MID CAP VALUE SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT --------------- ---------------- --------------- -------------------------------- 2014 (A) 2014 (A) 2014 (A) 2014 2013 --------------- ---------------- --------------- --------------- --------------- Units beginning of year.......... -- -- -- 1,719,853 1,769,793 Units issued and transferred from other funding options.... 1,515 1,592 478 151,338 220,661 Units redeemed and transferred to other funding options......... -- -- -- (289,914) (270,601) --------------- ---------------- --------------- --------------- --------------- Units end of year................ 1,515 1,592 478 1,581,277 1,719,853 =============== ================ =============== =============== =============== PIONEER VCT REAL ESTATE SHARES T. ROWE PRICE GROWTH STOCK SUB-ACCOUNT SUB-ACCOUNT -------------------------------- -------------------------------- 2014 2013 2014 2013 --------------- --------------- --------------- --------------- Units beginning of year.......... 11,399 10,700 62,571 66,302 Units issued and transferred from other funding options.... 225 1,372 6,322 6,234 Units redeemed and transferred to other funding options......... (2,852) (673) (16,639) (9,965) --------------- --------------- --------------- --------------- Units end of year................ 8,772 11,399 52,254 62,571 =============== =============== =============== =============== T. ROWE PRICE INTERNATIONAL STOCK SUB-ACCOUNT ---------------------------------- 2014 2013 --------------- --------------- Units beginning of year.......... 41,360 45,736 Units issued and transferred from other funding options.... 2,072 1,435 Units redeemed and transferred to other funding options......... (3,434) (5,811) --------------- --------------- Units end of year................ 39,998 41,360 =============== =============== (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. (c) For the period April 29, 2013 to December 31, 2013. 118
485BPOS212th Page of 388TOC1stPreviousNextBottomJust 212th
119
485BPOS213th Page of 388TOC1stPreviousNextBottomJust 213th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 7. SCHEDULES OF UNITS -- (CONCLUDED) FOR THE YEARS ENDED DECEMBER 31, 2014 AND 2013: [Enlarge/Download Table] TAP 1919 VARIABLE SOCIALLY UIF GLOBAL T. ROWE PRICE PRIME RESERVE RESPONSIVE BALANCED INFRASTRUCTURE SUB-ACCOUNT SUB-ACCOUNT SUB-ACCOUNT -------------------------------- --------------------------------- --------------- 2014 2013 2014 2013 2014 (A) --------------- --------------- ---------------- --------------- --------------- Units beginning of year.......... 31,743 40,746 7,932 9,185 -- Units issued and transferred from other funding options.... 28,287 30,026 427 363 664 Units redeemed and transferred to other funding options......... (30,543) (39,029) (1,953) (1,616) -- --------------- --------------- ---------------- --------------- --------------- Units end of year................ 29,487 31,743 6,406 7,932 664 =============== =============== ================ =============== =============== VAN ECK VIP LONG/SHORT EQUITY INDEX FUND SUB-ACCOUNT ---------------- 2014 (A) ---------------- Units beginning of year.......... -- Units issued and transferred from other funding options.... 1,662 Units redeemed and transferred to other funding options......... -- ---------------- Units end of year................ 1,662 ================ (a) For the period November 19, 2014 to December 31, 2014. (b) For the period April 28, 2014 to December 31, 2014. (c) For the period April 29, 2013 to December 31, 2013. 120
485BPOS214th Page of 388TOC1stPreviousNextBottomJust 214th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 8. FINANCIAL HIGHLIGHTS The Company sells a number of variable annuity products which have unique combinations of features and fees, some of which directly affect the unit values of the Sub-Accounts. Differences in the fee structures result in a variety of unit values, expense ratios, and total returns. The following table is a summary of unit values and units outstanding for the Contracts, net investment income ratios, and expense ratios, excluding expenses for the underlying portfolio, series or fund, for the respective stated periods in the five years ended December 31, 2014: [Enlarge/Download Table] AS OF DECEMBER 31 --------------------------------------------- UNIT VALUE LOWEST TO NET UNITS HIGHEST ($) ASSETS ($) ------------ --------------- -------------- Alger Small Cap Growth 2014 3,970,857 14.28 - 14.58 57,195,868 Sub-Account 2013 4,387,118 14.41 - 14.70 63,772,199 2012 4,795,545 10.89 - 11.09 52,626,085 2011 5,212,661 9.82 - 9.98 51,540,007 2010 5,634,931 10.28 - 10.44 58,325,342 American Funds Bond 2014 8,333,829 16.47 - 19.48 151,245,946 Sub-Account 2013 8,361,945 15.94 - 18.68 146,158,351 2012 7,687,811 16.60 - 19.27 139,213,016 2011 6,703,194 16.06 - 18.46 116,697,267 2010 5,183,483 15.43 - 17.57 86,203,052 American Funds Global 2014 8,193,931 32.79 - 42.00 312,209,187 Growth Sub-Account 2013 8,333,553 32.79 - 41.42 314,826,203 2012 8,485,913 25.98 - 32.35 251,295,328 2011 8,205,329 21.69 - 26.44 200,460,185 2010 7,470,107 24.36 - 29.30 202,441,649 American Funds Global Small 2014 3,297,014 13.05 - 40.07 122,112,070 Capitalization Sub-Account 2013 3,375,743 33.79 - 39.59 124,184,003 2012 3,385,796 26.85 - 31.14 98,386,346 2011 3,080,674 23.15 - 26.58 76,801,888 2010 2,578,008 29.19 - 33.17 80,582,925 American Funds Growth 2014 3,527,704 179.03 - 276.84 821,201,132 Sub-Account 2013 3,937,244 168.83 - 257.41 856,560,204 2012 4,113,319 132.79 - 199.62 696,665,988 2011 3,976,212 115.27 - 170.85 577,437,630 2010 3,717,676 123.22 - 180.08 568,813,924 American Funds 2014 2,378,568 127.56 - 197.24 390,905,716 Growth-Income Sub-Account 2013 2,581,885 117.99 - 179.88 388,319,990 2012 2,745,842 90.43 - 135.94 312,823,451 2011 2,773,925 78.78 - 116.75 272,388,909 2010 2,639,070 82.11 - 119.99 266,511,951 BlackRock Global Allocation V.I. 2014 402 21.30 8,557 Sub-Account (Commenced 11/19/2014) Deutsche I International 2014 1,732,959 8.50 - 8.57 14,851,303 Sub-Account 2013 1,888,612 9.76 - 9.85 18,592,794 2012 2,040,232 8.24 - 8.30 16,933,216 2011 2,245,605 6.92 - 6.97 15,659,285 2010 2,471,385 8.43 - 8.48 20,962,763 FOR THE YEAR ENDED DECEMBER 31 -------------------------------------------------- INVESTMENT(1) EXPENSE RATIO(2) TOTAL RETURN(3) INCOME LOWEST TO LOWEST TO RATIO (%) HIGHEST (%) HIGHEST (%) ------------- ---------------- ----------------- Alger Small Cap Growth 2014 -- 1.25 - 1.40 (0.96) - (0.81) Sub-Account 2013 -- 1.25 - 1.40 32.40 - 32.59 2012 -- 1.25 - 1.40 10.93 - 11.09 2011 -- 1.25 - 1.40 (4.52) - (4.38) 2010 -- 1.25 - 1.40 23.54 - 23.73 American Funds Bond 2014 1.94 0.95 - 1.90 3.30 - 4.28 Sub-Account 2013 1.84 0.95 - 1.90 (4.00) - (3.08) 2012 2.64 0.95 - 1.90 3.38 - 4.37 2011 3.37 0.95 - 1.90 4.11 - 5.11 2010 3.44 0.95 - 1.90 4.44 - 5.44 American Funds Global 2014 1.16 0.90 - 2.30 (0.01) - 1.40 Growth Sub-Account 2013 1.26 0.90 - 2.30 26.24 - 28.02 2012 0.94 0.90 - 2.30 7.06 - 21.40 2011 1.37 0.95 - 2.30 (10.95) - (9.75) 2010 1.56 0.95 - 2.30 9.21 - 10.69 American Funds Global Small 2014 0.12 0.89 - 1.90 0.20 - 1.67 Capitalization Sub-Account 2013 0.87 0.89 - 1.90 25.87 - 27.14 2012 1.35 0.89 - 1.90 2.91 - 17.13 2011 1.34 0.89 - 1.90 (20.66) - (19.86) 2010 1.75 0.89 - 1.90 20.11 - 21.33 American Funds Growth 2014 0.77 0.89 - 2.30 6.04 - 7.55 Sub-Account 2013 0.93 0.89 - 2.30 27.15 - 28.95 2012 0.81 0.89 - 2.30 1.85 - 16.84 2011 0.63 0.89 - 2.30 (6.45) - (5.12) 2010 0.77 0.89 - 2.30 15.98 - 17.63 American Funds 2014 1.27 0.89 - 2.30 8.12 - 9.65 Growth-Income Sub-Account 2013 1.35 0.89 - 2.30 30.47 - 32.32 2012 1.64 0.89 - 2.30 14.80 - 16.44 2011 1.60 0.89 - 2.30 (4.06) - (2.70) 2010 1.55 0.89 - 2.30 8.90 - 10.44 BlackRock Global Allocation V.I. 2014 2.13 1.10 (0.45) Sub-Account (Commenced 11/19/2014) Deutsche I International 2014 1.76 1.35 - 1.40 (12.99) - (12.95) Sub-Account 2013 5.30 1.35 - 1.40 18.56 - 18.62 2012 2.19 1.35 - 1.40 18.96 - 19.02 2011 1.83 1.35 - 1.40 (17.83) - (17.79) 2010 2.18 1.35 - 1.40 0.21 - 0.26 121
485BPOS215th Page of 388TOC1stPreviousNextBottomJust 215th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 8. FINANCIAL HIGHLIGHTS -- (CONTINUED) [Enlarge/Download Table] AS OF DECEMBER 31 FOR THE YEAR ENDED DECEMBER 31 --------------------------------------------- ------------------------------------------------- UNIT VALUE INVESTMENT(1) EXPENSE RATIO(2) TOTAL RETURN(3) LOWEST TO NET INCOME LOWEST TO LOWEST TO UNITS HIGHEST ($) ASSETS ($) RATIO (%) HIGHEST (%) HIGHEST (%) ------------ --------------- -------------- ------------- ---------------- ---------------- Federated High Income Bond 2014 2,534 10.41 26,376 5.88 1.40 1.26 Sub-Account 2013 2,545 10.28 26,166 6.76 1.40 5.50 2012 2,556 9.74 24,908 8.87 1.40 13.09 2011 3,549 8.62 30,572 8.62 1.40 3.71 2010 3,566 8.31 29,620 7.89 1.40 13.13 Federated Kaufman 2014 5,676 8.33 47,253 -- 1.40 8.19 Sub-Account 2013 5,836 7.70 44,907 -- 1.40 38.18 (Commenced 3/15/2010) 2012 6,002 5.57 33,424 -- 1.40 15.65 2011 12,138 4.82 58,454 1.12 1.40 (14.47) 2010 14,184 5.63 79,874 -- 1.40 13.09 Fidelity VIP Asset Manager 2014 5,426,360 15.54 - 16.47 84,977,763 1.47 0.89 - 1.40 4.36 - 4.90 Sub-Account 2013 5,885,530 14.88 - 15.70 88,274,483 1.55 0.89 - 1.40 14.10 - 14.68 2012 6,517,939 13.04 - 13.69 85,640,352 1.49 0.89 - 1.40 10.91 - 11.48 2011 7,353,740 11.75 - 12.28 87,071,337 1.88 0.89 - 1.40 (3.91) - (3.42) 2010 8,263,984 12.22 - 12.71 101,784,889 1.66 0.89 - 1.40 12.67 - 13.26 Fidelity VIP Contrafund 2014 20,382,633 6.24 - 71.28 631,948,733 0.89 0.89 - 2.25 9.33 - 10.95 Sub-Account 2013 17,717,451 5.67 - 64.36 611,972,926 1.04 0.89 - 2.25 10.23 - 30.12 2012 15,604,750 12.42 - 49.54 471,113,726 1.36 0.89 - 2.25 13.71 - 15.38 2011 15,588,853 10.76 - 43.00 388,526,965 1.01 0.89 - 2.25 (4.80) - (3.38) 2010 15,707,574 11.14 - 44.59 379,741,596 1.25 0.89 - 2.25 14.51 - 16.18 Fidelity VIP Equity-Income 2014 303,711 18.69 5,676,328 2.75 1.40 7.21 Sub-Account 2013 341,560 17.43 5,954,600 2.41 1.40 26.37 2012 400,352 13.80 5,523,241 2.96 1.40 15.67 2011 460,289 11.93 5,489,918 2.37 1.40 (0.43) 2010 530,175 11.98 6,350,751 1.75 1.40 13.56 Fidelity VIP FundsManager 2014 268,426,412 13.11 - 13.28 3,538,458,593 1.45 1.90 - 2.05 2.96 - 3.12 50% Sub-Account 2013 158,954,030 12.73 - 12.88 2,033,793,788 1.55 1.90 - 2.05 12.57 - 12.74 (Commenced 7/23/2012) 2012 39,080,828 11.31 - 11.42 443,823,085 2.69 1.90 - 2.05 1.76 - 4.11 Fidelity VIP FundsManager 2014 319,425,019 12.44 - 12.58 3,994,437,491 1.24 1.90 - 2.05 3.27 - 3.42 60% Sub-Account 2013 333,151,686 12.05 - 12.16 4,031,523,824 1.16 1.90 - 2.05 16.21 - 16.38 2012 345,636,001 10.37 - 10.45 3,596,633,088 1.53 1.90 - 2.05 9.33 - 9.49 2011 272,464,191 9.48 - 9.54 2,591,601,265 2.00 1.90 - 2.05 (4.01) - (3.87) 2010 118,824,451 9.88 - 9.93 1,176,598,687 2.72 1.90 - 2.05 11.32 - 11.49 Fidelity VIP Growth 2014 7,538,876 22.06 - 23.24 167,673,930 0.18 0.89 - 1.40 9.75 - 10.31 Sub-Account 2013 8,194,380 20.10 - 21.07 165,968,439 0.29 0.89 - 1.40 34.44 - 35.13 2012 9,085,626 14.95 - 15.59 136,799,312 0.59 0.89 - 1.40 13.09 - 13.67 2011 9,918,387 13.22 - 13.72 131,974,709 0.36 0.89 - 1.40 (1.19) - (0.68) 2010 10,951,340 13.38 - 13.81 147,385,504 0.28 0.89 - 1.40 22.44 - 23.08 Fidelity VIP Index 500 2014 2,778,454 25.25 - 26.71 70,165,982 1.59 0.89 - 1.35 12.05 - 12.56 Sub-Account 2013 3,091,556 22.53 - 23.73 69,677,247 1.84 0.89 - 1.35 30.47 - 31.07 2012 3,530,426 17.27 - 18.10 60,984,620 2.03 0.89 - 1.35 14.35 - 14.88 2011 3,976,112 15.10 - 15.76 60,061,917 1.87 0.89 - 1.35 0.67 - 1.14 2010 4,565,389 14.90 - 15.58 68,501,202 1.87 0.89 - 1.40 13.42 - 14.00 122
485BPOS216th Page of 388TOC1stPreviousNextBottomJust 216th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 8. FINANCIAL HIGHLIGHTS -- (CONTINUED) [Enlarge/Download Table] AS OF DECEMBER 31 --------------------------------------------- UNIT VALUE LOWEST TO NET UNITS HIGHEST ($) ASSETS ($) ------------ --------------- -------------- Fidelity VIP Mid Cap 2014 7,445,624 55.03 - 64.08 446,277,693 Sub-Account 2013 7,792,671 52.90 - 61.01 446,581,942 2012 7,598,912 39.68 - 45.33 324,832,892 2011 6,289,465 35.30 - 39.95 237,701,501 2010 4,364,581 40.36 - 45.24 187,246,537 Fidelity VIP Money Market 2014 5,894,288 6.95 - 10.53 50,947,648 Sub-Account 2013 8,307,410 7.04 - 10.73 76,155,346 2012 8,041,430 7.14 - 10.94 73,659,399 2011 8,001,050 7.23 - 11.14 73,068,632 2010 7,492,405 7.33 - 11.34 67,343,833 Fidelity VIP Overseas 2014 411,275 11.28 - 12.89 4,942,746 Sub-Account 2013 447,143 12.41 - 14.19 5,925,521 2012 509,517 9.62 - 11.02 5,241,037 2011 540,072 8.06 - 9.24 4,664,192 2010 593,728 9.85 - 11.30 6,266,276 FTVIPT Franklin Income VIP 2014 4,717,186 49.71 - 69.63 294,909,928 Sub-Account 2013 4,919,666 48.59 - 67.20 297,821,470 2012 4,708,870 43.62 - 59.54 253,164,341 2011 4,290,472 39.61 - 53.36 206,611,149 2010 3,722,732 39.56 - 52.61 176,548,647 FTVIPT Franklin Mutual 2014 5,080,687 27.45 - 32.61 153,109,223 Shares VIP Sub-Account 2013 5,477,366 26.11 - 30.73 156,078,571 2012 5,768,385 20.75 - 24.19 129,780,562 2011 5,952,328 18.51 - 21.38 118,532,870 2010 5,431,435 19.07 - 21.81 110,507,146 FTVIPT Franklin Small Cap 2014 9,145,054 1.42 - 14.25 126,502,556 Value VIP Sub-Account 2013 9,184,423 13.56 - 14.30 128,048,983 2012 8,321,925 10.13 - 10.60 86,296,073 2011 5,710,847 8.71 - 9.04 50,705,697 2010 3,178,430 9.21 - 9.48 29,718,643 FTVIPT Templeton Foreign VIP 2014 2,354,783 14.19 - 33.39 73,607,780 Sub-Account 2013 2,457,017 16.25 - 38.21 87,721,293 2012 2,730,167 13.46 - 31.61 80,788,377 2011 2,720,421 11.59 - 27.19 69,009,193 2010 2,782,005 13.20 - 30.95 79,683,759 FTVIPT Templeton Global 2014 12,667,617 18.48 - 21.01 250,150,012 Bond VIP Sub-Account 2013 12,950,902 18.47 - 20.82 254,683,414 2012 11,067,808 18.50 - 20.69 217,063,429 2011 8,104,261 16.36 - 18.15 139,986,041 2010 4,997,591 16.79 - 18.48 88,294,177 Invesco V.I. American 2014 1,911 7.90 15,107 Franchise Sub-Account 2013 22,147 7.39 163,713 2012 28,015 5.35 149,862 2011 18,874 4.77 90,033 2010 25,363 5.16 130,764 FOR THE YEAR ENDED DECEMBER 31 -------------------------------------------------- INVESTMENT(1) EXPENSE RATIO(2) TOTAL RETURN(3) INCOME LOWEST TO LOWEST TO RATIO (%) HIGHEST (%) HIGHEST (%) ------------- ---------------- ----------------- Fidelity VIP Mid Cap 2014 0.02 0.95 - 1.90 4.04 - 5.03 Sub-Account 2013 0.28 0.95 - 1.90 33.31 - 34.59 2012 0.43 0.95 - 1.90 12.40 - 13.47 2011 0.03 0.95 - 1.90 (12.53) - (11.70) 2010 0.14 0.95 - 1.90 26.16 - 27.36 Fidelity VIP Money Market 2014 0.01 0.89 - 2.05 (2.02) - (0.88) Sub-Account 2013 0.02 0.89 - 2.05 (2.01) - (0.86) 2012 0.12 0.89 - 2.05 (1.93) - (0.76) 2011 0.09 0.89 - 2.05 (1.94) - (0.77) 2010 0.17 0.89 - 2.05 (1.82) - (0.65) Fidelity VIP Overseas 2014 1.29 1.15 - 1.40 (9.36) - (9.13) Sub-Account 2013 1.34 1.15 - 1.40 28.62 - 28.95 2012 1.97 1.15 - 1.40 19.05 - 19.35 2011 1.35 1.15 - 1.40 (18.32) - (18.12) 2010 1.39 1.15 - 1.40 11.54 - 11.82 FTVIPT Franklin Income VIP 2014 4.98 0.95 - 2.25 2.29 - 3.63 Sub-Account 2013 6.33 0.95 - 2.25 11.41 - 12.86 2012 6.44 0.95 - 2.25 10.13 - 11.58 2011 5.75 0.95 - 2.25 0.11 - 1.42 2010 6.60 0.95 - 2.25 10.17 - 11.61 FTVIPT Franklin Mutual 2014 2.00 0.95 - 1.90 5.11 - 6.11 Shares VIP Sub-Account 2013 2.10 0.95 - 1.90 25.85 - 27.05 2012 2.06 0.95 - 1.90 12.08 - 13.16 2011 2.42 0.95 - 1.90 (2.90) - (1.98) 2010 1.62 0.95 - 1.90 9.10 - 10.14 FTVIPT Franklin Small Cap 2014 0.61 0.95 - 1.75 (1.17) - (0.38) Value VIP Sub-Account 2013 1.31 0.95 - 1.75 33.88 - 34.95 2012 0.78 0.95 - 1.75 16.32 - 17.26 2011 0.66 0.95 - 1.75 (5.43) - (4.67) 2010 0.73 0.95 - 1.75 26.00 - 27.01 FTVIPT Templeton Foreign VIP 2014 1.86 1.55 - 2.30 (13.15) - (12.50) Sub-Account 2013 2.38 1.55 - 2.30 20.18 - 21.08 2012 3.02 1.55 - 2.30 15.53 - 16.41 2011 1.71 1.55 - 2.30 (12.66) - (12.00) 2010 1.88 1.55 - 2.30 5.94 - 6.74 FTVIPT Templeton Global 2014 5.11 0.95 - 1.75 0.07 - 0.87 Bond VIP Sub-Account 2013 4.75 0.95 - 1.75 (0.13) - 0.67 2012 6.42 0.95 - 1.75 13.06 - 13.97 2011 5.46 0.95 - 1.75 (2.58) - (1.81) 2010 1.36 0.95 - 1.75 12.46 - 13.36 Invesco V.I. American 2014 -- 1.40 6.93 Franchise Sub-Account 2013 0.42 1.40 38.19 2012 -- 1.40 12.14 2011 -- 1.40 (7.49) 2010 -- 1.40 18.18 123
485BPOS217th Page of 388TOC1stPreviousNextBottomJust 217th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 8. FINANCIAL HIGHLIGHTS -- (CONTINUED) [Enlarge/Download Table] AS OF DECEMBER 31 --------------------------------------------- UNIT VALUE LOWEST TO NET UNITS HIGHEST ($) ASSETS ($) ------------ --------------- -------------- Invesco V.I. Core Equity 2014 34,703 6.68 231,978 Sub-Account 2013 39,835 6.27 249,696 2012 49,005 4.92 241,009 2011 63,191 4.38 276,761 2010 88,640 4.44 393,933 Invesco V.I. Equity and 2014 30,622,887 6.54 - 23.37 681,211,301 Income Sub-Account 2013 31,328,255 6.09 - 21.69 649,322,698 2012 29,563,858 4.93 - 17.54 496,945,594 2011 27,370,136 4.44 - 15.75 414,357,262 2010 22,199,448 14.98 - 16.11 345,124,808 Invesco V.I. Growth and 2014 665 10.41 6,927 Income Sub-Account 2013 13,799,854 9.57 - 36.41 365,970,613 2012 13,407,203 7.24 - 27.48 268,230,013 2011 11,777,382 6.40 - 24.26 206,338,231 2010 9,061,763 6.63 - 25.06 160,437,278 Invesco V.I. International 2014 8,820,511 9.07 - 34.18 275,880,972 Growth Sub-Account 2013 8,901,354 9.17 - 34.47 281,999,206 2012 8,127,475 7.81 - 29.32 219,783,700 2011 6,481,068 6.86 - 25.68 154,099,050 2010 4,327,573 7.46 - 27.87 111,888,065 Ivy Funds VIP Asset Strategy 2014 2,575 16.67 - 17.51 45,023 Sub-Account (Commenced 11/19/2014) LMPVET ClearBridge Variable 2014 11,333,726 17.67 - 30.99 316,448,933 Aggressive Growth 2013 11,979,001 15.00 - 25.98 280,745,200 Sub-Account 2012 11,687,754 10.38 - 17.75 186,988,862 2011 11,855,614 8.94 - 15.09 160,839,221 2010 11,742,971 8.92 - 14.87 156,471,918 LMPVET ClearBridge Variable 2014 8,268,721 42.06 - 56.87 426,519,441 Appreciation Sub-Account 2013 8,604,407 38.78 - 51.73 405,286,221 2012 7,908,912 30.52 - 40.17 290,191,379 2011 7,021,537 26.94 - 34.98 224,680,370 2010 5,515,253 26.87 - 34.42 173,626,503 LMPVET ClearBridge Variable 2014 9,796,222 13.81 - 22.59 205,573,482 Equity Income Sub-Account 2013 10,244,154 12.44 - 20.09 191,169,653 2012 9,055,914 10.11 - 16.14 134,931,130 2011 8,013,455 9.06 - 14.28 103,322,855 2010 6,778,039 10.29 - 13.39 81,006,913 LMPVET ClearBridge Variable 2014 200,379 21.16 - 24.18 4,631,601 Large Cap Growth Sub-Account 2013 242,954 18.99 - 21.53 5,012,390 2012 283,429 14.10 - 15.86 4,312,254 2011 363,040 11.99 - 13.38 4,673,796 2010 459,350 12.35 - 13.67 6,065,533 FOR THE YEAR ENDED DECEMBER 31 ------------------------------------------------- INVESTMENT(1) EXPENSE RATIO(2) TOTAL RETURN(3) INCOME LOWEST TO LOWEST TO RATIO (%) HIGHEST (%) HIGHEST (%) ------------- ---------------- ---------------- Invesco V.I. Core Equity 2014 0.87 1.40 6.64 Sub-Account 2013 1.36 1.40 27.45 2012 0.91 1.40 12.29 2011 0.92 1.40 (1.44) 2010 0.95 1.40 8.02 Invesco V.I. Equity and 2014 1.58 0.95 - 1.90 6.72 - 7.74 Income Sub-Account 2013 1.54 0.95 - 1.90 22.54 - 23.71 2012 1.85 0.95 - 1.90 10.26 - 11.32 2011 1.69 0.95 - 1.90 (8.77) - (2.23) 2010 1.92 0.95 - 1.90 9.92 - 10.97 Invesco V.I. Growth and 2014 -- 1.40 8.75 Income Sub-Account 2013 1.31 0.95 - 1.90 31.25 - 32.50 2012 1.36 0.95 - 1.90 12.18 - 13.26 2011 1.13 0.95 - 1.90 (4.10) - (3.18) 2010 0.09 0.95 - 1.90 10.09 - 11.13 Invesco V.I. International 2014 1.38 0.95 - 1.75 (1.65) - (0.86) Growth Sub-Account 2013 1.10 0.95 - 1.75 16.66 - 17.60 2012 1.38 0.95 - 1.75 13.25 - 14.16 2011 1.06 0.95 - 1.75 (8.60) - (7.87) 2010 2.01 0.95 - 1.75 10.66 - 11.55 Ivy Funds VIP Asset Strategy 2014 -- 1.10 - 1.35 (2.27) - (2.24) Sub-Account (Commenced 11/19/2014) LMPVET ClearBridge Variable 2014 0.17 0.95 - 2.30 17.66 - 19.26 Aggressive Growth 2013 0.28 0.95 - 2.30 44.42 - 46.38 Sub-Account 2012 0.43 0.95 - 2.30 16.01 - 17.60 2011 0.20 0.95 - 2.30 0.15 - 1.50 2010 0.15 0.95 - 2.30 22.17 - 23.83 LMPVET ClearBridge Variable 2014 1.17 0.95 - 2.30 8.47 - 9.94 Appreciation Sub-Account 2013 1.29 0.95 - 2.30 27.05 - 28.77 2012 1.75 0.95 - 2.30 13.30 - 14.85 2011 1.77 0.95 - 2.30 0.28 - 1.64 2010 1.83 0.95 - 2.30 10.07 - 11.56 LMPVET ClearBridge Variable 2014 2.05 0.95 - 2.30 11.03 - 12.41 Equity Income Sub-Account 2013 1.65 0.95 - 2.30 23.08 - 24.49 2012 3.04 0.95 - 2.30 11.60 - 12.99 2011 3.39 0.95 - 2.30 (2.15) - 6.69 2010 4.09 0.95 - 1.90 10.01 - 11.06 LMPVET ClearBridge Variable 2014 0.48 1.50 - 2.30 11.40 - 12.29 Large Cap Growth Sub-Account 2013 0.51 1.50 - 2.30 34.72 - 35.80 2012 0.66 1.50 - 2.30 17.60 - 18.55 2011 0.42 1.50 - 2.30 (2.91) - (2.12) 2010 0.11 1.50 - 2.30 7.34 - 8.19 124
485BPOS218th Page of 388TOC1stPreviousNextBottomJust 218th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 8. FINANCIAL HIGHLIGHTS -- (CONTINUED) [Enlarge/Download Table] AS OF DECEMBER 31 ------------------------------------------------ UNIT VALUE LOWEST TO NET UNITS HIGHEST ($) ASSETS ($) ------------- ---------------- --------------- LMPVET ClearBridge Variable 2014 369,225 21.58 - 24.70 8,744,177 Large Cap Value Sub-Account 2013 319,601 19.77 - 22.45 6,892,954 2012 286,427 15.28 - 17.21 4,743,489 2011 265,335 13.42 - 15.00 3,836,359 2010 194,899 13.09 - 14.51 2,729,796 LMPVET ClearBridge Variable 2014 4,105,606 23.02 - 32.61 115,942,801 Small Cap Growth Sub-Account 2013 4,102,827 22.63 - 31.63 112,499,020 2012 3,457,289 15.75 - 21.71 64,881,494 2011 2,686,955 13.50 - 18.35 42,564,777 2010 2,149,625 13.62 - 18.28 33,662,804 LMPVET Permal Alternative 2014 64,025 10.01 - 10.02 641,034 Select VIT Portfolio Sub-Account (Commenced 11/19/2014) LMPVET Variable Lifestyle 2014 1,866,299 20.59 - 24.41 42,335,472 Allocation 50% Sub-Account 2013 2,011,433 20.00 - 23.49 44,101,401 2012 1,699,443 17.68 - 20.56 32,620,028 2011 1,414,982 15.93 - 17.95 24,265,695 2010 769,522 16.05 - 17.94 13,086,823 LMPVET Variable Lifestyle 2014 98,417 18.64 - 20.02 1,923,838 Allocation 70% Sub-Account 2013 121,395 18.11 - 19.37 2,304,999 2012 162,342 15.15 - 16.14 2,573,509 2011 219,583 13.47 - 14.30 3,086,943 2010 236,121 13.81 - 14.60 3,395,287 LMPVET Variable Lifestyle 2014 4,529,329 18.63 - 22.09 92,760,220 Allocation 85% Sub-Account 2013 4,790,185 18.14 - 21.30 95,074,284 2012 5,015,187 14.61 - 17.00 79,817,339 2011 4,732,454 12.85 - 14.81 65,879,472 2010 4,289,092 13.41 - 15.30 62,035,149 LMPVIT Western Asset 2014 4,320,147 20.11 - 25.19 100,641,688 Variable Global High Yield 2013 4,386,878 20.82 - 25.72 104,740,451 Bond Sub-Account 2012 4,039,328 20.05 - 24.44 91,771,912 2011 3,594,817 17.34 - 20.85 69,717,903 2010 3,170,899 17.44 - 20.70 61,092,507 MFS VIT Investors Trust 2014 1,191 8.08 9,619 Sub-Account 2013 3,517 7.38 25,951 2012 3,616 5.67 20,488 2011 7,050 4.82 33,994 2010 8,683 5.00 43,404 MFS VIT New Discovery 2014 3,178 12.78 40,607 Sub-Account 2013 3,294 13.97 46,020 2012 4,161 10.01 41,661 2011 4,939 8.38 41,374 2010 4,951 9.47 46,865 FOR THE YEAR ENDED DECEMBER 31 -------------------------------------------------- INVESTMENT(1) EXPENSE RATIO(2) TOTAL RETURN(3) INCOME LOWEST TO LOWEST TO RATIO (%) HIGHEST (%) HIGHEST (%) ------------- ---------------- ----------------- LMPVET ClearBridge Variable 2014 1.96 1.50 - 2.30 9.17 - 10.05 Large Cap Value Sub-Account 2013 1.77 1.50 - 2.30 29.36 - 30.40 2012 2.37 1.50 - 2.30 13.84 - 14.76 2011 2.82 1.50 - 2.30 2.57 - 3.39 2010 3.02 1.50 - 2.30 6.98 - 7.83 LMPVET ClearBridge Variable 2014 -- 0.95 - 2.30 1.71 - 3.09 Small Cap Growth Sub-Account 2013 0.05 0.95 - 2.30 43.71 - 45.66 2012 0.42 0.95 - 2.30 16.70 - 18.29 2011 -- 0.95 - 2.30 (0.91) - 0.43 2010 -- 0.95 - 2.30 22.34 - 24.00 LMPVET Permal Alternative 2014 0.57 1.10 - 1.60 (0.55) - (0.49) Select VIT Portfolio Sub-Account (Commenced 11/19/2014) LMPVET Variable Lifestyle 2014 2.46 0.95 - 1.90 2.93 - 3.92 Allocation 50% Sub-Account 2013 2.21 0.95 - 1.90 13.16 - 14.24 2012 2.95 0.95 - 1.90 10.96 - 12.02 2011 3.19 1.10 - 1.90 (0.73) - 0.07 2010 4.10 1.10 - 1.90 6.21 - 12.65 LMPVET Variable Lifestyle 2014 1.74 1.50 - 1.90 2.93 - 3.34 Allocation 70% Sub-Account 2013 1.41 1.50 - 1.90 19.53 - 20.01 2012 2.16 1.50 - 1.90 12.43 - 12.88 2011 1.88 1.50 - 1.90 (2.45) - (2.06) 2010 2.04 1.50 - 1.90 12.84 - 13.30 LMPVET Variable Lifestyle 2014 1.77 0.95 - 1.90 2.72 - 3.70 Allocation 85% Sub-Account 2013 1.66 0.95 - 1.90 24.12 - 25.30 2012 1.84 0.95 - 1.90 13.70 - 14.79 2011 1.55 0.95 - 1.90 (4.15) - (3.23) 2010 1.73 0.95 - 1.90 13.52 - 14.60 LMPVIT Western Asset 2014 7.11 0.95 - 2.30 (3.40) - (2.09) Variable Global High Yield 2013 6.19 0.95 - 2.30 3.85 - 5.27 Bond Sub-Account 2012 7.84 0.95 - 2.30 15.62 - 17.20 2011 8.38 0.95 - 2.30 (0.59) - 0.75 2010 9.47 0.95 - 2.30 12.31 - 13.83 MFS VIT Investors Trust 2014 0.61 1.40 9.46 Sub-Account 2013 1.10 1.40 30.22 2012 0.67 1.40 17.52 2011 0.90 1.40 (3.54) 2010 1.30 1.40 9.56 MFS VIT New Discovery 2014 -- 1.40 (8.55) Sub-Account 2013 -- 1.40 39.55 2012 -- 1.40 19.53 2011 -- 1.40 (11.51) 2010 -- 1.40 34.44 125
485BPOS219th Page of 388TOC1stPreviousNextBottomJust 219th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 8. FINANCIAL HIGHLIGHTS -- (CONTINUED) [Enlarge/Download Table] AS OF DECEMBER 31 -------------------------------------------- UNIT VALUE LOWEST TO NET UNITS HIGHEST ($) ASSETS ($) ------------ --------------- ------------- MFS VIT Research Sub-Account 2014 3,115 8.53 26,571 2013 8,132 7.85 63,835 2012 8,335 6.02 50,155 2011 8,675 5.20 45,142 2010 21,202 5.30 112,388 MIST AllianceBernstein 2014 275,344,937 11.84 - 12.49 3,373,491,338 Global Dynamic Allocation 2013 286,256,086 11.32 - 11.74 3,313,674,192 Sub-Account 2012 267,334,005 10.40 - 10.66 2,823,843,417 (Commenced 5/2/2011) 2011 168,434,681 9.68 - 9.75 1,639,379,077 MIST Allianz Global Investors 2014 18,219,524 1.04 - 10.55 18,986,456 Dynamic Multi-Asset Plus Sub-Account (Commenced 4/28/2014) MIST American Funds 2014 264,143,945 12.26 - 13.41 3,417,834,574 Balanced Allocation 2013 276,830,535 11.83 - 12.78 3,430,387,038 Sub-Account 2012 292,605,761 10.22 - 10.89 3,106,060,329 2011 306,967,734 9.22 - 9.69 2,914,777,188 2010 251,644,506 9.64 - 10.00 2,478,289,324 MIST American Funds Growth 2014 142,940,560 12.29 - 13.37 1,852,260,667 Allocation Sub-Account 2013 147,794,512 11.83 - 12.67 1,828,322,375 2012 149,020,463 9.68 - 10.24 1,496,665,592 2011 159,224,115 8.53 - 8.92 1,398,390,722 2010 155,386,301 9.17 - 9.47 1,454,861,016 MIST American Funds Growth 2014 71,860,704 1.37 - 13.78 648,671,484 Sub-Account 2013 59,593,818 1.29 - 12.90 632,386,636 2012 54,812,434 9.59 - 10.07 545,665,799 2011 64,256,598 8.36 - 8.69 553,292,806 2010 52,406,611 8.97 - 9.23 480,253,525 MIST American Funds 2014 137,310,606 12.03 - 13.16 1,744,157,123 Moderate Allocation 2013 147,773,215 11.61 - 12.53 1,796,366,977 Sub-Account 2012 159,499,085 10.47 - 11.15 1,734,325,945 2011 168,982,398 9.67 - 10.16 1,683,464,896 2010 143,876,667 9.88 - 10.25 1,452,175,003 MIST AQR Global Risk 2014 265,908,083 10.20 - 11.40 3,001,302,195 Balanced Sub-Account 2013 295,108,196 9.93 - 11.09 3,248,475,977 (Commenced 5/2/2011) 2012 324,843,850 10.42 - 11.61 3,753,309,463 2011 179,038,392 10.54 - 10.62 1,898,124,083 MIST BlackRock Global 2014 463,962,556 11.30 - 11.92 5,423,637,032 Tactical Strategies 2013 487,574,727 10.92 - 11.35 5,457,878,761 Sub-Account 2012 471,913,542 10.13 - 10.38 4,856,824,935 (Commenced 5/2/2011) 2011 297,189,715 9.51 - 9.58 2,842,712,285 MIST BlackRock High Yield 2014 9,596,910 15.21 - 28.99 238,215,887 Sub-Account 2013 10,783,682 14.92 - 28.32 265,149,806 2012 11,949,833 13.83 - 26.13 276,977,302 2011 10,891,616 12.03 - 21.28 221,624,841 2010 9,034,810 11.92 - 21.07 182,367,303 FOR THE YEAR ENDED DECEMBER 31 ------------------------------------------------- INVESTMENT(1) EXPENSE RATIO(2) TOTAL RETURN(3) INCOME LOWEST TO LOWEST TO RATIO (%) HIGHEST (%) HIGHEST (%) ------------- ---------------- ---------------- MFS VIT Research Sub-Account 2014 0.79 1.40 8.67 2013 0.33 1.40 30.45 2012 0.79 1.40 15.63 2011 0.72 1.40 (1.83) 2010 0.92 1.40 14.29 MIST AllianceBernstein 2014 1.94 0.90 - 2.35 0.77 - 6.39 Global Dynamic Allocation 2013 1.28 0.90 - 2.35 8.56 - 10.15 Sub-Account 2012 0.10 0.90 - 2.35 3.45 - 8.82 (Commenced 5/2/2011) 2011 0.87 1.15 - 2.25 (3.18) - (2.47) MIST Allianz Global Investors 2014 0.92 1.15 - 2.00 0.71 - 4.55 Dynamic Multi-Asset Plus Sub-Account (Commenced 4/28/2014) MIST American Funds 2014 1.27 1.00 - 2.35 (0.35) - 4.99 Balanced Allocation 2013 1.37 1.00 - 2.35 15.78 - 17.35 Sub-Account 2012 1.69 1.00 - 2.35 10.88 - 12.39 2011 1.26 1.00 - 2.35 (4.39) - (3.10) 2010 1.01 1.00 - 2.35 9.55 - 11.05 MIST American Funds Growth 2014 1.03 1.10 - 2.35 (0.52) - 5.17 Allocation Sub-Account 2013 1.00 1.15 - 2.35 22.20 - 23.68 2012 1.21 1.15 - 2.35 13.45 - 14.82 2011 1.10 1.15 - 2.35 (6.95) - (5.82) 2010 0.89 1.15 - 2.35 10.86 - 12.18 MIST American Funds Growth 2014 0.55 0.95 - 2.35 0.56 - 7.16 Sub-Account 2013 0.44 0.95 - 2.35 11.27 - 28.11 2012 0.33 1.30 - 2.35 14.67 - 15.89 2011 0.35 1.30 - 2.35 (6.81) - (5.83) 2010 0.20 1.30 - 2.35 15.57 - 16.79 MIST American Funds 2014 1.46 1.00 - 2.35 (0.26) - 5.04 Moderate Allocation 2013 1.65 1.00 - 2.35 10.88 - 12.39 Sub-Account 2012 2.04 1.00 - 2.35 8.25 - 9.73 2011 1.54 1.00 - 2.35 (2.14) - (0.81) 2010 1.41 1.00 - 2.35 7.36 - 8.82 MIST AQR Global Risk 2014 -- 0.90 - 2.35 (3.48) - 3.07 Balanced Sub-Account 2013 2.09 0.90 - 2.35 (5.64) - (4.26) (Commenced 5/2/2011) 2012 0.44 0.90 - 2.35 3.72 - 9.29 2011 3.00 1.15 - 2.25 1.94 - 2.70 MIST BlackRock Global 2014 1.12 0.90 - 2.35 (0.16) - 4.97 Tactical Strategies 2013 1.36 0.90 - 2.35 7.75 - 9.32 Sub-Account 2012 -- 0.90 - 2.35 3.27 - 7.89 (Commenced 5/2/2011) 2011 1.37 1.15 - 2.25 (4.84) - (4.14) MIST BlackRock High Yield 2014 6.09 0.90 - 2.35 (1.88) - 2.37 Sub-Account 2013 7.02 0.90 - 2.35 6.79 - 8.35 2012 7.05 0.90 - 2.35 7.68 - 15.15 2011 6.52 1.20 - 2.35 (0.03) - 1.12 2010 5.88 1.20 - 2.35 5.99 - 14.28 126
485BPOS220th Page of 388TOC1stPreviousNextBottomJust 220th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 8. FINANCIAL HIGHLIGHTS -- (CONTINUED) [Enlarge/Download Table] AS OF DECEMBER 31 --------------------------------------------- UNIT VALUE LOWEST TO NET UNITS HIGHEST ($) ASSETS ($) ------------ --------------- -------------- MIST Clarion Global Real 2014 17,245,897 17.00 - 72.26 330,178,643 Estate Sub-Account 2013 11,099,591 15.36 - 17.68 182,673,922 2012 10,967,900 15.19 - 17.23 177,317,957 2011 11,304,866 12.34 - 13.38 147,447,056 2010 9,934,760 13.39 - 14.36 139,330,754 MIST ClearBridge Aggressive 2014 38,472,258 12.71 - 214.41 586,572,505 Growth Sub-Account 2013 36,299,683 10.84 - 13.77 451,710,565 2012 33,802,849 7.55 - 9.54 292,871,764 2011 35,764,496 6.45 - 7.78 265,479,062 2010 13,863,499 6.97 - 7.63 102,505,758 MIST Goldman Sachs Mid Cap 2014 7,477,599 22.05 - 25.19 178,512,669 Value Sub-Account 2013 7,939,384 19.93 - 22.07 170,038,386 2012 8,486,283 15.38 - 16.85 139,211,779 2011 9,263,271 13.34 - 14.45 130,696,272 2010 7,332,195 14.57 - 15.63 112,015,664 MIST Harris Oakmark 2014 26,551,192 21.63 - 27.28 663,509,252 International Sub-Account 2013 25,769,452 23.43 - 29.23 693,983,244 2012 25,722,293 18.33 - 22.61 538,939,254 2011 28,033,038 14.49 - 17.04 461,860,538 2010 23,589,953 17.23 - 20.14 459,739,197 MIST Invesco Balanced-Risk 2014 758,894,714 1.07 - 11.10 832,374,445 Allocation Sub-Account 2013 800,860,953 1.04 - 1.06 843,160,697 (Commenced 4/30/2012) 2012 631,214,101 1.04 - 1.05 661,422,417 MIST Invesco Comstock 2014 43,175,673 15.33 - 24.28 813,000,076 Sub-Account 2013 26,889,264 14.36 - 22.42 443,561,923 2012 26,662,653 10.86 - 16.72 329,458,802 2011 25,137,797 9.39 - 14.24 266,463,408 2010 21,172,822 9.76 - 14.59 230,561,318 MIST Invesco Mid Cap Value 2014 6,927,870 17.85 - 41.71 258,407,609 Sub-Account 2013 4,619,902 30.27 - 38.39 158,040,375 2012 5,175,603 23.78 - 29.73 138,149,492 2011 5,366,862 21.23 - 24.69 127,004,689 2010 4,351,943 22.57 - 25.97 108,323,379 MIST Invesco Small Cap 2014 11,824,275 23.77 - 29.28 308,642,273 Growth Sub-Account 2013 13,003,134 22.53 - 27.31 319,189,345 2012 13,528,657 16.44 - 19.61 240,468,780 2011 13,942,780 14.22 - 16.69 212,672,795 2010 11,943,258 14.70 - 16.99 186,610,558 MIST JPMorgan Core Bond 2014 32,404,332 9.89 - 11.15 355,237,960 Sub-Account 2013 29,439,490 10.12 - 10.75 311,869,932 2012 31,242,391 10.69 - 11.23 346,492,447 2011 32,528,572 10.43 - 10.84 349,346,240 2010 26,655,400 10.10 - 10.38 274,791,792 FOR THE YEAR ENDED DECEMBER 31 -------------------------------------------------- INVESTMENT(1) EXPENSE RATIO(2) TOTAL RETURN(3) INCOME LOWEST TO LOWEST TO RATIO (%) HIGHEST (%) HIGHEST (%) ------------- ---------------- ----------------- MIST Clarion Global Real 2014 1.03 0.90 - 2.35 1.03 - 12.25 Estate Sub-Account 2013 6.85 0.90 - 2.35 1.14 - 2.62 2012 2.03 0.90 - 2.35 9.18 - 24.35 2011 3.80 1.30 - 2.35 (7.78) - (6.80) 2010 7.76 1.30 - 2.35 13.41 - 14.61 MIST ClearBridge Aggressive 2014 0.11 0.90 - 2.35 1.60 - 17.83 Growth Sub-Account 2013 0.22 0.90 - 2.35 42.22 - 44.30 2012 0.02 0.90 - 2.35 3.28 - 17.38 2011 -- 0.95 - 2.35 (9.34) - 1.91 2010 -- 1.30 - 2.35 20.92 - 22.20 MIST Goldman Sachs Mid Cap 2014 0.54 1.10 - 2.35 2.29 - 11.77 Value Sub-Account 2013 0.89 1.30 - 2.35 29.57 - 30.94 2012 0.59 1.30 - 2.35 15.36 - 16.58 2011 0.48 1.30 - 2.35 (8.46) - (7.50) 2010 0.92 1.30 - 2.35 21.35 - 22.63 MIST Harris Oakmark 2014 2.41 0.95 - 2.35 (7.98) - 0.25 International Sub-Account 2013 2.44 0.95 - 2.35 27.46 - 29.26 2012 1.63 0.95 - 2.35 15.61 - 27.58 2011 -- 1.30 - 2.35 (16.24) - (15.36) 2010 1.82 1.30 - 2.35 13.71 - 14.92 MIST Invesco Balanced-Risk 2014 -- 0.90 - 2.35 0.40 - 4.63 Allocation Sub-Account 2013 -- 0.90 - 2.35 (0.50) - 0.95 (Commenced 4/30/2012) 2012 0.55 0.90 - 2.35 3.03 - 4.04 MIST Invesco Comstock 2014 0.60 0.90 - 2.35 0.28 - 8.33 Sub-Account 2013 1.07 0.90 - 2.35 32.25 - 34.18 2012 1.22 0.90 - 2.35 5.55 - 17.40 2011 1.09 0.95 - 2.35 (3.76) - (2.39) 2010 1.45 0.95 - 2.35 12.19 - 13.80 MIST Invesco Mid Cap Value 2014 0.33 0.90 - 2.35 1.20 - 8.70 Sub-Account 2013 0.74 0.90 - 2.35 27.28 - 29.14 2012 0.40 0.90 - 2.35 2.26 - 13.21 2011 0.51 1.30 - 2.35 (5.93) - (4.94) 2010 0.55 1.30 - 2.35 22.62 - 23.91 MIST Invesco Small Cap 2014 -- 0.89 - 2.35 1.89 - 7.22 Growth Sub-Account 2013 0.23 0.89 - 2.35 36.92 - 39.29 2012 -- 0.89 - 2.35 15.47 - 17.45 2011 -- 0.89 - 2.35 (3.37) - (1.73) 2010 -- 0.89 - 2.35 23.26 - 25.35 MIST JPMorgan Core Bond 2014 1.42 1.10 - 2.20 0.48 - 3.73 Sub-Account 2013 0.28 1.30 - 2.35 (5.04) - (4.05) 2012 2.57 1.30 - 2.35 2.47 - 3.55 2011 2.09 1.30 - 2.35 3.34 - 4.42 2010 1.64 1.30 - 2.35 3.63 - 4.73 127
485BPOS221st Page of 388TOC1stPreviousNextBottomJust 221st
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 8. FINANCIAL HIGHLIGHTS -- (CONTINUED) [Enlarge/Download Table] AS OF DECEMBER 31 --------------------------------------------- UNIT VALUE LOWEST TO NET UNITS HIGHEST ($) ASSETS ($) ------------ --------------- -------------- MIST JPMorgan Global Active 2014 747,266,184 1.18 - 12.14 905,975,458 Allocation Sub-Account 2013 649,853,969 1.13 - 1.16 746,849,717 (Commenced 4/30/2012) 2012 269,034,003 1.04 - 1.05 282,572,135 MIST JPMorgan Small Cap 2014 1,417,944 18.69 - 20.92 27,932,500 Value Sub-Account 2013 1,455,583 18.28 - 20.23 27,866,566 2012 1,643,159 14.04 - 15.36 24,014,976 2011 1,650,824 12.42 - 13.17 21,224,281 2010 1,677,961 14.14 - 14.87 24,426,974 MIST Loomis Sayles Global 2014 10,444,732 15.85 - 17.90 177,351,030 Markets Sub-Account 2013 10,842,823 15.69 - 17.47 180,595,781 2012 12,318,466 13.71 - 14.91 177,780,410 2011 13,161,956 12.01 - 12.74 165,018,207 2010 10,620,691 12.48 - 13.10 137,171,845 MIST Lord Abbett Bond 2014 8,190,115 10.35 - 33.68 234,576,558 Debenture Sub-Account 2013 9,341,018 9.99 - 32.33 259,294,487 2012 10,178,078 9.36 - 30.15 266,010,291 2011 10,848,076 8.39 - 26.88 255,107,548 2010 11,708,304 8.12 - 25.87 267,920,695 MIST Met/Eaton Vance 2014 6,743,439 10.59 - 11.23 73,909,210 Floating Rate Sub-Account 2013 7,519,969 10.76 - 11.18 83,115,837 (Commenced 5/3/2010) 2012 5,007,151 10.61 - 10.91 54,197,004 2011 4,263,176 10.13 - 10.30 43,696,769 2010 1,600,145 10.16 - 10.23 16,334,315 MIST Met/Franklin Low 2014 17,421,682 9.65 - 10.18 173,124,917 Duration Total Return 2013 14,050,793 9.78 - 10.16 140,307,146 Sub-Account 2012 4,349,231 9.92 - 10.14 43,609,944 (Commenced 5/2/2011) 2011 2,835,514 9.70 - 9.78 27,661,832 MIST Met/Templeton 2014 3,537,497 12.87 - 13.66 47,183,875 International Bond 2013 3,905,329 13.00 - 13.53 52,286,139 Sub-Account 2012 4,238,395 13.19 - 13.56 57,001,253 2011 4,276,073 11.74 - 12.02 51,093,268 2010 2,982,596 12.04 - 12.22 36,302,425 MIST MetLife Asset 2014 39,915,870 14.91 - 17.28 641,574,794 Allocation 100 Sub-Account 2013 42,451,280 14.53 - 16.59 659,971,504 2012 44,655,767 11.48 - 12.93 545,044,070 2011 49,390,389 10.07 - 10.98 524,691,864 2010 45,689,702 10.94 - 11.78 522,967,837 MIST MetLife Balanced Plus 2014 569,859,186 12.32 - 13.00 7,268,454,132 Sub-Account 2013 547,096,627 11.51 - 11.96 6,454,726,976 (Commenced 5/2/2011) 2012 438,994,467 10.30 - 10.55 4,593,209,415 2011 257,076,022 9.33 - 9.40 2,411,774,661 MIST MetLife Multi-Index 2014 281,516,918 1.19 - 12.18 421,513,955 Targeted Risk Sub-Account 2013 153,950,143 1.12 - 11.26 209,957,052 (Commenced 11/12/2012) 2012 11,094,386 1.01 11,247,979 FOR THE YEAR ENDED DECEMBER 31 -------------------------------------------------- INVESTMENT(1) EXPENSE RATIO(2) TOTAL RETURN(3) INCOME LOWEST TO LOWEST TO RATIO (%) HIGHEST (%) HIGHEST (%) ------------- ---------------- ----------------- MIST JPMorgan Global Active 2014 1.13 0.90 - 2.35 0.35 - 6.02 Allocation Sub-Account 2013 0.08 0.90 - 2.35 8.41 - 9.99 (Commenced 4/30/2012) 2012 0.73 0.90 - 2.35 3.02 - 4.03 MIST JPMorgan Small Cap 2014 1.07 0.90 - 2.30 2.28 - 3.89 Value Sub-Account 2013 0.69 0.90 - 2.30 30.22 - 31.71 2012 0.84 0.90 - 2.30 2.73 - 13.98 2011 1.69 1.20 - 2.30 (12.17) - (11.43) 2010 0.82 1.20 - 2.30 16.82 - 17.83 MIST Loomis Sayles Global 2014 2.08 0.95 - 2.35 (0.82) - 2.49 Markets Sub-Account 2013 2.41 0.95 - 2.35 14.41 - 16.02 2012 2.32 1.10 - 2.35 2.75 - 15.41 2011 2.32 1.30 - 2.35 (3.77) - (2.75) 2010 2.99 1.30 - 2.35 19.18 - 20.43 MIST Lord Abbett Bond 2014 5.67 0.89 - 2.35 (0.50) - 4.19 Debenture Sub-Account 2013 6.62 0.89 - 2.35 5.47 - 7.21 2012 7.20 0.89 - 2.35 5.77 - 12.18 2011 5.92 0.89 - 2.35 2.04 - 3.90 2010 6.21 0.89 - 2.35 10.34 - 12.18 MIST Met/Eaton Vance 2014 3.65 1.10 - 2.35 (1.60) - (0.57) Floating Rate Sub-Account 2013 3.38 1.30 - 2.35 1.42 - 2.50 (Commenced 5/3/2010) 2012 3.39 1.30 - 2.35 4.83 - 5.94 2011 1.99 1.30 - 2.30 (0.31) - 0.69 2010 -- 1.30 - 2.30 1.64 - 2.31 MIST Met/Franklin Low 2014 2.15 0.90 - 2.35 (1.29) - 0.15 Duration Total Return 2013 1.07 0.90 - 2.35 (1.19) - 0.25 Sub-Account 2012 1.91 0.90 - 2.20 1.17 - 3.15 (Commenced 5/2/2011) 2011 -- 1.20 - 2.35 (2.83) - (2.08) MIST Met/Templeton 2014 4.63 1.10 - 2.15 (2.28) - (0.17) International Bond 2013 2.02 1.30 - 2.15 (1.11) - (0.27) Sub-Account 2012 10.26 1.30 - 2.05 11.96 - 12.80 2011 6.86 1.30 - 2.20 (2.49) - (1.61) 2010 0.51 1.30 - 2.20 11.07 - 12.08 MIST MetLife Asset 2014 0.71 0.90 - 2.35 0.05 - 4.15 Allocation 100 Sub-Account 2013 0.75 0.90 - 2.35 26.50 - 28.35 2012 0.64 0.90 - 2.35 2.91 - 15.40 2011 1.10 1.15 - 2.35 (7.96) - (6.85) 2010 1.18 1.15 - 2.35 13.80 - 15.17 MIST MetLife Balanced Plus 2014 1.75 0.90 - 2.35 0.70 - 8.67 Sub-Account 2013 1.19 0.90 - 2.35 11.71 - 13.34 (Commenced 5/2/2011) 2012 -- 0.90 - 2.35 4.67 - 11.81 2011 0.27 1.15 - 2.25 (6.68) - (6.00) MIST MetLife Multi-Index 2014 -- 1.15 - 2.25 0.83 - 8.01 Targeted Risk Sub-Account 2013 0.55 1.15 - 2.25 4.04 - 11.65 (Commenced 11/12/2012) 2012 -- 1.15 - 2.00 2.56 - 2.68 128
485BPOS222nd Page of 388TOC1stPreviousNextBottomJust 222nd
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 8. FINANCIAL HIGHLIGHTS -- (CONTINUED) [Enlarge/Download Table] AS OF DECEMBER 31 ---------------------------------------------- UNIT VALUE LOWEST TO NET UNITS HIGHEST ($) ASSETS ($) ------------ ---------------- -------------- MIST MetLife Small Cap 2014 12,299,087 21.73 - 26.68 291,013,900 Value Sub-Account 2013 13,992,716 21.87 - 26.40 330,701,962 2012 15,859,523 16.91 - 20.06 287,540,317 2011 18,611,699 14.67 - 17.11 290,532,427 2010 18,793,984 16.49 - 18.91 327,520,477 MIST MFS Emerging Markets 2014 42,182,331 9.40 - 11.38 425,619,386 Equity Sub-Account 2013 41,623,177 10.29 - 12.45 456,076,892 2012 38,352,212 11.09 - 13.41 448,693,258 2011 37,004,554 9.55 - 11.54 369,675,163 2010 29,287,659 12.03 - 14.53 365,169,255 MIST MFS Research 2014 18,585,662 14.00 - 18.24 287,913,009 International Sub-Account 2013 19,616,483 15.39 - 18.44 331,488,461 2012 21,667,563 13.21 - 15.60 311,615,422 2011 22,841,018 11.58 - 13.42 285,814,827 2010 22,399,698 13.27 - 15.17 318,521,626 MIST Morgan Stanley Mid Cap 2014 12,928,550 2.79 - 25.03 240,528,688 Growth Sub-Account 2013 13,099,903 2.79 - 24.94 244,579,234 2012 12,225,316 2.03 - 18.06 166,100,095 2011 8,735,505 1.88 - 16.63 109,412,403 2010 6,606,286 2.04 - 17.98 89,015,672 MIST Oppenheimer Global 2014 2,866,078 21.68 - 27.83 72,350,999 Equity Sub-Account 2013 3,127,720 21.72 - 27.49 78,398,573 2012 500,711 18.48 - 21.83 9,983,469 2011 559,531 15.55 - 17.64 9,330,001 2010 608,969 17.31 - 19.88 11,272,119 MIST PanAgora Global 2014 9,788,108 1.03 - 10.44 10,161,644 Diversified Risk Sub-Account (Commenced 4/28/2014) MIST PIMCO Inflation 2014 50,751,209 13.20 - 15.63 732,596,404 Protected Bond Sub-Account 2013 57,648,505 13.13 - 15.33 821,456,089 2012 64,013,091 14.82 - 17.05 1,021,039,296 2011 63,087,877 13.90 - 15.36 936,595,819 2010 52,467,468 12.81 - 13.99 711,162,874 MIST PIMCO Total Return 2014 103,504,587 12.40 - 19.84 1,787,038,026 Sub-Account 2013 118,419,838 12.03 - 19.16 1,993,786,948 2012 128,302,689 12.42 - 19.67 2,234,370,461 2011 132,311,947 11.50 - 18.11 2,140,758,433 2010 111,149,390 11.27 - 17.67 1,761,602,464 MIST Pioneer Fund 2014 12,549,377 2.83 - 30.99 305,917,464 Sub-Account 2013 12,432,551 2.58 - 28.13 297,755,670 2012 11,331,680 9.91 - 21.33 220,043,655 2011 9,480,402 9.11 - 19.29 168,467,083 2010 5,977,317 16.24 - 20.40 112,914,666 FOR THE YEAR ENDED DECEMBER 31 -------------------------------------------------- INVESTMENT(1) EXPENSE RATIO(2) TOTAL RETURN(3) INCOME LOWEST TO LOWEST TO RATIO (%) HIGHEST (%) HIGHEST (%) ------------- ---------------- ----------------- MIST MetLife Small Cap 2014 0.04 0.89 - 2.35 (0.65) - 1.06 Value Sub-Account 2013 0.99 0.89 - 2.35 29.37 - 31.64 2012 -- 0.89 - 2.35 15.23 - 17.22 2011 1.10 0.89 - 2.35 (11.09) - (9.50) 2010 1.17 0.89 - 2.35 17.11 - 19.08 MIST MFS Emerging Markets 2014 0.84 0.90 - 2.35 (8.69) - (4.92) Equity Sub-Account 2013 1.07 0.90 - 2.35 (7.19) - (5.83) 2012 0.75 0.90 - 2.35 3.96 - 17.77 2011 1.39 0.95 - 2.35 (20.59) - (19.48) 2010 0.97 0.95 - 2.35 20.79 - 22.49 MIST MFS Research 2014 2.24 0.89 - 2.35 (9.11) - (3.46) International Sub-Account 2013 2.58 0.90 - 2.35 16.49 - 18.19 2012 1.89 0.90 - 2.35 6.35 - 15.60 2011 1.88 0.95 - 2.35 (12.79) - (11.56) 2010 1.70 0.95 - 2.35 8.83 - 10.35 MIST Morgan Stanley Mid Cap 2014 -- 0.89 - 2.30 (1.40) - 0.39 Growth Sub-Account 2013 0.60 0.89 - 2.30 35.86 - 38.07 2012 -- 0.89 - 2.30 (4.93) - 8.58 2011 0.56 0.89 - 2.30 (9.04) - (7.49) 2010 0.01 0.89 - 2.30 17.15 - 30.84 MIST Oppenheimer Global 2014 0.82 0.90 - 2.30 (0.31) - 1.23 Equity Sub-Account 2013 0.35 0.90 - 2.30 24.22 - 25.97 2012 1.40 0.90 - 1.95 8.80 - 19.84 2011 1.79 0.95 - 1.95 (10.17) - (9.41) 2010 1.34 0.95 - 1.95 13.69 - 14.83 MIST PanAgora Global 2014 0.46 1.15 - 2.00 (0.35) - 3.75 Diversified Risk Sub-Account (Commenced 4/28/2014) MIST PIMCO Inflation 2014 1.54 0.90 - 2.35 (1.54) - 1.97 Protected Bond Sub-Account 2013 2.20 0.90 - 2.35 (11.38) - (10.09) 2012 3.02 0.90 - 2.35 4.22 - 7.82 2011 1.62 1.20 - 2.35 8.56 - 9.82 2010 2.23 1.20 - 2.35 5.26 - 6.48 MIST PIMCO Total Return 2014 2.34 0.89 - 2.35 0.40 - 3.56 Sub-Account 2013 4.27 0.89 - 2.35 (4.19) - (2.59) 2012 3.13 0.89 - 2.35 4.10 - 8.58 2011 2.62 0.89 - 2.35 (0.31) - 2.51 2010 3.20 0.89 - 2.35 5.65 - 7.45 MIST Pioneer Fund 2014 1.66 0.90 - 2.35 1.00 - 10.16 Sub-Account 2013 3.15 0.90 - 2.30 9.33 - 31.88 2012 1.45 0.90 - 2.30 0.85 - 9.54 2011 1.11 0.95 - 2.30 (11.94) - (5.45) 2010 0.78 0.95 - 2.30 13.47 - 15.12 129
485BPOS223rd Page of 388TOC1stPreviousNextBottomJust 223rd
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 8. FINANCIAL HIGHLIGHTS -- (CONTINUED) [Enlarge/Download Table] AS OF DECEMBER 31 --------------------------------------------- UNIT VALUE LOWEST TO NET UNITS HIGHEST ($) ASSETS ($) ------------ --------------- -------------- MIST Pioneer Strategic 2014 54,471,343 2.60 - 32.57 943,852,832 Income Sub-Account 2013 41,450,021 2.53 - 31.43 919,328,857 2012 29,638,373 13.34 - 31.23 804,777,040 2011 24,444,162 12.25 - 27.99 600,261,549 2010 17,115,149 12.17 - 27.26 419,601,867 MIST Pyramis Government 2014 62,286,953 10.55 - 11.13 680,446,278 Income Sub-Account 2013 69,488,361 10.04 - 10.44 715,739,557 (Commenced 5/2/2011) 2012 88,599,553 10.77 - 11.03 968,887,238 2011 45,618,019 10.69 - 10.77 490,473,351 MIST Pyramis Managed Risk 2014 14,204,266 11.35 - 11.58 163,513,389 Sub-Account 2013 7,294,047 10.69 - 10.77 78,417,229 (Commenced 4/29/2013) MIST Schroders Global 2014 400,460,215 1.20 - 12.36 493,380,979 Multi-Asset Sub-Account 2013 375,261,358 1.14 - 1.17 435,205,689 (Commenced 4/30/2012) 2012 179,641,654 1.06 - 1.07 191,885,161 MIST SSgA Growth and Income 2014 101,616,119 13.79 - 15.77 1,513,705,632 ETF Sub-Account 2013 110,435,377 13.34 - 15.03 1,578,178,677 2012 118,446,237 12.09 - 13.24 1,521,502,479 2011 120,297,977 10.97 - 11.83 1,390,741,062 2010 85,827,962 11.20 - 11.84 995,772,752 MIST SSgA Growth ETF 2014 34,092,389 13.66 - 15.62 501,804,705 Sub-Account 2013 35,919,224 13.27 - 14.96 509,607,858 2012 36,733,044 11.51 - 12.55 448,167,959 2011 37,984,453 10.24 - 11.04 409,132,829 2010 29,136,066 10.71 - 11.41 325,453,346 MIST T. Rowe Price Large 2014 13,521,347 40.58 - 144.85 838,816,422 Cap Value Sub-Account 2013 11,320,980 38.18 - 128.69 657,944,319 2012 12,231,249 28.88 - 96.83 536,790,380 2011 13,446,503 24.76 - 82.60 507,039,092 2010 14,212,118 26.09 - 86.60 558,423,606 MIST T. Rowe Price Mid Cap 2014 32,310,271 15.06 - 17.30 537,586,208 Growth Sub-Account 2013 37,965,912 13.67 - 15.54 568,882,747 2012 41,941,697 10.24 - 11.53 467,536,275 2011 44,089,511 9.22 - 10.28 439,146,325 2010 40,356,445 9.67 - 10.58 414,850,131 MIST WMC Large Cap Research 2014 1,151,671 13.60 - 16.68 17,260,395 Sub-Account 2013 1,260,254 12.25 - 14.84 16,869,650 2012 1,423,242 9.34 - 11.16 14,439,147 2011 1,414,721 8.42 - 9.34 12,849,849 2010 1,044,239 8.60 - 9.47 9,613,588 MSF Baillie Gifford 2014 27,573,117 4.31 - 14.37 269,502,431 International Stock 2013 29,549,817 4.51 - 15.12 303,453,047 Sub-Account 2012 219,106 3.96 - 13.35 2,585,607 2011 282,028 3.36 - 11.37 2,803,543 2010 318,412 4.26 - 14.47 3,979,701 FOR THE YEAR ENDED DECEMBER 31 -------------------------------------------------- INVESTMENT(1) EXPENSE RATIO(2) TOTAL RETURN(3) INCOME LOWEST TO LOWEST TO RATIO (%) HIGHEST (%) HIGHEST (%) ------------- ---------------- ----------------- MIST Pioneer Strategic 2014 4.98 0.90 - 2.35 (0.93) - 3.65 Income Sub-Account 2013 4.82 0.90 - 2.35 (0.94) - 1.21 2012 4.73 0.90 - 2.35 6.09 - 10.56 2011 4.36 0.95 - 2.35 1.06 - 2.65 2010 4.58 0.95 - 2.20 5.21 - 11.12 MIST Pyramis Government 2014 2.60 0.90 - 2.35 0.96 - 6.59 Income Sub-Account 2013 1.55 0.90 - 2.35 (6.74) - (5.37) (Commenced 5/2/2011) 2012 0.02 0.90 - 2.35 0.74 - 1.96 2011 0.89 1.15 - 2.25 6.96 - 7.75 MIST Pyramis Managed Risk 2014 -- 1.10 - 2.25 0.98 - 7.40 Sub-Account 2013 1.65 1.15 - 2.25 4.66 - 5.43 (Commenced 4/29/2013) MIST Schroders Global 2014 1.32 0.90 - 2.35 0.43 - 6.77 Multi-Asset Sub-Account 2013 0.01 0.90 - 2.35 7.55 - 9.12 (Commenced 4/30/2012) 2012 1.49 0.90 - 2.35 5.01 - 6.03 MIST SSgA Growth and Income 2014 2.24 0.90 - 2.35 (0.03) - 4.86 ETF Sub-Account 2013 2.51 0.90 - 2.35 10.31 - 11.92 2012 2.40 1.10 - 2.35 4.01 - 11.55 2011 1.70 1.15 - 2.35 (1.29) - (0.09) 2010 1.05 1.15 - 2.20 9.80 - 10.96 MIST SSgA Growth ETF 2014 1.88 0.90 - 2.35 (0.05) - 4.43 Sub-Account 2013 2.10 0.90 - 2.35 15.33 - 17.01 2012 1.96 1.15 - 2.35 4.38 - 13.71 2011 1.56 1.15 - 2.35 (4.40) - (3.24) 2010 1.35 1.15 - 2.35 11.50 - 12.85 MIST T. Rowe Price Large 2014 1.18 0.89 - 2.35 1.20 - 12.56 Cap Value Sub-Account 2013 1.58 0.89 - 2.35 30.67 - 32.90 2012 1.50 0.89 - 2.35 6.92 - 17.22 2011 0.70 0.89 - 2.35 (6.24) - (4.62) 2010 1.11 0.89 - 2.35 14.30 - 16.29 MIST T. Rowe Price Mid Cap 2014 -- 1.30 - 2.35 10.16 - 11.32 Growth Sub-Account 2013 0.21 1.30 - 2.35 33.41 - 34.82 2012 -- 1.30 - 2.35 11.03 - 12.21 2011 -- 1.30 - 2.35 (3.93) - (2.92) 2010 -- 1.30 - 2.35 24.72 - 26.05 MIST WMC Large Cap Research 2014 0.80 0.90 - 2.30 1.80 - 12.40 Sub-Account 2013 1.28 0.90 - 2.30 31.12 - 32.97 2012 1.07 0.90 - 2.30 (0.27) - 11.75 2011 0.92 1.55 - 2.30 (2.06) - (1.33) 2010 1.06 1.55 - 2.30 10.01 - 10.85 MSF Baillie Gifford 2014 1.26 1.30 - 2.25 (5.49) - (1.36) International Stock 2013 0.02 1.30 - 2.25 9.68 - 13.94 Sub-Account 2012 1.14 1.40 - 1.90 17.11 - 17.85 2011 1.60 1.40 - 1.90 (21.63) - (20.99) 2010 1.41 1.40 - 1.90 4.85 - 5.74 130
485BPOS224th Page of 388TOC1stPreviousNextBottomJust 224th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 8. FINANCIAL HIGHLIGHTS -- (CONTINUED) [Download Table] AS OF DECEMBER 31 --------------------------------------------- UNIT VALUE LOWEST TO NET UNITS HIGHEST ($) ASSETS ($) ------------ --------------- -------------- MSF Barclays Aggregate Bond 2014 16,099,701 1.79 - 19.11 213,475,999 Index Sub-Account 2013 13,536,937 1.71 - 18.22 162,571,849 2012 10,756,748 1.78 - 18.82 151,553,766 2011 8,083,366 1.73 - 18.28 130,173,979 2010 5,646,137 14.02 - 17.15 86,674,964 MSF BlackRock Bond Income 2014 1,105,752 46.87 - 76.43 63,615,045 Sub-Account 2013 1,054,348 44.86 - 72.01 57,251,907 2012 1,045,629 46.32 - 73.22 57,888,933 2011 953,075 44.15 - 68.69 49,538,985 2010 952,834 42.45 - 65.04 47,336,145 MSF BlackRock Capital 2014 639,908 16.88 - 52.46 14,686,428 Appreciation Sub-Account 2013 721,215 15.83 - 48.60 15,272,342 2012 745,728 12.04 - 36.54 11,831,610 2011 814,200 10.75 - 32.23 11,348,650 2010 601,185 12.06 - 35.71 9,563,155 MSF BlackRock Large Cap 2014 229,967 17.66 - 19.31 4,201,564 Value Sub-Account 2013 225,190 16.80 - 17.73 3,792,926 2012 230,438 12.89 - 13.54 2,977,532 2011 252,494 11.44 - 11.96 2,890,664 2010 253,453 11.33 - 11.79 2,872,585 MSF BlackRock Money Market 2014 39,068,482 2.33 - 25.65 395,886,367 Sub-Account 2013 44,329,198 2.36 - 25.88 461,342,890 2012 53,484,009 9.33 - 25.53 569,109,901 2011 59,067,302 9.55 - 25.84 633,625,012 2010 51,015,018 9.77 - 26.15 553,885,805 MSF Frontier Mid Cap Growth 2014 4,248,372 17.69 - 19.79 81,297,538 Sub-Account 2013 4,767,721 16.33 - 18.08 83,651,163 (Commenced 4/29/2013) MSF Jennison Growth 2014 27,528,387 4.22 - 21.36 529,020,323 Sub-Account 2013 32,574,197 3.93 - 19.82 585,624,219 2012 35,125,323 2.91 - 14.55 468,764,846 2011 20,877,221 2.55 - 12.29 248,172,110 2010 20,230,170 2.57 - 12.42 243,817,657 MSF Loomis Sayles Small Cap 2014 261,060 46.83 - 58.80 13,706,471 Core Sub-Account 2013 283,327 46.30 - 57.49 14,610,773 2012 330,015 33.68 - 41.36 12,332,225 2011 310,374 30.16 - 36.63 10,317,247 2010 214,307 30.76 - 36.95 7,224,075 MSF Loomis Sayles Small Cap 2014 16,302 17.05 - 18.51 293,433 Growth Sub-Account 2013 12,506 17.15 - 18.50 226,802 (Commenced 4/30/2012) 2012 3,306 11.73 - 12.58 40,927 MSF Met/Artisan Mid Cap 2014 11,205,267 19.30 - 55.59 244,385,523 Value Sub-Account 2013 13,125,790 19.41 - 55.03 285,771,010 2012 13,419,571 14.54 - 40.57 217,257,576 2011 14,599,235 13.33 - 36.59 215,514,020 2010 15,163,945 12.80 - 34.58 213,857,206 FOR THE YEAR ENDED DECEMBER 31 ------------------------------------------------- INVESTMENT(1) EXPENSE RATIO(2) TOTAL RETURN(3) INCOME LOWEST TO LOWEST TO RATIO (%) HIGHEST (%) HIGHEST (%) ------------- ---------------- ---------------- MSF Barclays Aggregate Bond 2014 2.62 0.89 - 2.35 0.54 - 4.87 Index Sub-Account 2013 3.23 0.89 - 2.25 (4.74) - (3.19) 2012 3.45 0.89 - 2.25 1.27 - 2.98 2011 3.22 0.89 - 2.25 4.77 - 6.56 2010 2.64 0.89 - 2.25 3.30 - 5.11 MSF BlackRock Bond Income 2014 3.22 0.89 - 2.30 0.85 - 6.14 Sub-Account 2013 3.83 0.89 - 2.30 (3.17) - (1.65) 2012 2.54 0.89 - 2.30 3.74 - 6.59 2011 3.84 0.89 - 2.30 4.00 - 5.62 2010 3.77 0.89 - 2.30 5.72 - 7.38 MSF BlackRock Capital 2014 0.06 0.89 - 2.30 0.94 - 7.93 Appreciation Sub-Account 2013 0.79 0.89 - 2.30 31.17 - 33.03 2012 0.32 0.89 - 2.30 (0.88) - 13.35 2011 0.17 0.89 - 2.30 (11.01) - (9.75) 2010 0.22 0.89 - 2.30 17.10 - 18.76 MSF BlackRock Large Cap 2014 1.26 0.89 - 1.35 1.39 - 8.95 Value Sub-Account 2013 1.38 0.89 - 1.35 30.28 - 30.88 2012 1.61 0.89 - 1.35 12.74 - 13.27 2011 1.16 0.89 - 1.35 0.97 - 1.44 2010 1.09 0.89 - 1.35 7.75 - 8.26 MSF BlackRock Money Market 2014 -- 0.90 - 2.35 (2.32) - (0.13) Sub-Account 2013 -- 0.90 - 2.35 (2.32) - (0.37) 2012 -- 0.95 - 2.35 (2.34) - (0.74) 2011 -- 0.95 - 2.35 (2.32) - (0.94) 2010 -- 0.95 - 2.35 (2.32) - (0.64) MSF Frontier Mid Cap Growth 2014 -- 1.30 - 2.35 8.30 - 9.44 Sub-Account 2013 -- 1.30 - 2.35 19.21 - 20.07 (Commenced 4/29/2013) MSF Jennison Growth 2014 0.04 0.90 - 2.35 (0.16) - 7.81 Sub-Account 2013 0.20 0.90 - 2.35 33.56 - 35.51 2012 0.01 0.95 - 2.35 (4.12) - 14.17 2011 0.06 1.30 - 2.35 (2.11) - (0.86) 2010 0.38 1.30 - 2.35 8.74 - 10.07 MSF Loomis Sayles Small Cap 2014 -- 1.20 - 2.30 1.15 - 2.27 Core Sub-Account 2013 0.23 1.20 - 2.30 37.49 - 39.01 2012 -- 1.20 - 2.30 11.66 - 12.90 2011 -- 1.20 - 2.30 (1.94) - (0.86) 2010 -- 1.20 - 2.30 24.32 - 25.69 MSF Loomis Sayles Small Cap 2014 -- 0.90 - 1.50 (0.57) - 0.03 Growth Sub-Account 2013 -- 0.90 - 1.50 46.17 - 47.05 (Commenced 4/30/2012) 2012 -- 0.90 - 1.50 (1.28) - (0.88) MSF Met/Artisan Mid Cap 2014 0.55 0.89 - 2.35 (0.69) - 1.02 Value Sub-Account 2013 0.77 0.89 - 2.35 33.34 - 35.64 2012 0.80 0.89 - 2.35 8.98 - 10.87 2011 0.79 0.89 - 2.35 4.02 - 5.81 2010 0.59 0.89 - 2.35 12.09 - 14.02 131
485BPOS225th Page of 388TOC1stPreviousNextBottomJust 225th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 8. FINANCIAL HIGHLIGHTS -- (CONTINUED) [Enlarge/Download Table] AS OF DECEMBER 31 -------------------------------------------- UNIT VALUE LOWEST TO NET UNITS HIGHEST ($) ASSETS ($) ------------ --------------- ------------- MSF Met/Dimensional 2014 3,070,324 18.13 - 19.77 58,174,088 International Small Company 2013 3,208,551 19.88 - 21.38 66,162,419 Sub-Account 2012 3,203,412 15.91 - 16.90 52,618,293 2011 3,336,605 13.82 - 14.29 47,225,164 2010 2,082,274 16.89 - 17.28 35,750,236 MSF MetLife Asset 2014 2,973,577 13.22 - 15.00 41,687,543 Allocation 20 Sub-Account 2013 557,035 12.93 - 13.63 7,497,408 2012 735,694 12.67 - 13.27 9,655,026 2011 850,770 11.86 - 12.35 10,395,348 2010 830,223 11.74 - 12.15 9,998,191 MSF MetLife Asset 2014 341,017,115 13.43 - 15.56 4,991,456,808 Allocation 40 Sub-Account 2013 550,896 13.60 - 14.27 7,732,376 2012 588,986 12.52 - 13.07 7,576,787 2011 608,383 11.48 - 11.91 7,143,945 2010 782,775 11.60 - 11.97 9,257,856 MSF MetLife Asset 2014 489,838,225 14.27 - 19.73 7,527,991,156 Allocation 60 Sub-Account 2013 3,073,122 13.90 - 14.77 44,655,421 2012 3,326,548 12.05 - 12.71 41,689,448 2011 3,930,913 10.88 - 11.40 44,282,730 2010 4,192,524 11.28 - 11.74 48,715,861 MSF MetLife Asset 2014 420,572,925 14.33 - 20.54 6,507,894,347 Allocation 80 Sub-Account 2013 3,927,901 14.05 - 14.80 57,260,787 2012 4,335,356 11.55 - 12.09 51,720,857 2011 4,632,179 10.23 - 10.65 48,721,974 2010 5,194,016 10.86 - 11.24 57,766,976 MSF MetLife Mid Cap Stock 2014 5,178,461 2.86 - 30.60 127,735,872 Index Sub-Account 2013 5,501,359 2.64 - 28.20 125,884,078 2012 4,914,049 2.01 - 21.37 88,989,701 2011 4,708,991 1.73 - 18.33 77,805,929 2010 3,443,301 15.77 - 18.85 59,472,935 MSF MetLife Stock Index 2014 28,264,874 7.03 - 77.90 610,830,233 Sub-Account 2013 28,624,388 6.28 - 69.33 561,274,487 2012 29,109,224 4.82 - 52.98 446,759,028 2011 25,347,914 4.22 - 46.18 355,993,780 2010 23,801,960 11.03 - 45.76 343,187,076 MSF MFS Total Return 2014 756,067 49.00 - 76.52 45,817,455 Sub-Account 2013 814,124 46.24 - 71.07 46,044,412 2012 730,405 41.41 - 60.26 35,344,618 2011 826,212 38.00 - 54.49 36,390,818 2010 929,202 37.99 - 53.68 40,676,709 MSF MFS Value Sub-Account 2014 10,916,908 13.03 - 26.14 255,401,966 2013 12,139,878 12.05 - 23.85 260,473,964 2012 3,025,966 14.12 - 17.78 48,275,261 2011 3,145,406 12.27 - 14.81 43,754,913 2010 3,234,649 12.33 - 14.90 45,430,281 FOR THE YEAR ENDED DECEMBER 31 -------------------------------------------------- INVESTMENT(1) EXPENSE RATIO(2) TOTAL RETURN(3) INCOME LOWEST TO LOWEST TO RATIO (%) HIGHEST (%) HIGHEST (%) ------------- ---------------- ----------------- MSF Met/Dimensional 2014 2.02 0.90 - 2.30 (8.82) - (0.83) International Small Company 2013 1.72 0.90 - 2.30 24.70 - 26.46 Sub-Account 2012 2.19 0.90 - 2.35 3.91 - 16.37 2011 1.94 1.30 - 2.35 (18.19) - (17.33) 2010 1.30 1.30 - 2.35 19.74 - 21.01 MSF MetLife Asset 2014 1.17 0.90 - 2.20 0.07 - 3.02 Allocation 20 Sub-Account 2013 3.04 1.55 - 2.15 2.07 - 2.68 2012 3.27 1.55 - 2.15 6.85 - 7.49 2011 2.37 1.55 - 2.15 1.06 - 1.66 2010 4.06 1.55 - 2.15 7.71 - 8.36 MSF MetLife Asset 2014 0.01 0.90 - 2.35 0.04 - 3.47 Allocation 40 Sub-Account 2013 2.53 1.55 - 2.10 8.62 - 9.22 2012 2.95 1.55 - 2.10 9.13 - 9.74 2011 2.14 1.55 - 2.10 (1.04) - (0.50) 2010 3.38 1.55 - 2.10 9.21 - 9.81 MSF MetLife Asset 2014 0.02 0.90 - 2.35 0.03 - 3.93 Allocation 60 Sub-Account 2013 2.00 1.55 - 2.25 15.36 - 16.17 2012 2.39 1.55 - 2.25 10.71 - 11.49 2011 1.52 1.55 - 2.25 (3.55) - (2.89) 2010 2.53 1.55 - 2.25 10.65 - 11.44 MSF MetLife Asset 2014 0.02 0.90 - 2.35 (0.03) - 4.53 Allocation 80 Sub-Account 2013 1.46 1.55 - 2.15 21.67 - 22.40 2012 1.91 1.55 - 2.15 12.92 - 13.60 2011 1.43 1.55 - 2.15 (5.81) - (5.25) 2010 2.14 1.55 - 2.15 12.25 - 12.94 MSF MetLife Mid Cap Stock 2014 0.85 0.89 - 2.35 1.60 - 8.52 Index Sub-Account 2013 1.00 0.89 - 2.35 29.67 - 31.97 2012 0.82 0.89 - 2.35 14.53 - 16.55 2011 0.70 0.89 - 2.35 (4.50) - (2.76) 2010 0.76 0.89 - 2.20 23.19 - 25.17 MSF MetLife Stock Index 2014 1.51 0.89 - 2.90 0.87 - 12.36 Sub-Account 2013 1.68 0.89 - 2.90 28.14 - 30.85 2012 1.55 0.89 - 2.90 12.30 - 14.73 2011 1.55 0.89 - 2.90 (1.15) - 0.94 2010 1.63 0.89 - 2.90 11.41 - 13.81 MSF MFS Total Return 2014 2.25 0.89 - 2.30 5.95 - 7.68 Sub-Account 2013 2.31 0.89 - 2.30 16.06 - 17.94 2012 2.78 0.89 - 2.15 2.75 - 10.59 2011 2.68 0.89 - 2.15 0.04 - 1.51 2010 2.91 0.89 - 2.15 7.53 - 9.10 MSF MFS Value Sub-Account 2014 1.57 0.89 - 2.35 1.99 - 9.83 2013 0.55 0.89 - 2.35 17.10 - 34.53 2012 1.94 0.89 - 2.30 3.00 - 15.61 2011 1.57 0.89 - 2.30 (1.43) - (0.04) 2010 1.32 0.89 - 2.30 8.89 - 10.44 132
485BPOS226th Page of 388TOC1stPreviousNextBottomJust 226th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 8. FINANCIAL HIGHLIGHTS -- (CONTINUED) [Enlarge/Download Table] AS OF DECEMBER 31 ---------------------------------------------- UNIT VALUE LOWEST TO NET UNITS HIGHEST ($) ASSETS ($) ------------ ---------------- -------------- MSF MSCI EAFE Index 2014 8,697,532 1.49 - 16.21 101,223,288 Sub-Account 2013 8,809,646 1.61 - 17.40 112,197,169 2012 7,172,234 1.34 - 14.41 81,404,548 2011 6,390,970 1.15 - 12.29 69,159,210 2010 4,636,491 11.54 - 14.17 58,834,689 MSF Neuberger Berman 2014 7,109,782 18.11 - 27.46 150,104,225 Genesis Sub-Account 2013 8,020,175 18.58 - 27.70 172,247,460 2012 626,194 16.44 - 20.18 11,798,908 2011 647,811 15.96 - 18.50 11,266,993 2010 578,563 16.81 - 17.64 9,730,049 MSF Russell 2000 Index 2014 5,807,014 2.84 - 31.21 144,858,146 Sub-Account 2013 5,835,501 2.74 - 29.98 141,070,458 2012 5,078,788 2.01 - 21.83 91,750,975 2011 3,926,223 1.75 - 18.93 64,081,468 2010 2,703,578 7.11 - 19.92 46,792,763 MSF T. Rowe Price Large Cap 2014 15,015,374 8.02 - 57.25 166,959,337 Growth Sub-Account 2013 14,688,080 8.03 - 53.41 151,930,071 2012 39,346 35.99 - 39.07 1,501,612 2011 44,809 30.91 - 33.42 1,465,621 2010 40,496 31.93 - 34.38 1,365,647 MSF T. Rowe Price Small Cap 2014 321,073 27.11 - 37.87 9,976,420 Growth Sub-Account 2013 356,919 25.98 - 35.74 10,522,813 2012 380,162 18.41 - 24.95 7,808,995 2011 417,381 16.23 - 21.67 7,500,142 2010 465,332 16.01 - 21.48 8,285,648 MSF Van Eck Global Natural 2014 6,586,665 13.05 - 13.93 89,288,128 Resources Sub-Account 2013 6,278,667 16.43 - 17.17 106,449,499 2012 7,200,491 15.15 - 15.70 111,896,983 2011 6,910,683 15.07 - 15.51 106,332,935 2010 3,967,225 18.49 - 18.86 74,371,723 MSF Western Asset Management 2014 398 32.02 12,743 Strategic Bond Opportunities Sub-Account (Commenced 11/19/2014) MSF Western Asset 2014 15,346,536 14.95 - 19.83 276,085,662 Management U.S. Government 2013 16,417,493 14.93 - 19.52 291,870,388 Sub-Account 2012 17,244,875 15.42 - 19.89 313,310,285 2011 16,038,241 15.32 - 19.49 285,529,978 2010 12,558,586 14.90 - 18.69 214,907,918 MSF WMC Core Equity 2014 30,718,018 17.28 - 57.62 609,015,113 Opportunities Sub-Account 2013 36,209,587 16.00 - 52.55 658,561,438 2012 41,401,029 12.26 - 39.65 572,327,325 2011 48,368,185 11.12 - 35.45 599,153,697 2010 46,415,423 11.87 - 37.27 606,785,200 FOR THE YEAR ENDED DECEMBER 31 -------------------------------------------------- INVESTMENT(1) EXPENSE RATIO(2) TOTAL RETURN(3) INCOME LOWEST TO LOWEST TO RATIO (%) HIGHEST (%) HIGHEST (%) ------------- ---------------- ----------------- MSF MSCI EAFE Index 2014 2.43 0.89 - 2.25 (8.42) - (2.81) Sub-Account 2013 2.89 0.89 - 2.25 18.74 - 20.78 2012 2.89 0.89 - 2.15 15.42 - 17.27 2011 2.23 0.89 - 2.15 (14.50) - (13.28) 2010 2.24 0.89 - 2.15 5.47 - 7.24 MSF Neuberger Berman 2014 0.22 0.89 - 2.35 (2.62) - 0.40 Genesis Sub-Account 2013 0.10 0.89 - 2.35 24.94 - 37.30 2012 0.34 0.89 - 2.30 7.25 - 9.05 2011 0.73 0.89 - 1.95 (7.38) - 4.87 2010 0.51 0.89 - 1.35 19.95 - 20.50 MSF Russell 2000 Index 2014 0.96 0.89 - 2.35 2.30 - 4.11 Sub-Account 2013 1.29 0.89 - 2.35 34.91 - 37.33 2012 0.88 0.89 - 2.35 13.24 - 15.31 2011 0.84 0.89 - 2.35 (6.46) - (4.95) 2010 0.77 0.89 - 2.35 23.61 - 25.79 MSF T. Rowe Price Large Cap 2014 -- 0.89 - 2.35 (0.04) - 13.92 Growth Sub-Account 2013 -- 0.89 - 2.35 26.10 - 37.93 2012 -- 1.50 - 1.90 16.43 - 16.90 2011 -- 1.50 - 1.90 (3.19) - (2.80) 2010 0.07 1.50 - 1.90 14.55 - 15.01 MSF T. Rowe Price Small Cap 2014 0.01 0.89 - 2.15 2.47 - 5.96 Growth Sub-Account 2013 0.22 0.89 - 2.15 41.11 - 43.27 2012 -- 0.89 - 2.15 13.43 - 15.14 2011 -- 0.89 - 2.15 (0.70) - 0.87 2010 -- 0.89 - 2.30 31.60 - 33.71 MSF Van Eck Global Natural 2014 0.27 1.10 - 2.15 (20.55) - (11.40) Resources Sub-Account 2013 0.66 1.30 - 2.15 8.40 - 9.32 2012 -- 1.30 - 2.15 0.38 - 1.25 2011 1.10 1.30 - 2.20 (18.49) - (17.75) 2010 0.25 1.30 - 2.20 26.22 - 27.36 MSF Western Asset Management 2014 -- 1.10 (0.65) Strategic Bond Opportunities Sub-Account (Commenced 11/19/2014) MSF Western Asset 2014 1.68 0.95 - 2.35 0.17 - 1.58 Management U.S. Government 2013 1.95 0.95 - 2.35 (3.21) - (1.84) Sub-Account 2012 1.85 0.95 - 2.35 0.64 - 2.07 2011 1.20 0.95 - 2.35 2.83 - 4.28 2010 2.24 0.95 - 2.35 3.04 - 4.50 MSF WMC Core Equity 2014 0.59 0.89 - 2.35 1.34 - 9.65 Opportunities Sub-Account 2013 1.27 0.89 - 2.35 30.43 - 32.52 2012 0.72 0.89 - 2.35 1.16 - 11.86 2011 1.01 0.89 - 2.35 (11.86) - (4.88) 2010 0.87 0.89 - 2.35 9.22 - 11.01 133
485BPOS227th Page of 388TOC1stPreviousNextBottomJust 227th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA NOTES TO THE FINANCIAL STATEMENTS -- (CONTINUED) 8. FINANCIAL HIGHLIGHTS -- (CONTINUED) [Enlarge/Download Table] AS OF DECEMBER 31 -------------------------------------------- UNIT VALUE LOWEST TO NET UNITS HIGHEST ($) ASSETS ($) ------------ --------------- ------------- Neuberger Berman Genesis 2014 393 22.93 9,013 Sub-Account 2013 474 23.21 10,991 2012 474 17.11 8,101 2011 474 15.72 7,443 2010 571 15.16 8,663 Oppenheimer VA Core Bond 2014 1,362 6.13 8,346 Sub-Account 2013 1,493 5.79 8,646 2012 1,541 5.88 9,058 2011 1,878 5.41 10,150 2010 1,952 5.06 9,885 Oppenheimer VA Global 2014 443 10.29 4,556 Strategic Income Sub-Account 2013 443 10.15 4,492 2012 443 10.30 4,562 2011 443 9.20 4,075 2010 443 9.25 4,097 Oppenheimer VA Main Street 2014 4,346,502 17.83 - 30.77 126,466,514 Small Cap Sub-Account 2013 4,655,290 16.15 - 27.82 123,045,407 2012 5,041,901 11.62 - 19.97 96,092,155 2011 4,964,464 9.98 - 17.13 81,494,321 2010 4,127,208 10.35 - 17.72 70,331,777 Oppenheimer VA Main Street 2014 13,372 7.93 106,085 Sub-Account 2013 14,316 7.27 104,039 2012 14,959 5.59 83,663 2011 22,109 4.85 107,300 2010 24,227 4.92 119,249 Oppenheimer VA Money 2014 696 5.45 3,793 Sub-Account 2013 723 5.53 4,000 2012 20,150 5.61 112,965 2011 20,177 5.69 114,709 2010 20,177 5.76 116,310 PIMCO VIT CommodityRealReturn 2014 1,515 8.69 - 8.70 13,170 Strategy Sub-Account (Commenced 11/19/2014) PIMCO VIT Emerging Market 2014 1,592 9.55 15,202 Bond Sub-Account (Commenced 11/19/2014) PIMCO VIT Unconstrained 2014 478 9.96 4,759 Bond Sub-Account (Commenced 11/19/2014) Pioneer VCT Mid Cap Value 2014 1,581,277 42.37 - 51.68 74,902,996 Sub-Account 2013 1,719,853 37.64 - 45.45 71,900,042 2012 1,769,793 28.91 - 34.56 56,444,927 2011 1,688,831 26.60 - 31.48 49,145,077 2010 1,493,349 28.81 - 33.76 46,621,818 FOR THE YEAR ENDED DECEMBER 31 -------------------------------------------------- INVESTMENT(1) EXPENSE RATIO(2) TOTAL RETURN(3) INCOME LOWEST TO LOWEST TO RATIO (%) HIGHEST (%) HIGHEST (%) ------------- ---------------- ----------------- Neuberger Berman Genesis 2014 0.05 0.89 (1.19) Sub-Account 2013 0.32 0.89 35.68 2012 0.21 0.89 8.84 2011 0.84 0.89 3.67 2010 -- 0.89 20.30 Oppenheimer VA Core Bond 2014 5.29 1.40 5.77 Sub-Account 2013 5.14 1.40 (1.49) 2012 4.67 1.40 8.75 2011 5.76 1.40 6.77 2010 4.81 1.40 9.87 Oppenheimer VA Global 2014 4.25 1.40 1.41 Strategic Income Sub-Account 2013 4.99 1.40 (1.52) 2012 5.95 1.40 11.95 2011 3.19 1.40 (0.55) 2010 16.19 1.40 13.38 Oppenheimer VA Main Street 2014 0.63 0.95 - 1.75 9.72 - 10.60 Small Cap Sub-Account 2013 0.70 0.95 - 1.75 38.19 - 39.29 2012 0.33 0.95 - 1.75 15.62 - 16.55 2011 0.36 0.95 - 1.75 (4.07) - (3.30) 2010 0.37 0.95 - 1.75 20.92 - 21.90 Oppenheimer VA Main Street 2014 0.84 1.40 9.16 Sub-Account 2013 1.10 1.40 29.94 2012 0.86 1.40 15.24 2011 1.27 1.40 (1.40) 2010 1.11 1.40 14.49 Oppenheimer VA Money 2014 -- 1.40 (1.38) Sub-Account 2013 0.01 1.40 (1.38) 2012 0.01 1.40 (1.39) 2011 0.01 1.40 (1.37) 2010 0.03 1.40 (1.37) PIMCO VIT CommodityRealReturn 2014 0.20 1.10 - 1.35 (13.36) - (13.33) Strategy Sub-Account (Commenced 11/19/2014) PIMCO VIT Emerging Market 2014 0.32 1.10 - 1.60 (3.46) - (3.40) Bond Sub-Account (Commenced 11/19/2014) PIMCO VIT Unconstrained 2014 0.04 1.35 (0.10) Bond Sub-Account (Commenced 11/19/2014) Pioneer VCT Mid Cap Value 2014 0.65 0.95 - 1.95 12.58 - 13.71 Sub-Account 2013 0.74 0.95 - 1.95 30.19 - 31.50 2012 0.84 0.95 - 1.95 8.67 - 9.77 2011 0.64 0.95 - 1.95 (7.66) - (6.73) 2010 0.87 0.95 - 1.95 15.62 - 16.78 134
485BPOS228th Page of 388TOC1stPreviousNextBottomJust 228th
METLIFE INVESTORS USA SEPARATE ACCOUNT A OF METLIFE INSURANCE COMPANY USA NOTES TO THE FINANCIAL STATEMENTS -- (CONCLUDED) 8. FINANCIAL HIGHLIGHTS -- (CONCLUDED) [Enlarge/Download Table] AS OF DECEMBER 31 ---------------------------------------------- UNIT VALUE LOWEST TO NET UNITS HIGHEST ($) ASSETS ($) ------------ ---------------- -------------- Pioneer VCT Real Estate 2014 8,772 27.15 - 30.26 249,879 Shares Sub-Account 2013 11,399 21.20 - 23.46 252,653 2012 10,700 21.29 - 23.38 237,514 2011 12,968 18.70 - 20.38 251,847 2010 12,983 17.38 - 18.80 234,208 T. Rowe Price Growth Stock 2014 52,254 143.75 7,511,742 Sub-Account 2013 62,571 133.27 8,339,192 2012 66,302 96.60 6,404,585 2011 73,401 81.96 6,015,937 2010 85,875 83.50 7,170,858 T. Rowe Price International 2014 39,998 15.58 623,024 Stock Sub-Account 2013 41,360 15.85 655,401 2012 45,736 13.99 639,881 2011 59,337 11.89 705,529 2010 68,117 13.68 932,126 T. Rowe Price Prime Reserve 2014 29,487 17.44 514,215 Sub-Account 2013 31,743 17.59 558,449 2012 40,746 17.75 723,146 2011 54,384 17.91 973,756 2010 70,013 18.06 1,264,618 TAP 1919 Variable Socially 2014 6,406 37.02 - 40.53 253,840 Responsive Balanced 2013 7,932 34.52 - 37.64 292,286 Sub-Account 2012 9,185 29.64 - 32.19 289,329 2011 17,377 27.28 - 29.51 501,373 2010 17,424 27.81 - 29.97 510,680 UIF Global Infrastructure 2014 664 12.49 - 12.95 8,465 Sub-Account (Commenced 11/19/2014) Van Eck VIP Long/Short Equity 2014 1,662 10.08 - 10.09 16,769 Index Sub-Account (Commenced 11/19/2014) FOR THE YEAR ENDED DECEMBER 31 ------------------------------------------------- INVESTMENT(1) EXPENSE RATIO(2) TOTAL RETURN(3) INCOME LOWEST TO LOWEST TO RATIO (%) HIGHEST (%) HIGHEST (%) ------------- ---------------- ---------------- Pioneer VCT Real Estate 2014 2.29 1.20 - 1.95 28.04 - 29.00 Shares Sub-Account 2013 2.16 1.20 - 1.95 (0.42) - 0.33 2012 2.11 1.20 - 1.95 13.84 - 14.70 2011 2.24 1.20 - 1.95 7.64 - 8.45 2010 2.42 1.20 - 1.95 26.06 - 27.01 T. Rowe Price Growth Stock 2014 -- 0.89 7.86 Sub-Account 2013 0.04 0.89 37.97 2012 0.18 0.89 17.86 2011 0.02 0.89 (1.85) 2010 0.06 0.89 15.89 T. Rowe Price International 2014 1.13 0.89 (1.70) Stock Sub-Account 2013 0.97 0.89 13.26 2012 1.21 0.89 17.66 2011 1.20 0.89 (13.11) 2010 1.13 0.89 13.46 T. Rowe Price Prime Reserve 2014 0.01 0.89 (0.88) Sub-Account 2013 0.01 0.89 (0.87) 2012 0.01 0.89 (0.88) 2011 0.01 0.89 (0.87) 2010 0.01 0.89 (0.87) TAP 1919 Variable Socially 2014 0.87 1.50 - 1.90 7.25 - 7.68 Responsive Balanced 2013 0.83 1.50 - 1.90 16.47 - 16.94 Sub-Account 2012 1.06 1.50 - 1.90 8.62 - 9.06 2011 1.20 1.50 - 1.90 (1.89) - (1.51) 2010 1.24 1.50 - 1.90 10.04 - 10.48 UIF Global Infrastructure 2014 -- 1.10 - 1.35 0.27 - 0.30 Sub-Account (Commenced 11/19/2014) Van Eck VIP Long/Short Equity 2014 -- 1.10 - 1.35 0.67 - 0.70 Index Sub-Account (Commenced 11/19/2014) 1 These amounts represent the dividends, excluding distributions of capital gains, received by the Sub-Account from the underlying portfolio, series or fund, net of management fees assessed by the fund manager, divided by the average net assets, regardless of share class, if any. These ratios exclude those expenses, such as mortality and expense risk charges, that are assessed against contract owner accounts either through reductions in the unit values or the redemption of units. The investment income ratio is calculated for each period indicated or from the effective date through the end of the reporting period. The recognition of investment income by the Sub-Account is affected by the timing of the declaration of dividends by the underlying portfolio, series or fund in which the Sub-Account invests. The investment income ratio is calculated as a weighted average ratio since the Sub-Account may invest in two or more share classes, within the underlying portfolio, series or fund of the Trusts which may have unique investment income ratios. 2 These amounts represent annualized contract expenses of each of the applicable Sub-Accounts, consisting primarily of mortality and expense risk charges, for each period indicated. The ratios include only those expenses that result in a direct reduction to unit values. Charges made directly to contract owner accounts through the redemption of units and expenses of the underlying portfolio, series or fund have been excluded. 3 These amounts represent the total return for the period indicated, including changes in the value of the underlying portfolio, series or fund, and expenses assessed through the reduction of unit values. These ratios do not include any expenses assessed through the redemption of units. The total return is calculated for each period indicated or from the effective date through the end of the reporting period. The total return is presented as a range of minimum to maximum returns, based on the minimum and maximum returns within each product grouping of the applicable Sub-Account. 135
485BPOS229th Page of 388TOC1stPreviousNextBottomJust 229th
This page is intentionally left blank.
485BPOS230th Page of 388TOC1stPreviousNextBottomJust 230th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Item 8. Financial Statements and Supplementary Data Index to Consolidated Financial Statements, Notes and Schedules [Enlarge/Download Table] Page ---- Report of Independent Registered Public Accounting Firm.............................................. 2 Financial Statements at December 31, 2014 and 2013 and for the Years Ended December 31, 2014, 2013 and 2012: Consolidated Balance Sheets......................................................................... 3 Consolidated Statements of Operations............................................................... 4 Consolidated Statements of Comprehensive Income (Loss).............................................. 5 Consolidated Statements of Stockholder's Equity..................................................... 6 Consolidated Statements of Cash Flows............................................................... 7 Notes to the Consolidated Financial Statements...................................................... 9 Note 1 -- Business, Basis of Presentation and Summary of Significant Accounting Policies........ 9 Note 2 -- Segment Information................................................................... 27 Note 3 -- Mergers............................................................................... 33 Note 4 -- Dispositions.......................................................................... 34 Note 5 -- Insurance............................................................................. 35 Note 6 -- Deferred Policy Acquisition Costs, Value of Business Acquired and Other Intangibles... 43 Note 7 -- Reinsurance........................................................................... 46 Note 8 -- Investments........................................................................... 54 Note 9 -- Derivatives........................................................................... 76 Note 10 -- Fair Value........................................................................... 90 Note 11 -- Goodwill............................................................................. 117 Note 12 -- Debt................................................................................. 120 Note 13 -- Equity............................................................................... 120 Note 14 -- Other Expenses....................................................................... 126 Note 15 -- Income Tax........................................................................... 127 Note 16 -- Contingencies, Commitments and Guarantees............................................ 130 Note 17 -- Related Party Transactions........................................................... 134 Financial Statement Schedules at December 31, 2014 and 2013 and for the Years Ended December 31, 2014, 2013 and 2012: Schedule I -- Consolidated Summary of Investments -- Other Than Investments in Related Parties...... 135 Schedule III -- Consolidated Supplementary Insurance Information.................................... 136 Schedule IV -- Consolidated Reinsurance............................................................. 138 1
485BPOS231st Page of 388TOC1stPreviousNextBottomJust 231st
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors and Stockholder of MetLife Insurance Company USA: We have audited the accompanying consolidated balance sheets of MetLife Insurance Company USA (formerly MetLife Insurance Company of Connecticut) and subsidiaries (the "Company") as of December 31, 2014 and 2013, and the related consolidated statements of operations, comprehensive income (loss), stockholder's equity, and cash flows for each of the three years in the period ended December 31, 2014. Our audits also included the financial statement schedules listed in the Index to Consolidated Financial Statements, Notes and Schedules. These consolidated financial statements and financial statement schedules are the responsibility of the Company's management. Our responsibility is to express an opinion on the consolidated financial statements and financial statement schedules based on our audits. We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the consolidated financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion. In our opinion, such consolidated financial statements present fairly, in all material respects, the financial position of MetLife Insurance Company USA and subsidiaries as of December 31, 2014 and 2013, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2014, in conformity with accounting principles generally accepted in the United States of America. Also, in our opinion, such financial statement schedules, when considered in relation to the basic consolidated financial statements taken as a whole, present fairly, in all material respects, the information set forth therein. As discussed in Note 3 to the consolidated financial statements, on November 14, 2014, MetLife Insurance Company of Connecticut was renamed MetLife Insurance Company USA and merged with MetLife Investors USA Insurance Company, MetLife Investors Insurance Company, and Exeter Reassurance Company, Ltd., all subsidiaries of MetLife, Inc. As the mergers involved entities all under common control, the accompanying consolidated financial statements have been retrospectively adjusted for all periods presented to reflect the mergers in a manner similar to a pooling-of-interests. /s/ DELOITTE & TOUCHE LLP New York, New York March 27, 2015 2
485BPOS232nd Page of 388TOC1stPreviousNextBottomJust 232nd
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Consolidated Balance Sheets December 31, 2014 and 2013 (In millions, except share and per share data) [Enlarge/Download Table] 2014 2013 ----------- ----------- Assets Investments: Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $46,423 and $46,988, respectively)................................................... $ 50,697 $ 48,824 Equity securities available-for-sale, at estimated fair value (cost: $400 and $443, respectively)........................................................................ 459 463 Mortgage loans (net of valuation allowances of $25 and $35, respectively; includes $280 and $1,598, respectively, at estimated fair value, relating to variable interest entities)................................................................... 5,839 8,004 Policy loans........................................................................... 1,194 1,246 Real estate and real estate joint ventures (includes $93 and $0, respectively, of real estate held-for-sale)................................................................ 894 754 Other limited partnership interests.................................................... 2,234 2,162 Short-term investments, principally at estimated fair value............................ 1,232 4,964 Other invested assets, principally at estimated fair value............................. 4,531 5,899 ----------- ----------- Total investments.................................................................... 67,080 72,316 Cash and cash equivalents, principally at estimated fair value.......................... 1,206 1,400 Accrued investment income (includes $2 and $9, respectively, relating to variable interest entities).................................................................... 501 660 Premiums, reinsurance and other receivables............................................. 21,559 19,553 Deferred policy acquisition costs and value of business acquired........................ 4,890 5,691 Current income tax recoverable.......................................................... 537 398 Goodwill................................................................................ 381 526 Other assets............................................................................ 848 943 Separate account assets................................................................. 108,861 109,814 ----------- ----------- Total assets....................................................................... $ 205,863 $ 211,301 =========== =========== Liabilities and Stockholder's Equity Liabilities Future policy benefits.................................................................. $ 28,479 $ 30,603 Policyholder account balances........................................................... 35,486 37,389 Other policy-related balances........................................................... 3,320 4,130 Payables for collateral under securities loaned and other transactions.................. 7,501 6,914 Long-term debt (includes $139 and $1,461, respectively, at estimated fair value, relating to variable interest entities)............................................... 928 2,326 Deferred income tax liability........................................................... 1,338 251 Other liabilities (includes $1 and $7, respectively, relating to variable interest entities)............................................................................. 7,944 8,308 Separate account liabilities............................................................ 108,861 109,814 ----------- ----------- Total liabilities.................................................................. 193,857 199,735 ----------- ----------- Contingencies, Commitments and Guarantees (Note 16) Stockholder's Equity Common stock, par value $25,000 and $2.50 per share; 4,000 and 40,000,000 shares authorized; 3,000 and 34,595,317 shares issued and outstanding, respectively.......... 75 86 Additional paid-in capital.............................................................. 10,855 11,506 Retained earnings (deficit)............................................................. (1,350) (1,006) Accumulated other comprehensive income (loss)........................................... 2,426 980 ----------- ----------- Total stockholder's equity......................................................... 12,006 11,566 ----------- ----------- Total liabilities and stockholder's equity........................................ $ 205,863 $ 211,301 =========== =========== See accompanying notes to the consolidated financial statements. 3
485BPOS233rd Page of 388TOC1stPreviousNextBottomJust 233rd
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Consolidated Statements of Operations For the Years Ended December 31, 2014, 2013 and 2012 (In millions) [Enlarge/Download Table] 2014 2013 2012 --------- --------- --------- Revenues Premiums............................................................. $ 1,152 $ 689 $ 2,215 Universal life and investment-type product policy fees............... 3,193 3,130 3,014 Net investment income................................................ 2,669 2,999 3,060 Other revenues....................................................... 539 610 626 Net investment gains (losses): Other-than-temporary impairments on fixed maturity securities....... (6) (9) (54) Other-than-temporary impairments on fixed maturity securities transferred to other comprehensive income (loss).................. (6) (11) 3 Other net investment gains (losses)................................. (457) 47 241 --------- --------- --------- Total net investment gains (losses)............................... (469) 27 190 Net derivative gains (losses)....................................... (181) 441 (2,345) --------- --------- --------- Total revenues.................................................. 6,903 7,896 6,760 --------- --------- --------- Expenses Policyholder benefits and claims..................................... 2,764 3,147 4,321 Interest credited to policyholder account balances................... 1,062 1,168 1,281 Goodwill impairment.................................................. 33 66 394 Other expenses....................................................... 2,754 1,937 2,636 --------- --------- --------- Total expenses.................................................. 6,613 6,318 8,632 --------- --------- --------- Income (loss) from continuing operations before provision for income tax................................................................ 290 1,578 (1,872) Provision for income tax expense (benefit)........................... (5) 437 (813) --------- --------- --------- Income (loss) from continuing operations, net of income tax.......... 295 1,141 (1,059) Income (loss) from discontinued operations, net of income tax........ -- -- 8 --------- --------- --------- Net income (loss).................................................... $ 295 $ 1,141 $ (1,051) ========= ========= ========= See accompanying notes to the consolidated financial statements. 4
485BPOS234th Page of 388TOC1stPreviousNextBottomJust 234th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Consolidated Statements of Comprehensive Income (Loss) For the Years Ended December 31, 2014, 2013 and 2012 (In millions) [Enlarge/Download Table] 2014 2013 2012 --------- --------- --------- Net income (loss).................................................... $ 295 $ 1,141 $ (1,051) Other comprehensive income (loss): Unrealized investment gains (losses), net of related offsets........ 1,953 (2,232) 941 Unrealized gains (losses) on derivatives............................ 244 (206) 3 Foreign currency translation adjustments............................ (50) 54 101 --------- --------- --------- Other comprehensive income (loss), before income tax................. 2,147 (2,384) 1,045 Income tax (expense) benefit related to items of other comprehensive income (loss)...................................................... (701) 808 (344) --------- --------- --------- Other comprehensive income (loss), net of income tax................. 1,446 (1,576) 701 --------- --------- --------- Comprehensive income (loss).......................................... $ 1,741 $ (435) $ (350) ========= ========= ========= See accompanying notes to the consolidated financial statements. 5
485BPOS235th Page of 388TOC1stPreviousNextBottomJust 235th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Consolidated Statements of Stockholder's Equity For the Years Ended December 31, 2014, 2013 and 2012 (In millions) [Enlarge/Download Table] Accumulated Additional Retained Other Total Common Paid-in Earnings Comprehensive Stockholder's Stock Capital (Deficit) Income (Loss) Equity --------- ----------- ---------- ------------- ------------- Balance at January 1, 2012 (Note 3)...................... $ 86 $ 8,582 $ 1,034 $ 1,855 $ 11,557 Dividend of subsidiary (Note 4)...................... (347) (347) Dividend paid to MetLife, Inc... (522) (522) Capital contribution (Note 3)... 2,878 2,878 Net income (loss)............... (1,051) (1,051) Other comprehensive income (loss), net of income tax (1). 701 701 --------- ----------- ---------- --------- ---------- Balance at December 31, 2012.... 86 11,460 (886) 2,556 13,216 Dividend paid to MetLife, Inc... (1,261) (1,261) Capital contribution............ 46 46 Net income (loss)............... 1,141 1,141 Other comprehensive income (loss), net of income tax..... (1,576) (1,576) --------- ----------- ---------- --------- ---------- Balance at December 31, 2013.... 86 11,506 (1,006) 980 11,566 Redemption of common stock...... (11) (895) (484) (1,390) Dividend paid to MetLife, Inc... (155) (155) Capital contribution............ 244 244 Net income (loss)............... 295 295 Other comprehensive income (loss), net of income tax..... 1,446 1,446 --------- ----------- ---------- --------- ---------- Balance at December 31, 2014.... $ 75 $ 10,855 $ (1,350) $ 2,426 $ 12,006 ========= =========== ========== ========= ========== -------- (1)Includes amounts related to dividend of subsidiary. See Notes 4 and 13. See accompanying notes to the consolidated financial statements. 6
485BPOS236th Page of 388TOC1stPreviousNextBottomJust 236th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Consolidated Statements of Cash Flows For the Years Ended December 31, 2014, 2013 and 2012 (In millions) [Enlarge/Download Table] 2014 2013 2012 -------- -------- -------- Cash flows from operating activities Net income (loss).................................................................................. $ 295 $ 1,141 $ (1,051) Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Depreciation and amortization expenses........................................................... 30 35 33 Amortization of premiums and accretion of discounts associated with investments, net............. (166) (150) (170) (Gains) losses on investments and from sales of businesses, net.................................. 469 (27) (200) (Gains) losses on derivatives, net............................................................... 1,443 1,567 3,643 (Income) loss from equity method investments, net of dividends or distributions.................. (11) (82) (43) Interest credited to policyholder account balances............................................... 1,062 1,168 1,281 Universal life and investment-type product policy fees........................................... (3,193) (3,130) (3,014) Goodwill impairment.............................................................................. 33 66 394 Change in fair value option securities........................................................... -- -- (601) Change in accrued investment income.............................................................. 124 146 91 Change in premiums, reinsurance and other receivables............................................ (1,479) (190) (614) Change in deferred policy acquisition costs and value of business acquired, net.................. 711 (480) (154) Change in income tax............................................................................. 245 691 (798) Change in other assets........................................................................... 2,258 2,006 1,869 Change in insurance-related liabilities and policy-related balances.............................. 1,398 1,198 2,055 Change in other liabilities...................................................................... 1,390 31 308 Other, net....................................................................................... (67) (6) -- -------- -------- -------- Net cash provided by (used in) operating activities................................................ 4,542 3,984 3,029 -------- -------- -------- Cash flows from investing activities Sales, maturities and repayments of: Fixed maturity securities....................................................................... 20,249 20,330 16,647 Equity securities............................................................................... 98 69 60 Mortgage loans.................................................................................. 2,428 2,304 1,461 Real estate and real estate joint ventures...................................................... 28 104 72 Other limited partnership interests............................................................. 255 153 220 Purchases of: Fixed maturity securities....................................................................... (24,520) (17,068) (18,153) Equity securities............................................................................... (41) (133) (60) Mortgage loans.................................................................................. (343) (912) (879) Real estate and real estate joint ventures...................................................... (209) (201) (225) Other limited partnership interests............................................................. (345) (368) (357) Cash received in connection with freestanding derivatives........................................ 788 258 845 Cash paid in connection with freestanding derivatives............................................ (1,991) (3,615) (2,126) Sale of business, net of cash and cash equivalents disposed of $251, $0 and $0, respectively.................................................................................... 451 -- -- Dividend of subsidiary........................................................................... -- -- (53) Sales of loans to affiliates..................................................................... 520 -- -- Net change in policy loans....................................................................... 52 (3) (14) Net change in short-term investments............................................................. 3,581 2,060 1,273 Net change in other invested assets.............................................................. (305) 113 (113) Other, net....................................................................................... -- 3 -- -------- -------- -------- Net cash provided by (used in) investing activities................................................ 696 3,094 (1,402) -------- -------- -------- See accompanying notes to the consolidated financial statements. 7
485BPOS237th Page of 388TOC1stPreviousNextBottomJust 237th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Consolidated Statements of Cash Flows -- (Continued) For the Years Ended December 31, 2014, 2013 and 2012 (In millions) [Enlarge/Download Table] 2014 2013 2012 --------- --------- ---------- Cash flows from financing activities Policyholder account balances: Deposits............................................................................... 18,581 15,005 16,417 Withdrawals............................................................................ (21,564) (16,806) (16,549) Net change in payables for collateral under securities loaned and other transactions.... 703 (3,197) (1,395) Long-term debt repaid................................................................... (1,379) (1,009) (482) Financing element on certain derivative instruments..................................... (414) (197) 67 Redemption of common stock.............................................................. (906) -- -- Common stock redemption premium......................................................... (484) -- -- Dividends paid to MetLife, Inc.......................................................... (155) (1,261) (522) Capital contributions from MetLife, Inc................................................. 231 -- 800 --------- --------- ---------- Net cash provided by (used in) financing activities....................................... (5,387) (7,465) (1,664) --------- --------- ---------- Effect of change in foreign currency exchange rates on cash and cash equivalents balances. (45) (41) (15) --------- --------- ---------- Change in cash and cash equivalents....................................................... (194) (428) (52) Cash and cash equivalents, beginning of year.............................................. 1,400 1,828 1,880 --------- --------- ---------- Cash and cash equivalents, end of year.................................................... $ 1,206 $ 1,400 $ 1,828 ========= ========= ========== Supplemental disclosures of cash flow information Net cash paid (received) for: Interest............................................................................... $ 116 $ 199 $ 331 ========= ========= ========== Income tax............................................................................. $ (221) $ (272) $ 23 ========= ========= ========== Non-cash transactions: Disposal of subsidiary: (1) Assets disposed........................................................................ $ -- $ -- $ 4,857 Liabilities disposed................................................................... -- -- (4,567) --------- --------- ---------- Net assets disposed.................................................................... -- -- 290 Cash disposed.......................................................................... -- -- (53) Dividend of interests in subsidiary.................................................... -- -- (237) --------- --------- ---------- (Gain) loss on dividend of interests in subsidiary..................................... $ -- $ -- $ -- ========= ========= ========== Capital contributions from MetLife, Inc................................................. $ 13 $ 46 $ 2,078 ========= ========= ========== Assignment of senior notes to MetLife, Inc.............................................. $ -- $ -- $ 2,000 ========= ========= ========== Transfers of fixed maturity securities to affiliates.................................... $ 804 $ -- $ -- ========= ========= ========== Purchase of fixed maturity securities associated with business transfer................. $ -- $ -- $ 761 ========= ========= ========== Purchase of short-term investments associated with business transfer.................... $ -- $ -- $ 72 ========= ========= ========== Real estate and real estate joint ventures acquired in satisfaction of debt............. $ -- $ -- $ 50 ========= ========= ========== -------- (1)See Note 4. See accompanying notes to the consolidated financial statements. 8
485BPOS238th Page of 388TOC1stPreviousNextBottomJust 238th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements 1. Business, Basis of Presentation and Summary of Significant Accounting Policies Business "MetLife USA" and the "Company" refer to MetLife Insurance Company USA (formerly, MetLife Insurance Company of Connecticut ("MICC")), a Delaware corporation originally incorporated in Connecticut in 1863, and its subsidiaries. MetLife Insurance Company USA is a wholly-owned subsidiary of MetLife, Inc. The Company offers individual annuities, individual life insurance, and institutional protection and asset accumulation products. In November 2014, MetLife Insurance Company of Connecticut re-domesticated from Connecticut to Delaware, changed its name to MetLife Insurance Company USA and merged with its subsidiary, MetLife Investors USA Insurance Company ("MLI-USA"), and its affiliates, MetLife Investors Insurance Company ("MLIIC") and Exeter Reassurance Company, Ltd. ("Exeter"). See Note 3 for further information on the merger transactions and the prior periods' adjustments. The Company is organized into two segments: Retail and Corporate Benefit Funding. Basis of Presentation The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("GAAP") requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported in the consolidated financial statements. In applying these policies and estimates, management makes subjective and complex judgments that frequently require assumptions about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and financial services industries; others are specific to the Company's business and operations. Actual results could differ from estimates. Consolidation The accompanying consolidated financial statements include the accounts of MetLife Insurance Company USA and its subsidiaries, as well as partnerships and joint ventures in which the Company has control, and variable interest entities ("VIEs") for which the Company is the primary beneficiary. Intercompany accounts and transactions have been eliminated. Since the Company is a member of a controlled group of affiliated companies, its results may not be indicative of those of a stand-alone entity. Discontinued Operations The results of operations of a component of the Company that has either been disposed of or is classified as held-for-sale are reported in discontinued operations if certain criteria are met. Effective January 1, 2014, the Company early adopted new guidance regarding reporting of discontinued operations for disposals or classifications as held-for-sale that have not been previously reported in the consolidated financial statements. A disposal of a component is reported in discontinued operations if the disposal represents a strategic shift that has or will have a major effect on the Company's operations and financial results. See "-- Adoption of New Accounting Pronouncements." 9
485BPOS239th Page of 388TOC1stPreviousNextBottomJust 239th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) Separate Accounts Separate accounts are established in conformity with insurance laws and are generally not chargeable with liabilities that arise from any other business of the Company. Separate account assets are subject to general account claims only to the extent the value of such assets exceeds the separate account liabilities. The Company reports separately, as assets and liabilities, investments held in separate accounts and liabilities of the separate accounts if: . such separate accounts are legally recognized; . assets supporting the contract liabilities are legally insulated from the Company's general account liabilities; . investments are directed by the contractholder; and . all investment performance, net of contract fees and assessments, is passed through to the contractholder. The Company reports separate account assets at their fair value, which is based on the estimated fair values of the underlying assets comprising the individual separate account portfolios. Investment performance (including investment income, net investment gains (losses) and changes in unrealized gains (losses)) and the corresponding amounts credited to contractholders of such separate accounts are offset within the same line in the statements of operations. Separate accounts credited with a contractual investment return are combined on a line-by-line basis with the Company's general account assets, liabilities, revenues and expenses and the accounting for these investments is consistent with the methodologies described herein for similar financial instruments held within the general account. Unit-linked separate account investments that are directed by contractholders but do not meet one or more of the other above criteria are included in fair value option ("FVO") securities. See Note 4 for the disposition of MetLife Europe Limited ("MetLife Europe"). The Company's revenues reflect fees charged to the separate accounts, including mortality charges, risk charges, policy administration fees, investment management fees and surrender charges. Such fees are included in universal life and investment-type product policy fees in the statements of operations. Summary of Significant Accounting Policies The following are the Company's significant accounting policies with references to notes providing additional information on such policies and critical accounting estimates relating to such policies. [Enlarge/Download Table] ----------------------------------------------------------------------------------------- Accounting Policy Note ----------------------------------------------------------------------------------------- Insurance 5 ----------------------------------------------------------------------------------------- Deferred Policy Acquisition Costs, Value of Business Acquired and Other Intangibles 6 ----------------------------------------------------------------------------------------- Reinsurance 7 ----------------------------------------------------------------------------------------- Investments 8 ----------------------------------------------------------------------------------------- Derivatives 9 ----------------------------------------------------------------------------------------- Fair Value 10 ----------------------------------------------------------------------------------------- Goodwill 11 ----------------------------------------------------------------------------------------- Income Tax 15 ----------------------------------------------------------------------------------------- Litigation Contingencies 16 ----------------------------------------------------------------------------------------- 10
485BPOS240th Page of 388TOC1stPreviousNextBottomJust 240th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) Insurance Future Policy Benefit Liabilities and Policyholder Account Balances The Company establishes liabilities for amounts payable under insurance policies. Generally, amounts are payable over an extended period of time and related liabilities are calculated as the present value of future expected benefits to be paid reduced by the present value of future expected premiums. Such liabilities are established based on methods and underlying assumptions in accordance with GAAP and applicable actuarial standards. Principal assumptions used in the establishment of liabilities for future policy benefits are mortality, morbidity, policy lapse, renewal, retirement, disability incidence, disability terminations, investment returns, inflation, expenses and other contingent events as appropriate to the respective product type. These assumptions are established at the time the policy is issued and are intended to estimate the experience for the period the policy benefits are payable. Utilizing these assumptions, liabilities are established on a block of business basis. For long duration insurance contracts, assumptions such as mortality, morbidity and interest rates are "locked in" upon the issuance of new business. However, significant adverse changes in experience on such contracts may require the establishment of premium deficiency reserves. Such reserves are determined based on the then current assumptions and do not include a provision for adverse deviation. Liabilities for universal and variable life secondary guarantees are determined by estimating the expected value of death benefits payable when the account balance is projected to be zero and recognizing those benefits ratably over the accumulation period based on total expected assessments. The assumptions used in estimating the secondary guarantee liabilities are consistent with those used for amortizing deferred policy acquisition costs ("DAC"), and are thus subject to the same variability and risk as further discussed herein. The assumptions of investment performance and volatility for variable products are consistent with historical experience of appropriate underlying equity indices, such as the Standard & Poor's Ratings Services ("S&P") 500 Index. The benefits used in calculating the liabilities are based on the average benefits payable over a range of scenarios. The Company regularly reviews its estimates of liabilities for future policy benefits and compares them with its actual experience. Differences result in changes to the liability balances with related charges or credits to benefit expenses in the period in which the changes occur. Policyholder account balances ("PABs") relate to contract or contract features where the Company has no significant insurance risk. The Company issues directly and assumes through reinsurance, certain variable annuity products with guaranteed minimum benefits that provide the policyholder a minimum return based on their initial deposit (i.e., the benefit base) less withdrawals. These guarantees are accounted for as insurance liabilities or as embedded derivatives depending on how and when the benefit is paid. Specifically, a guarantee is accounted for as an embedded derivative if a guarantee is paid without requiring (i) the occurrence of specific insurable event, or (ii) the policyholder to annuitize. Alternatively, a guarantee is accounted for as an insurance liability if the guarantee is paid only upon either (i) the occurrence of a specific insurable event, or (ii) annuitization. In certain cases, a guarantee may have elements of both an insurance liability and an embedded derivative and in such cases the guarantee is split and accounted for under both models. 11
485BPOS241st Page of 388TOC1stPreviousNextBottomJust 241st
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) Guarantees accounted for as insurance liabilities in future policy benefits include guaranteed minimum death benefits ("GMDBs"), the portion of guaranteed minimum income benefits ("GMIBs") that require annuitization, and the life-contingent portion of guaranteed minimum withdrawal benefits ("GMWBs"). Guarantees accounted for as embedded derivatives in PABs include the non life-contingent portion of GMWBs, guaranteed minimum accumulation benefits ("GMABs") and the portion of GMIBs that do not require annuitization. At inception, the Company attributes to the embedded derivative a portion of the projected future guarantee fees to be collected from the policyholder equal to the present value of projected future guaranteed benefits. Any additional fees represent "excess" fees and are reported in universal life and investment-type product policy fees. Other Policy-Related Balances Other policy-related balances primarily include assumed affiliated reinsurance payables, affiliated deferred experience refunds, policy and contract claims and unearned revenue liabilities. The assumed affiliated reinsurance payable relates primarily to reinsurance for certain universal life business assumed from an affiliate, net of other reinsurance. The affiliated deferred experience refunds relate to the repayment of acquisition costs under an affiliated reinsurance agreement and represent part the net cost of reinsurance for the business reinsured. The deferred experience refund is being amortized consistent with the DAC methodology on the underlying contracts. The liability for policy and contract claims generally relates to incurred but not reported death, disability, and long-term care ("LTC") claims, as well as claims which have been reported but not yet settled. The liability for these claims is based on the Company's estimated ultimate cost of settling all claims. The Company derives estimates for the development of incurred but not reported claims principally from analyses of historical patterns of claims by business line. The methods used to determine these estimates are continually reviewed. Adjustments resulting from this continuous review process and differences between estimates and payments for claims are recognized in policyholder benefits and claims expense in the period in which the estimates are changed or payments are made. The unearned revenue liability relates to universal life-type and investment-type products and represents policy charges for services to be provided in future periods. The charges are deferred as unearned revenue and amortized using the product's estimated gross profits, similar to DAC as discussed further herein. Such amortization is recorded in universal life and investment-type product policy fees. Recognition of Insurance Revenues and Deposits Premiums related to traditional life and annuity policies with life contingencies are recognized as revenues when due from policyholders. Policyholder benefits and expenses are provided to recognize profits over the estimated lives of the insurance policies. When premiums are due over a significantly shorter period than the period over which benefits are provided, any excess profit is deferred and recognized into earnings in a constant relationship to insurance in-force or, for annuities, the amount of expected future policy benefit payments. Premiums related to non-medical health and disability contracts are recognized on a pro rata basis over the applicable contract term. 12
485BPOS242nd Page of 388TOC1stPreviousNextBottomJust 242nd
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) Deposits related to universal life-type and investment-type products are credited to PABs. Revenues from such contracts consist of fees for mortality, policy administration and surrender charges and are recorded in universal life and investment-type product policy fees in the period in which services are provided. Amounts that are charged to earnings include interest credited and benefit claims incurred in excess of related PABs. Premiums, policy fees, policyholder benefits and expenses are presented net of reinsurance. Deferred Policy Acquisition Costs, Value of Business Acquired and Other Intangibles The Company incurs significant costs in connection with acquiring new and renewal insurance business. Costs that are related directly to the successful acquisition or renewal of insurance contracts are capitalized as DAC. Such costs include: . incremental direct costs of contract acquisition, such as commissions; . the portion of an employee's total compensation and benefits related to time spent selling, underwriting or processing the issuance of new and renewal insurance business only with respect to actual policies acquired or renewed; . other essential direct costs that would not have been incurred had a policy not been acquired or renewed; and . the costs of direct-response advertising, the primary purpose of which is to elicit sales to customers who could be shown to have responded specifically to the advertising and that results in probable future benefits. All other acquisition-related costs, including those related to general advertising and solicitation, market research, agent training, product development, unsuccessful sales and underwriting efforts, as well as all indirect costs, are expensed as incurred. Value of business acquired ("VOBA") is an intangible asset resulting from a business combination that represents the excess of book value over the estimated fair value of acquired insurance, annuity, and investment-type contracts in-force at the acquisition date. The estimated fair value of the acquired liabilities is based on projections, by each block of business, of future policy and contract charges, premiums, mortality and morbidity, separate account performance, surrenders, operating expenses, investment returns, nonperformance risk adjustment and other factors. Actual experience on the purchased business may vary from these projections. DAC and VOBA are amortized as follows: [Download Table] ----------------------------------------------------------------------------- Products: In proportion to the following over estimated lives of the contracts: ----------------------------------------------------------------------------- . Nonparticipating and Historic actual and expected future non-dividend-paying traditional gross premiums. contracts (primarily term insurance) ----------------------------------------------------------------------------- . Participating, dividend-paying Actual and expected future gross traditional contracts margins. ----------------------------------------------------------------------------- . Fixed and variable universal life Actual and expected future gross contracts profits. . Fixed and variable deferred annuity contracts ----------------------------------------------------------------------------- See Note 6 for additional information on DAC and VOBA amortization. 13
485BPOS243rd Page of 388TOC1stPreviousNextBottomJust 243rd
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) The recovery of DAC and VOBA is dependent upon the future profitability of the related business. DAC and VOBA are aggregated in the financial statements for reporting purposes. The Company generally has two different types of sales inducements which are included in other assets: (i) the policyholder receives a bonus whereby the policyholder's initial account balance is increased by an amount equal to a specified percentage of the customer's deposit; and (ii) the policyholder receives a higher interest rate using a dollar cost averaging method than would have been received based on the normal general account interest rate credited. The Company defers sales inducements and amortizes them over the life of the policy using the same methodology and assumptions used to amortize DAC. The amortization of sales inducements is included in policyholder benefits and claims. Each year, or more frequently if circumstances indicate a potential recoverability issue exists, the Company reviews deferred sales inducements ("DSI") to determine the recoverability of the asset. Value of distribution agreements acquired ("VODA") is reported in other assets and represents the present value of expected future profits associated with the expected future business derived from the distribution agreements acquired as part of a business combination. Value of customer relationships acquired ("VOCRA") is also reported in other assets and represents the present value of the expected future profits associated with the expected future business acquired through existing customers of the acquired company or business. The VODA and VOCRA associated with past business combinations are amortized over useful lives ranging from 10 to 30 years and such amortization is included in other expenses. Each year, or more frequently if circumstances indicate a possible impairment exists, the Company reviews VODA and VOCRA to determine whether the asset is impaired. Reinsurance For each of its reinsurance agreements, the Company determines whether the agreement provides indemnification against loss or liability relating to insurance risk in accordance with applicable accounting standards. Cessions under reinsurance agreements do not discharge the Company's obligations as the primary insurer. The Company reviews all contractual features, including those that may limit the amount of insurance risk to which the reinsurer is subject or features that delay the timely reimbursement of claims. For reinsurance of existing in-force blocks of long-duration contracts that transfer significant insurance risk, the difference, if any, between the amounts paid (received), and the liabilities ceded (assumed) related to the underlying contracts is considered the net cost of reinsurance at the inception of the reinsurance agreement. The net cost of reinsurance is recorded as an adjustment to DAC when there is a gain at inception on the ceding entity and to other liabilities when there is a loss at inception. The net cost of reinsurance is recognized as a component of other expenses when there is a gain at inception and as policyholder benefits and claims when there is a loss and is subsequently amortized on a basis consistent with the methodology used for amortizing DAC related to the underlying reinsured contracts. Subsequent amounts paid (received) on the reinsurance of in-force blocks, as well as amounts paid (received) related to new business, are recorded as ceded (assumed) premiums and ceded (assumed) premiums, reinsurance and other receivables (future policy benefits) are established. Amounts currently recoverable under reinsurance agreements are included in premiums, reinsurance and other receivables and amounts currently payable are included in other liabilities. Assets and liabilities relating to 14
485BPOS244th Page of 388TOC1stPreviousNextBottomJust 244th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) reinsurance agreements with the same reinsurer may be recorded net on the balance sheet, if a right of offset exists within the reinsurance agreement. In the event that reinsurers do not meet their obligations to the Company under the terms of the reinsurance agreements, reinsurance recoverable balances could become uncollectible. In such instances, reinsurance recoverable balances are stated net of allowances for uncollectible reinsurance. The funds withheld liability represents amounts withheld by the Company in accordance with the terms of the reinsurance agreements. The Company withholds the funds rather than transferring the underlying investments and, as a result, records funds withheld liability within other liabilities. The Company recognizes interest on funds withheld, included in other expenses, at rates defined by the terms of the agreement which may be contractually specified or directly related to the investment portfolio. Premiums, fees and policyholder benefits and claims include amounts assumed under reinsurance agreements and are net of reinsurance ceded. Amounts received from reinsurers for policy administration are reported in other revenues. With respect to GMIBs, a portion of the directly written GMIBs are accounted for as insurance liabilities, but the associated reinsurance agreements contain embedded derivatives. These embedded derivatives are included in premiums, reinsurance and other receivables with changes in estimated fair value reported in net derivative gains (losses). If the Company determines that a reinsurance agreement does not expose the reinsurer to a reasonable possibility of a significant loss from insurance risk, the Company records the agreement using the deposit method of accounting. Deposits received are included in other liabilities and deposits made are included within premiums, reinsurance and other receivables. As amounts are paid or received, consistent with the underlying contracts, the deposit assets or liabilities are adjusted. Interest on such deposits is recorded as other revenues or other expenses, as appropriate. Periodically, the Company evaluates the adequacy of the expected payments or recoveries and adjusts the deposit asset or liability through other revenues or other expenses, as appropriate. Certain assumed GMWB, GMAB and GMIB are also accounted for as embedded derivatives with changes in estimated fair value reported in net derivative gains (losses). Investments Net Investment Income and Net Investment Gains (Losses) Income from investments is reported within net investment income, unless otherwise stated herein. Gains and losses on sales of investments, impairment losses and changes in valuation allowances are reported within net investment gains (losses), unless otherwise stated herein. Fixed Maturity and Equity Securities The majority of the Company's fixed maturity and equity securities are classified as available-for-sale ("AFS") and are reported at their estimated fair value. Unrealized investment gains and losses on these securities are recorded as a separate component of other comprehensive income (loss) ("OCI"), net of policy-related amounts and deferred income taxes. All security transactions are recorded on a trade date basis. Investment gains and losses on sales are determined on a specific identification basis. 15
485BPOS245th Page of 388TOC1stPreviousNextBottomJust 245th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) Interest income and prepayment fees are recognized when earned. Interest income is recognized using an effective yield method giving effect to amortization of premiums and accretion of discounts. Dividends on equity securities are recognized when declared. The Company periodically evaluates fixed maturity and equity securities for impairment. The assessment of whether impairments have occurred is based on management's case-by-case evaluation of the underlying reasons for the decline in estimated fair value, as well as an analysis of the gross unrealized losses by severity and/or age as described in Note 8 "-- Evaluation of AFS Securities for OTTI and Evaluating Temporarily Impaired AFS Securities." For fixed maturity securities in an unrealized loss position, an other-than-temporary impairment ("OTTI") is recognized in earnings when it is anticipated that the amortized cost will not be recovered. When either: (i) the Company has the intent to sell the security; or (ii) it is more likely than not that the Company will be required to sell the security before recovery, the OTTI recognized in earnings is the entire difference between the security's amortized cost and estimated fair value. If neither of these conditions exists, the difference between the amortized cost of the security and the present value of projected future cash flows expected to be collected is recognized as an OTTI in earnings ("credit loss"). If the estimated fair value is less than the present value of projected future cash flows expected to be collected, this portion of OTTI related to other-than-credit factors ("noncredit loss") is recorded in OCI. With respect to equity securities, the Company considers in its OTTI analysis its intent and ability to hold a particular equity security for a period of time sufficient to allow for the recovery of its estimated fair value to an amount equal to or greater than cost. If a sale decision is made for an equity security and recovery to an amount at least equal to cost prior to the sale is not expected, the security will be deemed to be other-than-temporarily impaired in the period that the sale decision was made and an OTTI loss will be recorded in earnings. The OTTI loss recognized is the entire difference between the security's cost and its estimated fair value. Mortgage Loans The Company disaggregates its mortgage loan investments into two portfolio segments: commercial and agricultural. The accounting policies that are applicable to all portfolio segments are presented below and the accounting policies related to each of the portfolio segments are included in Note 8. Mortgage loans are stated at unpaid principal balance, adjusted for any unamortized premium or discount, deferred fees or expenses, and are net of valuation allowances. Interest income and prepayment fees are recognized when earned. Interest income is recognized using an effective yield method giving effect to amortization of premiums and accretion of discounts. Also included in mortgage loans are commercial mortgage loans held by consolidated securitization entities ("CSEs") for which the FVO was elected, which are stated at estimated fair value. Changes in estimated fair value are recognized in net investment gains (losses) for commercial mortgage loans held by CSEs. Policy Loans Policy loans are stated at unpaid principal balances. Interest income is recorded as earned using the contractual interest rate. Generally, accrued interest is capitalized on the policy's anniversary date. Valuation allowances are not established for policy loans, as they are fully collateralized by the cash surrender value of 16
485BPOS246th Page of 388TOC1stPreviousNextBottomJust 246th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) the underlying insurance policies. Any unpaid principal and accrued interest is deducted from the cash surrender value or the death benefit prior to settlement of the insurance policy. Real Estate Real estate held-for-investment is stated at cost less accumulated depreciation. Depreciation is recorded on a straight-line basis over the estimated useful life of the asset (typically 20 to 55 years). Rental income is recognized on a straight-line basis over the term of the respective leases. The Company periodically reviews its real estate held-for-investment for impairment and tests for recoverability whenever events or changes in circumstances indicate the carrying value may not be recoverable and exceeds its estimated fair value. Properties whose carrying values are greater than their undiscounted cash flows are written down to their estimated fair value, which is generally computed using the present value of expected future cash flows discounted at a rate commensurate with the underlying risks. Real estate for which the Company commits to a plan to sell within one year and actively markets in its current condition for a reasonable price in comparison to its estimated fair value is classified as held-for-sale. Real estate held-for-sale is stated at the lower of depreciated cost or estimated fair value less expected disposition costs and is not depreciated. Real Estate Joint Ventures and Other Limited Partnership Interests The Company uses the equity method of accounting for equity securities when it has significant influence or at least 20% interest and for real estate joint ventures and other limited partnership interests ("investees") when it has more than a minor ownership interest or more than a minor influence over the investee's operations, but does not have a controlling financial interest. The Company generally recognizes its share of the investee's earnings on a three-month lag in instances where the investee's financial information is not sufficiently timely or when the investee's reporting period differs from the Company's reporting period. The Company uses the cost method of accounting for investments in which it has virtually no influence over the investee's operations. The Company recognizes distributions on cost method investments as earned or received. Because of the nature and structure of these cost method investments, they do not meet the characteristics of an equity security in accordance with applicable accounting standards. The Company routinely evaluates its equity method and cost method investments for impairment. For equity method investees, the Company considers financial and other information provided by the investee, other known information and inherent risks in the underlying investments, as well as future capital commitments, in determining whether an impairment has occurred. The Company considers its cost method investments for impairment when the carrying value of such investments exceeds the net asset value ("NAV"). The Company takes into consideration the severity and duration of this excess when determining whether the cost method investment is impaired. Short-term Investments Short-term investments include securities and other investments with remaining maturities of one year or less, but greater than three months, at the time of purchase and are stated at estimated fair value or amortized 17
485BPOS247th Page of 388TOC1stPreviousNextBottomJust 247th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) cost, which approximates estimated fair value. Short-term investments also include investments in affiliated money market pools. Other Invested Assets Other invested assets consist principally of the following: . Freestanding derivatives with positive estimated fair values which are described in "-- Derivatives" below. . Funds withheld which represent a receivable for amounts contractually withheld by ceding companies in accordance with reinsurance agreements. The Company recognizes interest on funds withheld at rates defined by the terms of the agreement which may be contractually specified or directly related to the underlying investments. . Tax credit and renewable energy partnerships which derive a significant source of investment return in the form of income tax credits or other tax incentives. Where tax credits are guaranteed by a creditworthy third party, the investment is accounted for under the effective yield method. Otherwise, the investment is accounted for under the equity method. . Investments in operating joint ventures that engage in insurance underwriting activities and are accounted for under the equity method. . Leveraged leases which are recorded net of non-recourse debt. Income is recognized by applying the leveraged lease's estimated rate of return to the net investment in the lease. The Company regularly reviews residual values for impairment. . Loans to affiliates which are stated at unpaid principal balance and adjusted for any unamortized premium or discount. Securities Lending Program Securities lending transactions, whereby blocks of securities are loaned to third parties, primarily brokerage firms and commercial banks, are treated as financing arrangements and the associated liability is recorded at the amount of cash received. The Company obtains collateral at the inception of the loan, usually cash, in an amount generally equal to 102% of the estimated fair value of the securities loaned, and maintains it at a level greater than or equal to 100% for the duration of the loan. The Company is liable to return to the counterparties the cash collateral received. Security collateral on deposit from counterparties in connection with securities lending transactions may not be sold or re-pledged, unless the counterparty is in default, and is not reflected in the Company's financial statements. The Company monitors the estimated fair value of the securities loaned on a daily basis and additional collateral is obtained as necessary. Income and expenses associated with securities lending transactions are reported as investment income and investment expense, respectively, within net investment income. Derivatives Freestanding Derivatives Freestanding derivatives are carried in the Company's balance sheets either as assets within other invested assets or as liabilities within other liabilities at estimated fair value. The Company does not offset the fair 18
485BPOS248th Page of 388TOC1stPreviousNextBottomJust 248th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) value amounts recognized for derivatives executed with the same counterparty under the same master netting agreement. Accruals on derivatives are generally recorded in accrued investment income or within other liabilities. However, accruals that are not scheduled to settle within one year are included with the derivatives carrying value in other invested assets or other liabilities. If a derivative is not designated as an accounting hedge or its use in managing risk does not qualify for hedge accounting, changes in the estimated fair value of the derivative are reported in net derivative gains (losses) except as follows: [Download Table] ----------------------------------------------------------------------------- Statement of Operations Presentation: Derivative: ----------------------------------------------------------------------------- Policyholder benefits and claims . Economic hedges of variable annuity guarantees included in future policy benefits ----------------------------------------------------------------------------- Net investment income . Economic hedges of equity method investments in joint ventures ----------------------------------------------------------------------------- Hedge Accounting To qualify for hedge accounting, at the inception of the hedging relationship, the Company formally documents its risk management objective and strategy for undertaking the hedging transaction, as well as its designation of the hedge. Hedge designation and financial statement presentation of changes in estimated fair value of the hedging derivatives are as follows: . Fair value hedge (a hedge of the estimated fair value of a recognized asset or liability) -- in net derivative gains (losses), consistent with the change in fair value of the hedged item attributable to the designated risk being hedged. . Cash flow hedge (a hedge of a forecasted transaction or of the variability of cash flows to be received or paid related to a recognized asset or liability) -- effectiveness in OCI (deferred gains or losses on the derivative are reclassified into the statement of operations when the Company's earnings are affected by the variability in cash flows of the hedged item); ineffectiveness in net derivative gains (losses). The changes in estimated fair values of the hedging derivatives are exclusive of any accruals that are separately reported in the statement of operations within interest income or interest expense to match the location of the hedged item. In its hedge documentation, the Company sets forth how the hedging instrument is expected to hedge the designated risks related to the hedged item and sets forth the method that will be used to retrospectively and prospectively assess the hedging instrument's effectiveness and the method that will be used to measure ineffectiveness. A derivative designated as a hedging instrument must be assessed as being highly effective in offsetting the designated risk of the hedged item. Hedge effectiveness is formally assessed at inception and at least quarterly throughout the life of the designated hedging relationship. Assessments of hedge effectiveness and measurements of ineffectiveness are also subject to interpretation and estimation and different interpretations or estimates may have a material effect on the amount reported in net income. 19
485BPOS249th Page of 388TOC1stPreviousNextBottomJust 249th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) The Company discontinues hedge accounting prospectively when: (i) it is determined that the derivative is no longer highly effective in offsetting changes in the estimated fair value or cash flows of a hedged item; (ii) the derivative expires, is sold, terminated, or exercised; (iii) it is no longer probable that the hedged forecasted transaction will occur; or (iv) the derivative is de-designated as a hedging instrument. When hedge accounting is discontinued because it is determined that the derivative is not highly effective in offsetting changes in the estimated fair value or cash flows of a hedged item, the derivative continues to be carried in the balance sheets at its estimated fair value, with changes in estimated fair value recognized in net derivative gains (losses). The carrying value of the hedged recognized asset or liability under a fair value hedge is no longer adjusted for changes in its estimated fair value due to the hedged risk, and the cumulative adjustment to its carrying value is amortized into income over the remaining life of the hedged item. Provided the hedged forecasted transaction is still probable of occurrence, the changes in estimated fair value of derivatives recorded in OCI related to discontinued cash flow hedges are released into the statements of operations when the Company's earnings are affected by the variability in cash flows of the hedged item. When hedge accounting is discontinued because it is no longer probable that the forecasted transactions will occur on the anticipated date or within two months of that date, the derivative continues to be carried in the balance sheets at its estimated fair value, with changes in estimated fair value recognized currently in net derivative gains (losses). Deferred gains and losses of a derivative recorded in OCI pursuant to the discontinued cash flow hedge of a forecasted transaction that is no longer probable are recognized immediately in net derivative gains (losses). In all other situations in which hedge accounting is discontinued, the derivative is carried at its estimated fair value in the balance sheets, with changes in its estimated fair value recognized in the current period as net derivative gains (losses). Embedded Derivatives The Company sells variable annuities and issues certain insurance products and investment contracts and is a party to certain reinsurance agreements that have embedded derivatives. The Company assesses each identified embedded derivative to determine whether it is required to be bifurcated. The embedded derivative is bifurcated from the host contract and accounted for as a freestanding derivative if: . the combined instrument is not accounted for in its entirety at fair value with changes in fair value recorded in earnings; . the terms of the embedded derivative are not clearly and closely related to the economic characteristics of the host contract; and . a separate instrument with the same terms as the embedded derivative would qualify as a derivative instrument. Such embedded derivatives are carried in the balance sheets at estimated fair value with the host contract and changes in their estimated fair value are generally reported in net derivative gains (losses) except for those in policyholder benefits and claims related to ceded reinsurance of GMIB. If the Company is unable to properly identify and measure an embedded derivative for separation from its host contract, the entire contract is carried on the balance sheet at estimated fair value, with changes in estimated fair value recognized in the current period in net investment gains (losses) or net investment income. Additionally, the Company may elect 20
485BPOS250th Page of 388TOC1stPreviousNextBottomJust 250th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) to carry an entire contract on the balance sheet at estimated fair value, with changes in estimated fair value recognized in the current period in net investment gains (losses) or net investment income if that contract contains an embedded derivative that requires bifurcation. At inception, the Company attributes to the embedded derivative a portion of the projected future guarantee fees to be collected from the policyholder equal to the present value of projected future guaranteed benefits. Any additional fees represent "excess" fees and are reported in universal life and investment-type product policy fees. Fair Value Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. In most cases, the exit price and the transaction (or entry) price will be the same at initial recognition. Subsequent to initial recognition, fair values are based on unadjusted quoted prices for identical assets or liabilities in active markets that are readily and regularly obtainable. When such quoted prices are not available, fair values are based on quoted prices in markets that are not active, quoted prices for similar but not identical assets or liabilities, or other observable inputs. If these inputs are not available, or observable inputs are not determinable, unobservable inputs and/or adjustments to observable inputs requiring management judgment are used to determine the estimated fair value of assets and liabilities. Goodwill Goodwill represents the future economic benefits arising from net assets acquired in a business combination that are not individually identified and recognized. Goodwill is calculated as the excess of cost over the estimated fair value of such net assets acquired, is not amortized, and is tested for impairment based on a fair value approach at least annually or more frequently if events or circumstances indicate that there may be justification for conducting an interim test. The Company performs its annual goodwill impairment testing during the third quarter of each year based upon data as of the close of the second quarter. Goodwill associated with a business acquisition is not tested for impairment during the year the business is acquired unless there is a significant identified impairment event. The impairment test is performed at the reporting unit level, which is the operating segment or a business one level below the operating segment, if discrete financial information is prepared and regularly reviewed by management at that level. For purposes of goodwill impairment testing, if the carrying value of a reporting unit exceeds its estimated fair value, there may be an indication of impairment. In such instances, the implied fair value of the goodwill is determined in the same manner as the amount of goodwill that would be determined in a business combination. The excess of the carrying value of goodwill over the implied fair value of goodwill would be recognized as an impairment and recorded as a charge against net income. On an ongoing basis, the Company evaluates potential triggering events that may affect the estimated fair value of the Company's reporting units to assess whether any goodwill impairment exists. Deteriorating or adverse market conditions for certain reporting units may have a significant impact on the estimated fair value of these reporting units and could result in future impairments of goodwill. 21
485BPOS251st Page of 388TOC1stPreviousNextBottomJust 251st
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) Employee Benefit Plans Pension, postretirement and postemployment benefits are provided to associates under plans sponsored and administered by Metropolitan Life Insurance Company ("MLIC"), an affiliate of the Company. The Company's obligation and expense related to these benefits is limited to the amount of associated expense allocated from MLIC. Income Tax MetLife Insurance Company USA and its includable subsidiaries join with MetLife, Inc. and its includable subsidiaries in filing a consolidated U.S. life and non-life federal income tax return in accordance with the provisions of the Internal Revenue Code of 1986, as amended. Current taxes (and the benefits of tax attributes such as losses) are allocated to MetLife Insurance Company USA and its subsidiaries under the consolidated tax return regulations and a tax sharing agreement. Under the consolidated tax return regulations, MetLife, Inc. has elected the "percentage method" (and 100% under such method) of reimbursing companies for tax attributes e.g. net operating losses. As a result, 100% of tax attributes are reimbursed by MetLife, Inc. to the extent that consolidated federal income tax of the consolidated federal tax return group is reduced in a year by tax attributes. On an annual basis, each of the profitable subsidiaries pays to MetLife, Inc. the federal income tax which it would have paid based upon that year's taxable income. If MetLife Insurance Company USA or its includable subsidiaries has current or prior deductions and credits (including but not limited to losses) which reduce the consolidated tax liability of the consolidated federal tax return group, the deductions and credits are characterized as realized (or realizable) by MetLife Insurance Company USA and its includable subsidiaries when those tax attributes are realized (or realizable) by the consolidated federal tax return group, even if MetLife Insurance Company USA or its includable subsidiaries would not have realized the attributes on a stand-alone basis under a "wait and see" method. The Company's accounting for income taxes represents management's best estimate of various events and transactions. Deferred tax assets and liabilities resulting from temporary differences between the financial reporting and tax bases of assets and liabilities are measured at the balance sheet date using enacted tax rates expected to apply to taxable income in the years the temporary differences are expected to reverse. The realization of deferred tax assets depends upon the existence of sufficient taxable income within the carryback or carryforward periods under the tax law in the applicable tax jurisdiction. Valuation allowances are established when management determines, based on available information, that it is more likely than not that deferred income tax assets will not be realized. Significant judgment is required in determining whether valuation allowances should be established, as well as the amount of such allowances. When making such determination, the Company considers many factors, including: . the nature, frequency, and amount of cumulative financial reporting income and losses in recent years; . the jurisdiction in which the deferred tax asset was generated; . the length of time that carryforward can be utilized in the various taxing jurisdiction; . future taxable income exclusive of reversing temporary differences and carryforwards; . future reversals of existing taxable temporary differences; 22
485BPOS252nd Page of 388TOC1stPreviousNextBottomJust 252nd
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) . taxable income in prior carryback years; and . tax planning strategies. The Company may be required to change its provision for income taxes in certain circumstances. Examples of such circumstances include when estimates used in determining valuation allowances on deferred tax assets significantly change or when receipt of new information indicates the need for adjustment in valuation allowances. Additionally, future events, such as changes in tax laws, tax regulations, or interpretations of such laws or regulations, could have an impact on the provision for income tax and the effective tax rate. Any such changes could significantly affect the amounts reported in the financial statements in the year these changes occur. The Company determines whether it is more likely than not that a tax position will be sustained upon examination by the appropriate taxing authorities before any part of the benefit can be recorded in the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50% likely of being realized upon settlement. Unrecognized tax benefits due to tax uncertainties that do not meet the threshold are included within other liabilities and are charged to earnings in the period that such determination is made. The Company classifies interest recognized as interest expense and penalties recognized as a component of income tax. Litigation Contingencies The Company is a party to a number of legal actions and is involved in a number of regulatory investigations. Given the inherent unpredictability of these matters, it is difficult to estimate the impact on the Company's financial position. Liabilities are established when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Legal costs are recognized as incurred. On a quarterly and annual basis, the Company reviews relevant information with respect to liabilities for litigation, regulatory investigations and litigation-related contingencies to be reflected in the Company's financial statements. Other Accounting Policies Cash and Cash Equivalents The Company considers all highly liquid securities and other investments purchased with an original or remaining maturity of three months or less at the date of purchase to be cash equivalents. Cash equivalents are stated at amortized cost, which approximates estimated fair value. Property, Equipment, Leasehold Improvements and Computer Software Property, equipment and leasehold improvements, which are included in other assets, are stated at cost, less accumulated depreciation and amortization. Depreciation is determined using the straight-line method over the estimated useful lives of the assets, as appropriate. Estimated lives generally range from five to 10 years for leasehold improvements, and from three to seven years for all other property and equipment. The net book value of the property, equipment and leasehold improvements was insignificant at both December 31, 2014 and 2013. 23
485BPOS253rd Page of 388TOC1stPreviousNextBottomJust 253rd
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) Computer software, which is included in other assets, is stated at cost, less accumulated amortization. Purchased software costs, as well as certain internal and external costs incurred to develop internal-use computer software during the application development stage, are capitalized. Such costs are amortized generally over a four-year period using the straight-line method. The cost basis of computer software was $235 million and $215 million at December 31, 2014 and 2013, respectively. Accumulated amortization of capitalized software was $107 million and $105 million at December 31, 2014 and 2013, respectively. Related amortization expense was $2 million, $7 million and $12 million for the years ended December 31, 2014, 2013 and 2012, respectively. Other Revenues Other revenues primarily include, in addition to items described elsewhere herein, fee income on financial reinsurance agreements and broker-dealer fees. Foreign Currency Assets, liabilities and operations of foreign affiliates and subsidiaries are recorded based on the functional currency of each entity. The determination of the functional currency is made based on the appropriate economic and management indicators. The local currencies of foreign operations are the functional currencies. Assets and liabilities of foreign affiliates and subsidiaries are translated from the functional currency to U.S. dollars at the exchange rates in effect at each year-end and income and expense accounts are translated at the average exchange rates during the year. The resulting translation adjustments are charged or credited directly to OCI, net of applicable taxes. Gains and losses from foreign currency transactions, including the effect of re-measurement of monetary assets and liabilities to the appropriate functional currency, are reported as part of net investment gains (losses) in the period in which they occur. Adoption of New Accounting Pronouncements Effective November 18, 2014, the Company adopted new guidance on when, if ever, the cost of acquiring an entity should be used to establish a new accounting basis ("pushdown") in the acquired entity's separate financial statements. The guidance provides an acquired entity and its subsidiaries with an irrevocable option to apply pushdown accounting in its separate financial statements upon occurrence of an event in which an acquirer obtains control of the acquired entity. If a reporting entity elects to apply pushdown accounting, its stand-alone financial statements would reflect the acquirer's new basis in the acquired entity's assets and liabilities. The election to apply pushdown accounting should be determined by an acquired entity for each individual change-in-control event in which an acquirer obtains control of the acquired entity; however, an entity that does not elect to apply pushdown accounting in the period of a change-in-control can later elect to retrospectively apply pushdown accounting to the most recent change-in-control transaction as a change in accounting principle. The new guidance did not have a material impact on the financial statements upon adoption. Effective January 1, 2014, the Company early adopted new guidance regarding reporting of discontinued operations and disclosures of disposals of components of an entity. The guidance increases the threshold for a disposal to qualify as a discontinued operation, expands the disclosures for discontinued operations and requires new disclosures for certain disposals that do not meet the definition of a discontinued operation. Disposals must now represent a strategic shift that has or will have a major effect on the entity's operations and financial results to qualify as discontinued operations. As discussed in Note 4, the Company sold its wholly-owned subsidiary, 24
485BPOS254th Page of 388TOC1stPreviousNextBottomJust 254th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) MetLife Assurance Limited ("MAL"). As a result of the adoption of this new guidance, the results of operations of MAL and the loss on sale have been included in income from continuing operations. Effective July 17, 2013, the Company adopted guidance regarding derivatives that permits the Fed Funds Effective Swap Rate (or Overnight Index Swap Rate) to be used as a U.S. benchmark interest rate for hedge accounting purposes, in addition to the United States Treasury and London Interbank Offered Rate ("LIBOR"). Also, this new guidance removes the restriction on using different benchmark rates for similar hedges. The new guidance did not have a material impact on the financial statements upon adoption. Effective January 1, 2013, the Company adopted guidance regarding comprehensive income that requires an entity to provide information about the amounts reclassified out of accumulated OCI ("AOCI") by component. In addition, an entity is required to present, either on the face of the statement where net income is presented or in the notes, significant amounts reclassified out of AOCI by the respective line items of net income but only if the amount reclassified is required under GAAP to be reclassified to net income in its entirety in the same reporting period. For other amounts that are not required under GAAP to be reclassified in their entirety to net income, an entity is required to cross-reference to other disclosures required under GAAP that provide additional detail about those amounts. The adoption was prospectively applied and resulted in additional disclosures in Note 13. Effective January 1, 2013, the Company adopted guidance regarding balance sheet offsetting disclosures which requires an entity to disclose information about offsetting and related arrangements for derivatives, including bifurcated embedded derivatives, repurchase and reverse repurchase agreements, and securities borrowing and lending transactions, to enable users of its financial statements to understand the effects of those arrangements on its financial position. Entities are required to disclose both gross information and net information about both instruments and transactions eligible for offset in the statement of financial position and instruments and transactions subject to an agreement similar to a master netting arrangement. The adoption was retrospectively applied and resulted in additional disclosures related to derivatives in Note 9. On January 1, 2012, the Company adopted guidance regarding accounting for DAC, which was retrospectively applied. The guidance specifies that only costs related directly to successful acquisition of new or renewal contracts can be capitalized as DAC; all other acquisition-related costs must be expensed as incurred. As a result, certain sales manager compensation and administrative costs previously capitalized by the Company will no longer be deferred. On January 1, 2012, the Company adopted guidance regarding comprehensive income, which was retrospectively applied, that provides companies with the option to present the total of comprehensive income, components of net income, and the components of OCI either in a single continuous statement of comprehensive income or in two separate but consecutive statements in annual financial statements. The standard eliminates the option to present components of OCI as part of the statement of changes in stockholder's equity. The Company adopted the two-statement approach for annual financial statements. Effective January 1, 2012, the Company adopted guidance on goodwill impairment testing that simplifies how an entity tests goodwill for impairment. This new guidance allows an entity to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value as a basis for determining whether it needs to perform the quantitative two-step goodwill impairment test. Only if an entity determines, based on qualitative assessment, that it is more likely than not that a reporting unit's fair value 25
485BPOS255th Page of 388TOC1stPreviousNextBottomJust 255th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) is less than its carrying value will it be required to calculate the fair value of the reporting unit. The qualitative assessment is optional and the Company is permitted to bypass it for any reporting unit in any period and begin its impairment analysis with the quantitative calculation. The Company is permitted to perform the qualitative assessment in any subsequent period. Effective January 1, 2012, the Company adopted guidance regarding fair value measurements that establishes common requirements for measuring fair value and for disclosing information about fair value measurements in accordance with GAAP and International Financial Reporting Standards. Some of the amendments clarify the Financial Accounting Standards Board's ("FASB") intent on the application of existing fair value measurement requirements. Other amendments change a particular principle or requirement for measuring fair value or for disclosing information about fair value measurements. The adoption did not have a material impact on the Company's financial statements other than the expanded disclosures in Note 10. Future Adoption of New Accounting Pronouncements In February 2015, the FASB issued new guidance to improve consolidation guidance for legal entities (Accounting Standards Update ("ASU") 2015-02, Consolidation (Topic 810): Amendments to the Consolidation Analysis), effective for fiscal years beginning after December 15, 2015 and interim periods within those years and early adoption is permitted. The new standard is intended to improve targeted areas of the consolidation guidance for legal entities such as limited partnerships, limited liability corporations, and securitization structures. The amendments in the ASU affect the consolidation evaluation for reporting organizations. In addition, the amendments in this ASU simplify and improve current GAAP by reducing the number of consolidation models. The Company is currently evaluating the impact of this guidance on its consolidated financial statements. In June 2014, the FASB issued new guidance on transfers and servicing (ASU 2014-11, Transfers and Servicing (Topic 860): Repurchase-to-Maturity Transactions, Repurchase Financings, and Disclosure), effective prospectively for fiscal years beginning after December 15, 2014 and interim periods within those years. The new guidance requires that repurchase-to-maturity transactions and repurchase financing arrangements be accounted for as secured borrowings and provides for enhanced disclosures, including the nature of collateral pledged and the time to maturity. Certain interim period disclosures for repurchase agreements and securities lending transactions are not required until the second quarter of 2015. The adoption of this new guidance will not have a material impact on the Company's consolidated financial statements. In May 2014, the FASB issued a comprehensive new revenue recognition standard (ASU 2014-09, Revenue from Contracts with Customers (Topic 606)), effective retrospectively for fiscal years beginning after December 15, 2016 and interim periods within those years. Early adoption of this standard is not permitted. The new guidance will supersede nearly all existing revenue recognition guidance under GAAP; however, it will not impact the accounting for insurance contracts, leases, financial instruments and guarantees. For those contracts that are impacted by the new guidance, the guidance will require an entity to recognize revenue upon the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled, in exchange for those goods or services. The Company is currently evaluating the impact of this guidance on its consolidated financial statements. 26
485BPOS256th Page of 388TOC1stPreviousNextBottomJust 256th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued) In January 2014, the FASB issued new guidance regarding investments (ASU 2014-01, Investments -- Equity Method and Joint Ventures (Topic 323): Accounting for Investments in Qualified Affordable Housing Projects), effective retrospectively for fiscal years beginning after December 15, 2014 and interim reporting periods within those years. The new guidance is applicable to investments in flow-through limited liability entities that manage or invest in affordable housing projects that qualify for the low-income housing tax credit. Under the guidance, an entity that meets certain conditions is permitted to make an accounting policy election to amortize the initial cost of its investment in proportion to the tax credits and other tax benefits received, and recognize the net investment performance on the statement of operations as a component of income tax expense (benefit). The adoption of this new guidance will not have an impact on the Company's consolidated financial statements. 2. Segment Information The Company is organized into two segments: Retail and Corporate Benefit Funding. In addition, the Company reports certain of its results of operations in Corporate & Other. Retail The Retail segment offers a broad range of protection products and a variety of annuities primarily to individuals, and is organized into two businesses: Annuities and Life & Other. Annuities includes a variety of variable, fixed and equity index-linked annuities which provide for both asset accumulation and asset distribution needs. Life & Other insurance products and services include variable life, universal life, term life and whole life products, as well as individual disability income products. Additionally, through broker-dealer affiliates, the Company offers a full range of mutual funds and other securities products. Corporate Benefit Funding The Corporate Benefit Funding segment offers a broad range of annuity and investment products, including guaranteed interest products and other stable value products, income annuities, and separate account contracts for the investment management of defined benefit and defined contribution plan assets. This segment also includes structured settlements and certain products to fund company-, bank- or trust-owned life insurance used to finance non-qualified benefit programs for executives. Corporate & Other Corporate & Other contains the excess capital not allocated to the segments, various start-up businesses (including direct and digital marketing products), run-off businesses, the Company's ancillary international operations and interest expense related to the majority of the Company's outstanding debt, as well as expenses associated with certain legal proceedings and income tax audit issues. Corporate & Other also includes assumed reinsurance of certain variable annuity products from a former affiliated operating joint venture in Japan. Under this in-force reinsurance agreement, the Company reinsures living and death benefit guarantees issued in connection with variable annuity products. Additionally, Corporate & Other includes a reinsurance agreement to assume certain blocks of indemnity reinsurance from an affiliate. These reinsurance agreements were recaptured effective November 1, 2014. Corporate & Other also includes the elimination of intersegment amounts. 27
485BPOS257th Page of 388TOC1stPreviousNextBottomJust 257th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 2. Segment Information (continued) Financial Measures and Segment Accounting Policies Operating earnings is the measure of segment profit or loss the Company uses to evaluate segment performance and allocate resources. Consistent with GAAP guidance for segment reporting, operating earnings is the Company's measure of segment performance and is reported below. Operating earnings should not be viewed as a substitute for income (loss) from continuing operations, net of income tax. The Company believes the presentation of operating earnings as the Company measures it for management purposes enhances the understanding of its performance by highlighting the results of operations and the underlying profitability drivers of the business. Operating earnings is defined as operating revenues less operating expenses, both net of income tax. Operating revenues and operating expenses exclude results of discontinued operations and other businesses that have been or will be sold or exited by the Company and are referred to as divested businesses. Operating revenues also excludes net investment gains (losses) and net derivative gains (losses). Operating expenses also excludes goodwill impairments. The following additional adjustments are made to GAAP revenues, in the line items indicated, in calculating operating revenues: . Universal life and investment-type product policy fees excludes the amortization of unearned revenue related to net investment gains (losses) and net derivative gains (losses) and certain variable annuity GMIB fees ("GMIB Fees"); and . Net investment income: (i) includes amounts for scheduled periodic settlement payments and amortization of premium on derivatives that are hedges of investments or that are used to replicate certain investments, but do not qualify for hedge accounting treatment, (ii) includes income from discontinued real estate operations, (iii) excludes post-tax operating earnings adjustments relating to insurance joint ventures accounted for under the equity method, (iv) excludes certain amounts related to contractholder-directed unit-linked investments, and (v) excludes certain amounts related to securitization entities that are VIEs consolidated under GAAP. The following additional adjustments are made to GAAP expenses, in the line items indicated, in calculating operating expenses: . Policyholder benefits and claims excludes: (i) amounts associated with periodic crediting rate adjustments based on the total return of a contractually referenced pool of assets, (ii) benefits and hedging costs related to GMIBs ("GMIB Costs"), and (iii) market value adjustments associated with surrenders or terminations of contracts ("Market Value Adjustments"); . Interest credited to policyholder account balances includes adjustments for scheduled periodic settlement payments and amortization of premium on derivatives that are hedges of PABs but do not qualify for hedge accounting treatment and excludes amounts related to net investment income earned on contractholder-directed unit-linked investments; . Amortization of DAC and VOBA excludes amounts related to: (i) net investment gains (losses) and net derivative gains (losses), (ii) GMIB Fees and GMIB Costs, and (iii) Market Value Adjustments; 28
485BPOS258th Page of 388TOC1stPreviousNextBottomJust 258th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 2. Segment Information (continued) . Interest expense on debt excludes certain amounts related to securitization entities that are VIEs consolidated under GAAP; and . Other expenses excludes costs related to: (i) implementation of new insurance regulatory requirements, and (ii) acquisition and integration costs. In the first quarter of 2014, the Company began reporting the operations of MAL as divested business. See Note 4. Set forth in the tables below is certain financial information with respect to the Company's segments, as well as Corporate & Other, for the years ended December 31, 2014, 2013 and 2012 and at December 31, 2014 and 2013. The segment accounting policies are the same as those used to prepare the Company's consolidated financial statements, except for operating earnings adjustments as defined above. In addition, segment accounting policies include the method of capital allocation described below. Economic capital is an internally developed risk capital model, the purpose of which is to measure the risk in the business and to provide a basis upon which capital is deployed. The economic capital model accounts for the unique and specific nature of the risks inherent in MetLife, Inc.'s and the Company's business. MetLife, Inc.'s economic capital model aligns segment allocated equity with emerging standards and consistent risk principles. The model applies statistics-based risk evaluation principles to the material risks to which the Company is exposed. These consistent risk principles include calibrating required economic capital shock factors to a specific confidence level and time horizon and applying an industry standard method for the inclusion of diversification benefits among risk types. MetLife, Inc.'s management is responsible for the ongoing production and enhancement of the economic capital model and reviews its approach periodically to ensure that it remains consistent with emerging industry practice standards. Segment net investment income is credited or charged based on the level of allocated equity; however, changes in allocated equity do not impact the Company's consolidated net investment income, operating earnings or income (loss) from continuing operations, net of income tax. Net investment income is based upon the actual results of each segment's specifically identifiable investment portfolios adjusted for allocated equity. Other costs are allocated to each of the segments based upon: (i) a review of the nature of such costs; (ii) time studies analyzing the amount of employee compensation costs incurred by each segment; and (iii) cost estimates included in the Company's product pricing. Effective January 1, 2015, the Company implemented certain segment reporting changes related to the measurement of segment operating earnings, including revising the Company's capital allocation methodology. The changes will be applied retrospectively beginning with the first quarter of 2015. The changes will not impact total consolidated operating earnings or net income. 29
485BPOS259th Page of 388TOC1stPreviousNextBottomJust 259th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 2. Segment Information (continued) [Enlarge/Download Table] Operating Results --------------------------------------- Corporate Benefit Corporate Total Year Ended December 31, 2014 Retail Funding (1) & Other Total Adjustments Consolidated -------------------------------------------------------- -------- ----------- --------- -------- ----------- ------------ (In millions) Revenues Premiums................................................ $ 1,080 $ (26) $ 96 $ 1,150 $ 2 $ 1,152 Universal life and investment-type product policy fees.. 2,700 33 146 2,879 314 3,193 Net investment income................................... 2,062 896 (211) 2,747 (78) 2,669 Other revenues.......................................... 532 5 1 538 1 539 Net investment gains (losses)........................... -- -- -- -- (469) (469) Net derivative gains (losses)........................... -- -- -- -- (181) (181) -------- ------- ------- -------- ---------- ---------- Total revenues........................................ 6,374 908 32 7,314 (411) 6,903 -------- ------- ------- -------- ---------- ---------- Expenses Policyholder benefits and claims........................ 1,768 390 55 2,213 551 2,764 Interest credited to policyholder account balances...... 943 116 -- 1,059 3 1,062 Goodwill impairment..................................... -- -- -- -- 33 33 Capitalization of DAC................................... (221) (1) (57) (279) -- (279) Amortization of DAC and VOBA............................ 678 2 22 702 288 990 Interest expense on debt................................ 5 -- 68 73 36 109 Other expenses.......................................... 1,722 28 172 1,922 12 1,934 -------- ------- ------- -------- ---------- ---------- Total expenses........................................ 4,895 535 260 5,690 923 6,613 -------- ------- ------- -------- ---------- ---------- Provision for income tax expense (benefit).............. 518 129 (227) 420 (425) (5) -------- ------- ------- -------- ---------- Operating earnings...................................... $ 961 $ 244 $ (1) 1,204 ======== ======= ======= Adjustments to:......................................... Total revenues........................................ (411) Total expenses........................................ (923) Provision for income tax (expense) benefit............ 425 -------- Income (loss) from continuing operations, net of income tax.................................................... $ 295 $ 295 ======== ========== -------- (1)Premiums and policyholder benefits and claims both include ($87) million of ceded reinsurance with MLIC related to merger transactions. See Notes 3 and 7. [Download Table] Corporate Benefit Corporate At December 31, 2014 Retail Funding & Other Total ----------------------------- ---------- --------- --------- ---------- (In millions) Total assets................. $ 175,336 $ 25,080 $ 5,447 $ 205,863 Separate account assets...... $ 106,667 $ 2,194 $ -- $ 108,861 Separate account liabilities. $ 106,667 $ 2,194 $ -- $ 108,861 30
485BPOS260th Page of 388TOC1stPreviousNextBottomJust 260th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 2. Segment Information (continued) [Enlarge/Download Table] Operating Results ------------------------------------- Corporate Benefit Corporate Total Year Ended December 31, 2013 Retail Funding & Other Total Adjustments Consolidated -------------------------------------------------------- -------- --------- --------- -------- ----------- ------------ (In millions) Revenues Premiums................................................ $ 469 $ 92 $ 36 $ 597 $ 92 $ 689 Universal life and investment-type product policy fees.. 2,648 35 179 2,862 268 3,130 Net investment income................................... 2,019 1,002 (151) 2,870 129 2,999 Other revenues.......................................... 605 5 -- 610 -- 610 Net investment gains (losses)........................... -- -- -- -- 27 27 Net derivative gains (losses)........................... -- -- -- -- 441 441 -------- -------- -------- -------- ---------- ----------- Total revenues........................................ 5,741 1,134 64 6,939 957 7,896 -------- -------- -------- -------- ---------- ----------- Expenses Policyholder benefits and claims........................ 1,087 527 13 1,627 1,520 3,147 Interest credited to policyholder account balances...... 1,034 139 -- 1,173 (5) 1,168 Goodwill impairment..................................... -- -- -- -- 66 66 Capitalization of DAC................................... (483) (2) (27) (512) -- (512) Amortization of DAC and VOBA............................ 586 5 1 592 (387) 205 Interest expense on debt................................ 5 -- 68 73 122 195 Other expenses.......................................... 1,935 17 78 2,030 19 2,049 -------- -------- -------- -------- ---------- ----------- Total expenses........................................ 4,164 686 133 4,983 1,335 6,318 -------- -------- -------- -------- ---------- ----------- Provision for income tax expense (benefit).............. 585 156 (129) 612 (175) 437 -------- -------- -------- -------- ----------- Operating earnings...................................... $ 992 $ 292 $ 60 1,344 ======== ======== ======== Adjustments to: Total revenues........................................ 957 Total expenses........................................ (1,335) Provision for income tax (expense) benefit............ 175 -------- Income (loss) from continuing operations, net of income tax.................................................... $ 1,141 $ 1,141 ======== =========== [Download Table] Corporate Benefit Corporate At December 31, 2013 Retail Funding & Other Total ----------------------------- ---------- --------- --------- ---------- (In millions) Total assets................. $ 171,355 $ 31,300 $ 8,646 $ 211,301 Separate account assets...... $ 107,726 $ 2,088 $ -- $ 109,814 Separate account liabilities. $ 107,726 $ 2,088 $ -- $ 109,814 31
485BPOS261st Page of 388TOC1stPreviousNextBottomJust 261st
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 2. Segment Information (continued) [Enlarge/Download Table] Operating Results ----------------------------------------- Corporate Benefit Corporate Total Year Ended December 31, 2012 Retail Funding & Other Total Adjustments Consolidated -------------------------------------------------------- ---------- --------- --------- ---------- ----------- ------------ (In millions) Revenues Premiums................................................ $ 571 $ 73 $ 1,015 $ 1,659 $ 556 $ 2,215 Universal life and investment-type product policy fees.. 2,530 29 195 2,754 260 3,014 Net investment income................................... 1,828 1,016 (19) 2,825 235 3,060 Other revenues.......................................... 621 5 -- 626 -- 626 Net investment gains (losses)........................... -- -- -- -- 190 190 Net derivative gains (losses)........................... -- -- -- -- (2,345) (2,345) ---------- -------- -------- ---------- ----------- ----------- Total revenues........................................ 5,550 1,123 1,191 7,864 (1,104) 6,760 ---------- -------- -------- ---------- ----------- ----------- Expenses Policyholder benefits and claims........................ 1,001 496 1,101 2,598 1,723 4,321 Interest credited to policyholder account balances...... 1,073 166 -- 1,239 42 1,281 Goodwill impairment..................................... -- -- -- -- 394 394 Capitalization of DAC................................... (869) (5) (34) (908) -- (908) Amortization of DAC and VOBA............................ 720 10 3 733 1 734 Interest expense on debt................................ 5 -- 149 154 163 317 Other expenses.......................................... 2,371 21 77 2,469 24 2,493 ---------- -------- -------- ---------- ----------- ----------- Total expenses........................................ 4,301 688 1,296 6,285 2,347 8,632 ---------- -------- -------- ---------- ----------- ----------- Provision for income tax expense (benefit).............. 433 151 (111) 473 (1,286) (813) ---------- -------- -------- ---------- ----------- Operating earnings...................................... $ 816 $ 284 $ 6 1,106 ========== ======== ======== Adjustments to: Total revenues........................................ (1,104) Total expenses........................................ (2,347) Provision for income tax (expense) benefit............ 1,286 ---------- Income (loss) from continuing operations, net of income tax.................................................... $ (1,059) $ (1,059) ========== =========== The following table presents total premiums, universal life and investment-type product policy fees and other revenues by major product groups of the Company's segments, as well as Corporate & Other: [Download Table] Years Ended December 31, -------------------------- 2014 2013 2012 -------- -------- -------- (In millions) Annuities..................... $ 3,926 $ 3,486 $ 4,739 Life insurance................ 953 937 1,109 Accident and health insurance. 5 6 7 -------- -------- -------- Total........................ $ 4,884 $ 4,429 $ 5,855 ======== ======== ======== 32
485BPOS262nd Page of 388TOC1stPreviousNextBottomJust 262nd
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 2. Segment Information (continued) The following table presents total premiums, universal life and investment-type product policy fees and other revenues associated with the Company's U.S. and foreign operations: [Download Table] Years Ended December 31, -------------------------- 2014 2013 2012 -------- -------- -------- (In millions) U.S............. $ 4,712 $ 4,158 $ 4,089 Foreign: United Kingdom. 63 128 1,608 Other.......... 109 143 158 -------- -------- -------- Total........ $ 4,884 $ 4,429 $ 5,855 ======== ======== ======== Revenues derived from any customer did not exceed 10% of consolidated premiums, universal life and investment-type product policy fees and other revenues for the years ended December 31, 2014, 2013 and 2012. 3. Mergers In November 2014, MetLife Insurance Company of Connecticut, a wholly-owned subsidiary of MetLife, Inc., re-domesticated from Connecticut to Delaware, changed its name to MetLife Insurance Company USA and merged with its subsidiary, MLI-USA, and its affiliate, MLIIC, each a U.S. insurance company that issued variable annuity products in addition to other products, and Exeter, a former offshore, reinsurance subsidiary of MetLife, Inc. and affiliate of MICC that mainly reinsured guarantees associated with variable annuity products (the "Mergers"). The surviving entity of the Mergers was MetLife USA. Exeter, formerly a Cayman Islands company, was re-domesticated to Delaware in October 2013. Prior to the Mergers, 40,000,000 authorized shares of common stock, of which 30,000,000 shares were issued and outstanding, were converted to 4,000 authorized shares of common stock, of which 3,000 shares were issued and outstanding. Prior to the Mergers, effective January 1, 2014, following receipt of New York State Department of Financial Services (the "Department of Financial Services") approval, MetLife Insurance Company of Connecticut withdrew its license to issue insurance policies and annuity contracts in New York. Also effective January 1, 2014, MetLife Insurance Company of Connecticut reinsured with MLIC, an affiliate, all existing New York insurance policies and annuity contracts that include a separate account feature and deposited investments with an estimated fair market value of $6.3 billion into a custodial account to secure MetLife Insurance Company of Connecticut's remaining New York policyholder liabilities not covered by such reinsurance. Also prior to the Mergers, certain risks ceded to Exeter were recaptured. See Note 7 for information regarding additional reinsurance transactions. See Notes 8, 9 and 11 for information regarding additional transactions in connection with the Mergers. The Mergers represent a transaction among entities under common control and have been accounted for in a manner similar to the pooling-of-interests method, which requires that the merged entities be combined at their historical cost. The Company's consolidated financial statements and related footnotes are presented as if the transaction occurred at the beginning of the earliest date presented and the prior periods have been retrospectively adjusted. 33
485BPOS263rd Page of 388TOC1stPreviousNextBottomJust 263rd
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 3. Mergers (continued) Information regarding adjustments to stockholder's equity upon the consummation of the Mergers is as follows: [Enlarge/Download Table] Accumulated Additional Retained Other Total Common Paid-in Earnings Comprehensive Stockholder's Stock Capital (Deficit) Income Equity ------- ---------- --------- ------------- ------------- (In millions) Balance of MICC's equity at January 1, 2012... $ 86 $ 6,673 $ 1,081 $ 1,771 $ 9,611 Balance of MLIIC's equity at January 1, 2012.. 6 636 541 35 1,218 Balance of Exeter's equity at January 1, 2012. 13 1,253 (801) 49 514 Mergers adjustments (1)....................... (19) 20 213 -- 214 ------- --------- -------- ---------- --------- Balance of MetLife USA's equity at January 1, 2012........................................ $ 86 $ 8,582 $ 1,034 $ 1,855 $ 11,557 ======= ========= ======== ========== ========= -------- (1)Includes a reclassification from common stock to additional paid-in capital to eliminate MLIIC's and Exeter's common stock and an adjustment to retained earnings to eliminate reinsurance transactions among the merging companies. During 2012, Exeter issued $2.0 billion of preferred stock to MetLife, Inc. in exchange for MetLife, Inc.'s assumption of $2.0 billion of Exeter's senior notes. In November 2014, upon the consummation of the Mergers, the outstanding preferred stock of Exeter was canceled. Consequently, MetLife, Inc.'s preferred capital stock investment was added to its common capital stock investment in MetLife USA. See Note 13 for information regarding additional equity transactions. 4. Dispositions 2014 Disposition In May 2014, the Company completed the sale of its wholly-owned subsidiary, MAL, for $702 million ((Pounds)418 million) in net cash consideration. As a result of the sale, a loss of $608 million ($436 million, net of income tax), was recorded for the year ended December 31, 2014, which includes a reduction to goodwill of $112 million ($94 million, net of income tax). The loss is reflected within net investment gains (losses) on the consolidated statements of operations and comprehensive income (loss). Compared to the expected loss at the time of the sales agreement, the actual loss on the sale was increased by net income from MAL of $77 million for the year ended December 31, 2014. MAL's results of operations are included in continuing operations. They were historically included in the Corporate Benefit Funding segment. 2012 Disposition In June 2012, the Company distributed all of the issued and outstanding shares of common stock of its wholly-owned subsidiary, MetLife Europe to its stockholders as an in-kind dividend. The net book value of MetLife Europe at the time of the dividend was $290 million which was recorded as a dividend of retained earnings of $347 million and an increase to OCI of $57 million, net of income tax. As of the date of dividend, the Company 34
485BPOS264th Page of 388TOC1stPreviousNextBottomJust 264th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 4. Dispositions (continued) no longer consolidates the assets, liabilities and operations of MetLife Europe. The net income of MetLife Europe was not material to the Company for the periods prior to the dividend. The results of MetLife Europe were reported in Corporate & Other. Discontinued Operations The following table summarizes the amounts that have been reflected as discontinued operations in the consolidated statements of operations. Income (loss) from discontinued operations includes real estate classified as held-for-sale or sold. [Enlarge/Download Table] Year Ended December 31, 2012 ---------------------------- (In millions) Total revenues................................................ $ 12 Total expenses................................................ -- --------------------- Income (loss) before provision for income tax................. 12 Provision for income tax expense (benefit).................... 4 --------------------- Income (loss) from discontinued operations, net of income tax. $ 8 ===================== There was no income (loss) from discontinued operations, net of income tax, for both of the years ended December 31, 2014 and 2013. 5. Insurance Insurance Liabilities Insurance liabilities, including affiliated insurance liabilities on reinsurance assumed and ceded, are comprised of future policy benefits, PABs and other policy-related balances. Information regarding insurance liabilities by segment, as well as Corporate & Other, was as follows at: [Download Table] December 31, ------------------- 2014 2013 --------- --------- (In millions) Retail.................... $ 42,974 $ 41,020 Corporate Benefit Funding. 17,544 22,627 Corporate & Other......... 6,767 8,475 --------- --------- Total.................... $ 67,285 $ 72,122 ========= ========= See Note 7 for discussion of affiliated reinsurance liabilities included in the table above. 35
485BPOS265th Page of 388TOC1stPreviousNextBottomJust 265th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 5. Insurance (continued) Future policy benefits are measured as follows: Product Type: Measurement Assumptions: --------------------------------------------------------------------------- Participating life Aggregate of (i) net level premium reserves for death and endowment policy benefits (calculated based upon the non-forfeiture interest rate of 4%, and mortality rates guaranteed in calculating the cash surrender values described in such contracts); and (ii) the liability for terminal dividends. --------------------------------------------------------------------------- Nonparticipating life Aggregate of the present value of expected future benefit payments and related expenses less the present value of expected future net premiums. Assumptions as to mortality and persistency are based upon the Company's experience when the basis of the liability is established. Interest rate assumptions for the aggregate future policy benefit liabilities range from 3% to 8%. --------------------------------------------------------------------------- Individual and group traditional Present value of expected future fixed annuities after annuitization payments. Interest rate assumptions used in establishing such liabilities range from 4% to 8%. --------------------------------------------------------------------------- Non-medical health insurance The net level premium method and assumptions as to future morbidity, withdrawals and interest, which provide a margin for adverse deviation. Interest rate assumptions used in establishing such liabilities range from 4% to 7%. --------------------------------------------------------------------------- Disabled lives Present value of benefits method and experience assumptions as to claim terminations, expenses and interest. Interest rate assumptions used in establishing such liabilities range from 3% to 7%. --------------------------------------------------------------------------- Participating business represented 6% and 3% of the Company's life insurance in-force at December 31, 2014 and 2013, respectively. Participating policies represented 39%, 36% and 28% of gross life insurance premiums for the years ended December 31, 2014, 2013 and 2012, respectively. PABs are equal to: (i) policy account values, which consist of an accumulation of gross premium payments; (ii) credited interest, ranging from 1% to 8%, less expenses, mortality charges and withdrawals; and (iii) fair value adjustments relating to business combinations. 36
485BPOS266th Page of 388TOC1stPreviousNextBottomJust 266th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 5. Insurance (continued) Guarantees The Company issues variable annuity products with guaranteed minimum benefits. The non-life contingent portion of GMWBs and the portion of certain GMIBs that does not require annuitization are accounted for as embedded derivatives in PABs and are further discussed in Note 9. Guarantees accounted for as insurance liabilities include: [Enlarge/Download Table] Guarantee: Measurement Assumptions: ------------------------------------------------------------------------------------------------- GMDBs . A return of purchase payment upon Present value of expected death benefits in death even if the account value is excess of the projected account balance reduced to zero. recognizing the excess ratably over the accumulation period based on the present value of total expected assessments. . An enhanced death benefit may be Assumptions are consistent with those used available for an additional fee. for amortizing DAC, and are thus subject to the same variability and risk. Investment performance and volatility assumptions are consistent with the historical experience of the appropriate underlying equity index, such as the S&P 500 Index. Benefit assumptions are based on the average benefits payable over a range of scenarios. ------------------------------------------------------------------------------------------------- GMIBs . After a specified period of time Present value of expected income benefits in determined at the time of issuance excess of the projected account balance at of the variable annuity contract, any future date of annuitization and a minimum accumulation of purchase recognizing the excess ratably over the payments, even if the account accumulation period based on present value value is reduced to zero, that can of total expected assessments. be annuitized to receive a monthly income stream that is not less than a specified amount. . Certain contracts also provide for Assumptions are consistent with those used a guaranteed lump sum return of for estimating GMDB liabilities. purchase premium in lieu of the annuitization benefit. Calculation incorporates an assumption for the percentage of the potential annuitizations that may be elected by the contractholder. ------------------------------------------------------------------------------------------------- GMWBs. . A return of purchase payment via Expected value of the life contingent partial withdrawals, even if the payments and expected assessments using account value is reduced to zero, assumptions consistent with those used for provided that cumulative estimating the GMDB liabilities. withdrawals in a contract year do not exceed a certain limit. . Certain contracts include guaranteed withdrawals that are life contingent. 37
485BPOS267th Page of 388TOC1stPreviousNextBottomJust 267th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 5. Insurance (continued) Information regarding the liabilities for guarantees (excluding base policy liabilities and embedded derivatives) relating to annuity and universal and variable life contracts was as follows: [Download Table] Universal and Variable Life Annuity Contracts Contracts ------------------ ------------- Secondary GMDBs GMIBs Guarantees Total -------- --------- ------------- --------- (In millions) Direct Balance at January 1, 2012....... $ 180 $ 528 $ 1,036 $ 1,744 Incurred guaranteed benefits..... 119 499 332 950 Paid guaranteed benefits......... (39) -- -- (39) -------- --------- --------- --------- Balance at December 31, 2012..... 260 1,027 1,368 2,655 Incurred guaranteed benefits..... 166 128 416 710 Paid guaranteed benefits......... (22) -- -- (22) -------- --------- --------- --------- Balance at December 31, 2013..... 404 1,155 1,784 3,343 Incurred guaranteed benefits (1). 231 285 590 1,106 Paid guaranteed benefits......... (24) -- -- (24) -------- --------- --------- --------- Balance at December 31, 2014..... $ 611 $ 1,440 $ 2,374 $ 4,425 ======== ========= ========= ========= Net Ceded/(Assumed) Balance at January 1, 2012....... $ (163) $ (65) $ 727 $ 499 Incurred guaranteed benefits..... (100) (69) 258 89 Paid guaranteed benefits......... 45 -- -- 45 -------- --------- --------- --------- Balance at December 31, 2012..... (218) (134) 985 633 Incurred guaranteed benefits..... (26) (21) 327 280 Paid guaranteed benefits......... 39 -- -- 39 -------- --------- --------- --------- Balance at December 31, 2013..... (205) (155) 1,312 952 Incurred guaranteed benefits (1). 175 98 477 750 Paid guaranteed benefits......... 1 -- -- 1 -------- --------- --------- --------- Balance at December 31, 2014..... $ (29) $ (57) $ 1,789 $ 1,703 ======== ========= ========= ========= Net Balance at January 1, 2012....... $ 343 $ 593 $ 309 $ 1,245 Incurred guaranteed benefits..... 219 568 74 861 Paid guaranteed benefits......... (84) -- -- (84) -------- --------- --------- --------- Balance at December 31, 2012..... 478 1,161 383 2,022 Incurred guaranteed benefits..... 192 149 89 430 Paid guaranteed benefits......... (61) -- -- (61) -------- --------- --------- --------- Balance at December 31, 2013..... 609 1,310 472 2,391 Incurred guaranteed benefits (1). 56 187 113 356 Paid guaranteed benefits......... (25) -- -- (25) -------- --------- --------- --------- Balance at December 31, 2014..... $ 640 $ 1,497 $ 585 $ 2,722 ======== ========= ========= ========= -------- (1)See Note 7. 38
485BPOS268th Page of 388TOC1stPreviousNextBottomJust 268th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 5. Insurance (continued) Account balances of contracts with insurance guarantees were invested in separate account asset classes as follows at: [Download Table] December 31, --------------------- 2014 2013 ---------- ---------- (In millions) Fund Groupings: Balanced........ $ 55,287 $ 49,149 Equity.......... 43,430 50,645 Bond............ 5,226 4,820 Money Market.... 801 887 ---------- ---------- Total.......... $ 104,744 $ 105,501 ========== ========== Based on the type of guarantee, the Company defines net amount at risk ("NAR") as listed below. Variable Annuity Guarantees In the Event of Death Defined as the death benefit less the total contract account value, as of the balance sheet date. It represents the amount of the claim that the Company would incur if death claims were filed on all contracts on the balance sheet date and includes any additional contractual claims associated with riders purchased to assist with covering income taxes payable upon death. At Annuitization Defined as the amount (if any) that would be required to be added to the total contract account value to purchase a lifetime income stream, based on current annuity rates, equal to the minimum amount provided under the guaranteed benefit. This amount represents the Company's potential economic exposure to such guarantees in the event all contractholders were to annuitize on the balance sheet date, even though the contracts contain terms that allow annuitization of the guaranteed amount only after the 10th anniversary of the contract, which not all contractholders have achieved. Universal and Variable Life Contracts Defined as the guarantee amount less the account value, as of the balance sheet date. It represents the amount of the claim that the Company would incur if death claims were filed on all contracts on the balance sheet date. The amounts in the table below include direct business, but exclude offsets from hedging or reinsurance, if any. See Note 7 for a discussion of certain living and death benefit guarantees which have been reinsured. Therefore, the NARs presented below reflect the economic exposures of living and death benefit guarantees associated with variable annuities, but not necessarily their impact on the Company. 39
485BPOS269th Page of 388TOC1stPreviousNextBottomJust 269th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 5. Insurance (continued) Information regarding the types of guarantees relating to annuity contracts and universal and variable life contracts was as follows at: [Enlarge/Download Table] December 31, --------------------------------------------------------- 2014 2013 ---------------------------- ---------------------------- In the At In the At Event of Death Annuitization Event of Death Annuitization -------------- ------------- -------------- ------------- (In millions) Annuity Contracts (1) Variable Annuity Guarantees Total contract account value............ $ 112,298 $ 64,550 $ 129,284 $ 65,753 Separate account value.................. $ 107,261 $ 63,206 $ 108,478 $ 64,275 Net amount at risk...................... $ 3,151 $ 1,297 $ 3,148 $ 678 Average attained age of contractholders. 65 years 65 years 64 years 64 years [Download Table] December 31, ----------------------- 2014 2013 ----------- ----------- Secondary Guarantees ----------------------- (In millions) Universal and Variable Life Contracts (1) Account value (general and separate account). $ 6,702 $ 6,915 Net amount at risk........................... $ 91,204 $ 96,974 Average attained age of policyholders........ 59 years 58 years -------- (1)The Company's annuity and life contracts with guarantees may offer more than one type of guarantee in each contract. Therefore, the amounts listed above may not be mutually exclusive. Obligations Under Funding Agreements The Company issues fixed and floating rate funding agreements, which are denominated in either U.S. dollars or foreign currencies, to certain special purpose entities ("SPEs") that have issued either debt securities or commercial paper for which payment of interest and principal is secured by such funding agreements. During the years ended December 31, 2014, 2013 and 2012, the Company issued $12.2 billion, $10.9 billion and $10.3 billion, respectively, and repaid $13.9 billion, $11.7 billion and $9.6 billion, respectively, of such funding agreements. At December 31, 2014 and 2013, liabilities for funding agreements outstanding, which are included in PABs, were $3.5 billion and $5.3 billion, respectively. MetLife Insurance Company USA, is a member of regional banks in the Federal Home Loan Bank ("FHLB") system ("FHLBanks"). Holdings of common stock of FHLBanks, included in equity securities, were as follows at: [Download Table] December 31, --------------------- 2014 2013 ---------- ---------- (In millions) FHLB of Boston..... $ 55 $ 64 FHLB of Des Moines. $ 16 $ 26 FHLB of Pittsburgh. $ 24 $ 20 40
485BPOS270th Page of 388TOC1stPreviousNextBottomJust 270th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 5. Insurance (continued) The Company has also entered into funding agreements with FHLBanks and the Federal Agricultural Mortgage Corporation, a federally chartered instrumentality of the U.S. ("Farmer Mac"). The liability for such funding agreements is included in PABs. Information related to such funding agreements was as follows at: [Download Table] Liability Collateral -------------------- --------------------- December 31, ------------------------------------------ 2014 2013 2014 2013 --------- ---------- ---------- ---------- (In millions) FHLB of Boston (1)..... $ 575 $ 450 $ 666 (2) $ 808 (2) FHLB of Des Moines (1). $ 405 $ 405 $ 546 (2) $ 477 (2) Farmer Mac (3)......... $ 200 $ 200 $ 231 $ 230 FHLB of Pittsburgh (1). $ 185 $ 200 $1,154 (2) $ 602 (2) -------- (1)Represents funding agreements issued to the applicable FHLBank in exchange for cash and for which such FHLBank has been granted a lien on certain assets, some of which are in the custody of such FHLBank, including residential mortgage-backed securities ("RMBS"), to collateralize obligations under advances evidenced by funding agreements. The Company is permitted to withdraw any portion of the collateral in the custody of such FHLBank as long as there is no event of default and the remaining qualified collateral is sufficient to satisfy the collateral maintenance level. Upon any event of default by the Company, such FHLBank's recovery on the collateral is limited to the amount of the Company's liability to such FHLBank. (2)Advances are collateralized by mortgage-backed securities. The amount of collateral presented is at estimated fair value. (3)Represents funding agreements issued to certain SPEs that have issued debt securities for which payment of interest and principal is secured by such funding agreements, and such debt securities are also guaranteed as to payment of interest and principal by Farmer Mac. The obligations under these funding agreements are secured by a pledge of certain eligible agricultural real estate mortgage loans and may, under certain circumstances, be secured by other qualified collateral. The amount of collateral presented is at carrying value. 41
485BPOS271st Page of 388TOC1stPreviousNextBottomJust 271st
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 5. Insurance (continued) Liabilities for Unpaid Claims and Claim Expenses Information regarding the liabilities for unpaid claims and claim expenses relating to group accident and non-medical health policies and contracts, which are reported in future policy benefits and other policy-related balances, was as follows: [Download Table] Years Ended December 31, ---------------------------- 2014 2013 2012 -------- -------- -------- (In millions) Balance at January 1,........... $ 1,325 $ 1,216 $ 1,079 Less: Reinsurance recoverables. 1,235 1,124 980 -------- -------- -------- Net balance at January 1,....... 90 92 99 -------- -------- -------- Incurred related to: Current year................... 3 5 5 Prior years (1)................ 2 4 (2) -------- -------- -------- Total incurred............... 5 9 3 -------- -------- -------- Paid related to: Current year................... -- -- -- Prior years.................... (12) (11) (10) -------- -------- -------- Total paid................... (12) (11) (10) -------- -------- -------- Net balance at December 31,..... 83 90 92 Add: Reinsurance recoverables.. 1,400 1,235 1,124 -------- -------- -------- Balance at December 31,......... $ 1,483 $ 1,325 $ 1,216 ======== ======== ======== -------- (1)During 2014, 2013 and 2012, claims and claim adjustment expenses associated with prior years changed due to differences between the actual benefits paid and expected benefits owed during those periods. Separate Accounts Separate account assets and liabilities include two categories of account types: pass-through separate accounts totaling $108.7 billion and $109.6 billion at December 31, 2014 and 2013, respectively, for which the policyholder assumes all investment risk, and separate accounts for which the Company contractually guarantees either a minimum return or account value to the policyholder which totaled $187 million and $179 million at December 31, 2014 and 2013, respectively. The latter category consists of bank owned life insurance contracts. The average interest rate credited on these contracts was 2.52% and 2.59% at December 31, 2014 and 2013, respectively. For the years ended December 31, 2014, 2013 and 2012, there were no investment gains (losses) on transfers of assets from the general account to the separate accounts. 42
485BPOS272nd Page of 388TOC1stPreviousNextBottomJust 272nd
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 6. Deferred Policy Acquisition Costs, Value of Business Acquired and Other Intangibles See Note 1 for a description of capitalized acquisition costs. Nonparticipating and Non-Dividend-Paying Traditional Contracts The Company amortizes DAC and VOBA related to these contracts (primarily term insurance) over the appropriate premium paying period in proportion to the historic actual and expected future gross premiums that were set at contract issue. The expected premiums are based upon the premium requirement of each policy and assumptions for mortality, persistency and investment returns at policy issuance, or policy acquisition (as it relates to VOBA), include provisions for adverse deviation, and are consistent with the assumptions used to calculate future policyholder benefit liabilities. These assumptions are not revised after policy issuance or acquisition unless the DAC or VOBA balance is deemed to be unrecoverable from future expected profits. Absent a premium deficiency, variability in amortization after policy issuance or acquisition is caused only by variability in premium volumes. Participating, Dividend-Paying Traditional Contracts The Company amortizes DAC related to these contracts over the estimated lives of the contracts in proportion to actual and expected future gross margins. The amortization includes interest based on rates in effect at inception or acquisition of the contracts. The future gross margins are dependent principally on investment returns, policyholder dividend scales, mortality, persistency, expenses to administer the business, creditworthiness of reinsurance counterparties and certain economic variables, such as inflation. Of these factors, the Company anticipates that investment returns, expenses, persistency and other factor changes, as well as policyholder dividend scales, are reasonably likely to impact significantly the rate of DAC amortization. Each reporting period, the Company updates the estimated gross margins with the actual gross margins for that period. When the actual gross margins change from previously estimated gross margins, the cumulative DAC amortization is re-estimated and adjusted by a cumulative charge or credit to current operations. When actual gross margins exceed those previously estimated, the DAC amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the actual gross margins are below the previously estimated gross margins. Each reporting period, the Company also updates the actual amount of business in-force, which impacts expected future gross margins. When expected future gross margins are below those previously estimated, the DAC amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the expected future gross margins are above the previously estimated expected future gross margins. Each period, the Company also reviews the estimated gross margins for each block of business to determine the recoverability of DAC balances. Fixed and Variable Universal Life Contracts and Fixed and Variable Deferred Annuity Contracts The Company amortizes DAC and VOBA related to these contracts over the estimated lives of the contracts in proportion to actual and expected future gross profits. The amortization includes interest based on rates in effect at inception or acquisition of the contracts. The amount of future gross profits is dependent principally upon returns in excess of the amounts credited to policyholders, mortality, persistency, interest crediting rates, expenses to administer the business, creditworthiness of reinsurance counterparties, the effect of any hedges used and certain economic variables, such as inflation. Of these factors, the Company anticipates that investment returns, expenses and persistency are reasonably likely to impact significantly the rate of DAC and VOBA amortization. Each reporting period, the Company updates the estimated gross profits with the actual gross 43
485BPOS273rd Page of 388TOC1stPreviousNextBottomJust 273rd
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 6. Deferred Policy Acquisition Costs, Value of Business Acquired and Other Intangibles (continued) profits for that period. When the actual gross profits change from previously estimated gross profits, the cumulative DAC and VOBA amortization is re-estimated and adjusted by a cumulative charge or credit to current operations. When actual gross profits exceed those previously estimated, the DAC and VOBA amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the actual gross profits are below the previously estimated gross profits. Each reporting period, the Company also updates the actual amount of business remaining in-force, which impacts expected future gross profits. When expected future gross profits are below those previously estimated, the DAC and VOBA amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the expected future gross profits are above the previously estimated expected future gross profits. Each period, the Company also reviews the estimated gross profits for each block of business to determine the recoverability of DAC and VOBA balances. Factors Impacting Amortization Separate account rates of return on variable universal life contracts and variable deferred annuity contracts affect in-force account balances on such contracts each reporting period, which can result in significant fluctuations in amortization of DAC and VOBA. Returns that are higher than the Company's long-term expectation produce higher account balances, which increases the Company's future fee expectations and decreases future benefit payment expectations on minimum death and living benefit guarantees, resulting in higher expected future gross profits. The opposite result occurs when returns are lower than the Company's long-term expectation. The Company's practice to determine the impact of gross profits resulting from returns on separate accounts assumes that long-term appreciation in equity markets is not changed by short-term market fluctuations, but is only changed when sustained interim deviations are expected. The Company monitors these events and only changes the assumption when its long-term expectation changes. The Company also periodically reviews other long-term assumptions underlying the projections of estimated gross margins and profits. These assumptions primarily relate to investment returns, policyholder dividend scales, interest crediting rates, mortality, persistency and expenses to administer business. Management annually updates assumptions used in the calculation of estimated gross margins and profits which may have significantly changed. If the update of assumptions causes expected future gross margins and profits to increase, DAC and VOBA amortization will decrease, resulting in a current period increase to earnings. The opposite result occurs when the assumption update causes expected future gross margins and profits to decrease. Periodically, the Company modifies product benefits, features, rights or coverages that occur by the exchange of a contract for a new contract, or by amendment, endorsement, or rider to a contract, or by election or coverage within a contract. If such modification, referred to as an internal replacement, substantially changes the contract, the associated DAC or VOBA is written off immediately through income and any new deferrable costs associated with the replacement contract are deferred. If the modification does not substantially change the contract, the DAC or VOBA amortization on the original contract will continue and any acquisition costs associated with the related modification are expensed. Amortization of DAC and VOBA is attributed to net investment gains (losses) and net derivative gains (losses), and to other expenses for the amount of gross margins or profits originating from transactions other than investment gains and losses. Unrealized investment gains and losses represent the amount of DAC and VOBA that would have been amortized if such gains and losses had been recognized. 44
485BPOS274th Page of 388TOC1stPreviousNextBottomJust 274th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 6. Deferred Policy Acquisition Costs, Value of Business Acquired and Other Intangibles (continued) Information regarding DAC and VOBA was as follows: [Enlarge/Download Table] Years Ended December 31, ---------------------------- 2014 2013 2012 -------- -------- -------- (In millions) DAC Balance at January 1,............................................ $ 4,795 $ 4,086 $ 3,893 Capitalizations.................................................. 279 512 908 Amortization related to: Net investment gains (losses) and net derivative gains (losses). (152) 219 (15) Other expenses.................................................. (699) (287) (513) -------- -------- -------- Total amortization............................................ (851) (68) (528) -------- -------- -------- Unrealized investment gains (losses)............................. (61) 83 (28) Disposition and other (1), (2)................................... -- 182 (159) -------- -------- -------- Balance at December 31,.......................................... 4,162 4,795 4,086 -------- -------- -------- VOBA Balance at January 1,............................................ 896 718 1,072 Amortization related to: Net investment gains (losses) and net derivative gains (losses). (1) 5 -- Other expenses.................................................. (138) (142) (206) -------- -------- -------- Total amortization............................................ (139) (137) (206) -------- -------- -------- Unrealized investment gains (losses)............................. (29) 315 (148) -------- -------- -------- Balance at December 31,.......................................... 728 896 718 -------- -------- -------- Total DAC and VOBA Balance at December 31,.......................................... $ 4,890 $ 5,691 $ 4,804 ======== ======== ======== -------- (1)The year ended December 31, 2013 includes $182 million that was reclassified to DAC from premiums, reinsurance and other receivables. The amounts reclassified relate to an affiliated reinsurance agreement accounted for using the deposit method of accounting and represent the DAC amortization on the expense allowances ceded on the agreement from inception. These amounts were previously included in the calculated value of the deposit receivable on this agreement and recorded within premiums, reinsurance and other receivables. (2)See Note 4 for information on the disposition of a subsidiary. 45
485BPOS275th Page of 388TOC1stPreviousNextBottomJust 275th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 6. Deferred Policy Acquisition Costs, Value of Business Acquired and Other Intangibles (continued) Information regarding total DAC and VOBA by segment, as well as Corporate & Other, was as follows at: [Download Table] December 31, ----------------- 2014 2013 -------- -------- (In millions) Retail.................... $ 4,824 $ 5,659 Corporate Benefit Funding. 5 6 Corporate & Other......... 61 26 -------- -------- Total.................... $ 4,890 $ 5,691 ======== ======== Information regarding other intangibles was as follows: [Download Table] Years Ended December 31, ---------------------- 2014 2013 2012 ------ ------ ------ (In millions) DSI Balance at January 1,................ $ 619 $ 633 $ 656 Capitalization....................... 4 6 22 Amortization......................... (73) (20) (45) Unrealized investment gains (losses). (28) -- -- ------ ------ ------ Balance at December 31,.............. $ 522 $ 619 $ 633 ====== ====== ====== VODA and VOCRA Balance at January 1,................ $ 159 $ 175 $ 190 Amortization......................... (17) (16) (15) ------ ------ ------ Balance at December 31,.............. $ 142 $ 159 $ 175 ====== ====== ====== Accumulated amortization............. $ 98 $ 81 $ 65 ====== ====== ====== The estimated future amortization expense to be reported in other expenses for the next five years is as follows: [Download Table] VOBA VODA and VOCRA -------------- -------------- (In millions) 2015.......................... $ 158 $ 17 2016.......................... $ 130 $ 15 2017.......................... $ 105 $ 14 2018.......................... $ 87 $ 13 2019.......................... $ 69 $ 12 7. Reinsurance The Company enters into reinsurance agreements primarily as a purchaser of reinsurance for its various insurance products and also as a provider of reinsurance for some insurance products issued by affiliated and unaffiliated companies. The Company participates in reinsurance activities in order to limit losses, minimize exposure to significant risks and provide additional capacity for future growth. 46
485BPOS276th Page of 388TOC1stPreviousNextBottomJust 276th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 7. Reinsurance (continued) Accounting for reinsurance requires extensive use of assumptions and estimates, particularly related to the future performance of the underlying business and the potential impact of counterparty credit risks. The Company periodically reviews actual and anticipated experience compared to the aforementioned assumptions used to establish assets and liabilities relating to ceded and assumed reinsurance and evaluates the financial strength of counterparties to its reinsurance agreements using criteria similar to that evaluated in the security impairment process discussed in Note 8. Retail The Company's Retail Annuities business currently reinsures 90% of certain fixed annuities to an affiliate. The Company also reinsures portions of the living and death benefit guarantees issued in connection with certain variable annuities to unaffiliated reinsurers. Under these reinsurance agreements, the Company pays a reinsurance premium generally based on fees associated with the guarantees collected from policyholders, and receives reimbursement for benefits paid or accrued in excess of account values, subject to certain limitations. The Company also assumes 100% of the living and death benefit guarantees issued in connection with certain variable annuities issued by certain affiliates. For its Retail Life & Other insurance products, the Company has historically reinsured the mortality risk primarily on an excess of retention basis or on a quota share basis. The Company currently reinsures 100% of the mortality risk in excess of $100,000 per life for most new policies and reinsures up to 100% of the mortality risk for certain other policies. In addition to reinsuring mortality risk as described above, the Company reinsures other risks, as well as specific coverages. Placement of reinsurance is done primarily on an automatic basis and also on a facultative basis for risks with specified characteristics. The Company also reinsures portions of certain whole life, level premium term and universal life policies with secondary death benefit guarantees to certain affiliates. The Company evaluates its reinsurance programs routinely and may increase or decrease its retention at any time. Corporate Benefit Funding The Company's Corporate Benefit Funding segment has periodically engaged in reinsurance activities, on an opportunistic basis. The impact of these activities on the financial results of this segment has not been significant and there were no significant transactions during the periods presented. Corporate & Other The Company reinsures, through 100% quota share reinsurance agreements, certain run-off LTC and workers' compensation business written by the Company. The Company also assumes risk on certain client arrangements from both foreign affiliates and unaffiliated companies. This reinsurance activity relates to risk-sharing agreements and multinational pooling. Catastrophe Coverage The Company has exposure to catastrophes, which could contribute to significant fluctuations in the Company's results of operations. The Company uses excess of retention and quota share reinsurance agreements to provide greater diversification of risk and minimize exposure to larger risks. 47
485BPOS277th Page of 388TOC1stPreviousNextBottomJust 277th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 7. Reinsurance (continued) Reinsurance Recoverables The Company reinsures its business through a diversified group of well-capitalized reinsurers. The Company analyzes recent trends in arbitration and litigation outcomes in disputes, if any, with its reinsurers. The Company monitors ratings and evaluates the financial strength of its reinsurers by analyzing their financial statements. In addition, the reinsurance recoverable balance due from each reinsurer is evaluated as part of the overall monitoring process. Recoverability of reinsurance recoverable balances is evaluated based on these analyses. The Company generally secures large reinsurance recoverable balances with various forms of collateral, including secured trusts, funds withheld accounts and irrevocable letters of credit. These reinsurance recoverable balances are stated net of allowances for uncollectible reinsurance, which at December 31, 2014 and 2013, were not significant. The Company has secured certain reinsurance recoverable balances with various forms of collateral, including secured trusts, funds withheld accounts and irrevocable letters of credit. The Company had $2.3 billion and $2.1 billion of unsecured unaffiliated reinsurance recoverable balances at December 31, 2014 and 2013, respectively. At December 31, 2014, the Company had $8.1 billion of net unaffiliated ceded reinsurance recoverables. Of this total, $7.1 billion, or 87%, were with the Company's five largest unaffiliated ceded reinsurers, including $1.3 billion of net unaffiliated ceded reinsurance recoverables which were unsecured. At December 31, 2013, the Company had $7.7 billion of net unaffiliated ceded reinsurance recoverables. Of this total, $6.8 billion, or 88%, were with the Company's five largest unaffiliated ceded reinsurers, including $1.2 billion of net unaffiliated ceded reinsurance recoverables which were unsecured. 48
485BPOS278th Page of 388TOC1stPreviousNextBottomJust 278th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 7. Reinsurance (continued) The amounts in the consolidated statements of operations include the impact of reinsurance. Information regarding the significant effects of reinsurance was as follows: [Enlarge/Download Table] Years Ended December 31, ---------------------------- 2014 2013 2012 -------- -------- -------- (In millions) Premiums Direct premiums............................................... $ 2,226 $ 1,590 $ 2,075 Reinsurance assumed........................................... 94 73 962 Reinsurance ceded............................................. (1,168) (974) (822) -------- -------- -------- Net premiums............................................... $ 1,152 $ 689 $ 2,215 ======== ======== ======== Universal life and investment-type product policy fees Direct universal life and investment-type product policy fees. $ 3,610 $ 3,492 $ 3,210 Reinsurance assumed........................................... 398 398 390 Reinsurance ceded............................................. (815) (760) (586) -------- -------- -------- Net universal life and investment-type product policy fees. $ 3,193 $ 3,130 $ 3,014 ======== ======== ======== Other revenues Direct other revenues......................................... $ 259 $ 284 $ 256 Reinsurance assumed........................................... 28 1 23 Reinsurance ceded............................................. 252 325 347 -------- -------- -------- Net other revenues......................................... $ 539 $ 610 $ 626 ======== ======== ======== Policyholder benefits and claims Direct policyholder benefits and claims....................... $ 4,797 $ 4,693 $ 4,756 Reinsurance assumed........................................... 263 149 1,180 Reinsurance ceded............................................. (2,296) (1,695) (1,615) -------- -------- -------- Net policyholder benefits and claims....................... $ 2,764 $ 3,147 $ 4,321 ======== ======== ======== Interest credited to policyholder account balances Direct interest credited to policyholder account balances..... $ 1,125 $ 1,202 $ 1,303 Reinsurance assumed........................................... 76 91 87 Reinsurance ceded............................................. (139) (125) (109) -------- -------- -------- Net interest credited to policyholder account balances..... $ 1,062 $ 1,168 $ 1,281 ======== ======== ======== Other expenses Direct other expenses......................................... $ 2,524 $ 1,861 $ 2,428 Reinsurance assumed........................................... 106 19 88 Reinsurance ceded............................................. 124 57 120 -------- -------- -------- Net other expenses......................................... $ 2,754 $ 1,937 $ 2,636 ======== ======== ======== 49
485BPOS279th Page of 388TOC1stPreviousNextBottomJust 279th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 7. Reinsurance (continued) The amounts in the consolidated balance sheets include the impact of reinsurance. Information regarding the significant effects of reinsurance was as follows at: [Enlarge/Download Table] December 31, ----------------------------------------------------------------- 2014 2013 -------------------------------- -------------------------------- Total Total Balance Balance Direct Assumed Ceded Sheet Direct Assumed Ceded Sheet ------- ------- ------- ------- ------- ------- ------- ------- (In millions) Assets Premiums, reinsurance and other receivables.......................... $ 516 $ 57 $20,986 $21,559 $ 471 $ 177 $18,905 $19,553 Deferred policy acquisition costs and value of business acquired........... 5,367 246 (723) 4,890 6,013 294 (616) 5,691 ------- ------- ------- ------- ------- ------- ------- ------- Total assets........................ $ 5,883 $ 303 $20,263 $26,449 $ 6,484 $ 471 $18,289 $25,244 ======= ======= ======= ======= ======= ======= ======= ======= Liabilities Future policy benefits................ $27,242 $1,237 $ -- $28,479 $28,407 $2,196 $ -- $30,603 Policyholder account balances......... 34,659 827 -- 35,486 36,201 1,188 -- 37,389 Other policy-related balances......... 866 1,691 763 3,320 815 2,504 811 4,130 Other liabilities..................... 2,469 63 5,412 7,944 3,992 173 4,143 8,308 ------- ------- ------- ------- ------- ------- ------- ------- Total liabilities................... $65,236 $3,818 $ 6,175 $75,229 $69,415 $6,061 $ 4,954 $80,430 ======= ======= ======= ======= ======= ======= ======= ======= In November 2014, prior to the Mergers, guaranteed minimum benefit guarantees on certain variable annuities previously ceded to Exeter from an unaffiliated foreign company were recaptured. As a result of this recapture, the significant impacts to the Company were decreases in future policy benefits of $101 million, in other policy-related balances of $1.2 billion, in cash and cash equivalents of $705 million and in other invested assets of $553 million. Reinsurance agreements that do not expose the Company to a reasonable possibility of a significant loss from insurance risk are recorded using the deposit method of accounting. The deposit assets on reinsurance were $6.2 billion and $5.8 billion at December 31, 2014 and 2013, respectively. The deposit liabilities on reinsurance were $1 million at both December 31, 2014 and 2013. Related Party Reinsurance Transactions The Company has reinsurance agreements with certain MetLife, Inc. subsidiaries, including MLIC, MetLife Reinsurance Company of South Carolina, First MetLife Investors Insurance Company ("First MetLife"), General American Life Insurance Company, MetLife Europe, MetLife Reinsurance Company of Vermont, New England Life Insurance Company ("NELICO"), MetLife Reinsurance Company of Delaware ("MRD") and Delaware American Life Insurance Company, all of which are related parties. 50
485BPOS280th Page of 388TOC1stPreviousNextBottomJust 280th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 7. Reinsurance (continued) Information regarding the significant effects of affiliated reinsurance included in the consolidated statements of operations was as follows: [Enlarge/Download Table] Years Ended December 31, ------------------------- 2014 2013 2012 ------- ------- ------- (In millions) Premiums Reinsurance assumed........................................... $ 55 $ 28 $ 912 Reinsurance ceded............................................. (830) (638) (477) ------- ------- ------- Net premiums............................................... $ (775) $ (610) $ 435 ======= ======= ======= Universal life and investment-type product policy fees Reinsurance assumed........................................... $ 291 $ 259 $ 235 Reinsurance ceded............................................. (361) (344) (227) ------- ------- ------- Net universal life and investment-type product policy fees. $ (70) $ (85) $ 8 ======= ======= ======= Other revenues Reinsurance assumed........................................... $ 28 $ 1 $ 23 Reinsurance ceded............................................. 252 325 347 ------- ------- ------- Net other revenues......................................... $ 280 $ 326 $ 370 ======= ======= ======= Policyholder benefits and claims Reinsurance assumed........................................... $ 229 $ 137 $ 1,064 Reinsurance ceded............................................. (942) (673) (581) ------- ------- ------- Net policyholder benefits and claims....................... $ (713) $ (536) $ 483 ======= ======= ======= Interest credited to policyholder account balances Reinsurance assumed........................................... $ 76 $ 91 $ 87 Reinsurance ceded............................................. (139) (125) (109) ------- ------- ------- Net interest credited to policyholder account balances..... $ (63) $ (34) $ (22) ======= ======= ======= Other expenses Reinsurance assumed........................................... $ 92 $ 33 $ 45 Reinsurance ceded............................................. 156 94 159 ------- ------- ------- Net other expenses......................................... $ 248 $ 127 $ 204 ======= ======= ======= 51
485BPOS281st Page of 388TOC1stPreviousNextBottomJust 281st
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 7. Reinsurance (continued) Information regarding the significant effects of affiliated reinsurance included in the consolidated balance sheets was as follows at: [Enlarge/Download Table] December 31, ----------------------------------- 2014 2013 ---------------- ----------------- Assumed Ceded Assumed Ceded -------- ------- -------- ------- (In millions) Assets Premiums, reinsurance and other receivables............. $ 45 $12,718 $ 143 $11,105 Deferred policy acquisition costs and value of business acquired.............................................. 164 (707) 203 (600) -------- ------- -------- ------- Total assets........................................... $ 209 $12,011 $ 346 $10,505 ======== ======= ======== ======= Liabilities Future policy benefits.................................. $ 593 $ -- $ 1,480 $ -- Policyholder account balances........................... 827 -- (74) -- Other policy-related balances........................... 1,689 763 2,496 811 Other liabilities....................................... 16 5,109 116 3,850 -------- ------- -------- ------- Total liabilities...................................... $ 3,125 $ 5,872 $ 4,018 $ 4,661 ======== ======= ======== ======= In September 2012, the Company entered into a reinsurance agreement to assume 100% quota share of certain blocks of indemnity reinsurance from MetLife Europe. This agreement covers a portion of liabilities under defined portfolios of living time annuities contracts issued on or after the effective date. This agreement transfers risk to the Company, and therefore, is accounted for as reinsurance. As a result of the agreement, the Company recorded future policy benefits of $454 million and $649 million, other reinsurance liabilities of $2 million and $17 million, and other reinsurance payables, included in other liabilities, were $29 million and $44 million at December 31, 2014 and 2013, respectively. The Company's consolidated statement of operations reflects a loss for this agreement of $3 million, $9 million and $4 million, which includes premiums of less than $1 million, less than $1 million and $881 million and policyholder benefits of $3 million, $9 million and $885 million for the years ended December 31, 2014, 2013 and 2012, respectively. In October 2012, the Company entered into a reinsurance agreement to cede two blocks of business to MRD, on a 90% coinsurance with funds withheld basis. This agreement covers certain term and certain universal life policies issued in 2012 by the Company and was amended in 2013 to include certain term and universal life policies issued by the Company through December 31, 2013. This agreement transfers risk to MRD and, therefore, is accounted for as reinsurance. As a result of the agreement, affiliated reinsurance recoverables, included in premiums, reinsurance and other receivables, were $675 million and $917 million at December 31, 2014 and 2013, respectively. The Company also recorded a funds withheld liability and other reinsurance payables, included in other liabilities, which were $564 million and $798 million at December 31, 2014 and 2013, respectively. Certain contractual features of this agreement qualify as embedded derivatives, which are separately accounted for at fair value on the Company's consolidated balance sheets. The embedded derivative related to this cession is included within other liabilities and was $59 million and ($14) million at December 31, 2014 and 2013, respectively. The Company's consolidated statements of operations reflect a loss for this agreement of $162 million, $50 million and $37 million for the years ended December 31, 2014, 2013 and 2012, respectively. The loss related to this agreement includes net derivative gains (losses) associated with the 52
485BPOS282nd Page of 388TOC1stPreviousNextBottomJust 282nd
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 7. Reinsurance (continued) embedded derivatives of ($73) million, $20 million and ($6) million for the years ended December 31, 2014, 2013 and 2012, respectively. The Company assumes risks from affiliates related to guaranteed minimum benefit guarantees written directly by the affiliates. These assumed reinsurance agreements contain embedded derivatives and changes in their fair value are also included within net derivative gains (losses). The embedded derivatives associated with the cessions are included within PABs and were liabilities of $827 million and ($74) million at December 31, 2014 and 2013, respectively. For the years ended December 31, 2014, 2013 and 2012, net derivative gains (losses) included ($541) million, $2.1 billion and ($12) million, respectively, in changes in fair value of such embedded derivatives. The Company ceded two blocks of business to an affiliate on a 90% coinsurance with funds withheld basis. Certain contractual features of this agreement qualify as embedded derivatives, which are separately accounted for at estimated fair value on the Company's consolidated balance sheets. The embedded derivative related to the funds withheld associated with this reinsurance agreement is included within other liabilities and increased the funds withheld balance by $323 million and $48 million at December 31, 2014 and 2013, respectively. Net derivative gains (losses) associated with the embedded derivatives were ($275) million, $498 million and ($107) million for the years ended December 31, 2014, 2013 and 2012, respectively. On December 31, 2014, the Company entered into a reinsurance agreement to cede two blocks of business to MRD on a 90% coinsurance with funds withheld basis. This agreement covers certain term and certain universal life policies issued in 2014 by the Company. This agreement transfers risk to MRD and, therefore, is accounted for as reinsurance. As a result of the agreement, affiliated reinsurance recoverables, included in premiums, reinsurance and other receivables, were $54 million at December 31, 2014. The Company also recorded a funds withheld liability and other reinsurance payables, included in other liabilities, which were $118 million at December 31, 2014. The Company's consolidated statement of operations reflects a loss for this agreement of less than $1 million for the year ended December 31, 2014. Prior to the Mergers, certain related party transactions were consummated as summarized below. See Note 3 for additional information on the Mergers. . Effective January 1, 2014, the Company reinsured with MLIC all existing New York insurance policies and annuity contracts that include a separate account feature. As a result of the reinsurance agreements, the significant effects to the Company were increases in premiums, reinsurance and other receivables of $700 million and in other liabilities of $206 million, as well as decreases in cash and cash equivalents and total investments of $494 million. . In October 2014, MLIC recaptured a block of universal life secondary guarantee business ceded to Exeter on a 75% coinsurance with funds withheld basis. As a result of this recapture, the significant effects to the Company were decreases in premiums, reinsurance and other receivables of $14 million, in DAC of $30 million, in other invested assets of $418 million, in future policy benefits of $67 million and in other policy-related balances of $435 million. . In November 2014, MLIC, First MetLife and NELICO partially recaptured risks related to guaranteed minimum benefit guarantees on certain variable annuities previously ceded to Exeter. As a result of this recapture, the significant effects to the Company were decreases in future policy benefits of 53
485BPOS283rd Page of 388TOC1stPreviousNextBottomJust 283rd
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 7. Reinsurance (continued) $284 million, in other policy-related balances of $469 million, in other liabilities of $23 million, in other invested assets of $441 million and in cash and cash equivalents of $385 million. There was also a decrease in net income of $57 million. . Also in November 2014, certain foreign blocks of indemnity reinsurance and guaranteed minimum benefit guarantees on certain variable annuities previously ceded to Exeter from MetLife Europe were recaptured. As a result of this recapture, the significant effects to the Company were decreases in future policy benefits of $463 million, in other liabilities of $29 million and in other invested assets of $505 million, as well as increases in cash and cash equivalents of $122 million and in other policy-related balances of $109 million. The Company has secured certain reinsurance recoverable balances with various forms of collateral, including secured trusts, funds withheld accounts and irrevocable letters of credit. The Company had $6.2 billion and $5.7 billion of unsecured affiliated reinsurance recoverable balances at December 31, 2014 and 2013, respectively. Affiliated reinsurance agreements that do not expose the Company to a reasonable possibility of a significant loss from insurance risk are recorded using the deposit method of accounting. The deposit assets on affiliated reinsurance were $6.0 billion and $5.7 billion at December 31, 2014 and 2013, respectively. There were no deposit liabilities on affiliated reinsurance at both December 31, 2014 and 2013. 8. Investments See Note 10 for information about the fair value hierarchy for investments and the related valuation methodologies. Investment Risks and Uncertainties Investments are exposed to the following primary sources of risk: credit, interest rate, liquidity, market valuation, currency and real estate risk. The financial statement risks, stemming from such investment risks, are those associated with the determination of estimated fair values, the diminished ability to sell certain investments in times of strained market conditions, the recognition of impairments, the recognition of income on certain investments and the potential consolidation of VIEs. The use of different methodologies, assumptions and inputs relating to these financial statement risks may have a material effect on the amounts presented within the consolidated financial statements. The determination of valuation allowances and impairments is highly subjective and is based upon periodic evaluations and assessments of known and inherent risks associated with the respective asset class. Such evaluations and assessments are revised as conditions change and new information becomes available. The recognition of income on certain investments (e.g. structured securities, including mortgage-backed securities, asset-backed securities ("ABS") and certain structured investment transactions) is dependent upon certain factors such as prepayments and defaults, and changes in such factors could result in changes in amounts to be earned. 54
485BPOS284th Page of 388TOC1stPreviousNextBottomJust 284th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 8. Investments (continued) Fixed Maturity and Equity Securities AFS Fixed Maturity and Equity Securities AFS by Sector The following table presents the fixed maturity and equity securities AFS by sector. Redeemable preferred stock is reported within U.S. corporate and foreign corporate fixed maturity securities and non-redeemable preferred stock is reported within equity securities. Included within fixed maturity securities are structured securities including RMBS, commercial mortgage-backed securities ("CMBS") and ABS. [Enlarge/Download Table] December 31, 2014 December 31, 2013 --------------------------------------------- -------------------------------------------- Gross Unrealized Gross Unrealized Cost or ----------------------- Cost or ----------------------- Amortized Temporary OTTI Estimated Amortized Temporary OTTI Estimated Cost Gains Losses Losses Fair Value Cost Gains Losses Losses Fair Value --------- ------ --------- ------ ---------- --------- ------ --------- ------ ---------- (In millions) Fixed maturity securities U.S. corporate............ $15,286 $1,635 $ 119 $-- $16,802 $16,860 $1,196 $ 218 $-- $17,838 U.S. Treasury and agency................... 14,147 1,686 7 -- 15,826 8,760 337 246 -- 8,851 RMBS...................... 5,858 291 33 35 6,081 4,960 214 66 45 5,063 Foreign corporate......... 5,162 310 58 -- 5,414 8,868 500 89 -- 9,279 State and political subdivision.............. 2,180 413 1 -- 2,592 2,278 148 63 -- 2,363 CMBS (1).................. 1,637 45 4 (1) 1,679 1,975 71 13 -- 2,033 ABS....................... 1,546 26 10 -- 1,562 2,211 36 12 -- 2,235 Foreign government........ 607 136 2 -- 741 1,076 105 19 -- 1,162 --------- ------ --------- ------ ---------- --------- ------ --------- ------ ---------- Total fixed maturity securities.............. $46,423 $4,542 $ 234 $34 $50,697 $46,988 $2,607 $ 726 $45 $48,824 ========= ====== ========= ====== ========== ========= ====== ========= ====== ========== Equity securities Common stock.............. $ 176 $ 60 $ 3 $-- $ 233 $ 187 $ 41 $ 1 $-- $ 227 Non-redeemable preferred stock.................... 224 9 7 -- 226 256 9 29 -- 236 --------- ------ --------- ------ ---------- --------- ------ --------- ------ ---------- Total equity securities.. $ 400 $ 69 $ 10 $-- $ 459 $ 443 $ 50 $ 30 $-- $ 463 ========= ====== ========= ====== ========== ========= ====== ========= ====== ========== -------- (1)The noncredit loss component of OTTI losses for CMBS was in an unrealized gain position of $1 million at December 31, 2014, due to increases in estimated fair value subsequent to initial recognition of noncredit losses on such securities. See also "-- Net Unrealized Investment Gains (Losses)." The Company held non-income producing fixed maturity securities with an estimated fair value of $14 million and $30 million with unrealized gains (losses) of $4 million and $6 million at December 31, 2014 and 2013, respectively. Methodology for Amortization of Premium and Accretion of Discount on Structured Securities Amortization of premium and accretion of discount on structured securities considers the estimated timing and amount of prepayments of the underlying loans. Actual prepayment experience is periodically reviewed and effective yields are recalculated when differences arise between the originally anticipated and the actual prepayments received and currently anticipated. Prepayment assumptions for single class and multi-class mortgage-backed and ABS are estimated using inputs obtained from third-party specialists and based on management's knowledge of the current market. For credit-sensitive mortgage-backed and ABS and certain 55
485BPOS285th Page of 388TOC1stPreviousNextBottomJust 285th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 8. Investments (continued) prepayment-sensitive securities, the effective yield is recalculated on a prospective basis. For all other mortgage-backed and ABS, the effective yield is recalculated on a retrospective basis. Maturities of Fixed Maturity Securities The amortized cost and estimated fair value of fixed maturity securities, by contractual maturity date, were as follows at: [Download Table] December 31, --------------------------------------- 2014 2013 ------------------- ------------------- Estimated Estimated Amortized Fair Amortized Fair Cost Value Cost Value --------- --------- --------- --------- (In millions) Due in one year or less.................... $ 3,200 $ 3,223 $ 3,420 $ 3,454 Due after one year through five years...... 11,658 12,009 9,662 10,097 Due after five years through ten years..... 7,592 8,011 8,308 8,877 Due after ten years........................ 14,932 18,132 16,452 17,065 --------- --------- --------- --------- Subtotal................................ 37,382 41,375 37,842 39,493 Structured securities (RMBS, CMBS and ABS). 9,041 9,322 9,146 9,331 --------- --------- --------- --------- Total fixed maturity securities..... $ 46,423 $ 50,697 $ 46,988 $ 48,824 ========= ========= ========= ========= Actual maturities may differ from contractual maturities due to the exercise of call or prepayment options. Fixed maturity securities not due at a single maturity date have been presented in the year of final contractual maturity. RMBS, CMBS and ABS are shown separately, as they are not due at a single maturity. 56
485BPOS286th Page of 388TOC1stPreviousNextBottomJust 286th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 8. Investments (continued) Continuous Gross Unrealized Losses for Fixed Maturity and Equity Securities AFS by Sector The following table presents the estimated fair value and gross unrealized losses of fixed maturity and equity securities AFS in an unrealized loss position, aggregated by sector and by length of time that the securities have been in a continuous unrealized loss position. [Enlarge/Download Table] December 31, 2014 December 31, 2013 ----------------------------------------- ----------------------------------------- Equal to or Greater Equal to or Greater Less than 12 Months than 12 Months Less than 12 Months than 12 Months -------------------- -------------------- -------------------- -------------------- Estimated Gross Estimated Gross Estimated Gross Estimated Gross Fair Unrealized Fair Unrealized Fair Unrealized Fair Unrealized Value Losses Value Losses Value Losses Value Losses --------- ---------- --------- ---------- --------- ---------- --------- ---------- (In millions, except number of securities) Fixed maturity securities U.S. corporate................ $ 1,346 $ 45 $ 685 $ 74 $ 2,659 $ 150 $ 487 $ 68 U.S. Treasury and agency...... 4,067 5 163 2 4,023 246 -- -- RMBS.......................... 684 26 530 42 1,097 40 491 71 Foreign corporate............. 1,031 49 133 9 1,762 79 143 10 State and political subdivision.................. 11 -- 24 1 645 45 64 18 CMBS.......................... 124 1 78 2 279 13 7 -- ABS........................... 334 2 231 8 707 5 108 7 Foreign government............ 27 1 9 1 264 18 2 1 --------- ---------- --------- ---------- --------- ---------- --------- ---------- Total fixed maturity securities.................. $ 7,624 $ 129 $ 1,853 $ 139 $ 11,436 $ 596 $ 1,302 $ 175 ========= ========== ========= ========== ========= ========== ========= ========== Equity securities Common stock.................. $ 11 $ 3 $ -- $ -- $ 2 $ 1 $ 8 $ -- Non-redeemable preferred stock 28 1 44 6 105 21 51 8 --------- ---------- --------- ---------- --------- ---------- --------- ---------- Total equity securities...... $ 39 $ 4 $ 44 $ 6 $ 107 $ 22 $ 59 $ 8 ========= ========== ========= ========== ========= ========== ========= ========== Total number of securities in an unrealized loss position.. 752 333 1,247 317 ========= ========= ========= ========= Evaluation of AFS Securities for OTTI and Evaluating Temporarily Impaired AFS Securities Evaluation and Measurement Methodologies Management considers a wide range of factors about the security issuer and uses its best judgment in evaluating the cause of the decline in the estimated fair value of the security and in assessing the prospects for near-term recovery. Inherent in management's evaluation of the security are assumptions and estimates about the operations of the issuer and its future earnings potential. Considerations used in the impairment evaluation process include, but are not limited to: (i) the length of time and the extent to which the estimated fair value has been below cost or amortized cost; (ii) the potential for impairments when the issuer is experiencing significant financial difficulties; (iii) the potential for impairments in an entire industry sector or sub-sector; (iv) the potential for impairments in certain economically depressed geographic locations; (v) the potential for impairments where the issuer, series of issuers or industry has suffered a catastrophic loss or has exhausted 57
485BPOS287th Page of 388TOC1stPreviousNextBottomJust 287th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 8. Investments (continued) natural resources; (vi) with respect to fixed maturity securities, whether the Company has the intent to sell or will more likely than not be required to sell a particular security before the decline in estimated fair value below amortized cost recovers; (vii) with respect to structured securities, changes in forecasted cash flows after considering the quality of underlying collateral, expected prepayment speeds, current and forecasted loss severity, consideration of the payment terms of the underlying assets backing a particular security, and the payment priority within the tranche structure of the security; (viii) the potential for impairments due to weakening of foreign currencies on non-functional currency denominated fixed maturity securities that are near maturity; and (ix) other subjective factors, including concentrations and information obtained from regulators and rating agencies. The methodology and significant inputs used to determine the amount of credit loss on fixed maturity securities are as follows: . The Company calculates the recovery value by performing a discounted cash flow analysis based on the present value of future cash flows. The discount rate is generally the effective interest rate of the security prior to impairment. . When determining collectability and the period over which value is expected to recover, the Company applies considerations utilized in its overall impairment evaluation process which incorporates information regarding the specific security, fundamentals of the industry and geographic area in which the security issuer operates, and overall macroeconomic conditions. Projected future cash flows are estimated using assumptions derived from management's best estimates of likely scenario-based outcomes after giving consideration to a variety of variables that include, but are not limited to: payment terms of the security; the likelihood that the issuer can service the interest and principal payments; the quality and amount of any credit enhancements; the security's position within the capital structure of the issuer; possible corporate restructurings or asset sales by the issuer; and changes to the rating of the security or the issuer by rating agencies. . Additional considerations are made when assessing the unique features that apply to certain structured securities including, but not limited to: the quality of underlying collateral, expected prepayment speeds, current and forecasted loss severity, consideration of the payment terms of the underlying loans or assets backing a particular security, and the payment priority within the tranche structure of the security. . When determining the amount of the credit loss for U.S. and foreign corporate securities, foreign government securities and state and political subdivision securities, the estimated fair value is considered the recovery value when available information does not indicate that another value is more appropriate. When information is identified that indicates a recovery value other than estimated fair value, management considers in the determination of recovery value the same considerations utilized in its overall impairment evaluation process as described above, as well as any private and public sector programs to restructure such securities. With respect to securities that have attributes of debt and equity (perpetual hybrid securities), consideration is given in the OTTI analysis as to whether there has been any deterioration in the credit of the issuer and the likelihood of recovery in value of the securities that are in a severe and extended unrealized loss position. Consideration is also given as to whether any perpetual hybrid securities, with an unrealized loss, regardless of 58
485BPOS288th Page of 388TOC1stPreviousNextBottomJust 288th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 8. Investments (continued) credit rating, have deferred any dividend payments. When an OTTI loss has occurred, the OTTI loss is the entire difference between the perpetual hybrid security's cost and its estimated fair value with a corresponding charge to earnings. The cost or amortized cost of fixed maturity and equity securities is adjusted for OTTI in the period in which the determination is made. The Company does not change the revised cost basis for subsequent recoveries in value. In periods subsequent to the recognition of OTTI on a fixed maturity security, the Company accounts for the impaired security as if it had been purchased on the measurement date of the impairment. Accordingly, the discount (or reduced premium) based on the new cost basis is accreted over the remaining term of the fixed maturity security in a prospective manner based on the amount and timing of estimated future cash flows. Current Period Evaluation Based on the Company's current evaluation of its AFS securities in an unrealized loss position in accordance with its impairment policy, and the Company's current intentions and assessments (as applicable to the type of security) about holding, selling and any requirements to sell these securities, the Company concluded that these securities were not other-than-temporarily impaired at December 31, 2014. Future OTTI will depend primarily on economic fundamentals, issuer performance (including changes in the present value of future cash flows expected to be collected), and changes in credit ratings, collateral valuation, interest rates and credit spreads. If economic fundamentals deteriorate or if there are adverse changes in the above factors, OTTI may be incurred in upcoming periods. Gross unrealized losses on fixed maturity securities decreased $503 million during the year ended December 31, 2014 from $771 million to $268 million. The decrease in gross unrealized losses for the year ended December 31, 2014, was primarily attributable to a decrease in interest rates, partially offset by widening credit spreads. At December 31, 2014, $38 million of the total $268 million of gross unrealized losses were from 12 fixed maturity securities with an unrealized loss position of 20% or more of amortized cost for six months or greater. Investment Grade Fixed Maturity Securities Of the $38 million of gross unrealized losses on fixed maturity securities with an unrealized loss of 20% or more of amortized cost for six months or greater, $20 million, or 53%, were related to gross unrealized losses on seven investment grade fixed maturity securities. Unrealized losses on investment grade fixed maturity securities are principally related to widening credit spreads, and with respect to fixed-rate fixed maturity securities, rising interest rates since purchase. Below Investment Grade Fixed Maturity Securities Of the $38 million of gross unrealized losses on fixed maturity securities with an unrealized loss of 20% or more of amortized cost for six months or greater, $18 million, or 47%, were related to gross unrealized losses on five below investment grade fixed maturity securities. Unrealized losses on below investment grade fixed maturity securities are principally related to non-agency RMBS (primarily alternative residential mortgage 59
485BPOS289th Page of 388TOC1stPreviousNextBottomJust 289th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 8. Investments (continued) loans) and are the result of significantly wider credit spreads resulting from higher risk premiums since purchase, largely due to economic and market uncertainties including concerns over valuations of residential real estate supporting non-agency RMBS. Management evaluates non-agency RMBS based on actual and projected cash flows after considering the quality of underlying collateral, expected prepayment speeds, current and forecasted loss severity, consideration of the payment terms of the underlying assets backing a particular security, and the payment priority within the tranche structure of the security. Equity Securities Gross unrealized losses on equity securities decreased $20 million during the year ended December 31, 2014 from $30 million to $10 million. Of the $10 million, $4 million were from two equity securities with gross unrealized losses of 20% or more of cost for 12 months or greater, all of which were financial services industry investment grade non-redeemable preferred stock. Mortgage Loans Mortgage Loans by Portfolio Segment Mortgage loans are summarized as follows at: [Enlarge/Download Table] December 31, -------------------------------------------- 2014 2013 --------------------- ---------------------- Carrying % of Carrying % of Value Total Value Total ------------- ------- ------------- -------- (In millions) (In millions) Mortgage loans: Commercial.................................... $ 4,281 73.3% $ 5,115 63.9% Agricultural.................................. 1,303 22.3 1,326 16.5 ------------- ------- ------------- -------- Subtotal.................................... 5,584 95.6 6,441 80.4 Valuation allowances.......................... (25) (0.4) (35) (0.4) ------------- ------- ------------- -------- Subtotal mortgage loans, net................ 5,559 95.2 6,406 80.0 Commercial mortgage loans held by CSEs -- FVO. 280 4.8 1,598 20.0 ------------- ------- ------------- -------- Total mortgage loans, net................. $ 5,839 100.0% $ 8,004 100.0% ============= ======= ============= ======== See "-- Variable Interest Entities" for discussion of CSEs. See "-- Related Party Investment Transactions" for discussion of related party mortgage loans. 60
485BPOS290th Page of 388TOC1stPreviousNextBottomJust 290th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 8. Investments (continued) Mortgage Loans, Valuation Allowance and Impaired Loans by Portfolio Segment Mortgage loans by portfolio segment, by method of evaluation of credit loss, impaired mortgage loans including those modified in a troubled debt restructuring, and the related valuation allowances, were as follows at and for the years ended: [Enlarge/Download Table] Evaluated Individually for Credit Losses Evaluated Collectively for Credit Losses ---------------------------------------------------------------------------- ---------------------------------------- Impaired Loans without a Valuation Impaired Loans with a Valuation Allowance Allowance ----------------------------------------- ---------------------------------- Unpaid Principal Recorded Valuation Unpaid Principal Recorded Recorded Valuation Balance Investment Allowances Balance Investment Investment Allowances December 31, ---------------- ---------- ---------- ---------------- ---------- ---------- ---------- (In millions) 2014 Commercial... $ -- $ -- $ -- $ -- $ -- $ 4,281 $ 21 Agricultural. 4 3 -- -- -- 1,300 4 ---------------- ---------- ---------- ---------------- ---------- ---------- ---------- Total........ $ 4 $ 3 $ -- $ -- $ -- $ 5,581 $ 25 ================ ========== ========== ================ ========== ========== ========== 2013 Commercial... $ 22 $ 22 $ 7 $ 52 $ 50 $ 5,043 $ 24 Agricultural. 4 4 -- -- -- 1,322 4 ---------------- ---------- ---------- ---------------- ---------- ---------- ---------- Total........ $ 26 $ 26 $ 7 $ 52 $ 50 $ 6,365 $ 28 ================ ========== ========== ================ ========== ========== ========== [Download Table] Impaired Loans ------------------- Average Carrying Recorded Value Investment December 31, -------- ---------- 2014 Commercial... $ -- $ 43 Agricultural. 3 3 -------- ---------- Total........ $ 3 $ 46 ======== ========== 2013 Commercial... $ 65 $ 73 Agricultural. 4 2 -------- ---------- Total........ $ 69 $ 75 ======== ========== The average recorded investment for commercial and agricultural mortgage loans was $67 million and $0, respectively, for the year ended December 31, 2012. Valuation Allowance Rollforward by Portfolio Segment The changes in the valuation allowance, by portfolio segment, were as follows: [Download Table] Commercial Agricultural Total ---------- ------------- ------- (In millions) Balance at January 1, 2012... $ 60 $ 3 $ 63 Provision (release).......... (26) -- (26) ---------- ------------- ------- Balance at December 31, 2012. 34 3 37 Provision (release).......... (3) 1 (2) ---------- ------------- ------- Balance at December 31, 2013. 31 4 35 Provision (release).......... (10) -- (10) ---------- ------------- ------- Balance at December 31, 2014. $ 21 $ 4 $ 25 ========== ============= ======= Valuation Allowance Methodology Mortgage loans are considered to be impaired when it is probable that, based upon current information and events, the Company will be unable to collect all amounts due under the loan agreement. Specific valuation allowances are established using the same methodology for both portfolio segments as the excess carrying 61
485BPOS291st Page of 388TOC1stPreviousNextBottomJust 291st
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 8. Investments (continued) value of a loan over either (i) the present value of expected future cash flows discounted at the loan's original effective interest rate, (ii) the estimated fair value of the loan's underlying collateral if the loan is in the process of foreclosure or otherwise collateral dependent, or (iii) the loan's observable market price. A common evaluation framework is used for establishing non-specific valuation allowances for both loan portfolio segments; however, a separate non-specific valuation allowance is calculated and maintained for each loan portfolio segment that is based on inputs unique to each loan portfolio segment. Non-specific valuation allowances are established for pools of loans with similar risk characteristics where a property-specific or market-specific risk has not been identified, but for which the Company expects to incur a credit loss. These evaluations are based upon several loan portfolio segment-specific factors, including the Company's experience for loan losses, defaults and loss severity, and loss expectations for loans with similar risk characteristics. These evaluations are revised as conditions change and new information becomes available. Commercial and Agricultural Mortgage Loan Portfolio Segments The Company typically uses several years of historical experience in establishing non-specific valuation allowances which captures multiple economic cycles. For evaluations of commercial mortgage loans, in addition to historical experience, management considers factors that include the impact of a rapid change to the economy, which may not be reflected in the loan portfolio, and recent loss and recovery trend experience as compared to historical loss and recovery experience. For evaluations of agricultural mortgage loans, in addition to historical experience, management considers factors that include increased stress in certain sectors, which may be evidenced by higher delinquency rates, or a change in the number of higher risk loans. On a quarterly basis, management incorporates the impact of these current market events and conditions on historical experience in determining the non-specific valuation allowance established for commercial and agricultural mortgage loans. All commercial mortgage loans are reviewed on an ongoing basis which may include an analysis of the property financial statements and rent roll, lease rollover analysis, property inspections, market analysis, estimated valuations of the underlying collateral, loan-to-value ratios, debt service coverage ratios, and tenant creditworthiness. The monitoring process focuses on higher risk loans, which include those that are classified as restructured, delinquent or in foreclosure, as well as loans with higher loan-to-value ratios and lower debt service coverage ratios. All agricultural mortgage loans are monitored on an ongoing basis. The monitoring process for agricultural mortgage loans is generally similar to the commercial mortgage loan monitoring process, with a focus on higher risk loans, including reviews on a geographic and property-type basis. Higher risk loans are reviewed individually on an ongoing basis for potential credit loss and specific valuation allowances are established using the methodology described above. Quarterly, the remaining loans are reviewed on a pool basis by aggregating groups of loans that have similar risk characteristics for potential credit loss, and non-specific valuation allowances are established as described above using inputs that are unique to each segment of the loan portfolio. For commercial mortgage loans, the primary credit quality indicator is the debt service coverage ratio, which compares a property's net operating income to amounts needed to service the principal and interest due under the loan. Generally, the lower the debt service coverage ratio, the higher the risk of experiencing a credit loss. The Company also reviews the loan-to-value ratio of its commercial mortgage loan portfolio. Loan-to-value ratios compare the unpaid principal balance of the loan to the estimated fair value of the underlying collateral. Generally, the higher the loan-to-value ratio, the higher the risk of experiencing a credit loss. The 62
485BPOS292nd Page of 388TOC1stPreviousNextBottomJust 292nd
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 8. Investments (continued) debt service coverage ratio and loan-to-value ratio, as well as the values utilized in calculating these ratios, are updated annually, on a rolling basis, with a portion of the loan portfolio updated each quarter. For agricultural mortgage loans, the Company's primary credit quality indicator is the loan-to-value ratio. The values utilized in calculating this ratio are developed in connection with the ongoing review of the agricultural mortgage loan portfolio and are routinely updated. Credit Quality of Commercial Mortgage Loans The credit quality of commercial mortgage loans were as follows at: [Enlarge/Download Table] Recorded Investment ---------------------------------------------- Debt Service Coverage Ratios Estimated ------------------------------ % of Fair % of > 1.20x 1.00x - 1.20x < 1.00x Total Total Value Total -------- ------------- ------- -------- ------ ------------- ------ (In millions) (In millions) December 31, 2014 Loan-to-value ratios: Less than 65%......... $ 3,668 $ 267 $ 125 $ 4,060 94.8% $ 4,431 95.1% 65% to 75%............ 113 14 -- 127 3.0 134 2.9 76% to 80%............ 9 -- -- 9 0.2 10 0.2 Greater than 80%...... 45 26 14 85 2.0 83 1.8 -------- ------------- ------- -------- ------ ------------- ------ Total................ $ 3,835 $ 307 $ 139 $ 4,281 100.0% $ 4,658 100.0% ======== ============= ======= ======== ====== ============= ====== December 31, 2013 Loan-to-value ratios: Less than 65%......... $ 3,946 $ 135 $ 122 $ 4,203 82.2% $ 4,452 83.0% 65% to 75%............ 720 -- 37 757 14.8 766 14.3 76% to 80%............ 80 12 -- 92 1.8 93 1.7 Greater than 80%...... 37 26 -- 63 1.2 53 1.0 -------- ------------- ------- -------- ------ ------------- ------ Total................ $ 4,783 $ 173 $ 159 $ 5,115 100.0% $ 5,364 100.0% ======== ============= ======= ======== ====== ============= ====== Credit Quality of Agricultural Mortgage Loans The credit quality of agricultural mortgage loans were as follows at: [Download Table] December 31, --------------------------------------------- 2014 2013 ---------------------- ---------------------- Recorded % of Recorded % of Investment Total Investment Total ------------- -------- ------------- -------- (In millions) (In millions) Loan-to-value ratios: Less than 65%......... $ 1,239 95.1% $ 1,256 94.7% 65% to 75%............ 64 4.9 70 5.3 ------------- -------- ------------- -------- Total................ $ 1,303 100.0% $ 1,326 100.0% ============= ======== ============= ======== The estimated fair value of agricultural mortgage loans was $1.4 billion at both December 31, 2014 and 2013. 63
485BPOS293rd Page of 388TOC1stPreviousNextBottomJust 293rd
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 8. Investments (continued) Past Due and Interest Accrual Status of Mortgage Loans The Company has a high quality, well performing, mortgage loan portfolio, with over 99% of all mortgage loans classified as performing at both December 31, 2014 and 2013. The Company defines delinquency consistent with industry practice, when mortgage loans are past due as follows: commercial mortgage loans -- 60 days and agricultural mortgage loans -- 90 days. The Company had no mortgage loans past due and no mortgage loans in nonaccrual status at December 31, 2014. The Company had no agricultural mortgage loans past due and one commercial mortgage loan in nonaccrual status with a recorded investment of $22 million at December 31, 2013. Mortgage Loans Modified in a Troubled Debt Restructuring For a small portion of the mortgage loan portfolio, classified as troubled debt restructurings, concessions are granted related to borrowers experiencing financial difficulties. Generally, the types of concessions include: reduction of the contractual interest rate, extension of the maturity date at an interest rate lower than current market interest rates, and/or a reduction of accrued interest. The amount, timing and extent of the concession granted is considered in determining any impairment or changes in the specific valuation allowance. During the years ended December 31, 2014 and 2013, the Company did not have a significant amount of mortgage loans modified in a troubled debt restructuring. Other Invested Assets Other invested assets is comprised primarily of freestanding derivatives with positive estimated fair values (see Note 9), funds withheld, tax credit and renewable energy partnerships, operating joint ventures, leveraged leases and loans to affiliates (see " -- Related Party Investment Transactions). Leveraged Leases Investment in leveraged leases consisted of the following at: [Enlarge/Download Table] December 31, ------------------- 2014 2013 --------- --------- (In millions) Rental receivables, net............................................. $ 92 $ 92 Estimated residual values........................................... 14 14 --------- --------- Subtotal......................................................... 106 106 Unearned income..................................................... (34) (35) --------- --------- Investment in leveraged leases, net of non-recourse debt..... $ 72 $ 71 ========= ========= Rental receivables are generally due in periodic installments. The payment periods for leveraged leases range from one to 18 years. For rental receivables, the primary credit quality indicator is whether the rental receivable is performing or nonperforming, which is assessed monthly. The Company generally defines nonperforming rental receivables as those that are 90 days or more past due. At December 31, 2014 and 2013, all rental receivables were performing. 64
485BPOS294th Page of 388TOC1stPreviousNextBottomJust 294th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 8. Investments (continued) The deferred income tax liability related to leveraged leases was $71 million and $63 million at December 31, 2014 and 2013, respectively. Cash Equivalents The carrying value of cash equivalents, which includes securities and other investments with an original or remaining maturity of three months or less at the time of purchase, was $681 million and $527 million at December 31, 2014 and 2013, respectively. Net Unrealized Investment Gains (Losses) Unrealized investment gains (losses) on fixed maturity and equity securities AFS and the effect on DAC, VOBA, DSI and future policy benefits that would result from the realization of the unrealized gains (losses), are included in net unrealized investment gains (losses) in AOCI. The components of net unrealized investment gains (losses), included in AOCI, were as follows: [Enlarge/Download Table] Years Ended December 31, -------------------------- 2014 2013 2012 -------- -------- -------- (In millions) Fixed maturity securities.............................................. $ 4,311 $ 1,884 $ 5,232 Fixed maturity securities with noncredit OTTI losses in AOCI........... (34) (45) (70) -------- -------- -------- Total fixed maturity securities....................................... 4,277 1,839 5,162 Equity securities...................................................... 69 13 9 Derivatives............................................................ 282 38 244 Short-term investments................................................. -- -- (2) Other.................................................................. 9 (71) (18) -------- -------- -------- Subtotal.............................................................. 4,637 1,819 5,395 -------- -------- -------- Amounts allocated from: Future policy benefits................................................ (503) -- (740) DAC and VOBA related to noncredit OTTI losses recognized in AOCI................................................................ (2) -- 5 DAC, VOBA and DSI..................................................... (403) (287) (690) -------- -------- -------- Subtotal............................................................ (908) (287) (1,425) Deferred income tax benefit (expense) related to noncredit OTTI losses recognized in AOCI................................................... 12 15 22 Deferred income tax benefit (expense).................................. (1,308) (606) (1,423) -------- -------- -------- Net unrealized investment gains (losses).............................. $ 2,433 $ 941 $ 2,569 ======== ======== ======== 65
485BPOS295th Page of 388TOC1stPreviousNextBottomJust 295th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 8. Investments (continued) The changes in fixed maturity securities with noncredit OTTI losses included in AOCI were as follows: [Download Table] Years Ended December 31, --------------------------- 2014 2013 ------------- ------------- (In millions) Balance at January 1,................................... $ (45) $ (70) Noncredit OTTI losses and subsequent changes recognized. 6 11 Securities sold with previous noncredit OTTI loss....... 9 23 Subsequent changes in estimated fair value.............. (4) (9) ------------- ------------- Balance at December 31,................................. $ (34) $ (45) ============= ============= The changes in net unrealized investment gains (losses) were as follows: [Enlarge/Download Table] Years Ended December 31, -------------------------------- 2014 2013 2012 ---------- ---------- ---------- (In millions) Balance at January 1,.............................................. $ 941 $ 2,569 $ 1,971 Fixed maturity securities on which noncredit OTTI losses have been recognized....................................................... 11 25 65 Unrealized investment gains (losses) during the year............... 2,807 (3,601) 1,460 Unrealized investment gains (losses) relating to: Future policy benefits............................................ (503) 740 (405) DAC and VOBA related to noncredit OTTI losses recognized in AOCI............................................................ (2) (5) (6) DAC, VOBA and DSI................................................. (116) 403 (170) Deferred income tax benefit (expense) related to noncredit OTTI losses recognized in AOCI....................................... (3) (7) (21) Deferred income tax benefit (expense)............................. (702) 817 (325) ---------- ---------- ---------- Balance at December 31,............................................ $ 2,433 $ 941 $ 2,569 ========== ========== ========== Change in net unrealized investment gains (losses)................ $ 1,492 $ (1,628) $ 598 ========== ========== ========== Concentrations of Credit Risk There were no investments in any counterparty that were greater than 10% of the Company's stockholder's equity, other than the U.S. government and its agencies, at both December 31, 2014 and 2013. 66
485BPOS296th Page of 388TOC1stPreviousNextBottomJust 296th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 8. Investments (continued) Securities Lending Elements of the securities lending program are presented below at: [Download Table] December 31, --------------------- 2014 2013 ---------- ---------- (In millions) Securities on loan: (1) Amortized cost........................................ $ 5,748 $ 6,180 Estimated fair value.................................. $ 6,703 $ 6,226 Cash collateral on deposit from counterparties (2)..... $ 6,781 $ 6,389 Security collateral on deposit from counterparties (3). $ 60 $ -- Reinvestment portfolio -- estimated fair value......... $ 6,846 $ 6,392 -------- (1)Included within fixed maturity securities, short-term investments, cash and cash equivalents and equity securities. (2)Included within payables for collateral under securities loaned and other transactions. (3)Security collateral on deposit from counterparties may not be sold or re-pledged, unless the counterparty is in default, and is not reflected in the consolidated financial statements. Invested Assets on Deposit, Held in Trust and Pledged as Collateral Invested assets on deposit, held in trust and pledged as collateral are presented below at estimated fair value for all asset classes, except mortgage loans, which are presented at carrying value at: [Enlarge/Download Table] December 31, --------------------- 2014 2013 ---------- ---------- (In millions) Invested assets on deposit (regulatory deposits) (1)........................ $ 7,334 $ 63 Invested assets held in trust (reinsurance agreements) (2).................. 936 2,754 Invested assets pledged as collateral (3)................................... 3,174 3,431 ---------- ---------- Total invested assets on deposit, held in trust, and pledged as collateral. $ 11,444 $ 6,248 ========== ========== -------- (1)See Note 3 for information about invested assets that became restricted in connection with MetLife Insurance Company of Connecticut's withdrawal of its New York license. (2)The Company has held in trust certain investments, primarily fixed maturity securities, in connection with certain reinsurance transactions. (3)The Company has pledged invested assets in connection with various agreements and transactions, including funding agreements (see Note 5) and derivative transactions (see Note 9). See "-- Securities Lending" for information regarding securities on loan. 67
485BPOS297th Page of 388TOC1stPreviousNextBottomJust 297th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 8. Investments (continued) Purchased Credit Impaired Investments Investments acquired with evidence of credit quality deterioration since origination and for which it is probable at the acquisition date that the Company will be unable to collect all contractually required payments are classified as purchased credit impaired ("PCI") investments. For each investment, the excess of the cash flows expected to be collected as of the acquisition date over its acquisition date fair value is referred to as the accretable yield and is recognized as net investment income on an effective yield basis. If subsequently, based on current information and events, it is probable that there is a significant increase in cash flows previously expected to be collected or if actual cash flows are significantly greater than cash flows previously expected to be collected, the accretable yield is adjusted prospectively. The excess of the contractually required payments (including interest) as of the acquisition date over the cash flows expected to be collected as of the acquisition date is referred to as the nonaccretable difference, and this amount is not expected to be realized as net investment income. Decreases in cash flows expected to be collected can result in OTTI. The Company's PCI fixed maturity securities were as follows at: [Download Table] December 31, --------------------- 2014 2013 ---------- ---------- (In millions) Outstanding principal and interest balance (1). $ 653 $ 667 Carrying value (2)............................. $ 504 $ 508 -------- (1)Represents the contractually required payments, which is the sum of contractual principal, whether or not currently due, and accrued interest. (2)Estimated fair value plus accrued interest. The following table presents information about PCI fixed maturity securities acquired during the periods indicated: [Download Table] Years Ended December 31, ------------------------ 2014 2013 ---------- ---------- (In millions) Contractually required payments (including interest). $ 102 $ 260 Cash flows expected to be collected (1).............. $ 78 $ 198 Fair value of investments acquired................... $ 54 $ 138 -------- (1)Represents undiscounted principal and interest cash flow expectations, at the date of acquisition. 68
485BPOS298th Page of 388TOC1stPreviousNextBottomJust 298th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 8. Investments (continued) The following table presents activity for the accretable yield on PCI fixed maturity securities for: [Download Table] Years Ended December 31, ------------------------ 2014 2013 ---------- ---------- (In millions) Accretable yield, January 1,........................ $ 315 $ 309 Investments purchased............................... 24 60 Accretion recognized in earnings.................... (25) (24) Disposals........................................... (13) (8) Reclassification (to) from nonaccretable difference. (50) (22) ---------- ---------- Accretable yield, December 31,...................... $ 251 $ 315 ========== ========== Collectively Significant Equity Method Investments The Company holds investments in real estate joint ventures, real estate funds and other limited partnership interests consisting of leveraged buy-out funds, hedge funds, private equity funds, joint ventures and other funds. The portion of these investments accounted for under the equity method had a carrying value of $2.9 billion at December 31, 2014. The Company's maximum exposure to loss related to these equity method investments is limited to the carrying value of these investments plus unfunded commitments of $777 million at December 31, 2014. Except for certain real estate joint ventures, the Company's investments in real estate funds and other limited partnership interests are generally of a passive nature in that the Company does not participate in the management of the entities. As described in Note 1, the Company generally records its share of earnings in its equity method investments using a three-month lag methodology and within net investment income. Aggregate net investment income from these equity method investments exceeded 10% of the Company's consolidated pre-tax income (loss) from continuing operations for the three most recent annual periods: 2014, 2013 and 2012. This aggregated summarized financial data does not represent the Company's proportionate share of the assets, liabilities, or earnings of such entities. The aggregated summarized financial data presented below reflects the latest available financial information and is as of, and for, the years ended December 31, 2014, 2013 and 2012. Aggregate total assets of these entities totaled $264.7 billion and $217.3 billion at December 31, 2014 and 2013, respectively. Aggregate total liabilities of these entities totaled $23.2 billion and $16.3 billion at December 31, 2014 and 2013, respectively. Aggregate net income (loss) of these entities totaled $25.1 billion, $20.9 billion and $13.1 billion for the years ended December 31, 2014, 2013 and 2012, respectively. Aggregate net income (loss) from the underlying entities in which the Company invests is primarily comprised of investment income, including recurring investment income and realized and unrealized investment gains (losses). Variable Interest Entities The Company has invested in certain structured transactions (including CSEs) that are VIEs. In certain instances, the Company holds both the power to direct the most significant activities of the entity, as well as an economic interest in the entity and, as such, is deemed to be the primary beneficiary or consolidator of the entity. 69
485BPOS299th Page of 388TOC1stPreviousNextBottomJust 299th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 8. Investments (continued) The determination of the VIE's primary beneficiary requires an evaluation of the contractual and implied rights and obligations associated with each party's relationship with or involvement in the entity, an estimate of the entity's expected losses and expected residual returns and the allocation of such estimates to each party involved in the entity. The Company generally uses a qualitative approach to determine whether it is the primary beneficiary. However, for VIEs that are investment companies or apply measurement principles consistent with those utilized by investment companies, the primary beneficiary is based on a risks and rewards model and is defined as the entity that will absorb a majority of a VIE's expected losses, receive a majority of a VIE's expected residual returns if no single entity absorbs a majority of expected losses, or both. The Company reassesses its involvement with VIEs on a quarterly basis. The use of different methodologies, assumptions and inputs in the determination of the primary beneficiary could have a material effect on the amounts presented within the consolidated financial statements. Consolidated VIEs The following table presents the total assets and total liabilities relating to VIEs for which the Company has concluded that it is the primary beneficiary and which are consolidated at December 31, 2014 and 2013. Creditors or beneficial interest holders of VIEs where the Company is the primary beneficiary have no recourse to the general credit of the Company, as the Company's obligation to the VIEs is limited to the amount of its committed investment. [Download Table] December 31, ----------------- 2014 2013 -------- -------- (In millions) CSEs: (1) Assets: Mortgage loans (commercial mortgage loans). $ 280 $ 1,598 Accrued investment income.................. 2 9 -------- -------- Total assets............................. $ 282 $ 1,607 ======== ======== Liabilities: Long-term debt............................. $ 139 $ 1,461 Other liabilities.......................... 1 7 -------- -------- Total liabilities........................ $ 140 $ 1,468 ======== ======== -------- (1)The Company consolidates entities that are structured as CMBS. The assets of these entities can only be used to settle their respective liabilities, and under no circumstances is the Company liable for any principal or interest shortfalls should any arise. The Company's exposure was limited to that of its remaining investment in these entities of $123 million and $120 million at estimated fair value at December 31, 2014 and 2013, respectively. The long-term debt bears interest primarily at fixed rates ranging from 2.25% to 5.57%, payable primarily on a monthly basis. Interest expense related to these obligations, included in other expenses, was $36 million, $122 million and $163 million for the years ended December 31, 2014, 2013 and 2012, respectively. 70
485BPOS300th Page of 388TOC1stPreviousNextBottomJust 300th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 8. Investments (continued) Unconsolidated VIEs The carrying amount and maximum exposure to loss relating to VIEs in which the Company holds a significant variable interest but is not the primary beneficiary and which have not been consolidated were as follows at: [Enlarge/Download Table] December 31, ------------------------------------------- 2014 2013 --------------------- --------------------- Maximum Maximum Carrying Exposure Carrying Exposure Amount to Loss (1) Amount to Loss (1) --------- ----------- --------- ----------- (In millions) Fixed maturity securities AFS: Structured securities (RMBS, CMBS and ABS) (2). $ 9,322 $ 9,322 $ 9,331 $ 9,331 U.S. and foreign corporate..................... 526 526 494 494 Other limited partnership interests............. 1,774 2,162 1,670 2,096 Real estate joint ventures...................... 47 51 41 45 Other invested assets........................... 37 47 9 44 Equity securities AFS: Non-redeemable preferred stock................. 19 19 18 18 --------- --------- --------- --------- Total........................................ $ 11,725 $ 12,127 $ 11,563 $ 12,028 ========= ========= ========= ========= -------- (1)The maximum exposure to loss relating to fixed maturity and equity securities AFS is equal to their carrying amounts or the carrying amounts of retained interests. The maximum exposure to loss relating to other limited partnership interests and real estate joint ventures is equal to the carrying amounts plus any unfunded commitments of the Company. For certain of its investments in other invested assets, the Company's return is in the form of income tax credits which are guaranteed by creditworthy third parties. For such investments, the maximum exposure to loss is equal to the carrying amounts plus any unfunded commitments, reduced by income tax credits guaranteed by third parties of less than $1 million and $0 at December 31, 2014 and 2013, respectively. Such a maximum loss would be expected to occur only upon bankruptcy of the issuer or investee. (2)For these variable interests, the Company's involvement is limited to that of a passive investor in mortgage-backed or asset-backed securities issued by trusts that do not have substantial equity. As described in Note 16, the Company makes commitments to fund partnership investments in the normal course of business. Excluding these commitments, the Company did not provide financial or other support to investees designated as VIEs during the years ended December 31, 2014, 2013 and 2012. 71
485BPOS301st Page of 388TOC1stPreviousNextBottomJust 301st
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 8. Investments (continued) Net Investment Income The components of net investment income were as follows: [Download Table] Years Ended December 31, ------------------------ 2014 2013 2012 ------ ------ ------ (In millions) Investment income: Fixed maturity securities............................... $1,954 $2,235 $2,245 Equity securities....................................... 17 13 11 Mortgage loans.......................................... 337 360 372 Policy loans............................................ 59 57 61 Real estate and real estate joint ventures.............. 80 56 83 Other limited partnership interests..................... 266 270 168 Cash, cash equivalents and short-term investments....... 5 7 11 Operating joint ventures................................ 2 (5) (2) Other................................................... 3 (2) (6) ------ ------ ------ Subtotal.............................................. 2,723 2,991 2,943 Less: Investment expenses............................... 103 124 117 ------ ------ ------ Subtotal, net......................................... 2,620 2,867 2,826 ------ ------ ------ FVO securities (1)....................................... -- -- 62 FVO CSEs -- interest income -- commercial mortgage loans. 49 132 172 ------ ------ ------ Subtotal.............................................. 49 132 234 ------ ------ ------ Net investment income............................... $2,669 $2,999 $3,060 ====== ====== ====== -------- (1)There were no changes in estimated fair value subsequent to purchase for securities still held as of the end of the year included in net investment income for the year ended December 31, 2012. See "-- Variable Interest Entities" for discussion of CSEs. See "-- Related Party Investment Transactions" for discussion of affiliated net investment income and investment expenses. 72
485BPOS302nd Page of 388TOC1stPreviousNextBottomJust 302nd
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 8. Investments (continued) Net Investment Gains (Losses) Components of Net Investment Gains (Losses) The components of net investment gains (losses) were as follows: [Enlarge/Download Table] Years Ended December 31, -------------------------- 2014 2013 2012 ------ ----- ----- (In millions) Total gains (losses) on fixed maturity securities: Total OTTI losses recognized -- by sector and industry: U.S. and foreign corporate securities -- by industry: Transportation..................................................... $ (2) $ (3) $(16) Consumer........................................................... (2) -- -- Finance............................................................ -- (3) (8) Utility............................................................ -- -- (4) Communications..................................................... -- -- (2) Industrial......................................................... -- -- (1) ------ ----- ----- Total U.S. and foreign corporate securities...................... (4) (6) (31) RMBS................................................................. (8) (14) (20) ------ ----- ----- OTTI losses on fixed maturity securities recognized in earnings....................................................... (12) (20) (51) Fixed maturity securities -- net gains (losses) on sales and disposals. 26 61 144 ------ ----- ----- Total gains (losses) on fixed maturity securities 14 41 93 ------ ----- ----- Total gains (losses) on equity securities: Total OTTI losses recognized -- by sector: Non-redeemable preferred stock....................................... (8) (3) -- Common stock......................................................... (7) (2) (9) ------ ----- ----- OTTI losses on equity securities recognized in earnings.......... (15) (5) (9) Equity securities -- net gains (losses) on sales and disposals......... 14 10 9 ------ ----- ----- Total gains (losses) on equity securities (1) 5 -- ------ ----- ----- Mortgage loans......................................................... 17 5 26 Real estate and real estate joint ventures............................. (4) 2 (3) Other limited partnership interests.................................... (9) (6) (2) Other investment portfolio gains (losses).............................. 43 (2) (12) ------ ----- ----- Subtotal -- investment portfolio gains (losses) 60 45 102 ------ ----- ----- FVO CSEs: Commercial mortgage loans............................................ (13) (56) 7 Long-term debt -- related to commercial mortgage loans............... 19 88 27 Non-investment portfolio gains (losses) (1)............................. (535) (50) 54 ------ ----- ----- Subtotal FVO CSEs and non-investment portfolio gains (losses) (529) (18) 88 ------ ----- ----- Total net investment gains (losses).............................. $(469) $ 27 $ 190 ====== ===== ===== -------- (1)Non-investment portfolio gains (losses) for the year ended December 31, 2014 includes a loss of $608 million related to the disposition of MAL as more fully described in Note 4. 73
485BPOS303rd Page of 388TOC1stPreviousNextBottomJust 303rd
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 8. Investments (continued) See "-- Variable Interest Entities" for discussion of CSEs. See "-- Related Party Investment Transactions" for discussion of affiliated net investment gains (losses) related to transfers of invested assets to affiliates. Gains (losses) from foreign currency transactions included within net investment gains (losses) were $66 million, ($59) million and $39 million for the years ended December 31, 2014, 2013 and 2012, respectively. Sales or Disposals and Impairments of Fixed Maturity and Equity Securities Proceeds from sales or disposals of fixed maturity and equity securities and the components of fixed maturity and equity securities net investment gains (losses) are as shown in the table below. Investment gains and losses on sales of securities are determined on a specific identification basis. [Download Table] Years Ended December 31, ------------------------------------------------- 2014 2013 2012 2014 2013 2012 -------- -------- ------- ------- ------- ------- Fixed Maturity Securities Equity Securities ------------------------- ----------------------- (In millions) Proceeds....................... $ 14,649 $ 11,719 $ 7,300 $ 57 $ 75 $ 48 ======== ======== ======= ======= ======= ======= Gross investment gains......... $ 84 $ 194 $ 189 $ 15 $ 18 $ 9 Gross investment losses........ (58) (133) (45) (1) (8) -- OTTI losses (1)................ (12) (20) (51) (15) (5) (9) -------- -------- ------- ------- ------- ------- Net investment gains (losses). $ 14 $ 41 $ 93 $ (1) $ 5 $ -- ======== ======== ======= ======= ======= ======= -------- (1)OTTI losses recognized in earnings include noncredit-related impairment losses of $0, $3 million and $8 million for the years ended December 31, 2014, 2013 and 2012, respectively, on (i) perpetual hybrid securities classified within fixed maturity securities where the primary reason for the impairment was the severity and/or the duration of an unrealized loss position and, (ii) fixed maturity securities where there is an intent to sell or it is more likely than not that the Company will be required to sell the security before recovery of the decline in estimated fair value. 74
485BPOS304th Page of 388TOC1stPreviousNextBottomJust 304th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 8. Investments (continued) Credit Loss Rollforward The table below presents a rollforward of the cumulative credit loss component of OTTI loss recognized in earnings on fixed maturity securities still held for which a portion of the OTTI loss was recognized in OCI: [Enlarge/Download Table] Years Ended December 31, --------------------------- 2014 2013 ------------- ------------- (In millions) Balance at January 1,.................................................. $ 59 $ 61 Additions: Initial impairments -- credit loss OTTI recognized on securities not previously impaired................................................. -- 1 Additional impairments -- credit loss OTTI recognized on securities previously impaired................................................. 7 12 Reductions: Sales (maturities, pay downs or prepayments) of securities previously impaired as credit loss OTTI........................................ (9) (15) ------------- ------------- Balance at December 31,................................................ $ 57 $ 59 ============= ============= Related Party Investment Transactions The Company transfers invested assets, primarily consisting of fixed maturity securities, to and from affiliates. Invested assets transferred to and from affiliates were as follows: [Enlarge/Download Table] Years Ended December 31, --------------------------- 2014 2013 2012 ---------- -------- ------- (In millions) Estimated fair value of invested assets transferred to affiliates... $ 1,441 $ 874 $ -- Amortized cost of invested assets transferred to affiliates......... $ 1,362 $ 827 $ -- Net investment gains (losses) recognized on transfers............... $ 79 $ 47 $ -- Estimated fair value of invested assets transferred from affiliates. $ 132 $ 834 $ 857 Prior to the Mergers, certain related party investment transactions were consummated as summarized below. See Note 3 for additional information on the Mergers. . In July 2014, the Company sold affiliated loans to other affiliates, which were included in other invested assets and in the table above, at estimated fair value totaling $520 million and a $45 million gain was recognized in net investment gains (losses). The affiliated loans had an unpaid principal balance of $350 million and $125 million and were due on July 15, 2021 and December 16, 2021, respectively, and bore interest, payable semi-annually, at 5.64% and 5.86%, respectively. Net investment income from these affiliated loans was $13 million, $28 million and $4 million for the years ended December 31, 2014, 2013 and 2012, respectively. . In 2013, the Company transferred invested assets to and from MLIC of $739 million and $751 million, respectively, related to the establishment of a custodial account to secure certain policyholder liabilities, which is included in the table above. 75
485BPOS305th Page of 388TOC1stPreviousNextBottomJust 305th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 8. Investments (continued) The Company has affiliated loans outstanding to wholly-owned real estate subsidiaries of an affiliate, MLIC, which are included in mortgage loans, with a carrying value of $242 million and $364 million at December 31, 2014 and 2013, respectively. A loan with a carrying value of $110 million, at both December 31, 2014 and 2013, bears interest at one-month LIBOR + 1.95% with quarterly interest only payments of $1 million through January 2015, when the principal balance is due. A loan with a carrying value of $132 million and $134 million at December 31, 2014 and 2013, respectively, bears interest at 7.26% due in quarterly principal and interest payments of $3 million through January 2020, when the principal balance is due. In November 2014, two mortgage loans with a total carrying value of $120 million were paid off early. These affiliated loans are secured by interests in the real estate subsidiaries, which own operating real estate with a fair value in excess of the loans. Net investment income from these affiliated loans was $34 million, $16 million and $17 million for the years ended December 31, 2014, 2013 and 2012, respectively. Included in net investment income for the year ended December 31, 2014, is $16 million in mortgage loan prepayment income from the two early loan payoffs described above. The Company receives investment administrative services from an affiliate. The related investment administrative service charges were $62 million, $76 million, and $78 million for years ended December 31, 2014, 2013 and 2012, respectively. The Company also had affiliated net investment income of less than $1 million, $1 million, and less than $1 million for the years ended December 31, 2014, 2013, and 2012, respectively. 9. Derivatives Accounting for Derivatives See Note 1 for a description of the Company's accounting policies for derivatives and Note 10 for information about the fair value hierarchy for derivatives. Derivative Strategies The Company is exposed to various risks relating to its ongoing business operations, including interest rate, foreign currency exchange rate, credit and equity market. The Company uses a variety of strategies to manage these risks, including the use of derivatives. Derivatives are financial instruments whose values are derived from interest rates, foreign currency exchange rates, credit spreads and/or other financial indices. Derivatives may be exchange-traded or contracted in the over-the-counter ("OTC") market. Certain of the Company's OTC derivatives are cleared and settled through central clearing counterparties ("OTC-cleared"), while others are bilateral contracts between two counterparties ("OTC-bilateral"). The types of derivatives the Company uses include swaps, forwards, futures and option contracts. To a lesser extent, the Company uses credit default swaps to synthetically replicate investment risks and returns which are not readily available in the cash market. Interest Rate Derivatives The Company uses a variety of interest rate derivatives to reduce its exposure to changes in interest rates, including interest rate swaps, caps, floors, futures and forwards. 76
485BPOS306th Page of 388TOC1stPreviousNextBottomJust 306th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Derivatives (continued) Interest rate swaps are used by the Company primarily to reduce market risks from changes in interest rates and to alter interest rate exposure arising from mismatches between assets and liabilities (duration mismatches). In an interest rate swap, the Company agrees with another party to exchange, at specified intervals, the difference between fixed rate and floating rate interest amounts as calculated by reference to an agreed notional amount. The Company utilizes interest rate swaps in fair value, cash flow and non-qualifying hedging relationships. The Company purchases interest rate caps and floors primarily to protect its floating rate liabilities against rises in interest rates above a specified level, and against interest rate exposure arising from mismatches between assets and liabilities, as well as to protect its minimum rate guarantee liabilities against declines in interest rates below a specified level, respectively. In certain instances, the Company locks in the economic impact of existing purchased caps and floors by entering into offsetting written caps and floors. The Company utilizes interest rate caps and floors in non-qualifying hedging relationships. In exchange-traded interest rate (Treasury and swap) futures transactions, the Company agrees to purchase or sell a specified number of contracts, the value of which is determined by the different classes of interest rate securities, and to post variation margin on a daily basis in an amount equal to the difference in the daily market values of those contracts. The Company enters into exchange-traded futures with regulated futures commission merchants that are members of the exchange. Exchange-traded interest rate (Treasury and swap) futures are used primarily to hedge mismatches between the duration of assets in a portfolio and the duration of liabilities supported by those assets, to hedge against changes in value of securities the Company owns or anticipates acquiring, to hedge against changes in interest rates on anticipated liability issuances by replicating Treasury or swap curve performance and to hedge minimum guarantees embedded in certain variable annuity products offered by the Company. The Company utilizes exchange-traded interest rate futures in non-qualifying hedging relationships. Swaptions are used by the Company to hedge interest rate risk associated with the Company's long-term liabilities and invested assets. A swaption is an option to enter into a swap with a forward starting effective date. In certain instances, the Company locks in the economic impact of existing purchased swaptions by entering into offsetting written swaptions. The Company pays a premium for purchased swaptions and receives a premium for written swaptions. The Company utilizes swaptions in non-qualifying hedging relationships. Swaptions are included in interest rate options. The Company enters into interest rate forwards to buy and sell securities. The price is agreed upon at the time of the contract and payment for such a contract is made at a specified future date. The Company utilizes interest rate forwards in cash flow hedging relationships. Foreign Currency Exchange Rate Derivatives The Company uses foreign currency swaps to reduce the risk from fluctuations in foreign currency exchange rates associated with its assets and liabilities denominated in foreign currencies. In a foreign currency swap transaction, the Company agrees with another party to exchange, at specified intervals, the difference between one currency and another at a fixed exchange rate, generally set at inception, calculated by reference to an agreed upon notional amount. The notional amount of each currency is exchanged at the inception and termination of the currency swap by each party. The Company utilizes foreign currency swaps in fair value, cash flow and non-qualifying hedging relationships. 77
485BPOS307th Page of 388TOC1stPreviousNextBottomJust 307th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Derivatives (continued) To a lesser extent, the Company uses foreign currency forwards and exchange-traded currency futures in non-qualifying hedging relationships. Credit Derivatives The Company enters into purchased credit default swaps to hedge against credit-related changes in the value of its investments. In a credit default swap transaction, the Company agrees with another party to pay, at specified intervals, a premium to hedge credit risk. If a credit event occurs, as defined by the contract, the contract may be cash settled or it may be settled gross by the delivery of par quantities of the referenced investment equal to the specified swap notional amount in exchange for the payment of cash amounts by the counterparty equal to the par value of the investment surrendered. Credit events vary by type of issuer but typically include bankruptcy, failure to pay debt obligations, repudiation, moratorium, involuntary restructuring or governmental intervention. In each case, payout on a credit default swap is triggered only after the Credit Derivatives Determinations Committee of the International Swaps and Derivatives Association, Inc. ("ISDA") deems that a credit event has occurred. The Company utilizes credit default swaps in non-qualifying hedging relationships. The Company enters into written credit default swaps to synthetically create credit investments that are either more expensive to acquire or otherwise unavailable in the cash markets. These transactions are a combination of a derivative and one or more cash instruments, such as U.S. Treasury securities, agency securities or other fixed maturity securities. These credit default swaps are not designated as hedging instruments. To a lesser extent, the Company uses credit forwards to lock in the price to be paid for forward purchases of certain securities. The Company utilizes credit forwards in cash flow hedging relationships. Equity Derivatives The Company uses a variety of equity derivatives to reduce its exposure to equity market risk, including equity index options, equity variance swaps, exchange-traded equity futures and total rate of return swaps ("TRRs"). Equity index options are used by the Company primarily to hedge minimum guarantees embedded in certain variable annuity products offered by the Company. To hedge against adverse changes in equity indices, the Company enters into contracts to sell the equity index within a limited time at a contracted price. The contracts will be net settled in cash based on differentials in the indices at the time of exercise and the strike price. Certain of these contracts may also contain settlement provisions linked to interest rates. In certain instances, the Company may enter into a combination of transactions to hedge adverse changes in equity indices within a pre-determined range through the purchase and sale of options. The Company utilizes equity index options in non-qualifying hedging relationships. Equity variance swaps are used by the Company primarily to hedge minimum guarantees embedded in certain variable annuity products offered by the Company. In an equity variance swap, the Company agrees with another party to exchange amounts in the future, based on changes in equity volatility over a defined period. The Company utilizes equity variance swaps in non-qualifying hedging relationships. 78
485BPOS308th Page of 388TOC1stPreviousNextBottomJust 308th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Derivatives (continued) In exchange-traded equity futures transactions, the Company agrees to purchase or sell a specified number of contracts, the value of which is determined by the different classes of equity securities, and to post variation margin on a daily basis in an amount equal to the difference in the daily market values of those contracts. The Company enters into exchange-traded futures with regulated futures commission merchants that are members of the exchange. Exchange-traded equity futures are used primarily to hedge minimum guarantees embedded in certain variable annuity products offered by the Company. The Company utilizes exchange-traded equity futures in non-qualifying hedging relationships. TRRs are swaps whereby the Company agrees with another party to exchange, at specified intervals, the difference between the economic risk and reward of an asset or a market index and the LIBOR, calculated by reference to an agreed notional amount. No cash is exchanged at the outset of the contract. Cash is paid and received over the life of the contract based on the terms of the swap. The Company uses TRRs to hedge its equity market guarantees in certain of its insurance products. TRRs can be used as hedges or to synthetically create investments. The Company utilizes TRRs in non-qualifying hedging relationships. 79
485BPOS309th Page of 388TOC1stPreviousNextBottomJust 309th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Derivatives (continued) Primary Risks Managed by Derivatives The following table presents the gross notional amount, estimated fair value and primary underlying risk exposure of the Company's derivatives, excluding embedded derivatives, held at: [Enlarge/Download Table] December 31, --------------------------------------------------------------- 2014 2013 ------------------------------- ------------------------------- Estimated Fair Value Estimated Fair Value -------------------- -------------------- Gross Gross Notional Notional Primary Underlying Risk Exposure Amount Assets Liabilities Amount Assets Liabilities -------------------------------- ---------- -------- ----------- ---------- -------- ----------- (In millions) Derivatives Designated as Hedging Instruments Fair value hedges: Interest rate swaps..... Interest rate.................... $ 379 $ 33 $ 2 $ 446 $ 5 $ 10 Foreign currency swaps.. Foreign currency exchange rate... -- -- -- 122 -- 13 ---------- -------- -------- ---------- -------- -------- Subtotal.............................................. 379 33 2 568 5 23 ---------- -------- -------- ---------- -------- -------- Cash flow hedges: Interest rate swaps..... Interest rate.................... 369 81 -- 537 6 32 Interest rate forwards.. Interest rate.................... 155 45 -- 245 3 3 Foreign currency swaps.. Foreign currency exchange rate... 728 56 9 574 26 38 ---------- -------- -------- ---------- -------- -------- Subtotal.............................................. 1,252 182 9 1,356 35 73 ---------- -------- -------- ---------- -------- -------- Total qualifying hedges............................. 1,631 215 11 1,924 40 96 ---------- -------- -------- ---------- -------- -------- Derivatives Not Designated or Not Qualifying as Hedging Instruments Interest rate swaps....... Interest rate.................... 25,919 1,709 601 46,224 1,933 1,026 Interest rate floors...... Interest rate.................... 16,404 83 69 19,644 112 103 Interest rate caps........ Interest rate.................... 7,901 11 -- 9,651 36 -- Interest rate futures..... Interest rate.................... 325 1 -- 5,905 9 9 Interest rate options..... Interest rate.................... 29,870 446 16 17,690 131 236 Foreign currency swaps.... Foreign currency exchange rate... 672 59 4 920 53 46 Foreign currency forwards. Foreign currency exchange rate... 48 3 -- 2,380 1 172 Currency futures.......... Foreign currency exchange rate... -- -- -- 365 1 1 Credit default swaps -- purchased....... Credit........................... 45 -- 1 166 -- 1 Credit default swaps -- written......... Credit........................... 1,924 29 1 2,263 38 -- Equity futures............ Equity market.................... 3,086 34 -- 5,105 1 43 Equity index options...... Equity market.................... 27,212 854 613 35,011 1,329 1,047 Equity variance swaps..... Equity market.................... 15,433 120 435 21,187 174 564 TRRs...................... Equity market.................... 2,332 12 67 3,802 -- 179 ---------- -------- -------- ---------- -------- -------- Total non-designated or non-qualifying derivatives.... 131,171 3,361 1,807 170,313 3,818 3,427 ---------- -------- -------- ---------- -------- -------- Total............................................... $ 132,802 $ 3,576 $ 1,818 $ 172,237 $ 3,858 $ 3,523 ========== ======== ======== ========== ======== ======== Based on gross notional amounts, a substantial portion of the Company's derivatives was not designated or did not qualify as part of a hedging relationship at both December 31, 2014 and 2013. The Company's use of derivatives includes (i) derivatives that serve as macro hedges of the Company's exposure to various risks and that generally do not qualify for hedge accounting due to the criteria required under the portfolio hedging rules; (ii) derivatives that economically hedge insurance liabilities that contain mortality or morbidity risk and that generally do not qualify for hedge accounting because the lack of these risks in the derivatives cannot support an expectation of a highly effective hedging relationship; (iii) derivatives that economically hedge embedded derivatives that do not qualify for hedge accounting because the changes in estimated fair value of the embedded derivatives are already recorded in net income; and (iv) written credit default swaps that are used to synthetically 80
485BPOS310th Page of 388TOC1stPreviousNextBottomJust 310th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Derivatives (continued) create credit investments and that do not qualify for hedge accounting because they do not involve a hedging relationship. For these non-qualified derivatives, changes in market factors can lead to the recognition of fair value changes on the statement of operations without an offsetting gain or loss recognized in earnings for the item being hedged. Net Derivative Gains (Losses) The components of net derivative gains (losses) were as follows: [Download Table] Years Ended December 31, -------------------------- 2014 2013 2012 -------- -------- -------- (In millions) Derivatives and hedging gains (losses) (1). $ 868 $(5,826) $(2,851) Embedded derivatives....................... (1,049) 6,267 506 -------- -------- -------- Total net derivative gains (losses)....... $ (181) $ 441 $(2,345) ======== ======== ======== -------- (1)Includes foreign currency transaction gains (losses) on hedged items in cash flow and non-qualifying hedging relationships, which are not presented elsewhere in this note. The following table presents earned income on derivatives: [Download Table] Years Ended December 31, ------------------------ 2014 2013 2012 ---- ------ ------ (In millions) Qualifying hedges: Net investment income.............................. $ 4 $ 2 $ 2 Interest credited to policyholder account balances. (1) 2 18 Non-qualifying hedges: Net derivative gains (losses)...................... 273 (157) 172 Policyholder benefits and claims................... 32 (292) (120) ---- ------ ------ Total............................................ $308 $(445) $ 72 ==== ====== ====== 81
485BPOS311th Page of 388TOC1stPreviousNextBottomJust 311th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Derivatives (continued) Non-Qualifying Derivatives and Derivatives for Purposes Other Than Hedging The following table presents the amount and location of gains (losses) recognized in income for derivatives that were not designated or qualifying as hedging instruments: [Download Table] Net Policyholder Net Derivative Investment Benefits and Gains (Losses) Income (1) Claims (2) -------------- ---------- ------------ (In millions) Year Ended December 31, 2014 Interest rate derivatives.................. $ 1,174 $ -- $ 43 Foreign currency exchange rate derivatives. 4 -- -- Credit derivatives -- purchased............ (22) -- -- Credit derivatives -- written.............. 18 -- -- Equity derivatives......................... (591) (8) (279) -------------- ---------- ------------ Total.................................... $ 583 $(8) $(236) ============== ========== ============ Year Ended December 31, 2013 Interest rate derivatives.................. $(1,534) $ -- $ (27) Foreign currency exchange rate derivatives. (542) -- -- Credit derivatives -- purchased............ -- -- -- Credit derivatives -- written.............. 27 -- -- Equity derivatives......................... (3,625) (7) (726) -------------- ---------- ------------ Total.................................... $(5,674) $(7) $(753) ============== ========== ============ Year Ended December 31, 2012 Interest rate derivatives.................. $ (208) $ -- $ -- Foreign currency exchange rate derivatives. (290) -- -- Credit derivatives -- purchased............ (12) -- -- Credit derivatives -- written.............. 42 -- -- Equity derivatives......................... (2,530) (4) (419) -------------- ---------- ------------ Total.................................... $(2,998) $(4) $(419) ============== ========== ============ -------- (1)Changes in estimated fair value related to economic hedges of equity method investments in joint ventures. (2)Changes in estimated fair value related to economic hedges of variable annuity guarantees included in future policy benefits. Fair Value Hedges The Company designates and accounts for the following as fair value hedges when they have met the requirements of fair value hedging: (i) interest rate swaps to convert fixed rate assets and liabilities to floating rate assets and liabilities; and (ii) foreign currency swaps to hedge the foreign currency fair value exposure of foreign currency denominated liabilities. 82
485BPOS312th Page of 388TOC1stPreviousNextBottomJust 312th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Derivatives (continued) The Company recognizes gains and losses on derivatives and the related hedged items in fair value hedges within net derivative gains (losses). The following table presents the amount of such net derivative gains (losses): [Enlarge/Download Table] Net Derivative Net Derivative Ineffectiveness Gains (Losses) Gains (Losses) Recognized in Derivatives in Fair Value Hedged Items in Fair Value Recognized Recognized for Net Derivative Hedging Relationships Hedging Relationships for Derivatives Hedged Items Gains (Losses) ------------------------- ----------------------------- --------------- -------------- --------------- (In millions) Year Ended December 31, 2014 Interest rate swaps: Fixed maturity securities.... $ 1 $ (1) $ -- Policyholder liabilities (1). 32 (31) 1 Foreign currency swaps: Foreign-denominated PABs (2). -- -- -- ------------ ------------- -------------- Total............................................... $ 33 $ (32) $ 1 ============ ============= ============== Year Ended December 31, 2013 Interest rate swaps: Fixed maturity securities.... $ 7 $ (9) $ (2) Policyholder liabilities (1). (30) 28 (2) Foreign currency swaps: Foreign-denominated PABs (2). 2 (2) -- ------------ ------------- -------------- Total............................................... $ (21) $ 17 $ (4) ============ ============= ============== Year Ended December 31, 2012 Interest rate swaps: Fixed maturity securities.... $ (3) $ 1 $ (2) Policyholder liabilities (1). (10) 8 (2) Foreign currency swaps: Foreign-denominated PABs (2). (29) 20 (9) ------------ ------------- -------------- Total............................................... $ (42) $ 29 $ (13) ============ ============= ============== -------- (1)Fixed rate liabilities reported in PABs or future policy benefits. (2)Fixed rate or floating rate liabilities. All components of each derivative's gain or loss were included in the assessment of hedge effectiveness. Cash Flow Hedges The Company designates and accounts for the following as cash flow hedges when they have met the requirements of cash flow hedging: (i) interest rate swaps to convert floating rate assets and liabilities to fixed rate assets and liabilities; (ii) foreign currency swaps to hedge the foreign currency cash flow exposure of foreign currency denominated assets and liabilities; (iii) interest rate forwards and credit forwards to lock in the price to be paid for forward purchases of investments; and (iv) interest rate swaps and interest rate forwards to hedge the forecasted purchases of fixed-rate investments. In certain instances, the Company discontinued cash flow hedge accounting because the forecasted transactions were no longer probable of occurring. Because certain of the forecasted transactions also were not probable of occurring within two months of the anticipated date, the Company reclassified certain amounts from AOCI into net derivative gains (losses). These amounts were not significant for both years ended December 31, 2014 and 2013 and $0 for the year ended December 31, 2012. At December 31, 2014 and 2013, the maximum length of time over which the Company was hedging its exposure to variability in future cash flows for forecasted transactions did not exceed five years and six years, respectively. 83
485BPOS313th Page of 388TOC1stPreviousNextBottomJust 313th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Derivatives (continued) At December 31, 2014 and 2013, the balance in AOCI associated with cash flow hedges was $282 million and $38 million, respectively. The following table presents the effects of derivatives in cash flow hedging relationships on the consolidated statements of operations and the consolidated statements of stockholder's equity: [Enlarge/Download Table] Amount and Location Amount and Location Amount of Gains of Gains (Losses) of Gains (Losses) Derivatives in Cash Flow (Losses) Deferred in Reclassified from Recognized in Income Hedging Relationships AOCI on Derivatives AOCI into Income (Loss) (Loss) on Derivatives ------------------------ -------------------- ----------------------------- ----------------------- (Effective Portion) (Effective Portion) (Ineffective Portion) -------------------- ----------------------------- ----------------------- Net Derivative Net Investment Net Derivative Gains (Losses) Income Gains (Losses) -------------- -------------- ----------------------- (In millions) Year Ended December 31, 2014 Interest rate swaps...... $ 131 $ 1 $ 1 $ -- Interest rate forwards... 55 1 1 -- Foreign currency swaps... 56 (6) -- -- Credit forwards.......... -- -- -- -- ---------------- ----------- ------------ ----------------------- Total.................. $ 242 $ (4) $ 2 $ -- ================ =========== ============ ======================= Year Ended December 31, 2013 Interest rate swaps...... $ (120) $ -- $ 1 $ -- Interest rate forwards... (57) 9 1 -- Foreign currency swaps... (17) -- -- 1 Credit forwards.......... (1) -- -- -- ---------------- ----------- ------------ ----------------------- Total.................. $ (195) $ 9 $ 2 $ 1 ================ =========== ============ ======================= Year Ended December 31, 2012 Interest rate swaps...... $ 21 $ -- $ -- $ 1 Interest rate forwards... 1 1 1 -- Foreign currency swaps... (16) 1 -- (1) Credit forwards.......... -- -- -- -- ---------------- ----------- ------------ ----------------------- Total.................. $ 6 $ 2 $ 1 $ -- ================ =========== ============ ======================= All components of each derivative's gain or loss were included in the assessment of hedge effectiveness. At December 31, 2014, $13 million of deferred net gains (losses) on derivatives in AOCI was expected to be reclassified to earnings within the next 12 months. Credit Derivatives In connection with synthetically created credit investment transactions, the Company writes credit default swaps for which it receives a premium to insure credit risk. Such credit derivatives are included within the non-qualifying derivatives and derivatives for purposes other than hedging table. If a credit event occurs, as defined by the contract, the contract may be cash settled or it may be settled gross by the Company paying the counterparty the specified swap notional amount in exchange for the delivery of par quantities of the referenced credit obligation. The Company's maximum amount at risk, assuming the value of all referenced credit obligations is zero, was $1.9 billion and $2.3 billion at December 31, 2014 and 2013, respectively. The Company can terminate these contracts at any time through cash settlement with the counterparty at an amount equal to the then current fair value of the credit default swaps. At December 31, 2014 and 2013, the Company would have received $28 million and $38 million, respectively, to terminate all of these contracts. 84
485BPOS314th Page of 388TOC1stPreviousNextBottomJust 314th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Derivatives (continued) The following table presents the estimated fair value, maximum amount of future payments and weighted average years to maturity of written credit default swaps at: [Enlarge/Download Table] December 31, --------------------------------------------------------------------------------- 2014 2013 ---------------------------------------- ---------------------------------------- Estimated Maximum Estimated Maximum Fair Value Amount of Future Weighted Fair Value Amount of Future Weighted Rating Agency Designation of of Credit Payments under Average of Credit Payments under Average Referenced Default Credit Default Years to Default Credit Default Years to Credit Obligations (1) Swaps Swaps (2) Maturity (3) Swaps Swaps (2) Maturity (3) ---------------------------- ---------- ---------------- ------------ ---------- ---------------- ------------ (In millions) (In millions) Aaa/Aa/A..................... Single name credit default swaps (corporate).......... $ 2 $ 155 2.1 $ 2 $ 115 2.7 Credit default swaps referencing indices........ 1 134 1.3 6 650 1.1 --------- ------------- --------- -------------- Subtotal.................... 3 289 1.7 8 765 1.3 --------- ------------- --------- -------------- Baa Single name credit default swaps (corporate).......... 5 454 2.3 8 446 3.0 Credit default swaps referencing indices........ 18 1,145 5.0 19 1,016 4.9 --------- ------------- --------- -------------- Subtotal.................... 23 1,599 4.2 27 1,462 4.3 --------- ------------- --------- -------------- B Single name credit default swaps (corporate).......... -- -- -- -- -- -- Credit default swaps referencing indices........ 2 36 5.0 3 36 5.0 --------- ------------- --------- -------------- Subtotal.................... 2 36 5.0 3 36 5.0 --------- ------------- --------- -------------- Total..................... $ 28 $ 1,924 3.8 $ 38 $ 2,263 3.3 ========= ============= ========= ============== -------- (1)The rating agency designations are based on availability and the midpoint of the applicable ratings among Moody's Investors Service ("Moody's"), S&P and Fitch Ratings. If no rating is available from a rating agency, then an internally developed rating is used. (2)Assumes the value of the referenced credit obligations is zero. (3)The weighted average years to maturity of the credit default swaps is calculated based on weighted average gross notional amounts. Credit Risk on Freestanding Derivatives The Company may be exposed to credit-related losses in the event of nonperformance by counterparties to derivatives. Generally, the current credit exposure of the Company's derivatives is limited to the net positive 85
485BPOS315th Page of 388TOC1stPreviousNextBottomJust 315th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Derivatives (continued) estimated fair value of derivatives at the reporting date after taking into consideration the existence of master netting or similar agreements and any collateral received pursuant to such agreements. The Company manages its credit risk related to derivatives by entering into transactions with creditworthy counterparties and establishing and monitoring exposure limits. The Company's OTC-bilateral derivative transactions are generally governed by ISDA Master Agreements which provide for legally enforceable set-off and close-out netting of exposures to specific counterparties in the event of early termination of a transaction, which includes, but is not limited to, events of default and bankruptcy. In the event of an early termination, the Company is permitted to set off receivables from the counterparty against payables to the same counterparty arising out of all included transactions. Substantially all of the Company's ISDA Master Agreements also include Credit Support Annex provisions which require both the pledging and accepting of collateral in connection with its OTC-bilateral derivatives. The Company's OTC-cleared derivatives are effected through central clearing counterparties and its exchange-traded derivatives are effected through regulated exchanges. Such positions are marked to market and margined on a daily basis (both initial margin and variation margin), and the Company has minimal exposure to credit-related losses in the event of nonperformance by counterparties to such derivatives. See Note 10 for a description of the impact of credit risk on the valuation of derivatives. 86
485BPOS316th Page of 388TOC1stPreviousNextBottomJust 316th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Derivatives (continued) The estimated fair values of the Company's net derivative assets and net derivative liabilities after the application of master netting agreements and collateral were as follows at: [Enlarge/Download Table] December 31, 2014 December 31, 2013 Derivatives Subject to a Master Netting Arrangement or a Similar -------------------- -------------------- Arrangement Assets Liabilities Assets Liabilities ---------------------------------------------------------------- -------- ----------- -------- ----------- (In millions) Gross estimated fair value of derivatives: OTC-bilateral (1).............................................. $ 3,554 $ 1,767 $ 3,905 $ 3,476 OTC-cleared (1)................................................ 75 73 50 10 Exchange-traded................................................ 35 -- 11 53 -------- -------- -------- -------- Total gross estimated fair value of derivatives (1).......... 3,664 1,840 3,966 3,539 Amounts offset on the consolidated balance sheets............... -- -- -- -- -------- -------- -------- -------- Estimated fair value of derivatives presented on the consolidated balance sheets (1)............................... 3,664 1,840 3,966 3,539 Gross amounts not offset on the consolidated balance sheets: Gross estimated fair value of derivatives: (2) OTC-bilateral.................................................. (1,592) (1,592) (2,544) (2,544) OTC-cleared.................................................... (54) (54) (8) (8) Exchange-traded................................................ -- -- (5) (5) Cash collateral: (3), (4) OTC-bilateral.................................................. (753) -- (396) -- OTC-cleared.................................................... (21) (18) (40) (2) Exchange-traded................................................ -- -- -- (44) Securities collateral: (5) OTC-bilateral.................................................. (1,152) (175) (934) (833) OTC-cleared.................................................... -- -- -- -- Exchange-traded................................................ -- -- -- (3) -------- -------- -------- -------- Net amount after application of master netting agreements and collateral.................................................... $ 92 $ 1 $ 39 $ 100 ======== ======== ======== ======== -------- (1)At December 31, 2014 and 2013, derivative assets include income or expense accruals reported in accrued investment income or in other liabilities of $88 million and $108 million, respectively, and derivative liabilities include income or expense accruals reported in accrued investment income or in other liabilities of $22 million and $16 million, respectively. (2)Estimated fair value of derivatives is limited to the amount that is subject to set-off and includes income or expense accruals. (3)Cash collateral received by the Company for OTC-bilateral and OTC-cleared derivatives is included in cash and cash equivalents, short-term investments or in fixed maturity securities, and the obligation to return it is included in payables for collateral under securities loaned and other transactions on the balance sheet. In certain instances, cash collateral pledged to the Company as initial margin for OTC-bilateral derivatives is 87
485BPOS317th Page of 388TOC1stPreviousNextBottomJust 317th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Derivatives (continued) held in separate custodial accounts and is not recorded on the Company's balance sheet because the account title is in the name of the counterparty (but segregated for the benefit of the Company). The amount of this off-balance sheet collateral was $121 million and $0 at December 31, 2014 and 2013, respectively. (4)The receivable for the return of cash collateral provided by the Company is inclusive of initial margin on exchange-traded and OTC-cleared derivatives and is included in premiums, reinsurance and other receivables on the balance sheet. The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements. At December 31, 2014 and 2013, the Company received excess cash collateral of $33 million (all of which is off-balance sheet cash collateral held in separate custodial accounts) and $54 million, respectively, and provided excess cash collateral of $30 million and $204 million, respectively, which is not included in the table above due to the foregoing limitation. (5)Securities collateral received by the Company is held in separate custodial accounts and is not recorded on the balance sheet. Subject to certain constraints, the Company is permitted by contract to sell or re-pledge this collateral, but at December 31, 2014 none of the collateral had been sold or re-pledged. Securities collateral pledged by the Company is reported in fixed maturity securities on the balance sheet. Subject to certain constraints, the counterparties are permitted by contract to sell or re-pledge this collateral. The amount of securities collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements and cash collateral. At December 31, 2014 and 2013, the Company received excess securities collateral with an estimated fair value of $122 million and $131 million, respectively, for its OTC-bilateral derivatives, which are not included in the table above due to the foregoing limitation. At December 31, 2014 and 2013, the Company provided excess securities collateral with an estimated fair value of $17 million and $1 million, respectively, for its OTC-bilateral derivatives, $37 million and $30 million, respectively, for its OTC-cleared derivatives and $165 million and $81 million, respectively, for its exchange-traded derivatives, which are not included in the table above due to the foregoing limitation. The Company's collateral arrangements for its OTC-bilateral derivatives generally require the counterparty in a net liability position, after considering the effect of netting agreements, to pledge collateral when the fair value of that counterparty's derivatives reaches a pre-determined threshold. Certain of these arrangements also include financial strength-contingent provisions that provide for a reduction of these thresholds (on a sliding scale that converges toward zero) in the event of downgrades in the financial strength ratings of the Company and/or the credit ratings of the counterparty. In addition, certain of the Company's netting agreements for derivatives contain provisions that require both the Company and the counterparty to maintain a specific investment grade financial strength or credit rating from each of Moody's and S&P. If a party's financial strength or credit ratings were to fall below that specific investment grade financial strength or credit rating, that party would be in violation of these provisions, and the other party to the derivatives could terminate the transactions and demand immediate settlement and payment based on such party's reasonable valuation of the derivatives. The following table presents the estimated fair value of the Company's OTC-bilateral derivatives that are in a net liability position after considering the effect of netting agreements, together with the estimated fair value and balance sheet location of the collateral pledged. The table also presents the incremental collateral that the Company would be required to provide if there was a one notch downgrade in the Company's financial strength rating at the reporting date or if the Company's financial strength rating sustained a downgrade to a level that 88
485BPOS318th Page of 388TOC1stPreviousNextBottomJust 318th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Derivatives (continued) triggered full overnight collateralization or termination of the derivative position at the reporting date. OTC-bilateral derivatives that are not subject to collateral agreements are excluded from this table. [Enlarge/Download Table] Estimated Fair Value of Collateral Provided Fair Value of Incremental Collateral Provided Upon ------------------- -------------------------------------------------- Downgrade in the Company's Financial Strength Rating One Notch to a Level that Estimated Downgrade in Triggers Full Overnight Fair Value of the Company's Collateralization or Derivatives in Net Fixed Maturity Financial Strength Termination of Liability Position (1) Securities Rating the Derivative Position ---------------------- ------------------- ------------------ -------------------------- (In millions) December 31, 2014 $ 175 $ 192 $ -- $ -- December 31, 2013 $ 932 $ 834 $ 21 $ 24 -------- (1)After taking into consideration the existence of netting agreements. Embedded Derivatives The Company issues certain products or purchases certain investments that contain embedded derivatives that are required to be separated from their host contracts and accounted for as freestanding derivatives. These host contracts principally include: variable annuities with guaranteed minimum benefits, including GMWBs, GMABs and certain GMIBs; affiliated ceded reinsurance of guaranteed minimum benefits related to GMWBs, GMABs and certain GMIBs; affiliated assumed reinsurance of guaranteed minimum benefits related to GMWBs and certain GMIBs; funds withheld on ceded reinsurance; fixed annuities with equity indexed returns; and certain debt and equity securities. The following table presents the estimated fair value and balance sheet location of the Company's embedded derivatives that have been separated from their host contracts at: [Download Table] December 31, ----------------- Balance Sheet Location 2014 2013 -------------------------- ------- --------- (In millions) Net embedded derivatives within asset host contracts: Ceded guaranteed minimum benefits... Premiums, reinsurance and other receivables......... $ 217 $ 123 Funds withheld on assumed reinsurance........................ Other invested assets..... 53 24 Options embedded in debt or equity securities......................... Investments............... (48) (30) ------- --------- Net embedded derivatives within asset host contracts....... $ 222 $ 117 ======= ========= Net embedded derivatives within liability host contracts: Direct guaranteed minimum benefits.. PABs...................... $ (609) $ (1,369) Assumed guaranteed minimum benefits. PABs...................... 827 1,188 Funds withheld on ceded reinsurance. Other liabilities......... 382 34 Other............................... PABs...................... 17 6 ------- --------- Net embedded derivatives within liability host contracts... $ 617 $ (141) ======= ========= 89
485BPOS319th Page of 388TOC1stPreviousNextBottomJust 319th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 9. Derivatives (continued) The following table presents changes in estimated fair value related to embedded derivatives: [Download Table] Years Ended December 31, --------------------------------- 2014 2013 2012 ----------- ---------- ---------- (In millions) Net derivative gains (losses) (1) (2). $ (1,049) $ 6,267 $ 506 Policyholder benefits and claims...... $ 87 $ (139) $ 71 -------- (1)The valuation of direct and assumed guaranteed minimum benefits includes a nonperformance risk adjustment. The amounts included in net derivative gains (losses), in connection with this adjustment, were $73 million, ($1.0) billion and ($1.7) billion for the years ended December 31, 2014, 2013 and 2012, respectively. (2)See Note 7 for discussion of affiliated net derivative gains (losses) included in the table above. Related Party Freestanding Derivative Transactions In November 2014, as part of the settlement of related party reinsurance transactions, the Company transferred derivatives to affiliates. The estimated fair value of freestanding derivative assets and liabilities transferred was $1.8 billion and $1.2 billion, respectively. See Note 7 for additional information regarding related party reinsurance transactions in connection with the Mergers. 10. Fair Value When developing estimated fair values, the Company considers three broad valuation techniques: (i) the market approach, (ii) the income approach, and (iii) the cost approach. The Company determines the most appropriate valuation technique to use, given what is being measured and the availability of sufficient inputs, giving priority to observable inputs. The Company categorizes its assets and liabilities measured at estimated fair value into a three-level hierarchy, based on the significant input with the lowest level in its valuation. The input levels are as follows: Level 1 Unadjusted quoted prices in active markets for identical assets or liabilities. The Company defines active markets based on average trading volume for equity securities. The size of the bid/ask spread is used as an indicator of market activity for fixed maturity securities. Level 2 Quoted prices in markets that are not active or inputs that are observable either directly or indirectly. These inputs can include quoted prices for similar assets or liabilities other than quoted prices in Level 1, quoted prices in markets that are not active, or other significant inputs that are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 Unobservable inputs that are supported by little or no market activity and are significant to the determination of estimated fair value of the assets or liabilities. Unobservable inputs reflect the reporting entity's own assumptions about the assumptions that market participants would use in pricing the asset or liability. 90
485BPOS320th Page of 388TOC1stPreviousNextBottomJust 320th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 10. Fair Value (continued) Financial markets are susceptible to severe events evidenced by rapid depreciation in asset values accompanied by a reduction in asset liquidity. The Company's ability to sell securities, or the price ultimately realized for these securities, depends upon the demand and liquidity in the market and increases the use of judgment in determining the estimated fair value of certain securities. Considerable judgment is often required in interpreting market data to develop estimates of fair value, and the use of different assumptions or valuation methodologies may have a material effect on the estimated fair value amounts. 91
485BPOS321st Page of 388TOC1stPreviousNextBottomJust 321st
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 10. Fair Value (continued) Recurring Fair Value Measurements The assets and liabilities measured at estimated fair value on a recurring basis and their corresponding placement in the fair value hierarchy, including those items for which the Company has elected the FVO, are presented below. [Enlarge/Download Table] December 31, 2014 --------------------------------------------- Fair Value Hierarchy ----------------------------- Total Estimated Level 1 Level 2 Level 3 Fair Value --------- ---------- -------- --------------- (In millions) Assets Fixed maturity securities: U.S. corporate............................................. $ -- $ 15,447 $ 1,355 $ 16,802 U.S. Treasury and agency................................... 10,226 5,600 -- 15,826 RMBS....................................................... -- 5,365 716 6,081 Foreign corporate.......................................... -- 4,704 710 5,414 State and political subdivision............................ -- 2,592 -- 2,592 CMBS....................................................... -- 1,531 148 1,679 ABS........................................................ -- 1,381 181 1,562 Foreign government......................................... -- 741 -- 741 --------- ---------- -------- ---------- Total fixed maturity securities........................... 10,226 37,361 3,110 50,697 --------- ---------- -------- ---------- Equity securities: Common stock............................................... 105 99 29 233 Non-redeemable preferred stock............................. -- 155 71 226 --------- ---------- -------- ---------- Total equity securities................................... 105 254 100 459 --------- ---------- -------- ---------- Short-term investments (1)................................... 253 812 71 1,136 Mortgage loans held by CSEs -- FVO........................... -- 280 -- 280 Other invested assets: FVO securities............................................. -- -- -- -- Derivative assets: (2) Interest rate............................................. 1 2,363 45 2,409 Foreign currency exchange rate............................ -- 118 -- 118 Credit.................................................... -- 28 1 29 Equity market............................................. 34 770 216 1,020 --------- ---------- -------- ---------- Total derivative assets................................. 35 3,279 262 3,576 --------- ---------- -------- ---------- Total other invested assets............................ 35 3,279 262 3,576 --------- ---------- -------- ---------- Net embedded derivatives within asset host contracts (3)..... -- -- 270 270 Separate account assets (4).................................. 249 108,454 158 108,861 --------- ---------- -------- ---------- Total assets........................................... $ 10,868 $ 150,440 $ 3,971 $ 165,279 ========= ========== ======== ========== Liabilities Derivative liabilities: (2) Interest rate.............................................. $ -- $ 688 $ -- $ 688 Foreign currency exchange rate............................. -- 13 -- 13 Credit..................................................... -- 2 -- 2 Equity market.............................................. -- 657 458 1,115 --------- ---------- -------- ---------- Total derivative liabilities.............................. -- 1,360 458 1,818 --------- ---------- -------- ---------- Net embedded derivatives within liability host contracts (3). -- -- 617 617 Long-term debt of CSEs -- FVO................................ -- 139 -- 139 --------- ---------- -------- ---------- Total liabilities...................................... $ -- $ 1,499 $ 1,075 $ 2,574 ========= ========== ======== ========== 92
485BPOS322nd Page of 388TOC1stPreviousNextBottomJust 322nd
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 10. Fair Value (continued) [Enlarge/Download Table] December 31, 2013 -------------------------------------------- Fair Value Hierarchy ---------------------------- Total Estimated Level 1 Level 2 Level 3 Fair Value -------- ---------- -------- --------------- (In millions) Assets Fixed maturity securities: U.S. corporate............................................. $ -- $ 16,568 $ 1,270 $ 17,838 U.S. Treasury and agency................................... 4,872 3,979 -- 8,851 RMBS....................................................... -- 4,613 450 5,063 Foreign corporate.......................................... -- 8,500 779 9,279 State and political subdivision............................ -- 2,363 -- 2,363 CMBS....................................................... -- 1,904 129 2,033 ABS........................................................ -- 1,809 426 2,235 Foreign government......................................... -- 1,162 -- 1,162 -------- ---------- -------- ----------- Total fixed maturity securities.......................... 4,872 40,898 3,054 48,824 -------- ---------- -------- ----------- Equity securities: Common stock............................................... 86 110 31 227 Non-redeemable preferred stock............................. -- 136 100 236 -------- ---------- -------- ----------- Total equity securities.................................. 86 246 131 463 -------- ---------- -------- ----------- Short-term investments (1)................................... 3,036 1,833 -- 4,869 Mortgage loans held by CSEs -- FVO........................... -- 1,598 -- 1,598 Other invested assets: FVO securities............................................. -- 9 -- 9 Derivative assets: (2) Interest rate............................................ 10 2,202 23 2,235 Foreign currency exchange rate........................... 1 80 -- 81 Credit................................................... -- 32 6 38 Equity market............................................ 1 1,223 280 1,504 -------- ---------- -------- ----------- Total derivative assets................................. 12 3,537 309 3,858 -------- ---------- -------- ----------- Total other invested assets........................... 12 3,546 309 3,867 -------- ---------- -------- ----------- Net embedded derivatives within asset host contracts (3)..... -- -- 147 147 Separate account assets (4).................................. 259 109,402 153 109,814 -------- ---------- -------- ----------- Total assets.......................................... $ 8,265 $ 157,523 $ 3,794 $ 169,582 ======== ========== ======== =========== Liabilities Derivative liabilities: (2) Interest rate.............................................. $ 9 $ 1,398 $ 12 $ 1,419 Foreign currency exchange rate............................. 1 269 -- 270 Credit..................................................... -- 1 -- 1 Equity market.............................................. 43 1,201 589 1,833 -------- ---------- -------- ----------- Total derivative liabilities............................. 53 2,869 601 3,523 -------- ---------- -------- ----------- Net embedded derivatives within liability host contracts (3). -- -- (141) (141) Long-term debt of CSEs -- FVO................................ -- 1,461 -- 1,461 -------- ---------- -------- ----------- Total liabilities..................................... $ 53 $ 4,330 $ 460 $ 4,843 ======== ========== ======== =========== 93
485BPOS323rd Page of 388TOC1stPreviousNextBottomJust 323rd
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 10. Fair Value (continued) -------- (1)Short-term investments as presented in the tables above differ from the amounts presented on the consolidated balance sheets because certain short-term investments are not measured at estimated fair value on a recurring basis. (2)Derivative assets are presented within other invested assets on the consolidated balance sheets and derivative liabilities are presented within other liabilities on the consolidated balance sheets. The amounts are presented gross in the tables above to reflect the presentation on the consolidated balance sheets, but are presented net for purposes of the rollforward in the Fair Value Measurements Using Significant Unobservable Inputs (Level 3) tables. (3)Net embedded derivatives within asset host contracts are presented primarily within premiums, reinsurance and other receivables on the consolidated balance sheets. Net embedded derivatives within liability host contracts are presented primarily within PABs and other liabilities on the consolidated balance sheets. At December 31, 2014 and 2013, equity securities also included embedded derivatives of ($48) million and ($30) million, respectively. (4)Investment performance related to separate account assets is fully offset by corresponding amounts credited to contractholders whose liability is reflected within separate account liabilities. Separate account liabilities are set equal to the estimated fair value of separate account assets. The following describes the valuation methodologies used to measure assets and liabilities at fair value. The description includes the valuation techniques and key inputs for each category of assets or liabilities that are classified within Level 2 and Level 3 of the fair value hierarchy. Investments Valuation Controls and Procedures On behalf of the Company and MetLife, Inc.'s Chief Investment Officer and Chief Financial Officer, a pricing and valuation committee that is independent of the trading and investing functions and comprised of senior management, provides oversight of control systems and valuation policies for securities, mortgage loans and derivatives. On a quarterly basis, this committee reviews and approves new transaction types and markets, ensures that observable market prices and market-based parameters are used for valuation, wherever possible, and determines that judgmental valuation adjustments, when applied, are based upon established policies and are applied consistently over time. This committee also provides oversight of the selection of independent third party pricing providers and the controls and procedures to evaluate third party pricing. Periodically, the Chief Accounting Officer reports to MetLife Insurance Company USA's Audit Committee regarding compliance with fair value accounting standards. The Company reviews its valuation methodologies on an ongoing basis and revises those methodologies when necessary based on changing market conditions. Assurance is gained on the overall reasonableness and consistent application of input assumptions, valuation methodologies and compliance with fair value accounting standards through controls designed to ensure valuations represent an exit price. Several controls are utilized, including certain monthly controls, which include, but are not limited to, analysis of portfolio returns to corresponding benchmark returns, comparing a sample of executed prices of securities sold to the 94
485BPOS324th Page of 388TOC1stPreviousNextBottomJust 324th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 10. Fair Value (continued) fair value estimates, comparing fair value estimates to management's knowledge of the current market, reviewing the bid/ask spreads to assess activity, comparing prices from multiple independent pricing services and ongoing due diligence to confirm that independent pricing services use market-based parameters. The process includes a determination of the observability of inputs used in estimated fair values received from independent pricing services or brokers by assessing whether these inputs can be corroborated by observable market data. The Company ensures that prices received from independent brokers, also referred to herein as "consensus pricing," represent a reasonable estimate of fair value by considering such pricing relative to the Company's knowledge of the current market dynamics and current pricing for similar financial instruments. While independent non-binding broker quotations are utilized, they are not used for a significant portion of the portfolio. For example, fixed maturity securities priced using independent non-binding broker quotations represent 1% of the total estimated fair value of fixed maturity securities and 16% of the total estimated fair value of Level 3 fixed maturity securities. The Company also applies a formal process to challenge any prices received from independent pricing services that are not considered representative of estimated fair value. If prices received from independent pricing services are not considered reflective of market activity or representative of estimated fair value, independent non-binding broker quotations are obtained, or an internally developed valuation is prepared. Internally developed valuations of current estimated fair value, which reflect internal estimates of liquidity and nonperformance risks, compared with pricing received from the independent pricing services, did not produce material differences in the estimated fair values for the majority of the portfolio; accordingly, overrides were not material. This is, in part, because internal estimates of liquidity and nonperformance risks are generally based on available market evidence and estimates used by other market participants. In the absence of such market-based evidence, management's best estimate is used. Securities, Short-term Investments and Long-term Debt of CSEs -- FVO When available, the estimated fair value of these financial instruments is based on quoted prices in active markets that are readily and regularly obtainable. Generally, these are the most liquid of the Company's securities holdings and valuation of these securities does not involve management's judgment. When quoted prices in active markets are not available, the determination of estimated fair value is based on market standard valuation methodologies, giving priority to observable inputs. The significant inputs to the market standard valuation methodologies for certain types of securities with reasonable levels of price transparency are inputs that are observable in the market or can be derived principally from, or corroborated by, observable market data. When observable inputs are not available, the market standard valuation methodologies rely on inputs that are significant to the estimated fair value that are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. These unobservable inputs can be based in large part on management's judgment or estimation and cannot be supported by reference to market activity. Even though these inputs are unobservable, management believes they are consistent with what other market participants would use when pricing such securities and are considered appropriate given the circumstances. The estimated fair value of long-term debt of CSEs -- FVO is determined on a basis consistent with the methodologies described herein for securities. 95
485BPOS325th Page of 388TOC1stPreviousNextBottomJust 325th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 10. Fair Value (continued) The valuation of most instruments listed below are determined using independent pricing sources, matrix pricing, discounted cash flow methodologies or other similar techniques that use either observable market inputs or unobservable inputs. [Enlarge/Download Table] Instrument Level 2 Level 3 Observable Inputs Unobservable Inputs ------------------------------------------------------------------------------------------------------------------------------------ Fixed Maturity Securities ------------------------------------------------------------------------------------------------------------------------------------ U.S. corporate and foreign corporate securities ------------------------------------------------------------------------------------------------------------------------------------ Valuation Techniques: Principally the market and income Valuation Techniques: Principally the market approaches. approach. Key Inputs: Key Inputs: . quoted prices in markets that are not active . illiquidity premium . benchmark yields . delta spread adjustments to reflect specific . spreads off benchmark yields credit-related issues . new issuances . credit spreads . issuer rating . quoted prices in markets that are not active for . duration identical or similar securities that are less liquid . trades of identical or comparable securities and based on lower levels of trading activity than . Privately-placed securities are valued using the securities classified in Level 2 additional key inputs: . independent non-binding broker quotations . market yield curve . call provisions . observable prices and spreads for similar publicly traded or privately traded securities that incorporate the credit quality and industry sector of the issuer . delta spread adjustments to reflect specific credit- related issues ------------------------------------------------------------------------------------------------------------------------------------ Foreign government, U.S. Treasury and agency and state and political subdivision securities ------------------------------------------------------------------------------------------------------------------------------------ Valuation Techniques: Principally the market approach. Valuation Techniques: Principally the market approach. Key Inputs: Key Inputs: . quoted prices in markets that are not active . independent non-binding broker quotations . benchmark U.S. Treasury yield or other yields . quoted prices in markets that are not active for . the spread off the U.S. Treasury yield curve for the identical or similar securities that are less identical security liquid land based on ower levels of trading activity . issuer ratings and issuer spreads cthan securities lassified in Level 2 . broker-dealer quotes . credit spreads . comparable securities that are actively traded . reported trades of similar securities, including those that are actively traded, and those within the same sub- sector or with a similar maturity or credit rating ------------------------------------------------------------------------------------------------------------------------------------ Structured securities comprised of RMBS, CMBS and ABS ------------------------------------------------------------------------------------------------------------------------------------ Valuation Techniques: Principally the market and income Valuation Techniques: Principally the market and income approaches. approaches. Key Inputs: Key Inputs: . quoted prices in markets that are not active . credit spreads . spreads for actively traded securities . quoted prices in markets that are not active for . spreads off benchmark yields identical or similar securities that are less liquid . expected prepayment speeds and volumes and based on lower levels of trading activity than . current and forecasted loss severity securities classified in Level 2 . ratings . independent non-binding broker quotations . weighted average coupon and weighted average maturity . average delinquency rates . geographic region . debt-service coverage ratios . issuance-specific information, including, but not limited to: . collateral type . payment terms of the underlying assets . payment priority within the tranche . structure of the security . deal performance . vintage of loans 96
485BPOS326th Page of 388TOC1stPreviousNextBottomJust 326th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 10. Fair Value (continued) [Enlarge/Download Table] Instrument Level 2 Level 3 ------------------------------------------------------------------------------------------------------------------------------------ Equity Securities ------------------------------------------------------------------------------------------------------------------------------------ Common and non-redeemable preferred stock ------------------------------------------------------------------------------------------------------------------------------------ Valuation Techniques: Principally the market Valuation Techniques: Principally the market and income approach. approaches. Key Input: Key Inputs: . quoted prices in markets that are not considered active . credit ratings . issuance structures . quoted prices in markets that are not active for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2 . independent non-binding broker quotations ------------------------------------------------------------------------------------------------------------------------------------ FVO securities and Short-term investments ------------------------------------------------------------------------------------------------------------------------------------ . FVO securities and short-term investments are of a . Short-term investments are of a similar nature and class similar nature and class to the fixed maturity and to the fixed maturity and equity securities described equity securities described above; accordingly, the above; accordingly, the valuation techniques and valuation techniques and observable inputs used in unobservable inputs used in their valuation are also their valuation are also similar to those described similar to those described above. above. ------------------------------------------------------------------------------------------------------------------------------------ Mortgage loans held by CSEs -- FVO ------------------------------------------------------------------------------------------------------------------------------------ Valuation Techniques: Principally the market approach. N/A Key Input: . quoted securitization market price of the obligations of the CSEs determined principally by independent pricing services using observable inputs ------------------------------------------------------------------------------------------------------------------------------------ Separate Account Assets (1) ------------------------------------------------------------------------------------------------------------------------------------ Mutual funds without readily determinable fair values as prices are not published publicly ------------------------------------------------------------------------------------------------------------------------------------ Key Input: . quoted prices or reported NAV provided by the fund managers N/A ------------------------------------------------------------------------------------------------------------------------------------ Other limited partnership interests ------------------------------------------------------------------------------------------------------------------------------------ N/A Valuation Techniques: Valued giving consideration to the underlying holdings of the partnerships and by applying a premium or discount, if appropriate. Key Inputs: . liquidity . bid/ask spreads . the performance record of the fund manager . other relevant variables that may impact the exit value of the particular partnership interest -------- (1)Estimated fair value equals carrying value, based on the value of the underlying assets, including: mutual fund interests, fixed maturity securities, equity securities, derivatives, other limited partnership interests, short-term investments and cash and cash equivalents. Fixed maturity securities, equity securities, derivatives, short-term investments and cash and cash equivalents are similar in nature to the instruments described under "-- Securities, Short-term Investments and Long-term Debt of CSEs -- FVO" and "-- Derivatives -- Freestanding Derivatives Valuation Techniques and Key Inputs." Derivatives The estimated fair value of derivatives is determined through the use of quoted market prices for exchange-traded derivatives, or through the use of pricing models for OTC-bilateral and OTC-cleared derivatives. The determination of estimated fair value, when quoted market values are not available, is based on market standard 97
485BPOS327th Page of 388TOC1stPreviousNextBottomJust 327th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 10. Fair Value (continued) valuation methodologies and inputs that management believes are consistent with what other market participants would use when pricing such instruments. Derivative valuations can be affected by changes in interest rates, foreign currency exchange rates, financial indices, credit spreads, default risk, nonperformance risk, volatility, liquidity and changes in estimates and assumptions used in the pricing models. The valuation controls and procedures for derivatives are described in "-- Investments." The significant inputs to the pricing models for most OTC-bilateral and OTC-cleared derivatives are inputs that are observable in the market or can be derived principally from, or corroborated by, observable market data. Certain OTC-bilateral and OTC-cleared derivatives may rely on inputs that are significant to the estimated fair value that are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. These unobservable inputs may involve significant management judgment or estimation. Even though unobservable, these inputs are based on assumptions deemed appropriate given the circumstances and management believes they are consistent with what other market participants would use when pricing such instruments. Most inputs for OTC-bilateral and OTC-cleared derivatives are mid-market inputs but, in certain cases, liquidity adjustments are made when they are deemed more representative of exit value. Market liquidity, as well as the use of different methodologies, assumptions and inputs, may have a material effect on the estimated fair values of the Company's derivatives and could materially affect net income. The credit risk of both the counterparty and the Company are considered in determining the estimated fair value for all OTC-bilateral and OTC-cleared derivatives, and any potential credit adjustment is based on the net exposure by counterparty after taking into account the effects of netting agreements and collateral arrangements. The Company values its OTC-bilateral and OTC-cleared derivatives using standard swap curves which may include a spread to the risk-free rate, depending upon specific collateral arrangements. This credit spread is appropriate for those parties that execute trades at pricing levels consistent with similar collateral arrangements. As the Company and its significant derivative counterparties generally execute trades at such pricing levels and hold sufficient collateral, additional credit risk adjustments are not currently required in the valuation process. The Company's ability to consistently execute at such pricing levels is in part due to the netting agreements and collateral arrangements that are in place with all of its significant derivative counterparties. An evaluation of the requirement to make additional credit risk adjustments is performed by the Company each reporting period. Freestanding Derivatives Valuation Techniques and Key Inputs: Level 2 This level includes all types of derivatives utilized by the Company with the exception of exchange-traded derivatives included within Level 1 and those derivatives with unobservable inputs as described in Level 3. Level 3 These valuation methodologies generally use the same inputs as described in the corresponding sections for Level 2 measurements of derivatives. However, these derivatives result in Level 3 classification because one or more of the significant inputs are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. 98
485BPOS328th Page of 388TOC1stPreviousNextBottomJust 328th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 10. Fair Value (continued) Freestanding derivatives are principally valued using the income approach. Valuations of non-option-based derivatives utilize present value techniques, whereas valuations of option-based derivatives utilize option pricing models. Key inputs are as follows: [Enlarge/Download Table] Foreign Currency Instrument Interest Rate Exchange Rate Credit --------------------------------------------------------------------------------------------------------------- Inputs common to Level 2 and Level 3 . swap yield curve . swap yield curve . swap yield curve by instrument type . basis curves . basis curves . credit curves . interest rate . currency spot rates . recovery rates volatility (1) . cross currency basis curves --------------------------------------------------------------------------------------------------------------- Level 3 . swap yield curve (2) N/A . swap yield curve (2) . basis curves (2) . credit curves (2) . credit spreads . repurchase rates . independent non- binding broker quotations [Download Table] Instrument Equity market ------------------------------------------------------------------- Inputs common to Level 2 and Level 3 . swap yield curve by instrument type . spot equity index levels . dividend yield curves . equity volatility ------------------------------------------------------------------- Level 3 . dividend yield curves (2) . equity volatility (2) . correlation between model inputs (1) -------- (1)Option-based only. (2)Extrapolation beyond the observable limits of the curve(s). Embedded Derivatives Embedded derivatives principally include certain direct, assumed and ceded variable annuity guarantees and embedded derivatives related to funds withheld on ceded reinsurance and within certain annuity contracts. Embedded derivatives are recorded at estimated fair value with changes in estimated fair value reported in net income. The Company issues certain variable annuity products with guaranteed minimum benefits. GMWBs, GMABs and certain GMIBs contain embedded derivatives, which are measured at estimated fair value separately from the host variable annuity contract, with changes in estimated fair value reported in net derivative gains (losses). These embedded derivatives are classified within PABs on the consolidated balance sheets. The Company's actuarial department calculates the fair value of these embedded derivatives, which are estimated as the present value of projected future benefits minus the present value of projected future fees using actuarial and capital market assumptions including expectations concerning policyholder behavior. The calculation is based on in-force business, and is performed using standard actuarial valuation software which projects future cash flows from the embedded derivative over multiple risk neutral stochastic scenarios using observable risk-free rates. Capital market assumptions, such as risk-free rates and implied volatilities, are based on market prices for publicly traded instruments to the extent that prices for such instruments are observable. Implied volatilities beyond the observable period are extrapolated based on observable implied volatilities and historical volatilities. Actuarial assumptions, including mortality, lapse, withdrawal and utilization, are unobservable and are reviewed at least annually based on actuarial studies of historical experience. 99
485BPOS329th Page of 388TOC1stPreviousNextBottomJust 329th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 10. Fair Value (continued) The valuation of these guarantee liabilities includes nonperformance risk adjustments and adjustments for a risk margin related to non-capital market inputs. The nonperformance adjustment is determined by taking into consideration publicly available information relating to spreads in the secondary market for MetLife, Inc.'s debt, including related credit default swaps. These observable spreads are then adjusted, as necessary, to reflect the priority of these liabilities and the claims paying ability of the issuing insurance subsidiaries compared to MetLife, Inc. Risk margins are established to capture the non-capital market risks of the instrument which represent the additional compensation a market participant would require to assume the risks related to the uncertainties of such actuarial assumptions as annuitization, premium persistency, partial withdrawal and surrenders. The establishment of risk margins requires the use of significant management judgment, including assumptions of the amount and cost of capital needed to cover the guarantees. These guarantees may be more costly than expected in volatile or declining equity markets. Market conditions including, but not limited to, changes in interest rates, equity indices, market volatility and foreign currency exchange rates; changes in nonperformance risk; and variations in actuarial assumptions regarding policyholder behavior, mortality and risk margins related to non-capital market inputs, may result in significant fluctuations in the estimated fair value of the guarantees that could materially affect net income. The Company assumed, from an affiliated insurance company, the risk associated with certain GMIBs. These embedded derivatives are included in other policy-related balances on the consolidated balance sheets with changes in estimated fair value reported in net derivative gains (losses). The value of the embedded derivatives on these assumed risks is determined using a methodology consistent with that described previously for the guarantees directly written by the Company. The Company ceded, to an affiliated reinsurance company, the risk associated with certain of the GMIBs, GMABs and GMWBs described above that are also accounted for as embedded derivatives. In addition to ceding risks associated with guarantees that are accounted for as embedded derivatives, the Company also cedes, to the same affiliated reinsurance company, certain directly written GMIBs that are accounted for as insurance (i.e., not as embedded derivatives), but where the reinsurance agreement contains an embedded derivative. These embedded derivatives are included within premiums, reinsurance and other receivables on the consolidated balance sheets with changes in estimated fair value reported in net derivative gains (losses). The value of the embedded derivatives on the ceded risk is determined using a methodology consistent with that described previously for the guarantees directly written by the Company with the exception of the input for nonperformance risk that reflects the credit of the reinsurer. The estimated fair value of the embedded derivatives within funds withheld related to certain ceded reinsurance is determined based on the change in estimated fair value of the underlying assets held by the Company in a reference portfolio backing the funds withheld liability. The estimated fair value of the underlying assets is determined as previously described in "-- Investments -- Securities, Short-term Investments and Long-term Debt of CSEs." The estimated fair value of these embedded derivatives is included, along with their funds withheld hosts, in other liabilities on the consolidated balance sheets with changes in estimated fair value recorded in net derivative gains (losses). Changes in the credit spreads on the underlying assets, interest rates and market volatility may result in significant fluctuations in the estimated fair value of these embedded derivatives that could materially affect net income. 100
485BPOS330th Page of 388TOC1stPreviousNextBottomJust 330th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 10. Fair Value (continued) The Company issues certain annuity contracts which allow the policyholder to participate in returns from equity indices. These equity indexed features are embedded derivatives which are measured at estimated fair value separately from the host fixed annuity contract, with changes in estimated fair value reported in net derivative gains (losses). These embedded derivatives are classified within PABs on the consolidated balance sheets. The estimated fair value of the embedded equity indexed derivatives, based on the present value of future equity returns to the policyholder using actuarial and present value assumptions including expectations concerning policyholder behavior, is calculated by the Company's actuarial department. The calculation is based on in-force business and uses standard capital market techniques, such as Black-Scholes, to calculate the value of the portion of the embedded derivative for which the terms are set. The portion of the embedded derivative covering the period beyond where terms are set is calculated as the present value of amounts expected to be spent to provide equity indexed returns in those periods. The valuation of these embedded derivatives also includes the establishment of a risk margin, as well as changes in nonperformance risk. Embedded Derivatives Within Asset and Liability Host Contracts Level 3 Valuation Techniques and Key Inputs: Direct and assumed guaranteed minimum benefits These embedded derivatives are principally valued using the income approach. Valuations are based on option pricing techniques, which utilize significant inputs that may include swap yield curve, currency exchange rates and implied volatilities. These embedded derivatives result in Level 3 classification because one or more of the significant inputs are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. Significant unobservable inputs generally include: the extrapolation beyond observable limits of the swap yield curve and implied volatilities, actuarial assumptions for policyholder behavior and mortality and the potential variability in policyholder behavior and mortality, nonperformance risk and cost of capital for purposes of calculating the risk margin. Reinsurance ceded on certain guaranteed minimum benefits These embedded derivatives are principally valued using the income approach. The valuation techniques and significant market standard unobservable inputs used in their valuation are similar to those described above in "-- Direct and assumed guaranteed minimum benefits" and also include counterparty credit spreads. Transfers between Levels Overall, transfers between levels occur when there are changes in the observability of inputs and market activity. Transfers into or out of any level are assumed to occur at the beginning of the period. Transfers between Levels 1 and 2: For assets and liabilities measured at estimated fair value and still held at December 31, 2014 and 2013, transfers between Levels 1 and 2 were not significant. 101
485BPOS331st Page of 388TOC1stPreviousNextBottomJust 331st
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 10. Fair Value (continued) Transfers into or out of Level 3: Assets and liabilities are transferred into Level 3 when a significant input cannot be corroborated with market observable data. This occurs when market activity decreases significantly and underlying inputs cannot be observed, current prices are not available, and/or when there are significant variances in quoted prices, thereby affecting transparency. Assets and liabilities are transferred out of Level 3 when circumstances change such that a significant input can be corroborated with market observable data. This may be due to a significant increase in market activity, a specific event, or one or more significant input(s) becoming observable. Transfers into Level 3 for fixed maturity securities were due primarily to a lack of trading activity, decreased liquidity and credit ratings downgrades (e.g., from investment grade to below investment grade) which have resulted in decreased transparency of valuations and an increased use of independent non-binding broker quotations and unobservable inputs, such as illiquidity premiums, delta spread adjustments, or credit spreads. Transfers out of Level 3 for fixed maturity securities resulted primarily from increased transparency of both new issuances that, subsequent to issuance and establishment of trading activity, became priced by independent pricing services and existing issuances that, over time, the Company was able to obtain pricing from, or corroborate pricing received from, independent pricing services with observable inputs (such as observable spreads used in pricing securities) or increases in market activity and upgraded credit ratings. 102
485BPOS332nd Page of 388TOC1stPreviousNextBottomJust 332nd
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 10. Fair Value (continued) Assets and Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Level 3) The following table presents certain quantitative information about the significant unobservable inputs used in the fair value measurement, and the sensitivity of the estimated fair value to changes in those inputs, for the more significant asset and liability classes measured at fair value on a recurring basis using significant unobservable inputs (Level 3) at: [Enlarge/Download Table] December 31, 2014 --------------------------- Valuation Significant Weighted Techniques Unobservable Inputs Range Average (1) ----------------------------- ----------------------- --------------- ----------- Fixed maturity securities (3) U.S. corporate and foreign Delta spread (35) - 240 51 corporate................... Matrix pricing adjustments (4) Market pricing Quoted prices (5) -- - 750 418 Consensus pricing Offered quotes (5) 78 - 103 86 -------------------------------------------------------------------------------------- RMBS......................... Consensus pricing Offered quotes (5) 1 - 117 93 -------------------------------------------------------------------------------------- ABS.......................... Market pricing Quoted prices (5) 97 - 108 101 Consensus pricing Offered quotes (5) 62 - 106 99 -------------------------------------------------------------------------------------- Derivatives Interest rate................ Present value Swap yield (7) 278 - 297 techniques -------------------------------------------------------------------------------------- Credit....................... Present value Credit spreads (8) 99 - 99 techniques Consensus pricing Offered quotes (9) -------------------------------------------------------------------------------------- Equity market................ Present value Volatility (10) 15% - 27% techniques or option pricing models Correlation (12) 70% - 70% -------------------------------------------------------------------------------------- Embedded derivatives Direct and ceded guaranteed Option pricing techniques Mortality rates: minimum benefits............ Ages 0 - 40 0% - 0.10% Ages 41 - 60 0.04% - 0.65% Ages 61 - 115 0.26% - 100% Lapse rates: Durations 1 - 10 0.50% - 100% Durations 11 - 20 3% - 100% Durations 21 - 116 3% - 100% Utilization rates 20% - 50% Withdrawal rates 0.07% - 10% Long-term equity 17.40% - 25% volatilities Nonperformance 0.03% - 1.39% risk spread -------------------------------------------------------------------------------------- [Enlarge/Download Table] December 31, 2013 --------------------------- Valuation Significant Weighted Techniques Unobservable Inputs Range Average (1) ----------------------------- ----------------------- --------------- ----------- Fixed maturity securities (3) U.S. corporate and foreign Delta spread (10) - 240 49 corporate................... Matrix pricing adjustments (4) Market pricing Quoted prices (5) 14 - 122 99 Consensus pricing Offered quotes (5) 33 - 103 87 -------------------------------------------------------------------------------------- RMBS......................... Consensus pricing Offered quotes (5) 78 - 100 95 -------------------------------------------------------------------------------------- ABS.......................... Market pricing Quoted prices (5) -- - 104 101 Consensus pricing Offered quotes (5) 58 - 106 98 -------------------------------------------------------------------------------------- Derivatives Interest rate................ Present value Swap yield (7) 248 - 450 techniques -------------------------------------------------------------------------------------- Credit....................... Present value Credit spreads (8) 98 - 100 techniques Consensus pricing Offered quotes (9) -------------------------------------------------------------------------------------- Equity market................ Present value Volatility (10) 13% - 28% techniques or option pricing models Correlation (12) 60% - 60% -------------------------------------------------------------------------------------- Embedded derivatives Direct and ceded guaranteed Option pricing techniques Mortality rates: minimum benefits............ Ages 0 - 40 0% - 0.10% Ages 41 - 60 0.04% - 0.65% Ages 61 - 115 0.26% - 100% Lapse rates: Durations 1 - 10 0.50% - 100% Durations 11 - 20 3% - 100% Durations 21 - 116 3% - 100% Utilization rates 20% - 50% Withdrawal rates 0.07% - 10% Long-term equity 17.40% - 25% volatilities Nonperformance 0.03% - 1.32% risk spread -------------------------------------------------------------------------------------- [Enlarge/Download Table] Impact of Increase in Input on Valuation Significant Estimated Techniques Unobservable Inputs Fair Value (2) ----------------------------- ----------------------- -------------- Fixed maturity securities (3) U.S. corporate and foreign Delta spread Decrease corporate................... Matrix pricing adjustments (4) Market pricing Quoted prices (5) Increase Consensus pricing Offered quotes (5) Increase ----------------------------------------------------------------------- RMBS......................... Consensus pricing Offered quotes (5) Increase (6) ----------------------------------------------------------------------- ABS.......................... Market pricing Quoted prices (5) Increase (6) Consensus pricing Offered quotes (5) Increase (6) ----------------------------------------------------------------------- Derivatives Interest rate................ Present value Swap yield (7) Increase (11) techniques ----------------------------------------------------------------------- Credit....................... Present value Credit spreads (8) Decrease (8) techniques Consensus pricing Offered quotes (9) ----------------------------------------------------------------------- Equity market................ Present value Volatility (10) Increase (11) techniques or option pricing models Correlation (12) ----------------------------------------------------------------------- Embedded derivatives Direct and ceded guaranteed Option pricing techniques Mortality rates: minimum benefits............ Ages 0 - 40 Decrease (13) Ages 41 - 60 Decrease (13) Ages 61 - 115 Decrease (13) Lapse rates: Durations 1 - 10 Decrease (14) Durations 11 - 20 Decrease (14) Durations 21 - 116 Decrease (14) Utilization rates Increase (15) Withdrawal rates (16) Long-term equity Increase (17) volatilities Nonperformance Decrease (18) risk spread ----------------------------------------------------------------------- -------- (1)The weighted average for fixed maturity securities is determined based on the estimated fair value of the securities. (2)The impact of a decrease in input would have the opposite impact on the estimated fair value. For embedded derivatives, changes to direct guaranteed minimum benefits are based on liability positions and changes to ceded guaranteed minimum benefits are based on asset positions. (3)Significant increases (decreases) in expected default rates in isolation would result in substantially lower (higher) valuations. (4)Range and weighted average are presented in basis points. 103
485BPOS333rd Page of 388TOC1stPreviousNextBottomJust 333rd
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 10. Fair Value (continued) (5)Range and weighted average are presented in accordance with the market convention for fixed maturity securities of dollars per hundred dollars of par. (6)Changes in the assumptions used for the probability of default is accompanied by a directionally similar change in the assumption used for the loss severity and a directionally opposite change in the assumptions used for prepayment rates. (7)Ranges represent the rates across different yield curves and are presented in basis points. The swap yield curve is utilized among different types of derivatives to project cash flows, as well as to discount future cash flows to present value. Since this valuation methodology uses a range of inputs across a yield curve to value the derivative, presenting a range is more representative of the unobservable input used in the valuation. (8)Represents the risk quoted in basis points of a credit default event on the underlying instrument. Credit derivatives with significant unobservable inputs are primarily comprised of written credit default swaps. (9)At both December 31, 2014 and 2013, independent non-binding broker quotations were used in the determination of less than 1% of the total net derivative estimated fair value. (10)Ranges represent the underlying equity volatility quoted in percentage points. Since this valuation methodology uses a range of inputs across multiple volatility surfaces to value the derivative, presenting a range is more representative of the unobservable input used in the valuation. (11)Changes are based on long U.S. dollar net asset positions and will be inversely impacted for short U.S. dollar net asset positions. (12)Ranges represent the different correlation factors utilized as components within the valuation methodology. Presenting a range of correlation factors is more representative of the unobservable input used in the valuation. Increases (decreases) in correlation in isolation will increase (decrease) the significance of the change in valuations. (13)Mortality rates vary by age and by demographic characteristics such as gender. Mortality rate assumptions are based on company experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. (14)Base lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, as well as other factors, such as the applicability of any surrender charges. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in the money contracts are less likely to lapse. Lapse rates are also generally assumed to be lower in periods when a surrender charge applies. For any given contract, lapse rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. (15)The utilization rate assumption estimates the percentage of contract holders with a GMIB or lifetime withdrawal benefit who will elect to utilize the benefit upon becoming eligible. The rates may vary by the 104
485BPOS334th Page of 388TOC1stPreviousNextBottomJust 334th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 10. Fair Value (continued) type of guarantee, the amount by which the guaranteed amount is greater than the account value, the contract's withdrawal history and by the age of the policyholder. For any given contract, utilization rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. (16)The withdrawal rate represents the percentage of account balance that any given policyholder will elect to withdraw from the contract each year. The withdrawal rate assumption varies by age and duration of the contract, and also by other factors such as benefit type. For any given contract, withdrawal rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. For GMWBs, any increase (decrease) in withdrawal rates results in an increase (decrease) in the estimated fair value of the guarantees. For GMABs and GMIBs, any increase (decrease) in withdrawal rates results in a decrease (increase) in the estimated fair value. (17)Long-term equity volatilities represent equity volatility beyond the period for which observable equity volatilities are available. For any given contract, long-term equity volatility rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. (18)Nonperformance risk spread varies by duration and by currency. For any given contract, multiple nonperformance risk spreads will apply, depending on the duration of the cash flow being discounted for purposes of valuing the embedded derivative. The following is a summary of the valuation techniques and significant unobservable inputs used in the fair value measurement of assets and liabilities classified within Level 3 that are not included in the preceding table. Generally, all other classes of securities classified within Level 3, including those within separate account assets and embedded derivatives within funds withheld related to certain ceded reinsurance, use the same valuation techniques and significant unobservable inputs as previously described for Level 3 securities. This includes matrix pricing and discounted cash flow methodologies, inputs such as quoted prices for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2, as well as independent non-binding broker quotations. The sensitivity of the estimated fair value to changes in the significant unobservable inputs for these other assets and liabilities is similar in nature to that described in the preceding table. The valuation techniques and significant unobservable inputs used in the fair value measurement for the more significant assets measured at estimated fair value on a nonrecurring basis and determined using significant unobservable inputs (Level 3) are summarized in "-- Nonrecurring Fair Value Measurements." 105
485BPOS335th Page of 388TOC1stPreviousNextBottomJust 335th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 10. Fair Value (continued) The following tables summarize the change of all assets and (liabilities) measured at estimated fair value on a recurring basis using significant unobservable inputs (Level 3): [Enlarge/Download Table] Fair Value Measurements Using Significant Unobservable Inputs (Level 3) --------------------------------------------------------------------- Fixed Maturity Securities --------------------------------------------------------------------- State and U.S. Foreign Political Foreign Corporate RMBS Corporate Subdivision CMBS ABS Government --------- -------- --------- ----------- -------- -------- ---------- (In millions) Year Ended December 31, 2014 Balance at January 1,.................... $ 1,270 $ 450 $ 779 $ -- $ 129 $ 426 $ -- Total realized/unrealized gains (losses) included in: Net income (loss): (1), (2) Net investment income................. 7 6 1 -- -- -- -- Net investment gains (losses)......... (2) 3 (3) -- -- 1 -- Net derivative gains (losses)......... -- -- -- -- -- -- -- Policyholder benefits and claims...... -- -- -- -- -- -- -- OCI.................................... 87 13 (13) -- -- (1) -- Purchases (3)............................ 125 351 53 -- 45 105 -- Sales (3)................................ (143) (89) (51) -- (26) (162) -- Issuances (3)............................ -- -- -- -- -- -- -- Settlements (3).......................... -- -- -- -- -- -- -- Transfers into Level 3 (4)............... 158 1 5 -- 17 7 -- Transfers out of Level 3 (4)............. (147) (19) (61) -- (17) (195) -- -------- -------- -------- ------- -------- -------- -------- Balance at December 31,.................. $ 1,355 $ 716 $ 710 $ -- $ 148 $ 181 $ -- ======== ======== ======== ======= ======== ======== ======== Changes in unrealized gains (losses) included in net income (loss): (5) Net investment income.................. $ 6 $ 6 $ -- $ -- $ -- $ -- $ -- Net investment gains (losses).......... $ (1) $ -- $ (2) $ -- $ -- $ -- $ -- Net derivative gains (losses).......... $ -- $ -- $ -- $ -- $ -- $ -- $ -- Policyholder benefits and claims....... $ -- $ -- $ -- $ -- $ -- $ -- $ -- 106
485BPOS336th Page of 388TOC1stPreviousNextBottomJust 336th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 10. Fair Value (continued) [Enlarge/Download Table] Fair Value Measurements Using Significant Unobservable Inputs (Level 3) ------------------------------------------------------------------------------------ Equity Securities Net Derivatives (6) ------------------ -------------------------- Non- redeemable Net Separate Common Preferred Short-term Interest Equity Embedded Account Stock Stock Investments Rate Credit Market Derivatives (7) Assets (8) ------- ---------- ----------- -------- ------ ---------- --------------- ---------- (In millions) Year Ended December 31, 2014 Balance at January 1,.................... $ 31 $ 100 $ -- $ 11 $ 6 $ (309) $ 288 $ 153 Total realized/unrealized gains (losses) included in: Net income (loss): (1), (2) Net investment income................. -- -- -- -- -- -- -- -- Net investment gains (losses)......... (3) 1 -- -- -- -- -- (1) Net derivative gains (losses)......... -- -- -- 15 (5) (18) (1,044) -- Policyholder benefits and claims...... -- -- -- -- -- 4 87 -- OCI.................................... 6 1 -- 55 -- 2 107 -- Purchases (3)............................ -- -- 71 -- -- 4 -- 12 Sales (3)................................ (5) (19) -- -- -- -- -- (9) Issuances (3)............................ -- -- -- -- -- -- -- -- Settlements (3).......................... -- -- -- (36) -- 75 215 -- Transfers into Level 3 (4)............... -- 6 -- -- -- -- -- 3 Transfers out of Level 3 (4)............. -- (18) -- -- -- -- -- -- ------- ------- ------- ------- ------ ---------- ---------- -------- Balance at December 31,.................. $ 29 $ 71 $ 71 $ 45 $ 1 $ (242) $ (347) $ 158 ======= ======= ======= ======= ====== ========== ========== ======== Changes in unrealized gains (losses) included in net income (loss): (5) Net investment income.................. $ -- $ -- $ -- $ -- $ -- $ -- $ -- $ -- Net investment gains (losses).......... $ -- $ (1) $ -- $ -- $ -- $ -- $ -- $ -- Net derivative gains (losses).......... $ -- $ -- $ -- $ -- $ (1) $ (10) $ (1,069) $ -- Policyholder benefits and claims....... $ -- $ -- $ -- $ -- $ -- $ 4 $ 87 $ -- 107
485BPOS337th Page of 388TOC1stPreviousNextBottomJust 337th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 10. Fair Value (continued) [Enlarge/Download Table] Fair Value Measurements Using Significant Unobservable Inputs (Level 3) --------------------------------------------------------------------- Fixed Maturity Securities --------------------------------------------------------------------- State and U.S. Foreign Political Foreign Corporate RMBS Corporate Subdivision CMBS ABS Government --------- -------- --------- ----------- -------- -------- ---------- (In millions) Year Ended December 31, 2013 Balance at January 1,.................... $ 1,504 $ 292 $ 914 $ 25 $ 181 $ 347 $ 2 Total realized/unrealized gains (losses) included in: Net income (loss): (1), (2) Net investment income................. 7 1 1 -- -- 1 -- Net investment gains (losses)......... -- -- (7) -- -- 2 -- Net derivative gains (losses)......... -- -- -- -- -- -- -- Policyholder benefits and claims...... -- -- -- -- -- -- -- OCI.................................... (40) 13 (3) -- 1 (5) -- Purchases (3)............................ 154 183 63 -- 55 191 -- Sales (3)................................ (262) (50) (140) (2) (71) (53) (2) Issuances (3)............................ -- -- -- -- -- -- -- Settlements (3).......................... -- -- -- -- -- -- -- Transfers into Level 3 (4)............... 222 15 28 -- -- -- -- Transfers out of Level 3 (4)............. (315) (4) (77) (23) (37) (57) -- -------- -------- -------- ------- -------- -------- --------- Balance at December 31,.................. $ 1,270 $ 450 $ 779 $ -- $ 129 $ 426 $ -- ======== ======== ======== ======= ======== ======== ========= Changes in unrealized gains (losses) included in net income (loss): (5) Net investment income.................. $ 7 $ 1 $ -- $ -- $ -- $ -- $ -- Net investment gains (losses).......... $ 1 $ -- $ (3) $ -- $ -- $ -- $ -- Net derivative gains (losses).......... $ -- $ -- $ -- $ -- $ -- $ -- $ -- Policyholder benefits and claims....... $ -- $ -- $ -- $ -- $ -- $ -- $ -- 108
485BPOS338th Page of 388TOC1stPreviousNextBottomJust 338th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 10. Fair Value (continued) [Enlarge/Download Table] Fair Value Measurements Using Significant Unobservable Inputs (Level 3) ---------------------------------------------------------------------------------- Equity Securities Net Derivatives (6) ------------------ ------------------------ Non- redeemable Net Separate Common Preferred Short-term Interest Equity Embedded Account Stock Stock Investments Rate Credit Market Derivatives (7) Assets (8) ------- ---------- ----------- -------- ------ -------- --------------- ---------- (In millions) Year Ended December 31, 2013 Balance at January 1,.................... $ 26 $ 110 $ 18 $ 119 $ 10 $ 134 $ (5,309) $ 141 Total realized/unrealized gains (losses) included in:............................ Net income (loss): (1), (2) Net investment income................. -- -- -- -- -- -- -- -- Net investment gains (losses)......... 8 -- -- -- -- -- -- 6 Net derivative gains (losses)......... -- -- -- (16) (4) (465) 6,448 -- Policyholder benefits and claims...... -- -- -- -- -- 19 (139) -- OCI.................................... 7 14 -- (58) -- -- 292 -- Purchases (3)............................ 2 3 -- -- -- 7 -- 9 Sales (3)................................ (12) (27) (18) -- -- -- -- (6) Issuances (3)............................ -- -- -- -- -- -- -- -- Settlements (3).......................... -- -- -- (19) -- (4) (1,004) -- Transfers into Level 3 (4)............... -- -- -- -- -- -- -- 3 Transfers out of Level 3 (4)............. -- -- -- (15) -- -- -- -- ------- -------- -------- ------- ------ -------- ----------- -------- Balance at December 31,.................. $ 31 $ 100 $ -- $ 11 $ 6 $ (309) $ 288 $ 153 ======= ======== ======== ======= ====== ======== =========== ======== Changes in unrealized gains (losses) included in net income (loss): (5) Net investment income.................. $ -- $ -- $ -- $ -- $ -- $ -- $ -- $ -- Net investment gains (losses).......... $ (2) $ (3) $ -- $ -- $ -- $ -- $ -- $ -- Net derivative gains (losses).......... $ -- $ -- $ -- $ (8) $ (4) $ (450) $ 6,409 $ -- Policyholder benefits and claims....... $ -- $ -- $ -- $ -- $ -- $ 19 $ (139) $ -- 109
485BPOS339th Page of 388TOC1stPreviousNextBottomJust 339th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 10. Fair Value (continued) [Enlarge/Download Table] Fair Value Measurements Using Significant Unobservable Inputs (Level 3) ---------------------------------------------------------------------- Fixed Maturity Securities ---------------------------------------------------------------------- State and U.S. Foreign Political Foreign Corporate RMBS Corporate Subdivision CMBS ABS Government --------- -------- --------- ----------- -------- -------- ----------- (In millions) Year Ended December 31, 2012 Balance at January 1,.................... $ 1,464 $ 250 $ 588 $ 23 $ 189 $ 226 $ 2 Total realized/unrealized gains (losses) included in: Net income (loss): (1), (2) Net investment income................. 7 -- -- -- -- -- -- Net investment gains (losses)......... -- (4) (24) -- (2) -- -- Net derivative gains (losses)......... -- -- -- -- -- -- -- Policyholder benefits and claims...... -- -- -- -- -- -- -- OCI.................................... 67 42 46 3 6 8 -- Purchases (3)............................ 263 61 305 -- 37 153 -- Sales (3)................................ (185) (63) (55) (1) (71) (22) -- Issuances (3)............................ -- -- -- -- -- -- -- Settlements (3).......................... -- -- -- -- -- -- -- Transfers into Level 3 (4)............... 87 6 68 -- 39 -- -- Transfers out of Level 3 (4)............. (199) -- (14) -- (17) (18) -- -------- -------- -------- --------- -------- -------- ----------- Balance at December 31,.................. $ 1,504 $ 292 $ 914 $ 25 $ 181 $ 347 $ 2 ======== ======== ======== ========= ======== ======== =========== Changes in unrealized gains (losses) included in net income (loss): (5) Net investment income.................. $ 7 $ -- $ 1 $ -- $ -- $ -- $ -- Net investment gains (losses).......... $ -- $ (2) $ (16) $ -- $ -- $ -- $ -- Net derivative gains (losses).......... $ -- $ -- $ -- $ -- $ -- $ -- $ -- Policyholder benefits and claims....... $ -- $ -- $ -- $ -- $ -- $ -- $ -- 110
485BPOS340th Page of 388TOC1stPreviousNextBottomJust 340th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 10. Fair Value (continued) [Enlarge/Download Table] Fair Value Measurements Using Significant Unobservable Inputs (Level 3) ------------------------------------------------------------------------------------ Equity Securities Net Derivatives (6) -------------------- ---------------------- Non- redeemable Separate Common Preferred Short-term Interest Equity Net Embedded Account Stock Stock Investments Rate Credit Market Derivatives (7) Assets (8) --------- ---------- ----------- -------- ------ ------ --------------- ---------- (In millions) Year Ended December 31, 2012 Balance at January 1,.................... $ 41 $ 90 $ 50 $ 174 $ (1) $ 887 $ (5,443) $ 130 Total realized/unrealized gains (losses) included in: Net income (loss): (1), (2) Net investment income.................. -- -- -- -- -- -- -- -- Net investment gains (losses)......... (2) -- -- -- -- -- -- 16 Net derivative gains (losses)......... -- -- -- 1 10 (599) 511 -- Policyholder benefits and claims...... -- -- -- -- -- 29 71 -- OCI.................................... 10 22 -- 1 -- (3) 262 -- Purchases (3)............................ -- -- 18 -- -- 19 -- 1 Sales (3)................................ (3) (2) (50) -- -- -- -- (5) Issuances (3)............................ -- -- -- (10) -- (43) -- -- Settlements (3).......................... -- -- -- (47) -- (156) (710) -- Transfers into Level 3 (4)............... -- -- -- -- -- -- -- 1 Transfers out of Level 3 (4)............. (20) -- -- -- 1 -- -- (2) --------- ------- --------- ------ ----- ------ ---------- -------- Balance at December 31,.................. $ 26 $ 110 $ 18 $ 119 $ 10 $ 134 $ (5,309) $ 141 ========= ======= ========= ====== ===== ====== ========== ======== Changes in unrealized gains (losses) included in net income (loss): (5) Net investment income.................. $ -- $ -- $ -- $ -- $ -- $ -- $ -- $ -- Net investment gains (losses).......... $ (4) $ -- $ -- $ -- $ -- $ -- $ -- $ -- Net derivative gains (losses).......... $ -- $ -- $ -- $ 3 $ 11 $ (586) $ 475 $ -- Policyholder benefits and claims....... $ -- $ -- $ -- $ -- $ -- $ 29 $ 74 $ -- -------- (1)Amortization of premium/accretion of discount is included within net investment income. Impairments charged to net income (loss) on securities are included in net investment gains (losses). Lapses associated with net embedded derivatives are included in net derivative gains (losses). (2)Interest and dividend accruals, as well as cash interest coupons and dividends received, are excluded from the rollforward. (3)Items purchased/issued and then sold/settled in the same period are excluded from the rollforward. Fees attributed to embedded derivatives are included in settlements. (4)Gains and losses, in net income (loss) and OCI, are calculated assuming transfers into and/or out of Level 3 occurred at the beginning of the period. Items transferred into and then out of Level 3 in the same period are excluded from the rollforward. (5)Changes in unrealized gains (losses) included in net income (loss) relate to assets and liabilities still held at the end of the respective periods. (6)Freestanding derivative assets and liabilities are presented net for purposes of the rollforward. (7)Embedded derivative assets and liabilities are presented net for purposes of the rollforward. (8)Investment performance related to separate account assets is fully offset by corresponding amounts credited to contractholders within separate account liabilities. Therefore, such changes in estimated fair value are not recorded in net income. For the purpose of this disclosure, these changes are presented within net investment gains (losses). 111
485BPOS341st Page of 388TOC1stPreviousNextBottomJust 341st
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 10. Fair Value (continued) Fair Value Option The following table presents information for certain assets and liabilities of CSEs, which are accounted for under the FVO. These assets and liabilities were initially measured at fair value. [Enlarge/Download Table] December 31, ---------------- 2014 2013 ------- -------- (In millions) Assets (1) Unpaid principal balance.................................................. $ 223 $ 1,528 Difference between estimated fair value and unpaid principal balance...... 57 70 ------- -------- Carrying value at estimated fair value................................... $ 280 $ 1,598 ======= ======== Liabilities (1) Contractual principal balance............................................. $ 133 $ 1,436 Difference between estimated fair value and contractual principal balance. 6 25 ------- -------- Carrying value at estimated fair value................................... $ 139 $ 1,461 ======= ======== -------- (1)These assets and liabilities are comprised of commercial mortgage loans and long-term debt. Changes in estimated fair value on these assets and liabilities and gains or losses on sales of these assets are recognized in net investment gains (losses). Interest income on commercial mortgage loans held by CSEs -- FVO is recognized in net investment income. Interest expense from long-term debt of CSEs -- FVO is recognized in other expenses. Nonrecurring Fair Value Measurements The following table presents information for assets measured at estimated fair value on a nonrecurring basis during the periods and still held at the reporting dates (for example, when there is evidence of impairment). The estimated fair values for these assets were determined using significant unobservable inputs (Level 3). [Enlarge/Download Table] At December 31, Years Ended December 31, -------------------------------- ------------------------ 2014 2013 2012 2014 2013 2012 ---- ---- ---- ----- ----- ------ Carrying Value After Measurement Gains (Losses) -------------------------------- ------------------------ (In millions) Mortgage loans (1)...................... $ 3 $19 $65 $ -- $ (3) $ 4 Other limited partnership interests (2). $38 $ 5 $ 6 $ (6) $ (6) $ (3) Goodwill (3)............................ $-- $-- $-- $(33) $(66) $(394) -------- (1)Estimated fair values for impaired mortgage loans are based on independent broker quotations or valuation models using unobservable inputs or, if the loans are in foreclosure or are otherwise determined to be collateral dependent, are based on the estimated fair value of the underlying collateral or the present value of the expected future cash flows. 112
485BPOS342nd Page of 388TOC1stPreviousNextBottomJust 342nd
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 10. Fair Value (continued) (2)For these cost method investments, estimated fair value is determined from information provided in the financial statements of the underlying entities including NAV data. These investments include private equity and debt funds that typically invest primarily in various strategies including domestic and international leveraged buyout funds; power, energy, timber and infrastructure development funds; venture capital funds; and below investment grade debt and mezzanine debt funds. Distributions will be generated from investment gains, from operating income from the underlying investments of the funds and from liquidation of the underlying assets of the funds. It is estimated that the underlying assets of the funds will be liquidated over the next two to 10 years. Unfunded commitments for these investments at both December 31, 2014 and 2013 were not significant. (3)In 2014, the Company recorded an impairment of goodwill associated with the Retail Annuities reporting unit. In addition, the Company recorded impairments of goodwill associated with the Retail Life & Other and Retail Annuities reporting units in 2013 and 2012, respectively. See Note 11 for additional information on the impairments. These impairments have been categorized as Level 3 due to the significant unobservable inputs used in the determination of the estimated fair value. 113
485BPOS343rd Page of 388TOC1stPreviousNextBottomJust 343rd
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 10. Fair Value (continued) Fair Value of Financial Instruments Carried at Other Than Fair Value The following tables provide fair value information for financial instruments that are carried on the balance sheet at amounts other than fair value. These tables exclude the following financial instruments: cash and cash equivalents, accrued investment income, payables for collateral under securities loaned and other transactions and those short-term investments that are not securities, such as time deposits, and therefore are not included in the three level hierarchy table disclosed in the "-- Recurring Fair Value Measurements" section. The estimated fair value of the excluded financial instruments, which are primarily classified in Level 2 and, to a lesser extent, in Level 1, approximates carrying value as they are short-term in nature such that the Company believes there is minimal risk of material changes in interest rates or credit quality. All remaining balance sheet amounts excluded from the table below are not considered financial instruments subject to this disclosure. The carrying values and estimated fair values for such financial instruments, and their corresponding placement in the fair value hierarchy, are summarized as follows at: [Enlarge/Download Table] December 31, 2014 ------------------------------------------------- Fair Value Hierarchy ----------------------- Total Estimated Carrying Value Level 1 Level 2 Level 3 Fair Value -------------- ------- ------- ------- ---------- (In millions) Assets Mortgage loans.............................. $ 5,559 $-- $ -- $ 6,020 $ 6,020 Policy loans................................ $ 1,194 $-- $ 834 $ 454 $ 1,288 Real estate joint ventures.................. $ 37 $-- $ -- $ 83 $ 83 Other limited partnership interests......... $ 63 $-- $ -- $ 81 $ 81 Other invested assets....................... $ 1 $-- $ 1 $ -- $ 1 Premiums, reinsurance and other receivables. $ 6,231 $-- $ 51 $ 7,156 $ 7,207 Other assets................................ $ -- $-- $ -- $ -- $ -- Liabilities PABs........................................ $ 20,554 $-- $ -- $22,079 $22,079 Long-term debt.............................. $ 789 $-- $1,120 $ -- $ 1,120 Other liabilities........................... $ 245 $-- $ 76 $ 169 $ 245 Separate account liabilities................ $ 1,432 $-- $1,432 $ -- $ 1,432 December 31, 2013 ------------------------------------------------- Fair Value Hierarchy ----------------------- Total Estimated Carrying Value Level 1 Level 2 Level 3 Fair Value -------------- ------- ------- ------- ---------- (In millions) Assets Mortgage loans.............................. $ 6,406 $-- $ -- $ 6,730 $ 6,730 Policy loans................................ $ 1,246 $-- $ 875 $ 446 $ 1,321 Real estate joint ventures.................. $ 55 $-- $ -- $ 98 $ 98 Other limited partnership interests......... $ 79 $-- $ -- $ 90 $ 90 Other invested assets....................... $ 476 $-- $ 532 $ -- $ 532 Premiums, reinsurance and other receivables. $ 6,096 $-- $ 251 $ 6,159 $ 6,410 Other assets................................ $ 5 $-- $ 5 $ -- $ 5 Liabilities PABs........................................ $ 23,170 $-- $ -- $24,490 $24,490 Long-term debt.............................. $ 865 $-- $1,088 $ -- $ 1,088 Other liabilities........................... $ 260 $-- $ 98 $ 162 $ 260 Separate account liabilities................ $ 1,448 $-- $1,448 $ -- $ 1,448 The methods, assumptions and significant valuation techniques and inputs used to estimate the fair value of financial instruments are summarized as follows: 114
485BPOS344th Page of 388TOC1stPreviousNextBottomJust 344th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 10. Fair Value (continued) Mortgage Loans The estimated fair value of mortgage loans is primarily determined by estimating expected future cash flows and discounting them using current interest rates for similar mortgage loans with similar credit risk, or is determined from pricing for similar loans. Policy Loans Policy loans with fixed interest rates are classified within Level 3. The estimated fair values for these loans are determined using a discounted cash flow model applied to groups of similar policy loans determined by the nature of the underlying insurance liabilities. Cash flow estimates are developed by applying a weighted-average interest rate to the outstanding principal balance of the respective group of policy loans and an estimated average maturity determined through experience studies of the past performance of policyholder repayment behavior for similar loans. These cash flows are discounted using current risk-free interest rates with no adjustment for borrower credit risk as these loans are fully collateralized by the cash surrender value of the underlying insurance policy. Policy loans with variable interest rates are classified within Level 2 and the estimated fair value approximates carrying value due to the absence of borrower credit risk and the short time period between interest rate resets, which presents minimal risk of a material change in estimated fair value due to changes in market interest rates. Real Estate Joint Ventures and Other Limited Partnership Interests The estimated fair values of these cost method investments are generally based on the Company's share of the NAV as provided in the financial statements of the investees. In certain circumstances, management may adjust the NAV by a premium or discount when it has sufficient evidence to support applying such adjustments. Other Invested Assets These other invested assets are principally comprised of loans to affiliates and funds withheld. The estimated fair value of loans to affiliates is determined by discounting the expected future cash flows using market interest rates currently available for instruments with similar terms and remaining maturities. For funds withheld, the Company evaluates the specific facts and circumstances of each instrument to determine the appropriate estimated fair values. These estimated fair values were not materially different from the recognized carrying values. Premiums, Reinsurance and Other Receivables Premiums, reinsurance and other receivables are principally comprised of certain amounts recoverable under reinsurance agreements, amounts on deposit with financial institutions to facilitate daily settlements related to certain derivatives and amounts receivable for securities sold but not yet settled. Amounts recoverable under ceded reinsurance agreements, which the Company has determined do not transfer significant risk such that they are accounted for using the deposit method of accounting, have been classified as Level 3. The valuation is based on discounted cash flow methodologies using significant unobservable inputs. The estimated fair value is determined using interest rates determined to reflect the appropriate credit standing of the assuming counterparty. 115
485BPOS345th Page of 388TOC1stPreviousNextBottomJust 345th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 10. Fair Value (continued) The amounts on deposit for derivative settlements, classified within Level 2, essentially represent the equivalent of demand deposit balances and amounts due for securities sold are generally received over short periods such that the estimated fair value approximates carrying value. Other Assets Other assets are comprised of a receivable for the reimbursable portion of the estimated future guaranty liability that pertains to pre-acquisition business. With the exception of the receivable, other assets are not considered financial instruments subject to disclosure. Accordingly, the amount represents the receivable from an unaffiliated institution for which the estimated fair value was determined by discounting the expected future cash flows using a discount rate that reflects the credit standing of the unaffiliated institution. PABs These PABs include investment contracts. Embedded derivatives on investment contracts and certain variable annuity guarantees accounted for as embedded derivatives are excluded from this caption in the preceding tables as they are separately presented in "-- Recurring Fair Value Measurements." The investment contracts primarily include certain funding agreements, fixed deferred annuities, modified guaranteed annuities, fixed term payout annuities and total control accounts. The valuation of these investment contracts is based on discounted cash flow methodologies using significant unobservable inputs. The estimated fair value is determined using current market risk-free interest rates adding a spread to reflect the nonperformance risk in the liability. Long-term Debt The estimated fair value of long-term debt is principally determined using market standard valuation methodologies. Valuations of instruments are based primarily on quoted prices in markets that are not active or using matrix pricing that use standard market observable inputs such as quoted prices in markets that are not active and observable yields and spreads in the market. Instruments valued using discounted cash flow methodologies use standard market observable inputs including market yield curve, duration, observable prices and spreads for similar publicly traded or privately traded issues. Other Liabilities Other liabilities consist primarily of interest payable, amounts due for securities purchased but not yet settled and funds withheld amounts payable, which are contractually withheld by the Company in accordance with the terms of the reinsurance agreements. The Company evaluates the specific terms, facts and circumstances of each instrument to determine the appropriate estimated fair values, which are not materially different from the carrying values. Separate Account Liabilities Separate account liabilities represent those balances due to policyholders under contracts that are classified as investment contracts. 116
485BPOS346th Page of 388TOC1stPreviousNextBottomJust 346th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 10. Fair Value (continued) Separate account liabilities classified as investment contracts primarily represent variable annuities with no significant mortality risk to the Company such that the death benefit is equal to the account balance and certain contracts that provide for benefit funding. Since separate account liabilities are fully funded by cash flows from the separate account assets which are recognized at estimated fair value as described in the section "-- Recurring Fair Value Measurements," the value of those assets approximates the estimated fair value of the related separate account liabilities. The valuation techniques and inputs for separate account liabilities are similar to those described for separate account assets. 11. Goodwill Goodwill is the excess of cost over the estimated fair value of net assets acquired. Goodwill is not amortized but is tested for impairment at least annually or more frequently if events or circumstances, such as adverse changes in the business climate, indicate that there may be justification for conducting an interim test. The goodwill impairment process requires a comparison of the estimated fair value of a reporting unit to its carrying value. The Company tests goodwill for impairment by either performing a qualitative assessment or a two-step quantitative test. The qualitative assessment is an assessment of historical information and relevant events and circumstances to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill. The Company may elect not to perform the qualitative assessment for some or all of its reporting units and perform a two-step quantitative impairment test. In performing the two-step quantitative impairment test, the Company may use a market multiple valuation approach and a discounted cash flow valuation approach. For reporting units which are particularly sensitive to market assumptions, the Company may use additional valuation methodologies to estimate the reporting units' fair values. The market multiple valuation approach utilizes market multiples of companies with similar businesses and the projected operating earnings of the reporting unit. The discounted cash flow valuation approach requires judgments about revenues, operating earnings projections, capital market assumptions and discount rates. The key inputs, judgments and assumptions necessary in determining estimated fair value of the reporting units include projected operating earnings, current book value, the level of economic capital required to support the mix of business, long-term growth rates, comparative market multiples, the account value of in-force business, projections of new and renewal business, as well as margins on such business, the level of interest rates, credit spreads, equity market levels, and the discount rate that the Company believes is appropriate for the respective reporting unit. The valuation methodologies utilized are subject to key judgments and assumptions that are sensitive to change. Estimates of fair value are inherently uncertain and represent only management's reasonable expectation regarding future developments. These estimates and the judgments and assumptions upon which the estimates are based will, in all likelihood, differ in some respects from actual future results. Declines in the estimated fair value of the Company's reporting units could result in goodwill impairments in future periods which could materially adversely affect the Company's results of operations or financial position. For the 2014 annual goodwill impairment tests, the Company utilized the qualitative assessment for its Corporate Benefit Funding reporting unit and determined it was not more than likely that the fair value of the reporting unit was less than its carrying amount, and, therefore no further testing was needed for this reporting 117
485BPOS347th Page of 388TOC1stPreviousNextBottomJust 347th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 11. Goodwill (continued) unit. For the Retail Annuities reporting unit, for which goodwill was held at MLIIC prior to the Mergers, the Company utilized a market multiple valuation approach and determined that goodwill was not impaired. As a result of the Mergers (see Note 3) and the segment reporting changes discussed below, goodwill was re-tested for impairment during the fourth quarter of 2014. For the Corporate Benefit Funding reporting unit an updated qualitative assessment was performed and the Company determined it was not more than likely that the fair value of the reporting unit was less than its carrying amount, and, therefore, no further testing was needed for this reporting unit. For the Retail Annuities reporting unit, the Company performed a two-step quantitative impairment test comprised of a market multiple valuation and a discounted cash flow valuation and both approaches resulted in a fair value that was less than the carrying value, indicating a potential impairment. As a result, Step 2 of the goodwill impairment process was performed, which compares the implied fair value of the reporting unit's goodwill with its carrying value. This analysis indicated that the recorded goodwill associated with this reporting unit was not recoverable. Therefore, the Company recorded a non-cash charge of $33 million with no income tax impact for the impairment of the entire goodwill balance that is reported in goodwill impairment in the consolidated statements of operations for the year ended December 31, 2014. Effective January 1, 2015, the Company implemented certain segment reporting changes related to the measurement of segment operating earnings. The changes will be applied retrospectively beginning with the first quarter of 2015 and will not impact total consolidated operating earnings or net income. These changes include revising the Company's capital allocation methodology. As a result, re-testing of goodwill for the Corporate Benefit Funding and Retail Annuities reporting units, discussed above, was performed using the estimated revised carrying amounts of the reporting units. 118
485BPOS348th Page of 388TOC1stPreviousNextBottomJust 348th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 11. Goodwill (continued) Information regarding goodwill by segment, as well as Corporate & Other, was as follows: [Download Table] Corporate Benefit Corporate Retail Funding & Other (1) Total -------- --------- ----------- -------- (In millions) Balance at January 1, 2012 Goodwill..................... $ 274 $ 307 $ 405 $ 986 Accumulated impairment....... -- -- -- -- -------- --------- ----------- -------- Total goodwill, net......... $ 274 $ 307 $ 405 $ 986 Impairments (2).............. (218) -- (176) (394) Balance at December 31, 2012 Goodwill..................... $ 274 $ 307 $ 405 $ 986 Accumulated impairment....... (218) -- (176) (394) -------- --------- ----------- -------- Total goodwill, net......... $ 56 $ 307 $ 229 $ 592 Impairments (3).............. (23) -- (43) (66) Balance at December 31, 2013 Goodwill..................... $ 274 $ 307 $ 405 $ 986 Accumulated impairment....... (241) -- (219) (460) -------- --------- ----------- -------- Total goodwill, net......... $ 33 $ 307 $ 186 $ 526 Dispositions (4)............. -- (112) -- (112) Impairments.................. (33) -- -- (33) Balance at December 31, 2014 Goodwill..................... $ 274 $ 195 $ 405 $ 874 Accumulated impairment....... (274) -- (219) (493) -------- --------- ----------- -------- Total goodwill, net......... $ -- $ 195 $ 186 $ 381 ======== ========= =========== ======== -------- (1)For purposes of goodwill impairment testing in 2014, the $186 million of net goodwill in Corporate & Other at December 31, 2013 did not change. This balance resulted from goodwill acquired as part of the 2005 Travelers acquisition and was allocated to the Corporate Benefit Funding segment. (2)In connection with its annual goodwill impairment testing, the Company determined that recorded goodwill associated with the Retail Annuities reporting unit was not recoverable and recorded a non-cash charge of $394 million ($147 million, net of income tax) for the impairment in the consolidated statements of operations for the year ended December 31, 2012. (3)In connection with its annual goodwill impairment testing, the Company determined that all of the recorded goodwill associated with the Retail Life & Other reporting unit was not recoverable and recorded a non-cash charge of $66 million ($57 million, net of income tax) for the impairment of the entire goodwill balance in the consolidated statements of operations for the year ended December 31, 2013. (4)In connection with the sale of MAL, goodwill in the Corporate Benefit Funding reporting unit was reduced by $112 million during the year ended December 31, 2014. See Note 4. This goodwill was allocated to MAL based on the relative fair values of MAL and the remaining portion of the Corporate Benefit Funding reporting unit. 119
485BPOS349th Page of 388TOC1stPreviousNextBottomJust 349th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 12. Debt Long-term debt outstanding was as follows: [Download Table] December 31, Interest ----------------- Rate Maturity 2014 2013 -------- -------- -------- -------- (In millions) Surplus notes -- affiliated (1).... 8.60% 2038 $ 750 $ 750 Long-term debt -- affiliated (2)... 6.80% 2014 -- 75 Long-term debt -- unaffiliated (3). 7.03% 2030 39 40 -------- -------- Total long-term debt (4).......... $ 789 $ 865 ======== ======== -------- (1)Payments of interest and principal on affiliated surplus notes, which are subordinate to all other obligations at the operating company level, may be made only with the prior approval of the insurance department of the state of domicile. (2)In December 2014, MetLife USA repaid at maturity its $75 million 6.80% affiliated notes. (3)Principal and interest is paid quarterly. (4)Excludes $139 million and $1.5 billion of long-term debt relating to CSEs at December 31, 2014 and 2013, respectively. See Note 8. The aggregate maturities of long-term debt at December 31, 2014 are $1 million in each of 2015, 2016, and 2017, $2 million in each of 2018 and 2019 and $782 million thereafter. Interest expense related to the Company's indebtedness is included in other expenses and was $73 million for each of the years ended December 31, 2014 and 2013, and interest expense was $154 million for the year ended December 31, 2012. Letters of Credit The Company had access to credit facilities from various banks, either directly with the bank or indirectly through letters of credit available to MetLife, Inc. for the benefit of the Company and certain other affiliates of MetLife, Inc. These facilities were used for collateral for certain of the Company's affiliated reinsurance liabilities. Total fees expensed associated with letters of credit were $13 million, $27 million and $33 million for the years ended December 31, 2014, 2013 and 2012, respectively, and were included in other expenses. At December 31, 2014, the Company had $2 million in letters of credit outstanding. Remaining availability was $3.3 billion at December 31, 2014. 13. Equity See Note 3 for a discussion on the Mergers. 120
485BPOS350th Page of 388TOC1stPreviousNextBottomJust 350th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 13. Equity (continued) Common Stock In August 2014, MetLife Insurance Company of Connecticut redeemed for $1.4 billion and retired 4,595,317 shares of its common stock owned by MetLife Investors Group LLC. Capital Contributions In August 2014, MetLife Insurance Company of Connecticut received a capital contribution of $231 million in cash from MetLife, Inc. In December and June 2012, Exeter received capital contributions of $550 million and $250 million, respectively, in cash from MetLife, Inc. Statutory Equity and Income Each U.S. insurance company's state of domicile imposes risk-based capital ("RBC") requirements that were developed by the National Association of Insurance Commissioners ("NAIC"). Regulatory compliance is determined by a ratio of a company's total adjusted capital, calculated in the manner prescribed by the NAIC ("TAC") to its authorized control level RBC, calculated in the manner prescribed by the NAIC ("ACL RBC"). Companies below specific trigger levels or ratios are classified by certain levels, each of which requires specified corrective action. The minimum level of TAC before corrective action commences is twice ACL RBC. The RBC ratio for MetLife USA was in excess of 350% for all periods presented. MetLife USA prepares statutory-basis financial statements in accordance with statutory accounting practices prescribed or permitted by the insurance department of its state of domicile or applicable foreign jurisdiction. The NAIC has adopted the Codification of Statutory Accounting Principles ("Statutory Codification"). Statutory Codification is intended to standardize regulatory accounting and reporting to state insurance departments. However, statutory accounting principles continue to be established by individual state laws and permitted practices. Modifications by the various state insurance departments may impact the effect of Statutory Codification on the statutory capital and surplus of MetLife USA. Statutory accounting principles differ from GAAP primarily by charging policy acquisition costs to expense as incurred, establishing future policy benefit liabilities using different actuarial assumptions, reporting surplus notes as surplus instead of debt, reporting of reinsurance agreements and valuing securities on a different basis. In addition, certain assets are not admitted under statutory accounting principles and are charged directly to surplus. The most significant assets not admitted by MetLife USA are net deferred income tax assets resulting from temporary differences between statutory accounting principles basis and tax basis not expected to reverse and become recoverable within three years. The Delaware Department of Insurance approved two statutory accounting permitted practices for MetLife USA. For December 31, 2013, MetLife USA applied a U.S. GAAP reserving methodology for certain foreign blocks of business held by Exeter prior to the Mergers. These blocks of business were recaptured by the counterparties prior to the Mergers and are, therefore, not included in MetLife USA's statutory reserves as of December 31, 2014. In addition, the Delaware Department of Insurance granted permission for MetLife USA not 121
485BPOS351st Page of 388TOC1stPreviousNextBottomJust 351st
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 13. Equity (continued) to calculate, record or disclose the effect of this permitted practice on statutory surplus and net income. Additionally, the Delaware Department of Insurance granted approval for MetLife USA to present the statutory conversion of Exeter's capital and surplus accounts, which have been historically reported under U.S. GAAP, as an adjustment to MetLife USA's gross paid-in and contributed surplus in a manner similar to a quasi-reorganization for all periods presented. This permitted practice had the effect of decreasing gross paid-in and contributed surplus and increasing unassigned funds for MetLife USA by $4.4 billion for the year ended December 31, 2013 with no net effect on overall capital and surplus. The tables below present amounts from MetLife USA, which are derived from the most recent statutory-basis financial statements as filed with the Delaware Department of Insurance. Statutory net income (loss) was as follows: [Download Table] Years Ended December 31, ------------------------ Company State of Domicile 2014 2013 2012 ---------------- ----------------- ------ ------ ---- (In millions) MetLife USA (1). Delaware $1,543 $3,358 $848 -------- (1)Statutory net income (loss) for the year ended December 31, 2012 is as filed with the Connecticut Insurance Department by MetLife Insurance Company of Connecticut and does not reflect the results of the Mergers. Statutory capital and surplus was as follows at: [Download Table] December 31, --------------------- Company 2014 2013 ------------ ---------- ---------- (In millions) MetLife USA. $ 6,042 $ 3,566 As of December 31, 2013, the Company's sole foreign insurance subsidiary, MAL, was regulated by authorities in the United Kingdom and was subject to minimum capital and solvency requirements before corrective action commences. The required capital and surplus was $165 million and the actual regulatory capital and surplus was $573 million in the most recent capital adequacy calculation for the jurisdiction as of December 31, 2013. MAL exceeded the minimum capital and solvency requirements for all other periods presented. See Note 4 for information on the disposal of MAL. Dividend Restrictions Under Delaware State Insurance Law, MetLife USA is permitted, without prior insurance regulatory clearance, to pay a stockholder dividend as long as the amount of the dividend when aggregated with all other dividends in the preceding 12 months does not exceed the greater of: (i) 10% of its surplus to policyholders as of the end of the immediately preceding calendar year; or (ii) its net statutory gain from operations for the immediately preceding calendar year (excluding realized capital gains). MetLife USA will be permitted to pay a dividend in excess of the greater of such two amounts only if it files notice of the declaration of such a dividend and the amount thereof with the Delaware Commissioner of Insurance (the "Delaware Commissioner") and the Delaware 122
485BPOS352nd Page of 388TOC1stPreviousNextBottomJust 352nd
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 13. Equity (continued) Commissioner either approves the distribution of the dividend or does not disapprove the distribution within 30 days of its filing. In addition, any dividend that exceeds earned surplus (defined as "unassigned funds (surplus)") as of the immediately preceding calendar year requires insurance regulatory approval. Under Delaware State Insurance Law, the Delaware Commissioner has broad discretion in determining whether the financial condition of a stock life insurance company would support the payment of such dividends to its stockholders. During the year ended December 31, 2014, MetLife USA did not pay a dividend. The following dividends were paid prior to the Mergers: . During the year ended December 31, 2013, MetLife Insurance Company of Connecticut paid a dividend to MetLife, Inc. of $1.0 billion. . During the year ended December 31, 2013, MLIIC paid a dividend to MetLife, Inc. of $129 million. . During the years ended December 31, 2014 and 2013, Exeter paid dividends to MetLife, Inc. of $155 million and $132 million, respectively. Based on amounts at December 31, 2014, MetLife USA could pay a dividend to MetLife, Inc. in 2015 of $3.0 billion without prior approval of the Delaware Commissioner. 123
485BPOS353rd Page of 388TOC1stPreviousNextBottomJust 353rd
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 13. Equity (continued) Accumulated Other Comprehensive Income (Loss) Information regarding changes in the balances of each component of AOCI, net of income tax, was as follows: [Enlarge/Download Table] Unrealized Investment Gains Unrealized Foreign Currency (Losses), Net of Gains (Losses) on Translation Related Offsets (1) Derivatives Adjustments Total ------------------- ----------------- ---------------- ---------- (In millions) Balance at January 1, 2012.......................... $ 1,815 $ 156 $ (116) $ 1,855 OCI before reclassifications........................ 1,035 6 101 1,142 Deferred income tax benefit (expense)............... (380) (1) 2 (379) ------------------- ----------------- ---------------- ---------- OCI before reclassifications, net of income tax... 2,470 161 (13) 2,618 Amounts reclassified from AOCI...................... (94) (3) -- (97) Deferred income tax benefit (expense)............... 34 1 -- 35 ------------------- ----------------- ---------------- ---------- Amounts reclassified from AOCI, net of income tax. (60) (2) -- (62) ------------------- ----------------- ---------------- ---------- Balance at December 31, 2012........................ 2,410 159 (13) 2,556 OCI before reclassifications........................ (2,163) (195) 54 (2,304) Deferred income tax benefit (expense)............... 714 68 (2) 780 ------------------- ----------------- ---------------- ---------- OCI before reclassifications, net of income tax... 961 32 39 1,032 Amounts reclassified from AOCI...................... (69) (11) -- (80) Deferred income tax benefit (expense)............... 24 4 -- 28 ------------------- ----------------- ---------------- ---------- Amounts reclassified from AOCI, net of income tax. (45) (7) -- (52) ------------------- ----------------- ---------------- ---------- Balance at December 31, 2013........................ 916 25 39 980 OCI before reclassifications........................ 2,301 242 (56) 2,487 Deferred income tax benefit (expense)............... (707) (85) 4 (788) ------------------- ----------------- ---------------- ---------- OCI before reclassifications, net of income tax... 2,510 182 (13) 2,679 Amounts reclassified from AOCI...................... (28) 2 -- (26) Deferred income tax benefit (expense)............... 8 (1) -- 7 ------------------- ----------------- ---------------- ---------- Amounts reclassified from AOCI, net of income tax. (20) 1 -- (19) ------------------- ----------------- ---------------- ---------- Sale of subsidiary (2).............................. (320) -- 6 (314) Deferred income tax benefit (expense)............... 80 -- -- 80 ------------------- ----------------- ---------------- ---------- Sale of subsidiary, net of income tax............. (240) -- 6 (234) ------------------- ----------------- ---------------- ---------- Balance at December 31, 2014........................ $ 2,250 $ 183 $ (7) $ 2,426 =================== ================= ================ ========== -------- (1)See Note 8 for information on offsets to investments related to future policy benefits, DAC, VOBA and DSI. (2)See Note 4. 124
485BPOS354th Page of 388TOC1stPreviousNextBottomJust 354th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 13. Equity (continued) Information regarding amounts reclassified out of each component of AOCI, was as follows: [Enlarge/Download Table] Consolidated Statement of Operations and AOCI Components Amounts Reclassified from AOCI Comprehensive Income (Loss) Locations ------------------------------------------- ----------------------------- ---------------------------------------- Years Ended December 31, ----------------------------- 2014 2013 2012 --------- --------- --------- (In millions) Net unrealized investment gains (losses): Net unrealized investment gains(losses)............................. $ 13 $ 50 $ 99 Net investment gains (losses) Net unrealized investment gains (losses).................................. 11 17 7 Net investment income Net unrealized investment gains (losses).................................. 4 2 (12) Net derivative gains (losses) --------- --------- --------- Net unrealized investment gains (losses), before income tax............. 28 69 94 Income tax (expense) benefit............. (8) (24) (34) --------- --------- --------- Net unrealized investment gains (losses), net of income tax............ $ 20 $ 45 $ 60 ========= ========= ========= Unrealized gains (losses) on derivatives - cash flow hedges: Interest rate swaps........................ $ 1 $ -- $ -- Net derivative gains (losses) Interest rate swaps........................ 1 1 -- Net investment income Interest rate forwards..................... 1 9 1 Net derivative gains (losses) Interest rate forwards..................... 1 1 1 Net investment income Foreign currency swaps..................... (6) -- 1 Net derivative gains (losses) --------- --------- --------- Gains (losses) on cash flow hedges, before income tax....................... (2) 11 3 Income tax (expense) benefit............. 1 (4) (1) --------- --------- --------- Gains (losses) on cash flow hedges, net of income tax.............. $ (1) $ 7 $ 2 ========= ========= ========= Total reclassifications, net of income tax........................... $ 19 $ 52 $ 62 ========= ========= ========= 125
485BPOS355th Page of 388TOC1stPreviousNextBottomJust 355th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 14. Other Expenses Information on other expenses was as follows: [Enlarge/Download Table] Years Ended December 31, -------------------------- 2014 2013 2012 -------- -------- -------- (In millions) Compensation............................................... $ 320 $ 358 $ 410 Commissions................................................ 492 700 1,007 Volume-related costs....................................... 170 165 196 Affiliated interest costs on ceded and assumed reinsurance. 325 212 271 Capitalization of DAC...................................... (279) (512) (908) Amortization of DAC and VOBA............................... 990 205 734 Interest expense on debt................................... 109 195 317 Premium taxes, licenses and fees........................... 53 59 64 Professional services...................................... 58 42 26 Rent and related expenses.................................. 41 31 38 Other...................................................... 475 482 481 -------- -------- -------- Total other expenses...................................... $ 2,754 $ 1,937 $ 2,636 ======== ======== ======== Capitalization of DAC and Amortization of DAC and VOBA See Note 6 for additional information on DAC and VOBA including impacts of capitalization and amortization. Interest Expense on Debt Interest expense on debt includes interest expense on debt (see Note 12) and interest expense related to CSEs (see Note 8). Affiliated Expenses Commissions, capitalization of DAC and amortization of DAC and VOBA include the impact of affiliated reinsurance transactions. See Notes 7, 12 and 17 for a discussion of affiliated expenses included in the table above. 126
485BPOS356th Page of 388TOC1stPreviousNextBottomJust 356th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 15. Income Tax The provision for income tax from continuing operations was as follows: [Download Table] Years Ended December 31, ---------------------------- 2014 2013 2012 -------- --------- --------- (In millions) Current: Federal.......................................... $ (364) $ (271) $ (590) Foreign.......................................... 6 8 (10) -------- --------- --------- Subtotal....................................... (358) (263) (600) -------- --------- --------- Deferred: Federal.......................................... 355 682 (232) Foreign.......................................... (2) 18 19 -------- --------- --------- Subtotal....................................... 353 700 (213) -------- --------- --------- Provision for income tax expense (benefit)... $ (5) $ 437 $ (813) ======== ========= ========= The Company's income (loss) from continuing operations before income tax expense (benefit) from domestic and foreign operations were as follows: [Enlarge/Download Table] Years Ended December 31, -------------------------------------------------------- 2014 2013 2012 -------- -------- ---------- (In millions) Income (loss) from continuing operations: Domestic............................................... $ (174) $ 1,724 $ (531) Foreign................................................ 464 (146) (1,341) -------- -------- ---------- Total................................................ $ 290 $ 1,578 $ (1,872) ======== ======== ========== The reconciliation of the income tax provision at the U.S. statutory rate to the provision for income tax as reported for continuing operations was as follows: Years Ended December 31, -------------------------------------------------------- 2014 2013 2012 -------- -------- ---------- (In millions) Tax provision at U.S. statutory rate.................... $ 102 $ 551 $ (654) Tax effect of: Dividend received deduction............................ (114) (93) (81) Tax-exempt income...................................... -- -- (1) Prior year tax......................................... (20) (6) 6 Tax credits............................................ (14) (11) (9) Foreign tax rate differential.......................... -- (2) 13 Change in valuation allowance.......................... -- -- 22 Goodwill impairment.................................... 12 13 (109) Sale of subsidiary..................................... 24 (24) -- Other, net............................................. 5 9 -- -------- -------- ---------- Provision for income tax expense (benefit)........... $ (5) $ 437 $ (813) ======== ======== ========== 127
485BPOS357th Page of 388TOC1stPreviousNextBottomJust 357th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 15. Income Tax (continued) Deferred income tax represents the tax effect of the differences between the book and tax bases of assets and liabilities. Net deferred income tax assets and liabilities consisted of the following at: [Enlarge/Download Table] December 31, ----------------------------------- 2014 2013 ------------------ ---------------- (In millions) Deferred income tax assets: Policyholder liabilities and receivables........ $ 1,836 $ 1,872 Net operating loss carryforwards................ -- 89 Investments, including derivatives.............. -- 179 Tax credit carryforwards........................ 149 130 Other........................................... 40 9 ------------------ ---------------- Total deferred income tax assets.............. 2,025 2,279 ------------------ ---------------- Deferred income tax liabilities: Investments, including derivatives.............. 372 -- Intangibles..................................... 519 531 Net unrealized investment gains................. 1,296 591 DAC............................................. 1,176 1,310 Other........................................... -- 98 ------------------ ---------------- Total deferred income tax liabilities......... 3,363 2,530 ------------------ ---------------- Net deferred income tax asset (liability)... $ (1,338) $ (251) ================== ================ The following table sets forth the general business credits, foreign tax credits, and other tax credit carryforwards for tax purposes at December 31, 2014. [Download Table] Tax Credit Carryforwards ------------------------------------------------------- General Business Credits Foreign Tax Credits Other ------------------------ ------------------- ---------- (In millions) Expiration 2015-2019.. -- -- -- 2020-2024.. -- 32 -- 2025-2029.. -- -- -- 2030-2034.. 6 -- -- Indefinite. -- -- 101 ------------------------ ------------------- ---------- $ 6 $ 32 $ 101 ======================== =================== ========== Pursuant to Internal Revenue Service ("IRS") rules, the Company was excluded from MetLife, Inc.'s life/non-life consolidated federal tax return for the five years subsequent to MetLife, Inc.'s July 2005 acquisition of the Company. In 2011, MetLife Insurance Company of Connecticut and its subsidiaries joined the consolidated return and became a party to the MetLife Inc. tax sharing agreement. Prior to 2011, MetLife Insurance Company of Connecticut filed a consolidated tax return with its includable subsidiaries. Non-includable subsidiaries filed either separate individual corporate tax returns or separate consolidated tax returns. 128
485BPOS358th Page of 388TOC1stPreviousNextBottomJust 358th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 15. Income Tax (continued) The Company participates in a tax sharing agreement with MetLife Inc., as described in Note 1. Pursuant to this tax sharing agreement, the amounts due to (from) affiliates included ($537) million, ($400) million and ($406) million for the years ended December 31, 2014, 2013 and 2012, respectively. The Company files income tax returns with the U.S. federal government and various state and local jurisdictions, as well as foreign jurisdictions. The Company is under continuous examination by the IRS and other tax authorities in jurisdictions in which the Company has significant business operations. The income tax years under examination vary by jurisdiction and subsidiary. The Company is no longer subject to U.S. federal, state or local income tax examinations for years prior to 2007, except for 2003 through 2006 where the IRS disallowance relates predominantly to tax policyholder liability deductions and the Company continues to protest. During June 2014, the IRS concluded its audit of the Company's tax returns for the years 2003 through 2006 and issued a Revenue Agent's report. The Company agreed with certain tax adjustments and filed a protest in July 2014 for other tax adjustments. Management believes it has established adequate tax liabilities and final resolution of the audit for the years 2003 through 2006 is not expected to have a material impact on the Company's financial statements. The Company's liability for unrecognized tax benefits may increase or decrease in the next 12 months. A reasonable estimate of the increase or decrease cannot be made at this time. However, the Company continues to believe that the ultimate resolution of the pending issues will not result in a material change to its consolidated financial statements, although the resolution of income tax matters could impact the Company's effective tax rate for a particular future period. A reconciliation of the beginning and ending amount of unrecognized tax benefits was as follows: [Enlarge/Download Table] Years Ended December 31, ------------------------ 2014 2013 2012 ------- ------- -------- (In millions) Balance at January 1,.................................................... $ 26 $ (1) $ 29 Additions for tax positions of prior years............................... 15 28 46 Reductions for tax positions of prior years.............................. (5) (1) (76) Additions for tax positions of current year.............................. 2 1 9 Reductions for tax positions of current year............................. -- (1) (9) ------- ------- -------- Balance at December 31,.................................................. $ 38 $ 26 $ (1) ======= ======= ======== Unrecognized tax benefits that, if recognized would impact the effective rate................................................................... $ 28 $ 26 $ (1) ======= ======= ======== The Company classifies interest accrued related to unrecognized tax benefits in interest expense, included within other expenses, while penalties are included in income tax expense. 129
485BPOS359th Page of 388TOC1stPreviousNextBottomJust 359th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 15. Income Tax (continued) Interest was as follows: [Enlarge/Download Table] Years Ended December 31, ----------------------- 2014 2013 2012 ------- ------ -------- (In millions) Interest recognized in the consolidated statements of operations. $ -- $ 2 $ (9) December 31, --------------- 2014 2013 ------ -------- (In millions) Interest included in other liabilities in the consolidated balance sheets. $ 2 $ 2 The Company had no penalties for the years ended December 31, 2014, 2013 and 2012. The U.S. Treasury Department and the IRS have indicated that they intend to address through regulations the methodology to be followed in determining the dividends received deduction ("DRD"), related to variable life insurance and annuity contracts. The DRD reduces the amount of dividend income subject to tax and is a significant component of the difference between the actual tax expense and expected amount determined using the federal statutory tax rate of 35%. Any regulations that the IRS ultimately proposes for issuance in this area will be subject to public notice and comment, at which time insurance companies and other interested parties will have the opportunity to raise legal and practical questions about the content, scope and application of such regulations. As a result, the ultimate timing and substance of any such regulations are unknown at this time. For the years ended December 31, 2014 and 2013, the Company recognized an income tax benefit of $135 million and $106 million, respectively, related to the separate account DRD. The 2014 benefit included a benefit of $21 million related to a true-up of the 2013 tax return. The 2013 benefit included a benefit of $13 million related to a true-up of the 2012 tax return. 16. Contingencies, Commitments and Guarantees Contingencies Litigation The Company is a defendant in a number of litigation matters. In some of the matters, large and/or indeterminate amounts, including punitive and treble damages, are sought. Modern pleading practice in the U.S. permits considerable variation in the assertion of monetary damages or other relief. Jurisdictions may permit claimants not to specify the monetary damages sought or may permit claimants to state only that the amount sought is sufficient to invoke the jurisdiction of the trial court. In addition, jurisdictions may permit plaintiffs to allege monetary damages in amounts well exceeding reasonably possible verdicts in the jurisdiction for similar matters. This variability in pleadings, together with the actual experience of the Company in litigating or resolving through settlement numerous claims over an extended period of time, demonstrates to management that the monetary relief which may be specified in a lawsuit or claim bears little relevance to its merits or disposition value. Due to the vagaries of litigation, the outcome of a litigation matter and the amount or range of potential loss at particular points in time may normally be difficult to ascertain. Uncertainties can include how fact finders 130
485BPOS360th Page of 388TOC1stPreviousNextBottomJust 360th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 16. Contingencies, Commitments and Guarantees (continued) will evaluate documentary evidence and the credibility and effectiveness of witness testimony, and how trial and appellate courts will apply the law in the context of the pleadings or evidence presented, whether by motion practice, or at trial or on appeal. Disposition valuations are also subject to the uncertainty of how opposing parties and their counsel will themselves view the relevant evidence and applicable law. The Company establishes liabilities for litigation and regulatory loss contingencies when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. It is possible that some matters could require the Company to pay damages or make other expenditures or establish accruals in amounts that could not be estimated at December 31, 2014. Matters as to Which an Estimate Can Be Made For some loss contingency matters, the Company is able to estimate a reasonably possible range of loss. For such matters where a loss is believed to be reasonably possible, but not probable, no accrual has been made. As of December 31, 2014, the aggregate range of reasonably possible losses in excess of amounts accrued for these matters was not material for the Company. Matters as to Which an Estimate Cannot Be Made For other matters, the Company is not currently able to estimate the reasonably possible loss or range of loss. The Company is often unable to estimate the possible loss or range of loss until developments in such matters have provided sufficient information to support an assessment of the range of possible loss, such as quantification of a damage demand from plaintiffs, discovery from other parties and investigation of factual allegations, rulings by the court on motions or appeals, analysis by experts, and the progress of settlement negotiations. On a quarterly and annual basis, the Company reviews relevant information with respect to litigation contingencies and updates its accruals, disclosures and estimates of reasonably possible losses or ranges of loss based on such reviews. Unclaimed Property Litigation On December 28, 2012, the West Virginia Treasurer filed an action (West Virginia ex rel. John D. Perdue v. MetLife Insurance Company of Connecticut, Circuit Court of Putnam County), alleging that the Company violated the West Virginia Uniform Unclaimed Property Act, seeking to compel compliance with the Act, and seeking payment of unclaimed property, interest, and penalties. On November 14, 2012, the Treasurer filed a substantially identical suit against MLI-USA. On December 30, 2013, the court granted defendants' motions to dismiss all of the West Virginia Treasurer's actions. The Treasurer has appealed the dismissal order. Sales Practices Claims Over the past several years, the Company has faced claims and regulatory inquiries and investigations, alleging improper marketing or sales of individual life insurance policies, annuities, mutual funds or other products. The Company continues to defend vigorously against the claims in these matters. The Company believes adequate provision has been made in its consolidated financial statements for all probable and reasonably estimable losses for sales practices matters. 131
485BPOS361st Page of 388TOC1stPreviousNextBottomJust 361st
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 16. Contingencies, Commitments and Guarantees (continued) Summary Various litigation, claims and assessments against the Company, in addition to those discussed previously and those otherwise provided for in the Company's consolidated financial statements, have arisen in the course of the Company's business, including, but not limited to, in connection with its activities as an insurer, employer, investor, investment advisor and taxpayer. Further, state insurance regulatory authorities and other federal and state authorities regularly make inquiries and conduct investigations concerning the Company's compliance with applicable insurance and other laws and regulations. It is not possible to predict the ultimate outcome of all pending investigations and legal proceedings. In some of the matters referred to previously, large and/or indeterminate amounts, including punitive and treble damages, are sought. Although, in light of these considerations it is possible that an adverse outcome in certain cases could have a material effect upon the Company's financial position, based on information currently known by the Company's management, in its opinion, the outcomes of such pending investigations and legal proceedings are not likely to have such an effect. However, given the large and/or indeterminate amounts sought in certain of these matters and the inherent unpredictability of litigation, it is possible that an adverse outcome in certain matters could, from time to time, have a material effect on the Company's consolidated net income or cash flows in particular quarterly or annual periods. Insolvency Assessments Most of the jurisdictions in which the Company is admitted to transact business require insurers doing business within the jurisdiction to participate in guaranty associations, which are organized to pay contractual benefits owed pursuant to insurance policies issued by impaired, insolvent or failed insurers. These associations levy assessments, up to prescribed limits, on all member insurers in a particular state on the basis of the proportionate share of the premiums written by member insurers in the lines of business in which the impaired, insolvent or failed insurer engaged. Some states permit member insurers to recover assessments paid through full or partial premium tax offsets. Assets and liabilities held for insolvency assessments were as follows: [Download Table] December 31, --------------- 2014 2013 ------- ------- (In millions) Other Assets: Premium tax offset for future undiscounted assessments....... $ 13 $ 11 Premium tax offsets currently available for paid assessments. 13 10 Receivable for reimbursement of paid assessments (1)......... -- 5 ------- ------- $ 26 $ 26 ======= ======= Other Liabilities: Insolvency assessments....................................... $ 18 $ 20 ======= ======= -------- (1)The Company holds a receivable from the seller of a prior acquisition in accordance with the purchase agreement. 132
485BPOS362nd Page of 388TOC1stPreviousNextBottomJust 362nd
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 16. Contingencies, Commitments and Guarantees (continued) Commitments Mortgage Loan Commitments The Company commits to lend funds under mortgage loan commitments. The amounts of these mortgage loan commitments were $36 million and $153 million at December 31, 2014 and 2013, respectively. Commitments to Fund Partnership Investments and Private Corporate Bond Investments The Company commits to fund partnership investments and to lend funds under private corporate bond investments. The amounts of these unfunded commitments were $918 million and $1.0 billion at December 31, 2014 and 2013, respectively. Other Commitments The Company has entered into collateral arrangements with affiliates, which require the transfer of collateral in connection with secured demand notes. At December 31, 2014 and 2013, the Company had agreed to fund up to $32 million and $61 million, respectively, of cash upon the request by these affiliates and had transferred collateral consisting of various securities with a fair market value of $57 million and $74 million, respectively, to custody accounts to secure the demand notes. Each of these affiliates is permitted by contract to sell or re-pledge this collateral. Guarantees In the normal course of its business, the Company has provided certain indemnities, guarantees and commitments to third parties such that it may be required to make payments now or in the future. In the context of acquisition, disposition, investment and other transactions, the Company has provided indemnities and guarantees, including those related to tax, environmental and other specific liabilities and other indemnities and guarantees that are triggered by, among other things, breaches of representations, warranties or covenants provided by the Company. In addition, in the normal course of business, the Company provides indemnifications to counterparties in contracts with triggers similar to the foregoing, as well as for certain other liabilities, such as third-party lawsuits. These obligations are often subject to time limitations that vary in duration, including contractual limitations and those that arise by operation of law, such as applicable statutes of limitation. The maximum potential obligation under the indemnities and guarantees is subject to a contractual limitation, ranging from $36 million to $233 million, with a cumulative maximum of $269 million, in the case of MetLife International Insurance Company, Ltd. ("MLII"), a former affiliate, discussed below. In other cases such limitations are not specified or applicable. Since certain of these obligations are not subject to limitations, the Company does not believe that it is possible to determine the maximum potential amount that could become due under these guarantees in the future. Management believes that it is unlikely the Company will have to make any material payments under these indemnities, guarantees, or commitments. The Company has provided a guarantee on behalf of MLII that is triggered if MLII cannot pay claims because of insolvency, liquidation or rehabilitation. Life insurance coverage in-force, representing the maximum potential obligation under this guarantee, was $233 million at both December 31, 2014 and 2013. The Company does not hold any collateral related to this guarantee, but has a recorded liability of $1 million that was based on the total 133
485BPOS363rd Page of 388TOC1stPreviousNextBottomJust 363rd
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Notes to the Consolidated Financial Statements -- (Continued) 16. Contingencies, Commitments and Guarantees (continued) account value of the guaranteed policies plus the amounts retained per policy at both December 31, 2014 and 2013. The remainder of the risk was ceded to external reinsurers. In addition, the Company indemnifies its directors and officers as provided in its charters and by-laws. Also, the Company indemnifies its agents for liabilities incurred as a result of their representation of the Company's interests. Since these indemnities are generally not subject to limitation with respect to duration or amount, the Company does not believe that it is possible to determine the maximum potential amount that could become due under these indemnities in the future. 17. Related Party Transactions Service Agreements The Company has entered into various agreements with affiliates for services necessary to conduct its activities. Typical services provided under these agreements include management, policy administrative functions, personnel, investment advice and distribution services. For certain agreements, charges are based on various performance measures or activity-based costing. The bases for such charges are modified and adjusted by management when necessary or appropriate to reflect fairly and equitably the actual incidence of cost incurred by the Company and/or affiliate. Expenses and fees incurred with affiliates related to these agreements, recorded in other expenses, were $1.6 billion, $1.7 billion and $1.8 billion for the years ended December 31, 2014, 2013 and 2012, respectively. Revenues received from affiliates related to these agreements, recorded in universal life and investment-type product policy fees, were $266 million, $247 million and $213 million for the years ended December 31, 2014, 2013 and 2012, respectively. Revenues received from affiliates related to these agreements, recorded in other revenues, were $202 million, $211 million and $190 million for the years ended December 31, 2014, 2013 and 2012, respectively. The Company had net receivables (payables) from/to affiliates, related to the items discussed above, of $26 million and ($206) million at December 31, 2014 and 2013, respectively. See Notes 7, 8, 9 and 12 for additional information on related party transactions. 134
485BPOS364th Page of 388TOC1stPreviousNextBottomJust 364th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Schedule I Consolidated Summary of Investments -- Other Than Investments in Related Parties December 31, 2014 (In millions) [Enlarge/Download Table] Amount at Which Shown on Cost or Amortized Cost (1) Estimated Fair Value Balance Sheet Types of Investments -------------------------- -------------------- ------------------------ Fixed maturity securities: Bonds: U.S. Treasury and agency securities..................... $ 14,147 $ 15,826 $ 15,826 Public utilities................. 3,100 3,490 3,490 State and political subdivision securities..................... 2,180 2,592 2,592 Foreign government securities.... 607 741 741 All other corporate bonds........ 16,967 18,267 18,267 -------------------------- -------------------- ------------------------ Total bonds.................... 37,001 40,916 40,916 Mortgage-backed and asset-backed securities....................... 9,041 9,322 9,322 Redeemable preferred stock......... 381 459 459 -------------------------- -------------------- ------------------------ Total fixed maturity securities................. 46,423 50,697 50,697 -------------------------- -------------------- ------------------------ Equity securities: Common stock: Industrial, miscellaneous and all other............................ 176 233 233 Non-redeemable preferred stock..... 224 226 226 -------------------------- -------------------- ------------------------ Total equity securities........ 400 459 459 -------------------------- -------------------- ------------------------ Mortgage loans...................... 5,839 5,839 Policy loans........................ 1,194 1,194 Real estate and real estate joint ventures.......................... 894 894 Other limited partnership interests. 2,234 2,234 Short-term investments.............. 1,232 1,232 Other invested assets............... 4,531 4,531 -------------------------- ------------------------ Total investments........... $ 62,747 $ 67,080 ========================== ======================== -------- (1)Cost or amortized cost for fixed maturity securities and mortgage loans represents original cost reduced by repayments, valuation allowances and impairments from other-than-temporary declines in estimated fair value that are charged to earnings and adjusted for amortization of premiums or accretion of discounts; for equity securities, cost represents original cost reduced by impairments from other-than-temporary declines in estimated fair value; for real estate, cost represents original cost reduced by impairments and adjusted for valuation allowances and depreciation; for real estate joint ventures and other limited partnership interests, cost represents original cost reduced for impairments or original cost adjusted for equity in earnings and distributions. 135
485BPOS365th Page of 388TOC1stPreviousNextBottomJust 365th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Schedule III Consolidated Supplementary Insurance Information December 31, 2014, 2013 and 2012 (In millions) [Enlarge/Download Table] Future Policy DAC Benefits and Other and Policy-Related Policyholder Unearned Unearned Segment VOBA Balances Account Balances Premiums (1), (2) Revenue (1) -------------------------- -------- ------------------ ---------------- ----------------- ----------- 2014 Retail.................... $ 4,824 $ 14,184 $ 28,790 $ 9 $203 Corporate Benefit Funding. 5 10,849 6,695 -- 1 Corporate & Other......... 61 6,766 1 5 -- -------- ------------------ ---------------- ----------------- ----------- Total.................... $ 4,890 $ 31,799 $ 35,486 $ 14 $204 ======== ================== ================ ================= =========== 2013 Retail.................... $ 5,659 $ 13,156 $ 27,864 $ 9 $286 Corporate Benefit Funding. 6 14,270 8,357 -- 2 Corporate & Other......... 26 7,307 1,168 4 -- -------- ------------------ ---------------- ----------------- ----------- Total.................... $ 5,691 $ 34,733 $ 37,389 $ 13 $288 ======== ================== ================ ================= =========== 2012 Retail.................... $ 4,796 $ 11,909 $ 32,640 $ 9 $277 Corporate Benefit Funding. 8 15,078 9,093 -- 2 Corporate & Other......... -- 7,235 2,647 4 -- -------- ------------------ ---------------- ----------------- ----------- Total.................... $ 4,804 $ 34,222 $ 44,380 $ 13 $279 ======== ================== ================ ================= =========== -------- (1)Amounts are included within the future policy benefits and other policy-related balances column. (2)Includes premiums received in advance. 136
485BPOS366th Page of 388TOC1stPreviousNextBottomJust 366th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Schedule III Consolidated Supplementary Insurance Information -- (Continued) December 31, 2014, 2013 and 2012 (In millions) [Enlarge/Download Table] Policyholder Benefits Premiums and and Claims and Amortization of Universal Life and Interest Credited DAC and VOBA Investment-Type Net Investment to Policyholder Charged to Other Operating Segment Product Policy Fees Income Account Balances Other Expenses Expenses (1) ------------------ ------------------- -------------- --------------------- --------------- --------------- 2014 Retail............ $ 4,094 $ 1,947 $ 3,168 $ 966 $ 1,506 Corporate Benefit Funding......... 9 908 603 2 39 Corporate & Other. 242 (186) 55 22 219 ------------------- -------------- --------------------- --------------- --------------- Total............ $ 4,345 $ 2,669 $ 3,826 $ 990 $ 1,764 =================== ============== ===================== =============== =============== 2013 Retail............ $ 3,385 $ 1,906 $ 3,444 $ 199 $ 1,457 Corporate Benefit Funding......... 219 1,139 858 5 34 Corporate & Other. 215 (46) 13 1 241 ------------------- -------------- --------------------- --------------- --------------- Total............ $ 3,819 $ 2,999 $ 4,315 $ 205 $ 1,732 =================== ============== ===================== =============== =============== 2012 Retail............ $ 3,361 $ 1,725 $ 3,120 $ 721 $ 1,507 Corporate Benefit Funding......... 658 1,146 1,322 10 36 Corporate & Other. 1,210 189 1,160 3 359 ------------------- -------------- --------------------- --------------- --------------- Total............ $ 5,229 $ 3,060 $ 5,602 $ 734 $ 1,902 =================== ============== ===================== =============== =============== -------- (1)Includes other expenses, excluding amortization of DAC and VOBA charged to other expenses. 137
485BPOS367th Page of 388TOC1stPreviousNextBottomJust 367th
MetLife Insurance Company USA (A Wholly-Owned Subsidiary of MetLife, Inc.) Schedule IV Consolidated Reinsurance December 31, 2014, 2013 and 2012 (In millions) [Enlarge/Download Table] % Amount Gross Amount Ceded Assumed Net Amount Assumed to Net ------------ ---------- --------- ---------- -------------- 2014 Life insurance in-force....... $ 489,194 $ 450,342 $ 52,728 $ 91,580 57.6% ============ ========== ========= ========== Insurance premium Life insurance (1)............ $ 1,995 $ 943 $ 94 $ 1,146 8.2% Accident and health insurance. 231 225 -- 6 -- ------------ ---------- --------- ---------- Total insurance premium...... $ 2,226 $ 1,168 $ 94 $ 1,152 8.2% ============ ========== ========= ========== 2013 Life insurance in-force....... $ 467,458 $ 428,842 $ 10,931 $ 49,547 22.1% ============ ========== ========= ========== Insurance premium Life insurance (1)............ $ 1,356 $ 746 $ 73 $ 683 10.6% Accident and health insurance. 234 228 -- 6 -- ------------ ---------- --------- ---------- Total insurance premium...... $ 1,590 $ 974 $ 73 $ 689 10.6% ============ ========== ========= ========== 2012 Life insurance in-force....... $ 429,738 $ 389,156 $ 11,387 $ 51,969 21.9% ============ ========== ========= ========== Insurance premium Life insurance (1)............ $ 1,827 $ 581 $ 962 $ 2,208 43.5% Accident and health insurance. 248 241 -- 7 -- ------------ ---------- --------- ---------- Total insurance premium...... $ 2,075 $ 822 $ 962 $ 2,215 43.5% ============ ========== ========= ========== -------- (1)Includes annuities. For the year ended December 31, 2014, reinsurance ceded and assumed included affiliated transactions for life insurance in-force of $292.0 billion and $50.2 billion, respectively, and life insurance premiums of $830 million and $55 million, respectively. For the year ended December 31, 2013, reinsurance ceded and assumed included affiliated transactions for life insurance in-force of $270.0 billion and $10.0 billion, respectively, and life insurance premiums of $638 million and $28 million, respectively. For the year ended December 31, 2012, reinsurance ceded and assumed included affiliated transactions for life insurance in-force of $237.3 billion and $10.6 billion, respectively, and life insurance premiums of $477 million and $912 million, respectively. 138
485BPOS368th Page of 388TOC1stPreviousNextBottomJust 368th
[THIS PAGE INTENTIONALLY LEFT BLANK]
485BPOS369th Page of 388TOC1stPreviousNextBottomJust 369th
[THIS PAGE INTENTIONALLY LEFT BLANK]
485BPOS370th Page of 388TOC1stPreviousNextBottomJust 370th
PART C OTHER INFORMATION Item 24. FINANCIAL STATEMENTS AND EXHIBITS a. Financial Statements ---------------------------------------------------------------------------- The financial statements and financial highlights of each of the Sub-Accounts of the Separate Account are included in Part B hereof and include: 1. Report of Independent Registered Public Accounting Firm 2. Statements of Assets and Liabilities as of December 31, 2014 3. Statements of Operations for the year ended December 31, 2014 4. Statements of Changes in Net Assets for the years ended December 31, 2014 and 2013 5. Notes to the Financial Statements The consolidated financial statements and financial statement schedules of MetLife Insurance Company USA and subsidiaries are included in Part B hereof and include: 1. Report of Independent Registered Public Accounting Firm 2. Consolidated Balance Sheets as of December 31, 2014 and 2013 3. Consolidated Statements of Operations for the years ended December 31, 2014, 2013 and 2012 4. Consolidated Statements of Comprehensive Income (Loss) for the years ended December 31, 2014, 2013 and 2012 5. Consolidated Statements of Stockholder's Equity for the years ended December 31, 2014, 2013 and 2012 6. Consolidated Statements of Cash Flows for the years ended December 31, 2014, 2013 and 2012 7. Notes to the Consolidated Financial Statements 8. Financial Statement Schedules b. Exhibits 1. (i) Certification of Restated Resolutions of the Board of Directors of MetLife Investors USA Insurance Company authorizing the establishment of the Separate Account (adopted May 18, 2004) (4) (ii) Resolution of Board of Directors of MetLife Investors USA Insurance Company (including Agreement and Plan of Merger attached as Exhibit B to the resolutions) (adopted August 13, 2014) (3) (iii) Resolutions of the Board of Directors of MetLife Insurance Company of Connecticut authorizing the acceptance of the Separate Account (adopted September 17, 2014) (3) 2. Not Applicable. 3. (i)(a)Distribution and Principal Underwriting Agreement between MetLife Insurance Company of Connecticut and MetLife Investors Distribution Company (effective November 24, 2009) (2) (i)(b)Amendment to the Distribution and Principal Underwriting Agreement between MetLife Insurance Company of Connecticut and MetLife Investors Distribution Company (effective August 18, 2014) (3) (iii) Form of Enterprise Selling Agreement 09-12 (MetLife Investors Distribution Company Sales Agreement) (17) 4. (i) Form 226R1 Contract (3) (ii) Form 226R1 Certificate and Riders (3) (iii) Contract Loan Endorsement (3) (iv) Loan Endorsement (3) (v) Individual Retirement Annuity Endorsement (3) (vi) 403(b) Nationwide Tax Sheltered Annuity Endorsement (MLIU-398-3 (12/08)) (13) (vii) MetLife Insurance Company USA 457(B) Plan Endorsement (Governmental and Tax-Exempt). (MLIU-457-2 (5/11) (16) (viii)Endorsement (Name Change -- effective March 1, 2001) (MetLife Investors USA Insurance Company, formerly Security First Life Insurance Company) MI -- 2023 (6) (ix) Merger Endorsement (effective November 14, 2014) (MetLife Investors USA Insurance Company merged into MetLife Insurance Company USA) 6-E118-14 (3) 5. Form of Enrollment Form (3) 6. (i) Copy of Certificate of Incorporation of the Company and Certificate of Amendment (effective November 14, 2014) (3) (ii) Copy of the Bylaws of the Company (3) C-1
485BPOS371st Page of 388TOC1stPreviousNextBottomJust 371st
[Enlarge/Download Table] 7. Not Applicable. 8. (i) Participation Agreement among The Alger Portfolios, MetLife Insurance Company USA and Fred Alger & Company, Inc. effective November 17, 2014 (3) (ii) (a) Participation Agreement Among The Travelers Insurance Company, The Travelers Life and Annuity Company, American Funds Insurance Series, American Funds Distributors, Inc. and Capital Research and Management Company effective October 1, 1999 and amendments to the Participation Agreement (respectively effective May 1, 2001, December 31, 2002, April 14, 2003, October 20, 2005 and April 28, 2008.) (7) (b) Amendment dated April 30, 2010 (8) (c) Amendment effective November 17, 2014 (3) (iii) (a) Participation Agreement Among The Travelers Insurance Company, The Travelers Life and Annuity Company, Travelers Distribution LLC, Scudder Variable Series I, Scudder Distributors, Inc. and Deutsche Asset Management effective June 5, 2003 and Amendments to the Participation Agreement (respectively effective August 1, 2003, December 12, 2003, May 3, 2004 and April 15, 2005.) (12) (b) Amendment dated April 30, 2010 (14) (c) Amendment effective November 17, 2014 (3) (iv) (a) Amended and Restated Participation Agreement among The Travelers Insurance Company, Fidelity Distributors Corporation, VIP Fund, VIP Fund II and VIP Fund III effective May 1, 2001 and amendments to the Amended and Restated Participation Agreement (respectively effective May 1, 2003, December 8, 2004, October 1, 2005, June 18, 2007 and April 28, 2008.) (7) (b) Summary Prospectus Agreement (8) (c) Amendments effective November 17, 2014 (3) (v) (a) Participation Agreement among Met Investors Series Trust, Met Investors Advisory, LLC, MetLife Investors Distribution Company, The Travelers Insurance Company and The Travelers Life and Annuity Company effective November 1, 2005. (14) (b) First Amendment dated May 1, 2009 (10) (c) Amendment dated April 30, 2010. (10) (d) Amendment effective November 17, 2014 (3) (vi) Participation Agreement among Metropolitan Series Fund, Inc., MetLife Advisers, LLC, MetLife Investors Distribution Company and MetLife Insurance Company of Connecticut dated August 31, 2007 (9) (a) Amendment dated April 30, 2010. (10) (vii) T. Rowe Price Participation Agreement (3) 9. Opinion of Counsel (3) 10. Consent of Independent Registered Public Accounting Firm (Deloitte & Touche LLP) (11) 11. Not Applicable 12. Not Applicable 13. Powers of Attorney (11) (1)All previously filed Exhibits to MetLife Investors USA Separate Account A Registration Statement and all Post-Effective Amendments thereto are specifically incorporated herein by reference. (2)Incorporated herein by reference to MetLife of CT Separate Account Eleven for Variable Annuities Post-Effective Amendment No. 1 to Form N-4 (File Nos. 333-152199 and 811-21262) electronically filed on April 8, 2009. (3)Incorporated herein by reference to this Registration Statement on Form N-4 (File Nos 333-200240/811-03365) electronically filed on November 17, 2014. (4)Incorporated herein by reference to Registrant's Post-Effective Amendment No. 6 to Form N-4 (File Nos. 333-54464 and 811-03365) electronically filed on July 15, 2004. (5)[RESERVED] (6)Incorporated herein by reference to Registrant's Post-Effective Amendment No. 1 to Form N-4 (File Nos. 333-54464 and 811-03365) electronically filed on April 13, 2001. (7)Incorporated herein by reference to MetLife of CT Separate Account Eleven for Variable Annuities Post-Effective Amendment No. 19 to Form N-4 (File Nos. 333-101778 and 811-21262) electronically filed on April 7, 2009. (8)Incorporated herein by reference to MetLife of CT Separate Account Eleven for Variable Annuities Post-Effective Amendment No. 3 to Form N-4 (File Nos. 333-152194 and 811-21262) electronically filed on April 5, 2011. (9)Incorporated herein by reference to MetLife of CT Separate Account Nine for Variable Annuities Post-Effective Amendment No. 11 to Form N-4 (File Nos. 333-65926 and 811-09411) electronically filed on October 31, 2007. (10)Incorporated herein by reference to MetLife of CT Separate Account Eleven for Variable Annuities Post-Effective Amendment No. 4 to Form N-4 (File Nos. 333-152189 and 811-21262) electronically filed on April 4, 2012. (11)Filed herewith. (12)Incorporated herein by reference to MetLife of CT Separate Account Eleven for Variable Annuities Post-Effective Amendment No. 21 to Form N-4 (File Nos. 333-101778 and 811-21262) electronically filed on April 5, 2011. (13)Incorporated herein by reference to Registrant's Post-Effective Amendment No. 8 to Form N-4 (File Nos. 333-137968 and 811-03365) electronically filed on April 21, 2011. (14)Incorporated herein by reference to The Travelers Fund ABD for Variable Annuities Post-Effective Amendment No. 14 to Form N-4 (File Nos. 033-65343 and 811-07465) electronically filed on April 6, 2006. (15)[RESERVED] (16)Incorporated herein by reference to Registrant's Post-Effective Amendment No. 23 to Form N-4 (File Nos. 033-37128 and 811-03365) electronically filed on April 13, 2012. (17)Incorporated herein by reference to Registrant's Post-Effective Amendment No. 12 to Form N-4 (File Nos. 333-176374 and 811-03365) electronically filed on April 10, 2013. (18)Filed with Post-Effective Amendment No. 25 to this Registration Statement on April 11, 2014. Powers of Attorney for Kumar Das Gupta and Dina Rosalind Lumerman. C-2
485BPOS372nd Page of 388TOC1stPreviousNextBottomJust 372nd
ITEM 25. DIRECTORS AND OFFICERS OF THE DEPOSITOR The following are the Officers and Directors who are engaged directly or indirectly in activities relating to the Registrant or the variable annuity contracts offered by the Registrant and the executive officers of the Company: [Download Table] NAME AND PRINCIPAL BUSINESS ADDRESS POSITIONS AND OFFICES WITH DEPOSITOR ----------------------------------- ------------------------------------ Eric T. Steigerwalt Director, Chairman of the Board, President Gragg Building and Chief Executive Officer 11225 North Community House Road Charlotte, NC 28277 Elizabeth M. Forget Director and Senior Vice President Gragg Building 11225 North Community House Road Charlotte, NC 28277 Gene L. Lunman Director and Senior Vice President Gragg Building 11225 North Community House Road Charlotte, NC 28277 Peter M. Carlson Executive Vice President and Chief 1095 Avenue of the Americas Accounting Officer New York, NY 10036 Steven J. Goulart Executive Vice President and Chief 10 Park Avenue Investment Officer Morristown, NJ 07962 Ricardo A. Anzaldua Executive Vice President and General 1095 Avenue of the Americas Counsel New York, NY 10036 Robin F. Lenna Executive Vice President 200 Park Avenue 12/th/ Floor New York, NY 10166 Anant Bhalla Senior Vice President and Chief Financial Gragg Building Officer 11225 North Community House Road Charlotte, NC 28277 Marlene B. Debel Senior Vice President and Treasurer 1095 Avenue of the Americas New York, NY 10036 Roberto Baron Senior Vice President 1095 Avenue of the Americas New York, NY 10036 Steven J. Brash Senior Vice President 227 Park Avenue 46th Floor New York, NY 10172 Adam M. Hodes Senior Vice President 1095 Avenue of the Americas New York, NY 10036 Jason P. Manske Senior Vice President and Chief Hedging 10 Park Avenue Officer Morristown,. NJ -7962 Jean P. Vernor Senior Vice President 1095 Avenue of the Americas New York, NY 10036 Stewart M. Ashkenazy Vice President, Senior Actuary and 1095 Avenue of the Americas Illustration Actuary New York, NY 10036 S. Peter Headley Vice President and Assistant Secretary 10801 Mastin Boulevard Suite 930 Overland Parks, KS 66210 Andrew Kaniuk Vice President and Senior Actuary 501 Route 22 Bridgewater, NJ 08807 Christopher A. Kremer Vice President and Actuary 1 MetLife Plaza 27-01 Queens Plaza North Long Island City, NY 11101 C-3
485BPOS373rd Page of 388TOC1stPreviousNextBottomJust 373rd
[Download Table] NAME AND PRINCIPAL BUSINESS ADDRESS POSITIONS AND OFFICES WITH DEPOSITOR ----------------------------------- ------------------------------------ Lisa S. Kuklinski Vice President and Senior Actuary 1095 Avenue of the Americas New York, NY 10036 Enid M. Reichert Vice President and Actuary 501 Route 22 Bridgewater, NJ 08807 Ruth Y. Sayasith Vice President and Appointed Actuary 501 Route 22 Bridgewater, NJ 08807 Christopher Siudzinski Vice President and Actuary 1095 Avenue of the Americas New York, NY 10036 Wendy Lee Williams Vice President and Illustration Actuary Woodward Building 11215 North Community House Road Charlotte, NC 28277 Marian J. Zeldin Vice President and Actuary 501 Route 22 Bridgewater, NJ 08807 Scott E. Andrews Vice President 4700 Westown Pkwy. Suite 200 West Des Moines, IA 50266 Andrew T. Aoyama Vice President 200 Park Avenue 12/th/ Floor New York, NY 10166 Grant Barrans Vice President 600 North King Street Wilmington, DE 19801 Henry W. Blaylock Vice President 200 Park Avenue 12/th/ Floor New York, NY 10166 Timothy J. Brown Vice President 501 Route 22 Bridgewater, NJ 08807 Mark J. Davis Vice President 501 Route 22 Bridgewater, NJ 08807 Lynn A. Dumais Vice President 18210 Crane Nest Drive Tampa, FL 33647 Kevin G. Finneran Vice President Woodward Building 11215 North Community House Road Charlotte, NC 28277 Geoffrey A. Fradkin Vice President 501 Route 22 Bridgewater, NJ 08807 C-4
485BPOS374th Page of 388TOC1stPreviousNextBottomJust 374th
[Download Table] NAME AND PRINCIPAL BUSINESS ADDRESS POSITIONS AND OFFICES WITH DEPOSITOR ----------------------------------- ------------------------------------ Judith A. Gulotta Vice President 10 Park Avenue Morristown, NJ 07962 Jeffrey P. Halperin Vice President Gragg Building 11225 North Community House Road Charlotte, NC 29277 Regynald Heurtelou Vice President 334 Madison Avenue Morristown, NJ 07960 Gregory E. Illson Vice President Gragg Building 11225 North Community House Road Charlotte, NC 29277 John J. Iwanicki Vice President 18210 Crane Nest Drive Tampa, FL 33647 Karen A. Johnson Vice President One Financial Center Boston, MA 02111 Derrick L. Kelson Vice President 1200 Abernathy Road Suite 1400 Atlanta, GA 30328 James W. Koeger Vice President 13045 Tesson Ferry Road St. Louis, MO 63128 Cynthia A. Mallet Kosakowski Vice President One Financial Center 21st Floor Boston, MA 02111 John P. Kyne, III Vice President Gragg Building 11225 North Community House Road Charlotte, NC 29277 Timothy J. McLinden Vice President 277 Park Avenue 46th Floor New York, NY 10172 James J. Reilly Vice President One Financial Center 21st Floor Boston, MA 02111 Mark S. Reilly Vice President 1300 Hall Boulevard Bloomfield, CT 06002 Thomas J. Schuster Vice President 200 Park Avenue 12th Floor New York, NY 10166 Steven G. Sorrentino Vice President 501 Route 22 Bridgewater, NJ 08807 Robert L. Staffier, Jr. Vice President 1 MetLife Plaza 27-01 Queens Plaza North Long Island City, NY 11101 Barbara Stros Vice President Woodward Building 11215 North Community House Road Charlotte, NC 28277 Nan D. Tecotzky Vice President 200 Park Avenue 12th Floor New York, NY 10166 Mark H. Wilsmann Vice President 10 Park Avenue Morristown, NJ 07962 Jacob M. Jenkelowitz Secretary 1095 Avenue of the Americas New York, NY 10036 ITEM 26. PERSONS CONTROLLED BY OR UNDER COMMON CONTROL WITH THE DEPOSITOR OR THE REGISTRANT The Registrant is a separate account of MetLife Insurance Company USA under Delaware insurance law. MetLife Insurance Company USA is a wholly-owned subsidiary of MetLife, Inc., a publicly traded company. No person is controlled by the Registrant. The following outline indicates those entities that are controlled by MetLife, Inc. or are under the common control of MetLife, Inc. C-5
485BPOS375th Page of 388TOC1stPreviousNextBottomJust 375th
ORGANIZATIONAL STRUCTURE OF METLIFE, INC. AND SUBSIDIARIES AS OF December 31, 2014 The following is a list of subsidiaries of MetLife, Inc. updated as of December 31, 2014. Those entities which are listed at the left margin (labeled with capital letters) are direct subsidiaries of MetLife, Inc. Unless otherwise indicated, each entity which is indented under another entity is a subsidiary of that other entity and, therefore, an indirect subsidiary of MetLife, Inc. Certain inactive subsidiaries have been omitted from the MetLife, Inc. organizational listing. The voting securities (excluding directors' qualifying shares, if any) of the subsidiaries listed are 100% owned by their respective parent corporations, unless otherwise indicated. The jurisdiction of domicile of each subsidiary listed is set forth in the parenthetical following such subsidiary. A. MetLife Group, Inc. (NY) B. MetLife Home Loans LLC (DE) C. New England Securities Corporation (MA) D. Metropolitan Tower Life Insurance Company (DE) 1. EntreCap Real Estate II LLC (DE) a) PREFCO Dix-Huit LLC (CT) b) PREFCO X Holdings LLC (CT) c) PREFCO Ten Limited Partnership (CT) - a 99.9% limited partnership interest of PREFCO Ten Limited Partnership is held by EntreCap Real Estate II LLC and 0.1% general partnership is held by PREFCO X Holdings LLC. d) PREFCO Vingt LLC (CT) e) PREFCO Twenty Limited Partnership (CT) - a 99% limited partnership interest of PREFCO Twenty Limited Partnership is held by EntreCap Real Estate II LLC and 1% general partnership is held by PREFCO Vingt LLC. 2. Plaza Drive Properties, LLC (DE) 3. MTL Leasing, LLC (DE) a) PREFCO IX Realty LLC (CT) b) PREFCO XIV Holdings LLC (CT) c) PREFCO Fourteen Limited Partnership (CT) - a 99.9% limited partnership interest of PREFCO Fourteen Limited Partnership is held by MTL Leasing, LLC and 0.1% general partnership is held by PREFCO XIV Holdings LLC. d) 1320 Venture LLC (DE) i) 1320 Owner LP (DE) - a 99.9% limited partnership of 1320 Owner LP is held by 1320 Venture LLC and 0.1% general partnership is held by 1320 GP LLC. e) 1320 GP LLC (DE) E. MetLife Chile Inversiones Limitada (Chile) - 70.4345328853% of MetLife Chile Inversiones Limitada is owned by MetLife, Inc., 26.6071557459% by American Life Insurance Company ("ALICO"), 2.9583113284% is owned by Inversiones MetLife Holdco Dos Limitada and 0.0000000404% is owned by Natilportem Holdings, Inc. 1. MetLife Chile Seguros de Vida S.A. (Chile) - 99.9969% of MetLife Chile Seguros de Vida S.A. is held by MetLife Chile Inversiones Limitada and 0.0031% by International Technical and Advisory Services Limited ("ITAS"). a) MetLife Chile Administradora de Mutuos Hipotecarios S.A. (Chile) - 99.99% of MetLife Chile Administradora de Mutuos Hipotecarios S.A. is held by MetLife Chile Seguros de Vida S.A. and 0.01% is held by MetLife Chile Inversiones Limitada. 2. Legal Chile S.A. (Chile) - 51% of Legal Chile S.A. is owned by MetLife Chile Inversiones Limitada and the remaining interest is owned by a third party. a) Legagroup S.A. (Chile) - 99% of Legagroup S.A. is owned by Legal Chile S.A. and the remaining interest is owned by a third party. 3. Inversiones MetLife Holdco Tres Limitada (Chile) - 99.9% of Inversiones MetLife Holdco Tres Limitada is owned by MetLife Chile Inversiones Limitada and 0.1% is owned by Inversiones MetLife Holdco Dos Limitada. a) MetLife Chile Acquisition Co. S.A. (Chile) - 45% of MetLife Chile Acquisition Co. S.A. is owned by Inversiones MetLife Holdco Dos Limitada, 45% is owned by Inversiones MetLife Holdco Tres Limitada and 10% is owned by MetLife Chile Inversiones Limitada. i) Inversiones Previsionales S.A. (Chile) - 99.999% of Inversiones Previsionales S.A. is owned by MetLife Chile Acquisition Co. S.A. and 0.001% is owned by Inversiones MetLife Holdco Tres Limitada. aa) AFP Provida S.A. (Chile) - 51.62% of AFP Provida S.A. is owned by Inversiones Previsionales S.A., 21.97% is owned indirectly (by means of ADR) by MetLife Chile Acquisition Co. S.A., 17.79% is owned directly by MetLife Chile Acquisition Co. S.A. and the remainder is owned by third parties. 1) Provida Internacional S.A. (Chile) - 99.99% of Provida Internacional S.A. is owned by AFP Provida S.A. and 0.01% by Inversiones Previsionales S.A. ii) AFP Genesis Administradora de Fondos y Fidecomisos S.A. (Ecuador) - 99.9997% of AFP Genesis Administradora de Fondos y Fidecomisos S.A. is owned by Provida Internacional S.A. and 0.0003% is owned by Inversiones Previsionales S.A. 4. MetLife Chile Seguros Generales S.A. (Chile) - 99.9% of MetLife Chile Seguros Generales, S.A. is owned by MetLife Chile Inversiones Limitada and 0.1% is owned by Inversiones MetLife Holdco Dos Limitada. F. MetLife Securities, Inc. (DE) G. Enterprise General Insurance Agency, Inc. (DE) 1
485BPOS376th Page of 388TOC1stPreviousNextBottomJust 376th
H. Metropolitan Property and Casualty Insurance Company (RI) 1. Metropolitan General Insurance Company (RI) 2. Metropolitan Casualty Insurance Company (RI) 3. Metropolitan Direct Property and Casualty Insurance Company (RI) 4. MetLife Auto & Home Insurance Agency, Inc. (RI) 5. Metropolitan Group Property and Casualty Insurance Company (RI) 6. Metropolitan Lloyds, Inc. (TX) a) Metropolitan Lloyds Insurance Company of Texas (TX)- Metropolitan Lloyds Insurance Company of Texas, an affiliated association, provides automobile, homeowner and related insurance for the Texas market. It is an association of individuals designated as underwriters. Metropolitan Lloyds, Inc., a subsidiary of Metropolitan Property and Casualty Insurance Company, serves as the attorney-in-fact and manages the association. 7. Economy Fire & Casualty Company (IL) a) Economy Preferred Insurance Company (IL) b) Economy Premier Assurance Company (IL) I. First MetLife Investors Insurance Company (NY) J. Newbury Insurance Company, Limited (DE) K. MetLife Investors Group, LLC (DE) 1. MetLife Investors Distribution Company (MO) 2. MetLife Advisers, LLC (MA) 2
485BPOS377th Page of 388TOC1stPreviousNextBottomJust 377th
L. MetLife International Holdings, Inc. (DE) 1. MetLife Mexico Cares, S.A. de C.V. (Mexico) a) Fundacion MetLife Mexico, A.C. (Mexico) 2. Natiloportem Holdings, Inc. (DE) a) Excelencia Operativa y Tecnologica, S.A. de C.V. (Mexico) i) MLA Comercial, S.A. de C.V. (Mexico) 99% is owned by Excelencia Operativa y Tecnologica, S.A. de C.V. and 1% is owned by MetLife Mexico Cares, S.A. de C.V. ii) MLA Servicios, S.A. de C.V. (Mexico) 99% is owned by Excelencia Operativa y Tecnologica, S.A. de C.V. and 1% is owned by MetLife Mexico Cares, S.A. de C.V. 3. PNB MetLife India Insurance Company Limited (India)- 26% is owned by MetLife International Holdings, Inc. and 74% is owned by third parties. 4. Metropolitan Life Insurance Company of Hong Kong Limited (Hong Kong)- 99.99935% is owned by MetLife International Holdings, Inc. and 0.00065% is owned by Natiloporterm Holdings, Inc. 5. MetLife Seguros S.A. (Argentina)- 79.3196% is owned by MetLife International Holdings, Inc., 2.6753% is owned by Natiloportem Holdings, Inc., 16.2046% by ALICO and 1.8005% by ITAS. 6. Metropolitan Life Seguros e Previdencia Privada S.A. (Brazil)- 66.662% is owned by MetLife International Holdings, Inc., 33.337% is owned by MetLife Worldwide Holdings, Inc. and 0.001% is owned by Natiloportem Holdings, Inc. 7. MetLife Global, Inc. (DE) 8. MetLife Administradora de Fundos Multipatrocinados Ltda. (Brazil) - 99.99998% of MetLife Administradora de Fundos Multipatrocinados Ltda. is owned by MetLife International Holdings, Inc. and 0.00002% by Natiloportem Holdings, Inc. 9. MetLife Seguros de Retiro S.A. (Argentina) - 95.5883% is owned by MetLife International Holdings, Inc., 3.1102% is owned by Natiloportem Holdings, Inc., 1.3014% by ALICO and 0.0001% by ITAS. 10. Best Market S.A. (Argentina) - 5% of the shares are held by Natiloportem Holdings, Inc. and 95% is owned by MetLife International Holdings Inc. 11. Compania Inversora MetLife S.A. (Argentina) - 95.46% is owned by MetLife International Holdings, Inc. and 4.54% is owned by Natiloportem Holdings, Inc. a) MetLife Servicios S.A. (Argentina) - 18.87% of the shares of MetLife Servicios S.A. are held by Compania Inversora MetLife S.A., 79.88% is owned by MetLife Seguros S.A., 0.99% is held by Natiloportem Holdings, Inc. and 0.26% is held by MetLife Seguros de Retiro S.A. 12. MetLife Worldwide Holdings, Inc. (DE) a) MetLife Direct Co., LTD. (Japan) b) MetLife Limited (Hong Kong) i) BIDV MetLife Life Insurance Limited Liability Company (Vietnam) - 60% of BIDV MetLife Life Insurance Limited Liability Company is held by MetLife Limited (Hong Kong) and the remainder by third parties 13. MetLife International Limited, LLC (DE) 14. MetLife Planos Odontologicos Ltda. (Brazil) - 99.999% is owned by MetLife International Holdings, Inc. and 0.001% is owned by Natiloportem Holdings, Inc. 15. MetLife Ireland Holdings One Limited (Ireland) a) MetLife Global Holdings Corporation S.A. de C.V. (Mexico/Ireland) - 98.9% is owned by MetLife Ireland Holdings One Limited and 1.1% is owned by MetLife International Limited, LLC. i) MetLife Ireland Treasury Limited (Ireland) aa) MetLife General Insurance Limited (Australia) bb) MetLife Insurance Limited (Australia) - 91.16468% of MetLife Insurance Limited (Australia) is owned by MetLife Ireland Treasury Limited and 8.83532% is owned by MetLife Global Holdings Corp. S.A. de C.V. 1) The Direct Call Centre PTY Limited (Australia) 2) MetLife Investments PTY Limited (Australia) aa) MetLife Insurance and Investment Trust (Australia) - MetLife Insurance and Investment Trust is a trust vehicle, the trustee of which is MetLife Investments PTY Limited ("MIPL"). MIPL is a wholly owned subsidiary of MetLife Insurance Limited. ii) Metropolitan Global Management, LLC (DE/Ireland) - 99.7% is owned by MetLife Global Holdings Corporation S.A. de C.V. and 0.3% is owned by MetLife International Holdings, Inc. aa) MetLife Pensiones Mexico S.A. (Mexico)- 97.4738% is owned by Metropolitan Global Management, LLC and 2.5262% is owned by MetLife International Holdings, Inc. bb) MetLife Mexico Servicios, S.A. de C.V. (Mexico) - 98% is owned by Metropolitan Global Management, LLC and 2% is owned by MetLife International Holdings, Inc. cc) MetLife Mexico S.A. (Mexico)- 99.050271% is owned by Metropolitan Global Management, LLC and 0.949729% is owned by MetLife International Holdings, Inc. 1) MetLife Afore, S.A. de C.V. (Mexico)- 99.99% is owned by MetLife Mexico S.A. and 0.01% is owned by MetLife Pensiones Mexico S.A. aa) Met1 SIEFORE, S.A. de C.V. (Mexico)- 99.99% is owned by MetLife Afore, S.A. de C.V. and 0.01% is owned by MetLife Mexico S.A. ab) Met2 SIEFORE, S.A. de C.V. (Mexico)- 99.99% is owned by MetLife Afore, S.A. de C.V. and 0.01% is owned by MetLife Mexico S.A. ac) MetA SIEFORE Adicional, S.A. de C.V. (Mexico)- 99.99% is owned by MetLife Afore, S.A. de C.V. and 0.01% is owned by MetLife Mexico S.A. ad) Met3 SIEFORE Basica, S.A. de C.V. (Mexico) - 99.99% is owned by MetLife Afore, S.A. de C.V. and 0.01% is owned by MetLife Mexico S.A. ae) Met4 SIEFORE, S.A. de C.V. (Mexico) - 99.99% is owned by MetLife Afore, S.A. de C.V. and 0.01% is owned by MetLife Mexico S.A. af) Met5 SIEFORE, S.A. de C.V. (Mexico) - 99.99% is owned by MetLife Afore, S.A. de C.V. and 0.01% is owned by MetLife Mexico S.A. 2) ML Capacitacion Comercial S.A. de C.V.(Mexico) - 99% is owned by MetLife Mexico S.A. and 1% is owned by MetLife Mexico Cares, S.A. de C.V. dd) MetLife Saengmyoung Insurance Co. Ltd. (also known as MetLife Insurance Company of Korea Limited) (South Korea)- 14.64% is owned by MetLife Mexico, S.A. and 85.36% is owned by Metropolitan Global Management, LLC. ee) GlobalMKT S.A. (Uruguay) 16. MetLife Asia Limited (Hong Kong) 17. AmMetLife Insurance Berhad (Malaysia) - 50.000001% of AmMetLife Insurance Berhad is owned by MetLife International Holdings, Inc. and the remainder is owned by a third party. 18. AmMetLife Takaful Berhad (Malaysia) - 49.999999% of AmMetLife Takaful Berhad is owned by MetLife International Holdings, Inc. and the remainder is owned by a third party. 19. MAXIS GBN S.A.S. (France) - 50% of MAXIS GBN S.A.S. is held by MetLife International Holdings, Inc. and the remainder by third parties. M. Metropolitan Life Insurance Company ("MLIC") (NY) 1. 334 Madison Euro Investments, Inc. (DE) 2. St. James Fleet Investments Two Limited (Cayman Islands) a) Park Twenty Three Investments Company (United Kingdom) i) Convent Station Euro Investments Four Company (United Kingdom) aa) OMI MLIC Investments Limited (Cayman Islands) 3. CRB Co., Inc. (MA) 4. MLIC Asset Holdings II LLC (DE) a) El Conquistador MAH II LLC (DE) b) Mansell Office LLC (DE) - 73.0284% of Mansell Office LLC is owned by MLIC Asset Holdings II LLC and 26.9716% is owned by MLIC CB Holdings LLC. c) Mansell Retail LLC (DE) - 73.0284% of Mansell Retail LLC is owned by MLIC Asset Holdings II LLC and 26.9716% is owned by MLIC CB Holdings LLC. 3
485BPOS378th Page of 388TOC1stPreviousNextBottomJust 378th
5. CC Holdco Manager, LLC (DE) 6. Alternative Fuel I, LLC (DE) 7. Transmountain Land & Livestock Company (MT) 8. MetPark Funding, Inc. (DE) 9. HPZ Assets LLC (DE) 10. Missouri Reinsurance, Inc. (Cayman Islands) 11. Metropolitan Tower Realty Company, Inc. (DE) a) Midtown Heights, LLC (DE) 12. ML New River Village III, LLC (DE) 13. MetLife RC SF Member, LLC (DE) 14. MetLife Private Equity Holdings, LLC (DE) 15. 23rd Street Investments, Inc. (DE) a) MetLife Capital Credit L.P. (DE)- 1% General Partnership interest is held by 23rd Street Investments, Inc. and 99% Limited Partnership interest is held by Metropolitan Life Insurance Company. b) MetLife Capital, Limited Partnership (DE)- 1% General Partnership interest is held by 23rd Street Investments, Inc. and 99% Limited Partnership interest is held by Metropolitan Life Insurance Company. i) Long Island Solar Farm, LLC ("LISF")(DE) - 9.61% membership interest is held by MetLife Renewables Holding, LLC and 90.39% membership interest is held by LISF Solar Trust in which MetLife Capital Limited Partnership has 100% beneficial interest. ii) MetLife Canada Solar ULC (Canada) 16. Hyatt Legal Plans, Inc. (DE) a) Hyatt Legal Plans of Florida, Inc. (FL) 17. MetLife Holdings, Inc. (DE) a) MetLife Credit Corp. (DE) b) MetLife Funding, Inc. (DE) 4
485BPOS379th Page of 388TOC1stPreviousNextBottomJust 379th
18. MetLife Investments Asia Limited (Hong Kong) 19. MetLife Investments Limited (United Kingdom)- 23rd Street Investments, Inc. holds one share of MetLife Investments Limited. 20. MetLife Latin America Asesorias e Inversiones Limitada (Chile)- 23rd Street Investments, Inc. holds 0.01% of MetLife Latin America Asesorias e Inversiones Limitada. 21. New England Life Insurance Company (MA) 22. General American Life Insurance Company (MO) a) GALIC Holdings LLC (DE) 5
485BPOS380th Page of 388TOC1stPreviousNextBottomJust 380th
23. Corporate Real Estate Holdings, LLC (DE) 24. Ten Park SPC (Cayman Islands) - 1% voting control of Ten Park SPC is held by 23rd Street Investments, Inc. 25. MetLife Tower Resources Group, Inc. (DE) 26. Headland-Pacific Palisades, LLC (CA) 27. Headland Properties Associates (CA) - 99% is owned by Metropolitan Life Insurance Company and 1% is owned by Headland-Pacific Palisades, LLC. 28. WFP 1000 Holding Company GP, LLC (DE) 29. White Oak Royalty Company (OK) 30. 500 Grant Street GP LLC (DE) 31. 500 Grant Street Associates Limited Partnership (CT) - 99% of 500 Grant Street Associates Limited Partnership is held by Metropolitan Life Insurance Company and 1% by 500 Grant Street GP LLC. 32. MetLife Mall Ventures Limited Partnership (DE) - 99% LP interest of MetLife Mall Ventures Limited Partnership is owned by MLIC and 1% GP interest is owned by Metropolitan Tower Realty Company, Inc. a) HMS Master Limited Partnership (DE) - 60% LP interest of HMS Master Limited Partnership is owned by MetLife Mall Ventures Limited Partnership. A 40% LP interest is owned by a third party. Metropolitan Tower Realty Company, Inc. is the GP. i) HMS Southpark Residential LLC (DE) 33. MetLife Retirement Services LLC (NJ) a) MetLife Associates LLC (DE) 34. Euro CL Investments, LLC (DE) 35. MEX DF Properties, LLC (DE) 36. MSV Irvine Property, LLC (DE) - 4% of MSV Irvine Property, LLC is owned by Metropolitan Tower Realty Company, Inc. and 96% is owned by Metropolitan Life Insurance Company 37. MetLife Properties Ventures, LLC (DE) a) Citypoint Holdings II Limited (United Kingdom) 38. Housing Fund Manager, LLC (DE) a) MTC Fund I, LLC (DE) - 0.01% of MTC Fund I, LLC is held by Housing Fund Manager, LLC. - Housing Fund Manager, LLC is the managing member LLC and the remaining interests are held by a third party member. b) MTC Fund II, LLC (DE) - 0.01% of MTC Fund II, LLC is held by Housing Fund Manager, LLC. - Housing Fund Manager, LLC is the managing member LLC and the remaining interests are held by a third party member. c) MTC Fund III, LLC (DE) - 0.01% of MTC Fund III, LLC is held by Housing Fund Manager, LLC. - Housing Fund Manager, LLC is the managing member LLC and the remaining interests are held by a third party member. 39. MLIC Asset Holdings LLC (DE) 40. 85 Broad Street Mezzanine LLC (DE) a) 85 Broad Street LLC (DE) - 49.9% of 85 Broad Street LLC is owned by a third party. 41. The Building at 575 Fifth Avenue Mezzanine LLC (DE) a) The Building at 575 Fifth LLC (DE) 42. ML Bridgeside Apartments LLC (DE) 43. Para-Met Plaza Associates (FL)- 75% of the General Partnership is held by Metropolitan Life Insurance Company and 25% of the General Partnership is held by Metropolitan Tower Realty Company, Inc. 44. MLIC CB Holdings LLC (DE) 45. Met II Office Mezzanine LLC, (FL) - 10.4167% of the membership interest is owned by Metropolitan Tower Life Insurance Company and 89.5833% is owned by Metropolitan Life Insurance Company. a) Met II Office LLC (FL) 46. The Worthington Series Trust (DE) 47. MetLife CC Member, LLC (DE) - 63.415% of MetLife CC Member, LLC is held by Metropolitan Life Insurance Company, 31.707% by MetLife Insurance Company USA and 4.878% by General American Life Insurance Company. 48. Oconee Hotel Company, LLC (DE) 49. Oconee Land Company, LLC (DE) a) Oconee Land Development Company, LLC (DE) b) Oconee Golf Company, LLC (DE) c) Oconee Marina Company, LLC (DE) 50. 1201 TAB Manager, LLC (DE) 51. MetLife 1201 TAB Member, LLC (DE) - 69.66% of MetLife 1201 TAB Member, LLC is owned by Metropolitan Life Insurance Company, 27.24% is owned by MetLife Insurance Company USA and 3.10% is owned by Metropolitan Property and Casualty Insurance Company. a) 1201 TAB Owner, LLC (DE) - 50% of 1201 TAB Owner, LLC is owned by Metlife 1201 TAB Member, LLC and the remainder is owned by a third party. Metlife 1201 TAB Manager, LLC is the manager of 1201 TAB Owner, LLC. 52. MetLife LHH Member, LLC (DE) - 69.23% of MetLife LHH Member, LLC is owned by Metropolitan Life Insurance Company, 19.78% is owned by MetLife Insurance Company USA and 10.99% is owned by New England Life Insurance Company. 53. Ashton Southend GP, LLC (DE) 54. Tremont Partners, LP (DE) - 99.9% LP interest of Tremont Partners, LP is owned by Metropolitan Life Insurance Company and 0.1% GP interest is owned by Ashton Southend GP, LLC. 55. Riverway Residential, LP (DE) - 99.9% LP interest of Riverway Residential, LP is owned by Metropolitan Life Insurance Company and 0.1% GP interest is owned by Metropolitan Tower Realty Company, Inc. 56. 10420 McKinley Partners, LP (DE) - 99.9% LP interest of 10420 McKinley Partners, LP is owned by Metropolitan Life Insurance Company and 0.1% GP interest is owned by Metropolitan Tower Realty Company, Inc. 57. Ardrey Kell Townhomes, LLC (DE) 58. Boulevard Residential, LLC (DE) 59. 465 N. Park Drive, LLC (DE) 60. Ashton Judiciary Square, LLC (DE) 61. Sandpiper Cove Associates, LLC (DE) - 90.59% membership interest of Sandpiper Cove Associates, LLC is owned by MLIC and 9.41% is owned by Metropolitan Tower Realty Company. 62. 1900 McKinney Properties, LP (DE) - 99.9% LP interest of 1900 McKinney Properties, LP is owned by MLIC and 0.1% GP interest is owned by Metropolitan Tower Realty Company, Inc. 63. Marketplace Residences, LLC (DE) 64. ML Swan Mezz, LLC (DE) a) ML Swan GP, LLC (DE) 65. ML Dolphin Mezz, LLC (DE) a) ML Dolphin GP, LLC (DE) 66. Haskell East Village, LLC (DE) 67. MetLife Cabo Hilton Member, LLC (DE) - 54.129% of MetLife Cabo Hilton Member, LLC is owned by MLIC, 16.9% by General American Life Insurance Company, 28.971% by MetLife Insurance Company USA 68. ML Terraces, LLC (DE) 69. Chestnut Flats Wind, LLC (DE) 70. MetLife 425 MKT Member, LLC (DE) a) 425 MKT, LLC (DE) - 52.5% of 425 MKT, LLC is owned by MetLife 425 MKT Member, LLC and 47.5% is owned by a third party. 425 MKT, LLC is the managing member of 425 MKT REIT, LLC. i) 425 MKT REIT, LLC (DE) - 99.9% of 425 MKT REIT, LLC is owned by 425 MKT, LLC and the remaining 0.1% by third parties. 71. MetLife OFC Member, LLC (DE) a) OFC Boston, LLC (DE) - 52.5% of OFC Boston, LLC is owned by MetLife OFC Member, LLC and 47.5% is owned by a third party. i) OFC REIT, LLC (DE) - 99.9% of OFC REIT, LLC is owned by OFC Boston, LLC and the remaining 0.1% is owned by third parties. 1) Dewey Square Tower Associates, LLC (MA) 72. MetLife THR Investor, LLC (DE) - 85% of MetLife THR Investor, LLC is owned by MLIC and 15% is owned by MetLife Insurance Company USA. 73. ML Southmore, LLC (DE) - 75.12% of ML Southmore, LLC is owned by MLIC and 24.88% is owned by MetLife Insurance Company USA. 74. ML - AI MetLife Member 1, LLC (DE) - 83.675% of the membership interest is owned by MLIC, 10.563% by MetLife Insurance Company USA and 4.801% by Metropolitan Property and Casualty Insurance Company. a) ML - AI Venture 1, LLC (DE) - 51% of ML-AI Venture 1, LLC is owned by ML-AI MetLife Member 1, LLC and 49% is owned by a third party. MetLife Investment Management, LLC is the asset manager. i) ML-AI 125 Wacker, LLC (DE) 75. MetLife CB W/A, LLC (DE) 76. MetLife Camino Ramon Member, LLC (DE) - 78.6% of MetLife Camino Ramon Member, LLC is owned by MLIC and 21.4% is owned by MetLife Insurance Company USA. 77. 10700 Wilshire, LLC (DE) 78. Viridian Miracle Mile, LLC (DE) 79. MetLife 555 12th Member, LLC (DE) - MetLife 555 12th Member, LLC is owned at 69.4% by MLIC, 25.2% by MetLife Insurance Company USA and 5.4% by GALIC. a) 555 12th, LLC (DE) - 52.5% of 555 12th, LLC is owned by MetLife 555 12th Member, LLC and the remainder by a third party. i) 555 12 REIT, LLC (DE) 80. MetLife OBS Member, LLC (DE) a) OBS Boston, LLC (DE) - 52.5% of OBS Boston, LLC is owned by MetLife OBS Member, LLC and the remaining by third parties i) OBS REIT, LLC (DE) - 99.98% of OBS REIT, LLC is owned by OBS Boston, LLC and the remaining 0.02% by third parties 1) OBS BOS Services, LLC (DE) 81. MetLife 1007 Stewart, LLC (DE) 82. ML-AI MetLife Member 2, LLC (DE) a) ML-AI Venture 2, LLC (DE) - 50% of ML-AI Venture 2, LLC is owned by ML-AI MetLife Member 2, LLC and the remaining by third parties. i) ML-AI Normandale, LLC 83. 655 West Broadway, LLC (DE) - 90% of 655 West Broadway, LLC is owned by MLIC and 10% by Metropolitan Tower Realty Company, Inc. 84. MetLife FM Hotel Member, LLC (DE) a) LHCW Holdings (U.S.) LLC (DE) i) LHC Holdings (U.S.) LLC (DE) aa) LHCW Hotel Holding LLC (DE) 1) LHCW Hotel Holding (2002) LLC (DE) 2) LHCW Hotel Operating Company (2002) LLC (DE) 85. ML Mililani Member, LLC (DE)- is owned at 70% by MLIC, 25% by MetLife Insurance Company USA and 5% by General American Life Insurance Company. N. MetLife Capital Trust IV (DE) O. MetLife Insurance Company USA (DE) 1. MetLife Property Ventures Canada ULC (Canada) 2. Metropolitan Connecticut Property Ventures, LLC (DE) 3. MetLife Canadian Property Ventures LLC (NY) 4. Euro TI Investments LLC (DE) 5. Greenwich Street Investments, L.L.C. (DE) a) Greenwich Street Capital Offshore Fund, Ltd. (Virgin Islands) b) Greenwich Street Investments, L.P. (DE) 6. One Financial Place Corporation (DE) - 100% is owned in the aggregate by MetLife Insurance Company USA. 7. MetLife USA Assignment Company (CT) 8. TIC European Real Estate LP, LLC (DE) 9. MetLife European Holdings, LLC (DE) 10. Euro TL Investments LLC (DE) 11. Corrigan TLP LLC (DE) 12. TLA Holdings LLC (DE) a) The Prospect Company (DE) 13. TRAL & Co. (CT) - TRAL & Co. is a general partnership. Its partners are MetLife Insurance Company USA and Metropolitan Life Insurance Company. 14. MetLife Renewables Holding, LLC (DE) a) Greater Sandhill I, LLC (DE) 15. TLA Holdings II LLC (DE) 16. TLA Holdings III LLC (DE) 17. MetLife Greenstone Southeast Ventures, LLC (DE) - 95% of MetLife Greenstone Southeast Venture, LLC is owned by MetLife Insurance Company USA and 5% is owned by Metropolitan Connecticut Properties Ventures, LLC. a) MLGP Lakeside, LLC (DE) 18. Sino-US United MetLife Insurance Co., Ltd. (China) - Sino-US United MetLife Insurance Co., Ltd. is owned at 27.8% by MetLife Insurance Company USA, 22.2% by MLIC and 50% by a third party. P. MetLife Reinsurance Company of South Carolina (SC) Q. MetLife Investment Management, LLC (DE) 1. MetLife Alternatives GP, LLC (DE) a) MetLife International PE Fund I, LP (Cayman Islands) - 92.593% of the Limited Partnership interests of this entity is owned by MetLife Insurance K.K., 4.115% is owned by MetLife Mexico S.A., 2.716% is owned by MetLife Limited (Hong Kong) and the remaining 0.576% is owned by Metropolitan Life Insurance Company of Hong Kong Limited. b) MetLife International PE Fund II, LP (Cayman Islands) - 94.54% of the limited partnership interests of MetLife International PE Fund II, LP is owned by MetLife Insurance K.K., 2.77% is owned by MetLife Limited (Hong Kong), 2.1% by MetLife Mexico, S.A. and 0.59% is owned by MetLife Insurance Company of Hong Kong Limited. c) MetLife International HF Partners, LP (Cayman Islands) - 87.77% of the Limited partnership interests of this entity is owned by MetLife Insurance K.K. and 9.54% is owned by MetLife Insurance Company of Korea Limited, 2.67% is owned by MetLife Limited (Hong Kong) and 0.02% is owned by MetLife Alternatives, GP 2. MetLife Loan Asset Management LLC (DE) 3. MetLife Core Property Fund GP, LLC (DE) a) MetLife Core Property Fund, LP (DE) - MetLife Core Property Fund GP, LLC is the general partner of MetLife Core Property Fund, LP (the "Fund"). A substantial majority of the limited partnership interests in the Fund are held by third parties. The following affiliates hold a minority share of the limited partnership interests in the Fund: Metropolitan Life Insurance Company owns 23.7%, General American Life Insurance Company owns 0.1% and MetLife Insurance Company USA owns 0.2%. i) MetLife Core Property REIT, LLC (DE) aa) MetLife Core Property Holdings, LLC (DE) - MetLife Core Property Holdings, LLC holds the following single-property limited liability companies: MCP 7 Riverway, LLC; MCP SoCal Industrial-Redondo, LLC; MCP SoCal Industrial-Springdale, LLC; MCP SoCal Industrial-Concourse, LLC; MCP SoCal Industrial-Kellwood, LLC; MCP SoCal Industrial-Bernado, LLC; MCP SoCal Industrial-Canyon, LLC; MCP SoCal Industrial-Anaheim, LLC; MCP SoCal Industrial-LAX, LLC; MCP SoCal Industrial-Fullerton, LLC; MCP SoCal Industrial-Ontario, LLC; MCP SoCal Industrial-Loker, LLC; MCP Paragon Point, LLC; MCP 4600 South Syracuse, LLC; MCP The Palms at Doral, LLC; MCP Waterford Atrium, LLC; MCP EnV Chicago, LLC; MCP 100 Congress, LLC; MCP 1900 McKinney, LLC; MCP 550 West Washington, LLC; MCP Main Street Village, LLC; MCP Lodge At Lakecrest, LLC; MCP Ashton South End, LLC, MCP 3040 Post Oak, LLC; MCP Plaza at Legacy, LLC; MCP VOA Holdings, LLC; MCP VOA I & III, LLC and MCP VOA II, LLC. R. MetLife Standby I, LLC (DE) 1. MetLife Exchange Trust I (DE) S. MetLife Services and Solutions, LLC (DE) 1. MetLife Solutions Pte. Ltd. (Singapore) a) MetLife Services East Private Limited (India) b) MetLife Global Operations Support Center Private Limited (India) - 99.99999% is owned by MetLife Solutions Pte. Ltd. and 0.00001% is owned by Natiloportem Holdings, Inc. T. SafeGuard Health Enterprises, Inc. (DE) 1. MetLife Health Plans, Inc. (DE) 2. SafeGuard Health Plans, Inc. (CA) 3. SafeHealth Life Insurance Company (CA) 4. SafeGuard Health Plans, Inc. (FL) 5. SafeGuard Health Plans, Inc. (NV) 6. SafeGuard Health Plans, Inc. (TX) U. MetLife Capital Trust X (DE) V. Cova Life Management Company (DE) W. MetLife Reinsurance Company of Charleston (SC) X. MetLife Reinsurance Company of Vermont (VT) Y. Delaware American Life Insurance Company (DE) Z. Federal Flood Certification LLC (TX) AA. American Life Insurance Company (ALICO) (DE) 1. MetLife Insurance K.K. (Japan) a) Communication One Kabushiki Kaisha (Japan) 2. MetLife Global Holding Company I GmbH (Swiss I) (Switzerland) a) MetLife Global Holding Company II GmbH (Swiss II) (Switzerland) i) MetLife Emeklilik ve Hayat A.S. (Turkey) - 99.98% of MetLife Emeklilik ve Hayat A.S. is owned by Metlife Global Holding Company II GmbH (Swiss II) and the remainder by third parties. ii) ALICO European Holdings Limited (Ireland) aa) ZAO Master D (Russia) 1) Closed Joint Stock Company MetLife Insurance Company (Russia) - 51% of Closed Joint Stock Company MetLife Insurance Company is owned by ZAO Master D and 49% is owned by MetLife Global Holding Company II GmbH. iii) MetLife Asia Holding Company Pte. Ltd. (Singapore) 1) MetLife Innovation Centre Pte. Ltd. (Singapore) iv) MetLife Reinsurance Company of Bermuda Ltd. (Bermuda) v) MetLife Bulgaria Services EOOD (Bulgaria) vi) MetLife Investment Management Limited (United Kingdom) vii) MetLife EU Holding Company Limited (Ireland) aa) MetLife Europe Limited (Ireland) - 93% of MetLife Europe Limited is owned by MetLife EU Holding Company Limited and 7% is owned by ALICO. 1. MetLife Pension Trustees Limited (United Kingdom) bb) Agenvita S.r.l. (Italy) cc) MetLife Europe Insurance Limited (Ireland)- 93% of MetLife Europe Insurance Limited is owned by MetLife EU Holding Company Limited and 7% is owned by ALICO. dd) MetLife Europe Services Limited (Ireland) ee) MetLife Insurance Limited (United Kingdom) ff) MetLife Limited (United Kingdom) gg) MetLife Services, Sociedad Limitada (Spain) hh) MetLife Slovakia s.r.o. (Slovakia) - 99.956% of MetLife Slovakia s.r.o. is owned by MetLife EU Holding Company Limited and 0.044% is owned by ITAS. ii) MetLife Solutions S.A.S. (France) jj) Metlife Biztosito Zrt. (Hungary) 1) First American-Hungarian Insurance Agency Limited (Hungary) kk) Metropolitan Life Asigurari S.A. (Romania) - 99.9982018% of Metropolitan Life Asigurari S.A. is owned by MetLife EU Holding Company Limited and the remaining 0.0017982% is owned by ITAS. 1) MetLife Societate de Administrare a unui Fond de Pensii Administrat Privat S.A. (Romania) - 99.9836% of MetLife Societate de Administrare a unui Fond de Pensii Administrat Privat S.A. is owned by Metropolitan Life Asigurari S.A. and 0.0164% is owned by MetLife Services Sp z.o.o. 2) Metropolitan Life Training and Consulting S.R.L. (Romania) 3) APF Societate de Administrare a Fondurilor De Pensii Facultative (APF) (Romania) - 99.99% of APF is owned by Metropolitan Life Asigurari S.A. and 0.01% is owned by ITAS. ll) MetLife AMSLICO poist'ovna, a.s. (Slovakia) 1) ALICO Funds Central Europe sprav. spol., a.s. (Slovakia) mm) MetLife pojist'ovna a.s. (Czech Republic) nn) MetLife Towarzystwo Ubezpieczen na Zycie I Reasekuracji S.A. (Poland) 1) MetLife Services Sp z.o.o. (Poland) 2) MetLife Towarzystwo Funduszy Inwestycyjnych, S.A. (Poland) 3) MetLife Powszechne Towarzystwo Emerytalne S.A. (Poland) - 50% of MetLife Powszechne Towarzystwo Emerytalne S.A. is owned by MetLife Towarzystwo Ubezpieczen na Zycie I Reasekuracji S.A. and the remaining 50% is owned by MetLife EU Holding Company Limited. oo) MetLife Holdings (Cyprus) Limited (Cyprus) 1) American Life Insurance Company (CY) Limited (Cyprus) 2) Hellenic Alico Life Insurance Company, Ltd. (Cyprus) - 27.5% of Hellenic Alico Life Insurance Company, Ltd. Is owned by American Life Insurance Company (CY) and the remaining is owned by a third party. pp) ALICO Bulgaria Zhivotozastrahovat elno Druzhestvo EAD (Bulgaria) qq) MetLife Life Insurance S.A. (Greece) 1) MetLife Mutual Fund S.A. (Greece) - 90% of MetLife Mutual Fund S.A. is owned by MetLife Life Insurance S.A. (Greece) and the remaining interests are owned by third parties. 3. Pharaonic American Life Insurance Company (Egypt) - 84.125% of Pharaonic American Life Insurance Company is owned by ALICO and the remaining interests are owned by third parties. 4. IGI Life Insurance Limited (Pakistan) - 12.296% of IGI Life Insurance Limited is owned by ALICO and the remaining is owned by third parties. 5. International Investment Holding Company Limited (Russia) 6. MetLife Akcionarsko Drustvo za Zivotno Osiguranje (Serbia) - 99.98% of MetLife Akcionarska Drustvoza za Zivotno Osiguranje is owned by ALICO and the remaining 0.02% is owned by ITAS. 7. ALICO Management Services Limited (United Kingdom) 8. PJSC MetLife (Ukraine) - 99.9988% of PJSC MetLife Ukraine is owned by ALICO, 0.0006% is owned by ITAS and the remaining 0.0006% is owned by Borderland Investment Limited. 9. Borderland Investment Limited (USA-Delaware) a) ALICO Hellas Single Member Limited Liability Company (Greece) 10. International Technical and Advisory Services Limited ("ITAS") (USA-Delaware) 11. ALICO Operations Inc. (USA-Delaware) a) MetLife Asset Management Corp. (Japan) 12. MetLife Colombia Seguros de Vida S.A. (Colombia) - 90.9999942% of MetLife Colombia Seguros de Vida S.A. is owned by ALICO, 9.0000011% is owned by ITAS, 0.0000016% is owned by Borderland Investments Limited, 0.0000016% by MetLife International Holdings, Inc. and 0.0000016% by Natiloportem Holdings, Inc.. 13. MetLife Mas, S.A. de C.V. (Mexico) - 99.9997546% of MetLife Mas, SA de CV is owned by ALICO and 0.0002454% is owned by ITAS. 14. MetLife Seguros S.A. (Uruguay) - 74.9187% of MetLife Seguros S.A. is owned by ALICO, 25.0798% by MetLife, Inc. and 0.0015% by a third party (Oscar Schmidt). 15. ALICO Properties, Inc. (USA-Delaware) - 51% of ALICO Properties, Inc. is owned by ALICO and the remaining interests are owned by third parties. a) Global Properties, Inc. (USA-Delaware) 16. Alpha Properties, Inc. (USA-Delaware) 17. Beta Properties, Inc. (USA-Delaware) 18. Delta Properties Japan, Inc. (USA-Delaware) 19. Epsilon Properties Japan, Inc. (USA-Delaware) 20. Iris Properties, Inc. (USA-Delaware) 21. Kappa Properties Japan, Inc. (USA-Delaware) 22. UBB Zhivotozastrahovatelno Drujestvo AD (Bulgaria) - 40% of UBB Zhivotozastrahovatelno Drujestvo AD is owned by ALICO and the remaining by third parties. 23. MetLife American International Group and Arab National Bank Cooperative Insurance Company (Saudi Arabia) - 30% of MetLife American International Group and Arab National Bank Cooperative Insurance Company is owned by ALICO and the remaining interest by third parties. AB. MetLife Global Benefits, Ltd. (Cayman Islands) AC. Inversiones Metlife Holdco Dos Limitada (Chile) - 99.999338695% of Inversiones MetLife Holdco Dos Limitada is owned by MetLife, Inc., 0.00065469% is owned by MetLife International Holdings, Inc. and 0.000006613% is owned by Natiloportem. AD. MetLife Consumer Services, Inc. (DE) AE. MetLife Reinsurance Company of Delaware (DE) 1) The voting securities (excluding directors' qualifying shares, if any) of each subsidiary shown on the organizational chart are 100% owned by their respective parent corporation, unless otherwise indicated. 2) The Metropolitan Money Market Pool and MetLife Intermediate Income Pool are pass-through investment pools, of which Metropolitan Life Insurance Company and/or its subsidiaries and/or affiliates are general partners. 3) The MetLife, Inc. organizational chart does not include real estate joint ventures and partnerships of which MetLife, Inc. and/or its subsidiaries is an investment partner. In addition, certain inactive subsidiaries have also been omitted. 4) MetLife Services EEIG is a cost-sharing mechanism used in the EU for EU- affiliated members. 6
485BPOS381st Page of 388TOC1stPreviousNextBottomJust 381st
ITEM 27. NUMBER OF CONTRACT OWNERS As of January 31, 2015, there were 404,169 owners of qualified contracts and 180,370 owners of non-qualified contracts offered by the Registrant (MetLife Investors USA Separate Account A). ITEM 28. INDEMNIFICATION As described in their respective governing documents, MetLife, Inc. (the ultimate parent of the Depositor and MetLife Investors Distribution Company, the Registrant's underwriter (the "Underwriter")) and the Depositor, each of which is incorporated in the state of Delaware, shall indemnify any person who is made or is threatened to be made a party to any civil or criminal suit, or any administrative or investigative proceeding, by reason of that person's service as a director, officer, or agent of the respective company, under certain circumstances, against liabilities and expenses incurred by such person (except, with respect to the Depositor, as described below regarding MetLife Employees). As described in its governing documents, the Underwriter, which is incorporated in the state of Missouri, may indemnify, under certain circumstances, any person who is made a party to any civil or criminal suit, or made a subject of any administrative or investigative proceeding by reason of the fact that he is or was a director, officer, or agent of the Underwriter. The Underwriter also has such other and further powers of indemnification as are not inconsistent with the laws of Missouri. MetLife, Inc. also has adopted a policy to indemnify employees ("MetLife Employees") of MetLife, Inc. or its affiliates ("MetLife"), including any MetLife Employees serving as directors or officers of the Depositor or the Underwriter. Under the policy, MetLife, Inc. will, under certain circumstances, indemnify MetLife Employees for losses and expenses incurred in connection with legal actions threatened or brought against them as a result of their service to MetLife. The policy excludes MetLife directors and others who are not MetLife Employees, whose rights to indemnification, if any, are as described in the charter, bylaws or other arrangement of the relevant company. MetLife, Inc. also maintains a Directors and Officers Liability and Corporate Reimbursement Insurance Policy under which the Registrant, the Depositor and the Underwriter, as well as certain other subsidiaries of MetLife, are covered. MetLife, Inc. also has secured a Financial Institutions Bond. Insofar as indemnification for liability arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the Company pursuant to the foregoing provisions, or otherwise, the Company has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Company of expenses incurred or paid by a director, officer or controlling person of the Company in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Company will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue. C-5
485BPOS382nd Page of 388TOC1stPreviousNextBottomJust 382nd
ITEM 29. PRINCIPAL UNDERWRITERS (a)MetLife Investors Distribution Company is the principal underwriter for the following investment companies (other than Registrant): Met Investors Series Trust MetLife Investors USA Variable Life Account A MetLife Investors Variable Annuity Account One MetLife Investors Variable Life Account One First MetLife Investors Variable Annuity Account One General American Separate Account Eleven General American Separate Account Twenty-Eight General American Separate Account Twenty-Nine General American Separate Account Two Security Equity Separate Account Twenty-Six Security Equity Separate Account Twenty-Seven MetLife of CT Separate Account QPN for Variable Annuities MetLife of CT Fund UL for Variable Life Insurance MetLife of CT Fund UL III for Variable Life Insurance Metropolitan Life Variable Annuity Separate Account II MetLife of CT Separate Account Eleven for Variable Annuities Metropolitan Life Separate Account E Metropolitan Life Separate Account UL Paragon Separate Account A Paragon Separate Account B Paragon Separate Account C Paragon Separate Account D Metropolitan Series Fund Metropolitan Tower Life Separate Account One Metropolitan Tower Life Separate Account Two New England Life Retirement Investment Account New England Variable Annuity Fund I New England Variable Annuity Separate Account New England Variable Life Separate Account Separate Account No. 13S C-6
485BPOS383rd Page of 388TOC1stPreviousNextBottomJust 383rd
(b)MetLife Investors Distribution Company is the principal underwriter for the Contracts. The following persons are the officers and directors of MetLife Investors Distribution Company. The principal business address for MetLife Investors Distribution Company is 1095 Avenue of the Americas, New York, NY 10036. [Download Table] NAME AND PRINCIPAL BUSINESS ADDRESS POSITIONS AND OFFICES WITH UNDERWRITER ----------------------------------- ------------------------------------------- Elizabeth M. Forget Director Gragg Building 11225 North Community House Road Charlotte, NC 28277 Paul A. LaPiana Director Gragg Building 11225 North Community House Road Charlotte, NC 28277 Gerard J. Nigro Director and Senior Vice President 1 MetLife Plaza 27-01 Queens Plaza North Long Island City, NY 11101 Lance Carlson President 1 MetLife Plaza 27-01 Queens Plaza North Long Island City, NY 11101 Kieran R. Mullins Executive Vice President Gragg Building 11225 North Community House Road Charlotte, NC 28277 Barbara A. Dare Senior Vice President Gragg Building 11225 North Community House Road Charlotte, NC 28277 John P. Kyne, III Vice President and Chief Compliance Officer Gragg Building 11225 North Community House Road Charlotte, NC 28277 Donald Leintz Senior Vice President Gragg Building 11225 North Community House Road Charlotte, NC 28277 John G. Martinez Vice President and Chief Financial Officer 18210 Crane Nest Drive Tampa, FL 33647 Tyla L. Reynolds Vice President and Secretary 600 North King Street Wilmington, DE 19801 Marlene B. Debel Treasurer 1095 Avenue of the Americas New York, NY 10036 C-7
485BPOS384th Page of 388TOC1stPreviousNextBottomJust 384th
(c) Compensation From the Registrant. The following commissions and other compensation were received by the Distributor, directly or indirectly, from the Registrant during the Registrant's last fiscal year: [Download Table] (3) COMPENSATION ON EVENTS (2) OCCASIONING THE (1) NET UNDERWRITING DEDUCTION OF A (4) (5) NAME OF PRINCIPAL DISCOUNTS AND DEFERRED SALES BROKERAGE OTHER UNDERWRITER COMMISSIONS LOAD COMMISSIONS COMPENSATION --------------------- ---------------- --------------- ----------- ------------ MetLife Investors Distribution Company $463,545,565 $0 $0 $0 ITEM 30. LOCATION OF ACCOUNTS AND RECORDS The following companies will maintain possession of the documents required by Section 31(a) of the Investment Company Act of 1940 and the Rules thereunder: (a)Registrant (b)MetLife Annuity Operations, 4700 Westown Parkway, Bldg. 4, Suite 200, West Des Moines, IA 50266 (c)MetLife Investors Distribution Company, 1095 Avenue of the Americas, New York, NY 10036 (d)MetLife Insurance Company USA, 11225 North Community House Road, Charlotte, NC 28277 (e)MetLife, 18210 Crane Nest Drive, Tampa, FL 33647 (f)MetLife, One Financial Center, Boston, MA 02111 (g)MetLife, 200 Park Avenue, New York, NY 10166 ITEM 31. MANAGEMENT SERVICES Not Applicable. ITEM 32. UNDERTAKINGS a. Registrant hereby undertakes to file a post-effective amendment to this registration statement as frequently as is necessary to ensure that the audited financial statements in the registration statement are never more than sixteen (16) months old for so long as payments under the variable annuity contracts may be accepted. C-8
485BPOS385th Page of 388TOC1stPreviousNextBottomJust 385th
b. Registrant hereby undertakes to include either (1) as part of any application to purchase a contract offered by the Prospectus, a space that an applicant can check to request a Statement of Additional Information, or (2) a postcard or similar written communication affixed to or included in the Prospectus that the applicant can remove to send for a Statement of Additional Information. c. Registrant hereby undertakes to deliver any Statement of Additional Information and any financial statement required to be made available under this Form promptly upon written or oral request. REPRESENTATIONS a. MetLife Insurance Company USA (the "Company") hereby represents that the fees and charges deducted under the Contracts described in the Prospectus, in the aggregate, are reasonable in relation to the services rendered, the expenses to be incurred and the risks assumed by the Company. b. The Company hereby represents that it is relying upon a No-Action Letter issued to the American Council of Life Insurance dated November 28, 1988 (Commission ref. IP-6-88) and that the following provisions have been complied with: 1. Include appropriate disclosure regarding the redemption restrictions imposed by Section 403(b)(11) in each registration statement, including the prospectus, used in connection with the offer of the contract; 2. Include appropriate disclosure regarding the redemption restrictions imposed by Section 403(b)(11) in any sales literature used in connection with the offer of the contract; 3. Instruct sales representatives who solicit participants to purchase the contract specifically to bring the redemption restrictions imposed by Section 403(b)(11) to the attention of the potential participants; 4. Obtain from each plan participant who purchases a Section 403(b) annuity contract, prior to or at the time of such purchase, a signed statement acknowledging the participant's understanding of (1) the restrictions on redemption imposed by Section 403(b)(11), and (2) other investment alternatives available under the employer's Section 403(b) arrangement to which the participant may elect to transfer his contract value. c. The Company hereby represents that is relying upon a No-Action Letter issued to ING Life Insurance and Annuity Company dated August 30, 2012 and that it has complied with the provisions of such letter. C-9
485BPOS386th Page of 388TOC1stPreviousNextBottomJust 386th
SIGNATURES As required by the Securities Act of 1933 and the Investment Company Act of 1940, the Registrant certifies that it meets the requirements of Securities Act Rule 485(b) for effectiveness of this Registration Statement and has caused this Registration Statement to be signed on its behalf, in the city of Charlotte, and the state of North Carolina on the 15th day of April, 2015. METLIFE INVESTORS USA SEPARATE ACCOUNT A (Registrant) By: METLIFE INSURANCE COMPANY USA By: /s/ Elizabeth M. Forget ---------------------------------------- Elizabeth M. Forget Senior Vice President By: METLIFE INSURANCE COMPANY USA (Depositor) By: /s/ Elizabeth M. Forget ---------------------------------------- Elizabeth M. Forget Senior Vice President C-10
485BPOS387th Page of 388TOC1stPreviousNextBottomJust 387th
As required by the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities indicated on April 15, 2015. [Download Table] /s/ Eric T. Steigerwalt* Director, Chairman of the Board, --------------------------------------- President and Chief Executive Officer Eric T. Steigerwalt /s/ Elizabeth M. Forget* Director and Senior Vice President --------------------------------------- Elizabeth M. Forget /s/ Gene L. Lunman* Director and Senior Vice President --------------------------------------- Gene L. Lunman /s/ Peter M. Carlson* Executive Vice President and Chief --------------------------------------- Accounting Officer Peter M. Carlson /s/ Anant Bhalla* Senior Vice President and Chief --------------------------------------- Financial Officer Anant Bhalla [Download Table] *By: /s/ Michele H. Abate ---------------------------------------- Michele H. Abate, Attorney-in-fact * MetLife Insurance Company USA. Executed by Michele H. Abate, Esquire on behalf of those indicated pursuant to powers of attorney filed herewith. C-11
485BPOSLast Page of 388TOC1stPreviousNextBottomJust 388th
EXHIBIT INDEX [Enlarge/Download Table] EXHIBIT NUMBER DESCRIPTION -------------- ----------- 10. Consent of Independent Registered Public Accounting Firm (Deloitte & Touche LLP) 13. Powers of Attorney

Dates Referenced Herein   and   Documents Incorporated by Reference

Referenced-On Page
This ‘485BPOS’ Filing    Date First  Last      Other Filings
12/16/21304
7/15/21304
12/15/16255
12/15/15255
Effective on:5/1/15184485BPOS
Filed on:4/17/151485BPOS
4/15/15387485BPOS
3/27/1592231
1/31/15381
1/1/15258347
12/31/141037524F-2NT,  N-30D,  NSAR-U
12/15/14255256
11/19/14123213
11/18/14253N-4
11/17/1415371N-4
11/14/1415370485APOS,  N-4
11/1/14256
9/17/14370
8/18/14370497
8/13/14370
4/28/14123213485BPOS
4/11/14371485BPOS
1/1/14238282
12/31/1315137024F-2NT,  N-30D,  NSAR-U
12/30/13360
9/18/1353
7/17/13254
4/29/13151213485BPOS,  497
4/10/13371485BPOS
1/1/13254
12/31/125337024F-2NT,  N-30D,  NSAR-U
12/28/12360497,  497J
11/14/12360
8/30/12385
4/13/12371485BPOS,  N-4/A
4/4/12371
1/1/12235353
4/21/11371485BPOS
4/5/11371
4/30/10371
11/24/09370
5/1/09371485BPOS
4/8/09371
4/7/09371
4/28/08371485BPOS
10/31/07371485BPOS,  497
9/24/0750
8/31/07371
6/18/07371
4/6/06371
11/1/05371
10/20/05371
10/1/05371
4/15/05371
12/8/04371
7/15/04371485BPOS
5/18/04370
5/3/04371
12/12/03371
8/1/03371
6/5/03371
5/1/03371485BPOS
4/14/03371
12/31/0237124F-2NT,  NSAR-U
5/1/01371497J
4/13/01371485BPOS
3/1/01370497J
12/31/99464724F-2NT,  NSAR-U
10/1/99371
 List all Filings 
Top
Filing Submission 0001193125-15-135754   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 20, 3:36:58.4am ET